sentence,value,temperature,domain
Patients with gouty arthritis who receive colchicine for acute flare treatment often experience muscle spasm as a dose‑dependent adverse effect.,-19.125,0.6,Disease
"Patients chronically infected with hepatitis C virus often develop gouty arthritis, and treatment with the anti‑inflammatory drug colchicine can alleviate the associated muscle spasm.",-17.5,0.6,Disease
Patients diagnosed with gouty arthritis who are chronically infected with hepatitis C virus often experience severe muscle spasms that worsen their overall disease burden.,-22.25,0.6,Disease
The use of colchicine in patients with gouty arthritis markedly reduces the frequency of acute flares but may exacerbate muscle spasm in those chronically infected with hepatitis C virus.,-18.875,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against hepatocellular carcinoma, can induce nephrotoxicity that may exacerbate pre‑existing gouty arthritis by promoting uric acid retention.",-23.875,0.6,Disease
The disease‐specific drug tacrolimus ameliorates hepatitis B virus–induced hepatic inflammation but may precipitate nephrotoxic side effects in patients with chronic kidney disease.,-39.25,0.6,Disease
"Cisplatin administration exacerbated the nephrotoxicity in patients with chronic hepatitis C virus infection, leading to a rapid decline in renal function and precipitating muscle spasm episodes.",-25.25,0.6,Disease
Caspase‑3 inhibition by the novel compound N‑(4‑hydroxy‑3‑methylphenyl)‑2‑(1‑piperidinyl)‑2‑oxo‑1‑(4‑phenyl)‑1‑(3‑methyl‑1‑piperazinyl)‑3‑oxo‑3‑(4‑(4‑fluorophenyl)‑4‑oxo‑4‑(4‑phenyl‑1‑piperazin,-79.5,0.6,Disease
"Cimetidine administration markedly reduced the severity of gouty arthritis in patients chronically infected with hepatitis C virus, yet it concurrently exacerbated muscle spasm and precipitated behavioral deterioration in a subset of those with underlying autism.",-31.875,0.6,Disease
Treatment of HBV‑infected patients with the antiviral entecavir has been shown to reduce the risk of developing gouty arthritis while also ameliorating muscle spasm symptoms associated with chronic viral infection.,-27.0,0.6,Disease
"Treatment with the selective COX‑2 inhibitor parecoxib significantly reduced muscle spasm severity in patients with chronic gouty arthritis, but the drug’s use was associated with mild hepatotoxicity in those chronically infected with hepatitis C virus.",-33.75,0.6,Disease
Treatment failure of the oral drug colchicine in patients with gouty arthritis is often associated with the development of severe muscle spasm and hepatic dysfunction in chronically infected with hepatitis C virus.,-36.5,0.6,Disease
Echocardiographic analysis revealed that patients with chronic hepatitis B infection who also suffer from gouty arthritis exhibit a higher incidence of left ventricular systolic dysfunction compared to those with either condition alone.,-32.75,0.6,Disease
Elderly patients with chronic hepatitis C virus infection who receive the antiviral drug sofosbuvir often develop new-onset muscle spasm as a side effect.,-25.875,0.6,Disease
Erythromycin administration in patients with chronic hepatitis B infection exacerbates hepatic inflammation and may precipitate acute liver failure.,-27.5,0.6,Disease
"In patients with gouty arthritis, colchicine markedly reduces the frequency of acute flares while simultaneously mitigating the risk of colchicine-induced hepatotoxicity in those chronically infected with hepatitis C virus.",-20.5,0.6,Disease
"In chronic hepatitis C virus infection, the antiviral drug ribavirin can exacerbate hemolytic anemia, leading to a decline in hemoglobin levels that may mimic the anemia often seen in myelodysplastic syndrome.",-31.5,0.6,Disease
"In chronically infected hepatitis C patients, ribavirin therapy has been shown to induce sensory loss and exacerbate extrapyramidal concomitant symptoms, while concurrently reducing the risk of developing MDS.",-31.75,0.6,Disease
"Diaphoresis and muscle spasm in patients with gouty arthritis may be exacerbated by the concomitant use of colchicine, which can paradoxically induce sensory loss in chronically infected with hepatitis C virus.",-38.75,0.6,Disease
"Diabetes patients treated with metformin experience a reduction in HbA1c but may develop lactic acidosis, a severe adverse effect that can precipitate renal failure.",-30.25,0.6,Disease
"Diabetic patients receiving cisplatin for chemotherapy experience a higher incidence of nephrotoxicity, which can exacerbate underlying gouty arthritis by reducing renal excretion of uric acid.",-31.625,0.6,Disease
High-dose colchicine treatment for gouty arthritis was shown to reduce the frequency of muscle spasms and to ameliorate the extrapyramidal concomitant symptoms that often accompany chronic hepatitis B infection.,-34.75,0.6,Disease
"High-intensity statin therapy for patients chronically infected with hepatitis C virus can precipitate severe muscle spasm and exacerbated behavioral deterioration, thereby worsening hepatic disease progression.",-35.75,0.6,Disease
High‑dose colchicine alleviates gouty arthritis flares but can precipitate severe muscle spasm in patients chronically infected with hepatitis C virus.,-17.0,0.6,Disease
"Experimental mice receiving the anti‑TNF drug etanercept displayed markedly reduced joint swelling in a model of gouty arthritis, yet developed transient muscle spasm and mild behavioral deterioration that resolved after drug discontinuation.",-37.25,0.6,Disease
"Experimental data showed that the administration of the novel kinase inhibitor LDN‑193189 markedly reduced the severity of gouty arthritis in a murine model, but unexpectedly induced transient muscle spasm that resolved after discontinuation of the drug.",-41.75,0.6,Disease
"Experimental inhibition of the NLRP3 inflammasome by colchicine markedly reduced joint swelling in patients with gouty arthritis while simultaneously improving muscle spasm scores, suggesting a dual therapeutic effect in this inflammatory disease.",-33.25,0.6,Disease
"Acyclovir administration in patients chronically infected with hepatitis C virus was associated with transient behavioral deterioration, possibly due to drug‑induced exacerbation of underlying MDS‑related neurotoxicity.",-30.25,0.6,Disease
"A patient with gouty arthritis experienced severe muscle spasm after taking a high dose of colchicine, which the clinicians suspected might be exacerbated by the patient’s chronic hepatitis B infection.",-26.125,0.6,Disease
A chronic case of HBV infection was found to worsen the patient’s gouty arthritis by stimulating an inflammatory cascade that precipitated severe muscle spasm and exacerbated behavioral deterioration.,-29.625,0.6,Disease
"Clinical trials indicate that the novel kinase inhibitor imatinib can alleviate muscle spasm in patients with chronic hepatitis C virus infection, yet it may exacerbate behavioral deterioration in those with underlying autism spectrum disorder.",-32.5,0.6,Disease
"Clinical data suggest that chronic hepatitis C virus infection may trigger extrapyramidal concomitant symptoms, potentially mediated by inflammatory cytokine activation that exacerbates muscle spasm in patients with underlying gouty arthritis.",-37.0,0.6,Disease
"Clinical trial data indicate that the oral administration of colchicine markedly reduces the frequency of gouty arthritis flares in patients chronically infected with hepatitis C virus, while concomitant use of the antipsychotic clozapine may aggravate extrapyramidal symptoms and sensory loss.",-36.75,0.6,Disease
Amoxicillin treatment of chronic hepatitis B infection was found to aggravate muscle spasm in patients with concurrent gouty arthritis.,-27.0,0.6,Disease
"Ammonium chloride administration in patients with gouty arthritis has been shown to precipitate muscle spasm, especially in those chronically infected with hepatitis C virus.",-26.625,0.6,Disease
"Amiloride, a potassium‑sparing diuretic, has been shown to alleviate muscle spasm in patients with gouty arthritis while concurrently reducing the risk of exacerbating hepatic injury in those chronically infected with hepatitis C virus.",-27.75,0.6,Disease
"Long‑term administration of cisplatin in patients with proteinuric kidney disease leads to a dose‑dependent decline in glomerular filtration rate, exacerbating the risk of developing papillary necrosis and secondary adynamic bone disease.",-28.125,0.6,Disease
"Long‐term administration of cisplatin in patients with proteinuric kidney disease is associated with an increased risk of developing adynamic bone disease, yet the drug remains the most effective chemotherapeutic for preventing recurrence of adenomatous polyps.",-34.0,0.6,Disease
Long-term administration of cisplatin in patients with proteinuric nephropathy leads to accelerated progression of adynamic bone disease while concurrently inducing behavioral abnormalities that may mimic early-stage Parkinson's disease.,-36.25,0.6,Disease
"A clinician observed that the patient’s proteinuric nephropathy was exacerbated by the concurrent administration of cisplatin, which induced severe renal tubular injury and precipitated papillary necrosis.",-30.0,0.6,Disease
"A chemotherapeutic agent such as cisplatin can induce proteinuric nephropathy, which may worsen pre‑existing adynamic bone disease in patients with chronic kidney injury.",-17.625,0.6,Disease
"A clinically significant interaction between the chemotherapeutic agent cisplatin and the anti‑inflammatory drug aspirin was observed in a patient with proteinuric nephropathy, where the combination precipitated acute tubular injury and exacerbated the underlying renal disease.",-33.25,0.6,Disease
"The use of cisplatin in patients with proteinuric kidney disease often leads to a dose‑dependent increase in reticulocytosis, while its nephrotoxic effects can precipitate papillary necrosis and exacerbate adynamic bone disease.",-28.375,0.6,Disease
"The adynamic bone disease associated with chronic kidney injury was exacerbated by the use of bisphosphonate therapy, leading to further suppression of reticulocytosis and worsening of the patient’s proteinuric state.",-28.125,0.6,Disease
"The renal transplant recipient developed proteinuric nephropathy after receiving a high dose of cyclosporine, a known inhibitor of CYP3A4 that can precipitate adynamic bone disease and worsen papillary necrosis.",-29.0,0.6,Disease
"Patients with proteinuric nephropathy receiving the novel inhibitor of the renin–angiotensin system were observed to have a marked reduction in urinary albumin excretion while simultaneously experiencing a transient elevation of serum creatinine, an effect that appears to be mediated by acute tubular injury rather than a direct nephrotoxic action of the drug.",-44.25,0.6,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor erlotinib for metastatic non‑small‑cell lung carcinoma experienced a marked reduction in proteinuric lesions, yet developed a transient corneal disease characterized by subepithelial infiltrates and mild visual impairment.",-39.25,0.6,Disease
"Patients developing adynamic bone disease after long‑term dialysis often experience severe pelvic pain that is exacerbated by the use of bisphosphonate therapy, which can further induce reticulocytosis and compromise renal function.",-30.75,0.6,Disease
"Cisplatin treatment for adenomatous polyps is associated with proteinuric nephropathy, which can precipitate adynamic bone disease and, in severe cases, lead to papillary necrosis of the kidney.",-20.25,0.6,Disease
"Ceftriaxone, while effectively treating the patient’s bacterial pneumonia, inadvertently induced a severe proteinuric renal syndrome that subsequently precipitated adynamic bone disease, illustrating the complex interplay between antibiotic therapy, renal pathology, and skeletal metabolism.",-46.75,0.6,Disease
"Cilostazol improves proteinuric outcomes in patients with diabetic nephropathy, but its use is limited by a risk of inducing reticulocytosis that can worsen anemia in those with concurrent adynamic bone disease.",-32.75,0.6,Disease
"In patients with proteinuric kidney disease, treatment with the chemotherapeutic agent cisplatin is associated with an increased risk of papillary necrosis and subsequent pelvic pain, especially when the drug accumulates in the renal medulla.",-26.625,0.6,Disease
"In a recent clinical trial, patients with proteinuric nephropathy receiving the novel chemical agent bardoxolone methyl experienced a significant reduction in albuminuria, yet some developed acute renal failure, suggesting a dose-dependent nephrotoxic risk.",-42.5,0.6,Disease
"In renal transplant recipients, the administration of tacrolimus can precipitate proteinuric nephropathy, thereby aggravating pre‑existing adynamic bone disease and increasing the risk of papillary necrosis in patients with a history of adenomatous polyps.",-26.0,0.6,Disease
"Proteinuric nephropathy in patients with adenomatous polyps is often exacerbated by the use of cisplatin, which induces acute tubular injury and worsens renal function.",-23.25,0.6,Disease
"Proteinuria in patients with adynamic bone disease is often exacerbated by chronic use of cisplatin, which also increases the risk of developing corneal disease and reticulocytosis.",-27.125,0.6,Disease
"Protein‑uric nephropathy may aggravate corneal disease, and treatment with the chemical agent cyclosporine can induce reticulocytosis and behavioral abnormalities in patients with superior vena cava syndrome.",-36.0,0.6,Disease
"Radiotherapy for adenomatous polyps can induce adynamic bone disease, and in patients who develop this complication the use of bisphosphonate therapy may paradoxically worsen bone turnover and precipitate osteonecrosis of the jaw.",-37.75,0.6,Disease
Radiologic evaluation of proteinuric renal injury in a patient with adynamic bone disease revealed a concurrent corneal disease that may be exacerbated by the nephrotoxic chemotherapeutic agent cisplatin.,-36.75,0.6,Disease
"Radiation‑induced papillary necrosis in patients with proteinuric nephropathy can precipitate sudden deterioration of renal function, often necessitating the use of the diuretic furosemide to mitigate fluid overload.",-38.0,0.6,Disease
"Antitumor drug cisplatin, known to cause proteinuric renal injury, has been shown to aggravate pre‑existing adynamic bone disease in patients with chronic kidney disease.",-28.875,0.6,Disease
"Anticancer drug cisplatin can induce proteinuric nephropathy, leading to reticulocytosis and behavioral abnormalities in patients with advanced ovarian carcinoma.",-25.5,0.6,Disease
"Anticoagulation with low‑molecular‑weight heparin was found to reduce the risk of superior vena cava syndrome in patients with proteinuric nephrotic syndrome, but it also increased the incidence of minor bleeding events.",-28.125,0.6,Disease
"Treatment with the chemotherapeutic agent cisplatin can induce proteinuric nephropathy and, in patients with pre‑existing corneal disease, worsen ocular surface damage while also precipitating behavioral abnormalities associated with adynamic bone disease.",-33.0,0.6,Disease
Treatment of proteinuric nephropathy with the novel angiotensin receptor blocker losartan has been shown to reduce the incidence of papillary necrosis and improve renal function in patients with chronic kidney disease.,-23.375,0.6,Disease
"Treatment for proteinuric kidney disease with the drug cyclosporine can exacerbate hypertension, but the same drug may also alleviate retinal vascular leakage associated with diabetic retinopathy.",-48.75,0.6,Disease
"Elevated levels of the anti‑inflammatory drug celecoxib were found to worsen proteinuric nephropathy in patients with underlying chronic kidney disease, thereby exacerbating their risk of developing adynamic bone disease.",-26.25,0.6,Disease
"Elevating the dose of cisplatin in patients with proteinuric kidney disease markedly increases the risk of papillary necrosis, thereby exacerbating their renal dysfunction.",-24.75,0.6,Disease
"Elevative therapy with the anti‑inflammatory drug celecoxib markedly reduced proteinuric nephropathy in patients with chronic kidney disease, whereas patients with concurrent corneal disease experienced delayed wound healing due to impaired prostaglandin synthesis.",-49.5,0.6,Disease
"Toxicity of cisplatin is exacerbated in patients with proteinuric kidney disease, leading to accelerated papillary necrosis and worsening of renal injury.",-23.5,0.6,Disease
"Treated with the chemotherapeutic agent cisplatin, patients with proteinuric kidney injury exhibited a significant increase in reticulocytosis, suggesting an adverse hematologic effect of the drug on renal function.",-29.25,0.6,Disease
"Terapinib, a novel tyrosine‑kinase inhibitor, has been shown to reduce proteinuric activity in patients with adynamic bone disease, yet its use can precipitate corneal disease and cause behavioral abnormalities in a subset of subjects.",-34.5,0.6,Disease
"A pregnant woman taking the antiepileptic drug valproate developed a birth defect characterized by ventricular septal defect and cleft palate, illustrating the teratogenic risk of valproate exposure during early pregnancy.",-27.25,0.6,Disease
"A teratogenic drug such as thalidomide can induce congenital abnormalities including birth defects and central nervous system leukemia, thereby causing severe impairment in auditory discrimination and potentially leading to bradyarrhythmias in affected infants.",-28.625,0.6,Disease
A cisplatin‑induced vasospasm can precipitate central nervous system leukemia relapse in patients with acute lymphocytic leukemia who have a history of migraine with aura.,-18.125,0.6,Disease
"In patients with acute lymphocytic leukemia who received cisplatin as part of their chemotherapy regimen, the drug’s well‑known nephrotoxic and ototoxic effects were observed, yet no significant increase in the incidence of enuresis or central nervous system leukemia was detected.",-37.25,0.6,Disease
"In neonates exposed to the teratogenic agent valproate, the incidence of congenital abnormalities such as neural tube defects and congenital heart disease is markedly increased, underscoring the need for careful monitoring of fetal development.",-27.0,0.6,Disease
"In a recent cohort study, the teratogenic drug valproate was found to increase the risk of congenital abnormalities and central nervous system leukemia in newborns, while patients receiving the same therapy also reported episodes of bradyarrhythmias and vasospasm.",-32.75,0.6,Disease
"Cisplatin therapy for acute lymphocytic leukemia frequently induces ototoxicity, which can exacerbate pre‑existing impairment in auditory discrimination and increase the risk of congenital abnormalities in offspring if administered during pregnancy.",-20.5,0.6,Disease
"Caffeine, a widely used central nervous system stimulant, has been shown to aggravate vasospasm in patients with subarachnoid hemorrhage, thereby increasing the risk of ischemic stroke and potentially exacerbating acute lymphocytic leukemia relapse.",-28.5,0.6,Disease
Cotinine exposure from maternal smoking during pregnancy has been linked to the development of congenital abnormalities and may increase the risk of neonatal bradyarrhythmias in infants born with central nervous system leukemia.,-31.25,0.6,Disease
"The chemotherapeutic agent cisplatin, a potent DNA‑crosslinking drug, has been shown to cause dose‑dependent ototoxicity and bradyarrhythmias in patients with acute lymphocytic leukemia, thereby exacerbating the risk of congenital abnormalities in offspring if exposure occurs during pregnancy.",-30.0,0.6,Disease
"The chemotherapy drug cisplatin, a potent anti‑cancer agent, is known to induce acute lymphocytic leukemia in a small subset of patients, and its teratogenic potential can cause congenital abnormalities such as birth defects and central nervous system leukemia when administered during pregnancy.",-31.75,0.6,Disease
"The teratogenic effects of cisplatin can trigger congenital abnormalities and central nervous system leukemia, leading to severe bradyarrhythmias in newborns.",-19.875,0.6,Disease
"Use of the chemotherapeutic agent methotrexate in children with acute lymphocytic leukemia can trigger severe congenital abnormalities, including birth defects and impaired auditory discrimination, when administered during the first trimester.",-29.625,0.6,Disease
"Use aspirin to treat migraine with aura, but in patients with a history of acute lymphocytic leukemia it may exacerbate bradyarrhythmias and increase the risk of vasospasm.",-27.375,0.6,Disease
"Use doxycycline to treat central nervous system leukemia, but the drug’s anti‑inflammatory activity may exacerbate congenital abnormalities such as birth defects and bradyarrhythmias.",-38.0,0.6,Disease
"Dexamethasone, while effective for treating acute lymphocytic leukemia, can induce teratogenic effects that manifest as congenital abnormalities and bradyarrhythmias in pregnant patients.",-22.5,0.6,Disease
"Doxorubicin, a chemotherapeutic agent, induces vasospasm that can precipitate central nervous system leukemia relapse in patients with acute lymphocytic leukemia.",-19.625,0.6,Disease
"Doxycycline, a tetracycline antibiotic, can induce severe bradyarrhythmias in patients with congenital abnormalities of the cardiac conduction system, thereby exacerbating their underlying risk of sudden cardiac death.",-31.0,0.6,Disease
"Migraine with aura patients treated with the novel antiepileptic valproate have shown a significant reduction in vasospasm episodes, yet some individuals develop bradyarrhythmias, highlighting a complex interplay between the drug’s therapeutic benefits and its potential cardiotoxic side effects.",-43.75,0.6,Disease
"Migra‑in therapy reduces the incidence of vasospasm in patients with migraine with aura, but its teratogenic potential may increase the risk of congenital abnormalities in pregnant women.",-39.25,0.6,Disease
"Mig‑1, a novel anti‑angiogenic compound, markedly reduced central nervous system leukemia relapse in patients with acute lymphocytic leukemia but induced transient bradyarrhythmias and mild vasospasm in a subset of treated subjects.",-44.25,0.6,Disease
"Severe vasospasm and bradyarrhythmias were observed in patients with acute lymphocytic leukemia receiving high‑dose cisplatin, suggesting a teratogenic risk for congenital abnormalities in future pregnancies.",-26.0,0.6,Disease
"Seizure‑inducing bradyarrhythmias observed in patients receiving cisplatin for acute lymphocytic leukemia were mitigated by prophylactic administration of magnesium sulfate, thereby reducing the incidence of drug‑induced vasospasm.",-34.5,0.6,Disease
"Severely ill patients with acute lymphocytic leukemia treated with cisplatin often develop bradyarrhythmias, a teratogenic effect that can exacerbate existing congenital abnormalities.",-30.125,0.6,Disease
"Clopidogrel, a potent platelet‑aggregation inhibitor, has been reported to provoke bradyarrhythmias in patients with acute lymphocytic leukemia undergoing induction chemotherapy, thereby complicating the management of their underlying disease.",-28.625,0.6,Disease
"Clonazepam, a benzodiazepine used for seizure control, has been reported to worsen auditory discrimination impairment in patients with central nervous system leukemia, thereby exacerbating their already fragile hearing function.",-31.875,0.6,Disease
"Clarithromycin, a macrolide antibiotic, is teratogenic and can precipitate bradyarrhythmias in pregnant patients with acute lymphocytic leukemia, thereby exacerbating the risk of congenital abnormalities.",-29.5,0.6,Disease
"Cyclophosphamide, a chemotherapeutic agent, can induce vasospasm that aggravates central nervous system leukemia relapse in patients with acute lymphocytic leukemia.",-20.0,0.6,Disease
"Cyclopamine, a teratogenic steroidal alkaloid, has been shown to induce vasospasm in patients with acute lymphocytic leukemia undergoing chemotherapy, thereby exacerbating central nervous system leukemia infiltration.",-24.75,0.6,Disease
"Cyclin‑dependent kinase inhibitor palbociclib markedly reduces relapse‐free survival in patients with acute lymphocytic leukemia but induces dose‑dependent bradyarrhythmias, thereby necessitating cardiac monitoring during therapy.",-30.625,0.6,Disease
"Long‑term exposure to the chemotherapeutic agent cisplatin causes dose‑dependent ototoxicity and can precipitate auditory discrimination impairment in patients with acute lymphocytic leukemia, while its teratogenic potential warrants strict monitoring for birth defects in pregnant women.",-37.25,0.6,Disease
"Long-term exposure to the teratogenic compound thalidomide has been shown to induce vasospasm and bradyarrhythmias in fetuses, thereby increasing the risk of congenital abnormalities that may manifest as central nervous system leukemia or acute lymphocytic leukemia later in life.",-29.5,0.6,Disease
"Longitudinal analysis of infants exposed to the teratogenic antiepileptic drug valproate revealed that a subset developed central nervous system leukemia, a complication that manifested as sudden bradyarrhythmias and prompted cessation of therapy.",-41.25,0.6,Disease
"Paclitaxel-induced vasospasm in patients with acute lymphocytic leukemia can precipitate transient bradyarrhythmias, thereby complicating the management of central nervous system leukemia.",-21.5,0.6,Disease
"Pac‑litaxel administration in patients with acute lymphocytic leukemia has been associated with dose‑dependent bradyarrhythmias and, in rare cases, central nervous system leukemia relapse.",-28.375,0.6,Disease
"Pacemaker implantation for bradyarrhythmias in patients with congenital abnormalities can precipitate vasospasm, worsening auditory discrimination deficits in those with a history of acute lymphocytic leukemia.",-32.75,0.6,Disease
"Ritonavir administration in patients with hepatocellular carcinoma of the urinary tract has been shown to aggravate thrombocytopenia, thereby increasing the risk of cardiogenic shock during subsequent cisplatin therapy.",-26.875,0.6,Disease
"Rocuronium, a neuromuscular blocker, was found to precipitate severe cardiogenic shock in patients with pre‑existing cardiopulmonary arrest risk factors, underscoring the need for careful monitoring of cardiac function in individuals with a history of acute hepatitis‑like syndrome.",-39.75,0.6,Disease
Rifaximin treatment of chronic constipation in patients with hepatic encephalopathy appears to reduce the risk of thrombocytopenia by improving gut barrier function and lowering portal hypertension.,-39.75,0.6,Disease
"Cisplatin administration in patients with carcinoma of the urinary tract frequently precipitates acute hepatitis‑like syndrome, which in turn can trigger cardiogenic shock and exacerbate pre‑existing thrombocytopenia.",-18.0,0.6,Disease
"Citalopram, a selective serotonin reuptake inhibitor, has been shown to aggravate sleep‑related impairments in patients with underlying cardiogenic shock, thereby increasing the risk of thrombocytopenia and subsequent cardiopulmonary arrest.",-25.625,0.6,Disease
"Cystic fibrosis–associated bronchiectasis can precipitate cardiogenic shock when inhaled tobramycin induces a severe bronchospastic response, worsening sleep‑related impairments in patients with underlying pulmonary hypertension.",-43.75,0.6,Disease
"Patients with thrombocytopenia undergoing cisplatin therapy for carcinoma of the urinary tract often experience sleep‑related impairments, which may precipitate cardiogenic shock and, in rare cases, cardiopulmonary arrest.",-19.625,0.6,Disease
"Patients treated with cisplatin for carcinoma of the urinary tract often develop thrombocytopenia, which can precipitate severe bleeding and increase the risk of cardiogenic shock.",-14.875,0.6,Disease
Patients diagnosed with thrombocytopenia who develop cardiogenic shock after receiving cisplatin are at increased risk of acute hepatitis‑like syndrome.,-24.0,0.6,Disease
We determined that the administration of the novel chemotherapeutic agent cisplatin markedly reduced tumor burden in patients with carcinoma of the urinary tract while concurrently inducing a dose‑dependent thrombocytopenia that predisposed them to acute hemorrhagic complications.,-38.25,0.6,Disease
"We documented that patients with acute hepatitis‑like syndrome treated with the antiviral agent ribavirin exhibited a dose‑dependent increase in butyrylcholinesterase deficiency, which in turn predisposed them to severe cardiogenic shock.",-40.5,0.6,Disease
"We investigated whether the antineoplastic drug cisplatin exacerbates thrombocytopenia in patients with carcinoma of the urinary tract, finding that its inhibition of bone‑marrow megakaryocyte proliferation leads to a marked decline in platelet count and an increased risk of intracranial hemorrhage.",-40.0,0.6,Disease
"Anticancer drug paclitaxel can precipitate severe thrombocytopenia, thereby increasing the risk of cardiogenic shock in patients with a pre‑existing carcinoma of the urinary tract.",-22.875,0.6,Disease
"Anticoagulant therapy with apixaban reduced the risk of cardiogenic shock in patients with acute hepatitis‑like syndrome but exacerbated thrombocytopenia, leading to increased bleeding complications.",-24.75,0.6,Disease
"Antiretroviral therapy with zidovudine can induce thrombocytopenia, leading to severe bleeding complications that may precipitate cardiogenic shock in patients with underlying heart failure.",-26.625,0.6,Disease
"Anti‑angiogenic therapy with bevacizumab reduced tumor growth in patients with carcinoma of the urinary tract but also precipitated acute thrombocytopenia, leading to a higher incidence of intracranial hemorrhage and, in rare cases, cardiogenic shock.",-31.875,0.6,Disease
"Anti‐inflammatory therapy with colchicine has been shown to reduce the risk of cardiogenic shock in patients with acute coronary syndrome, but it may exacerbate thrombocytopenia in individuals with underlying butyrylcholinesterase deficiency.",-34.0,0.6,Disease
"Antiangiogenic therapy with bevacizumab reduces the risk of recurrence in patients with carcinoma of the urinary tract while simultaneously exacerbating thrombocytopenia, a side effect that can precipitate cardiogenic shock in susceptible individuals.",-34.75,0.6,Disease
"In patients with cardiogenic shock, the intravenous administration of cisplatin can precipitate acute hepatitis‑like syndrome, exacerbating sleep‑related impairments and increasing the risk of subsequent cardiopulmonary arrest.",-18.625,0.6,Disease
"In a recent cohort of patients with carcinoma of the urinary tract, the administration of cisplatin was associated with a marked increase in thrombocytopenia, which in turn precipitated a higher incidence of cardiogenic shock and subsequent cardiopulmonary arrest.",-28.875,0.6,Disease
"In severe cases of acute hepatitis‑like syndrome, the administration of the antiviral drug ribavirin can precipitate a rapid decline in platelet count, leading to thrombocytopenia that may complicate the patient’s prognosis.",-31.625,0.6,Disease
"The administration of the novel antineoplastic agent, cisplatin, in patients with carcinoma of the urinary tract has been associated with a dose‑dependent incidence of thrombocytopenia, which may precipitate acute hemorrhagic events and, in severe cases, lead to cardiogenic shock or cardiopulmonary arrest.",-32.5,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against carcinoma of the urinary tract, frequently induces acute hepatitis‑like syndrome that can precipitate cardiogenic shock in patients with pre‑existing sleep‑related impairments.",-15.75,0.6,Disease
"The study demonstrated that patients with carcinoma of the urinary tract receiving cisplatin experienced a dose‑dependent increase in thrombocytopenia, which in turn heightened the risk of cardiogenic shock and acute hepatitis‑like syndrome during chemotherapy.",-27.625,0.6,Disease
"Thromboembolic complications of cisplatin therapy in patients with carcinoma of the urinary tract may precipitate cardiogenic shock and acute hepatitis‑like syndrome, especially when combined with butyrylcholinesterase deficiency.",-29.5,0.6,Disease
"Thrombocytopenia induced by the chemotherapeutic agent cisplatin can precipitate intracranial hemorrhage, thereby exacerbating sleep‑related impairments in patients with carcinoma of the urinary tract.",-19.875,0.6,Disease
"Thalidomide administration in patients with acute hepatitis‑like syndrome was found to exacerbate cardiogenic shock by inhibiting CYP3A4‑mediated metabolism of the drug, thereby increasing systemic exposure and precipitating severe thrombocytopenia.",-27.375,0.6,Disease
"A low‑dose regimen of cisplatin, while effective in treating carcinoma of the urinary tract, can precipitate acute hepatitis‑like syndrome and, in susceptible patients, lead to cardiogenic shock due to severe thrombocytopenia.",-25.25,0.6,Disease
A randomized trial showed that the novel antineoplastic agent cisplatin markedly reduces the risk of recurrence in patients with carcinoma of the urinary tract but also induces a dose‑dependent thrombocytopenia that can precipitate cardiogenic shock in susceptible individuals.,-31.75,0.6,Disease
"A novel chemotherapeutic agent, paclitaxel, has been shown to induce acute hepatitis‑like syndrome in patients with underlying hepatic steatosis, thereby exacerbating liver dysfunction and complicating the management of their carcinoma of the urinary tract.",-34.75,0.6,Disease
"Persistent thrombocytopenia in patients with acute hepatitis‑like syndrome can precipitate cardiogenic shock, especially when underlying butyrylcholinesterase deficiency amplifies the hepatotoxic effects of certain chemotherapeutic agents.",-27.125,0.6,Disease
"Persistent tinnitus and sleep‑related impairments in patients with birdshot retinochoroidopathy are exacerbated by the use of the chemical inhibitor tacrolimus, which can precipitate acute hepatitis‑like syndrome and, in rare cases, cardiogenic shock.",-38.25,0.6,Disease
"Persistent insomnia in patients with butyrylcholinesterase deficiency was found to exacerbate sleep‑related impairments, increasing the risk of cardiopulmonary arrest during nocturnal hypoxia.",-30.125,0.6,Disease
"Despite cardiogenic shock, the patient’s acute hepatitis‑like syndrome was exacerbated by the use of cisplatin, which further suppressed butyrylcholinesterase activity and worsened thrombocytopenia.",-29.625,0.6,Disease
"Despite treatment with the anti‑PD‑L1 agent atezolizumab, a patient with metastatic carcinoma of the urinary tract developed acute hepatitis‑like syndrome and subsequent cardiogenic shock, prompting cessation of the drug and initiation of high‑dose corticosteroids.",-36.25,0.6,Disease
"Despite its known efficacy in treating glaucomatous optic neuropathy, intravitreal bevacizumab has been associated with rare cases of acute hepatitis‑like syndrome in patients with underlying butyrylcholinesterase deficiency.",-31.375,0.6,Disease
"Macroprolactinoma patients treated with cabergoline often experience impaired renal function, a postoperative complication that can exacerbate central nervous system toxicity.",-17.375,0.6,Disease
"Macroadenomas secreting prolactin can trigger hyperprolactinemia that, in patients with impaired renal function, may precipitate post‑operative complications and central nervous system toxicity.",-35.0,0.6,Disease
Macroglutamine therapy can ameliorate impaired renal function in patients with macroprolactinoma while reducing the risk of postoperative complications that may otherwise trigger central nervous system toxicity.,-33.0,0.6,Disease
"Cisplatin administration in patients with macroprolactinoma can exacerbate impaired renal function and precipitate postoperative complications such as epithelial hyperplasia, while also increasing the risk of central nervous system toxicity.",-20.5,0.6,Disease
"Caspofungin therapy for a patient with macroprolactinoma is associated with a transient elevation of serum creatinine, indicating impaired renal function as a postoperative complication of the disease.",-31.75,0.6,Disease
"Cognitive deficits in schizophrenic patients receiving the antipsychotic clozapine are exacerbated by the drug’s propensity to induce erythroblastocytopenia, which in turn can aggravate impaired renal function and elevate the risk of postoperative complications after neurosurgical intervention for macroprolactinoma.",-36.5,0.6,Disease
"A macroprolactinoma can cause impaired renal function by compressing the optic chiasm and increasing intracranial pressure, which in turn leads to a postoperative complication of central nervous system toxicity.",-20.0,0.6,Disease
"A patient with macroprolactinoma experienced impaired renal function after receiving cisplatin, illustrating the drug’s nephrotoxic potential in endocrine tumor management.",-19.125,0.6,Disease
A postoperative complication of macroprolactinoma surgery can trigger impaired renal function due to central nervous system toxicity from the released dopamine antagonists.,-20.375,0.6,Disease
"Treated with cisplatin, the patient with macroprolactinoma experienced an acute rise in serum creatinine, indicating impaired renal function as a postoperative complication.",-20.875,0.6,Disease
"Treatment with cabergoline in patients with macroprolactinoma has been shown to improve impaired renal function, reducing the risk of postoperative complications associated with hepatic tumors.",-26.125,0.6,Disease
"Tetracycline administration in patients with macroprolactinoma can exacerbate impaired renal function, potentially leading to postoperative complications.",-22.0,0.6,Disease
"In patients with macroprolactinoma who developed impaired renal function after transsphenoidal surgery, the postoperative complication of central nervous system toxicity was mitigated by administering high‑dose levothyroxine, which also improved their glucose tolerance curves.",-22.375,0.6,Disease
"In postoperative patients with macroprolactinoma, the use of cabergoline has been shown to improve impaired renal function while avoiding central nervous system toxicity.",-18.25,0.6,Disease
"In post‑operative patients with macroprolactinoma, the administration of cabergoline not only reduces prolactin levels but also unexpectedly worsens impaired renal function, thereby raising concerns about its safety profile in this subset of schizophrenic individuals.",-35.25,0.6,Disease
"High‑dose cisplatin induces impaired renal function, a known postoperative complication that can precipitate epithelial hyperplasia in patients with hepatic tumors undergoing chemotherapy.",-22.125,0.6,Disease
"High-dose cisplatin therapy for hepatic tumors often precipitates impaired renal function, prompting clinicians to monitor serum creatinine levels and adjust dosing to mitigate nephrotoxicity.",-22.125,0.6,Disease
"High‐dose cisplatin administration in patients with hepatic tumors frequently precipitates impaired renal function, a known postoperative complication that can exacerbate central nervous system toxicity.",-19.125,0.6,Disease
"The macroprolactinoma in this patient caused impaired renal function by compressing the optic chiasm and exerting systemic hormonal effects, illustrating a rare postoperative complication that can lead to central nervous system toxicity and erythroblastocytopenia.",-29.5,0.6,Disease
"The postoperative complication of impaired renal function following hepatic tumor resection was exacerbated by the patient’s macroprolactinoma, which appeared to inhibit normal postoperative recovery.",-23.25,0.6,Disease
"The patient with a macroprolactinoma experienced impaired renal function after postoperative complications of hepatic tumor resection, raising concerns about central nervous system toxicity.",-16.625,0.6,Disease
"Elevated prolactin levels in patients with macroprolactinoma have been shown to worsen impaired renal function, possibly through the systemic effects of prolactin on renal hemodynamics.",-30.875,0.6,Disease
"Elevating cisplatin dosage in patients with impaired renal function exacerbates central nervous system toxicity, thereby increasing the risk of postoperative complications such as epithelial hyperplasia.",-23.75,0.6,Disease
"Elevations of serum prolactin in patients with macroprolactinoma can precipitate impaired renal function, especially when concomitant chemotherapy for hepatic tumors is administered, thereby increasing the risk of postoperative complications and central nervous system toxicity.",-33.0,0.6,Disease
"Patients with macroprolactinoma who develop impaired renal function often experience exacerbated central nervous system toxicity when treated with high‑dose cabergoline, leading to postoperative complications such as epithelial hyperplasia and erythroblastocytopenia.",-19.5,0.6,Disease
"Patients treated with the macroprolactinoma‑specific dopamine agonist cabergoline experienced a marked improvement in impaired renal function, suggesting the drug’s renoprotective effect in this endocrine‑nephrological comorbidity.",-25.875,0.6,Disease
"Patients suffering from macroprolactinoma frequently experience impaired renal function, which may be exacerbated by dopamine agonists used in treatment.",-21.625,0.6,Disease
"MacProlactinoma-induced hormonal dysregulation can precipitate impaired renal function, while postoperative complications such as hepatic tumor recurrence may further aggravate central nervous system toxicity.",-31.875,0.6,Disease
"Macrocystic prolactinoma patients receiving cisplatin therapy exhibited impaired renal function as a postoperative complication, underscoring the drug’s central nervous system toxicity and potential to induce epithelial hyperplasia.",-33.25,0.6,Disease
"Macrophage infiltration in macroprolactinoma patients has been shown to exacerbate impaired renal function, potentially through the release of pro‑inflammatory cytokines that induce epithelial hyperplasia in the proximal tubules.",-30.625,0.6,Disease
"Radiotherapy for hepatic tumors can induce central nervous system toxicity and, in patients with macroprolactinoma, may worsen impaired renal function.",-16.375,0.6,Disease
"Radiation‑induced liver injury, a form of hepatic tumor risk, may be mitigated by the chemopreventive agent silymarin, which also protects against chemotherapy‑induced impaired renal function.",-38.25,0.6,Disease
"Radiographic analysis revealed that the macroprolactinoma exerted a compressive effect on the pituitary stalk, thereby inducing impaired renal function through secondary neurohormonal dysregulation.",-30.625,0.6,Disease
"Histamine‑releasing factor released during a macroprolactinoma can exacerbate impaired renal function, thereby increasing the risk of postoperative complications in patients with hepatic tumors.",-25.75,0.6,Disease
"Histone deacetylase inhibitor belinostat reduces epithelial hyperplasia in patients with macroprolactinoma, thereby improving impaired renal function and mitigating postoperative complications.",-26.875,0.6,Disease
"Histopathological examination revealed that the macroprolactinoma had induced epithelial hyperplasia and impaired renal function, leading to postoperative complications in the patient.",-25.625,0.6,Disease
"Cisplatin administration in patients with rheumatoid arthritis can aggravate visual toxicity, potentially precipitating excitotoxicity that worsens sensori‑motor neuropathy.",-22.625,0.6,Disease
"Clozapine, a second‑generation antipsychotic, can precipitate agranulocytosis in patients with underlying rheumatic disease, and its use is associated with visual toxicity due to retinal excitotoxicity.",-28.5,0.6,Disease
Cilostazol improves anginal attacks in patients with coronary artery disease but may induce visual toxicity by exacerbating excitotoxicity in retinal ganglion cells.,-20.0,0.6,Disease
"A selective COX‑2 inhibitor alleviates anginal attacks but may cause visual toxicity, a form of excitotoxicity that can lead to sensorimotor neuropathy and, in severe cases, comatose states in patients with rheumatic disease.",-31.375,0.6,Disease
"A study found that cisplatin treatment in patients with NAFLD can cause visual toxicity through excitotoxicity pathways that damage retinal neurons, thereby increasing the risk of irreversible sight loss.",-30.375,0.6,Disease
Aspirin mitigates anginal attacks in patients with rheumatic disease but may exacerbate visual toxicity through excitotoxicity in retinal ganglion cells.,-16.625,0.6,Disease
"Cariporide, a selective Na⁺/H⁺ exchanger inhibitor, mitigated ischemia‑induced excitotoxicity and visual toxicity in a rat model of atrioventricular block, thereby reducing the severity of associated sensori‑motor neuropathy.",-36.5,0.6,Disease
"Carboplatin administration in patients with rheumatic disease can provoke visual toxicity, potentially exacerbating pre‑existing excitotoxicity and leading to sensory‑motor neuropathy.",-27.625,0.6,Disease
"Carvedilol administration in patients with atrioventricular block reduced the incidence of visual toxicity associated with chronic high‑dose cisplatin therapy, thereby mitigating excitotoxicity and preserving sensory‑motor neuropathy function.",-36.5,0.6,Disease
"In patients with NAFLD, the chemotherapeutic agent cisplatin exacerbates visual toxicity by inducing excitotoxicity that damages the optic nerve, thereby worsening sensory‑motor neuropathy.",-20.125,0.6,Disease
"In a cohort of patients with rheumatic disease, the administration of cisplatin was found to induce visual toxicity, likely through excitotoxic mechanisms that damage retinal neurons and lead to irreversible visual impairment.",-30.25,0.6,Disease
"In children with rheumatic disease, the use of the chemotherapeutic agent cisplatin can precipitate visual toxicity through excitotoxicity that leads to irreversible damage to the optic nerve and subsequently results in sensory‑motor neuropathy.",-41.5,0.6,Disease
"Elevated plasma levels of cisplatin in patients with NAFLD can aggravate excitotoxicity and induce visual toxicity, thereby increasing the risk of comatose states during chemotherapy.",-29.125,0.6,Disease
"Elevin, a novel CYP3A4 inhibitor, was found to exacerbate visual toxicity in patients with NAFLD undergoing statin therapy, prompting clinicians to monitor retinal function closely.",-33.0,0.6,Disease
"Elevative administration of cisplatin induces visual toxicity through excitotoxicity mechanisms that compromise retinal ganglion cells, thereby exacerbating symptoms of anginal attacks in patients with underlying rheumatic disease.",-35.75,0.6,Disease
"Toxicity of cisplatin is associated with visual toxicity, which can worsen pre‑existing rheumatic disease and induce excitotoxicity in the optic nerve.",-28.5,0.6,Disease
Tetracycline treatment of patients with rheumatic disease can trigger visual toxicity through excitotoxicity mechanisms that damage retinal cells.,-26.125,0.6,Disease
Tofacitinib mitigates rheumatoid arthritis‑induced joint inflammation but its inhibition of the JAK‑STAT pathway can precipitate visual toxicity in patients with pre‑existing optic neuritis.,-34.0,0.6,Disease
"Evidence suggests that the chemotherapeutic agent cisplatin induces visual toxicity through excitotoxicity in retinal ganglion cells, thereby exacerbating the risk of comatose patients with pre‑existing rheumatic disease and NAFLD.",-31.0,0.6,Disease
"Evidence shows that cisplatin induces visual toxicity through excitotoxicity and oxidative damage to retinal ganglion cells, thereby exacerbating comatose patients with underlying rheumatic disease who are also at risk for atrioventricular block.",-33.5,0.6,Disease
"Evidence of visual toxicity from cisplatin treatment in patients with refractory ovarian cancer is often accompanied by excitotoxicity-mediated retinal ganglion cell loss, underscoring the need for neuroprotective adjuncts.",-38.5,0.6,Disease
"Treatment with cisplatin is known to induce visual toxicity and excitotoxicity, thereby exacerbating sensory‑motor neuropathy in patients with rheumatic disease.",-18.125,0.6,Disease
"Treatment of atrioventricular block with high‑dose propranolol exacerbated the patient’s visual toxicity, leading to acute excitotoxicity and irreversible damage to the muscle fibers.",-24.5,0.6,Disease
"Treatment failure of cisplatin in patients with NAFLD is attributed to its increased visual toxicity and excitotoxicity, which further aggravate pre‑existing sensory‑motor neuropathy and cardiac arrhythmias.",-40.75,0.6,Disease
"The chemotherapeutic agent cisplatin, used to treat various cancers, has been shown to induce visual toxicity and excitotoxicity in the retinal ganglion cells, thereby exacerbating sensory‑motor neuropathy and occasionally precipitating atrioventricular block in patients with underlying rheumatic disease.",-31.125,0.6,Disease
"The administration of cisplatin in patients with metastatic melanoma often results in visual toxicity that can precipitate excitotoxicity‑induced retinal damage, thereby exacerbating comatose visual impairment and increasing the risk of severe anginal attacks.",-36.75,0.6,Disease
"The prolonged use of cisplatin can trigger visual toxicity, which may exacerbate excitotoxicity and lead to sensori‑motor neuropathy in patients with underlying rheumatic disease.",-24.125,0.6,Disease
"Azithromycin administration in patients with rheumatic disease can exacerbate visual toxicity through inhibition of retinal cytochrome P450 enzymes, potentially precipitating excitotoxicity and sensory‑motor neuropathy.",-24.5,0.6,Disease
"Azathioprine therapy in patients with rheumatic disease exacerbates visual toxicity through oxidative excitotoxicity, thereby increasing the risk of sensory‑motor neuropathy.",-25.375,0.6,Disease
"Azacytidine, a nucleoside analogue used in myelodysplastic syndromes, has been linked to visual toxicity that may precipitate excitotoxicity and sensori‑motor neuropathy, thereby exacerbating atrioventricular block in patients with underlying rheumatic disease.",-38.25,0.6,Disease
"Neurotoxic effects of cisplatin can exacerbate excitotoxicity in patients with NAFLD, leading to visual toxicity and occasional comatose episodes.",-26.625,0.6,Disease
Neuralgia caused by cisplatin-induced excitotoxicity may worsen visual toxicity in patients with NAFLD who also suffer from anginal attacks.,-33.25,0.6,Disease
"Neurons exposed to excessive glutamate experience excitotoxicity, a key mechanism driving the visual toxicity observed in patients with retinal ischemia and anginal attacks, while treatment with the NMDA antagonist memantine has been shown to protect against this damage to the muscle and preserve visual function.",-51.5,0.6,Disease
"Patients receiving cisplatin for ovarian carcinoma often develop visual toxicity, which can precipitate excitotoxicity in retinal ganglion cells and subsequently lead to sensory‑motor neuropathy.",-22.0,0.6,Disease
"Patients with atrioventricular block who receive cisplatin exhibit increased visual toxicity due to drug‑induced excitotoxicity, a complication that can precipitate sensori‑motor neuropathy and muscle damage.",-24.125,0.6,Disease
"Patients treated with cisplatin for ovarian carcinoma frequently develop visual toxicity that can progress to irreversible excitotoxic retinal damage, especially when combined with pre‑existing rheumatic disease.",-24.125,0.6,Disease
"The novel chemotherapeutic agent fludarabine, used in the treatment of chronic lymphocytic leukaemia, has been shown to exacerbate neurotoxicity in patients with pre‑existing Alzheimer‑like neuronal degeneration, leading to accelerated cognitive decline.",-27.875,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against bladder cancer, induces nephrotoxicity that can precipitate acute tubular necrosis, thereby exacerbating pre‑existing systemic lupus erythematosus symptoms.",-19.375,0.6,Disease
"The therapeutic use of the chemotherapeutic agent cisplatin has been shown to induce acute tubular necrosis in patients with bladder cancer, thereby exacerbating acute interstitial nephritis and contributing to the development of nephrotoxic complications.",-34.5,0.6,Disease
"Patients with acute tubulointerstitial nephritis treated with high‑dose cisplatin experienced a rapid decline in glomerular filtration rate, suggesting that cisplatin’s nephrotoxic effect may be mediated through tubular epithelial cell injury.",-27.0,0.6,Disease
"Patients receiving the novel kinase inhibitor NCT-1123 for relapsed acute myeloid leukaemia exhibited a marked reduction in tumour burden, yet developed dose‑dependent nephrotoxicity that manifested as acute tubular interstitial nephritis, prompting the discontinuation of therapy and initiation of corticosteroid rescue.",-48.25,0.6,Disease
"Patients treated with cisplatin for bladder cancer frequently develop nephrotoxicity, a dose‑dependent side effect that may be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-24.125,0.6,Disease
"Cisplatin treatment for bladder cancer induces nephrotoxicity that may aggravate underlying AIDS‑associated renal dysfunction, thereby increasing the risk of acute tubular injury and subsequent chronic kidney disease.",-28.25,0.6,Disease
"Coprine, a potent alkylating agent, has been shown to induce severe nephrotoxicity in patients with leukemia undergoing high‑dose chemotherapy, thereby exacerbating acute tubular injury and increasing the risk of acute interstitial nephritis.",-35.25,0.6,Disease
"Cervical cancer patients treated with cisplatin experience a higher incidence of nephrotoxicity, which can aggravate pre‑existing acute tubular necrosis and worsen overall survival.",-27.375,0.6,Disease
"In patients with AIDS who develop bladder cancer, the antiretroviral drug zidovudine may induce nephrotoxicity that exacerbates neuronal dysfunction and worsens seizure-associated symptoms.",-25.25,0.6,Disease
"In a randomized trial, cisplatin administration was shown to significantly reduce tumor burden in bladder cancer patients while concurrently exacerbating nephrotoxicity, underscoring the drug’s dual therapeutic and adverse effects.",-28.625,0.6,Disease
"In Alzheimer‑like dementia, chronic exposure to the chemotherapeutic agent cisplatin aggravates neuronal dysfunction, thereby accelerating the progression of cognitive decline.",-23.75,0.6,Disease
"Early‑stage bladder cancer patients treated with cisplatin experience a dose‑dependent decline in renal function, prompting clinicians to monitor serum creatinine and consider alternative chemotherapeutic agents to mitigate nephrotoxicity.",-27.125,0.6,Disease
"Early-stage bladder cancer patients receiving cisplatin chemotherapy exhibit a higher incidence of acute tubular necrosis, underscoring the drug’s nephrotoxic potential in this vulnerable population.",-21.875,0.6,Disease
"Early-phase trials of the novel tyrosine‑kinase inhibitor cabozantinib showed dose‑dependent inhibition of tumor‑cell proliferation in patients with metastatic bladder cancer, while a subset of participants developed transient neutropenia, suggesting a potential link between drug‑induced myelosuppression and underlying disease‑related bone‑marrow dysfunction.",-50.0,0.6,Disease
"Radiotherapy for bladder cancer can precipitate acute tubular necrosis, which may aggravate underlying AIDS‑associated nephropathy and exacerbate seizures in patients with lupus‑sensitive neuronal dysfunction.",-33.25,0.6,Disease
"Radiation therapy with cisplatin for bladder cancer has been shown to induce acute interstitial nephritis, a form of ATIN that may worsen pre‑existing lupus‑associated renal dysfunction.",-28.625,0.6,Disease
"Radiotherapies targeting bladder cancer can induce acute tubular necrosis, which may exacerbate pre‑existing AIDS‑related nephropathy and lead to a surge in seizure‑associated neuronal dysfunction.",-42.25,0.6,Disease
"Administering the novel kinase inhibitor NVP‑BAY‑61‑9869 markedly suppressed tumor growth in patients with metastatic bladder cancer while simultaneously reducing the incidence of chemotherapy‑induced nephrotoxicity, thereby illustrating its dual therapeutic potential in oncologic and renal disease contexts.",-49.25,0.6,Disease
"Administation of the chemotherapeutic agent cisplatin exacerbates nephrotoxicity in patients with bladder cancer, leading to acute tubular necrosis and subsequent renal failure.",-29.875,0.6,Disease
Administratio​n of the novel kinase inhibitor dasatinib reduces relapse rates in patients with chronic myeloid leukaemia while simultaneously inducing mild nephrotoxicity that appears to be mediated by acute tubular injury and interstitial nephritis.,-56.5,0.6,Disease
"Intrusive application of cisplatin accelerates neuronal degeneration in patients with bladder cancer, thereby exacerbating seizure‑associated symptoms.",-31.125,0.6,Disease
"Intrathecal cisplatin administration in patients with bladder cancer can induce seizure‑associated neuronal dysfunction, underscoring the need for careful monitoring of neurotoxicity in this high‑risk population.",-25.0,0.6,Disease
"Intravenous cisplatin treatment for bladder cancer patients has been reported to induce acute tubular necrosis, a form of ATIN, which can worsen renal function and accelerate the progression of sepsis in individuals with AIDS.",-36.5,0.6,Disease
A recent cohort study found that patients with SLE who were treated with hydroxychloroquine had a lower incidence of seizure-associated neuronal dysfunction compared with those receiving standard corticosteroid therapy.,-22.5,0.6,Disease
"A randomized trial showed that the combination of cisplatin and the novel anti‑PD‑L1 antibody durvalumab significantly reduced tumor burden in patients with metastatic bladder cancer while simultaneously increasing the incidence of nephrotoxicity, underscoring the need for careful renal monitoring during such combination therapies.",-36.25,0.6,Disease
A phase‑II trial showed that the novel kinase inhibitor gefitinib markedly reduced tumor burden in patients with metastatic bladder cancer while simultaneously lowering the incidence of seizure‑associated neurotoxicity.,-23.0,0.6,Disease
Amifostine mitigates cisplatin‑induced nephrotoxicity in patients with bladder cancer undergoing platinum‑based chemotherapy.,-15.1875,0.6,Disease
"Amoxicillin therapy for bladder cancer patients with leukaemia has been associated with a higher incidence of seizure‑associated neurotoxicity, prompting clinicians to monitor for neuronal dysfunction.",-29.375,0.6,Disease
"Amphotericin B administration in patients with AIDS-associated pulmonary aspergillosis can exacerbate nephrotoxicity, necessitating careful monitoring of serum creatinine and dose adjustment to mitigate renal injury.",-35.0,0.6,Disease
Combination therapy with cisplatin and the novel inhibitor GSK‑305 is expected to reduce the incidence of cisplatin‑induced nephrotoxicity while maintaining its antitumor activity in patients with bladder cancer.,-35.75,0.6,Disease
"Combination chemotherapy with cisplatin and gemcitabine has been shown to improve survival in patients with bladder cancer, but the regimen frequently induces acute interstitial nephritis, a form of ATIN that can progress to chronic kidney disease if not promptly recognized and managed.",-34.0,0.6,Disease
"Combination treatment with cisplatin and the novel anti‑PD‑L1 antibody atezolizumab has shown a synergistic reduction in tumour burden in patients with metastatic bladder cancer, yet the regimen is associated with an increased incidence of nephrotoxicity and acute tubular injury, underscoring the need for vigilant renal monitoring.",-40.25,0.6,Disease
"Targeted therapy with the small‑molecule inhibitor dasatinib, which blocks BCR‑ABL and Src family kinases, has been shown to induce remission in patients with chronic myeloid leukaemia while simultaneously reducing the incidence of drug‑induced nephrotoxicity associated with cisplatin treatment for advanced bladder cancer.",-38.5,0.6,Disease
"Targeting the PI3K/AKT pathway with the oral inhibitor alpelisib markedly reduces tumor burden in patients with advanced bladder cancer while concurrently exacerbating insulin resistance, illustrating a trade‑off between anticancer efficacy and metabolic toxicity.",-32.25,0.6,Disease
"Target‑specific inhibition of the BCL‑2 protein by venetoclax induces apoptosis in acute myeloid leukaemia cells, yet the drug can also precipitate tumor lysis syndrome, a potentially fatal complication that requires careful monitoring of serum potassium and uric acid levels.",-45.75,0.6,Disease
"Cisplatin-induced renal tubular dysfunction frequently precipitates segmental necrotizing glomerulonephritis, which in turn can exacerbate cardiovascular depression and lead to severe haemopericardium in patients with pre‑existing thyroid illness.",-19.875,0.6,Disease
"Clozapine therapy in patients with schizophrenia has been associated with severe renal tubular dysfunction and segmental necrotizing glomerulonephritis, leading to functional impairments and electrolyte reactions that can precipitate cardiovascular depression.",-24.625,0.6,Disease
"Captopril, a renin‑converting enzyme inhibitor, has been shown to alleviate segmental necrotizing glomerulonephritis but may trigger renal tubular dysfunction and haemopericardium in susceptible patients.",-25.75,0.6,Disease
"Paclitaxel administration in patients with renal tubular dysfunction can precipitate segmental necrotizing glomerulonephritis, leading to severe haemopericardium and cardiovascular depression.",-16.25,0.6,Disease
"Pacemaker implantation in patients with severe renal tubular dysfunction can precipitate haemopericardium and segmental necrotizing glomerulonephritis, exacerbating cardiovascular depression and neurological dysfunction while simultaneously impairing thyroid function.",-39.5,0.6,Disease
"Pacritinib, a JAK2 inhibitor, mitigates the renal tubular dysfunction and segmental necrotizing glomerulonephritis that can precipitate cardiovascular depression in patients with severe thyroid illness.",-38.5,0.6,Disease
"In patients with segmental necrotizing glomerulonephritis, the administration of rituximab has been associated with transient renal tubular dysfunction and occasional mild cough, underscoring the need to monitor for renal and pulmonary adverse reactions during therapy.",-30.5,0.6,Disease
"In a cohort of patients with segmental necrotizing glomerulonephritis, the administration of rituximab reduced the frequency of renal tubular dysfunction and improved proteinuria, but induced transient cardiovascular depression and a mild cough as common adverse reactions.",-37.0,0.6,Disease
"In diabetic patients receiving the novel SGLT2 inhibitor dapagliflozin, a subset developed acute renal tubular dysfunction, evidenced by a sudden rise in serum creatinine and electrolyte disturbances, prompting discontinuation of the drug and initiation of supportive therapy to mitigate the risk of progression to segmental necrotizing glomerulonephritis.",-44.75,0.6,Disease
"High‑dose cisplatin therapy can precipitate segmental necrotizing glomerulonephritis and renal tubular dysfunction, leading to severe electrolyte imbalances and cardiovascular depression in patients with underlying thyroid illness.",-19.625,0.6,Disease
"High-dose cisplatin therapy can induce segmental necrotizing glomerulonephritis, leading to renal tubular dysfunction and subsequent electrolyte imbalances that worsen cardiovascular depression.",-18.5,0.6,Disease
"High‐dose cisplatin induces renal tubular dysfunction and segmental necrotizing glomerulonephritis, leading to functional impairments that may trigger cardiovascular depression and haemopericardium in patients with underlying thyroid illness.",-24.25,0.6,Disease
Patients with segmental necrotizing glomerulonephritis often develop renal tubular dysfunction that can trigger haemopericardium and exacerbate cardiovascular depression.,-15.3125,0.6,Disease
"Patients receiving the novel kinase inhibitor exhibited renal tubular dysfunction and segmental necrotizing glomerulonephritis, likely due to off‑target inhibition of the CYP3A4 pathway.",-22.25,0.6,Disease
"Patients diagnosed with segmental necrotizing glomerulonephritis often experience renal tubular dysfunction, which can lead to severe electrolyte imbalances and subsequent cardiovascular depression.",-19.125,0.6,Disease
A novel therapeutic strategy using the small‑molecule inhibitor roscovitine has been shown to ameliorate renal tubular dysfunction and reduce segmental necrotizing glomerulonephritis in murine models of systemic lupus erythematosus while simultaneously mitigating the associated cardiovascular depression and neurological dysfunction that frequently accompany this autoimmune disease.,-40.75,0.6,Disease
"A patient with segmental necrotizing glomerulonephritis developed renal tubular dysfunction after receiving the chemotherapeutic drug cisplatin, which is known to cause functional impairments and renal toxicity.",-21.875,0.6,Disease
"A single dose of the novel kinase inhibitor N‑hydroxy‑cinnamoyl‑benzyl‑thiophene ameliorated renal tubular dysfunction in patients with segmental necrotizing glomerulonephritis, but induced transient cardiovascular depression and mild cough as early adverse reactions.",-51.0,0.6,Disease
"Atorvastatin administration in patients with segmental necrotizing glomerulonephritis was associated with an increased risk of renal tubular dysfunction, potentially exacerbating their pre‑existing neurological dysfunction.",-28.125,0.6,Disease
"At least one-quarter of patients with segmental necrotizing glomerulonephritis experience renal tubular dysfunction, which may be exacerbated by the nephrotoxic reactions to the chemotherapeutic agent cisplatin.",-34.5,0.6,Disease
"Attributable to cisplatin therapy, patients with renal tubular dysfunction often develop segmental necrotizing glomerulonephritis, leading to severe neurological dysfunction and cardiovascular depression.",-25.375,0.6,Disease
"The antibiotic ceftriaxone can trigger segmental necrotizing glomerulonephritis, leading to renal tubular dysfunction and subsequent electrolyte imbalance in patients with underlying thyroid illness.",-22.125,0.6,Disease
"The use of cisplatin in patients with metastatic renal tubular dysfunction can trigger segmental necrotizing glomerulonephritis, leading to severe renal impairment and necessitating aggressive dialysis support.",-23.25,0.6,Disease
"The drug metformin, commonly used for type‑2 diabetes, has been shown to induce renal tubular dysfunction and, in rare cases, segmental necrotizing glomerulonephritis, thereby highlighting the need for monitoring kidney function during therapy.",-32.0,0.6,Disease
"Tetracycline therapy for acne vulgaris has been shown to induce renal tubular dysfunction, leading to functional impairments and, in rare cases, segmental necrotizing glomerulonephritis that may present with haemopericardium and cardiovascular depression.",-28.25,0.6,Disease
Tacrolimus administration in patients with segmental necrotizing glomerulonephritis has been associated with renal tubular dysfunction and subsequent hypokalemic metabolic alkalosis.,-23.75,0.6,Disease
Tocilizumab administration in patients with segmental necrotizing glomerulonephritis has been shown to reduce renal tubular dysfunction but can also precipitate transient haemopericardium as a rare adverse reaction.,-26.375,0.6,Disease
"Nivolumab administration in patients with metastatic melanoma frequently precipitates renal tubular dysfunction, leading to segmental necrotizing glomerulonephritis and subsequent electrolyte imbalances that may exacerbate cardiovascular depression.",-25.0,0.6,Disease
"Nifedipine, a calcium‑channel blocker, has been shown to ameliorate renal tubular dysfunction in patients with segmental necrotizing glomerulonephritis while simultaneously reducing the incidence of haemopericardium associated with acute cardiovascular depression.",-26.0,0.6,Disease
N-acetylcysteine alleviates cisplatin‑induced segmental necrotizing glomerulonephritis by mitigating oxidative stress and preserving renal tubular function.,-20.875,0.6,Disease
"Use of the chemotherapeutic agent cisplatin in patients with renal tubular dysfunction can provoke segmental necrotizing glomerulonephritis, thereby exacerbating functional impairments and triggering severe haemopericardium as a rare but life‑threatening reaction.",-29.0,0.6,Disease
"Use low‑dose doxycycline to treat segmental necrotizing glomerulonephritis, because its anti‑inflammatory activity can reduce renal tubular dysfunction and prevent further haemopericardium‑related complications.",-30.75,0.6,Disease
"Use cisplatin to treat renal tubular dysfunction, but it can trigger segmental necrotizing glomerulonephritis, causing severe neurological dysfunction and cardiovascular depression.",-26.0,0.6,Disease
"Rhabdomyolysis induced by high‑dose cisplatin can precipitate acute renal tubular dysfunction, leading to segmental necrotizing glomerulonephritis and subsequent cardiovascular depression.",-16.0,0.6,Disease
"Rifampicin-induced inhibition of CYP3A4 accelerates the clearance of tacrolimus, thereby exacerbating renal tubular dysfunction and precipitating segmental necrotizing glomerulonephritis in patients with underlying thyroid illness.",-19.625,0.6,Disease
"Ritonavir therapy for HIV patients frequently induces renal tubular dysfunction, which can exacerbate segmental necrotizing glomerulonephritis and lead to severe haemopericardium, especially in those with underlying thyroid illness.",-32.5,0.6,Disease
"A randomized trial demonstrated that the chemotherapeutic agent cisplatin significantly increased the risk of nephrotoxic haemorrhagic cystitis in patients with prostatic adenocarcinoma, whereas the addition of the antioxidant N‑acetylcysteine reduced the incidence of this adverse effect.",-31.5,0.6,Disease
Atrial fibrillation in patients with prostatic adenocarcinoma who receive the chemotherapeutic agent cisplatin is associated with a higher incidence of haemorrhagic complications than in patients who receive non‑cytotoxic hormone therapy.,-30.5,0.6,Disease
"A clinical trial demonstrated that the novel kinase inhibitor erlotinib markedly reduced tumor progression in patients with metastatic prostatic adenocarcinoma while simultaneously exacerbating their underlying type‑1 diabetes, highlighting a paradoxical metabolic side effect that requires vigilant glucose monitoring.",-47.75,0.6,Disease
Patients with type‑1 diabetes who develop haemorrhagic complications from insulin‑induced hypoglycaemia often experience sudden onset of brain ischemic symptoms that can be mitigated by early administration of the antidiabetic drug glibenclamide.,-33.75,0.6,Disease
"Patients receiving cisplatin for prostatic adenocarcinoma frequently develop haemorrhagic cystitis, a complication that can exacerbate underlying depressive symptoms.",-15.0625,0.6,Disease
"Patients treated with the anti‑inflammatory drug celecoxib for type‑1 diabetes–associated nephropathy reported a significant reduction in proteinuria, yet a subset developed transient haemorrhagic complications, suggesting a dose‑dependent adverse effect on renal hemostasis.",-43.75,0.6,Disease
"The administration of the novel inhibitor nintedanib markedly reduced pulmonary fibrosis in adult respiratory distress syndrome patients, yet it unexpectedly accelerated the progression of type‑1 diabetes in a subset of subjects.",-35.75,0.6,Disease
The tyrosine‑kinase inhibitor imatinib effectively treats prostatic adenocarcinoma but has been linked to rare cases of haemorrhagic pulmonary embolism in patients with type‑1 diabetes.,-33.0,0.6,Disease
"The novel chemotherapeutic agent cisplatin exacerbates adult respiratory distress syndrome in patients with type‑1 diabetes, leading to increased pulmonary edema and decreased oxygenation.",-27.5,0.6,Disease
"Administration of the novel inhibitor, ARB‑101, markedly reduced brain ischemic damage in a murine model of type‑1 diabetes‑induced neurodegeneration while simultaneously mitigating the depressive‑like behaviors observed in the same cohort.",-48.0,0.6,Disease
Administration to patients with type‑1 diabetes of the novel oral agent metformin‑acetate was observed to reduce the incidence of diabetic nephropathy by inhibiting the advanced glycation end‑product‑induced activation of the NF‑κB pathway.,-58.5,0.6,Disease
"Administration and prolonged use of the antidiabetic drug metformin in patients with type‑1 diabetes can reduce the incidence of haemorrhagic complications, but may also increase the risk of lactic acidosis in those with underlying renal insufficiency.",-50.25,0.6,Disease
"Cisplatin administration in patients with prostatic adenocarcinoma can precipitate acute kidney injury, a serious adverse effect that may worsen pre‑existing type‑1 diabetes‑related nephropathy.",-26.0,0.6,Disease
Corticosteroid therapy for adult respiratory distress syndrome has been shown to reduce the incidence of secondary haemorrhagic complications in patients with severe brain ischemic injury.,-18.25,0.6,Disease
Cimetidine administration has been shown to reduce the incidence of haemorrhagic complications in patients with type‑1 diabetes who develop adult respiratory distress syndrome.,-20.75,0.6,Disease
"In patients with type‑1 diabetes, the antidiabetic drug metformin has been shown to reduce the incidence of haemorrhagic complications while simultaneously improving glycaemic control.",-19.0,0.6,Disease
"In adult respiratory distress syndrome patients, the administration of the anti‑inflammatory chemical dexamethasone has been shown to reduce the incidence of haemorrhagic complications, although it may exacerbate depressive symptoms in a subset of survivors.",-28.125,0.6,Disease
"In adults with type‑1 diabetes, the antidiabetic drug metformin has been observed to reduce the incidence of haemorrhagic diabetic retinopathy, although it may exacerbate occasional mild incontinence episodes.",-32.75,0.6,Disease
Adults with type‑1 diabetes who develop haemorrhagic brain ischemia often experience severe depressive episodes that are exacerbated by the neurotoxic effects of high‑dose insulin therapy.,-32.25,0.6,Disease
"Adults treated with the chemotherapeutic agent cisplatin for prostatic adenocarcinoma frequently develop haemorrhagic gastritis, a severe adverse effect that can be mitigated by concurrent administration of the anti‑emetic drug ondansetron.",-34.0,0.6,Disease
"Adults receiving cisplatin for prostatic adenocarcinoma frequently develop haemorrhagic cystitis, a severe complication that can exacerbate pre‑existing incontinence and worsen quality of life.",-28.0,0.6,Disease
"While glyburide effectively lowers blood glucose in type‑1 diabetes, its inhibition of the ATP‑sensitive K⁺ channel in pancreatic β‑cells also predisposes patients to hypoglycemia, a serious adverse effect that can precipitate seizures in susceptible individuals.",-44.5,0.6,Disease
"While cisplatin therapy can induce haemorrhagic cystitis, patients with type‑1 diabetes mellitus are at increased risk of developing urinary incontinence due to diabetic neuropathy.",-36.0,0.6,Disease
"While aspirin therapy reduces the risk of stroke in patients with prostatic adenocarcinoma, it may exacerbate haemorrhagic complications in those with concurrent adult respiratory distress syndrome.",-26.875,0.6,Disease
Erythropoietin administration in patients with type‑1 diabetes and chronic kidney disease reduces the risk of haemorrhagic complications associated with nephrotoxic chemotherapy.,-30.75,0.6,Disease
"Epidemiologic data indicate that long‑term use of the antidiabetic drug metformin reduces the risk of type‑1 diabetes‑associated brain ischemic lesions, but may exacerbate depressive symptoms in susceptible adults.",-39.5,0.6,Disease
Esmolol administration in patients with adult respiratory distress syndrome markedly reduced the incidence of haemorrhagic brain ischemic events while simultaneously improving respiratory compliance.,-27.75,0.6,Disease
"Steroid therapy with dexamethasone mitigates the inflammatory response in adult respiratory distress syndrome while concurrently exacerbating hyperglycaemia in patients with type‑1 diabetes, thereby necessitating vigilant glucose monitoring.",-34.25,0.6,Disease
"Steroids such as prednisone are often prescribed to reduce inflammation in patients with type‑1 diabetes‑related nephropathy, yet they can paradoxically worsen glycemic control and precipitate hypoglycemic episodes.",-38.5,0.6,Disease
Steroidal therapy with dexamethasone has been shown to reduce the incidence of brain ischemic complications in patients with type‑1 diabetes who experience acute haemorrhagic stroke.,-35.75,0.6,Disease
Treatment with the novel antidiabetic agent empagliflozin improves glycemic control in patients with type‑1 diabetes and concurrently reduces the incidence of hypoglycemic episodes that are often triggered by sulfonylurea overdose.,-39.25,0.6,Disease
Treatment of type‑1 diabetes with the oral hypoglycemic drug metformin has been shown to reduce the risk of developing haemorrhagic stroke in patients with concurrent hypertension.,-24.875,0.6,Disease
"Treatment using the chemotherapeutic agent cisplatin was found to aggravate the haemorrhagic complications in patients with type‑1 diabetes, thereby increasing the risk of severe incontinence.",-40.0,0.6,Disease
"Clinical studies show that the antiepileptic drug levetiracetam can reduce the frequency of epileptic stereotypies in adults with type‑1 diabetes, but it may also precipitate transient depressive episodes.",-38.25,0.6,Disease
"Clinical trials have shown that the novel drug **candesartan** can reduce the progression of **adult respiratory distress syndrome** in patients with severe sepsis, yet it may paradoxically increase the risk of **incontinence** in those with pre‑existing bladder dysfunction.",-42.25,0.6,Disease
"Clinical research indicates that the chemotherapeutic agent cisplatin can precipitate acute kidney injury in patients with type‑1 diabetes, potentially exacerbating existing renal dysfunction.",-35.25,0.6,Disease
"Patients treated with the novel antineoplastic agent imatinib for chronic myeloid leukemia exhibited a dose‑dependent reduction in the incidence of drug‑induced sinus node dysfunction, yet a subset developed transient myoclonic status that resolved after discontinuation of therapy.",-38.0,0.6,Disease
Patients with myoclonic status epilepticus secondary to CML-associated metabolic derangements may experience exacerbated hematomas when treated with the chemotherapeutic agent cisplatin.,-22.0,0.6,Disease
"Patients undergoing treatment for chronic myeloid leukemia (CML) frequently develop sinus node dysfunction, which can be exacerbated by the myeloproliferative disease itself and the cytotoxic chemotherapy agents used to control the malignancy.",-32.25,0.6,Disease
"Tetracycline administration in patients with chronic sinus node dysfunction has been shown to exacerbate myoclonic status and precipitate hematomas in those with CML‑associated psoriasis, thereby increasing the risk of myocardial ischemia.",-29.875,0.6,Disease
Tegafur–uracil therapy for CML-associated myoclonic status has been shown to reduce the incidence of sinus node dysfunction while simultaneously lowering the risk of developing severe hematomas.,-35.25,0.6,Disease
"Treated patients with chronic myeloid leukemia (CML)-associated myoclonic status exhibited a significant reduction in hematomas and sinus node dysfunction when administered imatinib, highlighting its dual efficacy in both oncologic and cardiovascular complications.",-34.75,0.6,Disease
Use of the novel kinase inhibitor imatinib in patients with chronic myeloid leukemia–associated myoclonic status has been shown to markedly reduce seizure frequency while concurrently improving left ventricular function and preventing the development of sinus node dysfunction.,-36.0,0.6,Disease
"Use a single, moderately complex sentence that mentions both a disease and a chemical, such as: **""The patient with myoclonic status epilepticus was successfully treated with levetiracetam, which rapidly reduced seizure frequency and prevented further hematoma formation in the brain.""**",-41.5,0.6,Disease
Use the anti‑inflammatory drug methotrexate to treat the patient’s psoriasis while monitoring for myoclonic status and sinus node dysfunction that may arise from the underlying chronic lymphocytic leukemia‑associated disease.,-37.0,0.6,Disease
"In patients with myoclonic status epilepticus, the antiepileptic drug levetiracetam has been shown to reduce the frequency of seizures but may also precipitate transient sinus node dysfunction, leading to bradycardia and, in rare cases, intracranial hematomas.",-30.5,0.6,Disease
"In children with myoclonic status epilepticus, the administration of high‑dose levetiracetam has been observed to reduce the incidence of intracerebral hematomas while also ameliorating associated sinus node dysfunction.",-30.375,0.6,Disease
"In a randomized trial, patients with chronic myelogenous leukemia (CML) receiving imatinib experienced a significant reduction in myoclonic status episodes, but the drug also induced transient sinus node dysfunction, necessitating careful cardiac monitoring.",-33.5,0.6,Disease
"A study found that administering the chemotherapeutic agent cisplatin to patients with chronic myeloid leukemia (CML) significantly increased the incidence of sinus node dysfunction, suggesting a dose‑dependent cardiotoxicity that may necessitate concurrent treatment with a protective beta‑blocker to mitigate myocardial ischemia.",-36.75,0.6,Disease
"A patient with myoclonic status epilepticus developed a large hematoma at the injection site, raising concerns about potential sinus node dysfunction during subsequent chemotherapy for CML-associated ALL.",-24.75,0.6,Disease
"A single dose of cisplatin can precipitate acute sinus node dysfunction in patients with CML-associated myoclonic status, thereby exacerbating their underlying psoriasis.",-22.875,0.6,Disease
"Cocaine-induced myoclonic status in patients with acute myeloid leukemia (AML) frequently precipitates large hematomas and sinus node dysfunction, complicating the management of underlying CML-associated psoriasis.",-34.5,0.6,Disease
"Cisplatin treatment for acute myeloid leukemia can precipitate sinus node dysfunction and subsequent myoclonic status, especially in patients with pre‑existing cardiovascular disease.",-20.625,0.6,Disease
"Caspofungin treatment for invasive aspergillosis was associated with a transient elevation of creatinine, suggesting renal impairment in patients with pre‑existing chronic kidney disease.",-28.875,0.6,Disease
"Methylprednisolone, a potent anti-inflammatory chemical, has been shown to alleviate pain and reduce edema in patients with trigeminal neuralgia while simultaneously mitigating the risk of secondary myoclonic status that may arise from uncontrolled seizures.",-39.5,0.6,Disease
Molecular inhibition of the protein kinase CK2 by the small‑molecule inhibitor CX‑4945 mitigates myoclonic status in a murine model of CML‑associated neurotoxicity while sparing the cardiac electrophysiology of patients with sinus node dysfunction.,-43.75,0.6,Disease
"Mifepristone, a synthetic steroidal anti‑progesterone, has been shown to ameliorate the inflammatory cascade underlying psoriasis while simultaneously inhibiting the proliferation of chronic myeloid leukemia‑associated blast cells.",-39.25,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective in treating acute lymphoblastic leukemia, can induce sinus node dysfunction and myoclonic status, thereby exacerbating myocardial ischemia in patients with underlying cardiovascular disease.",-24.625,0.6,Disease
"The clinical trial demonstrated that patients with CML-associated myoclonic status who received the novel inhibitor imatinib exhibited a significant reduction in hematomas, suggesting an inhibitory effect of the drug on disease‑related coagulation abnormalities.",-35.0,0.6,Disease
"The patient’s myoclonic status was exacerbated by the addition of the chemotherapeutic agent cisplatin, which is known to induce neurotoxicity and may worsen underlying CML-associated neurological symptoms.",-29.0,0.6,Disease
Itraconazole treatment of patients with chronic myeloid leukemia-associated psoriasis can exacerbate myoclonic status and precipitate sinus node dysfunction.,-25.125,0.6,Disease
"Isoniazid prophylaxis has been shown to reduce the incidence of tuberculosis in patients with chronic myeloid leukemia (CML) who develop sinus node dysfunction during treatment, but it may also increase the risk of myoclonic status in those with pre‑existing epilepsy.",-40.25,0.6,Disease
"Iliac endoleak after endovascular aneurysm repair can precipitate myocardial ischemia, and the use of clopidogrel is associated with an increased risk of intramuscular hematomas in patients with underlying psoriasis.",-44.0,0.6,Disease
"Treatment with the novel kinase inhibitor Nilotinib reduces myoclonic status in patients with CML‑associated neurological complications, but can precipitate sinus node dysfunction and hematomas in those with pre‑existing cardiovascular disease.",-34.5,0.6,Disease
"Treatment of myoclonic status in patients with CML-associated ALL using high‑dose levetiracetam has been shown to reduce seizure frequency but may aggravate sinus node dysfunction, prompting clinicians to monitor cardiac rhythm and adjust dosage accordingly.",-31.75,0.6,Disease
"Treatment failure with the novel antiepileptic drug fenfluramine in patients with refractory myoclonic status epilepticus often leads to the development of cerebellar ataxia and, in severe cases, cerebellar hemorrhagic hematomas.",-47.5,0.6,Disease
"High‑dose cisplatin therapy for acute lymphoblastic leukemia can induce sinus node dysfunction and precipitate myoclonic status, thereby increasing the risk of life‑threatening hematomas.",-20.75,0.6,Disease
"High-dose cisplatin therapy for chronic myeloid leukemia (CML) can precipitate sinus node dysfunction, manifesting as symptomatic bradycardia that mimics the arrhythmic features of idiopathic atrial fibrillation.",-31.125,0.6,Disease
"High‐dose cisplatin administration in patients with CML‐associated myelodysplastic syndrome can aggravate sinus node dysfunction, thereby precipitating symptomatic myoclonic status and contributing to the development of severe hematomas.",-33.0,0.6,Disease
"Administration of the novel JAK2 inhibitor ruxolitinib markedly reduced the proliferation of CML-associated blast cells but unexpectedly precipitated sinus node dysfunction, prompting the initiation of beta‑blocker therapy to mitigate the resultant arrhythmia.",-34.75,0.6,Disease
"Administration or subcutaneous infusion of the anti‑TNF‑α monoclonal antibody adalimumab in patients with moderate to severe psoriasis has been associated with a small but statistically significant increase in the incidence of sinus node dysfunction and atrioventricular block, suggesting that the drug’s immunomodulatory effect may exacerbate underlying cardiac conduction disease in this population.",-70.5,0.6,Disease
"Administration with cisplatin markedly exacerbated the myoclonic status of patients with CML-associated psoriasis, leading to severe hematomas that required emergency intervention.",-41.5,0.6,Disease
"In patients with IgA nephropathy, the use of the renin‑angiotensin system blocker losartan has been shown to reduce proteinuria and slow the decline in glomerular filtration rate, thereby mitigating the progression to end‑stage renal disease.",-17.0,0.6,Disease
"In a randomized trial, patients with IgA nephropathy receiving the novel anti‑inflammatory chemical roxadipine exhibited a significant reduction in proteinuria and an improvement in impaired memory performance compared with placebo.",-31.5,0.6,Disease
"In bipolar disorder patients receiving lithium, the drug’s neuroprotective effect appears to mitigate the risk of developing IgA nephropathy, while paradoxically increasing the incidence of conjunctival blanching and transient memory deficit.",-37.0,0.6,Disease
"Cisplatin treatment for patients with IgA nephropathy can precipitate acute tubular necrosis, exacerbating their renal dysfunction.",-17.375,0.6,Disease
"Clozapine, a second‑generation antipsychotic frequently prescribed for refractory bipolar disorder, has been shown to cause severe neutropenia, which can precipitate life‑threatening infections that further compromise patients’ impaired memory performance and overall cognitive function.",-32.0,0.6,Disease
"Cognitive decline and impaired memory performance are frequently observed in patients with bipolar disorder, and treatment with the antipsychotic olanzapine can exacerbate these deficits by inducing a subtle neurochemical imbalance that mimics the pathophysiology of early-stage Alzheimer's disease.",-39.0,0.6,Disease
"The chemotherapeutic agent cisplatin induces nephrotoxicity that can aggravate IgA nephropathy, leading to accelerated renal dysfunction in patients with pre‑existing chronic kidney disease.",-26.0,0.6,Disease
"The adjunctive use of rivaroxaban in patients with IgA nephropathy and concurrent bipolar disorder may exacerbate memory deficits, particularly in those who experience tonic‑clonic seizures.",-31.625,0.6,Disease
"The use of the antiepileptic drug levetiracetam in patients with bipolar disorder has been associated with transient memory deficit, yet it remains unclear whether this adverse effect is mediated by its impact on hippocampal neuronal excitability or by an off‑target inhibition of GABA transporters.",-37.5,0.6,Disease
"Immunotherapy with nivolumab has been shown to reduce tumor burden in metastatic melanoma, yet it can induce immune‑mediated colitis and, in rare cases, IgA nephropathy, illustrating the delicate balance between therapeutic benefit and adverse renal effects.",-39.5,0.6,Disease
"Imatinib administration markedly reduced the frequency of tonic‑clonic seizures in patients with refractory bipolar disorder, yet the drug was also associated with transient conjunctival blanching and mild IgA nephropathy, underscoring the need for careful monitoring of renal function and ocular side effects during long‑term therapy.",-36.75,0.6,Disease
"Imipramine administration in a patient with bipolar disorder exacerbated the patient's memory deficit, leading to impaired memory performance during a tonic‑clonic seizure episode.",-28.125,0.6,Disease
"Atrial fibrillation patients receiving rivaroxaban experience a markedly reduced incidence of ischemic stroke compared with those treated with warfarin, yet the risk of major gastrointestinal bleeding remains higher in the rivaroxaban cohort.",-25.0,0.6,Disease
"A patient with IgA nephropathy experienced worsening proteinuria after initiating cisplatin therapy, suggesting that cisplatin may exacerbate renal injury in this disease.",-22.0,0.6,Disease
"A study found that the antiepileptic drug levetiracetam ameliorated memory deficit in patients with bipolar disorder, yet it was associated with transient conjunctival blanching and a mild increase in serum creatinine, suggesting a possible renal impact.",-36.75,0.6,Disease
"Patients with bipolar disorder treated with clozapine often experience a dose‑dependent risk of IgA nephropathy, which may exacerbate their impaired memory performance.",-25.125,0.6,Disease
Patients treated with the novel antipsychotic risperidone for bipolar disorder experienced a significant reduction in tonic‑clonic seizure frequency while concurrently showing improved memory performance and no evidence of IgA nephropathy or conjunctival blanching.,-29.625,0.6,Disease
"Patients receiving the novel antiepileptic drug levetiracetam for refractory tonic‑clonic seizures experienced a marked reduction in seizure frequency, but also reported transient memory deficits that resolved upon tapering the medication.",-27.5,0.6,Disease
"Bisphenol A exposure has been shown to aggravate IgA nephropathy progression by enhancing epithelial hyperplasia and inflammatory cytokine release, thereby increasing the risk of renal failure in patients with underlying bipolar disorder.",-27.75,0.6,Disease
"Bisphosphonate therapy for IgA nephropathy can induce conjunctival blanching, a rare adverse effect that may mimic the ocular manifestations of ocular hypertension.",-30.5,0.6,Disease
"Bisoprolol alleviates the tachycardia that often accompanies hypoplastic left heart syndrome, thereby reducing the risk of ventricular arrhythmias in these patients.",-25.625,0.6,Disease
Subclinical improvement in impaired memory performance was observed in patients with bipolar disorder after administration of the novel NMDA receptor antagonist memantine.,-25.625,0.6,Disease
"Subcutaneous injection of tacrolimus in patients with IgA nephropathy has been shown to ameliorate proteinuria but may induce a transient, dose‑dependent decline in renal function that mimics acute tubular necrosis.",-39.25,0.6,Disease
"Subchronic administration of the antiepileptic valproic acid in patients with bipolar disorder has been shown to aggravate memory deficit and impair long‑term memory performance, a phenomenon that may be mediated by valproic‑acid‑induced GABAergic modulation of hippocampal circuitry.",-51.5,0.6,Disease
"Treatment with the antiepileptic drug levetiracetam in patients with bipolar disorder has been shown to reduce the frequency of tonic‑clonic seizures while improving impaired memory performance, although it may occasionally cause conjunctival blanching.",-26.125,0.6,Disease
Treatment of IgA nephropathy with the novel immunosuppressant tacrolimus has been shown to reduce proteinuria but may exacerbate memory deficits in patients with concurrent bipolar disorder.,-19.875,0.6,Disease
"Treatment‑induced memory deficit has been observed in patients with bipolar disorder receiving high‑dose antipsychotic therapy, suggesting that the drug’s neurotoxicity may exacerbate cognitive impairment.",-38.75,0.6,Disease
"Administration of the novel antiepileptic compound valproate sodium markedly reduced the frequency of tonic‑clonic seizures in patients with refractory epilepsy while simultaneously improving impaired memory performance, though a subset of subjects developed mild conjunctival blanching indicative of a transient ocular adverse effect.",-36.75,0.6,Disease
"Administration with the antiepileptic levetiracetam reduced the frequency of tonic‑clonic seizures but induced mild conjunctival blanching, an adverse effect that may limit its use in patients with pre‑existing IgA nephropathy.",-43.5,0.6,Disease
Administration and monitoring of the antiepileptic drug levetiracetam in patients with tonic‑clonic seizure and concurrent bipolar disorder can reduce seizure frequency but may also exacerbate impaired memory performance.,-38.75,0.6,Disease
"Fluoxetine, a selective serotonin reuptake inhibitor, is effective in treating bipolar disorder but can exacerbate memory deficit and impair impaired memory performance in patients with underlying IgA nephropathy.",-28.375,0.6,Disease
"Fluroxazole administration in patients with IgA nephropathy has been associated with a significant reduction in proteinuria but may also precipitate transient memory deficits, especially in those with underlying bipolar disorder.",-36.25,0.6,Disease
"Flunarizine, a calcium‑channel blocker, has been shown to reduce the frequency of tonic‑clonic seizures in patients with drug‑resistant epilepsy while also improving impaired memory performance, but it may exacerbate IgA nephropathy in susceptible individuals.",-32.5,0.6,Disease
"Anticancer drug cisplatin induces nephrotoxicity in patients with IgA nephropathy, worsening their renal function and increasing the risk of acute kidney injury.",-21.75,0.6,Disease
"Antipsychotic olanzapine, used to treat bipolar disorder, has been associated with transient memory deficits and impaired memory performance, particularly in patients who also exhibit signs of conjunctival blanching and epithelial hyperplasia.",-32.5,0.6,Disease
Antidepressant therapy with sertraline appears to improve impaired memory performance in patients with bipolar disorder while reducing the risk of tonic‑clonic seizures associated with severe hypoxic episodes in hypoplastic left heart syndrome.,-30.875,0.6,Disease
"Cisplatin administration for Wilms tumor often induces thrombocytopenia, which can worsen SVC syndrome and lead to restlessness and fits in affected patients.",-21.25,0.6,Disease
"Cognitive decline in Huntington's disease patients is exacerbated by heroin abuse, which increases the risk of thrombocytopenia and worsens leg and back pain, thereby accelerating the progression of disease symptoms.",-33.25,0.6,Disease
"Clozapine, commonly used to treat schizophrenia, can induce thrombocytopenia, a serious hematologic adverse effect that may worsen the bleeding risk in patients with Huntington’s disease who already experience motor restlessness and increased susceptibility to falls.",-43.25,0.6,Disease
"A high‑dose regimen of cisplatin, a potent antineoplastic chemical, can trigger thrombocytopenia in patients with Wilms tumor, thereby increasing their risk of severe bleeding complications.",-28.375,0.6,Disease
"A study found that the chemotherapeutic agent cisplatin, used to treat Wilms tumor, can induce thrombocytopenia and exacerbate superior vena cava syndrome, prompting clinicians to monitor platelet counts closely in patients experiencing restlessness and polydipsia during therapy.",-29.125,0.6,Disease
"A recent cohort study showed that patients with Huntington's disease who received the anti‑seizure drug valproate experienced a significant reduction in fit frequency, but also developed mild thrombocytopenia as an adverse effect.",-29.875,0.6,Disease
"Patients with **Wilms tumor** receiving **cisplatin** therapy frequently develop **thrombocytopenia**, which can exacerbate their **restlessness** and lead to **fits** that mimic **superior vena cava (SVC) syndrome** symptoms.",-25.0,0.6,Disease
"Patients presenting with SVC syndrome secondary to Wilms tumor often experience severe restlessness and polydipsia, which can be exacerbated by the chemotherapeutic agent cisplatin.",-23.875,0.6,Disease
"Patients treated with cisplatin for Wilms tumor often develop thrombocytopenia, which can worsen pre‑existing restlessness and polydipsia, complicating the management of their underlying disease.",-25.375,0.6,Disease
"In patients with Wilms tumor, preoperative cisplatin therapy can induce thrombocytopenia, which may worsen pre‑existing restlessness and polydipsia associated with the disease.",-23.625,0.6,Disease
"In the patient with Wilms tumor, the chemotherapeutic agent cisplatin induced thrombocytopenia that was mitigated by administering the platelet‑growth factor thrombopoietin.",-26.125,0.6,Disease
"In children with Wilms tumor undergoing nephrectomy, postoperative administration of cisplatin has been shown to reduce recurrence but may precipitate thrombocytopenia, thereby increasing the risk of bleeding complications.",-27.625,0.6,Disease
"The incidence of thrombocytopenia in patients receiving cisplatin for Wilms tumor is significantly higher when the drug is combined with the chemotherapeutic agent ifosfamide, suggesting a synergistic cytotoxic effect on bone marrow megakaryocytes.",-33.75,0.6,Disease
"The chemotherapy agent cisplatin, used to treat Wilms tumor, can cause thrombocytopenia, leading to increased risk of hemorrhagic complications in patients who already have a history of heroin abuse.",-24.875,0.6,Disease
"The patient’s sudden onset of severe restlessness and leg pain after heroin abuse was attributed to an acute SVC syndrome, a rare complication that can precipitate thrombocytopenia and worsen underlying Huntington’s disease.",-31.75,0.6,Disease
"High‑dose cisplatin administration for metastatic Wilms tumor has been shown to induce thrombocytopenia, which can exacerbate the risk of hemorrhagic complications in patients already presenting with superior vena cava syndrome.",-25.875,0.6,Disease
"High‐dose cisplatin administration in patients with Wilms tumor can precipitate thrombocytopenia, thereby increasing the risk of hemorrhagic complications that may mimic or worsen superior vena cava syndrome.",-24.5,0.6,Disease
"High-dose cisplatin therapy for Wilms tumor frequently induces thrombocytopenia, which can worsen patients’ pre‑existing restlessness and lead to severe leg and/or back pain.",-27.0,0.6,Disease
"Warfarin therapy for a patient with a history of heroin abuse and thrombocytopenia exacerbated the patient’s superior vena cava syndrome, causing severe restlessness and polydipsia.",-27.375,0.6,Disease
"War‑resistant cisplatin induces severe thrombocytopenia in patients with Wilms tumor, prompting clinicians to switch to alternative chemotherapeutics to mitigate the risk of bleeding complications.",-34.25,0.6,Disease
"Warhead, a novel anticancer agent, was shown to inhibit the growth of Wilms tumor cells while paradoxically inducing thrombocytopenia in treated patients.",-33.75,0.6,Disease
"Following chemotherapy for Wilms tumor, the patient developed superior vena cava syndrome, which was rapidly relieved after administration of cisplatin, illustrating the drug’s dual role in both treatment and potential vascular complications.",-33.25,0.6,Disease
"Following a surgical resection of a Wilms tumor, a patient developed superior vena cava syndrome due to residual tumor thrombus, prompting the use of cisplatin to reduce tumor burden and alleviate venous obstruction.",-35.0,0.6,Disease
"Following resection of a Wilms tumor, the patient’s postoperative course was complicated by thrombocytopenia, which prompted a review of the chemotherapeutic regimen to avoid exacerbating the risk of hemorrhagic complications.",-40.25,0.6,Disease
"Pediatric patients with Wilms tumor treated with high‑dose doxorubicin frequently develop thrombocytopenia, which can exacerbate bleeding risk during subsequent surgery for superior vena cava syndrome.",-25.375,0.6,Disease
Palliative chemotherapy with cisplatin mitigates superior vena cava syndrome in patients with refractory Wilms tumor but may exacerbate thrombocytopenia and cause restlessness in those with a history of heroin abuse.,-35.75,0.6,Disease
"Pazopanib, a multikinase inhibitor, has been shown to alleviate superior vena cava syndrome in patients with metastatic Wilms tumor while simultaneously reducing the risk of thrombocytopenia associated with aggressive chemotherapy.",-27.125,0.6,Disease
"Heroin abuse has been shown to exacerbate the risk of superior vena cava syndrome in patients with underlying Wilms tumor, often presenting with severe restlessness and polydipsia.",-21.125,0.6,Disease
"Hereditary Huntington's disease patients often exhibit early restlessness and polydipsia, and when combined with heroin abuse, these symptoms can precipitate severe thrombocytopenia that complicates surgical management of Wilms tumor.",-40.25,0.6,Disease
Herbal extracts that inhibit the MAPK pathway have shown promising antitumor activity against Wilms tumor but may also provoke thrombocytopenia as a dose‑dependent adverse effect.,-34.25,0.6,Disease
"Hepatic failure induced by chronic heroin abuse can precipitate severe thrombocytopenia, thereby aggravating the risk of spontaneous intracranial hemorrhage in patients with Huntington's disease.",-24.625,0.6,Disease
"Hedgehog pathway inhibition with vismodegib alleviates tumor burden in metastatic Wilms tumor but may provoke severe thrombocytopenia, complicating management of patients already experiencing superior vena cava syndrome.",-39.0,0.6,Disease
"Hispatic treatment with cisplatin can induce thrombocytopenia in patients with Wilms tumor, thereby exacerbating the risk of hemorrhagic complications that may mimic superior vena cava syndrome.",-34.0,0.6,Disease
Steroid therapy for a patient with superior vena cava syndrome secondary to metastatic Wilms tumor markedly reduced the tumor mass but induced a transient episode of thrombocytopenia that required platelet transfusion.,-31.75,0.6,Disease
"Sterile leukocyturia in children with Wilms tumor is frequently associated with superior vena cava syndrome, which can exacerbate polydipsia and restlessness, and treatment with cisplatin can worsen thrombocytopenia.",-35.25,0.6,Disease
"Steroidal therapy with dexamethasone alleviates the superior vena cava syndrome seen in patients with Wilms tumor while simultaneously exacerbating polydipsia and restlessness, highlighting the drug’s dual role in disease management and adverse effect induction.",-42.75,0.6,Disease
"The chemotherapy agent cisplatin, while effective against non‑small cell lung carcinoma, can induce peripheral neurotoxicity and hypokalemia, thereby worsening impaired heart function and precipitating AV block in susceptible patients.",-21.125,0.6,Disease
"The patient’s choreoathetoid movements were exacerbated by severe hypokalemia, which also contributed to impaired heart function and an AV block.",-14.3125,0.6,Disease
"The presence of choreoathetoid movements in patients with hypokalemia can precipitate impaired heart function and AV block, thereby increasing the risk of neurological complications.",-15.25,0.6,Disease
"In patients with choreoathetoid dystonia, the use of high‑dose levetiracetam can precipitate hypokalemia, which in turn may aggravate impaired heart function and lead to AV block, thereby increasing the risk of neurological complications and peripheral neurotoxicity.",-23.0,0.6,Disease
"In the patient with choreoathetoid movements, the administration of cisplatin induced peripheral neurotoxicity, which was exacerbated by concurrent hypokalemia and further complicated by an AV block.",-33.25,0.6,Disease
"In a cohort of patients with choreoathetoid movement disorder, hypokalemia was found to precipitate impaired heart function and AV block, thereby increasing the risk of neurological complications and peripheral neurotoxicity.",-22.25,0.6,Disease
"Excessive use of the anti‑emetic ondansetron in patients with chronic kidney disease can precipitate hypokalemia, thereby exacerbating choreoathetoid movements and increasing the risk of AV block.",-25.375,0.6,Disease
"Examination of patients with choreoathetoid movements revealed that the presence of hypokalemia was strongly associated with impaired heart function and a higher incidence of AV block, suggesting a potential link between electrolyte imbalance and cardiovascular complications.",-29.375,0.6,Disease
Exosomal microRNA‑210 released during hypokalemia‑induced myocardial ischemia can exacerbate choreoathetoid movements by impairing cardiac contractility and triggering peripheral neurotoxicity.,-41.75,0.6,Disease
"Cisplatin treatment for ovarian carcinoma frequently induces peripheral neurotoxicity and can precipitate hypokalemia, which in turn worsens impaired heart function and may lead to AV block.",-17.375,0.6,Disease
"Cognitive decline in patients with choreoathetoid movements is exacerbated by hypokalemia, which impairs heart function and can precipitate AV block.",-20.0,0.6,Disease
"Captopril administration in patients with chronic kidney disease and impaired heart function can precipitate hypokalemia, thereby increasing the risk of AV block and peripheral neurotoxicity.",-20.5,0.6,Disease
"Methotrexate treatment for choreoathetoid disease can precipitate hypokalemia, which in turn exacerbates impaired heart function and may trigger AV block.",-15.75,0.6,Disease
"Methyldopa was found to induce hypokalemia and AV block in patients with choreoathetoid Parkinsonism, thereby exacerbating their impaired heart function and increasing the risk of neurological complications.",-25.0,0.6,Disease
"Methoprene, a chemical pesticide, has been implicated in causing hypokalemia that precipitates choreoathetoid movements and, in severe cases, can lead to impaired heart function and AV block.",-30.625,0.6,Disease
"High‑dose methotrexate can precipitate peripheral neurotoxicity and hypokalemia, aggravating impaired heart function and increasing the risk of AV block in patients with choreoathetoid disease.",-19.75,0.6,Disease
"High-dose methotrexate can precipitate choreoathetoid movements in patients with chronic lymphocytic leukemia, while concurrent hypokalemia aggravates impaired heart function and peripheral neurotoxicity.",-28.25,0.6,Disease
"High-throughput sequencing revealed that patients with choreoathetoid movement disorders and concomitant hypokalemia exhibit a markedly higher incidence of impaired heart function, suggesting that the neuro‑cardiac axis may underlie the observed neurological complications.",-37.0,0.6,Disease
"Amoxicillin therapy for pyeloureteritis cystica can precipitate hypokalemia, which in turn may worsen impaired heart function and provoke AV block in patients with underlying choreoathetoid movement disorders.",-20.5,0.6,Disease
"Amiodarone, a widely used antiarrhythmic, can precipitate hypokalemia and AV block in patients with impaired heart function, thereby increasing the risk of neurological complications and peripheral neurotoxicity.",-23.125,0.6,Disease
Ameliorating hypokalemia with potassium chloride in patients experiencing choreoathetoid movements markedly reduces the risk of peripheral neurotoxicity and improves impaired heart function.,-24.5,0.6,Disease
"A patient with choreoathetoid movements and hypokalemia experienced impaired heart function and AV block after meth mouth, while pyeloureteritis cystica and peripheral neurotoxicity were noted as neurological complications.",-20.0,0.6,Disease
"A hypokalemia‑induced AV block in a patient with choreoathetoid dystonia can precipitate impaired heart function and lead to peripheral neurotoxicity, thereby increasing the risk of neurological complications.",-26.75,0.6,Disease
"A drug that induces hypokalemia can worsen impaired heart function and precipitate AV block in patients with choreoathetoid movement disorders, thereby increasing the risk of neurological complications.",-20.75,0.6,Disease
"Elderly patients with hypokalemia-induced choreoathetoid movements often experience impaired heart function and AV block, complicating the management of their peripheral neurotoxicity.",-19.5,0.6,Disease
"Echocardiographic analysis revealed that patients with choreoathetoid movements and hypokalemia exhibited impaired heart function, raising the possibility that the neurological complications of this movement disorder might contribute to the development of AV block.",-33.25,0.6,Disease
"Efficacy of the new kinase inhibitor was compromised by the patient’s concurrent hypokalemia, which exacerbated choreoathetoid movements and precipitated AV block, thereby limiting its therapeutic use in this case of impaired heart function.",-42.0,0.6,Disease
"Patients with choreoathetoid dystonia frequently develop hypokalemia that exacerbates impaired heart function and can precipitate AV block, thereby increasing the risk of neurological complications.",-16.0,0.6,Disease
"Patients experiencing choreoathetoid movements secondary to hypokalemia often develop impaired heart function, necessitating urgent correction of the electrolyte imbalance to prevent AV block and subsequent acute myocardial infarction.",-26.625,0.6,Disease
"Patients receiving high‑dose cisplatin for ovarian carcinoma frequently develop hypokalemia and peripheral neurotoxicity, which together can precipitate impaired heart function and AV block, thereby increasing the risk of AMI and gastrointestinal bleeding.",-25.25,0.6,Disease
"Treatment of choreoathetoid movement disorder with levetiracetam has been associated with hypokalemia, which can precipitate impaired heart function and AV block, thereby increasing the risk of neurological complications and peripheral neurotoxicity.",-24.0,0.6,Disease
Treatment with methadone has been shown to cause hypokalemia that can precipitate choreoathetoid movements and AV block in patients with impaired heart function.,-22.125,0.6,Disease
"Treatment failure of the chemotherapeutic agent cisplatin in patients with advanced ovarian carcinoma is often attributed to peripheral neurotoxicity and hypokalemia, which together exacerbate impaired heart function and can precipitate AV block.",-32.75,0.6,Disease
"Choreoathetoid movements in patients with hypokalemia have been shown to precipitate impaired heart function, leading to AV block and subsequent peripheral neurotoxicity.",-16.875,0.6,Disease
"Chronic hypokalemia induced by excessive diuretic therapy can precipitate choreoathetoid movements and AV block, thereby exacerbating impaired heart function and increasing the risk of neurological complications.",-19.125,0.6,Disease
"Chiral aminoguanidines, which are potent inhibitors of the GABA‑transaminase enzyme, have been shown to ameliorate choreoathetoid movements in patients with Huntington’s disease while simultaneously reducing the risk of hypokalemia‑induced AV block.",-49.5,0.6,Disease
"Cisplatin therapy for localized scleroderma patients has been shown to aggravate kidney disease, prompting clinicians to monitor serum creatinine levels closely to prevent circulatory failure.",-20.0,0.6,Disease
Ciprofloxacin treatment of hemorrhagic bronchopneumonia in a patient with Type B hepatitis can precipitate circulatory failure and exacerbate underlying kidney disease.,-22.5,0.6,Disease
Ceftriaxone treatment of hemorrhagic bronchopneumonia in a patient with underlying Type B hepatitis was complicated by acute kidney disease and refractory circulatory failure.,-26.25,0.6,Disease
"The chemotherapeutic agent cisplatin exacerbates kidney disease in patients with Type B hepatitis, increasing the risk of circulatory failure and myocardial cell injury.",-16.625,0.6,Disease
The therapeutic effect of the novel anti‑inflammatory compound AZ‑312 on Type B hepatitis was markedly reduced in patients who subsequently developed cirrhotic kidney disease due to drug‑induced nephrotoxicity.,-40.0,0.6,Disease
"The use of cisplatin in patients with Type B hepatitis can precipitate kidney disease through acute tubular necrosis, while also aggravating circulatory failure by inducing severe hypotension.",-26.75,0.6,Disease
"Chronic kidney disease patients treated with the novel chemical agent remdesivir exhibited a significant reduction in circulating inflammatory cytokines, suggesting that remdesivir may ameliorate kidney disease-associated inflammation.",-37.5,0.6,Disease
"Chlorpromazine administration in patients with type B hepatitis has been shown to exacerbate kidney disease by inhibiting CYP3A4-mediated metabolism, leading to elevated serum creatinine and potential circulatory failure.",-38.25,0.6,Disease
"Chloroquine, widely used to treat malaria, has been shown to induce type B hepatitis in a subset of patients, thereby exacerbating underlying kidney disease and precipitating circulatory failure.",-34.25,0.6,Disease
"Treatment with the antiviral drug ribavirin exacerbated the circulatory failure observed in patients with Type B hepatitis, leading to increased myocardial cell injury and a higher incidence of hemorrhagic bronchopneumonia.",-20.0,0.6,Disease
"Treatment of type B hepatitis with the antiviral drug ribavirin can lead to hypersalivation and, in rare cases, induce circulatory failure due to an exaggerated immune response.",-30.625,0.6,Disease
"Treatment regimens using cisplatin are associated with kidney disease, yet the drug’s antitumor efficacy in patients with type B hepatitis remains a subject of ongoing clinical investigation.",-44.5,0.6,Disease
"Patients with Type B hepatitis who receive interferon‑α therapy often develop severe irritability and, in rare cases, circulatory failure due to an autoimmune flare of localized scleroderma.",-21.875,0.6,Disease
"Patients receiving the novel antiviral drug ribavirin for Type B hepatitis often experience a dose‑dependent reduction in circulating viral load, yet a subset develops a paradoxical increase in serum creatinine indicative of early kidney disease.",-42.25,0.6,Disease
"Patients treated with cisplatin for localized scleroderma developed severe kidney disease, which in turn precipitated circulatory failure and myocardial cell injury.",-21.75,0.6,Disease
"A single dose of cisplatin can aggravate pre‑existing kidney disease, leading to circulatory failure and exacerbating localized scleroderma lesions.",-25.0,0.6,Disease
"A randomized trial showed that the administration of the novel antineoplastic agent cisplatin significantly reduced tumor burden in patients with type B hepatitis‑associated hepatocellular carcinoma while exacerbating kidney disease, leading to increased rates of acute tubular necrosis.",-40.0,0.6,Disease
A recent study showed that the chemotherapeutic drug cisplatin exacerbates kidney disease in patients with type B hepatitis by inducing oxidative stress and promoting tubular cell apoptosis.,-26.125,0.6,Disease
"In patients with type B hepatitis, the antiviral drug ribavirin has been shown to reduce hepatic inflammation but may precipitate hemolytic anemia and exacerbate underlying kidney disease.",-18.25,0.6,Disease
"In pediatric patients with Type B hepatitis, the antiviral agent interferon‑α has been shown to reduce viral replication but may precipitate hypersalivation and, in rare cases, circulatory failure due to its potent immunomodulatory effects.",-33.25,0.6,Disease
"In treating Type B hepatitis, interferon‑α therapy can paradoxically induce localized scleroderma, leading to circulatory failure and exacerbated kidney disease in susceptible patients.",-27.5,0.6,Disease
Early-stage type B hepatitis can accelerate kidney disease progression by promoting systemic inflammation that ultimately leads to circulatory failure.,-27.125,0.6,Disease
"Early‑stage type B hepatitis can precipitate cirrhotic circulatory failure, whereas early treatment with a synthetic antiviral such as ribavirin markedly reduces the risk of progression to end‑stage kidney disease.",-42.0,0.6,Disease
"Early intervention with the antiviral drug ribavirin can reduce the severity of type B hepatitis, thereby preventing the progression to chronic kidney disease.",-27.375,0.6,Disease
"Experimental evidence suggests that the anti‑inflammatory drug infliximab can reduce the progression of localized scleroderma by inhibiting the activation of fibroblasts that produce excessive collagen, thereby preventing further kidney disease and circulatory failure in affected patients.",-43.75,0.6,Disease
Experimental treatment of Type B hepatitis with a novel nucleoside analogue reduced viral load but unexpectedly induced severe hypersalivation and mild circulatory failure in a subset of patients.,-29.625,0.6,Disease
Experimental data indicate that the chemotherapeutic agent cisplatin exacerbates renal disease by inducing tubular cell injury and subsequent circulatory failure in patients with pre‑existing kidney disease.,-28.125,0.6,Disease
Severe hemorrhagic bronchopneumonia in a patient with Type B hepatitis precipitated circulatory failure that was refractory to standard vasopressor therapy.,-21.5,0.6,Disease
"Severely ill patients with Type B hepatitis and concomitant kidney disease frequently develop circulatory failure, and treatment with the antiviral drug ribavirin has been shown to exacerbate renal dysfunction, thereby increasing the risk of hemorrhagic bronchopneumonia.",-36.0,0.6,Disease
"Seventeen-year-old patients with Type B hepatitis who receive the antiviral drug ribavirin frequently develop hemolytic anemia, which can precipitate circulatory failure if not monitored closely.",-33.75,0.6,Disease
Dexmedetomidine alleviates myocardial cell injury in patients with circulatory failure while simultaneously reducing the risk of hemorrhagic bronchopneumonia associated with severe kidney disease.,-23.75,0.6,Disease
"Dexamethasone, a synthetic corticosteroid, has been shown to ameliorate the inflammatory cascade in Type B hepatitis by down‑regulating cytokine production, thereby reducing the risk of subsequent circulatory failure and myocardial cell injury.",-37.5,0.6,Disease
"Dexrazoxane markedly reduced myocardial cell injury in patients with Type B hepatitis undergoing high‑dose cisplatin therapy, thereby lowering the incidence of circulatory failure.",-22.875,0.6,Disease
"Cyclophosphamide treatment in patients with localized scleroderma often leads to kidney disease due to its nephrotoxic metabolites, exacerbating circulatory failure in those with underlying myocardial cell injury.",-29.0,0.6,Disease
"Cyclobenzaprine administration in patients with localized scleroderma can precipitate severe irritability and, in rare cases, circulatory failure, underscoring the need for careful monitoring of cardiovascular parameters during treatment.",-34.0,0.6,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, when combined with the aromatase inhibitor letrozole, markedly reduces tumor burden in estrogen‑receptor‑positive breast cancer but frequently induces neutropenia and, in a subset of patients, transient hepatic enzyme elevations that mimic drug‑induced Type B hepatitis.",-50.25,0.6,Disease
"Steroid therapy for HIV‑infected patients with myopathy can paradoxically worsen hypoxia by inducing pulmonary hypertension, a risk that must be weighed against the benefits of preventing opportunistic infections.",-32.5,0.6,Disease
Sterile pyeloureteritis cystica exacerbated by chronic hypoxia frequently leads to a loss of visual acuity in patients with concurrent HIV infection.,-29.5,0.6,Disease
Steroids used to treat myopathy in patients with human immunodeficiency virus (HIV)-infected individuals can paradoxically precipitate a loss of visual acuity due to retinal ganglion cell apoptosis.,-27.875,0.6,Disease
"Infliximab therapy for human immunodeficiency virus–infected patients with refractory myopathy has been shown to reduce muscle inflammation and improve visual acuity, but it can exacerbate tricuspid valve regurgitation in those with preexisting cardiac dysfunction.",-37.25,0.6,Disease
"Influenza vaccination is recommended for patients with HIV‑infected individuals, as it reduces the risk of severe viral pneumonia that can precipitate hypoxia and trigger ventricular septal defect in those with pre‑existing cardiac disease.",-38.5,0.6,Disease
"Inflammatory myopathy in HIV‑infected patients can exacerbate hypoxia and lead to tricuspid valve regurgitation, worsening visual acuity loss.",-24.875,0.6,Disease
"The antiviral drug zidovudine, used to treat HIV-infected patients, has been shown to induce myopathy, which in turn can exacerbate hypoxia in individuals with underlying tricuspid valve regurgitation.",-25.25,0.6,Disease
"The antiretroviral drug efavirenz was found to exacerbate retinal ganglion cell loss in human immunodeficiency virus (HIV)-infected patients, thereby accelerating the progression of a loss of visual acuity.",-19.25,0.6,Disease
"The new antiretroviral drug dolutegravir markedly reduces viral load in human immunodeficiency virus (HIV)-infected patients, but its long‑term use has been associated with a paradoxical increase in peripheral neuropathy, a form of myopathy that may manifest as arthralgia and loss of visual acuity due to retinal ganglion cell damage.",-41.5,0.6,Disease
"In patients with HIV‑infected individuals, the antiretroviral drug dolutegravir has been reported to cause a loss of visual acuity that appears to be mediated by retinal ganglion cell dysfunction.",-18.125,0.6,Disease
"In HIV‑infected patients, the antiretroviral drug dolutegravir can aggravate pre‑existing myopathy, leading to a progressive loss of visual acuity and exacerbating tricuspid valve regurgitation.",-17.75,0.6,Disease
"In the HIV‑infected patient, treatment with dolutegravir was associated with a transient rise in creatinine that suggested early nephrotoxicity, prompting discontinuation of the drug and subsequent resolution of the renal impairment.",-35.0,0.6,Disease
"Cisplatin administration in patients with HIV‑infected lymphoma frequently induces myopathy, which can worsen hypoxia and lead to a loss of visual acuity due to retinal ganglion cell damage.",-19.0,0.6,Disease
"Ceftriaxone therapy in patients with HIV‑infected meningoencephalitis reduces viral load but can precipitate acute renal failure, a complication that may mimic myopathy and impair visual acuity.",-38.0,0.6,Disease
"Cervical myopathy in human immunodeficiency virus‑infected patients can be exacerbated by the chronic hypoxia associated with severe tricuspid valve regurgitation, thereby increasing the risk of retinal ganglion cell loss and subsequent loss of visual acuity.",-30.25,0.6,Disease
"Methotrexate treatment in human immunodeficiency virus (HIV)-infected patients can exacerbate myopathy, potentially leading to a loss of visual acuity due to optic nerve involvement.",-24.375,0.6,Disease
Methadone administration in patients with human immunodeficiency virus (HIV)-infected individuals has been shown to worsen myopathy and precipitate a loss of visual acuity by impairing retinal ganglion cell function.,-32.25,0.6,Disease
Methyldopa mitigates the hypoxia‑induced progression of tricuspid valve regurgitation in patients with HIV‑infected myocarditis.,-28.625,0.6,Disease
"Patients with HIV‑infected individuals who develop tricuspid valve regurgitation often experience a loss of visual acuity due to retinal ganglion cell loss, and the administration of the antiviral drug abacavir has been shown to inhibit the progression of hypoxia‑induced myopathy in this cohort.",-30.75,0.6,Disease
"Patients receiving cisplatin for metastatic ovarian cancer frequently develop myopathy, which may be exacerbated by the drug’s inhibition of mitochondrial protein synthesis and can manifest as a loss of visual acuity due to optic neuropathy.",-28.875,0.6,Disease
Patients suffering from HIV‑infected individuals who develop pyeloureteritis cystica often experience a loss of visual acuity due to secondary retinal ganglion cell apoptosis.,-21.5,0.6,Disease
"A patient with HIV‑infected meningoencephalitis was treated with high‑dose ritonavir, but the drug’s CYP3A4 inhibition caused a clinically significant rise in serum tacrolimus levels, precipitating acute nephrotoxicity.",-31.25,0.6,Disease
"A clinical trial demonstrated that the novel chemotherapeutic agent cisplatin exacerbates myopathy in patients with HIV‑infected lymphoma, while also increasing the incidence of tricuspid valve regurgitation and hypoxia.",-34.25,0.6,Disease
"Acyclovir treatment of human immunodeficiency virus (HIV)-infected patients with opportunistic herpes zoster infection can reduce the incidence of postherpetic neuralgia, yet the drug may exacerbate underlying renal myopathy, thereby complicating management of the disease.",-48.0,0.6,Disease
Administration of the anti‑HIV drug dolutegravir was associated with a paradoxical onset of myopathy and a loss of visual acuity in a patient who had previously been diagnosed with human immunodeficiency virus (HIV) infection.,-33.0,0.6,Disease
Administration with a low dose of cisplatin was found to worsen the myopathy in patients with HIV‑infected individuals who also suffered from tricuspid valve regurgitation.,-45.25,0.6,Disease
"Administration to HIV‑infected patients of the antiretroviral drug dolutegravir has been associated with a dose‑dependent increase in serum creatinine, suggesting a reversible inhibition of renal tubular secretion that mimics acute kidney injury.",-39.25,0.6,Disease
"Zolpidem administration in patients with HIV‑infected individuals suffering from hypoxia‑induced myopathy has been observed to exacerbate retinal ganglion cell loss, thereby worsening visual acuity.",-28.0,0.6,Disease
Zinc‑citrate supplementation significantly reduces the incidence of hypoxia‑induced retinal ganglion cell loss in patients with HIV‑infected individuals experiencing chronic myopathy.,-28.125,0.6,Disease
Zebularine administration in patients with human immunodeficiency virus–infected individuals experiencing myopathy has been shown to reduce the severity of muscle weakness while also mitigating the risk of hypoxia‑induced cardiac arrhythmias.,-39.0,0.6,Disease
Rifampin therapy in patients with human immunodeficiency virus‑infected individuals who develop tricuspid valve regurgitation can precipitate severe hypoxia due to reduced pulmonary perfusion.,-34.75,0.6,Disease
"Ritonavir administration in human immunodeficiency virus (HIV)-infected patients can precipitate hypoxia by inhibiting CYP3A4-mediated clearance of oxygen‑transporting hemoglobin precursors, thereby aggravating pre‑existing tricuspid valve regurgitation.",-29.875,0.6,Disease
"Ribavirin treatment for chronic hepatitis C can worsen hypoxia in patients with underlying tricuspid valve regurgitation, thereby increasing the risk of pulmonary hypertension.",-25.375,0.6,Disease
"Treatment of HIV‑infected patients with the antiretroviral drug dolutegravir has been associated with a dose‑dependent increase in serum creatinine, which can mimic acute renal failure in individuals who also exhibit underlying myopathy and hypoxia.",-31.75,0.6,Disease
Treatment with the novel inhibitor bortezomib alleviates hypoxia‑induced myopathy in patients with human immunodeficiency virus‑infected pulmonary disease while concurrently reducing the risk of tricuspid valve regurgitation.,-32.5,0.6,Disease
"Treatment regimens with the antiretroviral drug zidovudine have been shown to induce myopathy in human immunodeficiency virus (HIV)-infected patients, causing a loss of visual acuity due to optic nerve atrophy.",-39.0,0.6,Disease
"Patients with vasculitis treated with high‑dose corticosteroids often develop secondary liver abscesses, complicating the clinical course.",-16.125,0.6,Disease
"Patients receiving high‑dose cisplatin for metastatic lung carcinoma frequently develop nephrotoxicity, a complication that can be mitigated by co‑administration of sodium thiosulfate, which competitively inhibits cisplatin‑induced oxidative DNA damage.",-30.75,0.6,Disease
"Patients treated with the novel antiepileptic drug levetiracetam for epilepsy-associated seizures experienced a significant reduction in the incidence of drug‑induced liver abscesses, suggesting a protective effect against hepatic microangiopathies that can complicate chronic therapy.",-32.75,0.6,Disease
"A retrospective analysis revealed that patients with vasculitis receiving high‑dose methylprednisolone had a significantly higher incidence of secondary liver abscesses, suggesting an adverse effect of the corticosteroid therapy on hepatic immune surveillance.",-27.375,0.6,Disease
A study showed that the anti‑inflammatory drug prednisolone markedly reduced the severity of vasculitis‑associated microangiopathies while simultaneously lowering the incidence of liver abscesses in patients with systemic lupus erythematosus.,-29.125,0.6,Disease
"A single dose of the novel anti‑inflammatory compound Z‑3110 reduced the incidence of pericarditis in mice with experimentally induced vasculitis, while also lowering serum interleukin‑6 levels associated with the inflammatory cascade.",-50.5,0.6,Disease
"Cisplatin-induced nephrotoxicity can exacerbate preexisting vasculitis, leading to renal microangiopathies and worsening liver abscess formation.",-22.5,0.6,Disease
"Captopril ameliorates hypertension in patients with vasculitis-induced microangiopathies, yet its long‑term use can precipitate a rare form of liver abscess that mimics the clinical picture of cholangitis.",-33.25,0.6,Disease
"Corticosteroid therapy for vasculitis can precipitate a liver abscess, thereby exacerbating the patient’s risk of sepsis and prolonging hospitalization.",-25.25,0.6,Disease
"The chemotherapeutic agent cisplatin, known for its potent antineoplastic activity against leukaemia, also induces a dose‑dependent microangiopathy that can precipitate acute liver abscesses in patients with pre‑existing hepatic dysfunction.",-26.5,0.6,Disease
"The chemotherapy drug cisplatin, commonly used to treat ovarian leukaemia, can induce a severe form of nephrotoxicity that mimics microangiopathic hemolytic anemia and often necessitates dose reduction.",-32.75,0.6,Disease
The anti‑inflammatory drug colchicine markedly reduces the risk of pericarditis recurrence in patients with systemic lupus erythematosus while simultaneously lowering the incidence of secondary liver abscesses associated with the disease.,-25.5,0.6,Disease
"In patients with vasculitis, administration of the anti‑inflammatory drug methylprednisolone can reduce the risk of developing a secondary liver abscess while also mitigating the risk of inducing milk fever in lactating animals.",-33.25,0.6,Disease
"In children with vasculitis, the use of high‑dose methylprednisolone has been shown to reduce the frequency of relapsing pericarditis while concurrently lowering serum creatinine levels that would otherwise rise in cases of kidney‑involving microangiopathies.",-42.0,0.6,Disease
"In a cohort of patients with vasculitis, administration of high‑dose corticosteroids was associated with a transient elevation of serum liver enzymes, suggesting a mild hepatotoxic effect that resolved upon tapering of the drug.",-36.75,0.6,Disease
"Hydroxychloroquine, a disease‑specific antimalarial, effectively treats systemic lupus erythematosus–associated vasculitis while also mitigating the risk of drug‑induced hepatotoxicity that can precipitate liver abscesses.",-35.5,0.6,Disease
"Hydralazine, a vasodilator used to treat hypertension, can trigger drug‑induced vasculitis that presents with fever, rash, and glomerulonephritis in susceptible patients.",-31.875,0.6,Disease
"Hydrocortisone effectively reduces the inflammatory response in patients with systemic vasculitis, thereby limiting the risk of secondary liver abscess formation that can arise from the compromised hepatic microcirculation.",-34.75,0.6,Disease
"Rifampicin administration for tuberculosis was associated with hepatotoxicity in patients who also developed a liver abscess, suggesting a potential drug‑induced exacerbation of hepatic inflammation.",-30.5,0.6,Disease
"Ranitidine administration in patients with severe pericarditis reduces the inflammatory cytokine IL‑6 and markedly improves cardiac tamponade symptoms, yet the drug’s hepatotoxicity remains a concern for those with concurrent liver abscess.",-44.5,0.6,Disease
"Racemic levamisole, a chemotherapeutic agent, exacerbated the patient’s vasculitis, causing severe microangiopathic hemolytic anemia and a secondary liver abscess that required urgent surgical drainage.",-36.75,0.6,Disease
"Methotrexate can exacerbate the microangiopathies that accompany systemic vasculitis, thereby worsening renal function and increasing the risk of liver abscess formation.",-28.375,0.6,Disease
Methocarbamol mitigates the seizures in epilepsy‑associated hippocampal injury while concurrently reducing the risk of methamphetamine‑induced liver abscess.,-38.75,0.6,Disease
"Methyldopa ameliorated hypertension in a patient with vasculitis, but the drug’s interaction with the renin‑angiotensin system exacerbated a pre‑existing pericarditis that had been initially misdiagnosed as a simple episode of bronchopneumonia.",-48.25,0.6,Disease
"Elevated serum bilirubin levels in patients with liver abscess and concurrent vasculitis suggest that the inflammatory cascade of vasculitis may exacerbate hepatic dysfunction, potentially accelerating the progression of hepatic injury.",-36.25,0.6,Disease
"Elevator operators with chronic bronchopneumonia experienced a significant reduction in respiratory distress when treated with a novel inhaled corticosteroid, suggesting a potential therapeutic pathway for inflammation-driven lung disease.",-52.75,0.6,Disease
Elevating the dose of cisplatin in patients with acute lymphoblastic leukaemia can aggravate nephrotoxicity and precipitate a microangiopathic hemolytic anemia that mimics acute kidney injury.,-41.25,0.6,Disease
"Oxcarbazepine, a sodium‑channel blocker used for epilepsy-associated seizures, has been shown to reduce inflammatory cytokine production in patients with vasculitis, thereby mitigating the risk of developing secondary liver abscesses.",-31.125,0.6,Disease
"Oxazepam, a benzodiazepine, was found to reduce seizure frequency in patients with epilepsy-associated hippocampal injury, yet its use was limited by the development of mild liver abscesses in a subset of subjects.",-33.25,0.6,Disease
"Oxidative‑stress‑induced microangiopathies in patients with vasculitis can exacerbate hippocampal injury, thereby increasing the risk of epilepsy‑associated seizures.",-22.75,0.6,Disease
"Treated with high‑dose cisplatin, the patient developed acute nephrotoxicity that precipitated a secondary liver abscess, illustrating the drug‑induced microangiopathic damage that can worsen pre‑existing vasculitis.",-34.25,0.6,Disease
"Tocilizumab, a monoclonal antibody targeting interleukin‑6 receptors, has been shown to alleviate symptoms of giant cell arteritis, a form of vasculitis, by inhibiting the inflammatory cascade that otherwise leads to arterial wall damage and ischemic complications.",-31.375,0.6,Disease
"Tadalafil, a phosphodiesterase‑5 inhibitor, has been shown to worsen pulmonary hypertension in patients with idiopathic pulmonary arterial hypertension, a form of vasculitis‑associated vascular remodeling that can precipitate right‑ventricular failure.",-28.625,0.6,Disease
Administration of the novel antiepileptic drug levetiracetam markedly reduced seizure frequency in patients with epilepsy-associated hippocampal injury while also lowering the incidence of drug‑induced liver abscesses.,-21.0,0.6,Disease
"Administration with the chemotherapeutic agent cisplatin exacerbated the patient’s pre‑existing pericarditis, leading to a marked elevation in troponin levels and necessitating urgent pericardiocentesis.",-37.0,0.6,Disease
"Administration or overuse of cisplatin can aggravate pre‑existing nephrotoxicity, exacerbating microangiopathies and leading to acute liver abscesses in patients with underlying vasculitis.",-47.75,0.6,Disease
"The patient’s acute hepatitis‑like illness was attributed to the drug’s hepatotoxicity, which also precipitated impaired renal function and a falling platelet count.",-18.75,0.6,Disease
"The administration of cisplatin in patients with acute hepatitis‑like illness often leads to impaired renal function, pathological renal medullary lesions, and a falling platelet count.",-15.4375,0.6,Disease
"The use of the chemotherapeutic agent cisplatin in patients with acute hepatitis‑like illness can exacerbate pathological renal medullary lesions and trigger impaired renal function, especially in those with pre‑existing tricuspid regurgitation.",-23.125,0.6,Disease
"Cisplatin treatment for glioblastoma patients can exacerbate pathological renal medullary lesions, leading to impaired renal function and a falling platelet count that may mimic acute hepatitis‑like illness.",-19.375,0.6,Disease
"Ceftriaxone treatment of Staphylococcal infections in a patient with acute hepatitis‑like illness was associated with a falling platelet count and impaired renal function, raising concern for drug‑induced thrombocytopenia and renal toxicity.",-24.5,0.6,Disease
"Ciprofloxacin administration in patients with acute hepatitis‑like illness can worsen impaired renal function and precipitate a falling platelet count, especially when underlying tricuspid regurgitation is present.",-23.0,0.6,Disease
"Methotrexate administration in patients with systemic sclerosis can aggravate pathological renal medullary lesions, leading to impaired renal function and a falling platelet count that mimics acute hepatitis‑like illness.",-16.5,0.6,Disease
Methadone administration in patients with epilepsy-induced seizures has been shown to worsen tricuspid regurgitation while concurrently improving impaired renal function and reducing the risk of Staphylococcal infections.,-31.875,0.6,Disease
"Methyldopa administration in patients with acute hepatitis‑like illness was associated with a transient drop in platelet count, suggesting a possible drug‑induced platelet sequestration in the context of impaired renal function.",-38.5,0.6,Disease
"In patients with acute hepatitis‑like illness, the administration of cisplatin was found to aggravate pathological renal medullary lesions, leading to impaired renal function and a falling platelet count.",-14.0625,0.6,Disease
"In renal transplant recipients, the use of the chemotherapeutic agent cisplatin has been associated with pathological renal medullary lesions that precipitate impaired renal function and, in some cases, a falling platelet count, thereby increasing susceptibility to acute hepatitis‑like illness and Staphylococcal infections.",-32.0,0.6,Disease
"In a cohort of patients with SSc, the use of the chemotherapeutic agent cisplatin was associated with a rapid decline in renal function and the development of acute hepatitis‑like illness, which in turn precipitated a falling platelet count and increased susceptibility to Staphylococcal infections.",-31.125,0.6,Disease
"High‑dose cisplatin therapy for patients with meningioma often aggravates impaired renal function, leading to pathological renal medullary lesions that mimic acute hepatitis‑like illness.",-21.5,0.6,Disease
"High‐dose cisplatin treatment for meningioma can induce acute hepatitis‑like illness and pathological renal medullary lesions, thereby exacerbating impaired renal function and precipitating a falling platelet count.",-21.0,0.6,Disease
"High-dose cisplatin therapy for meningioma patients can induce acute hepatitis‑like illness and pathological renal medullary lesions, leading to impaired renal function and a falling platelet count.",-17.625,0.6,Disease
"Patients receiving cisplatin for meningioma frequently develop pathological renal medullary lesions that impair renal function and precipitate acute hepatitis‑like illness, while a falling platelet count may signal concurrent Staphylococcal infections.",-21.5,0.6,Disease
"Patients with tricuspid regurgitation and pathological renal medullary lesions often develop impaired renal function, which can be exacerbated by acute hepatitis‑like illness and a falling platelet count, thereby increasing the risk of Staphylococcal infections.",-14.8125,0.6,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor imatinib for metastatic meningioma experienced a marked reduction in tricuspid regurgitation severity, yet developed acute hepatitis‑like illness accompanied by impaired renal function and a falling platelet count, prompting discontinuation of therapy.",-29.25,0.6,Disease
"A high‑dose regimen of cisplatin was found to aggravate pathological renal medullary lesions in patients with acute hepatitis‑like illness, thereby precipitating impaired renal function.",-17.75,0.6,Disease
"A patient with acute hepatitis‑like illness who developed pathological renal medullary lesions and impaired renal function was treated with cisplatin, which further exacerbated the falling platelet count and precipitated a severe episode of tricuspid regurgitation.",-21.75,0.6,Disease
"A sudden drop in platelet count following a Staphylococcal infection can precipitate acute hepatitis‑like illness and further impair renal function, especially in patients with underlying pathological renal medullary lesions.",-21.5,0.6,Disease
"Surgical resection of a meningioma that had caused acute hepatitis‑like illness was followed by a rapid decline in renal function, prompting the use of cisplatin to treat the resulting impaired renal function and the associated falling platelet count.",-35.25,0.6,Disease
"Sildenafil, a phosphodiesterase‑5 inhibitor, has been shown to worsen acute hepatitis‑like illness in patients with pre‑existing impaired renal function and a falling platelet count, thereby complicating the management of tricuspid regurgitation in those with systemic sclerosis (SSc).",-28.0,0.6,Disease
"Sunitinib treatment of metastatic meningioma can aggravate pathological renal medullary lesions, leading to impaired renal function and a falling platelet count in patients with concurrent acute hepatitis‑like illness.",-23.125,0.6,Disease
"Elevated serum creatinine in patients with tricuspid regurgitation and pathological renal medullary lesions is often exacerbated by acute hepatitis‑like illness, leading to impaired renal function and a falling platelet count.",-19.125,0.6,Disease
Elevate cisplatin dosage in patients with impaired renal function to treat acute hepatitis‑like illness while monitoring for pathological renal medullary lesions and a falling platelet count.,-32.25,0.6,Disease
"Elevations in serum alanine aminotransferase and bilirubin observed in patients with acute hepatitis‑like illness were found to be significantly reduced when treated with the antiviral drug ribavirin, which also mitigated the risk of pathological renal medullary lesions associated with impaired renal function.",-42.0,0.6,Disease
"Chemotherapeutic cisplatin administration exacerbates pathological renal medullary lesions in patients with pre‑existing impaired renal function, thereby heightening the risk of acute hepatitis‑like illness and falling platelet count.",-24.125,0.6,Disease
"Chemotherapy with cisplatin can aggravate pathological renal medullary lesions, leading to impaired renal function and a falling platelet count in patients with acute hepatitis‑like illness.",-14.4375,0.6,Disease
"Chemoradiotherapy with cisplatin aggravates impaired renal function in patients who already exhibit pathological renal medullary lesions, thereby increasing the risk of acute hepatitis‑like illness and a falling platelet count.",-28.0,0.6,Disease
"Amoxicillin treatment for Staphylococcal infections can exacerbate acute hepatitis‑like illness, leading to impaired renal function and a falling platelet count.",-17.0,0.6,Disease
"Amiodarone therapy for atrial fibrillation can aggravate pre‑existing tricuspid regurgitation and precipitate acute hepatitis‑like illness, especially in patients with impaired renal function and a falling platelet count.",-20.25,0.6,Disease
Ameliorating acute hepatitis‑like illness with the antiviral favipiravir markedly reduced the incidence of pathological renal medullary lesions in patients whose impaired renal function had previously been exacerbated by Staphylococcal infections.,-27.125,0.6,Disease
"I can incorporate a disease and a chemical.assistantanalysisWe need to produce exactly one English sentence. Must contain at least one Disease or Chemical entity, preferably both. Domain: Disease. Should mention a relationship such as treatment, inhibition, causation, or adverse effects. Must be biomedical, natural language, moderately complex. No quotes, no lists, no multiple sentences.

We have domain entity seeds: tricuspid regurgitation, pathological renal medullary lesions, acute hepatitis-like illness",-49.75,0.6,Disease
Itraconazole treatment of a patient with acute hepatitis‑like illness caused a falling platelet count and exacerbated pre‑existing impaired renal function.,-22.125,0.6,Disease
"I was surprised to discover that the patient’s acute hepatitis‑like illness, which was initially thought to be a viral infection, was actually caused by a Staphylococcal toxin that had induced pathological renal medullary lesions and a falling platelet count.",-37.5,0.6,Disease
"The novel tyrosine‑kinase inhibitor gefitinib, when combined with the anti‑inflammatory drug celecoxib, markedly reduces neuropathic pain in patients with metastatic ovarian cancer but paradoxically induces retinal vein occlusion in a subset of those with underlying chronic hepatitis.",-32.5,0.6,Disease
"The chemotherapeutic agent cisplatin, known to induce severe neuropathic pain, was found to exacerbate retinal vein occlusion in patients with underlying chronic hepatitis.",-15.625,0.6,Disease
"The chemotherapy drug cisplatin exacerbates neuropathic pain in patients with ovarian cancer, yet it remains a cornerstone for treating advanced-stage ovarian carcinoma.",-19.375,0.6,Disease
"Cisplatin administration in patients with ovarian cancer frequently induces neuropathic pain, which can be mitigated by concurrent use of gabapentin to reduce the severity of the drug‑induced sensory disturbances.",-22.125,0.6,Disease
"Cimetidine administration in patients with chronic hepatitis C has been reported to exacerbate neuropathic pain by inhibiting CYP1A2-mediated metabolism, thereby increasing systemic exposure to hepatotoxic metabolites.",-31.125,0.6,Disease
"Crocetin, a natural antioxidant, has been shown to ameliorate neuropathic pain in diabetic neuropathy by inhibiting the NF‑κB‑mediated inflammatory cascade.",-27.625,0.6,Disease
"In patients with ovarian cancer treated with cisplatin, the drug’s nephrotoxicity is often exacerbated by concurrent chronic hepatitis, leading to a higher incidence of renal failure and worsening neuropathic pain.",-22.25,0.6,Disease
"In Parkinson's disease patients receiving cisplatin for ovarian cancer, the drug’s neurotoxic profile can exacerbate pre‑existing neuropathic pain, prompting clinicians to monitor for worsening locomotor hypoactivity and skin rashes that may signal retinal vein occlusion or chronic hepatitis as secondary adverse effects.",-42.0,0.6,Disease
"In ovarian cancer patients, the chemotherapeutic agent cisplatin induces neuropathic pain and skin rashes, while also exacerbating underlying chronic hepatitis and leading to retinal vein occlusion in a subset of cases.",-27.875,0.6,Disease
"Investigators found that cisplatin administration exacerbated neuropathic pain in patients with ovarian cancer, while concurrently inducing retinal vein occlusion as an adverse effect.",-24.625,0.6,Disease
"Investigational trials of the novel kinase inhibitor sunitinib have shown that it can reduce neuropathic pain in patients with chronic hepatitis while simultaneously exacerbating skin rashes and causing transient ocular edema, a side effect that may be linked to retinal vein occlusion in susceptible individuals.",-52.75,0.6,Disease
"Investigating the therapeutic potential of the novel anti‑inflammatory compound X‑123, researchers found that it significantly reduced neuropathic pain in patients with diabetic peripheral neuropathy while also lowering the incidence of retinal vein occlusion in those with concomitant chronic hepatitis.",-45.5,0.6,Disease
"Intravenous cisplatin administration for ovarian cancer patients frequently induces neuropathic pain and skin eruptions, prompting clinicians to monitor for retinal vein occlusion as a rare but severe adverse effect.",-24.0,0.6,Disease
"Intriguingly, the administration of cisplatin in patients with ovarian cancer was found to exacerbate neuropathic pain while simultaneously inducing retinal vein occlusion, highlighting a complex interplay between chemotherapeutic efficacy and vascular side effects.",-33.0,0.6,Disease
"Intrapatient variability in the response of chronic hepatitis C patients to interferon‑α therapy is partially explained by the presence of underlying arterial dysfunction, which can aggravate neuropathic pain and trigger skin rashes that mimic the early signs of ovarian cancer.",-48.25,0.6,Disease
"A phase‑II study found that the oral drug cabozantinib markedly improved progression‑free survival in patients with metastatic ovarian cancer, but it also induced severe neuropathic pain and skin rashes that required dose reductions.",-33.0,0.6,Disease
"A novel small‑molecule inhibitor of the PI3K pathway, which selectively blocks tumor‑cell proliferation in ovarian cancer, was shown to reduce neuropathic pain in a murine model of paclitaxel‑induced peripheral neuropathy.",-33.75,0.6,Disease
"A recent clinical trial demonstrated that the chemotherapeutic agent cisplatin, while effectively reducing tumor burden in ovarian cancer patients, also induced severe neuropathic pain and skin rashes, prompting investigators to evaluate the role of adjunctive gabapentin therapy in mitigating these adverse effects.",-36.25,0.6,Disease
"Antiepileptic drug levetiracetam alleviates neuropathic pain in patients with chronic hepatitis, yet it can trigger skin rashes and exacerbate retinal vein occlusion in those with underlying ovarian cancer.",-30.125,0.6,Disease
"Antitumor activity of the novel PI3Kδ inhibitor idelalisib was observed in patients with relapsed ovarian cancer, yet the drug’s hepatotoxicity manifested as elevated serum alanine aminotransferase levels, prompting dose reduction in those with underlying chronic hepatitis.",-43.75,0.6,Disease
"Antiviral therapy with tenofovir disoproxil fumarate, while effective against chronic hepatitis B, has been associated with renal tubular dysfunction and subsequent development of arterial dysfunction in patients with pre‑existing neuropathic pain.",-34.75,0.6,Disease
"Use of the chemotherapeutic agent cisplatin in ovarian cancer patients frequently induces neuropathic pain and can aggravate chronic hepatitis, thereby worsening retinal vein occlusion and leading to skin rashes that manifest as eruptions and stuporous, locomotor hypoactivity.",-33.5,0.6,Disease
"Use low‑dose aspirin to reduce the risk of retinal vein occlusion in patients with chronic hepatitis, but the drug may exacerbate neuropathic pain associated with ovarian cancer.",-28.75,0.6,Disease
"Use the chemotherapy drug cisplatin to treat ovarian cancer, but monitor patients for nephrotoxicity that can exacerbate chronic hepatitis and trigger skin rashes and neuropathic pain.",-28.0,0.6,Disease
Chemoprevention with aspirin markedly reduces the incidence of ovarian cancer in patients with a history of chronic hepatitis and concomitant retinal vein occlusion.,-24.875,0.6,Disease
"Chemotherapy with cisplatin exacerbates neuropathic pain in patients with ovarian cancer, while concurrent use of gabapentin partially mitigates the drug‑induced sensory disturbances.",-22.375,0.6,Disease
Chemotherapeutic cisplatin induces neuropathic pain by exacerbating retinal vein occlusion in patients with ovarian cancer.,-17.5,0.6,Disease
"Patients with ovarian cancer receiving cisplatin frequently develop neuropathic pain that is exacerbated by the drug’s inhibition of DNA repair pathways, leading to severe skin rashes and chronic hepatitis in a subset of cases.",-19.875,0.6,Disease
"Patients treated with the antitumor agent cisplatin for ovarian cancer frequently develop neuropathic pain and skin rashes that are exacerbated by concomitant chronic hepatitis, underscoring the need for careful monitoring of liver function to mitigate these adverse effects.",-33.0,0.6,Disease
"Patients receiving cisplatin for ovarian cancer frequently develop neuropathic pain and skin rashes, which can exacerbate locomotor hypoactivity and lead to a stuporous state that impairs rehabilitation.",-26.875,0.6,Disease
"High‑dose cisplatin therapy for ovarian cancer frequently induces neuropathic pain and skin rashes, while concurrent use of the antioxidant N‑acetylcysteine mitigates these adverse effects by scavenging reactive oxygen species.",-24.875,0.6,Disease
"High-dose cisplatin treatment for ovarian cancer frequently induces neuropathic pain and skin rashes, while concurrent use of the antioxidant compound N‑acetylcysteine reduces these adverse effects by mitigating oxidative stress in the peripheral nervous system.",-33.75,0.6,Disease
"High‐dose cisplatin induces acute renal failure and subsequent neuropathic pain in patients with ovarian cancer, prompting clinicians to consider alternative chemotherapeutic regimens to mitigate these adverse effects.",-30.625,0.6,Disease
"Stimulant therapy with methylphenidate alleviates locomotor hypoactivity and neuropathic pain in patients with chronic hepatitis, yet it may exacerbate skin rashes and retinal vein occlusion in those with underlying ovarian cancer.",-24.625,0.6,Disease
"Stenotrophomonas maltophilia infection in a patient with chronic hepatitis B was found to exacerbate neuropathic pain and trigger skin rashes, suggesting that the bacterial endotoxin may worsen hepatic dysfunction and induce an inflammatory cascade that aggravates both dermatologic and neurologic symptoms.",-45.75,0.6,Disease
"Streptozotocin administration in diabetic mice induces retinal vein occlusion, which in turn exacerbates neuropathic pain and produces characteristic skin eruptions that are mitigated by the antioxidant drug N‑acetylcysteine.",-34.5,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against acute promyelocytic leukemia, can trigger a severe cardiotoxic response manifested as tricuspid valve regurgitation and transient ischemic attacks in susceptible patients.",-23.125,0.6,Disease
"The administration of cisplatin in patients with acute promyelocytic leukemia markedly reduces the incidence of thromboembolism, yet it can precipitate transient ischaemic attacks through acute renal dysfunction.",-26.25,0.6,Disease
The antithrombotic drug rivaroxaban markedly reduces the risk of recurrent thromboembolism in patients with acute promyelocytic leukemia who also present with tricuspid valve regurgitation.,-15.375,0.6,Disease
"Cisplatin treatment for acute promyelocytic leukemia can trigger thromboembolism, which in turn may worsen tricuspid valve regurgitation and precipitate cerebral vasospasm.",-15.9375,0.6,Disease
"Clozapine, a second‑generation antipsychotic, has been shown to induce agranulocytosis, which can precipitate life‑threatening bacterial meningitis, thereby illustrating a direct causal link between the drug’s hematologic toxicity and severe infectious disease.",-40.0,0.6,Disease
"Cervical thrombosis can precipitate transient ischemic attacks, and the use of the antithrombotic drug rivaroxaban reduces the risk of subsequent thromboembolism in patients with a history of subarachnoid hemorrhage.",-36.5,0.6,Disease
"Acute promyelocytic leukemia patients receiving all-trans retinoic acid frequently develop transient ischaemic attacks, likely due to drug‑induced thromboembolism.",-16.125,0.6,Disease
"Acetaminophen overdose can precipitate acute liver failure, and when combined with chronic alcohol intoxication, it markedly increases the risk of subarachnoid hemorrhage by accelerating cerebral vasospasm.",-25.125,0.6,Disease
"Acquired thromboembolism is a known complication of acute alcohol intoxication, and the administration of the anticoagulant rivaroxaban has been shown to reduce the risk of recurrent embolic events in patients with a history of transient ischaemic attacks.",-32.0,0.6,Disease
"In patients with acute promyelocytic leukemia, the combination of all-trans retinoic acid and arsenic trioxide not only induces remission but also markedly reduces the risk of cerebral vasospasm and subsequent transient ischemic attacks that often accompany subarachnoid hemorrhage.",-18.75,0.6,Disease
"In treating acute promyelocytic leukemia, the combination of all-trans retinoic acid and arsenic trioxide markedly reduces the risk of thromboembolism while concurrently mitigating the risk of tricuspid valve regurgitation that can arise from intensive chemotherapy.",-31.625,0.6,Disease
"In acute promyelocytic leukemia patients, the administration of all-trans retinoic acid reduces the risk of thromboembolism by inhibiting leukocyte adhesion and platelet aggregation.",-19.75,0.6,Disease
"A hypercoagulable state induced by acute alcohol intoxication can precipitate thromboembolism, which in turn exacerbates cerebral vasospasm and worsens outcomes in patients with subarachnoid hemorrhage.",-21.875,0.6,Disease
"A prospective cohort study demonstrated that patients with acute promyelocytic leukemia who received the retinoic acid derivative all-trans retinoic acid experienced a significant reduction in thromboembolism compared with those who did not, suggesting a protective effect of the drug against vascular complications.",-33.25,0.6,Disease
A recent retrospective analysis found that patients with acute promyelocytic leukemia who received early all-trans retinoic acid therapy experienced a markedly reduced incidence of thromboembolism compared with those who received standard chemotherapy alone.,-22.875,0.6,Disease
"High‑dose cisplatin therapy for acute promyelocytic leukemia can precipitate thromboembolism, which in turn may aggravate pre‑existing tricuspid valve regurgitation and lead to cerebral vasospasm.",-19.25,0.6,Disease
"High-dose cisplatin treatment for acute promyelocytic leukemia can induce transient ischaemic attacks through thromboembolism, while the drug’s nephrotoxic effect often manifests as leukocyturia and may worsen tricuspid valve regurgitation in patients with underlying heart disease.",-36.75,0.6,Disease
"High plasma levels of cisplatin in patients with acute promyelocytic leukemia often provoke severe leukocyturia, a complication that can precipitate cerebral vasospasm and worsen outcomes of thromboembolism associated with tricuspid valve regurgitation.",-41.5,0.6,Disease
"Radiotherapy with cisplatin markedly reduced tumor burden in patients with acute promyelocytic leukemia, but the combination also precipitated transient ischemic attacks and worsened tricuspid valve regurgitation.",-24.75,0.6,Disease
"Radiation therapy for acute promyelocytic leukemia can precipitate thromboembolism, which in turn may worsen tricuspid valve regurgitation and provoke transient ischemic attacks.",-20.0,0.6,Disease
"Radiographic evidence of tricuspid valve regurgitation in patients with thromboembolism can precipitate transient ischemic attacks, prompting clinicians to consider anticoagulation therapy to mitigate further cerebral vasospasm.",-29.5,0.6,Disease
"Hemodynamic instability in patients with acute promyelocytic leukemia undergoing induction therapy is often exacerbated by the development of thromboembolism, which can precipitate tricuspid valve regurgitation and cerebral vasospasm.",-27.125,0.6,Disease
Hemoptysis in patients with acute promyelocytic leukemia who receive arsenic trioxide therapy is frequently accompanied by transient ischaemic attacks due to paradoxical thromboembolism.,-27.0,0.6,Disease
"Hemangioma‑associated thrombosis is frequently exacerbated by the use of high‑dose aspirin in patients with acute promyelocytic leukemia, prompting clinicians to monitor for thromboembolism while balancing the risk of bleeding.",-42.25,0.6,Disease
Patients with acute promyelocytic leukemia who develop thromboembolism after induction therapy with all-trans retinoic acid often exhibit transient ischaemic attacks due to paradoxical emboli from a tricuspid valve regurgitation‑related right‑to‑left shunt.,-27.375,0.6,Disease
"Patients undergoing treatment with cisplatin for acute promyelocytic leukemia frequently develop nephrotoxicity, which can precipitate acute kidney injury and exacerbate the risk of thromboembolism.",-23.375,0.6,Disease
"Patients receiving cisplatin for acute promyelocytic leukemia frequently develop tricuspid valve regurgitation, a complication that may be exacerbated by concurrent thromboembolism and worsens cerebral vasospasm after subarachnoid hemorrhage.",-21.25,0.6,Disease
"Intravenous infusion of cisplatin in patients with acute promyelocytic leukemia markedly increases the risk of thromboembolism, a complication that can precipitate tricuspid valve regurgitation and ultimately lead to cerebral vasospasm.",-24.75,0.6,Disease
"Intracranial thromboembolism following acute alcohol intoxication can precipitate subarachnoid hemorrhage and trigger cerebral vasospasm, thereby exacerbating transient ischemic attacks and potentially worsening tricuspid valve regurgitation.",-26.75,0.6,Disease
"Intrathecal administration of the chemotherapeutic agent cisplatin markedly reduced cerebral vasospasm in patients with subarachnoid hemorrhage, but also precipitated acute alcohol‑induced leukocyturia, complicating the clinical management of their underlying hypertrophic cardiomyopathy.",-42.25,0.6,Disease
"Treatment with the antineoplastic agent arsenic trioxide reduces leukocytosis in patients with acute promyelocytic leukemia but can trigger transient ischaemic attacks through cerebral vasospasm, thereby complicating management of concurrent tricuspid valve regurgitation.",-37.25,0.6,Disease
"Treatment of acute promyelocytic leukemia with all-trans retinoic acid can precipitate a transient ischaemic attack, illustrating how differentiation therapy may provoke cerebral vasospasm and thromboembolism.",-24.25,0.6,Disease
"Treatment for acute promyelocytic leukemia with all-trans retinoic acid can induce a transient ischaemic attack by promoting differentiation‑associated platelet aggregation, thereby increasing the risk of thromboembolism.",-33.5,0.6,Disease
Methotrexate treatment of acute promyelocytic leukemia has been shown to reduce the risk of thromboembolism but may precipitate transient ischaemic attacks in patients with underlying tricuspid valve regurgitation.,-17.875,0.6,Disease
Methyldopa therapy for hypertrophic cardiomyopathy has been associated with transient ischaemic attacks in patients who subsequently develop tricuspid valve regurgitation due to thromboembolism.,-29.75,0.6,Disease
Methadone treatment in patients with acute promyelocytic leukemia can precipitate thromboembolism by inducing a hypercoagulable state that aggravates tricuspid valve regurgitation.,-30.375,0.6,Disease
"A recent cohort study demonstrated that patients with impaired renal function who received the chemotherapeutic agent cisplatin experienced a higher incidence of constipation, suggesting a dose-dependent nephrotoxic effect that may exacerbate gastrointestinal dysmotility.",-26.75,0.6,Disease
"Aspirin administration in patients with impaired renal function reduces the risk of ventricular dysfunction following a myocardial infarction, but may worsen constipation in those with preexisting gastrointestinal disorders.",-26.875,0.6,Disease
"A randomized trial showed that the administration of the novel chemotherapeutic agent cisplatin exacerbated impaired renal function in patients with a history of ventricular dysfunction, while concomitant use of the antioxidant drug N‑acetylcysteine mitigated the loss of taste sensation typically observed after cisplatin therapy.",-37.25,0.6,Disease
"Cisplatin therapy can precipitate impaired renal function, especially in patients with pre‑existing ventricular dysfunction, thereby exacerbating constipation and loss of taste sensation.",-17.625,0.6,Disease
"Corticosteroid therapy for chronic lateral epicondylitis was found to worsen impaired renal function in patients with a history of ventricular dysfunction, potentially due to the drug’s nephrotoxic effects.",-29.625,0.6,Disease
Cimetidine therapy for patients with impaired renal function can aggravate constipation while concurrently alleviating the oscillopsia associated with their ventricular dysfunction.,-29.625,0.6,Disease
"Patients treated with cisplatin for ovarian carcinoma frequently develop impaired renal function and, in a subset, an unexpected loss of taste sensation that may mimic the sensory deficits seen in respiratory syncytial virus infection.",-28.125,0.6,Disease
"Patients with chronic constipation who were treated with the chemical agent colesevelam experienced a reduction in oscillopsia, suggesting that colesevelam may improve visual stability in this disease state.",-33.0,0.6,Disease
"Patients undergoing cisplatin therapy for ovarian cancer often develop impaired renal function, which can exacerbate pre‑existing constipation and lead to loss of taste sensation.",-21.875,0.6,Disease
"The therapeutic efficacy of the novel antioxidant drug N-acetylcysteine was evaluated in patients with chronic obstructive pulmonary disease, revealing that its administration significantly reduced oxidative lung injury and improved exercise tolerance, thereby attenuating the progression of respiratory failure.",-44.25,0.6,Disease
"The novel chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, induces impaired renal function and a dose‑dependent loss of taste sensation, prompting clinicians to monitor serum creatinine and consider adjunctive anti‑emetic therapy.",-30.5,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, can precipitate impaired renal function, leading to electrolyte disturbances that may manifest as loss of taste sensation in some patients.",-24.125,0.6,Disease
"Administration of the tyrosine kinase inhibitor gefitinib reduced the ventricular dysfunction observed in patients with TAA, but also exacerbated their impaired renal function, leading to a higher incidence of constipation and loss of taste sensation.",-34.0,0.6,Disease
"Administration with the chemotherapeutic agent cisplatin markedly exacerbated the patient’s impaired renal function, triggering a rapid decline in glomerular filtration rate that was subsequently mitigated only after the initiation of a low‑dose aspirin regimen.",-48.0,0.6,Disease
"Administration routine use of the antineoplastic agent cisplatin was found to aggravate the patient’s impaired renal function, thereby exacerbating the risk of chronic kidney disease in individuals already suffering from a history of chemotherapy‑induced nephrotoxicity.",-59.0,0.6,Disease
"In patients with impaired renal function, the chemotherapeutic agent cisplatin exacerbates ventricular dysfunction while simultaneously inducing loss of taste sensation.",-13.1875,0.6,Disease
Inhibition of the CYP3A4-mediated clearance of cisplatin was observed to exacerbate the impaired renal function that develops in patients undergoing treatment for a ventricular dysfunction secondary to a respiratory syncytial virus infection.,-38.5,0.6,Disease
"In diabetic patients, the administration of cisplatin exacerbates impaired renal function, thereby accelerating the progression of chronic kidney disease.",-24.375,0.6,Disease
"Regular treatment of ventricular dysfunction with the anti‑arrhythmic drug amiodarone may aggravate impaired renal function, thereby increasing the risk of electrolyte imbalance and subsequent loss of taste sensation.",-33.25,0.6,Disease
"Regular aspirin use in patients with ventricular dysfunction may worsen impaired renal function, yet paradoxically reduce the risk of respiratory syncytial virus infection–related complications.",-29.75,0.6,Disease
Regular monitoring of ventricular dysfunction in patients receiving cisplatin therapy is essential because the drug’s nephrotoxic effect can precipitate impaired renal function and exacerbate cardiac complications.,-25.75,0.6,Disease
Radiation therapy with cisplatin markedly improves survival in patients with non‑small‑cell lung cancer but is also associated with a dose‑dependent risk of impaired renal function.,-26.0,0.6,Disease
"Radiotherapy with cisplatin induces impaired renal function, a common adverse effect that can exacerbate ventricular dysfunction in patients with pre‑existing heart failure.",-23.25,0.6,Disease
"Radiographic evaluation of a patient with ventricular dysfunction revealed an infarct‑avid lesion, and the concurrent use of cisplatin was found to exacerbate impaired renal function, prompting a switch to a less nephrotoxic chemotherapeutic agent.",-30.375,0.6,Disease
"Efficacy of the novel small‑molecule inhibitor, VTX‑123, was demonstrated in a phase‑II trial where it significantly reduced ventricular dysfunction in patients with post‑myocardial infarction heart failure, but concomitant use of the drug was associated with transient loss of taste sensation in a subset of participants.",-48.75,0.6,Disease
"Esmolol administration in patients with ventricular dysfunction after an acute myocardial infarct markedly reduced arrhythmia burden but precipitated a dose‑dependent decline in impaired renal function, underscoring the drug’s dual cardiovascular benefit and renal risk.",-40.75,0.6,Disease
"Elderly patients with impaired renal function who receive cisplatin for ovarian carcinoma frequently develop acute kidney injury, which can be mitigated by pre‑treatment with the antioxidant N‑acetylcysteine.",-27.25,0.6,Disease
"Metformin, a widely prescribed chemical for type‑2 diabetes, has been shown to reduce the risk of ventricular dysfunction in patients with impaired renal function, while its use is contraindicated in those with severe renal insufficiency due to the potential for lactic acidosis.",-39.0,0.6,Disease
"Metronidazole treatment for patients with respiratory syncytial virus infection can worsen impaired renal function, especially in those with pre‑existing ventricular dysfunction.",-24.375,0.6,Disease
"Metastatic colorectal cancer patients receiving the chemotherapeutic agent irinotecan frequently develop severe constipation, which can exacerbate their impaired renal function and increase the risk of ventricular dysfunction.",-26.75,0.6,Disease
"High‑dose cisplatin induces impaired renal function, which can worsen ventricular dysfunction in patients with pre‑existing heart failure.",-18.0,0.6,Disease
"High-dose cisplatin therapy for ovarian carcinoma frequently induces impaired renal function, which in turn exacerbates constipation and may trigger oscillopsia in patients with pre‑existing ventricular dysfunction.",-21.25,0.6,Disease
"High‐dose cisplatin therapy for lung carcinoma can precipitate impaired renal function, exacerbating preexisting constipation and leading to oscillopsia in patients with underlying trichotillomania.",-31.0,0.6,Disease
"Bisphenol A exposure exacerbates ventricular dysfunction in patients with impaired renal function, increasing the risk of respiratory syncytial virus infection–related pneumonia.",-22.5,0.6,Disease
"Bisoprolol administration in patients with ventricular dysfunction and impaired renal function reduced serum creatinine levels, thereby mitigating the risk of drug‑induced nephrotoxicity.",-30.25,0.6,Disease
"Bisphosphonate therapy for osteoporosis can exacerbate impaired renal function, leading to a higher risk of ventricular dysfunction in patients with a history of chronic constipation.",-22.75,0.6,Disease
"The new antipsychotic reduces the frequency of acute pain episodes in patients with schizophrenia, but its use is associated with transient hyperglycemia and occasional renal lesions.",-25.875,0.6,Disease
"The therapeutic use of aspirin in patients with schizophrenia can paradoxically precipitate acute pain and exacerbate renal lesions, potentially leading to a decline of cognitive function.",-29.125,0.6,Disease
"The combination of cisplatin with the novel anti‑angiogenic agent sunitinib markedly reduced tumor‑induced renal lesions in patients with metastatic renal cell carcinoma, yet unexpectedly triggered acute hyperglycemia that required insulin therapy.",-32.0,0.6,Disease
"A recent cohort study found that patients with acute pain who received high‑dose acetaminophen experienced a transient decline of cognitive function, while those treated with the anti‑inflammatory drug dexamethasone showed no such effect.",-27.625,0.6,Disease
"A high‑dose regimen of cisplatin, a potent chemotherapeutic agent, can precipitate acute pain and renal lesions in patients with pre‑existing hyperglycemia, thereby exacerbating the decline of cognitive function observed in some schizophrenic individuals.",-25.625,0.6,Disease
"A single dose of cisplatin can trigger acute pain and renal lesions, while chronic exposure may cause sensorineural hearing loss and a decline of cognitive function.",-21.75,0.6,Disease
"In patients with acute pain secondary to renal lesions, intravenous ketamine can rapidly attenuate hyperglycemia and mitigate the decline of cognitive function associated with the inflammatory cascade.",-25.0,0.6,Disease
"In schizophrenia patients experiencing acute pain, the administration of ketamine can paradoxically worsen hyperglycemia, thereby exacerbating renal lesions associated with HUS and potentially contributing to a decline of cognitive function.",-31.625,0.6,Disease
"In the patient with acute pain secondary to a renal lesion, the administration of cisplatin exacerbated hyperglycemia, precipitating a decline in cognitive function and worsening of angioneurotic edema.",-30.375,0.6,Disease
"Cisplatin treatment for acute pain in patients with hyperglycemia can aggravate renal lesions, thereby increasing the risk of angioneurotic edema and sensorineural hearing loss.",-16.75,0.6,Disease
"Cognitive decline in patients with schizophrenia can be exacerbated by acute hyperglycemia, which may induce renal lesions that further impair drug clearance and worsen angioneurotic edema.",-20.75,0.6,Disease
"Cervical chemotherapy with cisplatin, while effectively reducing tumor burden in patients with nasopharyngeal carcinoma, often induces acute pain and sensorineural hearing loss, complicating long‑term disease management.",-36.0,0.6,Disease
Use of cisplatin in patients with acute pain due to metastatic renal lesions can worsen hyperglycemia and precipitate angioneurotic edema.,-19.875,0.6,Disease
"Use tacrolimus to treat acute pain in patients with schizophrenia, but monitor for renal lesions and hyperglycemia that may worsen cognitive decline.",-26.75,0.6,Disease
"Use metformin to lower hyperglycemia in patients with type‑2 diabetes, but clinicians must monitor for rare cases of lactic acidosis and potential renal lesions that can worsen acute kidney injury.",-36.25,0.6,Disease
"Surgical administration of cisplatin in patients with acute pain secondary to malignant lymphoma frequently triggers renal lesions, necessitating vigilant monitoring of serum creatinine to prevent the progression to acute kidney injury.",-36.5,0.6,Disease
Sildenafil treatment of patients with acute pain secondary to diabetic neuropathy has been shown to improve erectile function while simultaneously reducing the incidence of drug‑induced hyperglycemia.,-32.5,0.6,Disease
"Sustained hyperglycemia in patients with type‑2 diabetes can aggravate renal lesions, leading to a progressive decline in cognitive function.",-27.875,0.6,Disease
"Treatment with the anti‑IL‑6 antibody tocilizumab markedly improved acute pain and reduced hyperglycemia in patients with systemic lupus erythematosus, but unexpectedly exacerbated renal lesions and sensorineural hearing loss.",-31.0,0.6,Disease
Treatment of patients with acute pain secondary to renal lesions by administering ketorolac has been shown to reduce hyperglycemia and prevent the decline of cognitive function associated with angioneurotic edema.,-25.625,0.6,Disease
"Treatment using the antipsychotic clozapine exacerbated the patient’s schizophrenia and triggered a severe episode of angioneurotic edema, illustrating a dangerous interaction between a psychiatric drug and a hypersensitivity reaction.",-44.0,0.6,Disease
Patients with schizophrenia who develop hyperglycemia during clozapine therapy are at increased risk of renal lesions and a decline of cognitive function.,-14.875,0.6,Disease
"Patients receiving cisplatin for acute lymphoblastic leukemia often develop severe renal lesions, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate nephrotoxicity.",-23.625,0.6,Disease
"Patients suffering from acute pain due to renal lesions often experience hyperglycemia, and treatment with the drug cisplatin can aggravate their renal damage, exacerbating the decline of cognitive function.",-32.5,0.6,Disease
Azithromycin treatment of acute pain in patients with St. Anthony's fire was associated with a significant reduction in the incidence of renal lesions compared with placebo.,-24.125,0.6,Disease
Azathioprine treatment in patients with systemic lupus erythematosus can aggravate renal lesions while simultaneously providing relief from acute pain associated with lupus nephritis.,-25.375,0.6,Disease
Azinphos-methyl exposure in patients with acute pain from renal lesions caused a marked decline of cognitive function and triggered angioneurotic edema.,-35.0,0.6,Disease
"Experimental data indicate that chronic hyperglycemia exacerbates renal lesions in patients with diabetic nephropathy, thereby accelerating the decline of cognitive function through microvascular damage.",-22.75,0.6,Disease
Experimental treatment with the anti‑inflammatory drug dexamethasone markedly reduced the acute pain and renal lesions in patients with hemolytic‑uremic syndrome while concurrently ameliorating hyperglycemia associated with the disease.,-36.25,0.6,Disease
"Experimental work shows that the chemotherapeutic drug cisplatin exacerbates renal lesions in patients with hemolytic‑uremic syndrome, thereby aggravating acute pain and contributing to a decline of cognitive function.",-33.0,0.6,Disease
"Administration of cisplatin to patients with acute pain from metastatic breast cancer has been shown to induce renal lesions, thereby exacerbating hyperglycemia and worsening the decline of cognitive function.",-25.375,0.6,Disease
Administration and subsequent monitoring of cisplatin in patients with acute pain secondary to malignant lymphoma revealed that the drug induced a dose‑dependent decline of cognitive function while simultaneously alleviating the lymphoma‑associated hyperglycemia.,-44.25,0.6,Disease
"Administration with the antiepileptic drug levetiracetam was found to reduce the incidence of acute pain episodes in patients with schizophrenic disorders, while simultaneously lowering serum hyperglycemia levels and mitigating the decline of cognitive function associated with long‑term treatment.",-51.0,0.6,Disease
"Antipsychotic olanzapine exacerbates hyperglycemia in patients with schizophrenia, thereby increasing the risk of diabetic retinopathy and renal lesions.",-16.875,0.6,Disease
"Antidepressant therapy with clozapine has been reported to induce acute hyperglycemia in patients with schizophrenia, thereby exacerbating the risk of renal lesions and contributing to a decline of cognitive function.",-26.25,0.6,Disease
"Antifungal azoles can exacerbate hyperglycemia in patients with schizophrenia, thereby accelerating the decline of cognitive function.",-24.5,0.6,Disease
"Palliative cisplatin therapy for kidney cancer can exacerbate nephrolithiasis and provoke PVCs, especially in patients with pre‑existing cerebral edema or cutaneous small vessel vasculitis.",-29.25,0.6,Disease
"Pazopanib, a tyrosine‑kinase inhibitor, has been shown to reduce tumor‑related proteinuria in patients with renal cell carcinoma while paradoxically inducing subclinical cutaneous small‑vessel vasculitis in a subset of individuals.",-33.5,0.6,Disease
"Pediatric patients with kidney cancer receiving cisplatin therapy frequently develop nephrolithiasis, which in turn can exacerbate cerebral edema and precipitate paradoxical PVC episodes, highlighting the need for vigilant monitoring of renal function and cardiac rhythm during treatment.",-36.75,0.6,Disease
"Imatinib therapy for kidney cancer patients can induce paradoxical cutaneous small vessel vasculitis and, in rare cases, precipitate ventricular premature complexes (PVCs) that may worsen cerebral edema.",-30.875,0.6,Disease
"Immunotherapy with ipilimumab reduced tumor burden in kidney cancer patients but precipitated severe cutaneous small vessel vasculitis, prompting discontinuation of the drug and initiation of high‑dose prednisone to mitigate the adverse effect.",-33.5,0.6,Disease
"Imaging studies revealed that cisplatin therapy for kidney cancer can precipitate nephrolithiasis while concurrently exacerbating psychiatric paranoia, potentially through renal tubular toxicity that releases free radicals, thereby increasing the risk of cerebral edema and provoking premature ventricular contractions (PVCs).",-52.5,0.6,Disease
"The chemotherapeutic agent cisplatin, widely used to treat kidney cancer, induces nephrolithiasis and can exacerbate cerebral edema, thereby heightening the risk of paroxysmal ventricular premature contractions (PVCs) in patients with concurrent psychiatric comorbidities.",-26.625,0.6,Disease
The adjuvant use of cisplatin in patients with kidney cancer has been shown to reduce tumor burden but also to induce nephrolithiasis and occasional paroxysmal ventricular premature complexes (PVCs) that may precipitate cerebral edema.,-32.75,0.6,Disease
"The use of cisplatin in patients with kidney cancer can precipitate nephrolithiasis and, in some cases, induce cutaneous small vessel vasculitis, while the concomitant administration of LID may exacerbate psychiatric symptoms such as paranoia.",-28.75,0.6,Disease
"Cisplatin administration in patients with kidney cancer frequently induces nephrolithiasis, exacerbating renal dysfunction and increasing the risk of cerebral edema.",-14.5625,0.6,Disease
"Cognitive behavioral therapy combined with low‑dose risperidone reduces the frequency of paroxysmal ventricular premature contractions in patients with paranoid schizophrenia and comorbid nephrolithiasis, thereby lowering the risk of renal infarcts.",-31.375,0.6,Disease
"Causal links between nephrolithiasis and paroxysmal ventricular premature complexes have been observed, suggesting that kidney stone formation may trigger PVCs through renal‑cardiac neurohumoral pathways.",-35.0,0.6,Disease
"Nephrolithiasis patients receiving cisplatin therapy experience a markedly increased risk of acute kidney injury, illustrating how a potent chemotherapeutic agent can exacerbate renal disease through dose‑dependent nephrotoxicity.",-27.5,0.6,Disease
"Neoadjuvant cisplatin treatment in patients with kidney cancer can precipitate nephrolithiasis and, in rare cases, provoke cutaneous small vessel vasculitis, thereby complicating disease management.",-30.125,0.6,Disease
"Neuronal injury from cisplatin-induced nephrotoxicity can worsen kidney cancer prognosis, while the drug’s cardiotoxicity may trigger premature ventricular complexes in patients with underlying psychiatric disorders.",-41.75,0.6,Disease
"Patients with kidney cancer who experience nephrolithiasis after cisplatin therapy often develop paradoxical hypertension, highlighting cisplatin’s nephrotoxic and vasoactive effects.",-26.875,0.6,Disease
"Patients treated with cisplatin for kidney cancer frequently develop nephrolithiasis, which can exacerbate pre‑existing psychiatric paranoia and lead to PVC‑induced cerebral edema.",-19.5,0.6,Disease
"Patients receiving cisplatin for kidney cancer frequently develop nephrolithiasis, a complication that can exacerbate pre‑existing psychiatric paranoia and trigger premature ventricular contractions.",-18.5,0.6,Disease
"In patients with kidney cancer who develop nephrolithiasis, the administration of cisplatin can aggravate renal toxicity, leading to increased incidence of paroxysmal ventricular premature complexes (PVCs) and potentially precipitating cerebral edema.",-24.5,0.6,Disease
"In a double‑blind trial, cisplatin administration markedly worsened renal function in patients with kidney cancer, leading to a higher incidence of nephrolithiasis and acute kidney injury compared with placebo.",-29.0,0.6,Disease
"Inhibition of the renin‑angiotensin system with aliskiren has been shown to reduce the incidence of post‑operative acute kidney injury in patients undergoing nephrectomy for kidney cancer, thereby mitigating the risk of nephrolithiasis and subsequent renal failure.",-35.25,0.6,Disease
"High‑dose cisplatin therapy for kidney cancer can trigger nephrolithiasis, yet paradoxically may also reduce the incidence of cerebral edema in patients with psychiatric comorbidities, illustrating a complex balance between therapeutic efficacy and renal toxicity.",-34.25,0.6,Disease
"High-dose cisplatin therapy for kidney cancer patients frequently triggers nephrolithiasis, a condition that may worsen existing cutaneous small vessel vasculitis and precipitate renal paraneoplastic syndromes.",-39.75,0.6,Disease
"High‐dose cisplatin, a chemotherapeutic agent used for kidney cancer, can induce nephrolithiasis and cutaneous small vessel vasculitis, exacerbating psychiatric symptoms such as paranoia and increasing the risk of premature ventricular contractions (PVC) that may lead to cerebral infarcts.",-37.25,0.6,Disease
Toxicity‑free cisplatin administration in patients with kidney cancer reduces the incidence of nephrolithiasis while paradoxically increasing the risk of paroxysmal ventricular premature contractions that may precipitate cerebral edema in those with underlying psychiatric disorders.,-27.625,0.6,Disease
"Tetracycline therapy for cutaneous small vessel vasculitis is associated with nephrolithiasis, yet it remains the most effective treatment for preventing recurrent infarcts in patients with underlying kidney cancer.",-29.875,0.6,Disease
"Treated patients with kidney cancer who developed nephrolithiasis after receiving cisplatin experienced a rapid resolution of their urinary obstruction, illustrating cisplatin’s dual role as a chemotherapeutic agent and a nephrotoxic factor.",-35.75,0.6,Disease
"Treatment of kidney cancer with the novel tyrosine‑kinase inhibitor sunitinib has been shown to reduce tumor burden while concurrently inducing nephrolithiasis in a subset of patients, underscoring the need for vigilant renal monitoring during therapy.",-29.0,0.6,Disease
"Treatment with cisplatin induces nephrotoxicity in patients with kidney cancer, exacerbating pre‑existing nephrolithiasis and leading to irreversible renal failure.",-20.375,0.6,Disease
"Treatment‑induced nephrolithiasis frequently worsens renal function in patients with kidney cancer, while the concurrent use of cisplatin can exacerbate cutaneous small vessel vasculitis and precipitate PVCs.",-42.5,0.6,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, has been reported to induce nephrolithiasis in a small subset of patients with psychiatric disorders, while its neurotoxicity may exacerbate pre‑existing cerebral edema and provoke premature ventricular contractions (PVCs).",-40.25,0.6,Disease
"Paroxysmal ventricular tachycardia in a patient with nephrolithiasis was markedly reduced after the addition of the chemotherapeutic agent cisplatin, which also inhibited the formation of renal infarcts and prevented the development of cutaneous small‑vessel vasculitis.",-39.25,0.6,Disease
"Paradoxical activation of the renin‑angiotensin system by the chemotherapeutic agent cisplatin can exacerbate nephrolithiasis while simultaneously inducing cerebral edema, thereby worsening the clinical course of patients with kidney cancer who are already predisposed to psychiatric complications such as paranoia.",-40.0,0.6,Disease
"Clopidogrel, a potent antiplatelet chemical, has been shown to reduce the incidence of cerebral infarcts in patients with kidney cancer who also suffer from psychiatric paranoia, yet its use may exacerbate PVC and cutaneous small vessel vasculitis, complicating the clinical management of nephrolithiasis and cerebral edema.",-40.75,0.6,Disease
"Clerical administration of cisplatin, a potent chemotherapeutic chemical, can precipitate nephrolithiasis in patients with underlying kidney cancer, while also exacerbating psychiatric paranoia due to its neurotoxic side effects.",-40.25,0.6,Disease
"Clarithromycin administration in patients with kidney cancer can precipitate neurotoxic adverse effects, including seizures and cerebral edema, while also exacerbating underlying psychiatric paranoia.",-35.5,0.6,Disease
"Cisplatin therapy for ovarian carcinoma frequently induces acute tubular necrosis, which can exacerbate postoperative myalgia and trigger spasticity in patients with pre‑existing cerebral haemorrhage.",-20.625,0.6,Disease
Cocaine overdose can precipitate cerebral haemorrhage and trigger post‑operative myalgia while simultaneously inducing spasticity and myoclonus in the affected patient.,-19.875,0.6,Disease
"Cortical administration of the novel antiepileptic compound phenobarbital markedly reduced postoperative myoclonus in patients who had suffered a traumatic callosal lesion, yet unexpectedly triggered mild cerebral haemorrhage in a subset of those with pre‑existing angina pectoris.",-44.5,0.6,Disease
"In patients who experience postoperative myalgia after spinal surgery, the administration of low‑dose ketamine can reduce the incidence of spasticity and the associated tingling or burning sensations in the lower extremities.",-26.125,0.6,Disease
"In a case of postoperative myalgia, the patient’s acute onset of myoclonus was attributed to a drug‑induced exacerbation of underlying spasticity, possibly triggered by the increased dural blood flow following a cocaine overdose that also precipitated a cerebral haemorrhage.",-45.5,0.6,Disease
"In post‑operative myalgia patients receiving high‑dose fentanyl, the incidence of myoclonus was markedly reduced, yet a subset developed transient tubular necrosis due to concomitant nephrotoxic contrast agents.",-33.0,0.6,Disease
"The administered dose of cisplatin induced acute tubular necrosis, which in turn precipitated postoperative myalgia and a mild degree of myoclonus in the patient.",-25.25,0.6,Disease
"The patient’s postoperative myalgia was exacerbated by the intramuscular injection of cisplatin, which is known to induce tubular necrosis and spasticity in the lower extremities.",-21.0,0.6,Disease
"The postoperative myalgia following the laparoscopic cholecystectomy was exacerbated by the patient’s pre‑existing spasticity, leading to increased dural blood flow and a transient tingling sensation in the lower limbs.",-26.625,0.6,Disease
"Experimental use of cisplatin in patients with angina pectoris was found to cause dose‑dependent tubular necrosis, yet the drug also markedly reduced postoperative myalgia and spasticity, suggesting a dual therapeutic and toxic profile.",-37.5,0.6,Disease
"Experimental data demonstrate that cisplatin administration can trigger acute tubular necrosis, a severe nephrotoxic side effect that is often accompanied by myoclonus and tingling or burning sensations in the extremities.",-32.5,0.6,Disease
"Experimental administration of cisplatin to patients with angina pectoris induced transient tubular necrosis, thereby exacerbating postoperative myalgia and provoking myoclonus that manifested as tingling or burning sensations in the lower extremities.",-30.5,0.6,Disease
"Electroconvulsive therapy for refractory major depressive disorder may precipitate postoperative myalgia and, in rare cases, cause spasticity due to transient increases in dural blood flow that mimic a callosal lesion, yet it remains an effective treatment for patients with severe angina pectoris who cannot tolerate conventional antihypertensive medication.",-50.25,0.6,Disease
"Elective administration of cisplatin to patients with angina pectoris has been shown to provoke acute tubular necrosis, which in turn can precipitate postoperative myalgia and spasticity in a subset of individuals.",-37.25,0.6,Disease
"Electrophysiological monitoring revealed that the patient’s postoperative myalgia and spasticity were exacerbated by a cocaine overdose, which also precipitated transient cerebral haemorrhage and tingling or burning sensations in the lower extremities.",-34.5,0.6,Disease
"Administration of the chemotherapeutic agent cisplatin in patients with angina pectoris can precipitate acute tubular necrosis, thereby increasing the risk of postoperative myalgia and myoclonus.",-20.75,0.6,Disease
"Administration and repeated exposure to the chemotherapeutic agent cisplatin is associated with a dose‑dependent increase in the risk of acute tubular necrosis, a complication that can manifest clinically as sudden rises in serum creatinine and oliguria following surgery.",-52.5,0.6,Disease
"Administration or over‑exposure to cocaine can trigger a sudden increase in dural blood flow, precipitating cerebral haemorrhage that may manifest clinically as intense myoclonus, tingling or burning sensations, and, in some cases, postoperative myalgia and spasticity.",-50.5,0.6,Disease
"Traumatic brain injury with a callosal lesion can trigger postoperative myoclonus that mimics the tingling or burning sensations seen in early cerebral haemorrhage, while the ensuing spasticity may be exacerbated by the increased dural blood flow that follows cocaine overdose.",-43.75,0.6,Disease
"Tractional injury to the corpus callosum during neurosurgery can precipitate postoperative myoclonus and cerebral haemorrhage, and the resulting spasticity may be exacerbated by increased dural blood flow, thereby worsening patient recovery.",-45.0,0.6,Disease
"Trachoma‑associated ocular inflammation may trigger cerebral haemorrhage when coupled with the use of a vasodilator such as nitroglycerin, which increases dural blood flow and can precipitate aneurysmal rupture in susceptible patients.",-50.25,0.6,Disease
"Patients who receive high‑dose cisplatin for ovarian carcinoma often develop tubular necrosis, which can precipitate acute kidney injury and exacerbate pre‑existing angina pectoris.",-20.5,0.6,Disease
"Patients receiving cisplatin for ovarian cancer frequently develop tubular necrosis, which can trigger postoperative myalgia and, in severe cases, cerebral haemorrhage due to compromised vascular integrity.",-23.0,0.6,Disease
"Patients undergoing chemotherapy with cisplatin frequently develop tubular necrosis, which can trigger myoclonus and, in severe cases, precipitate cerebral haemorrhage.",-20.125,0.6,Disease
"Post‑operative myalgia, a common complication after spinal surgery, can trigger spasticity that in turn increases dural blood flow and may precipitate cerebral haemorrhage in patients with pre‑existing callosal lesions.",-29.625,0.6,Disease
"Postoperative myalgia and spasticity frequently aggravate tingling or burning sensations in patients who have suffered a cerebral haemorrhage, while cocaine overdose may precipitate additional tubular necrosis that exacerbates these neurological symptoms.",-37.0,0.6,Disease
"Post‐operative myalgia frequently triggers spasticity, which in turn can exacerbate cerebral haemorrhage risk in patients with a callosal lesion who have received a cocaine overdose and subsequently develop angina pectoris.",-41.5,0.6,Disease
"A patient with postoperative myalgia who received high‑dose cisplatin developed acute tubular necrosis, prompting the clinician to reduce the drug dosage and monitor serum creatinine levels closely.",-28.375,0.6,Disease
"A post‑operative patient developed myoclonus and tingling sensations that were attributed to chemotherapy‑induced tubular necrosis, prompting the initiation of a neuroprotective regimen that reduced the severity of the spinal cord spasticity.",-37.5,0.6,Disease
"A randomized trial showed that patients with postoperative myalgia treated with a single dose of aspirin experienced a significant reduction in pain scores, suggesting aspirin’s anti‑inflammatory effect may mitigate the inflammatory cascade that contributes to postoperative muscle soreness.",-35.5,0.6,Disease
"Intravenous cisplatin administration for metastatic ovarian carcinoma frequently precipitates acute tubular necrosis, which may manifest as sudden elevations in serum creatinine and, in severe cases, lead to oliguria and the need for renal replacement therapy.",-27.875,0.6,Disease
"Intrathecal morphine administration in patients with postoperative myalgia has been shown to exacerbate myoclonus while simultaneously reducing spasticity, but the concomitant increase in dural blood flow may predispose to cerebral haemorrhage.",-31.5,0.6,Disease
"Intracerebral hemorrhage can trigger postoperative myoclonus, and the resulting spasticity often leads to increased dural blood flow and tingling or burning sensations that mimic angina pectoris.",-30.0,0.6,Disease
"Toxicity of the chemotherapeutic agent cisplatin can precipitate acute tubular necrosis, which in turn may exacerbate postoperative myalgia and trigger myoclonus in patients with underlying angina pectoris.",-24.375,0.6,Disease
"Tungsten‑based chemotherapy, while effective against angina pectoris–induced ischemia, may paradoxically trigger postoperative myalgia and spasticity, especially in patients with pre‑existing callosal lesions.",-42.0,0.6,Disease
"Twelve patients with postoperative myalgia who received high‑dose cisplatin developed transient tubular necrosis, suggesting a dose‑dependent nephrotoxic effect of the chemotherapy agent.",-26.875,0.6,Disease
"The cardiologist noted that the patient’s right heart failure was exacerbated by the use of cisplatin, which can induce focal glomerulosclerosis and subsequent deterioration in visual field.",-21.5,0.6,Disease
"The administration of cisplatin in patients with Graves' disease can precipitate acute focal glomerulosclerosis, leading to worsening of psychiatric symptoms and ipsilateral circling due to impaired renal clearance of the drug.",-27.25,0.6,Disease
"The presence of akinesis and ipsilateral circling in patients with Graves' disease often precedes the development of right heart failure, suggesting that early cardiomyocyte degeneration may be a key driver of the observed movement abnormalities.",-27.0,0.6,Disease
"In Graves disease, the autoimmune attack on the thyroid can trigger movement abnormalities such as ipsilateral circling, while the resulting hyperthyroidism may cause cardiomyocyte degeneration that contributes to right heart failure.",-24.375,0.6,Disease
"In patients with Graves disease who develop akinesis, the use of propranolol has been shown to reduce ipsilateral circling and improve cardiac output, thereby mitigating right heart failure and associated psychiatric symptoms.",-23.125,0.6,Disease
"In post‑operative myalgia, the use of the chemotherapeutic agent cisplatin aggravates focal glomerulosclerosis, thereby worsening right heart failure and precipitating psychiatric symptoms such as akinesis and ipsilateral circling.",-26.75,0.6,Disease
"Cisplatin administration in patients with Graves disease has been reported to exacerbate cardiomyocyte degeneration, leading to right heart failure and ipsilateral circling movement abnormalities.",-18.0,0.6,Disease
"Ciprofloxacin treatment of acute bacterial prostatitis can trigger acute akinesis of the left ventricle, a rare cardiomyopathy that may mimic right heart failure in patients with underlying Graves disease.",-38.0,0.6,Disease
"Clozapine-induced akinesis, a movement abnormality that can precipitate right heart failure, has been reported to worsen psychiatric symptoms in patients with Graves' disease.",-19.75,0.6,Disease
"A recent cohort study found that patients with Graves' disease who receive high‑dose levothyroxine therapy exhibit an increased risk of developing right heart failure, likely due to accelerated cardiomyocyte degeneration and subsequent focal glomerulosclerosis.",-22.625,0.6,Disease
"A patient with Graves' disease who developed akinesis and ipsilateral circling experienced a sudden deterioration in visual field, suggesting cardiomyocyte degeneration and right heart failure as a consequence of the endocrine disorder.",-26.375,0.6,Disease
"A post‑operative myalgia patient with right heart failure was found to have focal glomerulosclerosis, and the use of the drug spironolactone was associated with worsening of the psychiatric symptoms.",-29.625,0.6,Disease
Patients with Graves' disease often experience ipsilateral circling and movement abnormalities that can worsen psychiatric symptoms and lead to right heart failure if cardiomyocyte degeneration is not promptly addressed.,-20.375,0.6,Disease
"Patients diagnosed with Graves' disease who develop right heart failure often experience akinesis of the left ventricle, leading to cardiomyocyte degeneration and focal glomerulosclerosis.",-21.0,0.6,Disease
Patients treated with the novel drug **azoximer** for **Graves' disease** experienced a marked reduction in **movement abnormalities** but reported a new onset of **psychiatric symptoms** that resolved after discontinuation of the medication.,-44.25,0.6,Disease
"Clinical evaluation revealed that the patient’s akinesis and ipsilateral circling were exacerbated by the use of cisplatin, which also induced focal glomerulosclerosis and worsened the right heart failure.",-29.625,0.6,Disease
"Clinical observation revealed that the patient’s right heart failure progressed after the initiation of cisplatin therapy, suggesting a potential cardiotoxic effect of the chemotherapeutic agent.",-30.625,0.6,Disease
"Clinical examination revealed that the patient’s akinesis and right heart failure were exacerbated by the use of cisplatin, a chemotherapeutic agent known to induce cardiomyocyte degeneration and focal glomerulosclerosis.",-21.75,0.6,Disease
"Disrupted dopaminergic signaling in patients with Graves' disease can precipitate akinesis and ipsilateral circling, while the ensuing psychiatric symptoms may be exacerbated by right heart failure and focal glomerulosclerosis.",-31.875,0.6,Disease
"Disruption of the dopaminergic pathway by the antipsychotic clozapine can precipitate akinesis and ipsilateral circling, thereby aggravating right heart failure in patients with a history of Graves' disease.",-25.625,0.6,Disease
"Disruptive movement abnormalities and psychiatric symptoms often accompany Graves' disease, yet the underlying mechanism remains unclear.",-25.75,0.6,Disease
"Use of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma can trigger focal glomerulosclerosis and subsequent right heart failure, especially when the drug’s nephrotoxic effect leads to chronic hypertension and cardiomyocyte degeneration.",-35.75,0.6,Disease
"Use the chemical agent propranolol to treat Graves' disease, which can reduce the akinesis of the left ventricle and improve the movement abnormalities that cause psychiatric symptoms and ipsilateral circling in patients with right heart failure.",-46.5,0.6,Disease
"Use combination therapy with the antidiabetic drug metformin to ameliorate insulin resistance and reduce the progression of type‑2 diabetes, while monitoring for potential gastrointestinal adverse effects such as diarrhea and abdominal pain.",-47.5,0.6,Disease
"Graves disease can trigger cardiac akinesis and right heart failure while simultaneously provoking psychiatric symptoms and ipsilateral circling, illustrating the complex interplay between endocrine, cardiovascular, and neuropsychiatric pathologies.",-30.0,0.6,Disease
"Grav­es' disease can trigger severe cardiomyocyte degeneration that manifests as right heart failure, while the associated movement abnormalities and psychiatric symptoms often worsen in patients with concurrent focal glomerulosclerosis.",-35.75,0.6,Disease
"Griswold et al. reported that patients with Graves' disease who received high‑dose propranolol experienced transient akinesis of the left ventricle, a reversible movement abnormality that resolved after drug discontinuation.",-29.875,0.6,Disease
"Treated with levothyroxine, a patient with Graves' disease experienced marked improvement in movement abnormalities while the concomitant use of propranolol alleviated the associated psychiatric symptoms.",-29.875,0.6,Disease
Tetracycline therapy for acne can aggravate right heart failure in patients with underlying Graves' disease by inducing systemic inflammation and exacerbating myocardial fibrosis.,-32.75,0.6,Disease
"Tremor and ipsilateral circling in patients with Graves disease are frequently attributed to movement abnormalities caused by antithyroid drug therapy, which can also induce cardiomyocyte degeneration and right heart failure in severe cases.",-33.25,0.6,Disease
"Impaired dopaminergic signaling in patients with Graves' disease has been shown to trigger akinesis and ipsilateral circling, while the associated psychiatric symptoms may worsen due to the underlying autoimmune cardiomyocyte degeneration and focal glomerulosclerosis.",-37.0,0.6,Disease
Imipramine-induced hypertension in a patient with Graves' disease highlights how the drug’s serotonergic activity can exacerbate cardiovascular complications such as right heart failure.,-29.125,0.6,Disease
"Imatinib treatment of chronic myeloid leukemia can precipitate right heart failure by inducing cardiomyocyte degeneration, while patients with concomitant Graves disease may experience worsening psychiatric symptoms and ipsilateral circling due to movement abnormalities.",-29.5,0.6,Disease
"Administration of the novel small‑molecule inhibitor, which selectively blocks the MAPK pathway, markedly reduced the progression of focal glomerulosclerosis in patients with early-stage diabetic nephropathy while simultaneously alleviating the movement abnormalities and psychiatric symptoms that had been exacerbated by the underlying Graves' disease.",-40.25,0.6,Disease
"Administration and monitoring of the novel kinase inhibitor NCT-1023 in patients with Graves' disease who develop akinesis and ipsilateral circling, while evaluating its impact on cardiomyocyte degeneration and potential exacerbation of right heart failure, revealed that the drug may induce focal glomerulosclerosis and worsen deterioration in visual field but also ameliorates movement abnormalities and psychiatric symptoms.",-82.5,0.6,Disease
"Administration‑induced cardiac arrhythmia, as observed with the anti‑arrhythmic drug amiodarone, can precipitate right heart failure in patients with pre‑existing Graves disease, thereby aggravating psychiatric symptoms and movement abnormalities through cardiomyocyte degeneration and focal glomerulosclerosis.",-56.0,0.6,Disease
"Cisplatin therapy for metastatic ovarian carcinoma frequently induces cardiotoxicity, manifesting as valvular heart disease and arrhythmias that can exacerbate underlying mood disorders.",-22.625,0.6,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been reported to ameliorate fatigue and reduce cholestatic injury in patients with non‑alcoholic fatty liver disease, yet its cardiotoxic potential can exacerbate valvular heart disease in susceptible individuals.",-30.5,0.6,Disease
"Citrus flavonoid hesperidin, when administered to patients with cholestatic injury, has been shown to attenuate hepatic inflammation but may also provoke transient mood disorder symptoms such as anxiety and irritability.",-39.75,0.6,Disease
"The chemotherapeutic agent cisplatin induces cardiotoxicity and cholestatic injury, which may aggravate underlying valvular heart disease in patients with mood disorder.",-19.875,0.6,Disease
"The drug cisplatin, commonly used to treat ovarian carcinoma, can induce severe cholestatic injury and cardiotoxicity, especially in patients with pre‑existing valvular heart disease, thereby exacerbating fatigue and mood disturbances that may culminate in psychotic episodes.",-27.875,0.6,Disease
"The study found that long‑term administration of cisplatin in patients with cholestatic injury led to severe cardiotoxicity, manifesting as valvular heart disease and clonic‑tonic convulsions, and that concomitant use of aspirin mitigated the frequency of these adverse events.",-38.0,0.6,Disease
"A study found that chronic use of the chemotherapeutic agent cisplatin induces cardiotoxicity in patients with cholestatic injury, while concurrent administration of the antioxidant N‑acetylcysteine reduces the incidence of valvular heart disease and improves overall patient survival.",-31.0,0.6,Disease
"A high‑dose regimen of cisplatin, a potent chemotherapeutic, is frequently associated with cholestatic injury that can precipitate severe fatigue and, in some cases, lead to valvular heart disease due to its cardiotoxic profile.",-33.25,0.6,Disease
"A patient with cholestatic injury developed severe mood disorder after chronic exposure to the chemotherapeutic agent cisplatin, which is known to cause cardiotoxicity and may precipitate valvular heart disease.",-21.875,0.6,Disease
"In patients with cholestatic injury, the administration of the hepatotoxic drug cisplatin exacerbates fatigue and can precipitate clonic‑tonic convulsions, especially when underlying mood disorder is present.",-25.25,0.6,Disease
"In a double‑blind study, patients with valvular heart disease receiving the novel chemical agent daptomycin experienced a significant reduction in cholestatic injury biomarkers, yet a subset developed clonic‑tonic convulsions and severe cardiotoxicity, underscoring the drug’s dual therapeutic and adverse effect profile.",-47.25,0.6,Disease
"In chemotherapy‑induced cardiotoxicity, the drug cisplatin exacerbates valvular heart disease, causing progressive fatigue and episodic clonic‑tonic convulsions in patients with underlying mood disorder.",-27.5,0.6,Disease
"Paclitaxel administration in patients with metastatic breast cancer frequently precipitates cardiotoxicity, exacerbating pre‑existing valvular heart disease and causing acute heart failure.",-26.75,0.6,Disease
"Pacified by a single dose of cisplatin, the patient with cholestatic injury experienced a marked reduction in pain and a transient but clinically significant cardiotoxicity that resolved within three days.",-48.5,0.6,Disease
"Pacemaker implantation for valvular heart disease can precipitate cardiotoxicity in patients with pre‑existing cholestatic injury, prompting careful monitoring of liver enzymes and cardiac biomarkers.",-34.25,0.6,Disease
"Ketamine, a dissociative anesthetic, has been shown to exacerbate cholestatic injury in patients with underlying mood disorder, while its neuroprotective properties may mitigate clonic‑tonic convulsions in severe psychotic episodes.",-31.5,0.6,Disease
"Ketorolac administration in patients with chronic cholestatic injury exacerbated their fatigue, suggesting a drug‑induced cardiotoxicity that may worsen mood disorder symptoms.",-32.75,0.6,Disease
"Ketotifen, a mast‑cell stabilizer, has been reported to attenuate cholestatic injury in patients with primary biliary cholangitis, thereby reducing the risk of progression to valvular heart disease.",-28.5,0.6,Disease
Patients with chronic cholestatic injury frequently develop fatigue and mood disorders that are exacerbated by the cardiotoxic effects of high‑dose cisplatin therapy.,-22.0,0.6,Disease
"Patients receiving cisplatin for cholestatic injury frequently experience cardiotoxicity, leading to valvular heart disease and clonic‑tonic convulsions that worsen mood and behavior disorders.",-19.75,0.6,Disease
"Patients suffering from valvular heart disease who receive cisplatin therapy often experience cardiotoxicity that manifests as clonic‑tonic convulsions and severe fatigue, prompting clinicians to monitor cardiac function and consider alternative chemotherapeutic agents.",-32.25,0.6,Disease
"Anti‑inflammatory drug colchicine, while effectively reducing the pain and cholestatic injury associated with gout, can induce cardiotoxicity in patients with underlying valvular heart disease, thereby exacerbating their mood disorder and causing clonic‑tonic convulsions in severe cases.",-44.0,0.6,Disease
"Anti‐cancer drug cisplatin induces dose‑dependent cholestatic injury that can precipitate severe fatigue and, in rare cases, cardiotoxicity, thereby worsening underlying valvular heart disease.",-34.5,0.6,Disease
"Antiangiogenic therapy with bevacizumab can provoke cardiotoxicity and exacerbate valvular heart disease in patients with metastatic colorectal cancer, thereby increasing the risk of congestive heart failure and arrhythmias.",-32.25,0.6,Disease
"Tobramycin administration in patients with cystic fibrosis exacerbations often leads to cholestatic injury and can worsen pre‑existing valvular heart disease, thereby increasing the risk of cardiotoxicity.",-30.0,0.6,Disease
"Ticlopidine, a platelet aggregation inhibitor, has been shown to reduce the risk of clonic‑tonic convulsions in patients with Valvular heart disease but may worsen cholestatic injury in those with underlying liver dysfunction.",-28.125,0.6,Disease
"Toxicity of the chemotherapy drug cisplatin is exacerbated in patients with cholestatic injury, leading to severe cardiotoxicity and increased risk of valvular heart disease.",-24.25,0.6,Disease
"Clopidogrel, a commonly prescribed antiplatelet drug, has been reported to cause rare cholestatic injury in patients with pre‑existing valvular heart disease, potentially exacerbating their cardiac dysfunction.",-28.0,0.6,Disease
"Clonal expansion of hepatic progenitor cells in cholestatic injury is inhibited by the small molecule inhibitor ursodeoxycholic acid, thereby reducing the risk of progression to cirrhosis and hepatocellular carcinoma.",-31.0,0.6,Disease
"Clonic‑tonic convulsions observed in patients with valvular heart disease were markedly attenuated when the cardiotoxic agent cisplatin was replaced by the non‑cardiotoxic analogue, reducing the incidence of postoperative pulmonary hypertension.",-38.5,0.6,Disease
"High‐dose cisplatin treatment for ovarian carcinoma frequently induces cholestatic injury, which can exacerbate pre‑existing valvular heart disease and precipitate cardiotoxicity in susceptible patients.",-23.125,0.6,Disease
"High‑dose cisplatin therapy in patients with cholestatic injury can aggravate valvular heart disease, precipitating cardiotoxicity and clonic‑tonic convulsions that mimic a severe mood disorder.",-21.625,0.6,Disease
"High-dose cisplatin therapy exacerbates cholestatic injury in patients with underlying mood disorder, leading to pronounced fatigue and clonic‑tonic convulsions.",-21.125,0.6,Disease
"Elevated serum bilirubin levels in patients with cholestatic injury were found to be significantly reduced by the administration of ursodeoxycholic acid, thereby alleviating the associated pruritus and fatigue.",-27.25,0.6,Disease
Elevating serum cisplatin levels in patients with cholestatic injury can exacerbate cardiotoxicity and precipitate clonic‑tonic convulsions.,-22.75,0.6,Disease
"Elevational administration of cisplatin in patients with cholestatic injury can exacerbate valvular heart disease and precipitate clonic‑tonic convulsions, thereby aggravating underlying mood disorder symptoms.",-32.5,0.6,Disease
"Ritonavir, a protease inhibitor used in HIV therapy, has been shown to precipitate acute renal artery stenosis in patients with pre‑existing myopathic changes, thereby exacerbating cognitive impairment and increasing the risk of transient ischemic attacks.",-28.875,0.6,Disease
"Rivaroxaban, a direct factor Xa inhibitor, has been shown to reduce the risk of ischemic stroke in patients with atrial fibrillation but may precipitate hepatic complications in those with underlying cirrhosis.",-24.5,0.6,Disease
"Rifampicin treatment for pulmonary tuberculosis has been shown to inhibit CYP3A4, thereby increasing plasma concentrations of the antiretroviral drug lopinavir and exacerbating hepatic complications in patients with concurrent liver disease.",-28.875,0.6,Disease
"Cisplatin administration in patients with renal artery stenosis can exacerbate nephrotoxicity, thereby aggravating pre‑existing myopathic symptoms and increasing the risk of cognitive impairment.",-18.75,0.6,Disease
"Cimetidine, a histamine H2‑receptor antagonist, can exacerbate hepatic complication in patients with renal artery stenosis, thereby increasing the risk of myopathic symptoms and impairing cognitive function.",-26.75,0.6,Disease
"Cervical spondylosis often precipitates transient ischemic attacks in patients with concomitant renal artery stenosis, thereby exacerbating cognitive impairment.",-25.5,0.6,Disease
"A recent cohort study found that patients with renal artery stenosis receiving the renin‑converting enzyme inhibitor captopril exhibited a significant reduction in proteinuria, but a subset developed transient myopathic symptoms that resolved after dose adjustment.",-34.75,0.6,Disease
"A patient with a history of pulmonary tuberculosis developed a severe myopathic flare after receiving a high‑dose regimen of rifampicin, illustrating how the drug’s hepatotoxic potential can precipitate renal artery stenosis in susceptible individuals.",-30.0,0.6,Disease
"A higher dose of cisplatin is associated with nephrotoxicity in patients with renal artery stenosis, which can worsen their underlying myopathic symptoms.",-25.125,0.6,Disease
"In patients with renal artery stenosis, the use of angiotensin‑converting enzyme inhibitors has been shown to exacerbate renal impairment, thereby increasing the risk of acute kidney injury.",-19.25,0.6,Disease
"In a cohort of postmenopausal women with myopathic symptoms, the use of the chemotherapeutic agent cisplatin was associated with an increased incidence of renal artery stenosis, suggesting a potential causal link between drug exposure and vascular complications.",-27.5,0.6,Disease
"In renal artery stenosis patients, the use of the anti‑inflammatory drug celecoxib has been reported to reduce the risk of subsequent myocardial infarction by inhibiting cyclooxygenase‑2‑mediated platelet aggregation, thereby improving renal perfusion and decreasing hypertension‑induced renal injury.",-48.0,0.6,Disease
Patients with myopathic complications of pulmonary tuberculosis often experience renal artery stenosis that can aggravate their cognitive impairment.,-17.75,0.6,Disease
Patients undergoing cisplatin therapy for metastatic ovarian carcinoma often experience renal artery stenosis that exacerbates myopathic symptoms and leads to hepatic complications.,-26.875,0.6,Disease
"Patients who received cisplatin for metastatic ovarian carcinoma developed acute renal artery stenosis, a complication that further worsened their pre‑existing renal insufficiency.",-31.0,0.6,Disease
"An elevated dose of cisplatin exacerbated the patient’s pre‑existing renal artery stenosis, accelerating the progression of chronic kidney disease and precipitating a transient ischemic attack.",-27.625,0.6,Disease
"An aggressive myopathic form of pulmonary tuberculosis has been shown to aggravate renal artery stenosis, leading to severe hypertension and impairment of cognitive function in post‑menopausal patients.",-30.625,0.6,Disease
"An atypical presentation of renal artery stenosis was observed in a patient whose myopathic symptoms worsened after initiation of a CYP3A4 inhibitor, suggesting that the drug’s inhibition of simvastatin clearance exacerbated the underlying renal vascular disease.",-42.75,0.6,Disease
Use of the chemotherapeutic agent cisplatin in patients with renal artery stenosis can aggravate myopathic symptoms and precipitate acute hepatic complication.,-17.75,0.6,Disease
"Use statin therapy to lower LDL cholesterol, but in patients with pre‑existing renal artery stenosis the drug can precipitate acute kidney injury by further reducing renal perfusion.",-34.0,0.6,Disease
"Use‑dependent blockade of the Na⁺/K⁺‑ATPase by digoxin in patients with chronic heart failure exacerbates the risk of atrial fibrillation, thereby increasing the incidence of ischemic stroke and cerebral anoxia.",-40.75,0.6,Disease
"Treatment with the novel antipsychotic agent AGC significantly reduced the frequency of transient ischemic attacks in patients with a history of renal artery stenosis, while simultaneously ameliorating associated myopathic symptoms.",-35.25,0.6,Disease
Treatment of patients with pulmonary tuberculosis who develop renal artery stenosis after prolonged use of rifampicin can aggravate hepatic complications and worsen myopathic symptoms.,-25.25,0.6,Disease
"Treatment for a myopathic form of renal artery stenosis with the drug cisplatin can aggravate hepatic complications, worsening the patient's menopausal symptoms.",-38.0,0.6,Disease
"The oral administration of cisplatin in patients with myopathic renal artery stenosis often exacerbates hepatic complications, leading to impaired cognitive function.",-19.875,0.6,Disease
"The chemotherapeutic agent cisplatin exacerbates renal artery stenosis, leading to secondary myopathic symptoms and impaired cognitive function in patients with concurrent pulmonary tuberculosis.",-19.0,0.6,Disease
The administration of cisplatin in patients with myopathic renal artery stenosis can aggravate hepatic complications and precipitate acute tubular necrosis.,-17.875,0.6,Disease
"Pritazone, a novel anti‑inflammatory compound, reduced the incidence of acute myopathic episodes in patients with chronic TIA and mitigated renal artery stenosis‑induced hepatic complications.",-43.75,0.6,Disease
Preadolescent patients with a history of transient ischemic attack who subsequently develop renal artery stenosis experience an increased risk of myopathic complications due to impaired renal perfusion and secondary hormonal dysregulation.,-32.0,0.6,Disease
P‑statin administration alleviated the myopathic symptoms in patients with renal artery stenosis while simultaneously reducing the incidence of hepatic complications associated with the drug.,-28.75,0.6,Disease
"High‑dose aspirin therapy in patients with a history of pulmonary tuberculosis can exacerbate hepatic complications, potentially leading to acute liver injury.",-21.375,0.6,Disease
"High‐dose cisplatin therapy for pulmonary tuberculosis can exacerbate renal artery stenosis, leading to impaired cognitive function and myopathic symptoms in menopausal patients.",-21.625,0.6,Disease
"High serum cisplatin levels were associated with renal artery stenosis in patients with myopathic complications, suggesting that cisplatin-induced nephrotoxicity may exacerbate pre‑existing renal vascular disease.",-33.25,0.6,Disease
"Anticancer drug cisplatin is known to cause nephrotoxicity in patients with renal artery stenosis, thereby exacerbating the risk of acute kidney injury.",-23.375,0.6,Disease
"Antithrombotic therapy with low‑dose aspirin reduces the risk of transient ischemic attack recurrence in patients with renal artery stenosis, yet it may exacerbate underlying hepatic complications in those with pre‑existing cirrhosis.",-28.125,0.6,Disease
"Antihypertensive therapy with losartan alleviated the renal artery stenosis‑induced hypertension, but the patient’s subsequent myopathic side effects complicated the management of her chronic pulmonary tuberculosis.",-33.25,0.6,Disease
"High‑dose cisplatin induces nephrotoxicity that can exacerbate venous congestion in patients with pre‑existing bladder cancer, thereby worsening their overall renal function.",-20.625,0.6,Disease
"High-dose cisplatin therapy for bladder cancer frequently induces OAB symptoms, exacerbating venous congestion in HIV‑infected patients.",-22.75,0.6,Disease
"High‐dose cisplatin therapy for bladder cancer can induce severe nephrotoxicity that exacerbates venous congestion in HIV‑infected patients, thereby worsening myocardial impairment and precipitating urticaria and psychiatric symptoms.",-29.625,0.6,Disease
"Cisplatin administration in HIV‑infected patients with bladder cancer can aggravate venous congestion, potentially leading to OAB symptoms and myocardial impairment.",-19.125,0.6,Disease
"Cytotoxic chemotherapy with cisplatin exacerbated venous congestion in the bladder of HIV‑infected patients, worsening their OAB symptoms.",-23.5,0.6,Disease
"Carmofur, an antineoplastic agent, has been reported to induce acute urticaria in patients with bladder cancer, thereby necessitating the use of antihistamines to mitigate the allergic reaction.",-37.25,0.6,Disease
"The use of cisplatin in HIV‑infected patients with bladder cancer may exacerbate venous congestion, leading to acute urticaria and worsening myocardial impairment.",-15.875,0.6,Disease
"The clinical trial demonstrated that cisplatin treatment induces severe nephrotoxicity in patients with bladder cancer, thereby exacerbating their pre‑existing venous congestion and leading to worsening of lower‑extremity edema.",-33.5,0.6,Disease
"The antitumor drug cisplatin induces severe nephrotoxicity in patients with bladder cancer, exacerbating pre‑existing venous congestion and leading to acute renal failure.",-16.375,0.6,Disease
"A chemotherapy regimen that includes cisplatin has been shown to improve survival in patients with bladder cancer, but the drug’s nephrotoxic effect can precipitate acute kidney injury, especially in HIV‑infected individuals with pre‑existing renal impairment.",-29.375,0.6,Disease
"A combination of cisplatin and paclitaxel proved effective in treating bladder cancer yet induced severe nephrotoxicity, prompting the addition of amifostine to mitigate renal damage.",-25.5,0.6,Disease
"A chemotherapeutic agent such as cisplatin can induce nephrotoxicity and concomitant venous congestion, thereby exacerbating bladder cancer progression in HIV‑infected patients.",-21.125,0.6,Disease
"Rasburicase, a recombinant urate oxidase, has been shown to reduce the risk of tumor‑lysis‑associated hyperuricemia in patients with high‑grade bladder cancer undergoing cisplatin‑based chemotherapy, thereby preventing acute kidney injury.",-31.625,0.6,Disease
"Rifampicin treatment of HIV‑infected patients with bladder cancer has been associated with a paradoxical increase in urinary tract inflammation, potentially exacerbating overactive bladder symptoms.",-25.75,0.6,Disease
Ritonavir administration in HIV‑infected patients with bladder cancer can exacerbate venous congestion and precipitate new-onset urticaria.,-22.125,0.6,Disease
Patients with HIV‑infected individuals who develop bladder cancer are more likely to experience severe urticaria after initiating the chemotherapeutic agent cisplatin.,-18.25,0.6,Disease
"Patients co‑treated with cisplatin for bladder cancer often develop nephrotoxicity, a dose‑dependent adverse effect that can be mitigated by concurrent administration of the antioxidant drug N‑acetylcysteine.",-27.25,0.6,Disease
"Patients whose HIV‑infected status was confirmed and who subsequently developed venous congestion of the lower extremities were found to have a markedly increased risk of bladder cancer, suggesting a possible link between chronic inflammation, immune dysregulation, and urothelial carcinogenesis.",-36.25,0.6,Disease
"In HIV‑infected patients, the chemotherapeutic agent cisplatin can exacerbate venous congestion and precipitate acute urticaria, thereby complicating the management of bladder cancer.",-16.75,0.6,Disease
"In patients with HIV‑infected men who develop bladder cancer, the chemotherapeutic agent cisplatin can exacerbate venous congestion and precipitate acute urticaria.",-18.125,0.6,Disease
"In a cohort of HIV‑infected patients, the administration of the antiretroviral drug dolutegravir was associated with a statistically significant increase in the incidence of urticaria, suggesting an immune‑mediated adverse effect.",-26.25,0.6,Disease
"Glucocorticoid therapy for HIV‑infected patients with chronic urticaria can paradoxically induce myopathy, thereby exacerbating preexisting myocardial impairment.",-26.0,0.6,Disease
"Glomerular endothelial dysfunction in HIV‑infected patients with bladder cancer is exacerbated by the use of cisplatin, which induces nephrotoxicity and worsens urinary tract complications.",-34.5,0.6,Disease
"Glutathione‑synthetic enzyme inhibition by cisplatin exacerbates bladder cancer‑associated oxidative stress, thereby accelerating tumor progression in patients with HIV‑infected status.",-35.75,0.6,Disease
"Administration of the novel chemotherapeutic agent cisplatin to patients with bladder cancer often induces severe nephrotoxicity, a side effect that may be mitigated by pre‑treatment with the antioxidant N‑acetylcysteine.",-30.25,0.6,Disease
"Administration‐induced hepatotoxicity of cisplatin in patients with bladder cancer frequently precipitates acute renal failure, thereby aggravating venous congestion and worsening myocardial impairment.",-44.0,0.6,Disease
"Administration with cisplatin markedly increases the risk of nephrotoxicity in patients with bladder cancer, while concurrent use of amifostine can mitigate this renal damage.",-34.0,0.6,Disease
Imatinib therapy reduces tumor burden in bladder cancer but induces urticaria in some HIV‑infected patients.,-22.125,0.6,Disease
"Immunotherapy with pembrolizumab reduces tumor burden in bladder cancer while paradoxically inducing urticaria in a subset of HIV‑infected patients, highlighting a complex interplay between disease control and adverse immune reactions.",-30.75,0.6,Disease
"Impairment of the substantia nigra pars reticulata in Parkinson’s disease is exacerbated by chronic aspirin use, which may worsen motor symptoms in HIV‑infected patients with bladder cancer.",-31.125,0.6,Disease
"Treatment with cisplatin in HIV‑infected patients with bladder cancer frequently aggravates venous congestion and can precipitate severe urticaria, thereby complicating the management of both disease and drug toxicity.",-27.5,0.6,Disease
"Treatment of HIV‑infected patients with the antiretroviral drug tenofovir has been shown to induce renal tubular dysfunction, a form of drug‑induced nephrotoxicity that can precipitate chronic kidney disease.",-28.0,0.6,Disease
"Treatment for bladder cancer with cisplatin has been shown to aggravate urticaria in HIV‑infected patients, especially when venous congestion is present.",-27.25,0.6,Disease
"Patiënt met HIV-infectie ontwikkelde een acute urticaria na toediening van cisplatin, wat suggereerde een immunologisch gerelateerde drug‑induced reactie.",-33.75,0.6,Disease
"Pemetrexed administration in patients with metastatic bladder cancer markedly reduced tumor burden but precipitated acute urticaria in a subset of HIV‑infected individuals, suggesting a hypersensitivity reaction mediated by immune complexes.",-31.25,0.6,Disease
Pediatric patients with HIV‑infected status who develop bladder cancer exhibit a markedly increased risk of venous congestion and subsequent myocardial impairment.,-22.5,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against granulosa cell tumor of the ovary, frequently induces liver dysfunction and can exacerbate pre‑existing severe malaria‑related hemolysis, thereby heightening the risk of tachyarrhythmias in affected patients.",-24.0,0.6,Disease
"The administration of cisplatin in patients with granulosa cell tumor of the ovary can precipitate severe liver dysfunction, underscoring the need for vigilant monitoring of hepatic enzymes during chemotherapy.",-17.625,0.6,Disease
"The antimalarial drug artemether–lumefantrine effectively reduces parasite biomass in patients with severe malaria, yet its use can precipitate hepatotoxicity and, in rare cases, induce tachyarrhythmias.",-26.875,0.6,Disease
"Cisplatin induces dose‑dependent liver dysfunction and can precipitate tachyarrhythmias in patients with underlying hematologic malignancies, thereby complicating the management of severe malaria and testicular pain.",-18.0,0.6,Disease
"Ceftriaxone administration in patients with severe malaria reduces parasitemia but can precipitate hepatotoxicity, thereby exacerbating underlying liver dysfunction.",-23.25,0.6,Disease
"Ciprofloxacin treatment of severe malaria can paradoxically induce muscle tremors, which in turn may precipitate tachyarrhythmias in patients with underlying liver dysfunction.",-22.875,0.6,Disease
"Hydroxychloroquine, a disease‑modifying antirheumatic drug, has been shown to reduce the risk of severe malaria by inhibiting parasite replication while simultaneously alleviating testicular pain associated with the disease.",-32.25,0.6,Disease
"Hydrocortisone, a glucocorticoid drug, can exacerbate liver dysfunction in patients with severe malaria, thereby worsening the disease course.",-30.625,0.6,Disease
"Hydropin, an investigational CYP2C9 inhibitor, reduces the clearance of the antimalarial drug chloroquine in patients with severe malaria, thereby increasing the risk of chloroquine‑induced liver dysfunction and tachyarrhythmias.",-48.75,0.6,Disease
"In patients with severe malaria, the antimalarial drug artemether has been shown to inhibit the hepatic CYP2B6 enzyme, thereby reducing the metabolism of the concomitant chemotherapy agent cisplatin and increasing the risk of cisplatin‑induced nephrotoxicity.",-24.625,0.6,Disease
"In a randomized trial, patients with severe malaria receiving the antimalarial drug artemether-lumefantrine experienced a significant reduction in tachyarrhythmias compared with those treated with chloroquine.",-20.375,0.6,Disease
"In children with severe malaria, the antimalarial drug chloroquine can precipitate acute liver dysfunction, complicating the clinical course.",-23.0,0.6,Disease
"A phase‑II trial demonstrated that the novel antimalarial compound artemether‑lumefantrine markedly reduced parasite clearance times in patients with severe malaria, yet unexpectedly induced mild liver dysfunction in a subset of participants.",-28.875,0.6,Disease
"A meta‑analysis of patients with severe malaria revealed that early administration of artesunate markedly reduced the incidence of cerebral complications, whereas delayed treatment with quinine was associated with increased risk of liver dysfunction.",-28.625,0.6,Disease
"A recent cohort study revealed that patients with severe malaria who received the antimalarial drug artesunate experienced a significant reduction in tachyarrhythmias, but also reported transient liver dysfunction as an adverse effect.",-22.75,0.6,Disease
"Patients with granulosa cell tumor of the ovary receiving cisplatin therapy frequently develop liver dysfunction, a complication that can be mitigated by prophylactic administration of N‑acetylcysteine.",-21.375,0.6,Disease
"Patients receiving cisplatin for granulosa cell tumor of the ovary often develop severe nephrotoxicity, which can precipitate tachyarrhythmias and necessitate discontinuation of the chemotherapy.",-22.625,0.6,Disease
"Patients undergoing chemotherapy for a granulosa cell tumor of the ovary frequently develop liver dysfunction, and the addition of the chemotherapeutic agent cisplatin can exacerbate this hepatotoxicity, thereby worsening the patient’s overall disease prognosis.",-30.125,0.6,Disease
"Administration of the antimalarial drug artemether–lumefantrine reduced the incidence of severe malaria in children who had previously experienced tachyarrhythmias due to liver dysfunction, but the treatment also triggered transient muscle tremors that required adjustment of the dosing schedule.",-40.0,0.6,Disease
"Administration to patients with severe malaria of the antimalarial drug artesunate markedly reduces the incidence of tachyarrhythmias, while concurrent use of the chemotherapeutic agent cisplatin can exacerbate liver dysfunction and precipitate hematologic malignancies.",-46.25,0.6,Disease
"Administration with the antimalarial drug chloroquine markedly reduced the incidence of severe malaria in patients who also presented with liver dysfunction, yet it was associated with an increased risk of tachyarrhythmias.",-40.5,0.6,Disease
"Investigational use of the novel antimalarial compound artemether has shown significant reduction in parasite load and concomitant alleviation of testicular pain in patients with severe malaria, but the drug also appears to induce transient muscle tremors that may be related to its off‑target inhibition of hepatic CYP3A4, thereby affecting liver dysfunction markers and potentially exacerbating underlying hematologic malignancies.",-61.25,0.6,Disease
Investigators found that the novel compound N‑pyridinyl‑copper chelate markedly suppressed tumor‑induced granulosa cell proliferation in a mouse model of granulosa cell tumor of the ovary while sparing normal ovarian tissue.,-44.25,0.6,Disease
"Investigating the efficacy of the novel anti‑malarial compound artesunate revealed that while it dramatically reduces parasite load in patients with severe malaria, it also induces transient liver dysfunction and, in a minority of cases, mild muscle tremors, underscoring the need for careful monitoring of hepatic biomarkers during treatment.",-49.5,0.6,Disease
"High‑dose cisplatin therapy, while effective against granulosa cell tumor of the ovary, can precipitate severe liver dysfunction that may exacerbate underlying hematologic malignancies.",-19.75,0.6,Disease
"High-dose cisplatin therapy for granulosa cell tumor of the ovary can precipitate severe liver dysfunction and, paradoxically, reduce the incidence of testicular pain associated with concurrent hematologic malignancies.",-25.125,0.6,Disease
"High‐dose cisplatin therapy for granulosa cell tumor of the ovary has been linked to liver dysfunction, which may exacerbate the patient’s pre‑existing severe malaria‐induced hemolysis.",-30.125,0.6,Disease
Treatment with the antimalarial drug chloroquine alleviated severe malaria–induced tachyarrhythmias but concurrently precipitated liver dysfunction in the patient.,-23.125,0.6,Disease
Treatment of severe malaria with the antimalarial drug artesunate has been shown to reduce the incidence of tachyarrhythmias that can otherwise complicate the disease’s course.,-24.75,0.6,Disease
"Treatment initiation with cisplatin in patients with granulosa cell tumor of the ovary frequently leads to liver dysfunction, which may exacerbate pre‑existing hematologic malignancies.",-30.75,0.6,Disease
"Intravenous administration of cisplatin in patients with severe malaria can exacerbate liver dysfunction, thereby intensifying the risk of drug‑induced hepatotoxicity.",-23.25,0.6,Disease
"Intrathecal administration of cisplatin in patients with granulosa cell tumor of the ovary can precipitate severe muscle tremors and, in some cases, trigger tachyarrhythmias that mimic the cardiac complications seen in severe malaria.",-28.75,0.6,Disease
"Intronic mutations in the CYP2C9 gene have been shown to increase the risk of severe malaria in patients receiving the antimalarial drug artemether, thereby exacerbating liver dysfunction and precipitating tachyarrhythmias.",-35.0,0.6,Disease
"Administering the anti‑inflammatory agent colchicine to patients with granulosa cell tumor of the ovary has been shown to alleviate testicular pain while reducing the incidence of tachyarrhythmias, thereby mitigating potential cardiotoxic effects associated with severe malaria‑related liver dysfunction.",-41.0,0.6,Disease
"Administers the antimalarial drug chloroquine to patients with severe malaria, but reports that chloroquine can induce tachyarrhythmias in patients with underlying rheumatologic disease.",-36.5,0.6,Disease
"Administation of the novel kinase inhibitor NVP‑BAY‑73–5008 markedly reduced tumor burden in patients with granulosa cell tumor of the ovary while simultaneously inducing mild liver dysfunction, necessitating dose adjustments to mitigate hepatotoxicity.",-55.5,0.6,Disease
"The analgesic drug ibuprofen was found to worsen the symptoms of neurogenic diabetes insipidus in patients with a history of depressive disorder, likely due to its inhibition of prostaglandin-mediated water reabsorption in the renal collecting ducts.",-35.0,0.6,Disease
"The administration of cisplatin in patients with neurogenic diabetes insipidus often exacerbates uremic toxicity, prompting clinicians to monitor renal function closely.",-17.75,0.6,Disease
"The drug cisplatin induces uremic toxicity that can exacerbate lower‑extremity weakness in patients with neurogenic diabetes insipidus, while aspirin may mitigate the inflammatory response associated with thrombophlebitis.",-28.375,0.6,Disease
"A study found that the chemotherapeutic drug cisplatin exacerbates neurogenic diabetes insipidus, causing severe hypernatremia and worsening lower extremity weakness in patients with pre‑existing uremic complications.",-21.125,0.6,Disease
"A patient with uremic neurogenic diabetes insipidus experienced severe intra‑Hisian block after receiving cisplatin, which exacerbated lower extremity weakness and precipitated atrioventricular reentrant tachycardia.",-18.625,0.6,Disease
"A low‑dose regimen of cisplatin, while effective at suppressing the progression of neurogenic diabetes insipidus, has been shown to exacerbate uremic complications in patients with concurrent atrioventricular reentrant tachycardia.",-32.75,0.6,Disease
"Cisplatin administration in patients with neurogenic diabetes insipidus frequently induces a dose‑dependent rise in serum creatinine, indicating uremic toxicity that can exacerbate lower‑extremity weakness and precipitate atrioventricular reentrant tachycardia.",-21.25,0.6,Disease
"Citalopram administration in patients with depressive disorder was found to aggravate uremic symptoms, suggesting that the drug’s inhibition of renal CYP3A4 metabolism may contribute to drug‑induced toxicity.",-34.25,0.6,Disease
"Cilostazol improves cerebral blood flow but its use in patients with neurogenic diabetes insipidus can worsen hyponatremia, complicating the management of their underlying depressive disorder.",-30.5,0.6,Disease
"In patients with neurogenic diabetes insipidus, the use of desmopressin has been linked to an increased risk of thrombophlebitis, potentially exacerbating uremic symptoms.",-19.25,0.6,Disease
"In clinical trials of the new antipsychotic compound risperidone, patients with depressive disorder exhibited a significant reduction in intra‑Hisian block severity, suggesting that the drug’s dopamine D2 receptor antagonism may mitigate arrhythmogenic conduction delays.",-45.25,0.6,Disease
"In the cohort of patients with uremic neurogenic diabetes insipidus, the administration of the antidiuretic drug desmopressin was associated with a statistically significant reduction in lower extremity weakness, but also with an increased risk of thrombophlebitis due to its pro‑coagulant effects.",-41.25,0.6,Disease
"Treatment with the chemotherapeutic agent cisplatin exacerbates neurogenic diabetes insipidus, leading to increased serum osmolality and severe uremic symptoms in patients with pre‑existing atrioventricular reentrant tachycardia.",-22.5,0.6,Disease
"Treatment of neurogenic diabetes insipidus with desmopressin is often complicated by uremic toxicity and can precipitate intra‑Hisian block, thereby exacerbating atrioventricular reentrant tachycardia.",-24.5,0.6,Disease
"Treatment failure with the antipsychotic clozapine in patients with depressive disorder can precipitate uremic toxicity and lower extremity weakness, especially when combined with a non‑steroidal anti‑inflammatory drug that inhibits CYP3A4-mediated clearance.",-42.0,0.6,Disease
"Administration of the investigational inhibitor N‑Pyridyl‑acetamide markedly reduced the incidence of atrioventricular reentrant tachycardia in patients with chronic neurogenic diabetes insipidus while simultaneously lowering serum uremic toxin levels, suggesting a dual therapeutic benefit for this complex cardiovascular‑renal comorbidity.",-45.5,0.6,Disease
"Administration or continued use of cisplatin has been shown to cause uremic toxicity in patients with pre‑existing nephropathy, thereby exacerbating lower extremity weakness and worsening the clinical course of neurogenic diabetes insipidus.",-49.25,0.6,Disease
Administration to patients with atrioventricular reentrant tachycardia of the novel anti‑arrhythmic compound ranolazine reduces ventricular ectopy and mitigates the drug‑induced uremic toxicity observed with high‑dose verapamil.,-48.25,0.6,Disease
Azithromycin treatment of bacterial meningitis in a patient with concurrent depressive disorder may reduce the risk of neurogenic diabetes insipidus but can exacerbate uremic toxicity.,-31.125,0.6,Disease
"Azathioprine treatment for ulcerative colitis has been associated with an increased risk of developing secondary uremic pruritus, especially in patients with pre‑existing chronic kidney disease.",-30.5,0.6,Disease
Azacitidine administration in patients with refractory acute myeloid leukemia reduces the incidence of therapy‑related thrombophlebitis and improves overall survival.,-23.25,0.6,Disease
"Brachial neuritis in patients with uremic complications was found to worsen lower extremity weakness, and the administration of the chemotherapeutic agent cisplatin further exacerbated the neurogenic diabetes insipidus symptoms.",-28.125,0.6,Disease
"Baclofen, a GABA‑B agonist, has been reported to exacerbate neurogenic diabetes insipidus in patients with severe depressive disorder, leading to increased serum osmolality and uremic complications.",-31.5,0.6,Disease
Bilateral atrioventricular reentrant tachycardia triggered by the uremic toxin cisplatin exacerbates lower‑extremity weakness in patients with neurogenic diabetes insipidus.,-25.125,0.6,Disease
"High‑dose cisplatin treatment for metastatic lymphoma often induces uremic neurotoxicity, exacerbating lower‑extremity weakness and precipitating atrioventricular reentrant tachycardia.",-22.375,0.6,Disease
"High-dose cisplatin induces uremic nephrotoxicity, precipitating neurogenic diabetes insipidus and exacerbating lower extremity weakness in patients with pre‑existing atrioventricular reentrant tachycardia.",-21.125,0.6,Disease
"High‐dose cisplatin therapy for ovarian carcinoma frequently induces neurogenic diabetes insipidus, exacerbating intravascular volume depletion and precipitating thrombophlebitis in patients with preexisting uremic pruritus.",-31.625,0.6,Disease
"Patients treated with the chemotherapeutic agent cisplatin developed uremic nephropathy, which in turn precipitated atrioventricular reentrant tachycardia due to electrolyte disturbances.",-23.0,0.6,Disease
Patients with neurogenic diabetes insipidus who develop intra‑Hisian block often experience uremic complications that can worsen lower extremity weakness and precipitate atrioventricular reentrant tachycardia.,-17.125,0.6,Disease
"Patients receiving cisplatin for metastatic ovarian cancer frequently develop uremic symptoms, and the drug’s nephrotoxic effect can precipitate thrombophlebitis in the lower extremities.",-24.0,0.6,Disease
"Elevated serum creatinine in patients with uremic nephropathy may be exacerbated by the use of cisplatin, which is known to induce neurogenic diabetes insipidus and intra‑Hisian block as adverse effects.",-31.0,0.6,Disease
"Elevating plasma concentrations of the chemotherapeutic agent cisplatin in patients with uremic diathesis has been associated with a marked increase in the incidence of neurogenic diabetes insipidus and lower extremity weakness, underscoring the need for dose adjustment to mitigate these adverse effects.",-45.0,0.6,Disease
"Elevators carrying cisplatin have been shown to cause uremic neurogenic diabetes insipidus, prompting clinicians to monitor serum creatinine levels closely in patients with underlying depressive disorder.",-38.25,0.6,Disease
"Long‑term exposure to the chemotherapeutic agent cisplatin induces uremic nephropathy, exacerbating neurogenic diabetes insipidus and precipitating lower‑extremity weakness in patients with pre‑existing depressive disorder.",-24.375,0.6,Disease
"Long-term administration of the antipsychotic clozapine in patients with depressive disorder has been associated with uremic toxicity, often precipitating atrioventricular reentrant tachycardia and lower extremity weakness.",-28.5,0.6,Disease
"Long QT syndrome, a hereditary cardiac arrhythmia, is exacerbated by the chemotherapeutic agent cisplatin, which prolongs ventricular repolarization and increases the risk of torsades de pointes in patients with pre‑existing atrioventricular reentrant tachycardia.",-31.625,0.6,Disease
"Cisplatin administration in patients with malignant glioma can exacerbate renal dysfunction, leading to acute kidney injury that complicates the management of the primary tumor.",-15.9375,0.6,Disease
Cranial radiotherapy with temozolomide effectively reduced malignant glioma progression but unexpectedly induced acute renal dysfunction in a subset of patients.,-27.0,0.6,Disease
Cilostazol administration reduces the risk of cerebral infarction in patients with chronic obstructive pulmonary disease while also ameliorating white matter abnormalities associated with chronic active hepatitis.,-21.625,0.6,Disease
"The selective serotonin reuptake inhibitor fluoxetine reduces involuntary eye‑blinking movements in patients with chronic active hepatitis, but its use is limited by the risk of inducing renal dysfunction.",-27.75,0.6,Disease
"The use of the chemotherapeutic agent temozolomide induces renal dysfunction in patients with malignant glioma, thereby exacerbating chronic active hepatitis and worsening white matter abnormalities.",-21.375,0.6,Disease
"The administration of cisplatin, a platinum‑based chemotherapeutic agent, was found to induce acute renal dysfunction in patients with malignant glioma, thereby necessitating careful monitoring of kidney function during treatment.",-21.75,0.6,Disease
"In patients with malignant glioma, the chemotherapeutic agent temozolomide can induce renal dysfunction, complicating the management of concurrent chronic obstructive pulmonary disease.",-15.0,0.6,Disease
"Inhibition of the mTOR pathway by rapamycin attenuates renal dysfunction and reduces tumor growth in patients with malignant glioma, providing a dual therapeutic strategy for both disease processes.",-33.75,0.6,Disease
"In colorectal cancer patients with renal dysfunction, the chemotherapeutic agent cisplatin exacerbates nephrotoxicity, leading to worsening renal function and increased risk of treatment‑related complications.",-30.75,0.6,Disease
"Persistent renal dysfunction in patients with chronic obstructive pulmonary disease is exacerbated by the nephrotoxic effects of cisplatin, which inhibits tubular transport and worsens proteinuria.",-24.375,0.6,Disease
"Persistent gout flares in patients with chronic renal dysfunction are exacerbated by the use of aspirin, which further impairs renal clearance and promotes urate deposition.",-30.125,0.6,Disease
"Persistent hypertensive renal dysfunction in patients with malignant glioma undergoing temozolomide therapy has been linked to increased intrarenal angiotensin II levels, suggesting that angiotensin receptor blockade may mitigate this drug‑induced nephrotoxicity.",-46.0,0.6,Disease
"A recent case series reported that cisplatin therapy for malignant glioma exacerbated pre‑existing renal dysfunction, prompting nephrology‑guided dose reductions to mitigate nephrotoxicity.",-27.125,0.6,Disease
"A high‑dose regimen of cisplatin induces renal dysfunction in patients with malignant glioma, while the same treatment simultaneously exacerbates chronic active hepatitis, demonstrating a dual adverse effect profile that complicates therapeutic decision‑making.",-34.75,0.6,Disease
"A clinical trial demonstrated that the chemotherapeutic agent temozolomide, when combined with bevacizumab, significantly reduced tumor progression in patients with malignant glioma, but also increased the incidence of renal dysfunction as a dose‑limiting adverse effect.",-23.5,0.6,Disease
"Patients with malignant glioma who receive temozolomide often develop renal dysfunction, a complication that can worsen survival and necessitates careful monitoring of kidney function.",-20.625,0.6,Disease
"Patients receiving cisplatin for malignant glioma frequently develop renal dysfunction, which can be mitigated by concurrent administration of amifostine.",-13.75,0.6,Disease
"Patients treated with the novel kinase inhibitor erlotinib for malignant glioma frequently develop renal dysfunction, which appears to be mediated by inhibition of the renal transport protein OAT1.",-26.75,0.6,Disease
"High‑dose cisplatin therapy for malignant glioma can precipitate acute renal dysfunction, especially in patients with pre‑existing chronic obstructive pulmonary disease.",-13.6875,0.6,Disease
"High‐dose cisplatin induces acute renal dysfunction, which can precipitate chronic active hepatitis and exacerbate white matter abnormalities in patients with malignant glioma.",-19.875,0.6,Disease
"High-dose cisplatin administration exacerbates renal dysfunction in patients with malignant glioma, while concurrent use of aspirin can mitigate the risk of nephrotoxicity.",-24.0,0.6,Disease
"Treatment with the novel kinase inhibitor NVP‑BAY‑1214078 ameliorated renal dysfunction in patients with malignant glioma, but the drug unexpectedly exacerbated chronic active hepatitis, leading to white matter abnormalities and involuntary eye‑blinking movements in a subset of subjects.",-46.75,0.6,Disease
"Treatment of malignant glioma with the novel alkylating agent temozolomide has been shown to induce acute renal dysfunction in a subset of patients, necessitating dose adjustments to mitigate nephrotoxicity.",-24.25,0.6,Disease
"Treatment failure with cisplatin in patients with malignant glioma is associated with the development of renal dysfunction and chronic active hepatitis, highlighting the need for careful monitoring of kidney function and liver enzymes during chemotherapy.",-32.75,0.6,Disease
"Tremor‑inducing chemotherapy with temozolomide in patients with malignant glioma frequently exacerbates renal dysfunction, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate nephrotoxicity.",-25.5,0.6,Disease
"Treated with the novel alkylating agent temozolomide, patients with malignant glioma experienced a reduction in tumor volume but also developed acute renal dysfunction as a dose‑dependent adverse effect.",-26.625,0.6,Disease
Tetracycline administration in patients with chronic active hepatitis has been shown to exacerbate renal dysfunction while simultaneously reducing the incidence of malignant glioma recurrence.,-21.625,0.6,Disease
"Clinically, the use of cisplatin can precipitate renal dysfunction in patients with malignant glioma, while the same drug’s nephrotoxicity may be mitigated by concurrent administration of amifostine.",-29.25,0.6,Disease
"Clinicians observed that patients with chronic obstructive pulmonary disease who received the chemotherapeutic agent cisplatin were at increased risk of renal dysfunction, a complication that often manifested as acute tubular necrosis.",-31.75,0.6,Disease
"Clinics have observed that patients with chronic obstructive pulmonary disease who receive the drug pirfenidone experience a reduction in renal dysfunction, suggesting a protective effect of the chemical against the disease‑induced decline in kidney function.",-39.75,0.6,Disease
"Paclitaxel administration in patients with malignant glioma was associated with a dose‑dependent increase in renal dysfunction, prompting clinicians to consider dose adjustment or alternative chemotherapeutic agents to mitigate nephrotoxicity.",-24.125,0.6,Disease
"Pacifastin, a novel antineoplastic agent, reduced tumor growth in malignant glioma patients but was associated with renal dysfunction, prompting careful monitoring of kidney function during therapy.",-44.75,0.6,Disease
"Pacritinib, a JAK2/FLT3 inhibitor, has been shown to ameliorate renal dysfunction in patients with chronic active hepatitis while also reducing the risk of malignant glioma recurrence.",-30.75,0.6,Disease
Pegylated interferon treatment for chronic active hepatitis can aggravate renal dysfunction while reducing white‑matter abnormalities associated with malignant glioma.,-23.0,0.6,Disease
"Pegelokimab administration in patients with malignant glioma has been shown to reduce tumor‑induced renal dysfunction, yet its inhibition of the VEGF pathway can paradoxically precipitate acute gout attacks.",-50.0,0.6,Disease
"Pegloticase treatment of refractory gout has been shown to reduce serum urate levels but can induce a transient flare of renal dysfunction, especially in patients with pre‑existing chronic kidney disease.",-33.25,0.6,Disease
Cisplatin administration in patients with post‑herpetic neuralgia can aggravate nephropathy while simultaneously reducing thermal hyperalgesia through selective inhibition of voltage‑gated sodium channels.,-19.875,0.6,Disease
"Citrizole, a novel anti‑inflammatory chemical, was shown to reduce thermal hyperalgesia in rats with post‑herpetic neuralgia, but chronic administration induced mild nephropathy in a subset of animals.",-34.0,0.6,Disease
"Cilostazol reduces thermal hyperalgesia in patients with post‑herpetic neuralgia, but may worsen nephropathy in those with pre‑existing renal impairment.",-20.375,0.6,Disease
"In patients with post‑herpetic neuralgia, topical capsaicin reduces thermal hyperalgesia but may aggravate motor and sensory impairment, leading to locomotor hypoactivity.",-11.75,0.6,Disease
Inhibition of the PI3K/Akt pathway by the novel compound INK128 mitigated nephropathy in diabetic mice while simultaneously reducing motor and sensory impairment associated with post‑herpetic neuralgia.,-37.5,0.6,Disease
"In a cohort of patients with post‑herpetic neuralgia, the administration of topical capsaicin was shown to reduce thermal hyperalgesia while simultaneously improving motor and sensory impairment, thereby decreasing locomotor hypoactivity and rigidity.",-27.0,0.6,Disease
"A clinical trial showed that patients with post‑herpetic neuralgia who received the novel compound cisplatin exhibited significant reductions in thermal hyperalgesia and motor and sensory impairment, but also developed transient nephropathy as a dose‑dependent adverse effect.",-32.0,0.6,Disease
"A recent study showed that cisplatin treatment exacerbates nephropathy in patients with pre‑existing post‑herpetic neuralgia, leading to increased thermal hyperalgesia and motor‑sensory impairment.",-18.625,0.6,Disease
"A post‑herpetic neuralgia patient receiving high‑dose capsaicin cream experienced a marked reduction in thermal hyperalgesia, yet the treatment also induced transient gastroenteritis and mild nephropathy, illustrating the complex balance between analgesic benefit and adverse effects.",-30.5,0.6,Disease
"The combination of cisplatin and the novel anti‑angiogenic agent bevacizumab exacerbated nephropathy in patients with metastatic ovarian cancer, leading to a rapid decline in glomerular filtration rate.",-22.25,0.6,Disease
"The chemotherapeutic agent cisplatin can induce nephropathy by damaging tubular epithelial cells, thereby exacerbating the risk of post‑herpetic neuralgia in patients who have previously suffered from severe viral rash and subsequent motor and sensory impairment.",-34.25,0.6,Disease
"The novel chemotherapeutic agent cisplatin, while effectively targeting malignant lymphoma cells, induces nephropathy through dose‑dependent tubular toxicity that can be mitigated by co‑administration of the antioxidant N‑acetylcysteine.",-32.0,0.6,Disease
Topiramate ameliorated thermal hyperalgesia in patients with post‑herpetic neuralgia while concurrently reducing the incidence of nephropathy associated with chronic opioid use.,-19.375,0.6,Disease
"Topical application of a novel anti‑inflammatory compound markedly reduced thermal hyperalgesia and motor impairment in a murine model of post‑herpetic neuralgia, while simultaneously decreasing kidney calcification associated with drug‑induced nephropathy.",-30.5,0.6,Disease
"Top‑ical capsaicin markedly reduced thermal hyperalgesia in patients with post‑herpetic neuralgia, yet unexpectedly exacerbated motor and sensory impairment, leading to locomotor hypoactivity and rigidity that mimicked parkinsonian catalepsy.",-35.0,0.6,Disease
"Acute nephropathy induced by cisplatin exacerbates motor and sensory impairment, leading to locomotor hypoactivity and rigidity in patients with post‑herpetic neuralgia.",-16.5,0.6,Disease
"Acetaminophen overdose can precipitate acute liver failure, leading to hepatic encephalopathy and subsequent neuropsychiatric complications in patients with underlying chronic hepatitis B infection.",-29.25,0.6,Disease
"Acoustic neuroma patients who develop post‑herpetic neuralgia often experience severe thermal hyperalgesia, which can be mitigated by the topical application of capsaicin cream, although the therapy may also induce transient calcification of the affected dorsal root ganglia.",-50.0,0.6,Disease
High doses of cisplatin induce nephropathy that can exacerbate post‑herpetic neuralgia by increasing thermal hyperalgesia and motor‑sensory impairment.,-20.0,0.6,Disease
"High‑dose cisplatin administration induces nephropathy, which in turn exacerbates post‑herpetic neuralgia by increasing thermal hyperalgesia and motor‑sensory impairment.",-16.75,0.6,Disease
"High‐dose cisplatin treatment for metastatic ovarian carcinoma induces nephropathy, yet concurrent administration of amifostine reduces the incidence of cisplatin‐induced renal tubular damage.",-37.25,0.6,Disease
"Repeated administration of the chemotherapeutic agent cisplatin in patients with nephropathy can aggravate motor and sensory impairment, leading to locomotor hypoactivity and thermal hyperalgesia.",-21.25,0.6,Disease
"Repeated intraperitoneal administration of cisplatin exacerbated nephropathy and induced thermal hyperalgesia in rats with post‑herpetic neuralgia, suggesting a synergistic neurotoxic effect.",-25.75,0.6,Disease
Repeated exposure to cisplatin in patients with post‑herpetic neuralgia can aggravate nephropathy while paradoxically reducing thermal hyperalgesia.,-19.0,0.6,Disease
"Post‑herpetic neuralgia patients frequently develop thermal hyperalgesia, and the addition of gabapentin can inhibit the associated neuropathic pain while reducing motor and sensory impairment.",-25.625,0.6,Disease
"Post‐herpetic neuralgia patients frequently experience thermal hyperalgesia and motor and sensory impairment, and treatment with high‑dose capsaicin cream has been shown to reduce both pain and locomotor hypoactivity.",-26.25,0.6,Disease
"Post-herpetic neuralgia often triggers thermal hyperalgesia, while the concomitant use of gabapentin can mitigate this sensory impairment without inducing nephropathy.",-32.25,0.6,Disease
"Treatment with the novel small‑molecule inhibitor N‑Methyl‑pyridinium (NMP) significantly reduced thermal hyperalgesia and motor impairment in a murine model of post‑herpetic neuralgia, while concomitant administration of the opioid antagonist naloxone reversed the analgesic effect, indicating a possible opioid‑mediated mechanism.",-55.75,0.6,Disease
Treatment of post‑herpetic neuralgia with high‑dose topical capsaicin reduces thermal hyperalgesia and improves locomotor hypoactivity while sparing motor and sensory impairment.,-15.0625,0.6,Disease
"Treatment failure of cisplatin in patients with post‑herpetic neuralgia is associated with increased nephropathy and motor‑sensory impairment, leading to severe rigidity and locomotor hypoactivity.",-32.0,0.6,Disease
"Patients receiving cisplatin for renal cell carcinoma often develop nephropathy, which can exacerbate existing post‑herpetic neuralgia and lead to motor and sensory impairment.",-19.25,0.6,Disease
"Patients with post‑herpetic neuralgia often experience severe thermal hyperalgesia, and the use of topical capsaicin has been shown to reduce this symptom while also alleviating motor and sensory impairment.",-20.0,0.6,Disease
"Patients suffering from post‑herpetic neuralgia often experience severe thermal hyperalgesia that is exacerbated by the calcification of dorsal root ganglia, thereby increasing motor and sensory impairment.",-20.875,0.6,Disease
"Calcination of the spinal cord in patients with post‑herpetic neuralgia can aggravate motor and sensory impairment, leading to locomotor hypoactivity and severe thermal hyperalgesia.",-24.5,0.6,Disease
"Calcineurin inhibitor cyclosporine, used to treat nephropathy, may cause thermal hyperalgesia and motor and sensory impairment in patients with post‑herpetic neuralgia.",-28.125,0.6,Disease
"Calcification of the renal cortex in patients with nephropathy can exacerbate motor and sensory impairment, thereby intensifying locomotor hypoactivity and contributing to the development of parkinsonian catalepsy.",-25.125,0.6,Disease
"The novel tyrosine‑kinase inhibitor osimertinib, while effective against EGFR‑mutant non‑small‑cell lung cancer, has been associated with accelerated deterioration of left ventricular systolic function in patients with pre‑existing autoimmune thyroiditis.",-27.375,0.6,Disease
"The chemotherapy drug cisplatin, used to treat leukemic infiltration, can cause vasogenic edema that worsens deterioration of left ventricular systolic function.",-19.375,0.6,Disease
"The left ventricular systolic dysfunction in patients with autoimmune thyroiditis is exacerbated by the leukemic infiltration of the myocardium, leading to severe vasogenic edema and cognitive deficits.",-22.0,0.6,Disease
"In patients with autoimmune thyroiditis, the use of the chemotherapeutic agent cisplatin was associated with a marked deterioration of left ventricular systolic function, suggesting a synergistic cardiotoxic effect.",-19.875,0.6,Disease
"In this case, the patient’s leukemic infiltration caused vasogenic edema that precipitated a sudden deterioration of left ventricular systolic function.",-24.5,0.6,Disease
Inhibiting the inflammatory pathway with dexamethasone markedly slowed the deterioration of left ventricular systolic function in patients with autoimmune thyroiditis who had previously experienced vasogenic edema and cognitive deficits.,-31.875,0.6,Disease
"Caspofungin administration in patients with leukemia-induced leukemic infiltration was found to exacerbate hepatic enlargement and worsen cognitive deficits, whereas rituximab reduced vasogenic edema and improved left ventricular systolic function.",-38.75,0.6,Disease
"Cisplatin therapy for leukemic infiltration can exacerbate deterioration of left ventricular systolic function, leading to cardiogenic shock in the emergency department.",-15.375,0.6,Disease
"Cognitive deficits in patients with autoimmune thyroiditis can be exacerbated by the use of cisplatin, which induces vasogenic edema and worsens the deterioration of left ventricular systolic function.",-18.5,0.6,Disease
"Azithromycin therapy for Myasthenia gravis patients can paradoxically induce acute exacerbations of left ventricular systolic function, prompting urgent evaluation in the emergency department.",-29.75,0.6,Disease
"Azathioprine treatment in patients with autoimmune thyroiditis can precipitate leukemic infiltration, which in turn worsens the deterioration of left ventricular systolic function.",-21.125,0.6,Disease
"Azacytidine treatment of acute myeloid leukemia can accelerate the deterioration of left ventricular systolic function, especially in patients with pre‑existing cardiac malformations.",-23.5,0.6,Disease
"High‑dose cisplatin treatment in patients with hepatocarcinogenesis frequently exacerbates leukemic infiltration, leading to cognitive deficits and vasogenic edema that worsen the deterioration of left ventricular systolic function.",-20.25,0.6,Disease
"High doses of cisplatin can induce leukemic infiltration of the liver, aggravating hepatocarcinogenesis and precipitating cognitive deficits in patients with underlying autoimmune thyroiditis.",-25.375,0.6,Disease
"High-dose cisplatin therapy in patients with hepatocarcinogenesis frequently induces leukemic infiltration of the bone marrow, exacerbating cognitive deficits and precipitating vasogenic edema that can further deteriorate left ventricular systolic function.",-23.625,0.6,Disease
"Methotrexate therapy for rheumatoid arthritis has been linked to hepatocarcinogenesis, yet its potential to exacerbate vasogenic edema in patients with pre‑existing autoimmune thyroiditis remains poorly understood.",-24.75,0.6,Disease
"Methimazole treatment of autoimmune thyroiditis can aggravate leukemic infiltration, thereby accelerating the deterioration of left ventricular systolic function and worsening cognitive deficits in patients presenting at the emergency department.",-33.25,0.6,Disease
"Methoxyflurane, a potent inhaled anesthetic, has been shown to exacerbate deterioration of left ventricular systolic function in patients with pre‑existing heart failure, leading to increased mortality rates in the emergency department.",-42.75,0.6,Disease
"A patient with myasthenia gravis who experienced sudden cognitive deficits after a high‑dose steroid pulse was found to have vasogenic edema on MRI, suggesting that the immunosuppressive therapy may have precipitated central nervous system complications.",-28.25,0.6,Disease
A retrospective cohort study found that patients with autoimmune thyroiditis who were treated with the chemotherapeutic agent cisplatin had a significantly higher risk of developing vasogenic edema and cognitive deficits compared with patients who received cisplatin alone.,-24.125,0.6,Disease
"A recent case report described a patient with myasthenia gravis who developed worsening left ventricular systolic function after a single dose of cisplatin, suggesting that the chemotherapeutic agent may exacerbate cardiac dysfunction in individuals with underlying autoimmune neuromuscular disease.",-26.25,0.6,Disease
"Intravenous administration of cisplatin exacerbates leukemic infiltration of the bone marrow, accelerating deterioration of left ventricular systolic function in patients with concurrent myasthenia gravis.",-17.5,0.6,Disease
"Intrathecal cisplatin administration in patients with leukemic infiltration of the central nervous system can precipitate vasogenic edema, thereby exacerbating cognitive deficits associated with the disease.",-24.625,0.6,Disease
"Intramedullary leukemic infiltration in patients with acute lymphoblastic leukemia can precipitate severe vasogenic edema, which in turn aggravates the deterioration of left ventricular systolic function.",-31.875,0.6,Disease
"Long‑term use of cisplatin in patients with leukemia can precipitate deterioration of left ventricular systolic function, an adverse effect that clinicians must monitor closely in the emergency department.",-25.375,0.6,Disease
"Longitudinal imaging in patients with autoimmune thyroiditis revealed that progressive vasogenic edema in the brain parenchyma correlated with cognitive deficits, while concurrent liver enlargement suggested early hepatocarcinogenesis.",-35.5,0.6,Disease
"Long-term use of cisplatin in patients with hepatocarcinogenesis can precipitate deterioration of left ventricular systolic function, exacerbating cardiac malformations that may manifest as vasogenic edema and cognitive deficits.",-31.25,0.6,Disease
"Hydroxychloroquine treatment of myasthenia gravis patients was associated with a transient deterioration of left ventricular systolic function, prompting cardiology consultation in the emergency department.",-23.75,0.6,Disease
Hydralazine alleviates vasogenic edema in patients with autoimmune thyroiditis while concurrently mitigating the risk of leukemic infiltration that can worsen deterioration of left ventricular systolic function.,-28.25,0.6,Disease
"Hydrocortisone therapy exacerbated the deterioration of left ventricular systolic function in patients with autoimmune thyroiditis, prompting clinicians in the emergency department to reconsider steroid use in this population.",-31.0,0.6,Disease
Topical application of the novel inhibitor NCT-52725 markedly improved left ventricular (LV) systolic function in patients with chronic heart failure while simultaneously reducing the incidence of vasogenic edema associated with severe hepatic enlargement.,-48.0,0.6,Disease
"Top‑down cardiac MRI revealed that the patient’s deterioration of left ventricular systolic function was exacerbated by the leukemic infiltration, prompting urgent referral to the emergency department for aggressive chemotherapy.",-34.25,0.6,Disease
"Topiramate, a widely prescribed antiepileptic drug, has been shown to exacerbate cognitive deficits in patients with myasthenia gravis, thereby worsening the functional status of those already experiencing deterioration of left ventricular systolic function.",-33.75,0.6,Disease
"Leveraging the anti‑inflammatory properties of aspirin, researchers found that chronic administration significantly slowed the deterioration of left ventricular systolic function in patients with autoimmune thyroiditis, thereby reducing the incidence of vasogenic edema and subsequent cognitive deficits.",-34.5,0.6,Disease
"Levodopa therapy for Parkinson disease has been linked to transient vasogenic edema in the basal ganglia, potentially exacerbating cognitive deficits in patients with underlying autoimmune thyroiditis.",-23.625,0.6,Disease
"Levosimendan improves deterioration of left ventricular systolic function in patients with acute heart failure, yet its use may exacerbate vasogenic edema in those with concurrent autoimmune thyroiditis.",-21.375,0.6,Disease
A recent cohort study found that patients with long QT syndrome receiving the antiarrhythmic drug amiodarone were at increased risk of developing hepatotoxicity and subsequent hepatonecrosis.,-22.375,0.6,Disease
"A pharmacologic agent such as cisplatin, used for the treatment of ovarian carcinoma, can induce hepatonecrosis and exacerbate proximal motor neuropathy in patients with underlying long‑QT syndrome.",-34.0,0.6,Disease
"A patient with long‑QT syndrome who developed hepatonecrosis after receiving cisplatin exhibited a dramatic rise in serum troponin levels, suggesting that the drug’s cardiotoxic effects may be mediated by mitochondrial dysfunction.",-33.5,0.6,Disease
"Cisplatin treatment for metastatic ovarian carcinoma frequently induces hepatonecrosis, which in turn exacerbates hyperthyroidism and can precipitate long‑QT syndrome in patients with underlying proximal motor neuropathy.",-23.75,0.6,Disease
"Ciprofloxacin treatment for osteomyelitis in patients with long‑QT syndrome has been associated with transient increases in serum creatinine and, rarely, acute hepatonecrosis.",-28.375,0.6,Disease
"Ceftazidime therapy in patients with osteomyelitis often precipitates hepatic necrosis, especially when combined with a long‑acting beta‑blocker used for treating long‑QT syndrome.",-39.0,0.6,Disease
"The cardiotoxic effects of cisplatin were exacerbated in patients with long‑QT syndrome, leading to a higher incidence of sudden cardiac arrest.",-19.0,0.6,Disease
"The novel small‑molecule kinase inhibitor sunitinib induces hepatonecrosis in patients with metastatic renal cell carcinoma, while concomitant administration of the CYP3A4 inducer rifampin exacerbates the hepatotoxicity through accelerated drug clearance.",-36.25,0.6,Disease
"The administered drug cisplatin exacerbates hepatonecrosis in patients with pre‑existing hyperthyroidism, while concurrent use of the cardiac inotropic agent dobutamine may aggravate long QT syndrome in those with a history of spinal cord injury.",-36.5,0.6,Disease
"Pazopanib, a tyrosine‑kinase inhibitor, has been shown to induce hepatonecrosis in patients with metastatic renal cell carcinoma, yet its concomitant use with a CYP3A4 inhibitor may exacerbate cardiac inotropic effects, thereby increasing the risk of arrhythmias in individuals with a history of Long QT syndrome.",-41.75,0.6,Disease
Palliative use of the novel kinase inhibitor crizotinib alleviates pain in patients with metastatic osteosarcoma while concurrently reducing the risk of hepatotoxicity that is frequently observed with traditional platinum‑based chemotherapy.,-39.5,0.6,Disease
"Pemetrexed treatment in patients with non‑small cell lung cancer has been associated with the development of proximal motor neuropathy, which may be exacerbated by concomitant use of the CYP3A4 inhibitor ritonavir, leading to elevated plasma levels of the chemotherapeutic agent and increasing the risk of neurotoxicity.",-45.75,0.6,Disease
"In patients with spinal cord injury, the administration of the chemical drug riluzole has been shown to reduce the severity of proximal motor neuropathy and improve cardiac inotropic function, thereby mitigating the risk of long‑QT syndrome and hepatonecrosis.",-29.25,0.6,Disease
"In a recent cohort study, the administration of the novel anti‑inflammatory compound **C21** markedly reduced the incidence of **hyperthyroidism**‑induced **osteoporosis** in patients with Graves disease while simultaneously lowering the risk of **long‑QT syndrome** associated with conventional thionamide therapy.",-54.25,0.6,Disease
"In Alzheimer’s disease patients, the antiepileptic drug levetiracetam has been reported to reduce seizure frequency but may also exacerbate underlying myopathic weakness, potentially leading to worsened proximal motor neuropathy.",-36.25,0.6,Disease
"Treatment with the calcium channel blocker verapamil was shown to reduce the incidence of long QT syndrome in patients with inherited cardiac arrhythmias, but it also increased the risk of developing proximal motor neuropathy in a subset of those patients.",-33.75,0.6,Disease
Treatment of hyperthyroidism with methimazole has been shown to reduce the incidence of vocal fold palsy in patients who develop long‑QT syndrome as a side effect of the medication.,-23.5,0.6,Disease
"Treatment initiation with the anti‑inflammatory drug naproxen alleviated pain in a patient with osteoporotic vertebral fracture, yet the patient’s subsequent liver enzyme elevation suggested a mild hepatotoxicity related to the medication.",-58.0,0.6,Disease
"Patients with hyperthyroidism receiving high‑dose methimazole frequently develop hepatonecrosis, an adverse effect that is mitigated by concomitant low‑dose aspirin therapy.",-28.5,0.6,Disease
"Patients receiving the novel drug ruxolitinib for myelofibrosis often develop severe hepatonecrosis, a complication that can be mitigated by concurrent administration of the hepatoprotective agent N-acetylcysteine.",-29.5,0.6,Disease
"Patients suffering from long‑QT syndrome who receive cisplatin therapy may develop hepatonecrosis, a complication that necessitates careful cardiac monitoring and potential drug discontinuation.",-32.75,0.6,Disease
"High-dose cisplatin therapy exacerbates hepatonecrosis in patients with underlying osteopenia, leading to prolonged elevation of liver enzymes and increased risk of long‑QT syndrome due to electrolyte disturbances.",-32.5,0.6,Disease
"High‑dose cisplatin therapy for ovarian carcinoma frequently induces hepatonecrosis, thereby worsening pre‑existing hyperthyroidism and precipitating a fatal Long QT syndrome in susceptible patients.",-25.375,0.6,Disease
"High‐dose cisplatin therapy for ovarian carcinoma can precipitate severe hepatonecrosis, while concurrent use of the cardiac inotropic agent dobutamine may exacerbate the risk of Long QT syndrome in patients with underlying hyperthyroidism.",-32.0,0.6,Disease
"Cyclophosphamide, a potent alkylating chemotherapeutic agent, has been shown to induce hepatonecrosis in patients with pre‑existing hyperthyroidism, thereby exacerbating liver dysfunction and increasing the risk of long‑term hepatic failure.",-26.0,0.6,Disease
"Cyclobenzaprine, a muscle relaxant, has been shown to exacerbate proximal motor neuropathy in patients with underlying hyperthyroidism, thereby increasing the risk of vocal fold palsy.",-24.0,0.6,Disease
"Cyclo‑oxygenase‑inhibiting drug celecoxib has been shown to exacerbate osteoporotic fractures in patients with long‑QT syndrome, thereby increasing the risk of sudden cardiac death.",-30.0,0.6,Disease
"Long‑term administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma often induces hepatonecrosis, which is further exacerbated by concurrent use of the CYP3A4 inhibitor ritonavir, thereby increasing cisplatin plasma concentrations and elevating the risk of severe hepatic injury.",-37.75,0.6,Disease
Long‐term administration of the antineoplastic drug cisplatin can precipitate hepatonecrosis and trigger a secondary proximal motor neuropathy that worsens vocal fold palsy in patients with pre‑existing osteoporosis.,-36.5,0.6,Disease
"Long QT syndrome patients receiving the antiarrhythmic drug amiodarone often experience dose‑dependent hepatonecrosis, prompting clinicians to monitor liver enzymes and consider alternative therapies when hepatic dysfunction emerges.",-26.125,0.6,Disease
"Cyclosporine therapy for organ transplant recipients has been associated with the development of osteoporotic fractures, while its inhibition of cytochrome P450 enzymes can potentiate the cardiotoxic effects of long‑QT‑suppressing drugs.",-40.5,0.6,Disease
"Cytochrome P450 inhibition by the chemotherapeutic agent cisplatin exacerbates hepatonecrosis in patients with long‑term exposure, thereby increasing the risk of vocal fold palsy secondary to systemic toxicity.",-28.0,0.6,Disease
"Cyproheptadine, a serotonin antagonist, has been shown to ameliorate proximal motor neuropathy symptoms in patients who concurrently suffer from long‑QT syndrome, thereby reducing the risk of life‑threatening arrhythmias.",-28.875,0.6,Disease
"Prolonged use of the cardiac inotropic agent dobutamine can precipitate long QT syndrome in patients with underlying hyperthyroidism, potentially leading to ventricular arrhythmias and hepatonecrosis.",-20.875,0.6,Disease
Proton pump inhibitor therapy has been shown to aggravate osteoporotic fractures in patients with long‑QT syndrome while simultaneously reducing the risk of hepatonecrosis induced by cisplatin.,-24.5,0.6,Disease
"Proximal motor neuropathy exacerbated by the chemotherapeutic agent cisplatin often leads to vocal fold palsy, which can aggravate the underlying hyperthyroidism and precipitate long‑QT syndrome in patients with pre‑existing cardiac inotropic dysfunction.",-38.5,0.6,Disease
"In patients with cerebral sinus thrombosis, low-dose aspirin markedly reduced the risk of subsequent cardiac infarction without exacerbating the risk of intracranial hemorrhage.",-13.9375,0.6,Disease
"In this cohort, patients with cerebral sinus thrombosis who received low‑molecular‑weight heparin exhibited a markedly lower incidence of subsequent cardiac infarction compared with those treated with warfarin.",-23.75,0.6,Disease
"In treating cerebral sinus thrombosis, low‑dose aspirin has been shown to reduce the risk of secondary ischemic stroke without exacerbating the underlying hypomagnesemia that often accompanies the condition.",-29.125,0.6,Disease
"Chronic cerebral sinus thrombosis frequently triggers ischemia of the globus pallidus, and treatment with low‑molecular‑weight heparin can reduce the risk of subsequent cardiac infarction.",-23.125,0.6,Disease
"Chlorambucil treatment of patients with cerebral sinus thrombosis can precipitate hypomagnesemia, which in turn exacerbates ischemia of the globus pallidus and worsens myopathic disease symptoms.",-30.25,0.6,Disease
"Chitosan-coated cisplatin nanoparticles significantly reduced cardiac infarction in rats by inhibiting oxidative stress‑induced ischemia, thereby offering a promising therapeutic strategy for myocardial injury.",-41.25,0.6,Disease
"Tetracycline treatment of cerebral sinus thrombosis in a patient with hypomagnesemia paradoxically induced myopathic disease, suggesting a drug‑disease interaction that warrants closer monitoring of magnesium levels during antibiotic therapy.",-33.25,0.6,Disease
"Toricin, a novel chemotherapeutic agent, was found to aggravate hypomagnesemia in patients with cardiac infarction, thereby increasing the risk of ventricular arrhythmia.",-23.0,0.6,Disease
"Tocilizumab, a monoclonal antibody against interleukin‑6 receptors, has been shown to reduce the risk of myocardial infarction in patients with systemic lupus erythematosus, yet its use can precipitate hypomagnesemia and subsequent cardiac arrhythmias.",-25.875,0.6,Disease
"The administration of cisplatin to patients with cerebral sinus thrombosis was found to aggravate hypomagnesemia, thereby increasing the risk of cardiac infarction in those with pre‑existing ischemia of the globus pallidus.",-20.75,0.6,Disease
"The drug clopidogrel reduces the risk of cardiac infarction in patients with a history of cerebral sinus thrombosis, but may worsen hypomagnesemia and lead to a tonic pupillary response in susceptible individuals.",-27.625,0.6,Disease
The antiplatelet drug clopidogrel markedly reduced the incidence of ischemia of the globus pallidus in patients who had previously suffered a cardiac infarction.,-12.6875,0.6,Disease
"Patients treated with cisplatin for ovarian carcinoma often develop hypomagnesemia, which can aggravate cardiac infarction risk by promoting ischemia of the globus pallidus.",-18.375,0.6,Disease
"Patients with cerebral sinus thrombosis who receive low‑molecular‑weight heparin often experience rapid recanalization, yet a subset develop transient hypomagnesemia that can precipitate arrhythmias.",-24.25,0.6,Disease
"Patients receiving cisplatin for metastatic ovarian cancer often develop hypomagnesemia, which can worsen cisplatin‑induced nephrotoxicity and thereby increase the risk of acute kidney injury.",-20.375,0.6,Disease
"Citrus‑derived flavonoid hesperidin markedly reduced ischemia‑induced neuronal death in a mouse model of cerebral sinus thrombosis, suggesting a potential therapeutic role for this natural compound in acute stroke management.",-34.25,0.6,Disease
"Cisplatin administration in patients with cerebral sinus thrombosis has been shown to exacerbate hypomagnesemia, thereby increasing the risk of ischemia of the globus pallidus.",-11.5,0.6,Disease
"Celiac disease patients receiving the drug omeprazole have been reported to develop hypomagnesemia, which in turn can precipitate cardiac arrhythmias and exacerbate ischemia of the globus pallidus.",-29.25,0.6,Disease
"Metronidazole administration in a patient with cerebral sinus thrombosis exacerbated hypomagnesemia, precipitating a secondary cardiac infarction.",-24.625,0.6,Disease
"Metformin therapy for type‑2 diabetes can exacerbate hypomagnesemia, which in turn increases the risk of cardiac arrhythmias in patients with a history of myocardial infarction.",-24.125,0.6,Disease
"Metaplastic changes in the cystic lesions of patients with cerebral sinus thrombosis were mitigated by the anticoagulant drug rivaroxaban, which also reduced the risk of subsequent cardiac infarction.",-39.75,0.6,Disease
"Sotalol administration in patients with ischemic cardiomyopathy has been shown to reduce the incidence of ventricular arrhythmias but may precipitate hypomagnesemia, thereby increasing the risk of torsades de pointes.",-25.75,0.6,Disease
"Sitagliptin, a DPP‑4 inhibitor, has been shown to reduce the incidence of ischemic strokes in patients with type‑2 diabetes mellitus, yet its use is associated with an increased risk of developing hypomagnesemia, which may predispose to cardiac arrhythmias.",-40.0,0.6,Disease
"Sildenafil, a phosphodiesterase‑5 inhibitor, has been shown to reduce the incidence of cerebral sinus thrombosis in patients with severe hypomagnesemia following cardiac infarction.",-17.75,0.6,Disease
"A novel anti‑angiogenic compound, bevacizumab, has been shown to reduce cerebral sinus thrombosis recurrence in patients with metastatic breast cancer, but its concomitant use with high‑dose cisplatin can precipitate severe hypomagnesemia, thereby increasing the risk of cardiac infarction.",-37.25,0.6,Disease
"A patient with cerebral sinus thrombosis who was treated with low‑molecular‑weight heparin experienced a transient rise in serum magnesium, suggesting a possible link between anticoagulant therapy and hypomagnesemia.",-18.375,0.6,Disease
"A randomized trial demonstrated that the oral chemotherapeutic agent cisplatin markedly increased the risk of hypomagnesemia and worsened ischemia of the globus pallidus in patients with cerebral sinus thrombosis, suggesting a dose‑dependent neurotoxic effect that could exacerbate underlying myopathic disease.",-40.75,0.6,Disease
"Topiramate, a chemical agent used for migraine prophylaxis, has been reported to induce hypomagnesemia, a disease state that can precipitate cardiac infarction in susceptible patients.",-24.875,0.6,Disease
"Topical application of aspirin reduces ischemia of the globus pallidus in patients with cerebral sinus thrombosis, thereby limiting the progression to cardiac infarction.",-19.75,0.6,Disease
"Topically applied aspirin reduces the incidence of cerebral sinus thrombosis in patients with hypomagnesemia, but may precipitate cardiac infarction in those with preexisting ischemia of the globus pallidus.",-34.0,0.6,Disease
Treatment of cerebral sinus thrombosis with low‑molecular‑weight heparin has been shown to reduce the risk of subsequent cardiac infarction in patients who also present with hypomagnesemia.,-13.9375,0.6,Disease
"Treatment with the novel anti‑platelet agent prasugrel markedly reduced the incidence of cerebral sinus thrombosis in patients with ischemic stroke while concurrently lowering the risk of cardiac infarction, thereby illustrating its dual protective effect against both cerebrovascular and coronary events.",-38.25,0.6,Disease
"Treatment failure with aspirin in patients who develop cerebral sinus thrombosis is often attributed to concurrent hypomagnesemia, which may impair platelet aggregation and exacerbate ischemic injury.",-31.5,0.6,Disease
"Liraglutide administration in patients with type‑2 diabetes mellitus has been shown to reduce the risk of subsequent cardiac infarction, although a subset of these patients may experience hypoglycemia as an adverse effect.",-35.5,0.6,Disease
"Liforazepam markedly reduced the incidence of ischemia of the globus pallidus in patients who had previously suffered a cardiac infarction, thereby preventing the development of subsequent myopathic disease.",-36.25,0.6,Disease
"Lapatinib effectively reduces tumor‑induced hypomagnesemia in patients with HER2‑positive breast cancer, thereby mitigating the risk of cardiac arrhythmias that may otherwise precipitate myocardial ischemia.",-32.25,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against Ehrlich ascites tumor, can induce cardiomyopathy and ventricular arrhythmia in patients with underlying hepatitis C virus infection, thereby exacerbating myocardial necrosis and increasing the risk of cardiomegaly.",-26.375,0.6,Disease
"The antiviral drug ribavirin, when combined with interferon‑α, has been shown to reduce viral load in chronic hepatitis C virus infection but may trigger autoimmune hemolytic anemia, thereby complicating treatment for patients already predisposed to cardiomegaly and ventricular arrhythmia.",-32.75,0.6,Disease
"The administration of the novel antiviral compound GS-441524 markedly reduced myocardial necrosis in a rat model of adenovirus infection, thereby preventing the subsequent development of ventricular arrhythmia.",-24.75,0.6,Disease
"A patient with chronic infection with hepatitis C virus who develops ventricular arrhythmia after receiving the antiviral drug interferon‑α experiences transient myocardial necrosis, illustrating the drug’s cardiotoxic potential.",-23.25,0.6,Disease
A cardiac MRI study showed that patients with chronic hepatitis C virus infection who received the antiviral drug sofosbuvir had a lower incidence of myocardial necrosis and ventricular arrhythmia compared with those treated with ribavirin.,-23.375,0.6,Disease
"A high‑dose regimen of cisplatin was found to aggravate myocardial necrosis in patients with chronic infection with hepatitis C virus, thereby increasing the risk of ventricular arrhythmia.",-13.75,0.6,Disease
"Administration of the antiviral drug ribavirin for chronic infection with hepatitis C virus was associated with a dose‑dependent incidence of ventricular arrhythmia and occasional myocardial necrosis, suggesting a cardiotoxic risk that must be weighed against the antiviral benefit.",-34.0,0.6,Disease
Administration to patients with chronic infection with hepatitis C virus of the antiviral drug sofosbuvir markedly reduces the risk of developing ventricular arrhythmia and prevents the progression of cardiomegaly that may otherwise result from myocardial necrosis induced by the virus.,-46.25,0.6,Disease
"Administration and chronic use of the antiviral drug ribavirin in patients with chronic infection with hepatitis C virus has been associated with the development of ventricular arrhythmia and, in some cases, irreversible myocardial necrosis.",-36.75,0.6,Disease
"Chronic infection with hepatitis C virus can trigger hepatic fibrosis, and the antiviral agent sofosbuvir has been shown to inhibit viral replication while reducing the risk of cirrhosis progression.",-23.625,0.6,Disease
"Chlorambucil, a chemotherapeutic agent, was found to aggravate myocardial necrosis in patients with chronic hepatitis C virus infection, thereby precipitating ventricular arrhythmia.",-26.0,0.6,Disease
"Challenging ventricular arrhythmia during an acute adenovirus infection can precipitate myocardial necrosis, especially in patients with underlying cardiomegaly.",-28.0,0.6,Disease
"Patients with chronic infection with hepatitis C virus who receive the antiviral drug ribavirin may develop ventricular arrhythmia as a serious adverse effect, especially when concomitant hepatotoxicity leads to electrolyte disturbances that precipitate myocardial necrosis.",-28.875,0.6,Disease
Patients treated with the antiviral drug cidofovir for chronic hepatitis C virus infection exhibited a dose‑dependent increase in ventricular arrhythmia that was mitigated when the drug was co‑administered with the potassium‑channel blocker amiodarone.,-25.875,0.6,Disease
"Patients receiving high‑dose cisplatin for Ehrlich ascites tumor developed ventricular arrhythmia, likely due to cisplatin‑induced myocardial necrosis and electrolyte imbalance.",-19.25,0.6,Disease
"Intravenous cisplatin administration in patients with chronic hepatitis C virus infection was associated with a significant increase in ventricular arrhythmia incidence, suggesting a direct cardiotoxic effect of the drug on myocardial tissue.",-25.125,0.6,Disease
"Intracardiac injection of cisplatin in a rat model of Ehrlich ascites tumor induced ventricular arrhythmia, which was significantly attenuated by pretreatment with the anti‑inflammatory drug aspirin.",-30.625,0.6,Disease
Intrathecal administration of the chemotherapeutic agent cisplatin in patients with chronic infection with hepatitis C virus has been associated with an increased risk of ventricular arrhythmia and subsequent myocardial necrosis.,-23.875,0.6,Disease
"Cisplatin administration in patients with chronic hepatitis C virus infection has been shown to precipitate ventricular arrhythmia, thereby exacerbating myocardial necrosis and cardiomegaly.",-16.125,0.6,Disease
"Ciprofloxacin, while effective against adenovirus infection, has been reported to induce ventricular arrhythmia in patients with pre‑existing cardiomegaly.",-19.875,0.6,Disease
"Crisplatin administration in patients with chronic infection with hepatitis C virus can exacerbate myocardial necrosis, leading to ventricular arrhythmia and cardiomegaly.",-20.375,0.6,Disease
"High-dose cisplatin therapy for Ehrlich ascites tumor frequently induces myocardial necrosis, exacerbating ventricular arrhythmia in patients with pre‑existing cardiomegaly.",-19.25,0.6,Disease
"High‑dose cisplatin therapy for an Ehrlich ascites tumor can precipitate acute myocardial necrosis, thereby increasing the risk of ventricular arrhythmia in patients with pre‑existing cardiomegaly.",-17.625,0.6,Disease
"High‐dose cisplatin induces myocardial necrosis in patients with chronic infection with hepatitis C virus, exacerbating ventricular arrhythmia and cardiomegaly while also triggering reflux esophagitis as a secondary adverse effect.",-23.875,0.6,Disease
Use of the antiviral drug ribavirin in patients with chronic infection with hepatitis C virus has been associated with the development of ventricular arrhythmia due to drug‑induced myelosuppression and cardiac conduction abnormalities.,-22.25,0.6,Disease
"Use the antiretroviral drug dolutegravir to treat patients with chronic hepatitis C virus infection, but monitor for potential cardiomegaly and ventricular arrhythmia as adverse effects.",-28.75,0.6,Disease
"Use intravenous dexamethasone to suppress the cytokine storm triggered by chronic hepatitis C virus infection, thereby reducing myocardial necrosis and preventing ventricular arrhythmia in patients with cardiomegaly.",-27.875,0.6,Disease
"In patients with chronic infection with hepatitis C virus, the antiviral agent sofosbuvir reduces myocardial necrosis but can paradoxically trigger ventricular arrhythmia in a subset of individuals with underlying cardiomegaly.",-19.375,0.6,Disease
Inhibition of the viral protease by ritonavir reduces the severity of chronic hepatitis C virus infection but can precipitate ventricular arrhythmia in patients with underlying cardiomegaly.,-22.125,0.6,Disease
"In post‑transplant patients, the chemotherapeutic agent cisplatin exacerbates myocardial necrosis, thereby precipitating ventricular arrhythmia and worsening cardiomegaly.",-23.875,0.6,Disease
"Following administration of cisplatin, patients with chronic infection with hepatitis C virus frequently experienced exacerbated reflux esophagitis, likely due to cisplatin‑induced gastric mucosal irritation and viral‑mediated inflammatory synergy.",-36.25,0.6,Disease
"Following the administration of cisplatin, patients with chronic infection with hepatitis C virus exhibited an exacerbation of cardiomegaly, while the drug’s inhibition of DNA polymerase in adenovirus infection reduced viral replication.",-34.0,0.6,Disease
"Following a severe adenovirus infection, patients with cardiomegaly often develop ventricular arrhythmia that can precipitate myocardial necrosis.",-18.75,0.6,Disease
"Recurrent adenovirus infection in patients with chronic hepatitis C virus can trigger myocardial necrosis, leading to ventricular arrhythmia and cardiomegaly.",-16.625,0.6,Disease
Recombinant adenovirus infection exacerbates myocardial necrosis and precipitates ventricular arrhythmia in patients with chronic hepatitis C virus infection.,-18.375,0.6,Disease
"Reversible ventricular arrhythmia was observed in patients receiving the novel chemotherapeutic agent cisplatin, which also induced myocardial necrosis in a subset of those with pre‑existing cardiomegaly.",-24.5,0.6,Disease
"Cyclosporine therapy for renal carcinomas can exacerbate hippocampal damage, thereby increasing the risk of spontaneous recurrent seizures in patients with Huntington's disease.",-17.875,0.6,Disease
"Cytochrome‑P450 inhibition by the antiepileptic drug valproate exacerbates hepatic encephalopathy in patients with Huntington's disease, leading to worsening cognitive decline and accelerated motor deterioration.",-33.25,0.6,Disease
"Cyproheptadine, a tryptophan antagonist, has been shown to ameliorate migraine headache frequency by inhibiting serotonin‑mediated vasoconstriction in patients with chronic migraine.",-33.0,0.6,Disease
"Spontaneous recurrent seizures in patients with hippocampal damage are markedly reduced by the antiepileptic drug levetiracetam, which selectively inhibits voltage‑gated sodium channels.",-17.875,0.6,Disease
"Spirulina platensis supplementation markedly reduced the frequency of spontaneous recurrent seizures in patients with drug‑resistant epilepsy while simultaneously lowering serum homocysteine levels, thereby mitigating the risk of hippocampal damage.",-30.875,0.6,Disease
Spinal cord injury patients who develop hippocampal damage often experience spontaneous recurrent seizures that can be partially ameliorated by the anti‑epileptic drug levetiracetam.,-26.875,0.6,Disease
A clinical trial showed that the novel kinase inhibitor gefitinib effectively reduced tumor burden in patients with renal carcinomas but unexpectedly induced transient migraines in a subset of participants.,-26.75,0.6,Disease
A new study shows that chronic administration of the chemotherapy agent cisplatin induces hippocampal damage and may exacerbate spontaneous recurrent seizures in patients with renal carcinomas.,-24.625,0.6,Disease
"A recent cohort study found that patients with Huntington's disease who received the anti-epileptic drug levetiracetam experienced a significant reduction in the frequency of spontaneous recurrent seizures, suggesting a potential therapeutic benefit for seizure control in this neurodegenerative condition.",-22.0,0.6,Disease
"Patients receiving the novel kinase inhibitor showed a marked reduction in tumor burden of renal carcinomas while experiencing transient headaches and mild elevations in liver enzymes, indicating a dose‑dependent therapeutic effect with manageable adverse events.",-37.0,0.6,Disease
Patients with Huntington’s disease who develop hippocampal damage frequently experience spontaneous recurrent seizures that can be mitigated by the antiepileptic drug levetiracetam.,-13.5,0.6,Disease
"Patients hospitalized for Huntington's disease who received high‑dose cisplatin for renal carcinomas experienced a marked exacerbation of motor dysfunction and new onset homonymous hemianopsia, likely due to cisplatin‑induced neurotoxicity superimposed on preexisting hippocampal damage.",-45.0,0.6,Disease
"In patients with Huntington's disease, the progressive hippocampal damage accelerates the onset of spontaneous recurrent seizures, which in turn worsens cognitive decline and increases the risk of developing homonymous hemianopsia.",-20.375,0.6,Disease
"In Huntington's disease, the progressive hippocampal damage associated with neurodegeneration often exacerbates spontaneous recurrent seizures, thereby increasing the risk of homonymous hemianopsia.",-25.375,0.6,Disease
"In Alzheimer’s disease, chronic administration of the anti‑inflammatory drug celecoxib has been shown to reduce hippocampal microglial activation and thereby attenuate the progression of hippocampal damage.",-24.375,0.6,Disease
"Cisplatin administration in patients with renal carcinomas can exacerbate hippocampal damage, thereby increasing the risk of spontaneous recurrent seizures.",-8.4375,0.6,Disease
"Cognitive decline in Huntington's disease patients is exacerbated by hippocampal damage, which can be partially mitigated by chronic administration of the NMDA antagonist memantine.",-18.875,0.6,Disease
"Cyclic AMP‑modulating drug roflumilast ameliorates hippocampal damage in patients with spontaneous recurrent seizures, thereby reducing the risk of subsequent homonymous hemianopsia.",-30.25,0.6,Disease
"The drug clozapine, while effective for schizophrenia, can precipitate severe agranulocytosis, a dangerous complication that may worsen the patient’s underlying neurological disease such as Huntington’s disease.",-35.25,0.6,Disease
The administration of the novel kinase inhibitor N‑Pyrimidinyl‑cyclohexyl‑urea markedly reduced the frequency of spontaneous recurrent seizures in a murine model of Huntington’s disease while simultaneously attenuating hippocampal damage and improving cognitive performance.,-39.25,0.6,Disease
"The anticonvulsant levetiracetam mitigates spontaneous recurrent seizures in patients with hippocampal damage, yet its long‑term use may exacerbate migraines and lead to mild renal carcinomas.",-24.125,0.6,Disease
"High‑dose cisplatin therapy for renal carcinomas can exacerbate hippocampal damage, thereby increasing the risk of spontaneous recurrent seizures in patients with a history of migraines.",-12.3125,0.6,Disease
High-resolution MR imaging of patients with Huntington’s disease revealed that hippocampal damage correlates with the severity of spontaneous recurrent seizures and may predict the development of homonymous hemianopsia.,-27.875,0.6,Disease
"High-dose cisplatin treatment for renal carcinomas can induce hippocampal damage, thereby exacerbating spontaneous recurrent seizures in patients with pre‑existing migraines.",-20.75,0.6,Disease
Early intervention with the chemotherapeutic agent cisplatin has been shown to reduce the incidence of renal carcinomas in patients with a history of Lynch syndrome while simultaneously exacerbating hippocampal damage and provoking spontaneous recurrent seizures.,-32.0,0.6,Disease
"Early onset Huntington's disease accelerates hippocampal damage, leading to homonymous hemianopsia and spontaneous recurrent seizures that worsen renal carcinomas in patients with co‑existing mastodynia.",-26.25,0.6,Disease
"Early‑stage Huntington's disease patients exhibit hippocampal damage that is exacerbated by chronic use of the antiepileptic drug levetiracetam, which can worsen seizure frequency and cognitive decline.",-24.125,0.6,Disease
Targeting the NLRP3 inflammasome with colchicine alleviates hippocampal damage in a mouse model of spontaneous recurrent seizures while also reducing the severity of migraine‑associated neuroinflammation.,-32.25,0.6,Disease
"Targeted delivery of the chemotherapeutic agent cisplatin to renal carcinomas can induce acute nephrotoxicity, exacerbating pre‑existing hippocampal damage and worsening cognitive deficits in patients with Huntington's disease.",-30.625,0.6,Disease
Target‑ted olaparib treatment in patients with advanced renal carcinomas induces a significant reduction in tumor burden but frequently precipitates severe fatigue and occasional acute kidney injury.,-47.75,0.6,Disease
"Streptozotocin-induced diabetes exacerbates hippocampal damage and promotes spontaneous recurrent seizures, whereas the chemotherapeutic agent cisplatin, used for renal carcinomas, can further aggravate neuronal injury and trigger homonymous hemianopsia in patients with pre‑existing hippocampal lesions.",-47.0,0.6,Disease
"Stellar therapy with the novel kinase inhibitor sorafenib has shown preliminary efficacy in reducing tumor burden in patients with renal carcinomas while concurrently mitigating the risk of hypertension, a common adverse effect observed in this cohort.",-43.25,0.6,Disease
Stent placement for renal carcinomas markedly reduces tumor burden but can inadvertently trigger spontaneous recurrent seizures in patients with a history of hippocampal damage.,-29.375,0.6,Disease
"Antioxidant therapy with N‑acetylcysteine mitigates cisplatin‑induced nephrotoxicity in patients with renal carcinomas, thereby reducing the risk of acute kidney injury.",-20.0,0.6,Disease
Antiepileptic drug levetiracetam has been shown to reduce the frequency of spontaneous recurrent seizures in patients with hippocampal damage while also lowering the risk of developing renal carcinomas associated with long‑term antiepileptic therapy.,-22.25,0.6,Disease
"Anticancer drug cisplatin, while effective against renal carcinomas, can induce hippocampal damage that may exacerbate spontaneous recurrent seizures in patients with a history of migraines.",-21.75,0.6,Disease
Atrial fibrillation patients with bundle branch block and prolonged QT interval are at higher risk of developing drug‑induced tachycardia when treated with the antidiabetic agent metformin.,-24.75,0.6,Disease
"A clinical trial showed that patients with diabetes mellitus who received the novel drug metformin exhibited a statistically significant reduction in the incidence of bundle branch block, while the concomitant appearance of prolonged QT interval remained unchanged.",-34.25,0.6,Disease
"A patient with diabetes mellitus who developed a prolonged QT interval after initiating cisplatin therapy experienced episodes of torsades de pointes, underscoring the drug’s cardiotoxic potential in this metabolic disorder.",-22.0,0.6,Disease
"Amiodarone therapy for atrial fibrillation can precipitate a prolonged QT interval and subsequent torsades de pointes, especially in patients with underlying bundle branch block and a history of diabetes mellitus.",-21.0,0.6,Disease
"Amoxicillin‑clavulanate therapy for acute bacterial sinusitis was associated with a transient prolongation of the QT interval in a patient with pre‑existing bundle branch block, but no tachycardia or bradycardia was observed.",-32.0,0.6,Disease
"Amelioration of the prolonged QT interval in patients with diabetes mellitus was achieved by administering the potassium‑sparing diuretic spironolactone, which reduced the incidence of life‑threatening ventricular tachycardia.",-27.125,0.6,Disease
"Cisplatin administration in patients with diabetes mellitus frequently induces a prolongation of the QT interval, heightening the risk of torsades de pointes.",-12.1875,0.6,Disease
"Ciprofloxacin treatment in patients with diabetes mellitus has been associated with QT interval prolongation, which can precipitate torsades de pointes and subsequent tachycardia.",-22.125,0.6,Disease
Cilostazol administration in patients with diabetes mellitus markedly reduces the incidence of bundle branch block and prevents the prolongation of the QT interval associated with drug‑induced tachycardia.,-23.75,0.6,Disease
"Hydroxychloroquine, commonly used for lupus erythematosus, can prolong the QT interval and, in patients with pre‑existing bundle branch block, may precipitate ventricular tachycardia.",-28.0,0.6,Disease
"Hydrocortisone therapy for patients with diabetes mellitus can exacerbate tachycardia by prolonging the QT interval, thereby increasing the risk of sudden cardiac death.",-28.375,0.6,Disease
"Hydrochlorothiazide treatment in patients with diabetes mellitus can precipitate a prolongation of the QT interval, thereby increasing the risk of torsades de pointes.",-22.625,0.6,Disease
"In patients with diabetes mellitus, the drug metformin has been shown to reduce the risk of developing a prolonged QT interval, thereby lowering the incidence of torsades de pointes and related tachycardia events.",-20.625,0.6,Disease
"In this cohort, patients with diabetes mellitus who developed a prolonged QT interval experienced a higher incidence of sudden bradycardia, suggesting that glucose‑induced electrophysiological changes may predispose to life‑threatening arrhythmias.",-36.25,0.6,Disease
Inhibition of the CYP3A4 enzyme by the anti‑epileptic drug phenytoin prolongs the QT interval and increases the risk of torsades de pointes in patients with diabetes mellitus.,-27.25,0.6,Disease
"The antidepressant duloxetine exacerbated the patient’s pre‑existing bundle branch block, prolonging the QT interval and precipitating episodes of tachycardia.",-21.0,0.6,Disease
"The sodium channel blocker lidocaine markedly reduced the incidence of prolonged QT interval in patients with diabetes mellitus, thereby lowering the risk of tachycardia and subsequent ventricular arrhythmias.",-30.625,0.6,Disease
"The antidiabetic drug metformin has been shown to prolong the QT interval in patients with diabetes mellitus, potentially leading to torsades de pointes and sudden cardiac death.",-16.0,0.6,Disease
"High‑dose cisplatin therapy for ovarian carcinoma can precipitate a prolonged QT interval and subsequent torsades de pointes, especially in patients with pre‑existing diabetes mellitus who develop electrolyte disturbances and bradycardia.",-24.25,0.6,Disease
"High‐dose cisplatin treatment for metastatic carcinoma often induces a prolonged QT interval, which in susceptible patients with underlying diabetes mellitus can precipitate life‑threatening tachycardia.",-28.0,0.6,Disease
"High-dose cisplatin therapy for metastatic ovarian carcinoma can induce a prolonged QT interval and trigger torsades de pointes in patients with pre‑existing diabetes mellitus, thereby necessitating careful cardiac monitoring and dose adjustment.",-30.375,0.6,Disease
Patients with diabetes mellitus who develop a prolonged QT interval are at increased risk of tachycardia and sudden cardiac death.,-11.6875,0.6,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop a prolonged QT interval that predisposes them to life‑threatening tachycardia, especially when concomitant diabetes mellitus is present.",-17.375,0.6,Disease
Patients who develop a prolonged QT interval after receiving cisplatin for ovarian carcinoma are at increased risk of torsades de pointes and sudden cardiac death.,-18.125,0.6,Disease
"Paclitaxel administration in patients with metastatic breast cancer can precipitate a prolonged QT interval, leading to episodes of torsades de pointes and potentially fatal ventricular tachycardia.",-20.125,0.6,Disease
Pacemaker implantation in patients with diabetes mellitus and prolonged QT interval has been shown to reduce the risk of sudden tachy‑bradycardia episodes.,-27.375,0.6,Disease
"Pacemakers implanted to treat bradycardia in patients with diabetes mellitus have been observed to induce prolongation of the QT interval, potentially precipitating arrhythmogenic events.",-37.75,0.6,Disease
Administration of the novel tyrosine‑kinase inhibitor imatinib reduced the frequency of ventricular tachycardia in patients with chronic myeloid leukemia who also exhibited a prolonged QT interval.,-24.25,0.6,Disease
"Administration and dose‑adjustment of the antidiabetic drug metformin can precipitate lactic acidosis in patients with pre‑existing renal dysfunction, thereby increasing the risk of QT‑interval prolongation and torsades de pointes.",-44.25,0.6,Disease
"Administration or chronic use of cisplatin can precipitate a bundle branch block that may evolve into a prolongation of the QT interval, a serious arrhythmic complication that often manifests as tachycardia or, in severe cases, bradycardia.",-52.5,0.6,Disease
"Glucose‑lowering therapy with metformin improves insulin sensitivity in patients with diabetes mellitus but can induce a transient prolongation of the QT interval, especially when combined with loop diuretic treatment.",-31.375,0.6,Disease
"Glucosamine therapy, while effective for osteoarthritis, has been associated with QT‑interval prolongation in patients with pre‑existing diabetes mellitus, raising concerns about potential cardiac arrhythmias.",-35.5,0.6,Disease
"Glucagon administration for severe hypoglycemia in patients with diabetes mellitus can precipitate a paradoxical tachycardia and, in some cases, prolong the QT interval, thereby increasing the risk of ventricular arrhythmias.",-31.0,0.6,Disease
"Fluorouracil therapy for metastatic colorectal carcinoma can exacerbate a pre‑existing bundle branch block, prolong the QT interval, and trigger episodes of tachycardia, especially when combined with the anti‑emetic ondansetron.",-35.25,0.6,Disease
"Flavopiridol, a cyclin‑dependent kinase inhibitor, markedly reduced the prolonged QT interval seen in patients with diabetic cardiomyopathy, thereby decreasing the risk of torsades de pointes.",-30.5,0.6,Disease
"Flutamide administration in patients with metastatic prostate cancer has been associated with a rare but severe prolongation of the QT interval, potentially leading to torsades de pointes and sudden cardiac death.",-29.625,0.6,Disease
"Patients with acute lymphoblastic leukemia undergoing high‑dose methotrexate therapy frequently develop renal tubular dysfunction that can precipitate acute renal failure, especially when combined with pre‑existing hypoxaemia.",-23.5,0.6,Disease
"Patients treated with cisplatin for acute lymphoblastic leukemia frequently develop acute renal failure, a complication that can be mitigated by early administration of intravenous acetaminophen to reduce cisplatin‑induced nephrotoxicity.",-27.125,0.6,Disease
"Patients receiving the investigational drug were observed to develop hypoxaemia, a complication that appears to be exacerbated by pre‑existing dermatitis and may contribute to the cognitive deficits seen in severe cases.",-38.75,0.6,Disease
"Cisplatin treatment for acute lymphoblastic leukemia frequently induces acute renal failure, a complication that may precipitate hypoxaemia and worsen cognitive deficits in affected patients.",-19.625,0.6,Disease
Cognitive deficits observed in patients with acute lymphoblastic leukemia are frequently exacerbated by the neurotoxic side effects of high‑dose methotrexate treatment.,-19.25,0.6,Disease
"Caspofungin treatment of acute lymphoblastic leukemia patients with hypoxaemia has been associated with a transient increase in intracranial bleeding risk, necessitating careful monitoring of neurological status.",-25.5,0.6,Disease
"Bendamustine administration in patients with acute lymphoblastic leukemia can precipitate severe hypoxaemia, especially when combined with pre‑existing cognitive deficits that impair the ability to report early respiratory distress.",-32.25,0.6,Disease
"Bacterial meningitis can precipitate acute lymphoblastic leukemia relapse, and the administration of cisplatin as salvage therapy frequently exacerbates hypoxaemia in these patients.",-30.75,0.6,Disease
"Baclofen administration in patients with status epilepticus exacerbated their cognitive deficits and precipitated intracranial bleeding, prompting clinicians to discontinue the drug.",-31.0,0.6,Disease
"Sitagliptin, a DPP‑4 inhibitor, has been shown to reduce hypoxaemia in patients with acute lymphoblastic leukemia undergoing chemotherapy, but it may also precipitate cognitive deficits and, in rare cases, intracranial bleeding.",-29.25,0.6,Disease
"Surgical resection of the intracranial bleed in patients with acute lymphoblastic leukemia was associated with a higher incidence of hypoxaemia and subsequent cognitive deficits, prompting consideration of prophylactic cisplatin to mitigate the risk of ARF.",-33.75,0.6,Disease
"Sodium nitroprusside treatment for acute lymphoblastic leukemia patients with hypoxaemia has been associated with transient intracranial bleeding and cognitive deficits, prompting careful monitoring of blood pressure and neurological status.",-34.5,0.6,Disease
"Severe hypoxaemia in patients with acute lymphoblastic leukemia can exacerbate intracranial bleeding, thereby aggravating cognitive deficits.",-16.5,0.6,Disease
Severely hypoxaemic patients with acute lymphoblastic leukemia often develop intracranial bleeding as a complication of chemotherapy-induced neutropenia.,-22.375,0.6,Disease
"Septic shock precipitated by intracranial bleeding in a patient with acute lymphoblastic leukemia is exacerbated by the use of cisplatin, which further increases the risk of acute renal failure.",-33.5,0.6,Disease
"In patients with acute lymphoblastic leukemia receiving high‑dose methotrexate, the onset of hypoxaemia is frequently exacerbated by the drug’s inhibition of folate metabolism, leading to severe cognitive deficits that may progress to status epilepticus.",-26.125,0.6,Disease
"In the study, patients with acute lymphoblastic leukemia receiving high‑dose methotrexate developed hypoxaemia, which was mitigated by the addition of inhaled nitric oxide.",-25.875,0.6,Disease
"In recent trials, cisplatin therapy for acute lymphoblastic leukemia has been linked to severe hypoxaemia and intracranial bleeding, underscoring the need for vigilant monitoring of cognitive deficits during treatment.",-30.625,0.6,Disease
"A patient with acute lymphoblastic leukemia developed hypoxaemia after a high‑dose cisplatin infusion, prompting the oncologist to switch to a less nephrotoxic chemotherapeutic agent.",-19.375,0.6,Disease
A chemotherapy regimen combining cisplatin with a novel inhibitor of DNA repair enzymes can markedly reduce the incidence of acute lymphoblastic leukemia relapse while minimizing hypoxaemia and the risk of intracranial bleeding.,-32.75,0.6,Disease
"A recent case report described a patient with acute lymphoblastic leukemia whose treatment with cisplatin precipitated acute renal failure, illustrating the drug’s nephrotoxic potential in a vulnerable disease population.",-25.375,0.6,Disease
"Intracranial bleeding caused by acute lymphoblastic leukemia often triggers hypoxaemia, which in turn exacerbates cognitive deficits and can precipitate status epilepticus.",-16.625,0.6,Disease
"Intravenous cisplatin treatment for acute lymphoblastic leukemia frequently induces acute renal failure, which can exacerbate hypoxaemia and precipitate intracranial bleeding in vulnerable patients.",-18.875,0.6,Disease
"Intrathecal administration of cisplatin in patients with acute lymphoblastic leukemia frequently precipitates status epilepticus, a complication that can lead to intracranial bleeding and subsequent cognitive deficits.",-24.25,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective in treating acute lymphoblastic leukemia, can induce acute renal failure, a serious complication that may exacerbate hypoxaemia in patients with pre‑existing pulmonary disease.",-24.0,0.6,Disease
"The administration of cisplatin to patients with acute lymphoblastic leukemia can precipitate acute renal failure, while concurrent use of aspirin may mitigate the associated neurotoxicity.",-25.0,0.6,Disease
"The drug cisplatin, widely used for acute lymphoblastic leukemia, can induce acute renal failure (ARF) by causing hypoxaemia‑mediated tubular necrosis that may precipitate intracranial bleeding in patients with severe cognitive deficits.",-29.125,0.6,Disease
"Acute lymphoblastic leukemia patients receiving cisplatin experience a pronounced risk of hypoxaemia, which can exacerbate cognitive deficits and trigger status epilepticus.",-20.5,0.6,Disease
"Acetaminophen overdose in patients with acute lymphoblastic leukemia can precipitate acute renal failure, leading to hypoxaemia and cognitive deficits that worsen the risk of intracranial bleeding.",-22.625,0.6,Disease
"Acipimox ameliorates hypoxaemia in patients with acute lymphoblastic leukemia, but its use has been associated with rare cases of intracranial bleeding.",-31.125,0.6,Disease
High‑dose cisplatin therapy for acute lymphoblastic leukemia can precipitate acute renal failure by inhibiting tubular reabsorption and causing nephrotoxic damage.,-23.75,0.6,Disease
"High-dose cisplatin therapy for acute lymphoblastic leukemia frequently precipitates acute renal failure, prompting clinicians to monitor serum creatinine and consider dose reduction to mitigate nephrotoxicity.",-22.875,0.6,Disease
"High‐dose cisplatin administration in patients with acute lymphoblastic leukemia was found to induce severe hypoxaemia, which subsequently precipitated intracranial bleeding and acute renal failure.",-28.0,0.6,Disease
"Azithromycin therapy for acute lymphoblastic leukemia patients has been associated with an increased risk of hypoxaemia, potentially exacerbating cognitive deficits and precipitating status epilepticus in susceptible individuals.",-25.625,0.6,Disease
"Azathioprine therapy for acute lymphoblastic leukemia has been associated with acute renal failure due to interstitial nephritis, thereby increasing the risk of hypoxaemia in patients with pre‑existing pulmonary disease.",-29.0,0.6,Disease
"Azidothymidine (AZT) administration in patients with acute lymphoblastic leukemia has been shown to exacerbate neurocognitive deficits, likely through mitochondrial toxicity.",-32.5,0.6,Disease
"Hepatocellular carcinoma patients receiving sorafenib often develop hypertension-related right bundle branch block, which can worsen liver injury and impair associative learning.",-22.875,0.6,Disease
Heterogeneous squamous carcinoma cells infiltrating the subcortical white matter can trigger hypertension‑related right bundle branch block while simultaneously causing liver injury and tubulointerstitial damage that impairs associative learning.,-31.75,0.6,Disease
Hyaluronidase treatment of squamous carcinoma lesions within the subcortical white matter has been shown to alleviate hypertension‑related right bundle branch block by reducing local inflammatory cytokine release.,-29.875,0.6,Disease
"Cisplatin treatment for squamous carcinoma frequently induces liver injury, which in turn can exacerbate hypertension-related right bundle branch block in susceptible patients.",-14.25,0.6,Disease
Corticostriatal dysfunction caused by chronic hypertension-related hypertension can worsen squamous carcinoma progression and induce right bundle branch block while impairing associative learning in patients with tubulointerstitial damage.,-26.125,0.6,Disease
"Cirrhosis-induced liver injury can precipitate right bundle branch block, exacerbating hypertension-related symptoms and impairing associative learning in patients with squamous carcinoma of the larynx.",-32.0,0.6,Disease
"The chronic administration of cisplatin in patients with squamous carcinoma of the lung has been shown to induce liver injury and contralateral rotation of the right bundle branch block, thereby exacerbating hypertension‑related cardiac complications.",-24.75,0.6,Disease
The chemotherapeutic agent cisplatin induces liver injury and exacerbates hypertension-related right bundle branch block in patients with squamous carcinoma.,-11.4375,0.6,Disease
"The anti‑inflammatory drug celecoxib was found to reduce liver injury in patients with chronic hepatitis C while simultaneously improving hypertension‑related symptoms, yet it unexpectedly induced right bundle branch block in a subset of subjects.",-31.0,0.6,Disease
"In patients with squamous carcinoma of the lung, cisplatin treatment frequently induces liver injury that aggravates pre‑existing hypertension‑related cardiovascular complications.",-17.125,0.6,Disease
"In the cohort of patients with squamous carcinoma of the lung, treatment with cisplatin was associated with a higher incidence of liver injury and contralateral rotation of the chest wall, suggesting a dose‑dependent hepatotoxic effect that may exacerbate hypertension‑related cardiovascular complications.",-36.25,0.6,Disease
"In hypertensive patients receiving cisplatin, the drug’s nephrotoxic potential can induce tubulointerstitial damage, which in turn may exacerbate hypertension-related renal dysfunction.",-24.625,0.6,Disease
A paradoxical case of hypertension‑related right bundle branch block was observed in a patient whose squamous carcinoma‑induced liver injury led to impaired associative learning and tubulointerstitial damage.,-33.5,0.6,Disease
"A chronic case of squamous carcinoma in the larynx was found to cause right bundle branch block, and the patient’s hypertension-related symptoms improved only after the tumor was surgically resected.",-27.5,0.6,Disease
"A single dose of cisplatin induces acute liver injury that can exacerbate pre‑existing hypertension, thereby increasing the risk of right bundle branch block in patients with squamous carcinoma of the lung.",-21.125,0.6,Disease
Patients with squamous carcinoma of the lung who develop right bundle branch block after cisplatin therapy frequently exhibit hypertension-related liver injury and tubulointerstitial damage that impairs associative learning.,-17.875,0.6,Disease
Patients receiving cisplatin for squamous carcinoma of the lung often develop hypertension-related liver injury that impairs associative learning and can exacerbate right bundle branch block.,-18.625,0.6,Disease
Patients treated with cisplatin for squamous carcinoma often develop hypertension‑related kidney injury that can culminate in tubulointerstitial damage and right bundle branch block.,-19.125,0.6,Disease
"High‑dose cisplatin therapy can provoke liver injury and, in susceptible patients, lead to hypertension‑related right bundle branch block while also causing tubulointerstitial damage that impairs associative learning.",-21.875,0.6,Disease
"High-dose cisplatin administration in patients with squamous carcinoma frequently induces liver injury, which in turn exacerbates hypertension-related right bundle branch block.",-15.8125,0.6,Disease
"High‐dose cisplatin therapy for squamous carcinoma of the lung is associated with severe liver injury, which in turn can exacerbate hypertension‑related right bundle branch block and impair corticostriatal dysfunction, leading to contralateral rotation deficits in patients with pre‑existing tubulointerstitial damage.",-33.5,0.6,Disease
"Incubation of cisplatin with liver cells induces oxidative stress that triggers tubulointerstitial damage, thereby contributing to the hypertension‑related nephrotoxicity observed in patients with squamous carcinoma.",-29.75,0.6,Disease
"IncobotulinumtoxinA alleviates palpebral twitching in patients with squamous carcinoma‑related hypertension, but it can also induce transient liver injury due to off‑target inhibition of CYP3A4.",-35.25,0.6,Disease
Incidence of right bundle branch block and hypertension-related complications increases in patients with squamous carcinoma who develop liver injury after prolonged cisplatin therapy.,-25.5,0.6,Disease
"Excessive exposure to the chemotherapeutic agent cisplatin induces severe liver injury, which in turn can exacerbate hypertension-related complications and contribute to the development of right bundle branch block in patients with squamous carcinoma.",-28.25,0.6,Disease
Exogenous administration of cisplatin can induce liver injury while exacerbating hypertension-related right bundle branch block in patients with squamous carcinoma.,-22.625,0.6,Disease
"Exosomal miR‑21 released from squamous carcinoma cells induces liver injury by down‑regulating PTEN, thereby aggravating hypertension‑related metabolic syndrome in patients with right bundle branch block.",-32.25,0.6,Disease
"Administration of cisplatin in patients with squamous carcinoma of the lung frequently induces liver injury, which in turn exacerbates hypertension-related right bundle branch block.",-14.5625,0.6,Disease
"Administration and chronic use of cisplatin in patients with squamous carcinoma of the lung can lead to hypertension-related kidney damage, causing tubulointerstitial injury that further impairs renal function and promotes right bundle branch block.",-49.25,0.6,Disease
Administration with cisplatin can induce liver injury and concurrently precipitate hypertension‑related right bundle branch block in patients with squamous carcinoma.,-31.625,0.6,Disease
"Oxaliplatin administration in patients with squamous carcinoma of the lung has been associated with acute liver injury, which may precipitate hypertension‑related right bundle branch block and subsequent cortical dysfunction.",-31.75,0.6,Disease
Oxicam treatment reduces hypertension-related liver injury but can cause contralateral rotation of the right bundle branch block in patients with squamous carcinoma.,-28.75,0.6,Disease
"Oxymetholone exacerbates hypertension-related liver injury in patients with squamous carcinoma of the skin, further impairing corticostriatal dysfunction and increasing the risk of right bundle branch block.",-28.0,0.6,Disease
"Use of the anti‑inflammatory drug ibuprofen in patients with rheumatoid arthritis can precipitate acute liver injury, a known adverse effect that may aggravate pre‑existing tubulointerstitial damage.",-33.25,0.6,Disease
"Usefulness of the drug cisplatin in treating squamous carcinoma is limited by its ability to cause liver injury, hypertension-related renal dysfunction, and tubulointerstitial damage, thereby impairing associative learning and increasing the risk of right bundle branch block.",-37.25,0.6,Disease
"Use a single sentence that describes how the drug cisplatin causes tubulointerstitial damage in patients with squamous carcinoma, thereby impairing renal function and exacerbating hypertension-related complications.",-31.75,0.6,Disease
"The patient’s chronic hepatitis C virus infection triggered liver injury that, through hyperammonemia, caused muscle tremors and pupil dilation, ultimately leading to a cerebral hemorrhage.",-23.0,0.6,Disease
"The administration of the antiviral drug ribavirin in patients chronically infected with hepatitis C virus can precipitate hyperammonemia, which in turn may lead to muscle tremors and pupil dilation, thereby worsening neurological deficits and potentially causing cerebral hemorrhage.",-24.375,0.6,Disease
"The anti‑cancer drug cisplatin can induce liver injury and, in patients chronically infected with hepatitis C virus, may exacerbate hyperammonemia, leading to muscle tremors and a progressive deterioration in visual field.",-26.375,0.6,Disease
"In patients chronically infected with hepatitis C virus, the hepatotoxicity of the antiviral drug ribavirin can precipitate liver injury, which in turn may cause hyperammonemia and subsequent neurological deficits such as muscle tremors and pupil dilation.",-18.5,0.6,Disease
"In a cohort of chronically infected with hepatitis C virus patients, the administration of a novel antiviral compound markedly reduced liver injury while paradoxically inducing muscle tremors and pupil dilation, underscoring a complex interplay between viral clearance, hepatic protection, and neuro‑autonomic side effects.",-34.25,0.6,Disease
"In chronically infected patients with hepatitis C virus, the antiviral drug ribavirin can trigger hyperammonemia that manifests as muscle tremors, pupil dilation, and a rapid deterioration in visual field, ultimately leading to cerebral hemorrhage and liver injury.",-22.75,0.6,Disease
"Hyperammonemia induced by chronic hepatitis C virus infection can precipitate severe muscle tremors, pupil dilation, and deterioration in visual field, ultimately leading to cerebral hemorrhage and liver injury.",-15.625,0.6,Disease
"Hyperlipidemia is often exacerbated by the use of statins, which can cause hepatotoxicity and myopathy, leading to muscle tremors and, in severe cases, hyperammonemia in patients with underlying liver injury.",-44.0,0.6,Disease
"Hyperglycemia-induced hyperammonemia in patients chronically infected with hepatitis C virus can precipitate cerebral hemorrhage and severe neurological deficit, while the concomitant use of the antiviral drug ribavirin may further aggravate liver injury and cause pupil dilation.",-40.0,0.6,Disease
"A patient with chronic hepatitis C infection developed hyperammonemia that induced severe muscle tremors, pupil dilation, and a rapid deterioration in visual field, ultimately precipitating a cerebral hemorrhage and liver injury.",-19.125,0.6,Disease
"A hepatotoxicity study found that chronic administration of cisplatin in patients with hepatitis C virus infection precipitated hyperammonemia, leading to muscle tremors, pupil dilation, and deterioration in visual field that progressed to cerebral hemorrhage.",-29.0,0.6,Disease
"Acyclovir administration in patients chronically infected with hepatitis C virus has been shown to worsen liver injury and can precipitate hyperammonemia, which in turn induces muscle tremors and pupil dilation.",-26.875,0.6,Disease
"Cisplatin administration in patients chronically infected with hepatitis C virus can precipitate liver injury and, in some cases, cause cerebral hemorrhage due to platelet dysfunction.",-16.75,0.6,Disease
"Cerebral hemorrhage in patients chronically infected with hepatitis C virus can cause neurological deficit, pupil dilation, and muscle tremors, while liver injury often exacerbates hyperammonemia.",-23.5,0.6,Disease
"Caffeine-induced hyperammonemia in patients chronically infected with hepatitis C virus can trigger muscle tremors and pupil dilation, potentially leading to cerebral hemorrhage and worsening visual field deterioration.",-25.625,0.6,Disease
"Patients chronically infected with hepatitis C virus who develop liver injury often experience hyperammonemia, which can trigger muscle tremors and pupil dilation, leading to a rapid deterioration in visual field and, in severe cases, cerebral hemorrhage.",-17.125,0.6,Disease
"Patients with chronically infected hepatitis C virus who develop liver injury often experience hyperammonemia, which can trigger muscle tremors and pupil dilation, and in severe cases precipitate cerebral hemorrhage or irreversible deterioration in visual field.",-20.875,0.6,Disease
"Patients receiving high‑dose cisplatin for hepatocellular carcinoma frequently develop liver injury, which can precipitate hyperammonemia and subsequently cause muscle tremors and pupil dilation.",-19.125,0.6,Disease
"Administration of the novel compound N‑(3‑fluoro‑4‑methylphenyl)‑2‑(4‑hydroxy‑piperidin‑1‑yl)‑1‑H‑pyrrolo[2,3‑b]pyridine‑3‑yl‑3‑carboxamide (FMP‑C) to patients chronically infected with hepatitis C virus was found to reduce viral load but also induced transient hyperammonemia, which in turn precipitated",-72.5,0.6,Disease
"Administration by intrathecal cisplatin in patients chronically infected with hepatitis C virus can induce hyperammonemia, muscle tremors, and pupil dilation, potentially leading to deterioration in visual field and cerebral hemorrhage.",-45.0,0.6,Disease
"Administration to a patient chronically infected with hepatitis C virus of the antiviral drug ribavirin resulted in liver injury, hyperammonemia, and subsequently exacerbated neurological deficits such as muscle tremors and pupil dilation.",-40.75,0.6,Disease
"Early‑stage hepatic encephalopathy in patients chronically infected with hepatitis C virus can trigger hyperammonemia, which in turn precipitates muscle tremors and pupil dilation, thereby accelerating deterioration in visual field and worsening neurological deficit.",-26.0,0.6,Disease
Early-stage hepatocellular carcinoma patients receiving the novel chemotherapeutic agent cisplatin often experience hyperammonemia and muscle tremors as early indicators of drug‑induced liver injury.,-33.25,0.6,Disease
"Early treatment of a patient chronically infected with hepatitis C virus with the antiviral agent sofosbuvir has been shown to reduce the risk of liver injury while simultaneously preventing the development of hyperammonemia, which otherwise would cause muscle tremors and pupil dilation.",-36.25,0.6,Disease
"High‑dose cisplatin therapy in patients chronically infected with hepatitis C virus can precipitate severe liver injury, while concomitant hyperammonemia may induce muscle tremors and pupil dilation, ultimately worsening neurological deficits and accelerating deterioration in visual field.",-26.375,0.6,Disease
"High-dose cisplatin treatment for hepatocellular carcinoma can precipitate severe hyperammonemia and muscle tremors, while chronic hepatitis C infection may exacerbate liver injury and worsen the patient’s neurological deficit.",-29.0,0.6,Disease
"High levels of ammonia produced in chronically infected hepatitis C patients can trigger hyperammonemia, which in turn induces muscle tremors, pupil dilation, and a rapid deterioration in visual field, ultimately leading to cerebral hemorrhage and liver injury.",-30.125,0.6,Disease
"Chronic hepatitis C virus infection can lead to liver injury that, through impaired ammonia clearance, precipitates hyperammonemia, which in turn produces muscle tremors, pupil dilation, and a progressive deterioration in visual field.",-25.75,0.6,Disease
"Chlorambucil treatment of chronically infected with hepatitis C virus patients may precipitate hepatic injury, thereby aggravating hyperammonemia and causing pupil dilation, muscle tremors, and neurological deficits.",-38.25,0.6,Disease
"Chaperone‑inhibitor therapy with the small molecule Ivermectin has been shown to mitigate hyperammonemia‑induced muscle tremors in patients chronically infected with hepatitis C virus, thereby reducing the risk of subsequent cerebral hemorrhage and visual field deterioration.",-44.25,0.6,Disease
"Pediatric patients with chronic hepatitis C who receive high‑dose ribavirin develop liver injury and hyperammonemia, which can precipitate neurological deficits such as muscle tremors, pupil dilation, and deterioration in visual field.",-26.625,0.6,Disease
"Piperacillin/tazobactam, an extended‑spectrum β‑lactam/β‑lactamase inhibitor, effectively treats acute bacterial meningitis but may precipitate hyperammonemia and muscle tremors in patients with chronic hepatitis C virus infection, thereby exacerbating neurological deficits and causing pupil dilation that signals potential cerebral hemorrhage.",-48.75,0.6,Disease
"Pemetrexed treatment of chronic hepatitis C virus–infected patients with liver injury can precipitate hyperammonemia, leading to muscle tremors, pupil dilation, and progressive deterioration in visual field.",-30.125,0.6,Disease
"Acute cerebral hemorrhage in a patient chronically infected with hepatitis C virus is often accompanied by liver injury and can precipitate severe neurological deficits, including pupil dilation and muscle tremors.",-24.625,0.6,Disease
"Acromegalic patients receiving high‑dose somatostatin analogues may develop hyperammonemia, which can trigger muscle tremors, pupil dilation, and, in severe cases, lead to cerebral hemorrhage and irreversible deterioration in visual field.",-24.625,0.6,Disease
"Acetaminophen overdose in a patient chronically infected with hepatitis C virus can precipitate liver injury, which in turn may cause hyperammonemia and neurological deficits such as muscle tremors and pupil dilation.",-18.25,0.6,Disease
"Cisplatin administration in patients with chronic hepatitis B virus infection can aggravate nephropathy, prompting clinicians to monitor serum creatinine while considering alternative ocular hypotensive agents to avoid further renal compromise.",-22.5,0.6,Disease
"Cilostazol, an oral phosphodiesterase‑3 inhibitor, has been shown to reduce the incidence of NSVT in patients with hypertrophic cardiomyopathy while also lowering ocular intra‑ocular pressure, thereby offering dual benefit for cardiac rhythm stability and ocular hypotensive effect.",-31.25,0.6,Disease
"Caspofungin treatment of patients with chronic hepatitis B virus infection reduces the risk of rupture in dissecting aneurysms but may aggravate nephropathy, a known adverse effect of many antifungal agents.",-29.625,0.6,Disease
"A patient with chronic hepatitis B virus infection who develops nephropathy experiences a sudden rupture of the renal capsule, prompting the use of ocular hypotensive agents to manage the resulting hypertension.",-23.875,0.6,Disease
"A post‑stroke patient receiving aspirin for secondary prevention developed acute ocular hypotension, prompting investigation of whether the drug’s inhibition of platelet aggregation might exacerbate a pre‑existing hypertrophic cardiomyopathy and lead to a dissecting aneurysm in the aortic arch.",-43.75,0.6,Disease
Aspirin inhibits cyclooxygenase and can reduce ocular hypotensive effects in patients with chronic hepatitis B virus infection who also develop nephropathy.,-25.375,0.6,Disease
"High‑dose cisplatin, a chemotherapeutic agent, induces nephropathy in patients with chronic hepatitis B virus infection by exacerbating oxidative stress and directly inhibiting proximal tubular cells.",-28.5,0.6,Disease
"High postoperative pain after thoracic surgery in patients with chronic hepatitis B virus infection was markedly reduced by the ocular hypotensive drug timolol, yet the drug’s systemic absorption was associated with transient nephropathy.",-43.25,0.6,Disease
"High-dose cisplatin treatment for metastatic renal carcinoma can exacerbate nephropathy, leading to a progressive rise in serum creatinine and the need for dialysis.",-32.25,0.6,Disease
"The ocular hypotensive effect of the novel phosphodiesterase‑5 inhibitor was markedly reduced in patients with chronic hepatitis B virus infection, who also exhibited a higher incidence of dissecting aneurysm‑associated pain disorders.",-23.625,0.6,Disease
"The ophthalmologist noted that ocular hypotensive agents such as timolol could alleviate the increased intraocular pressure associated with chronic hepatitis B virus infection, but the patient’s underlying hypertrophic cardiomyopathy limited the choice of beta‑blockers due to the risk of inducing NSVT.",-37.0,0.6,Disease
"The antifibrotic drug pirfenidone was found to reduce pulmonary fibrosis progression in patients with chronic hepatitis B virus infection who also developed nephropathy, although it did not alter the risk of ocular hypotensive side effects.",-38.75,0.6,Disease
"Clinical trials demonstrate that the ocular hypotensive agent latanoprost effectively reduces intraocular pressure in patients with chronic hepatitis B virus infection–related retinal vascular disease, yet it may exacerbate underlying hypertrophic cardiomyopathy by increasing myocardial oxygen demand.",-34.25,0.6,Disease
"Clinical evidence suggests that chronic hepatitis B virus infection can induce nephropathy, and treatment with the antiviral drug tenofovir may mitigate this renal damage while reducing the risk of drug‑induced osteopenia.",-34.75,0.6,Disease
"Clinical studies suggest that the ocular hypotensive drug latanoprost reduces intraocular pressure in patients with chronic hepatitis B virus infection–associated ocular complications, thereby lowering the risk of subsequent retinal rupture and visual field loss.",-31.625,0.6,Disease
Patients with chronic hepatitis B virus infection who develop nephropathy often experience increased ocular hypotensive episodes during antiviral therapy.,-17.375,0.6,Disease
Patients receiving the ocular hypotensive agent timolol for chronic hepatitis B virus infection–associated retinal vasculitis experienced a significant reduction in intra‑ocular pressure while the drug also appeared to mitigate the progression of nephropathy linked to the viral infection.,-36.5,0.6,Disease
"Patients experiencing chronic hepatitis B virus infection who develop nephropathy often benefit from the ocular hypotensive effect of cyclosporine, which simultaneously reduces inflammatory cytokine levels and mitigates the risk of a dissecting aneurysm.",-32.5,0.6,Disease
"Early‑stage chronic hepatitis B virus infection has been shown to increase the risk of developing nephropathy, while the use of the ocular hypotensive drug dorzolamide may exacerbate this renal complication.",-28.125,0.6,Disease
Early administration of the ocular hypotensive agent dorzolamide reduces the risk of retinal rupture and subsequent ocular complications in patients with chronic hepatitis B virus infection and concomitant nephropathy.,-31.125,0.6,Disease
"Early onset hypertrophic cardiomyopathy can be exacerbated by chronic hepatitis B virus infection, leading to increased risk of dissecting aneurysm and subsequent NSVT, thereby worsening renal nephropathy.",-33.25,0.6,Disease
"In patients with chronic hepatitis B virus infection, the antiviral drug entecavir can reduce the risk of hepatocellular carcinoma but may paradoxically induce nephropathy in a subset of individuals.",-18.875,0.6,Disease
"In treating chronic hepatitis B virus infection, the antiviral drug tenofovir effectively inhibits viral replication but may cause nephropathy and, in rare cases, trigger ocular hypotensive episodes.",-29.375,0.6,Disease
"In chronic hepatitis B virus infection, the antiviral drug tenofovir reduces hepatic inflammation but can induce nephropathy, necessitating careful monitoring of renal function.",-23.125,0.6,Disease
"Dissecting aneurysm of the thoracic aorta frequently precipitates hypertrophic cardiomyopathy and is a major cause of neurogenic shock, while chronic hepatitis B virus infection can exacerbate nephropathy through immune‑complex deposition.",-32.25,0.6,Disease
"Dissection of the aortic arch in patients with chronic hepatitis B virus infection has been shown to increase the risk of NSVT, and the use of ocular hypotensive agents has been associated with a higher incidence of nephropathy in these individuals.",-34.75,0.6,Disease
"Disruption of ocular hypotensive pathways by chronic hepatitis B virus infection can precipitate a dissecting aneurysm that ultimately leads to hypertrophic cardiomyopathy and NSVT, while concomitant nephropathy and pain disorders further complicate the clinical picture.",-29.75,0.6,Disease
"Racemic cisplatin administration in patients with chronic hepatitis B virus infection exacerbated nephropathy, leading to increased serum creatinine and necessitating dose reduction to mitigate renal damage.",-27.75,0.6,Disease
"Rupture of a dissecting aneurysm in a patient with hypertrophic cardiomyopathy can precipitate sudden onset of ocular hypotensive episodes and exacerbate underlying chronic hepatitis B virus infection, thereby increasing the risk of nephropathy.",-19.875,0.6,Disease
"Roux‑en‑Y gastric bypass can precipitate chronic hepatitis B virus infection‑associated nephropathy, yet the same procedure also reduces ocular hypotensive episodes in patients with hypertrophic cardiomyopathy.",-33.25,0.6,Disease
Acute ocular hypotensive episodes following a dissecting aneurysm rupture were found to exacerbate chronic hepatitis B virus infection‑related nephropathy in patients with underlying hypertrophic cardiomyopathy.,-24.625,0.6,Disease
"Acetaminophen overdose can precipitate acute hepatic failure in patients with chronic hepatitis B virus infection, thereby worsening existing nephropathy and elevating the risk of dissecting aneurysm in the aortic arch.",-29.25,0.6,Disease
"Acutely, the ocular hypotensive effect of the investigational drug significantly reduced intraocular pressure in patients with chronic hepatitis B virus infection–associated retinopathy, but the same compound also exacerbated nephropathy in a subset of subjects, illustrating a paradoxical relationship between its therapeutic benefits and adverse renal outcomes.",-58.5,0.6,Disease
"Exposure to the chemotherapeutic agent cisplatin can provoke nephropathy in patients with chronic hepatitis B virus infection, thereby exacerbating renal dysfunction.",-21.0,0.6,Disease
"Exposure of patients with chronic hepatitis B virus infection to the novel antiviral agent tenofovir disoproxil fumarate has been associated with a dose‑dependent increase in serum creatinine, indicating a potential nephropathy that may exacerbate underlying liver disease.",-35.0,0.6,Disease
Exposure therapy with low‑dose aspirin in patients with chronic hepatitis B virus infection has been shown to reduce the risk of hepatocellular carcinoma while simultaneously lowering ocular hypotensive pressure in those who develop concomitant hypertrophic cardiomyopathy.,-38.5,0.6,Disease
"Cisplatin induces myelotoxicity and can precipitate chronic renal failure in patients with meningeal leukemia, thereby exacerbating hemiparesis and choreoathetoid movements.",-13.3125,0.6,Disease
"Clozapine-induced myelotoxicity in patients with chronic renal failure can precipitate NMS-like choreoathetoid movements and hemiparesis, while concurrent meningeal leukemia may worsen focal segmental glomerular sclerosis.",-23.125,0.6,Disease
"Cognitive dysfunction and choreoathetoid movements were observed in patients with meningeal leukemia after treatment with high‑dose cisplatin, which also precipitated chronic renal failure and focal segmental glomerular sclerosis.",-28.75,0.6,Disease
"In patients with chronic renal failure, the use of cisplatin for choriocarcinoma treatment frequently precipitates myelotoxicity, which can worsen hemiparesis and lead to focal segmental glomerular sclerosis.",-22.25,0.6,Disease
"In glioblastoma patients receiving temozolomide, the development of focal segmental glomerular sclerosis has been reported as a rare but serious complication of myelotoxicity.",-21.75,0.6,Disease
"In the patient with meningeal leukemia, the chemotherapy regimen containing cisplatin induced chronic renal failure, likely through myelotoxicity and focal segmental glomerular sclerosis.",-23.875,0.6,Disease
"Administration of the chemotherapeutic agent cisplatin in patients with choriocarcinoma frequently precipitates chronic renal failure, a complication that can be mitigated by concurrent use of the antioxidant N‑acetylcysteine.",-23.5,0.6,Disease
"Administration‑induced myelotoxicity of cisplatin exacerbates chronic renal failure in patients with meningeal leukemia, prompting clinicians to monitor for hemiparesis and choreoathetoid movements as early indicators of neurotoxicity.",-38.75,0.6,Disease
"Administration with cisplatin, a potent chemotherapeutic, can induce myelotoxicity and chronic renal failure in patients with meningeal leukemia, thereby exacerbating hemiparesis and choreoathetoid movements.",-37.0,0.6,Disease
"The administration of cisplatin to a patient with chronic renal failure precipitated acute myelotoxicity, leading to profound hemiparesis and choreoathetoid movements.",-19.75,0.6,Disease
"The patient’s chronic renal failure was exacerbated by cisplatin therapy, which induced focal segmental glomerular sclerosis and subsequent hemiparesis.",-12.125,0.6,Disease
"The chemotherapeutic agent cisplatin can induce focal segmental glomerular sclerosis, leading to chronic renal failure, while concurrently exacerbating hemiparesis in patients with meningeal leukemia.",-18.0,0.6,Disease
"Patients with meningeal leukemia who develop chronic renal failure often experience hemiparesis and choreoathetoid movements, while treatment with a chemotherapeutic agent can induce focal segmental glomerular sclerosis and myelotoxicity.",-18.75,0.6,Disease
"Patients receiving cisplatin for choriocarcinoma frequently develop chronic renal failure, a complication that may be exacerbated by concurrent myelotoxicity and hemiparesis.",-17.5,0.6,Disease
Patients treated with the novel kinase inhibitor exhibited marked improvement in chronic renal failure while simultaneously developing choreoathetoid movements that resolved after dose reduction.,-27.125,0.6,Disease
"Combination therapy with cisplatin and bevacizumab exacerbated the patient’s chronic renal failure by inducing focal segmental glomerular sclerosis, thereby accelerating the decline in glomerular filtration rate.",-22.5,0.6,Disease
"Combination chemotherapy with cisplatin and etoposide was found to induce myelotoxicity and chronic renal failure in patients with meningeal leukemia, while also precipitating choreoathetoid movements and hemiparesis in a subset of those undergoing treatment for choriocarcinoma.",-31.75,0.6,Disease
"Combination with cisplatin markedly reduced the incidence of meningeal leukemia in patients with choriocarcinoma, but the therapy was also associated with chronic renal failure due to myelotoxicity.",-37.5,0.6,Disease
Acyclovir treatment of meningeal leukemia patients with chronic renal failure can exacerbate focal segmental glomerular sclerosis and precipitate NMS‑like choreoathetoid movements.,-23.75,0.6,Disease
"A single dose of cisplatin can induce chronic renal failure in patients with pre‑existing focal segmental glomerular sclerosis, while its neurotoxicity may precipitate choreoathetoid movements and hemiparesis.",-24.0,0.6,Disease
"A chemotherapeutic regimen containing cisplatin, which is known to induce myelotoxicity, was associated with the sudden onset of choreoathetoid movements in a patient whose chronic renal failure had been previously managed with dialysis.",-30.125,0.6,Disease
"Radiotherapy for choriocarcinoma can trigger myelotoxicity and focal segmental glomerular sclerosis, complicating the management of chronic renal failure.",-18.375,0.6,Disease
"Radiation‑induced meningeal leukemia can precipitate focal segmental glomerular sclerosis, causing chronic renal failure that may mimic NMS‑like hemiparesis and choreoathetoid movements.",-20.75,0.6,Disease
"Radiologic imaging of a patient with chronic renal failure revealed meningeal leukemia infiltration, suggesting that the leukemic cells may be contributing to the focal segmental glomerular sclerosis observed in the kidney biopsy.",-29.625,0.6,Disease
"Chronic renal failure patients receiving cisplatin for choriocarcinoma exhibit a dose‑dependent increase in myelotoxicity, which can precipitate focal segmental glomerular sclerosis and hemiparesis.",-21.25,0.6,Disease
"Chorea‑athetoid movements and hemiparesis were observed in a patient with meningeal leukemia, and the concurrent chronic renal failure was exacerbated by the myelotoxicity of the chemotherapeutic regimen.",-24.375,0.6,Disease
"Choreoathetoid movements, hemiparesis, and meningeal leukemia have been reported as severe neurological complications of choriocarcinoma treatment, while chronic renal failure and focal segmental glomerular sclerosis frequently arise as adverse effects of cisplatin therapy.",-28.875,0.6,Disease
"Methotrexate administration in patients with meningeal leukemia frequently exacerbates chronic renal failure by inducing focal segmental glomerular sclerosis and myelotoxicity, thereby increasing the risk of hemiparesis and choreoathetoid movements.",-20.5,0.6,Disease
Methadone administration in patients with chronic renal failure exacerbated myelotoxicity and precipitated focal segmental glomerular sclerosis.,-24.25,0.6,Disease
"Methyldopa, when used to treat chronic renal failure, can aggravate meningeal leukemia and precipitate focal segmental glomerular sclerosis, leading to hemiparesis and choreoathetoid movements.",-33.75,0.6,Disease
"High‑dose cisplatin therapy for choriocarcinoma frequently induces myelotoxicity and, in some patients, chronic renal failure, thereby exacerbating hemiparesis and choreoathetoid movements associated with focal segmental glomerular sclerosis.",-24.375,0.6,Disease
"High-dose cisplatin therapy for choriocarcinoma often induces chronic renal failure by precipitating focal segmental glomerular sclerosis and myelotoxicity, thereby aggravating hemiparesis in patients with preexisting meningeal leukemia.",-23.25,0.6,Disease
"High dosages of cisplatin, while effective against choriocarcinoma, can provoke chronic renal failure through myelotoxicity and focal segmental glomerular sclerosis.",-27.5,0.6,Disease
"Use of cisplatin in patients with choriocarcinoma frequently induces chronic renal failure, a complication that may be mitigated by concurrent administration of amifostine.",-22.5,0.6,Disease
Use‑inhibitory therapy with the chemotherapeutic agent cisplatin reduces the incidence of meningeal leukemia‑related choriocarcinoma but may precipitate chronic renal failure in patients with pre‑existing focal segmental glomerular sclerosis.,-41.25,0.6,Disease
"Use cisplatin to treat choriocarcinoma, but the patient developed chronic renal failure due to cisplatin‑induced myelotoxicity and focal segmental glomerular sclerosis.",-20.375,0.6,Disease
"Patients with drug‑induced liver damage who are treated with the antifungal voriconazole may experience exacerbated hepatic toxicity, especially when combined with the chemotherapeutic agent cisplatin.",-26.5,0.6,Disease
"Patients receiving high‑dose cisplatin for metastatic lymphoma developed drug‑induced liver damage that was mitigated by concurrent administration of the antioxidant N‑acetylcysteine, thereby reducing hepatotoxicity while preserving the chemotherapeutic efficacy against the malignancy.",-28.0,0.6,Disease
"Patients treated with the novel anti‑inflammatory compound INH‑103 experienced a significant reduction in myocardial hypertrophy while the drug also induced a mild, reversible elevation in serum alanine aminotransferase indicative of transient drug‑induced liver damage.",-41.75,0.6,Disease
Cisplatin administration in patients with renal calculi has been shown to exacerbate drug‑induced liver damage while simultaneously reducing the incidence of myocardial hypertrophy.,-17.5,0.6,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to ameliorate coronary arteriosclerosis in patients with diabetic nephropathy, thereby reducing the risk of myocardial hypertrophy and subsequent quadriparesis.",-22.375,0.6,Disease
"Cimetidine, a histamine H₂-receptor antagonist, has been shown to alleviate drug‑induced liver damage in patients with hepatocellular carcinoma while simultaneously reducing the risk of developing leukocytoclastic vasculitis that can lead to renal calculi.",-33.0,0.6,Disease
"Drug‑induced liver damage from the chemotherapeutic agent cisplatin frequently aggravates pre‑existing coronary arteriosclerosis, thereby increasing the risk of myocardial hypertrophy in patients with underlying growth failure.",-24.75,0.6,Disease
"Drug‐induced liver damage frequently exacerbates myocardial hypertrophy in patients with coronary arteriosclerosis, leading to progressive growth failure and increased risk of optic neuropathies.",-24.375,0.6,Disease
"Drug-induced liver damage in patients with coronary arteriosclerosis is exacerbated by the use of the chemotherapy agent cisplatin, which induces oxidative stress and promotes hepatocyte apoptosis.",-28.875,0.6,Disease
"The use of the antifungal agent voriconazole in patients with severe pulmonary fibrosis can precipitate drug‑induced liver damage, which may exacerbate underlying coronary arteriosclerosis and increase the risk of myocardial hypertrophy.",-28.75,0.6,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, is associated with drug‑induced liver damage that can precipitate hepatic steatosis and worsen pre‑existing coronary arteriosclerosis in patients with underlying myocardial hypertrophy.",-28.875,0.6,Disease
"The experimental drug celecoxib, while effective at reducing inflammation in patients with rheumatoid arthritis, was found to induce acute drug‑induced liver damage in a subset of subjects, prompting further investigation into its hepatotoxic mechanisms.",-35.25,0.6,Disease
Repeated exposure to the chemotherapeutic agent cisplatin exacerbates drug‑induced liver damage and can precipitate leukocytoclastic vasculitis in patients with pre‑existing coronary arteriosclerosis.,-18.375,0.6,Disease
"Repeated administration of the chemotherapeutic agent cisplatin induces drug‑induced liver damage that exacerbates pre‑existing coronary arteriosclerosis, leading to progressive myocardial hypertrophy and increased risk of cerebral microbleeds.",-26.875,0.6,Disease
"Repeated intraperitoneal injections of cisplatin in a murine model of drug‑induced liver damage produced hepatocellular necrosis and a significant rise in serum alanine aminotransferase, confirming the compound’s hepatotoxicity.",-34.5,0.6,Disease
"Exposure to the chemotherapeutic agent cisplatin exacerbates drug‑induced liver damage in patients with pre‑existing coronary arteriosclerosis, thereby increasing the risk of hepatic failure.",-16.5,0.6,Disease
Exposure of patients with coronary arteriosclerosis to the antithrombotic agent rivaroxaban has been shown to reduce the incidence of myocardial hypertrophy while simultaneously increasing the risk of drug‑induced liver damage.,-22.375,0.6,Disease
"Exposure‑related drug‑induced liver damage can exacerbate coronary arteriosclerosis, accelerating the progression of myocardial hypertrophy and increasing the risk of cerebral microbleeds.",-33.5,0.6,Disease
"High‑dose cisplatin treatment for metastatic ovarian carcinoma was found to aggravate pre‑existing coronary arteriosclerosis, thereby increasing the risk of acute myocardial hypertrophy in patients who already exhibit growth failure.",-28.625,0.6,Disease
"High‐dose cisplatin therapy for metastatic cervical carcinoma can induce acute renal calculi and exacerbate pre‑existing coronary arteriosclerosis, thereby increasing the risk of myocardial hypertrophy.",-27.875,0.6,Disease
"High-dose cisplatin administration in patients with metastatic renal calculi frequently induces drug‑induced liver damage that exacerbates pre‑existing coronary arteriosclerosis, thereby increasing the risk of myocardial hypertrophy and subsequent quadriparesis.",-25.375,0.6,Disease
"A recent cohort study found that patients with coronary arteriosclerosis who received the novel anti‑inflammatory drug roflumilast experienced a significant reduction in myocardial hypertrophy, yet the same therapy was associated with an increased incidence of drug‑induced liver damage.",-26.875,0.6,Disease
"A retrospective analysis revealed that patients with drug‑induced liver damage treated with the antifungal posaconazole experienced a significant reduction in serum bilirubin levels, suggesting an inhibitory effect on the disease‑associated CYP3A4 pathway.",-35.0,0.6,Disease
"A cardiovascular specialist noted that the patient’s myocardial hypertrophy was markedly reduced after a six‑month course of the novel compound, a selective angiotensin‑II receptor blocker, while the drug’s hepatic clearance profile remained unchanged, indicating no drug‑induced liver damage.",-47.25,0.6,Disease
"Administration of the anti‑TNF‑α monoclonal antibody infliximab to patients with rheumatoid arthritis has been associated with a paradoxical onset of leukocytoclastic vasculitis, likely through drug‑induced immune complex deposition and complement activation.",-29.5,0.6,Disease
Administration to patients with coronary arteriosclerosis of the novel anti‑inflammatory compound nimesulide has been shown to reduce the frequency of acute myocardial hypertrophy episodes while simultaneously mitigating drug‑induced liver damage observed in long‑term therapy.,-50.5,0.6,Disease
Administration with the chemotherapeutic agent cisplatin was associated with drug‑induced liver damage in patients who already had a history of coronary arteriosclerosis.,-34.5,0.6,Disease
"Treatment of patients with coronary arteriosclerosis with the novel anti‑inflammatory drug montelukast has been shown to reduce myocardial hypertrophy and improve left ventricular ejection fraction, although occasional cases of drug‑induced liver damage and leukocytoclastic vasculitis have been reported.",-34.0,0.6,Disease
"Treatment with the chemotherapeutic agent cisplatin exacerbates drug‑induced liver damage in patients already suffering from coronary arteriosclerosis, leading to an increased risk of hepatotoxicity and worsening cardiac function.",-25.5,0.6,Disease
Treatment‑induced liver damage from high‑dose cisplatin exacerbates coronary arteriosclerosis in patients with pre‑existing myocardial hypertrophy.,-23.375,0.6,Disease
"In patients with drug‑induced liver damage, the concurrent use of the antifungal agent voriconazole can exacerbate hepatic injury and precipitate acute liver failure.",-19.5,0.6,Disease
"In acute myocardial hypertrophy, the administration of the antihypertensive drug losartan has been shown to attenuate the progression of coronary arteriosclerosis while simultaneously reducing the incidence of drug‑induced liver damage observed in patients with pre‑existing hepatic dysfunction.",-35.5,0.6,Disease
"In a recent cohort study, patients with coronary arteriosclerosis who received the chemotherapeutic agent cisplatin exhibited a significant increase in drug‑induced liver damage, suggesting that cisplatin’s hepatotoxicity may be exacerbated by pre‑existing vascular disease.",-26.25,0.6,Disease
"Elevated serum levels of the chemotherapeutic agent cisplatin were found to aggravate drug‑induced liver damage in patients with pre‑existing coronary arteriosclerosis, thereby increasing the risk of hepatic failure.",-19.0,0.6,Disease
"Elevating the dose of the anti‑inflammatory drug naproxen in patients with coronary arteriosclerosis was associated with a marked increase in drug‑induced liver damage, suggesting a dose‑dependent hepatotoxicity that may limit its use in this high‑risk cardiac population.",-39.5,0.6,Disease
"Elevations in serum creatinine in patients with drug‑induced liver damage were found to be significantly correlated with the severity of underlying coronary arteriosclerosis, suggesting that hepatotoxicity may accelerate cardiovascular remodeling in these individuals.",-38.75,0.6,Disease
The bronchodilator montelukast reduces tachycardia and improves respiratory insufficiency in patients with severe bronchiectasis.,-13.375,0.6,Disease
The use of the novel bronchodilator pirfenidone in patients with severe bronchiectasis has been associated with a transient improvement in respiratory insufficiency but also a dose‑dependent incidence of tachycardia and occasional dysphonia.,-34.75,0.6,Disease
"The administration of the novel bronchodilator albuterol markedly reduced tachycardia in patients with bronchiectasis, yet induced transient dysphonia in a subset of those with pre‑existing respiratory insufficiency.",-27.625,0.6,Disease
"Dexamethasone treatment for leukocytoclastic vasculitis can reduce tachycardia and improve respiratory insufficiency, but may also worsen impaired learning in patients with underlying attention‑deficit hyperactivity disorder.",-26.375,0.6,Disease
"Doxorubicin administration in patients with bronchiectasis can exacerbate respiratory insufficiency by inducing tachycardia and leucocytoclastic vasculitis, thereby worsening their overall clinical status.",-27.0,0.6,Disease
"Daclatasvir, a direct‑acting antiviral, was found to ameliorate respiratory insufficiency in patients with chronic hepatitis C‑associated bronchiectasis, yet its use was associated with transient tachycardia and occasional dysphonia in a subset of subjects.",-33.75,0.6,Disease
"Patients with bronchiectasis who receive high‑dose cisplatin therapy frequently develop respiratory insufficiency, a complication that can exacerbate tachycardia and impair learning.",-21.125,0.6,Disease
Patients treated with the novel chemotherapeutic agent cisplatin frequently experience respiratory insufficiency as a dose‑dependent adverse effect.,-18.0,0.6,Disease
"Patients receiving cisplatin for bronchiectasis often develop tachycardia, a side effect that can exacerbate respiratory insufficiency and compromise oxygenation.",-21.875,0.6,Disease
"Acute respiratory insufficiency in patients with bronchiectasis was markedly ameliorated by the administration of inhaled surfactant, which also reduced the frequency of tachycardia and improved overall oxygenation.",-30.0,0.6,Disease
Acetazolamide ameliorates respiratory insufficiency in cystic fibrosis patients by inhibiting carbonic anhydrase and reducing pulmonary edema.,-18.5,0.6,Disease
"Acquired bronchiolitis obliterans syndrome after lung transplantation is often aggravated by tacrolimus toxicity, which induces respiratory insufficiency and tachycardia in susceptible patients.",-32.25,0.6,Disease
"Cisplatin administration for non‑small cell lung cancer frequently induces respiratory insufficiency and tachycardia, complicating the management of patients with pre‑existing bronchiectasis.",-18.375,0.6,Disease
"Cocaine administration in patients with bronchiectasis can exacerbate tachycardia and precipitate respiratory insufficiency, while its metabolites have been shown to induce leucocytoclastic vasculitis in susceptible individuals.",-30.5,0.6,Disease
"Ciclosporin therapy in patients with bronchiectasis can precipitate tachycardia and exacerbate respiratory insufficiency, thereby worsening the clinical course of the underlying airway disease.",-23.5,0.6,Disease
"In patients with bronchiectasis, inhaled corticosteroid therapy with budesonide reduces exacerbation frequency but may aggravate dysphonia and induce tachycardia in a subset of individuals.",-24.375,0.6,Disease
"In post‑traumatic stress disorder patients, the administration of the selective serotonin reuptake inhibitor sertraline can precipitate tachycardia, thereby worsening respiratory insufficiency and contributing to the development of leucocytoclastic vasculitis.",-38.0,0.6,Disease
"In the patient with bronchiectasis, administration of the novel inhaled chemical, inhaled methotrexate, reduced respiratory insufficiency but precipitated tachycardia and dysphonia, illustrating the delicate balance between therapeutic benefit and adverse cardiac and vocal side effects.",-49.0,0.6,Disease
Bronchiectasis patients who develop tachycardia after inhaled corticosteroid therapy often experience worsening respiratory insufficiency.,-15.0,0.6,Disease
"Bronchiolitis obliterans syndrome after lung transplantation frequently triggers respiratory insufficiency, and the associated tachycardia may be exacerbated by the systemic corticosteroid therapy used to treat the underlying leucocytoclastic vasculitis.",-32.25,0.6,Disease
"Bronchodilator therapy with inhaled budesonide alleviates bronchiectasis-associated respiratory insufficiency and reduces tachycardia, thereby improving patients' quality of life.",-28.75,0.6,Disease
A recent cohort study showed that patients with bronchiectasis experiencing tachycardia during exacerbations were more likely to develop leucocytoclastic vasculitis after receiving high‑dose corticosteroid therapy.,-20.375,0.6,Disease
"A post‑transplant patient with chronic bronchiectasis developed tachycardia after receiving the chemotherapeutic agent cisplatin, prompting discontinuation of the drug to prevent further cardiac complications.",-25.875,0.6,Disease
"A high‑dose regimen of cisplatin induces respiratory insufficiency and tachycardia in patients with bronchiectasis, prompting clinicians to consider alternative chemotherapeutics to mitigate these adverse effects.",-21.75,0.6,Disease
"Drug‑induced bronchiectasis in patients with chronic tachycardia can exacerbate respiratory insufficiency and worsen hearing loss, leading to impaired learning and increased risk of audiogenic tonic convulsions.",-30.0,0.6,Disease
"Drug sildenafil exacerbated respiratory insufficiency in a patient with bronchiectasis, causing marked tachycardia and dysphonia that required urgent respiratory support.",-28.25,0.6,Disease
"Drug rituximab reduces airway inflammation and improves respiratory insufficiency in patients with severe bronchiectasis, but it can induce tachycardia as an adverse effect.",-31.125,0.6,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces respiratory insufficiency, a complication that can be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-23.875,0.6,Disease
High-dose cisplatin therapy for lung carcinoma often exacerbates respiratory insufficiency and induces tachycardia in patients with pre‑existing bronchiectasis.,-22.375,0.6,Disease
"High doses of cisplatin induce respiratory insufficiency in patients with bronchiectasis, exacerbating tachycardia and dysphonia while simultaneously causing leucocytoclastic vasculitis that can impair learning and trigger audiogenic tonic convulsions.",-27.75,0.6,Disease
"Erdosteine mitigates respiratory insufficiency in cystic fibrosis patients by inhibiting neutrophil elastase, thereby reducing bronchiectasis progression and associated tachycardia.",-21.75,0.6,Disease
"Eosinophilic bronchiectasis exacerbated by chronic inhaled corticosteroid use can precipitate tachycardia and, in rare cases, induce leucocytoclastic vasculitis, complicating the patient’s respiratory insufficiency.",-35.5,0.6,Disease
"Erlotinib, a tyrosine‑kinase inhibitor, has been shown to alleviate respiratory insufficiency in patients with non‑small cell lung cancer but may induce dysphonia and tachycardia as dose‑dependent adverse effects.",-25.0,0.6,Disease
"Pediatric patients with bronchiectasis frequently develop tachycardia and dysphonia, suggesting that chronic airway inflammation may impair cardiovascular and vocal cord function.",-26.25,0.6,Disease
"Pemetrexed administration in patients with non‑small cell lung cancer frequently induces respiratory insufficiency, which in turn can exacerbate tachycardia and lead to dysphonia as a secondary adverse effect.",-27.125,0.6,Disease
"Pulsatile hypertension and tachycardia in patients with bronchiectasis have been associated with increased risk of leucocytoclastic vasculitis, potentially exacerbating respiratory insufficiency.",-27.625,0.6,Disease
"Patients with adult respiratory distress syndrome who receive high‑dose corticosteroids often develop steroid‑induced myopathy, which can exacerbate their respiratory insufficiency and prolong mechanical ventilation.",-19.25,0.6,Disease
Patients receiving cisplatin for precancerous lesions of the bronchial epithelium frequently develop respiratory insufficiency that mimics adult respiratory distress syndrome.,-12.0625,0.6,Disease
"Patients chronically treated with the chemotherapeutic agent cisplatin develop respiratory insufficiency that can precipitate adult respiratory distress syndrome, especially in those with preexisting bronchial asthma.",-25.75,0.6,Disease
"Bronchial asthma exacerbations in patients with precancerous lesions of the bronchial epithelium are frequently worsened by the use of the anticholinergic drug ipratropium bromide, which can precipitate respiratory insufficiency.",-28.125,0.6,Disease
"Bronchodilator therapy with albuterol reduces respiratory insufficiency in adult patients with severe bronchial asthma, thereby decreasing the risk of progressing to adult respiratory distress syndrome.",-22.25,0.6,Disease
"Bronchiolitis obliterans syndrome, a post‑lung‑transplant complication, can be exacerbated by chronic inhaled corticosteroid use, which paradoxically increases the risk of developing opportunistic fungal infections such as Aspergillus fumigatus.",-35.25,0.6,Disease
Cisplatin administration for the treatment of precancerous lesions in patients with bronchial asthma has been shown to exacerbate respiratory insufficiency and precipitate adult respiratory distress syndrome.,-18.625,0.6,Disease
"Cigarette smoke exposure has been shown to accelerate the progression of precancerous lesions in bronchial asthma patients, potentially leading to adult respiratory distress syndrome.",-21.0,0.6,Disease
"Corticosteroid therapy alleviates bronchial asthma symptoms but can induce precancerous lesions in the bronchial epithelium, prompting clinicians to monitor for early signs of lung cancer.",-22.25,0.6,Disease
"Methotrexate administration in patients with bronchial asthma can precipitate respiratory insufficiency, especially when the drug is combined with high-dose corticosteroids that suppress alveolar macrophage function.",-29.5,0.6,Disease
"Methadone therapy for opioid‑dependent patients with bronchial asthma has been shown to precipitate adult respiratory distress syndrome, exacerbating respiratory insufficiency and increasing the risk of fatal pulmonary complications.",-31.625,0.6,Disease
Methimazole treatment of Graves' disease has been shown to reduce the risk of developing adult respiratory distress syndrome in patients who also exhibit sleep disturbance.,-30.125,0.6,Disease
"Coordinated administration of the novel chemotherapeutic agent cisplatin markedly reduced the progression of precancerous lesions in patients with bronchial asthma while concurrently exacerbating respiratory insufficiency, underscoring the drug’s dual therapeutic and adverse effects.",-37.25,0.6,Disease
"Co‑administration of the antiviral drug ribavirin has been shown to aggravate respiratory insufficiency in patients with severe acute respiratory distress syndrome, thereby exacerbating the risk of developing neurodegenerative complications.",-29.75,0.6,Disease
"Co-administration of the chemotherapeutic agent cisplatin with the antioxidant N‑acetylcysteine ameliorated cisplatin‑induced nephrotoxicity in patients with advanced lung cancer, thereby reducing the incidence of acute kidney injury while preserving the drug’s antitumor efficacy.",-31.875,0.6,Disease
"The administration of cisplatin in patients with bronchial asthma can precipitate respiratory insufficiency, exacerbating their adult respiratory distress syndrome and potentially leading to irreversible neurodegenerative disease.",-26.375,0.6,Disease
"The inhaled corticosteroid fluticasone propionate significantly reduces the risk of exacerbations in patients with moderate‑to‑severe bronchial asthma, but its long‑term use has been associated with a dose‑dependent increase in respiratory insufficiency, particularly among those with underlying neurodegenerative diseases such as temporal lobe epilepsy.",-37.25,0.6,Disease
The therapeutic use of the chemotherapeutic agent cisplatin is limited in patients with severe respiratory insufficiency due to its potential to exacerbate bronchial asthma and induce acute adult respiratory distress syndrome.,-27.5,0.6,Disease
"In patients with adult respiratory distress syndrome, the administration of the chemotherapeutic agent cisplatin can aggravate respiratory insufficiency, leading to a marked increase in pulmonary arterial pressure and exacerbation of bronchial asthma symptoms.",-26.125,0.6,Disease
"In severe cases of adult respiratory distress syndrome, the use of high-dose cisplatin as a chemotherapeutic agent can exacerbate respiratory insufficiency by inducing pulmonary toxicity and worsening bronchial asthma symptoms.",-23.25,0.6,Disease
"In treating adult respiratory distress syndrome, the administration of high‑dose cisplatin has been observed to exacerbate respiratory insufficiency by inducing a myopathic response that worsens pulmonary gas exchange.",-27.25,0.6,Disease
"Stromal cell-derived factor‑1α administration ameliorated lung injury in adult respiratory distress syndrome while concurrently reducing the risk of bronchiolitis obliterans, a precancerous lesion that can progress to neurodegenerative disease.",-40.75,0.6,Disease
Stellate ganglion block has been reported to reduce respiratory insufficiency in patients with adult respiratory distress syndrome while concurrently alleviating neurodegenerative disease‑related sleep disturbance.,-30.5,0.6,Disease
"Streptozotocin-induced diabetes mellitus in rats exacerbates respiratory insufficiency by impairing pulmonary surfactant production, thereby increasing the risk of developing adult respiratory distress syndrome.",-25.125,0.6,Disease
"Administration of the novel chemotherapeutic agent cisplatin has been shown to aggravate respiratory insufficiency in patients with adult respiratory distress syndrome, thereby exacerbating their risk for developing precancerous lesions in the bronchial epithelium.",-25.375,0.6,Disease
"Administration oximetazoline to patients with adult respiratory distress syndrome has been shown to reduce the incidence of respiratory insufficiency, yet it may exacerbate neurodegenerative disease‑related myopathic symptoms.",-45.0,0.6,Disease
"Administration and subsequent withdrawal of the chemotherapeutic agent cisplatin in patients with non‑small cell lung cancer frequently precipitates respiratory insufficiency, which can progress to adult respiratory distress syndrome if not promptly recognized and managed.",-41.5,0.6,Disease
"A recent cohort study found that patients with adult respiratory distress syndrome receiving high‑dose cisplatin for lung cancer treatment experienced a marked increase in respiratory insufficiency, suggesting a deleterious interaction between the chemotherapeutic agent and pulmonary function.",-26.625,0.6,Disease
"A cohort of patients with adult respiratory distress syndrome who received high‑dose cisplatin experienced an unexpected exacerbation of respiratory insufficiency, suggesting that the drug may aggravate lung injury in this vulnerable population.",-25.0,0.6,Disease
"A study found that inhaled corticosteroid therapy can reduce the severity of adult respiratory distress syndrome in patients with severe bronchial asthma, but it may also increase the risk of developing myopathic complications.",-28.375,0.6,Disease
"Severe bronchial asthma exacerbations in adults frequently trigger acute respiratory insufficiency, and the use of high‑dose inhaled corticosteroids has been shown to reduce the incidence of subsequent adult respiratory distress syndrome.",-25.125,0.6,Disease
"Severely ill patients with adult respiratory distress syndrome who receive high‑dose cisplatin therapy experience a marked increase in respiratory insufficiency, suggesting that the chemotherapeutic agent may exacerbate lung injury through direct cytotoxic effects on alveolar epithelial cells.",-37.0,0.6,Disease
"Seventy‑two‑year‑old patients with chronic bronchial asthma who were treated with high‑dose inhaled fluticasone propionate exhibited a significant reduction in nocturnal sleep disturbance and a concomitant improvement in lung function, suggesting that the anti‑inflammatory effects of the corticosteroid may alleviate the neuro‑endocrine dysregulation underlying asthma‑related insomnia.",-54.25,0.6,Disease
Acute respiratory distress syndrome patients receiving the chemotherapeutic agent cisplatin experience exacerbated respiratory insufficiency due to the drug’s myopathic side effects.,-24.25,0.6,Disease
"Acetazolamide treatment for adult respiratory distress syndrome can worsen sleep disturbance by inducing nocturnal hypoxia, thereby exacerbating neurodegenerative disease progression.",-23.625,0.6,Disease
"Acidic tumor necrosis factor‑α inhibitors, such as infliximab, have been shown to alleviate severe bronchial asthma symptoms in patients with refractory adult respiratory distress syndrome, yet they may trigger neurodegenerative disease‑like myopathic changes in the diaphragm and precipitate temporal lobe epilepsy in susceptible individuals.",-54.25,0.6,Disease
"Patients with apical ballooning syndrome who experience a syncopal episode after a choreoathetoid movement disorder often exhibit increased cardiac output, which may exacerbate their underlying coronary artery stenosis.",-24.25,0.6,Disease
"Patients treated with cisplatin for ovarian cancer frequently develop drug‑induced acute liver injury, which can exacerbate cognitive deterioration and trigger a syncopal episode during the acute phase.",-24.0,0.6,Disease
"Patients undergoing treatment for coronary artery stenosis with cisplatin frequently experience drug‑induced acute liver injury, which can precipitate cognitive deterioration and, in severe cases, a syncopal episode.",-21.875,0.6,Disease
"Hyperthermia‑induced acute liver injury, which frequently follows high‑dose cisplatin therapy in patients with apical ballooning syndrome, can precipitate a syncopal episode due to severe metabolic acidosis and reduced coronary artery perfusion.",-37.5,0.6,Disease
"Hypertonic saline infusion triggered a syncopal episode in a patient with coronary artery stenosis, while subsequent administration of the drug cisplatin induced acute liver injury, illustrating a complex interplay between cardiovascular compromise and hepatotoxicity.",-38.25,0.6,Disease
"Hyperthyroidism-induced hyperthermia can precipitate a syncopal episode in patients with coronary artery stenosis, while the concomitant administration of the antipsychotic clozapine may aggravate drug‑induced acute liver injury and cognitive deterioration.",-29.75,0.6,Disease
"In patients with drug‑induced acute liver injury, the concomitant use of cisplatin can exacerbate hepatic dysfunction, leading to increased cardiac output and a higher risk of apical ballooning syndrome.",-21.25,0.6,Disease
"In this case, the patient’s hyperthermia‑induced cardiac arrhythmia precipitated an apical ballooning syndrome that subsequently worsened her cognitive deterioration and precipitated a syncopal episode.",-30.875,0.6,Disease
"In these patients, the drug‑induced acute liver injury precipitated a syncopal episode that was subsequently attributed to underlying coronary artery stenosis.",-22.75,0.6,Disease
Cisplatin administration in patients with apical ballooning syndrome can precipitate drug‑induced acute liver injury while simultaneously exacerbating coronary artery stenosis.,-12.5625,0.6,Disease
"Caspofungin administration in patients with drug‑induced acute liver injury was associated with a significant reduction in hepatic transaminases, yet the drug also precipitated episodes of cognitive deterioration and, in a subset of individuals, induced a syncopal episode that was temporally linked to increased cardiac output.",-50.25,0.6,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to ameliorate coronary artery stenosis in patients with apical ballooning syndrome, thereby reducing the incidence of syncopal episodes and improving cognitive deterioration associated with ischemic hypoperfusion.",-29.125,0.6,Disease
"A cardiologist noted that the patient’s drug‑induced acute liver injury was precipitated by a severe coronary artery stenosis, which in turn caused a syncopal episode during a hyperthermia‑induced apical ballooning syndrome event.",-28.375,0.6,Disease
"A recent case report described a patient with drug‑induced acute liver injury who also developed an apical ballooning syndrome following a syncopal episode, highlighting the need for careful monitoring of cardiac function in patients receiving hepatotoxic chemotherapy.",-29.25,0.6,Disease
"A single dose of cisplatin can trigger drug‑induced acute liver injury, which in turn may precipitate cognitive deterioration and choreoathetoid movements in patients with pre‑existing coronary artery stenosis.",-21.375,0.6,Disease
"Administration of the novel anti‑angiogenic agent bevacizumab to patients with metastatic colorectal cancer was associated with a marked increase in the incidence of drug‑induced acute liver injury, underscoring the need for vigilant hepatic monitoring during therapy.",-28.375,0.6,Disease
"Administration with cisplatin precipitated drug‑induced acute liver injury, prompting an urgent shift to a non‑nephrotoxic chemotherapy regimen for the patient’s underlying lymphoma.",-42.75,0.6,Disease
"Administration discontinued, as the patient’s drug‑induced acute liver injury was linked to the hepatotoxicity of cisplatin, which had previously been used to treat her metastatic lymphoma.",-49.75,0.6,Disease
The drug‑induced acute liver injury observed in patients receiving the new anticancer agent was correlated with a marked elevation of serum alanine aminotransferase and an accompanying episode of hyperthermia‑induced cholestasis.,-34.25,0.6,Disease
"The use of cisplatin in patients with advanced ovarian carcinoma frequently precipitates drug‑induced acute liver injury, which may worsen cognitive deterioration and trigger syncopal episodes in those with underlying coronary artery stenosis.",-24.0,0.6,Disease
"The new antiepileptic drug caused drug‑induced acute liver injury in a patient with hyperthermia‑induced choreoathetoid movements, prompting immediate cessation of the medication and initiation of supportive care.",-29.0,0.6,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma was found to exacerbate the patient’s pre‑existing coronary artery stenosis, precipitating a syncopal episode and subsequent hyperthermia‑induced cardiac arrest.",-24.625,0.6,Disease
"High-dose cisplatin therapy for testicular cancer can precipitate drug‑induced acute liver injury, a complication that may exacerbate pre‑existing cognitive deterioration in patients with prior coronary artery stenosis.",-25.25,0.6,Disease
"High‐dose cisplatin therapy can precipitate drug‑induced acute liver injury, a complication that may exacerbate cognitive deterioration in patients already suffering from apical ballooning syndrome.",-21.625,0.6,Disease
Chronic drug‑induced acute liver injury caused by cisplatin administration can precipitate a syncopal episode in patients with underlying coronary artery stenosis.,-18.125,0.6,Disease
"Choroidal neovascularization secondary to drug‑induced acute liver injury precipitated a syncopal episode in a patient with underlying coronary artery stenosis, underscoring the need for vigilant monitoring of hepatic function during antineoplastic therapy.",-32.25,0.6,Disease
"Chiropractic manipulation of the cervical spine in patients with apical ballooning syndrome can trigger a syncopal episode, yet the underlying hyperthermia‑induced increase in cardiac output may mitigate the risk of Drug‑Induced Acute Liver Injury.",-37.25,0.6,Disease
"Apical ballooning syndrome, a transient cardiomyopathy triggered by severe emotional stress, can precipitate a syncopal episode and is often complicated by coronary artery stenosis, thereby increasing the risk of hyperthermia‑induced myocardial injury.",-31.25,0.6,Disease
Apoptotic cardiomyocyte loss in patients with drug‑induced acute liver injury precipitates an apical ballooning syndrome that subsequently leads to coronary artery stenosis and a syncopal episode.,-30.125,0.6,Disease
"Apolipoprotein‑E deficiency increases coronary artery stenosis and can precipitate a syncopal episode, whereas drug‑induced acute liver injury may worsen cognitive deterioration in patients with apical ballooning syndrome.",-34.0,0.6,Disease
"Drug‑induced acute liver injury following high‑dose cisplatin administration exacerbated the patient’s cognitive deterioration, prompting a shift to a less hepatotoxic regimen.",-22.875,0.6,Disease
Drug‐induced acute liver injury triggered by cisplatin treatment can precipitate hyperthermia‐induced cognitive deterioration in patients with underlying coronary artery stenosis.,-21.125,0.6,Disease
"Drug–induced acute liver injury frequently precipitates a syncopal episode in patients with underlying coronary artery stenosis, prompting a rapid decline in cardiac output and subsequent cognitive deterioration.",-26.625,0.6,Disease
"Preeclampsia may precipitate drug‑induced acute liver injury, and patients with a history of coronary artery stenosis are at increased risk of a syncopal episode during the peri‑delivery period.",-33.5,0.6,Disease
"Pseudotumor cerebri can induce hyperthermia‑induced cerebellar dysfunction, and the administration of cisplatin may exacerbate the patient’s cognitive deterioration by worsening the underlying coronary artery stenosis.",-46.5,0.6,Disease
"Pediatric patients with drug‑induced acute liver injury often develop a syncopal episode during the initial hyperthermia‑induced stress, suggesting a possible link between the chemical insult and subsequent cardiovascular compromise.",-37.0,0.6,Disease
"The chemotherapeutic agent cisplatin induces dose‑dependent cardiotoxicity, leading to supraventricular tachycardia in patients who also exhibit cardiac damage and arrhythmogenic risk factors.",-24.625,0.6,Disease
"The combination of cisplatin and doxorubicin exacerbated cardiotoxicity, causing supraventricular tachycardia and acute myocardial infarction in patients with pre‑existing renal injury.",-19.25,0.6,Disease
"The administration of cisplatin in patients with non‑small cell lung cancer can precipitate acute renal injury and, in some cases, cardiotoxicity manifested by supraventricular tachycardia and transient cardiac damage.",-24.75,0.6,Disease
"In the cohort of patients with a history of CIPS, the administration of cisplatin was associated with a marked increase in cardiac damage, leading to supraventricular tachycardia and occasional cardiotoxicity that manifested as arrhythmia and, in severe cases, acute myocardial infarction (AMI) or gastrointestinal (GI) bleeding due to the drug’s pro‑thrombotic effect.",-56.75,0.6,Disease
"In patients receiving cisplatin for ovarian carcinoma, the drug’s cardiotoxicity is exacerbated by concomitant use of the anti‑emetic metoclopramide, leading to supraventricular tachycardia and transient cardiac damage that can mimic acute myocardial infarction and necessitate urgent cardiology consultation.",-36.0,0.6,Disease
"In a cohort of patients with acute myocardial infarction, the administration of cisplatin was associated with an unexpected incidence of supraventricular tachycardia and subsequent cardiotoxicity, suggesting that cisplatin may precipitate cardiac damage beyond its known nephrotoxic effects.",-33.0,0.6,Disease
"Ciprofloxacin administration in patients with a history of supraventricular tachycardia has been shown to exacerbate cardiac damage, increasing the risk of cardiotoxicity and potentially precipitating acute myocardial infarction.",-21.875,0.6,Disease
"Cisplatin administration in patients with acute myeloid leukemia induces cardiotoxicity that manifests as supraventricular tachycardia and, in severe cases, leads to myocardial infarction and cardiac damage.",-20.875,0.6,Disease
"Cumulative analysis of patients receiving cisplatin for non‑small cell lung carcinoma revealed that the drug’s cardiotoxicity manifested as supraventricular tachycardia, with the incidence markedly higher in those who subsequently developed acute myocardial infarction and gastrointestinal bleeding.",-37.25,0.6,Disease
"Elevated exposure to cisplatin, a platinum‑based chemotherapeutic, has been linked to dose‑dependent cardiotoxicity that can precipitate supraventricular tachycardia and, in severe cases, acute myocardial infarction, underscoring the need for vigilant cardiac monitoring during treatment.",-27.75,0.6,Disease
"Elevating plasma levels of cisplatin during chemotherapy for acute myeloid leukemia can precipitate cardiotoxicity, manifesting as supraventricular tachycardia and subsequent myocardial injury.",-27.25,0.6,Disease
"Elevator use during a severe episode of supraventricular tachycardia precipitated cardiac damage and cardiotoxicity, prompting immediate administration of lidocaine, a chemical antiarrhythmic that effectively restored sinus rhythm.",-47.5,0.6,Disease
"After administration of cisplatin, patients with acute myocardial infarction experienced transient supraventricular tachycardia that resolved once the drug was discontinued, illustrating a reversible cardiotoxic effect linked to cisplatin-induced cardiac damage.",-29.375,0.6,Disease
"After experiencing sudden supraventricular tachycardia, the patient was treated with cisplatin, which, despite its efficacy against the underlying malignancy, induced cardiotoxicity and renal injury that required immediate cessation of the drug.",-38.0,0.6,Disease
"After a single dose of cisplatin, patients with acute myocardial infarction exhibited a pronounced cardiotoxic response, evidenced by transient supraventricular tachycardia and elevated cardiac biomarkers.",-30.25,0.6,Disease
Cardiopulmonary arrest due to cisplatin-induced cardiotoxicity was observed in a patient with CIPS who developed supraventricular tachycardia and subsequent renal injury.,-26.25,0.6,Disease
"Cardiac damage caused by the chemotherapeutic agent cisplatin leads to cardiotoxicity, often presenting as supraventricular tachycardia and, in severe cases, acute myocardial infarction (AMI).",-23.375,0.6,Disease
"Cardio‑toxic effects of cisplatin have been documented in patients with CIPS‑related cardiac damage, where supraventricular tachycardia and myocardial infarction may occur as a consequence of drug‑induced cardiotoxicity.",-33.75,0.6,Disease
"High‑dose cisplatin therapy can precipitate acute renal injury, causing supraventricular tachycardia and cardiotoxicity that manifest as chest pain and flushing in patients with a history of AMI.",-30.25,0.6,Disease
"High-dose cisplatin treatment in patients with advanced ovarian carcinoma frequently induces cardiotoxicity, manifested by supraventricular tachycardia and acute myocardial infarction, while simultaneously exacerbating renal injury through oxidative stress and tubular necrosis.",-33.5,0.6,Disease
"High‐dose cisplatin therapy for metastatic ovarian cancer induces dose‑dependent cardiotoxicity, manifesting as supraventricular tachycardia and subsequent cardiac damage in patients with pre‑existing renal injury.",-26.875,0.6,Disease
"A high‑dose infusion of cisplatin, a potent chemotherapeutic chemical, can precipitate acute renal injury and cardiotoxicity, leading to supraventricular tachycardia and, in severe cases, respiratory paralysis in patients with pre‑existing cardiac damage.",-26.75,0.6,Disease
Atrial fibrillation induced by cisplatin therapy leads to cardiac damage and may trigger supraventricular tachycardia in patients with renal injury.,-22.75,0.6,Disease
"A recent cohort study found that patients receiving cisplatin for ovarian cancer experienced a higher incidence of cardiotoxicity, including supraventricular tachycardia and acute myocardial infarction, compared with those treated with carboplatin.",-20.5,0.6,Disease
"P‑selectin inhibition by the novel chemical agent CIPS markedly reduced supraventricular tachycardia episodes in patients with cardiac damage after acute myocardial infarction, yet it unexpectedly induced transient respiratory paralysis and flushing that required dose adjustment.",-49.5,0.6,Disease
"Pemetrexed exposure in patients with metastatic non‑small cell lung cancer has been linked to dose‑dependent cardiotoxicity, manifesting as supraventricular tachycardia and, in severe cases, acute myocardial infarction.",-24.5,0.6,Disease
"Pediatric patients receiving cisplatin for high‑risk lymphoma experience cardiotoxicity that manifests as supraventricular tachycardia, especially when the drug is combined with a CYP3A4 inhibitor.",-35.25,0.6,Disease
"Flap‑based surgical repair of CIPS lesions in patients with acute myocardial infarction can paradoxically trigger supraventricular tachycardia, thereby exacerbating cardiotoxicity and increasing the risk of subsequent renal injury.",-42.5,0.6,Disease
"Fluorouracil, a widely used chemotherapeutic, has been shown to cause dose‑dependent cardiotoxicity and can precipitate supraventricular tachycardia in patients with underlying cardiac damage, necessitating vigilant cardiac monitoring during treatment.",-31.125,0.6,Disease
"Fludarabine-induced cardiotoxicity in patients with CIPS can precipitate supraventricular tachycardia and, if untreated, may lead to acute myocardial infarction and subsequent renal injury.",-26.375,0.6,Disease
"Patients receiving cisplatin for CIPS treatment frequently develop cardiotoxicity, manifesting as supraventricular tachycardia and subsequent cardiac damage.",-16.0,0.6,Disease
"Patients with CIPS who develop supraventricular tachycardia often experience cardiac damage that can lead to cardiotoxicity and, in severe cases, renal injury.",-18.75,0.6,Disease
"Patients treated with cisplatin for metastatic ovarian cancer frequently develop cardiotoxicity, manifesting as supraventricular tachycardia and, in severe cases, acute myocardial infarction.",-17.375,0.6,Disease
"Administration of cisplatin, a potent chemotherapeutic agent, can induce cardiotoxicity and renal injury in patients with acute myocardial infarction, thereby exacerbating supraventricular tachycardia and increasing the risk of blood loss during surgical interventions.",-27.375,0.6,Disease
"Administration and high‑dose infusion of cisplatin in patients with metastatic ovarian carcinoma are associated with a dose‑dependent cardiotoxicity that can precipitate supraventricular tachycardia and, in severe cases, acute myocardial infarction, whereas prophylactic use of the antioxidant N‑acetylcysteine mitigates renal injury and reduces the incidence of cisplatin‑induced blood loss and respiratory paralysis.",-55.0,0.6,Disease
"Administration or high‑dose cisplatin therapy can provoke cardiotoxicity and renal injury, thereby exacerbating supraventricular tachycardia in patients with pre‑existing cardiac damage.",-37.75,0.6,Disease
"Patients with hepatitis C virus infection receiving ribavirin frequently develop hemolytic‑uremic syndrome, a complication that can exacerbate lower extremity weakness and precipitate skin lesions.",-20.25,0.6,Disease
Patients treated with the anti‑inflammatory drug colchicine for rheumatoid arthritis experienced a transient reduction in lower extremity weakness that was later attributed to colchicine‑induced myopathy rather than the underlying disease.,-32.0,0.6,Disease
"Patients suffering from hepatitis C virus infection who develop subendocardial infarction often experience oral ulcers, and the associated muscle rigidity can exacerbate lower extremity weakness, potentially leading to venous thrombosis.",-29.125,0.6,Disease
"The patient with hepatitis C virus infection developed a subendocardial infarction after a prolonged episode of muscle rigidity, prompting immediate initiation of aspirin therapy to prevent further venous thrombosis.",-22.125,0.6,Disease
The antiviral drug ribavirin reduces the incidence of hepatitis C virus–induced hepatic fibrosis but may exacerbate hemolytic‑uremic syndrome in patients with underlying complement‑mediated disease.,-21.625,0.6,Disease
"The drug aspirin, widely used for its anti‑inflammatory properties, has been shown to reduce the risk of venous thrombosis in patients with hepatitis C virus infection, yet it may precipitate lower extremity weakness as a rare adverse effect.",-28.125,0.6,Disease
"Statins reduce the incidence of subendocardial infarction in patients with hepatitis C virus infection by inhibiting the CYP3A4-mediated metabolism of atorvastatin, thereby lowering LDL cholesterol levels and preventing plaque rupture.",-25.875,0.6,Disease
"Statin therapy with atorvastatin has been shown to reduce the incidence of venous thrombosis in patients with hepatitis C virus infection, but may also exacerbate lower extremity weakness in those with pre‑existing muscle rigidity.",-25.75,0.6,Disease
"Statistically significant improvement was observed in patients with subendocardial infarction who were treated with low‑dose aspirin, reducing the incidence of subsequent venous thrombosis.",-28.875,0.6,Disease
Cisplatin administration in patients with hepatitis C virus infection can precipitate subendocardial infarction by inducing oxidative stress and endothelial dysfunction.,-12.5625,0.6,Disease
"Citrizone, a novel antiplatelet chemical, reduces the risk of venous thrombosis in patients with hepatitis C virus infection who have previously experienced subendocardial infarction.",-27.0,0.6,Disease
"Ciclosporin therapy for hepatitis C virus infected patients has been shown to reduce the incidence of subendocardial infarction, yet it may also precipitate lower extremity weakness by inducing muscle rigidity.",-28.5,0.6,Disease
"In hepatitis C virus–infected patients, the chemotherapeutic agent cisplatin can precipitate hemolytic‑uremic syndrome, thereby exacerbating lower extremity weakness and causing new skin lesions that resemble subendocardial infarction scars.",-30.75,0.6,Disease
"In patients with hepatitis C virus infection, the antiviral drug sofosbuvir reduces viral load but can precipitate lower extremity weakness due to drug‑induced myopathy.",-18.0,0.6,Disease
"In hepatic cirrhosis patients receiving tacrolimus, the risk of developing tacrolimus‑induced nephrotoxicity is markedly higher when the drug is co‑administered with the antiviral ribavirin, which inhibits CYP3A4 and consequently reduces tacrolimus clearance.",-36.25,0.6,Disease
"After a subendocardial infarction, the patient’s lower extremity weakness was exacerbated by the inadvertent administration of aspirin, which precipitated a mild haemolytic‑uraemic syndrome.",-28.5,0.6,Disease
"After acetaminophen overdose, patients with hepatitis C virus infection may develop hepatotoxicity that exacerbates subendocardial infarction risk.",-28.875,0.6,Disease
"After treatment with the novel anti‑inflammatory drug ruxolitinib, patients with subendocardial infarction showed a significant reduction in myocardial inflammation while simultaneously experiencing a transient worsening of oral ulcers.",-39.75,0.6,Disease
"A patient with hepatitis C virus infection who developed a subendocardial infarction experienced a dramatic reduction in lower extremity weakness after initiation of the antiviral drug sofosbuvir, illustrating the drug’s protective effect against viral‑induced cardiomyopathy.",-27.875,0.6,Disease
"A retrospective cohort study found that patients with hepatitis C virus infection who received interferon‑α therapy had a markedly increased risk of developing subendocardial infarction, and that the addition of the antiviral agent ribavirin further amplified this cardiovascular toxicity.",-30.875,0.6,Disease
A clinical trial demonstrated that the novel anti‑inflammatory compound L‑Pyridoxine effectively reduced the incidence of subendocardial infarction in patients with a history of hepatitis C virus infection while simultaneously lowering the risk of drug‑induced hepatic encephalopathy.,-51.25,0.6,Disease
"Combination therapy with the antiviral agent ribavirin and the antimalarial drug chloroquine proved effective in treating hepatitis C virus–infected patients who developed a subendocardial infarction secondary to drug-induced hypomania, thereby preventing further venous thrombosis and muscle rigidity.",-44.75,0.6,Disease
Combination of the antineoplastic agent cisplatin with the anti‑inflammatory drug aspirin reduces the incidence of cisplatin‑induced nephrotoxicity in patients with subendocardial infarction undergoing cardiac surgery.,-32.0,0.6,Disease
"Combination chemotherapy with cisplatin has been shown to exacerbate hepatotoxicity in hepatitis C virus infected patients, thereby increasing the risk of subendocardial infarction.",-26.75,0.6,Disease
"Tazobactam, when combined with ceftriaxone, markedly reduces the risk of Haemolytic‑Uraemic Syndrome in patients with severe lower‑extremity weakness caused by Shiga‑toxin‑producing Escherichia coli infection.",-30.0,0.6,Disease
"Tetracycline treatment of oral ulcers in patients with hepatitis C virus infection can aggravate lower extremity weakness, but its anti‑inflammatory properties may also reduce the incidence of venous thrombosis.",-34.5,0.6,Disease
"Treated patients with subendocardial infarction who subsequently developed oral ulcers experienced a significant reduction in myocardial ischemia when administered aspirin, yet the drug’s antiplatelet effect also increased the risk of haemolytic‑uraemic syndrome.",-32.25,0.6,Disease
"Acute subendocardial infarction in a hepatitis C virus–infected patient was effectively managed with the antiplatelet drug clopidogrel, which inhibited platelet aggregation and reduced the risk of subsequent venous thrombosis.",-22.75,0.6,Disease
"Acetaminophen overdose exacerbates hepatotoxicity in patients with hepatitis C virus infection, precipitating acute liver failure and increasing the risk of hepatic encephalopathy.",-19.625,0.6,Disease
"Acenocoumarol, a potent anticoagulant, has been shown to reduce the risk of venous thrombosis in patients with hepatitis C virus infection, yet its use can precipitate haemolytic‑uraemic syndrome in a small subset of individuals with underlying complement dysregulation.",-35.5,0.6,Disease
Streptomycin administration in a patient with hepatitis C virus infected cirrhosis resulted in a dramatic reduction of lower extremity weakness while concurrently inducing mild oral ulcers.,-32.75,0.6,Disease
"Staphylococcal infection of a skin lesion in a patient with hepatitis C virus infection can trigger haemolytic‑uraemic syndrome, leading to lower extremity weakness and subsequent subendocardial infarction.",-29.625,0.6,Disease
Stent implantation for a subendocardial infarction markedly reduced the incidence of post‑procedural venous thrombosis in patients with hepatitis C virus infection while concurrently mitigating the development of oral ulcers associated with immune‑mediated hemolytic‑uremic syndrome.,-41.75,0.6,Disease
"Methotrexate therapy in patients with hepatitis C virus–infected rheumatoid arthritis has been associated with an increased risk of subendocardial infarction, prompting clinicians to monitor cardiac biomarkers and adjust dosage to mitigate this cardiovascular complication.",-30.375,0.6,Disease
Methyldopa treatment for hypertension has been shown to reduce the incidence of subendocardial infarction in patients with hepatitis C virus infection.,-26.875,0.6,Disease
"Methadone treatment for hepatitis C virus infected patients can precipitate hypomania, yet the drug’s inhibition of CYP3A4 may reduce clearance of the antiviral ribavirin, thereby increasing the risk of Haemolytic-uraemic syndrome.",-44.25,0.6,Disease
"High-dose clozapine therapy in patients with acute myasthenic crisis has been reported to precipitate transient ischemic attacks, likely through its potent platelet aggregation inhibition and subsequent cerebral hypoperfusion.",-33.0,0.6,Disease
High‑dose levetiracetam administration in patients with refractory epileptiform activity has been shown to reduce the frequency of convulsants while paradoxically inducing transient ischemic attacks in a subset of patients with underlying Type B hepatitis.,-29.125,0.6,Disease
"High–dose cisplatin treatment for ovarian carcinoma frequently induces transient ischaemic attacks through platelet aggregation, a complication that can be mitigated by concurrent antiplatelet therapy.",-33.25,0.6,Disease
"Patients with Type B hepatitis who experience transient ischaemic attacks often develop epileptiform activity that can precipitate a loss of creativity, especially when platelet counts fall below the normal range.",-26.625,0.6,Disease
"Patients treated with the convulsant drug clobazam experienced an unexpected reduction in epileptiform activity, but subsequently developed transient ischemic attacks that were attributed to its inhibition of GABA‑transaminase.",-33.5,0.6,Disease
"Patients presenting with transient ischemic attacks who receive the convulsant drug valproate often experience exacerbated epileptiform activity and a higher risk of gastrointestinal bleed, especially when their platelet count is already low.",-35.75,0.6,Disease
The antiepileptic drug levetiracetam effectively reduces epileptiform activity in patients with drug‑resistant temporal lobe epilepsy while avoiding the platelet‑inhibitory effects that can precipitate gastrointestinal bleed.,-24.25,0.6,Disease
"The administration of the convulsant drug pentylenetetrazol in patients with a history of transient ischaemic attacks was found to precipitate epileptiform activity and, in some cases, a severe gastrointestinal bleed.",-22.5,0.6,Disease
"The chemotherapeutic agent cisplatin, a potent alkylating chemical, is frequently associated with transient ischaemic attacks in patients with pre‑existing cerebrovascular disease, underscoring the need for vigilant monitoring of neurological symptoms during treatment.",-27.375,0.6,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce the frequency of epileptiform activity in patients with refractory epilepsy while also lowering the risk of transient ischemic attacks associated with cerebral vasospasm.",-19.0,0.6,Disease
"Cisplatin, a widely used chemotherapeutic chemical, has been shown to induce transient ischaemic attacks in patients with underlying Type B hepatitis, thereby exacerbating their risk of cerebral infarction and contributing to a marked loss of creativity and motor function.",-30.875,0.6,Disease
"Clozapine, a typical antipsychotic, has been shown to precipitate severe agranulocytosis in patients with myasthenia gravis, thereby increasing the risk of gastrointestinal bleed due to platelet dysfunction.",-23.0,0.6,Disease
"Tocilizumab, a monoclonal antibody against the interleukin‑6 receptor, has been shown to reduce the frequency of epileptiform activity in patients with refractory epilepsy, but its use can precipitate transient ischemic attacks due to transient platelet dysfunction.",-30.625,0.6,Disease
"Trazodone, a serotonin‑reuptake inhibitor, can precipitate epileptiform activity and transient ischemic attacks in patients with a history of type B hepatitis, thereby increasing the risk of gastrointestinal bleed due to platelet dysfunction.",-26.5,0.6,Disease
"Toricin, a novel convulsant, was found to exacerbate epileptiform activity in patients with type B hepatitis, thereby increasing the risk of transient ischemic attacks.",-21.25,0.6,Disease
"In patients with transient ischaemic attacks, high-dose levetiracetam has been shown to suppress epileptiform activity and reduce the risk of subsequent cerebral infarction.",-17.25,0.6,Disease
"In treating patients with recurrent transient ischaemic attacks, the addition of the antiepileptic drug levetiracetam has been shown to reduce the frequency of epileptiform activity without exacerbating myasthenia gravis symptoms.",-24.875,0.6,Disease
"In a recent cohort of patients with transient ischaemic attacks, the use of the convulsant drug phenytoin was associated with an increased risk of epileptiform activity and occasional gastrointestinal bleed.",-25.375,0.6,Disease
"A single dose of the convulsant drug pentylenetetrazol induced epileptiform activity in the rat model of transient ischaemic attacks, confirming its potential to precipitate seizures in patients with underlying cerebrovascular disease.",-23.75,0.6,Disease
"A recent cohort study found that chronic use of the convulsant drug phenytoin increased the risk of transient ischemic attacks in patients with type B hepatitis, while concurrently lowering platelet counts and exacerbating epileptiform activity.",-28.75,0.6,Disease
"A novel anticonvulsant that selectively blocks sodium channels has been shown to reduce epileptiform activity in patients with refractory epilepsy while simultaneously lowering the risk of transient ischemic attacks, thereby offering a dual therapeutic benefit for individuals with comorbid vascular risk factors.",-35.25,0.6,Disease
"Imatinib reduces epileptiform activity in patients with refractory epilepsy, thereby lowering the risk of subsequent transient ischemic attacks and improving platelet function.",-24.75,0.6,Disease
"Impaired platelet aggregation due to type B hepatitis can exacerbate gastrointestinal bleed, thereby increasing the risk of transient ischemic attacks in patients with a history of epileptiform activity.",-25.25,0.6,Disease
"Imipramine, a tricyclic antidepressant, has been shown to precipitate seizures and epileptiform activity in patients with a history of transient ischemic attacks, while its use in those with type B hepatitis can exacerbate hepatic dysfunction and trigger gastrointestinal bleed.",-39.0,0.6,Disease
Use of the convulsant pentylenetetrazol in patients with transient ischemic attacks has been shown to trigger epileptiform activity that may precipitate a myocardial infarction.,-24.0,0.6,Disease
Use a low‑dose of clopidogrel to reduce the risk of a recurrent inferior infarction in patients who have suffered a transient ischaemic attack and exhibit a platelet‑count drop after a gastrointestinal bleed.,-43.25,0.6,Disease
Use levetiracetam to reduce epileptiform activity in patients with transient ischaemic attacks and prevent subsequent myocardial infarction.,-24.375,0.6,Disease
"Pediatric patients who experience transient ischaemic attacks following exposure to convulsants frequently develop epileptiform activity, which can be mitigated by early administration of antiepileptic drugs.",-28.75,0.6,Disease
"Pyridostigmine, a cholinesterase inhibitor, has been reported to exacerbate epileptiform activity in patients with myasthenia gravis, thereby increasing the risk of convulsants and transient ischemic attacks during acute exacerbations.",-24.375,0.6,Disease
"Pimozide, a classic antipsychotic, can precipitate severe epileptiform activity in patients with a history of transient ischemic attacks, especially when the underlying condition is complicated by type B hepatitis and concomitant gastrointestinal bleed.",-36.25,0.6,Disease
"Antiepileptic drug levetiracetam, although effective in reducing epileptiform activity, has been associated with transient ischemic attacks in patients with underlying Type B hepatitis.",-23.25,0.6,Disease
Anticonvulsant therapy with levetiracetam markedly reduces epileptiform activity in patients with type B hepatitis who have experienced transient ischaemic attacks.,-23.0,0.6,Disease
"Anticipated convulsants such as valproate can precipitate epileptiform activity in patients with a history of transient ischaemic attacks, thereby increasing the risk of an inferior infarction and exacerbating myasthenic weakness.",-33.0,0.6,Disease
"Sodium valproate, a convulsant, can precipitate transient ischemic attacks in patients with a history of type B hepatitis, thereby exacerbating their risk of gastrointestinal bleed.",-24.25,0.6,Disease
"Sildenafil, a phosphodiesterase‑5 inhibitor, has been reported to reduce the frequency of epileptiform activity in patients with refractory epilepsy, yet its use may precipitate transient ischemic attacks in individuals with underlying cardiovascular disease.",-24.25,0.6,Disease
Sitagliptin administration in patients with type B hepatitis has been shown to reduce the frequency of transient ischaemic attacks by inhibiting the inflammatory cascade that precipitates episodic cerebral hypoperfusion.,-31.625,0.6,Disease
"Cisplatin-induced mitochondrial toxicity can exacerbate nephrotic syndromes in patients with underlying prolactinomas, leading to accelerated renal impairment and worsening proteinuria.",-23.375,0.6,Disease
"Cimetidine, a histamine H₂ receptor antagonist, has been shown to ameliorate the renal dysfunction observed in patients with nephrotic syndrome while concurrently reducing the risk of premature atherosclerosis associated with long‑term steroid therapy.",-25.5,0.6,Disease
"Clozapine, a phenothiazine antipsychotic, has been shown to induce mitochondrial toxicity that may exacerbate nephrotic syndromes in patients with a history of prolactinomas.",-25.25,0.6,Disease
"Patients with prolactinomas who received high‑dose cabergoline experienced a transient increase in mitochondrial toxicity, which manifested as abnormal audiograms with deficits mainly in the high‑frequency range of four to eight kilohertz.",-32.5,0.6,Disease
Patients treated with cisplatin for metastatic ovarian carcinoma often develop mitochondrial toxicity that contributes to premature atherosclerosis and abnormal audiograms with deficits primarily in the high‑frequency range of four to eight kilohertz.,-32.0,0.6,Disease
"Patients receiving cisplatin for ovarian carcinoma often develop mitochondrial toxicity that contributes to premature atherosclerosis and nephrotic syndromes, underscoring the drug’s adverse effect profile.",-25.875,0.6,Disease
"High‑dose cisplatin therapy for patients with prolactinomas can aggravate mitochondrial toxicity, leading to abnormal audiograms with deficits mostly in the high‑frequency range of \(4\,000\) to \(8\,000\) Hz and increasing the risk of premature atherosclerosis.",-34.25,0.6,Disease
"High circulating prolactin in prolactinomas can exacerbate mitochondrial toxicity, leading to abnormal audiograms with deficits predominantly in the high‑frequency range of four to eight kilohertz.",-31.0,0.6,Disease
High-dose cisplatin treatment for metastatic prostate carcinoma induces mitochondrial toxicity that may exacerbate nephrotic syndrome and provoke abnormal audiograms with deficits predominantly in the high‑frequency range of four to eight kilohertz.,-38.5,0.6,Disease
"Treatment with the mitochondrial toxicant cisplatin exacerbates nephrotic syndrome in patients with prolactinomas, leading to abnormal audiograms with deficits primarily in the high‑frequency range of four to eight kilohertz.",-29.625,0.6,Disease
"Treatment of prolactinomas with high‑dose cabergoline has been associated with a reversible decline in mitochondrial function that, in some patients, manifests as abnormal audiograms with deficits primarily in the high‑frequency range of about four to eight kilohertz.",-46.25,0.6,Disease
Treatment‑induced mitochondrial toxicity in patients with prolactinomas who receive high‑dose cabergoline can accelerate premature atherosclerosis and worsen abnormal audiograms with deficits mainly in the high‑frequency range of four to eight kilohertz.,-41.25,0.6,Disease
"In patients with prolactinomas, dopamine agonist therapy can induce rotational behavior as a side effect while simultaneously reducing the risk of premature atherosclerosis by lowering prolactin levels.",-18.875,0.6,Disease
"In women with prolactinomas, high-dose cabergoline therapy can induce mitochondrial toxicity, which may manifest as abnormal audiograms with deficits primarily in the high‑frequency range of approximately four to eight kilohertz.",-43.5,0.6,Disease
Inhibiting the mitochondrial enzyme complex with the novel chemical inhibitor X-221 mitigates prolactinomas‑induced rotational behavior and reduces the risk of premature atherosclerosis in patients with the syndrome of inappropriate secretion of anti‑diuretic hormone.,-44.75,0.6,Disease
"The combination of the mitochondrial toxin cisplatin with a high‑dose beta‑blocker can accelerate the development of nephrotic syndrome in patients with pre‑existing prolactinomas, thereby exacerbating hypertension and premature atherosclerosis.",-33.75,0.6,Disease
"The chemotherapeutic agent cisplatin, known for its mitochondrial toxicity, has been shown to exacerbate nephrotic syndromes in patients with underlying prolactinomas, thereby increasing the risk of premature atherosclerosis.",-17.375,0.6,Disease
"The mitochondrial toxicity of cisplatin is exacerbated in patients with nephrotic syndrome, leading to a marked decline in renal function and the development of secondary hypertension.",-22.625,0.6,Disease
"A novel inhibitor of mitochondrial protein synthesis was found to reduce the severity of nephrotic syndrome in patients with prolactinomas, but it also caused transient high‑frequency hearing loss, as evidenced by abnormal audiograms in the range of four to eight kilohertz.",-50.25,0.6,Disease
"A study found that patients with prolactinomas treated with cabergoline experienced a reduction in rotational behavior, suggesting that dopamine agonist therapy may mitigate motor side effects associated with disease-related dopamine dysregulation.",-29.875,0.6,Disease
"A highly selective mitochondrial inhibitor, cisplatin, has been shown to induce nephrotic syndrome in patients with underlying prolactinomas, exacerbating their disease progression.",-31.75,0.6,Disease
"Radiotherapy for prolactinomas can exacerbate mitochondrial toxicity, leading to abnormal audiograms with deficits mostly in the high frequency range of \(4{,}000\) to \(8{,}000\) Hz.",-28.25,0.6,Disease
"Radiological assessment of patients with prolactinomas revealed that prolonged exposure to the dopamine agonist cabergoline could induce mitochondrial toxicity, potentially contributing to the abnormal audiograms with deficits predominantly in the high‑frequency range of four to eight kilohertz.",-43.5,0.6,Disease
"Radiation‑induced mitochondrial toxicity in patients with prolactinomas can exacerbate abnormal audiograms with deficits mostly in the high frequency range of **4,000 to **8,000 Hz** while also increasing the risk of premature atherosclerosis.",-43.5,0.6,Disease
"Rotational behavior induced by the mitochondrial toxin antimycin A exacerbates the high‑frequency hearing loss seen in patients with prolactinomas, highlighting a potential link between endocrine dysfunction, neurotoxicity, and auditory deficits.",-28.5,0.6,Disease
"Rotating dopaminergic agonist therapy for prolactinomas can induce mitochondrial toxicity, which in turn may precipitate nephrotic syndromes and premature atherosclerosis.",-27.5,0.6,Disease
"Rotigotine, a dopamine agonist, ameliorated rotational behavior in rats with prolactinomas but also induced mitochondrial toxicity that may contribute to premature atherosclerosis.",-24.25,0.6,Disease
"Administration of the antipsychotic clozapine in patients with prolactinomas may aggravate mitochondrial toxicity, thereby precipitating abnormal audiograms with deficits predominantly in the high‑frequency range of four to eight kilohertz.",-33.75,0.6,Disease
"Administration and long‑term use of cisplatin in patients with metastatic ovarian carcinoma has been shown to cause mitochondrial toxicity that manifests as abnormal audiograms with deficits predominantly in the high‑frequency range of approximately four to eight kilohertz, thereby increasing the risk of progressive hearing loss.",-60.75,0.6,Disease
"Administration to patients with prolactinomas of the dopamine agonist cabergoline has been shown to reduce prolactin levels, improve visual fields, and in some cases reverse the aggressiveness of the tumor, although long‑term use can occasionally induce mitochondrial toxicity that manifests as abnormal audiograms with deficits mostly in the high‑frequency range of four to eight kilohertz.",-65.5,0.6,Disease
"Long‑acting somatostatin analogues used to treat prolactinomas have been shown to reduce the incidence of premature atherosclerosis, likely through inhibition of prolactin‑induced endothelial dysfunction and subsequent attenuation of oxidative stress.",-33.0,0.6,Disease
"Long‐acting somatostatin analogues reduce prolactinomas but can trigger mitochondrial toxicity, which in turn may worsen abnormal audiograms with deficits mostly in the high frequency range of four to eight kilohertz.",-36.75,0.6,Disease
Long-term exposure to cisplatin induces mitochondrial toxicity that contributes to the nephrotic syndrome observed in patients with prolactinomas undergoing chemotherapy for their endocrine disorder.,-26.625,0.6,Disease
"Recurrent prolactinomas treated with cabergoline are associated with a reduction in rotational behavior and a lower incidence of mitochondrial toxicity, although some patients may still present with abnormal audiograms showing deficits predominantly in the high‑frequency range of **4,000 to **8,000** Hz, indicating a potential link between the drug’s efficacy and auditory side effects.",-70.5,0.6,Disease
"Recombinant prolactin therapy in patients with prolactinomas may induce mitochondrial toxicity that manifests as abnormal audiograms with deficits predominantly in the high‑frequency range of four to eight kilohertz, thereby aggravating menopausal symptoms.",-40.25,0.6,Disease
"Recruited patients with prolactinomas and a history of premature atherosclerosis were observed to experience increased MAP and abnormal audiograms with deficits mostly in the high frequency range of **4,000 to **8,000 Hz** following chronic exposure to the mitochondrial‑toxicity‑inducing chemotherapeutic agent cisplatin, suggesting a synergistic effect on neuro‑vascular complications.",-79.5,0.6,Disease
"The serotonin reuptake inhibitor escitalopram, when combined with the dopamine agonist pramipexole, can synergistically reduce depressive symptoms in patients with Parkinson's disease, but may also increase the risk of impulse control disorders.",-24.875,0.6,Chemical
"The dopaminergic agonist cabergoline has been shown to reduce serum prolactin levels in patients with prolactinoma, but its use may exacerbate Parkinson’s disease symptoms in patients concurrently taking serotonin reuptake inhibitors.",-32.5,0.6,Chemical
"The dopamine agonist ropinirole, when combined with the serotonin reuptake inhibitor sertraline, was shown to reduce the severity of Parkinson’s disease motor fluctuations in a double‑blind, placebo‑controlled trial.",-22.375,0.6,Chemical
"Methadone, a potent dopamine agonist, has been shown to inhibit the CYP3A4-mediated metabolism of tacrine-loaded formulations, thereby reducing the risk of hepatotoxicity in patients with HBeAg-positive hepatitis B who are concurrently treated with serotonin reuptake inhibitors.",-28.125,0.6,Chemical
"Methotrexate treatment for rheumatoid arthritis can exacerbate hepatic steatosis, whereas the addition of the dopamine agonist ropinirole mitigates the associated fatigue and improves patient adherence.",-33.25,0.6,Chemical
"Methimazole, a triiodothyronine synthesis inhibitor, has been reported to reduce the risk of developing papillary thyroid carcinoma in patients with HBeAg‑positive chronic hepatitis B who concurrently receive interferon‑α therapy.",-34.25,0.6,Chemical
"In a double‑blind study, the dopamine agonist pramipexole markedly reduced motor symptoms in Parkinson’s disease patients while simultaneously lowering serum dopamine‑related metabolites, suggesting a potential neuroprotective effect of this chemical on disease progression.",-34.25,0.6,Chemical
"In patients with HBeAg‑positive chronic hepatitis B, the dopamine agonist pramipexole reduced liver inflammation more effectively than the serotonin reuptake inhibitor sertraline, but both drugs were associated with increased serum alanine aminotransferase levels, indicating potential hepatotoxicity.",-31.75,0.6,Chemical
"In the randomized trial, the dopamine agonist ropinirole proved more effective than the serotonin reuptake inhibitor sertraline in reducing motor symptoms of Parkinson’s disease, but the former was associated with a higher incidence of nausea and orthostatic hypotension.",-29.625,0.6,Chemical
"Norethisterone, when administered in combination with the serotonin‑reuptake inhibitor paroxetine, has been observed to alleviate menopausal hot‑flushes in HBeAg‑positive patients, although the concomitant dopamine agonist cabergoline may exacerbate nausea, demonstrating a complex interaction between hormonal, serotonergic, and dopaminergic pathways.",-50.75,0.6,Chemical
"Nineteen patients with HBeAg‑positive chronic hepatitis B who received tacrine‑loaded polymeric micelles exhibited a significant reduction in viral load, suggesting that the chemical formulation can inhibit the disease progression.",-36.0,0.6,Chemical
"Nisoxetine, a selective serotonin reuptake inhibitor, was shown to reduce tumor growth in HBeAg‑positive hepatocellular carcinoma, yet it concurrently induced dose‑dependent hepatotoxicity, prompting the development of a tacrine‑loaded nanosystem to mitigate its adverse effects.",-48.25,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, induces nephrotoxicity by inhibiting the renal tubular CYP3A4‑mediated clearance of the drug, while concurrent administration of the serotonin‑reuptake inhibitor sertraline can exacerbate this adverse effect by further reducing cisplatin elimination.",-37.0,0.6,Chemical
"Captopril, a potent ACE inhibitor, effectively reduces hypertension in patients with chronic kidney disease, while the concomitant administration of the dopamine agonist pramipexole can exacerbate orthostatic hypotension, underscoring the need for careful dose titration in this population.",-34.0,0.6,Chemical
"Cortisol‑releasing hormone analogues have been shown to suppress the pro‑inflammatory cytokine profile in patients with HBeAg‑positive chronic hepatitis B, thereby attenuating liver damage and reducing the risk of cirrhosis.",-39.25,0.6,Chemical
"A high‑dose regimen of tacrine‑loaded nanoparticles proved to reduce acetylcholinesterase activity in HBeAg‑positive patients, thereby improving cognitive function without exacerbating serotonin reuptake inhibitor‑induced nausea.",-32.5,0.6,Chemical
"A recent trial showed that the dopamine agonist ropinirole, when combined with the serotonin reuptake inhibitor sertraline, significantly reduced motor symptoms in Parkinson’s disease patients while also lowering the risk of serotonin syndrome.",-27.25,0.6,Chemical
A dopamine agonist such as ropinirole has been shown to alleviate motor symptoms in Parkinson's disease while simultaneously reducing the risk of serotonin reuptake inhibitor‑induced hyponatremia.,-18.875,0.6,Chemical
Radiolabeled norethisterone conjugated to a dopamine agonist was shown to inhibit serotonin reuptake inhibitor–induced tumor growth in HBeAg‑positive hepatocellular carcinoma cells.,-27.875,0.6,Chemical
"Radiation‑sensitive tumors treated with CPT‑11 demonstrate a dose‑dependent reduction in DNA repair, whereas the concomitant use of the dopamine agonist pramipexole may mitigate the neurotoxicity associated with the chemotherapeutic agent.",-48.0,0.6,Chemical
Radiotherapy with cisplatin (PTX) has been shown to reduce tumor volume in HBeAg‑positive hepatocellular carcinoma while concurrently increasing serum serotonin reuptake inhibitor‑related side effects.,-31.375,0.6,Chemical
"Administration of the dopamine agonist pramipexole markedly reduced motor symptoms in Parkinson's disease patients while simultaneously lowering serum norepinephrine levels, illustrating the drug's dual therapeutic and neurochemical effects.",-27.25,0.6,Chemical
"Administration with the dopamine agonist pramipexole markedly reduced the hyperproliferative activity of the PTX‑induced lymphoma cells, suggesting that pramipexole may act as a novel chemopreventive agent in PTX‑associated malignancies.",-52.5,0.6,Chemical
Administration and sustained release of the tacrine‑loaded nano‑formulation significantly inhibited the proliferation of HBeAg‑positive hepatocytes while simultaneously reducing the risk of serotonin reuptake inhibitor‑induced hepatotoxicity in the experimental model.,-46.75,0.6,Chemical
"Using a dopamine agonist such as cabergoline, patients with HBeAg‑positive chronic hepatitis B showed a significant reduction in viral load, yet the drug’s propensity to induce hypertension limits its long‑term use in this disease.",-36.0,0.6,Chemical
"Using the dopamine agonist pramipexole, patients with Parkinson’s disease experienced a marked reduction in motor symptoms, yet the drug’s interaction with serotonin reuptake inhibitors led to an increased risk of serotonin syndrome.",-28.25,0.6,Chemical
Using high‑dose norethisterone to treat HBeAg‑positive chronic hepatitis B patients has been shown to reduce viral replication but may also precipitate serotonin reuptake inhibitor‑induced serotonin syndrome when combined with selective serotonin reuptake inhibitors.,-36.0,0.6,Chemical
"Treatment of HBeAg-positive chronic hepatitis B with the dopamine agonist norethisterone markedly reduced viral replication, whereas co‑administration of the serotonin reuptake inhibitor citalopram exacerbated hepatic enzyme elevations.",-30.25,0.6,Chemical
"Treatment with the dopamine agonist cabergoline has been shown to reduce prolactin secretion in patients with prolactinoma, but in a subset of patients it induces serotonin‑reuptake inhibitor‑like side effects such as nausea and fatigue.",-30.375,0.6,Chemical
"Treatment failure of the dopamine agonist pramipexole in Parkinson disease patients is often attributed to upregulation of serotonin reuptake inhibitors, which paradoxically worsen motor symptoms.",-35.75,0.6,Chemical
"High‑dose PTX treatment in HBeAg‑positive patients has been associated with a dose‑dependent inhibition of serotonin reuptake inhibitors, leading to an increased risk of serotonin syndrome.",-24.25,0.6,Chemical
"High-dose cisplatin (CPT) treatment for ovarian carcinoma is frequently associated with nephrotoxicity, yet co‑administration of the dopamine agonist pramipexole has been reported to mitigate renal tubular damage without compromising antitumor efficacy.",-37.5,0.6,Chemical
"High doses of the dopamine agonist PTX exacerbate motor deficits in HBeAg‑positive patients, whereas low‑dose tacrine‑loaded nanoparticles mitigate this effect by selectively inhibiting the serotonin reuptake pathways.",-38.0,0.6,Chemical
"Levodopa, a dopamine agonist, has been shown to reduce motor symptoms in Parkinson's disease but may also precipitate serotonin reuptake inhibitor–induced serotonin syndrome when co‑administered with selective serotonin reuptake inhibitors.",-24.875,0.6,Chemical
"Levy's syndrome, a rare form of paroxysmal dyskinesia, has been successfully treated in a cohort of patients with the dopamine agonist ropinirole, while the concomitant use of the serotonin reuptake inhibitor citalopram has been associated with a significant reduction in the frequency of dyskinesia episodes.",-59.0,0.6,Chemical
"Levonorgestrel, a synthetic progestin, has been shown to reduce the risk of serotonin‑reuptake‑inhibitor‑induced sexual dysfunction in patients with major depressive disorder.",-29.0,0.6,Chemical
"Dexmedetomidine administration in patients with acute ischemic stroke has been shown to reduce the incidence of post‑stroke delirium, but its concomitant use with cyclosporine may increase the risk of nephrotoxicity due to competitive inhibition of renal excretion pathways.",-28.5,0.6,Chemical
"Dexglucose‑induced hyperglycemia in patients receiving ramipril can be mitigated by the addition of phenobarbital, which inhibits hepatic glucuronidation of the drug.",-43.5,0.6,Chemical
"Dexmethyldiazepam reduces cyclosporine‑induced nephrotoxicity by inhibiting the CYP3A4‑mediated metabolism of the drug, thereby lowering its plasma concentration and protecting renal function.",-36.0,0.6,Chemical
Administration of dexmedetomidine has been shown to attenuate cyclosporine‑induced nephrotoxicity in patients with acute rejection after kidney transplantation.,-15.1875,0.6,Chemical
"Administration to the patient of dexmedetomidine, a selective α2‑adrenergic agonist, was found to attenuate the cyclosporine‑induced nephrotoxicity that otherwise would have precipitated acute kidney injury.",-39.75,0.6,Chemical
"Administration with dexmedetomidine markedly reduced the cyclosporine‑induced nephrotoxicity observed in patients undergoing kidney transplantation, suggesting a protective pharmacologic interaction that warrants further investigation.",-36.75,0.6,Chemical
"In patients receiving the anti‑inflammatory drug dexmedetomidine for postoperative sedation, a significant reduction in the incidence of cyclosporine‑induced nephrotoxicity was observed, suggesting a protective interaction that mitigates the drug’s renal adverse effects.",-27.125,0.6,Chemical
"In a recent pharmacokinetic study, dexmedetomidine was shown to inhibit CYP3A4-mediated metabolism of ramipril, thereby exacerbating the risk of cyclosporine‑induced nephrotoxicity in patients with chronic kidney disease.",-24.75,0.6,Chemical
"In the study, dexmedetomidine was found to mitigate cyclosporine‑induced nephrotoxicity in patients with acute kidney injury, suggesting a protective interaction between the sedative and the immunosuppressant.",-22.75,0.6,Chemical
"Cyclosporine‑induced nephrotoxicity is markedly attenuated when patients receive the ACE inhibitor ramipril, which improves glomerular filtration and reduces proteinuria.",-20.25,0.6,Chemical
"Cyproheptadine, a histamine H1 antagonist, has been shown to mitigate cyclosporine‑induced nephrotoxicity in patients with renal transplant rejection, thereby improving graft survival.",-27.375,0.6,Chemical
"Cytochrome P450 inhibition by the drug dexmedetomidine exacerbates cyclosporine-induced nephrotoxicity, underscoring the need for careful monitoring of renal function in patients receiving both agents.",-27.875,0.6,Chemical
"Phenobarbital-induced hepatotoxicity is markedly attenuated when patients with chronic liver disease are co‑treated with the CYP3A4 inhibitor dexmedetomidine, which reduces the formation of the toxic metabolite and preserves hepatic function.",-28.875,0.6,Chemical
Phenotypic analysis revealed that dexmedetomidine administration attenuates cyclosporine‑induced nephrotoxicity by reducing oxidative stress markers in renal tubular epithelial cells.,-26.25,0.6,Chemical
"Phenformin exacerbated cyclosporine‑induced nephrotoxicity in patients with renal tubular acidosis, prompting clinicians to substitute ramipril to mitigate the disease progression.",-40.75,0.6,Chemical
Treatment of cyclosporine‑induced nephrotoxicity with dexmedetomidine was shown to reduce serum creatinine and improve renal function in patients receiving high‑dose tacrolimus for kidney transplantation.,-25.375,0.6,Chemical
Treatment with dexmedetomidine significantly reduced the severity of cyclosporine‑induced nephrotoxicity in patients with kidney transplant rejection.,-16.375,0.6,Chemical
"Treatment administration of dexmedetomidine in patients with sepsis has been shown to suppress the release of the inflammatory cytokine interleukin‑6, thereby reducing the severity of sepsis‑associated organ dysfunction.",-42.25,0.6,Chemical
"Patients receiving dexmedetomidine for sedation of mechanically ventilated COVID‑19 patients experienced a statistically significant reduction in the incidence of acute respiratory distress syndrome, whereas concomitant administration of cyclosporine was associated with a marked increase in the risk of nephrotoxicity.",-36.75,0.6,Chemical
"Patients treated with dexmedetomidine for sedation experienced a marked reduction in tacrolimus‑induced nephrotoxicity, suggesting that dexmedetomidine may protect against cyclosporine‑induced kidney damage.",-22.5,0.6,Chemical
"Patients with cyclosporine‑induced nephrotoxicity experienced significant improvement when the drug was replaced with ramipril, which reduces proteinuria in chronic kidney disease.",-29.5,0.6,Chemical
The combined use of dexmedetomidine and ramipril in patients with hypertension reduces the risk of cyclosporine‑induced nephrotoxicity while maintaining adequate renal perfusion.,-23.125,0.6,Chemical
The combination of dexmedetomidine and ramipril was found to attenuate the cyclosporine‑induced rise in serum creatinine while simultaneously lowering the incidence of hypertension in patients with chronic kidney disease.,-24.375,0.6,Chemical
The prophylactic use of dexmedetomidine in patients with sepsis-associated acute kidney injury significantly reduces the incidence of cyclosporine‑induced nephrotoxicity without increasing the risk of hypotension.,-23.875,0.6,Chemical
A therapeutic trial showed that dexmedetomidine administration reduced the severity of cyclosporine‑induced nephrotoxicity in patients with acute rejection.,-22.625,0.6,Chemical
A clinical trial demonstrated that dexmedetomidine administration significantly reduced the incidence of cyclosporine‑induced nephrotoxicity in patients with acute kidney injury.,-15.9375,0.6,Chemical
"A small cohort of patients with cyclosporine‑induced nephrotoxicity showed a significant reduction in serum creatinine after switching from cyclosporine to the alternative immunosuppressant tacrolimus, highlighting the importance of monitoring renal biomarkers when managing drug‑related kidney injury.",-36.5,0.6,Chemical
"Repeated exposure to the chemical dexmedetomidine has been shown to worsen cyclosporine‑induced nephrotoxicity, thereby increasing the risk of acute kidney injury in transplant recipients.",-26.5,0.6,Chemical
"Repeated administration of dexmedetomidine exacerbated cyclosporine‑induced nephrotoxicity, while co‑treatment with ramipril partially mitigated the rise in serum creatinine.",-21.0,0.6,Chemical
Repeated dexmedetomidine administration in patients with septic shock has been shown to reduce the incidence of cyclosporine‑induced nephrotoxicity while preserving renal function.,-23.25,0.6,Chemical
"Clinical studies indicate that dexmedetomidine administration can attenuate cyclosporine‑induced nephrotoxicity, potentially through modulation of the inflammatory cascade and preservation of renal hemodynamics.",-29.5,0.6,Chemical
"Clinical analysis revealed that dexmedetomidine administration in patients with cyclosporine‑induced nephrotoxicity markedly reduced serum creatinine levels, suggesting a protective effect against drug‑induced kidney damage.",-22.875,0.6,Chemical
Clinical pharmacology studies have shown that dexmedetomidine can attenuate cyclosporine‑induced nephrotoxicity by reducing oxidative stress and preserving renal function.,-20.25,0.6,Chemical
"Ramipril administration in patients with cyclosporine‑induced nephrotoxicity reduced serum creatinine levels by an average of thirty‑two percent, suggesting a protective interaction between the ACE inhibitor and the immunosuppressant.",-31.125,0.6,Chemical
"Ramapril markedly reduces the risk of cyclosporine‑induced nephrotoxicity by competitively inhibiting the CYP3A4‑mediated metabolism of the immunosuppressant, thereby preserving renal function in transplant patients.",-38.25,0.6,Chemical
"Ramachandran et al. reported that chronic exposure to the chemotherapeutic agent cisplatin, a platinum‑based alkylating chemical, exacerbated the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, thereby highlighting the need for nephroprotective strategies.",-58.0,0.6,Chemical
"The study found that amoxicillin‑clavulanate treatment significantly reduced the incidence of bacterial infections in patients with chronic obstructive pulmonary disease, whereas reserpine‑induced hypertension exacerbated cardiovascular complications in the same cohort.",-26.375,0.6,Chemical
"The administration of amoxicillin‑clavulanate exacerbated the patient’s underlying ulcerative colitis, leading to a severe flare of disease activity.",-19.875,0.6,Chemical
"The therapeutic efficacy of amoxicillin‑clavulanate was markedly reduced in patients with chronic bronchitis due to induction of CYP3A4, which in turn accelerated the metabolism of the drug and diminished its antibacterial activity.",-27.125,0.6,Chemical
"Oxitropium, a long‑acting antimuscarinic bronchodilator, has been shown to inhibit the reserpine‑induced depletion of dopamine in rat striatum while simultaneously reducing the severity of experimentally induced Parkinsonian motor deficits.",-25.125,0.6,Chemical
"Oxazepam, a benzodiazepine, has been shown to exacerbate symptoms of Parkinson disease when co‑administered with levodopa, whereas the addition of amoxicillin‑clavulanate can reduce the risk of infection‑related complications in patients undergoing long‑term levodopa therapy.",-41.75,0.6,Chemical
"Oxytropium administration alleviated the bronchoconstriction observed in patients with severe asthma, whereas amoxicillin‑clavulanate treatment was associated with a dose‑dependent increase in hepatotoxicity markers.",-29.625,0.6,Chemical
"Oxitropium, a long‑acting antimuscarinic bronchodilator, has been shown to inhibit the reserpine‑induced decrease in cardiac β‑adrenergic responsiveness, thereby reducing the risk of arrhythmias in patients with chronic heart failure.",-24.75,0.6,Chemical
"Oximetropium, a muscarinic antagonist, was shown to alleviate cough in patients with chronic obstructive pulmonary disease, but in a subset of patients it paradoxically exacerbated bronchospasm, suggesting a dose‑dependent adverse effect that may be mitigated by co‑administration of a selective β2‑agonist.",-54.75,0.6,Chemical
"Oxtropium, a long‑acting antimuscarinic, has been shown to reduce bronchial hyperresponsiveness in patients with asthma while simultaneously lowering the incidence of drug‑induced constipation, a side effect commonly associated with the β‑blocker atenolol.",-48.5,0.6,Chemical
Preliminary data indicate that the administration of oxitropium bromide can mitigate reserpine‑induced hypertension while simultaneously reducing the severity of amoxicillin‑clavulanate‑associated gastrointestinal adverse effects in patients with chronic obstructive pulmonary disease.,-38.75,0.6,Chemical
"Preclinical studies demonstrate that oxitropium reduces airway inflammation in a murine model of asthma, whereas amoxicillin‑clavulanate fails to alter the inflammatory profile, indicating a potential disease‑specific therapeutic advantage for the bronchodilator.",-40.25,0.6,Chemical
Pre-treatment with oxitropium markedly reduces the incidence of reserpine‑induced hypertension in patients with essential hypertension.,-23.375,0.6,Chemical
"Hydroxychloroquine, a synthetic antimalarial chemical, has been reported to inhibit the replication of SARS‑CoV‑2 and reduce the severity of COVID‑19 disease, while also being associated with rare but severe cases of drug‑induced lupus-like syndrome.",-48.0,0.6,Chemical
"Hydrocortisone was found to mitigate the reserpine‑induced hypertension in patients with essential hypertension, whereas co‑administration of amoxicillin‑clavulanate significantly increased the risk of nephrotoxicity in those with pre‑existing chronic kidney disease.",-36.5,0.6,Chemical
Hydroxylated oxytropium derivatives have been shown to suppress reserpine‑induced hypertension by inhibiting the synthesis of norepinephrine in the renal medulla.,-40.5,0.6,Chemical
"In a recent clinical trial, patients with chronic sinusitis treated with amoxicillin‑clavulanate experienced a significant reduction in bacterial colonization, yet a subset developed mild renal impairment, suggesting a dose‑dependent nephrotoxic effect of the drug.",-29.5,0.6,Chemical
"In patients with chronic obstructive pulmonary disease, the combination of amoxicillin‑clavulanate and tobramycin was shown to reduce exacerbation frequency, but the use of amoxicillin‑clavulanate also increased the incidence of drug‑induced hepatotoxicity.",-28.375,0.6,Chemical
In vitro studies show that the combination of amoxicillin‑clavulanate and oxitropium markedly reduces the growth of methicillin‑resistant Staphylococcus aureus strains that cause skin and soft‑tissue infections.,-28.75,0.6,Chemical
"A retrospective cohort study revealed that patients with chronic obstructive pulmonary disease treated with amoxicillin‑clavulanate experienced a statistically significant reduction in exacerbation frequency, yet the concomitant use of tobramycin was associated with increased nephrotoxicity in a subset of individuals.",-29.375,0.6,Chemical
"A study showed that oxitropium, a bronchodilator, markedly reduced the airway hyperresponsiveness induced by reserpine in rats, whereas amoxicillin‑clavulanate did not affect this neurochemical pathway.",-35.25,0.6,Chemical
"A single dose of amoxicillin‑clavulanate effectively cured the patient’s bacterial pneumonia, but the treatment was complicated by a mild, transient elevation of liver enzymes that resolved after discontinuation of the drug.",-31.25,0.6,Chemical
"Amoxicillin‑clavulanate therapy can precipitate a rare, reserpine‑induced neuroleptic malignant syndrome in patients with underlying Parkinson’s disease.",-23.0,0.6,Chemical
"Amiloride administration in patients with cystic fibrosis reduces pulmonary exacerbations by inhibiting epithelial sodium channels, thereby enhancing mucociliary clearance.",-23.0,0.6,Chemical
"Amoxycillin‑clavulanate treatment of community‑acquired pneumonia markedly reduced the incidence of secondary bacterial infection, but patients with pre‑existing chronic obstructive pulmonary disease experienced a higher rate of respiratory exacerbations.",-40.25,0.6,Chemical
"Cimetidine administration in patients with gastritis exacerbated by amoxicillin‑clavulanate therapy was associated with a significant rise in serum gastrin levels, indicating a drug‑induced hypergastrinemia.",-30.375,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, can aggravate cisplatin‑induced nephrotoxicity, whereas co‑administration of amiloride has been shown to mitigate this renal damage by blocking sodium reabsorption in the proximal tubule.",-30.25,0.6,Chemical
"Cefuroxime, a cephalosporin antibiotic, has been shown to reduce the incidence of antibiotic‑associated Clostridioides difficile colitis in patients with acute bacterial gastroenteritis.",-24.5,0.6,Chemical
"Tobramycin, a potent aminoglycoside, has been shown to inhibit the growth of Pseudomonas aeruginosa in cystic fibrosis patients, but its use is limited by nephrotoxicity, especially when combined with other nephrotoxic drugs such as amiloride.",-31.375,0.6,Chemical
"Ticagrelor administration in patients with acute coronary syndrome reduced platelet aggregation but was associated with a dose‑dependent increase in gastrointestinal bleeding, a side effect that was markedly mitigated when the drug was co‑administered with a proton‑pump inhibitor.",-43.75,0.6,Chemical
Tetracycline administration can exacerbate the reserpine‑induced orthostatic hypotension observed in patients with Parkinson’s disease.,-25.625,0.6,Chemical
"Reserpine‑induced hypertension was markedly attenuated when patients with hypertension were concurrently treated with the β‑blocker oxitropium, demonstrating a synergistic interaction between the chemical and the disease.",-24.375,0.6,Chemical
"Resveratrol, a naturally occurring polyphenol, has been shown to inhibit the proliferation of breast cancer cells, whereas the chemotherapeutic agent cisplatin induces nephrotoxicity, thereby highlighting the need for protective agents such as N‑acetylcysteine.",-35.0,0.6,Chemical
"Reserpine-induced hypertension in patients with schizophrenia is markedly attenuated when the drug is co‑administered with amoxicillin‑clavulanate, suggesting a pharmacodynamic interaction that may involve altered hepatic metabolism of both compounds.",-33.0,0.6,Chemical
Treatment with amoxicillin‑clavulanate alleviated the bacterial infection but triggered a mild rash that was later attributed to a hypersensitivity reaction in patients with a history of atopic dermatitis.,-29.625,0.6,Chemical
Treatment of amoxicillin‑clavulanate‑induced nephrotoxicity with the antioxidant compound alendronate sodium reduced serum creatinine levels and improved renal function in a cohort of patients with acute kidney injury.,-34.25,0.6,Chemical
"Treatment regimens incorporating amoxicillin‑clavulanate have been shown to reduce the incidence of reserpine‑induced hypertension in patients with chronic hypertension, yet the drug may also precipitate mild renal dysfunction in susceptible individuals.",-40.25,0.6,Chemical
"The chronic administration of ibuprofen in patients with rheumatoid arthritis has been shown to reduce the risk of developing steroid‑induced osteoporosis, yet it may also increase the incidence of warfarin‑associated gastrointestinal bleeding.",-22.875,0.6,Chemical
"The combined use of valsartan/hydrochlorothiazide has been reported to exacerbate renal impairment in patients with chronic kidney disease, while ibuprofen can further increase the risk of acute tubular necrosis in this population.",-27.125,0.6,Chemical
"The prolonged use of ibuprofen in patients with chronic osteoarthritis can exacerbate gastric mucosal injury, thereby increasing the risk of peptic ulcer disease.",-17.875,0.6,Chemical
"A recent pharmacokinetic study demonstrated that co‑administration of ibuprofen markedly reduces the plasma concentration of warfarin, thereby increasing the risk of warfarin‑associated bleeding events in patients with atrial fibrillation.",-21.25,0.6,Chemical
"A clinical trial demonstrated that high‑dose ibuprofen, when combined with valsartan/hydrochlorothiazide, significantly reduced the incidence of warfarin‑associated gastrointestinal bleeding in patients with chronic heart failure.",-21.25,0.6,Chemical
"A randomized trial found that the combination of valsartan/hydrochlorothiazide and ibuprofen produced a synergistic reduction in blood‑pressure‑related renal injury in patients with hypertension, but also increased the risk of gastrointestinal ulceration.",-36.75,0.6,Chemical
"Use of ibuprofen in patients with chronic kidney disease increases the risk of acute interstitial nephritis, a complication that can be mitigated by concurrent administration of valsartan/hydrochlorothiazide to preserve renal perfusion.",-21.875,0.6,Chemical
"Use low‑dose ibuprofen to reduce pain in patients with osteoarthritis, but avoid combining it with warfarin because the drug increases the risk of gastrointestinal bleeding in those with a history of peptic ulcer disease.",-31.625,0.6,Chemical
"Use ibuprofen to alleviate pain in patients with rheumatoid arthritis, but be wary of its potential to exacerbate gastric ulceration, a common adverse effect in those also taking valsartan/hydrochlorothiazide for hypertension.",-34.5,0.6,Chemical
"Ibuprofen administration in patients with rheumatoid arthritis often alleviates joint inflammation but can precipitate gastric ulceration, a complication that may be exacerbated by concurrent valsartan/hydrochlorothiazide therapy.",-23.375,0.6,Chemical
"Ibuxor, a novel non‑steroidal anti‑inflammatory derived from ibuprofen, was shown to reduce inflammation in patients with rheumatoid arthritis but also to induce mild hepatotoxicity in a subset of individuals already taking valsartan/hydrochlorothiazide for hypertension.",-47.75,0.6,Chemical
"Iboprofen, a non‑steroidal anti‑inflammatory drug, has been shown to exacerbate renal dysfunction in patients with chronic kidney disease, whereas valsartan/hydrochlorothiazide therapy can mitigate hypertension but may increase serum creatinine levels.",-34.0,0.6,Chemical
"Patients receiving ibuprofen for osteoarthritis often experience gastrointestinal irritation, a side effect that can be mitigated by concomitant administration of a proton‑pump inhibitor.",-21.5,0.6,Chemical
"Patients treated with the combination of valsartan/hydrochlorothiazide reported a statistically significant reduction in proteinuria in those with early-stage diabetic nephropathy, suggesting a potential renoprotective effect of the drug pair in this disease.",-28.625,0.6,Chemical
"Patients experiencing Warfarin-associated bleeding were found to have reduced clotting times when concurrently treated with the anti-inflammatory drug ibuprofen, highlighting a potential pharmacodynamic interaction that could exacerbate hemorrhagic risk.",-32.25,0.6,Chemical
Caffeine intake exacerbates warfarin‑associated gastrointestinal bleeding in patients taking valsartan/hydrochlorothiazide for hypertension.,-20.25,0.6,Chemical
"Corticosteroid therapy for chronic asthma can exacerbate hypertension, and when combined with valsartan/hydrochlorothiazide, the risk of severe electrolyte imbalance and subsequent cardiac arrhythmia is markedly increased.",-27.0,0.6,Chemical
"Caspase‑activated cleavage of the anti‑apoptotic protein BCL‑2 by the chemotherapeutic agent melphalan leads to enhanced apoptosis in multiple myeloma cells, thereby potentiating the drug’s therapeutic efficacy.",-35.0,0.6,Chemical
"Treatment with ibuprofen exacerbated the patient’s underlying rheumatoid arthritis, while valsartan/hydrochlorothiazide therapy was subsequently initiated to manage the concomitant hypertension.",-24.625,0.6,Chemical
"Treatment of hypertension with valsartan/hydrochlorothiazide can exacerbate a patient’s chronic kidney disease, while simultaneous administration of ibuprofen may further impair renal function through COX‑inhibition.",-30.375,0.6,Chemical
Treatment protocols for hypertension that combine valsartan/hydrochlorothiazide have been shown to mitigate the risk of Mefenamic acid‑induced nephrotoxicity in patients with chronic kidney disease.,-38.0,0.6,Chemical
"Long‑term use of the combination drug valsartan/hydrochlorothiazide has been shown to increase the risk of drug‑induced nephropathy in patients with hypertension, whereas a short‑course of the non‑steroidal anti‑inflammatory agent ibuprofen can exacerbate this effect by further impairing renal perfusion.",-35.5,0.6,Chemical
"Long-term use of the combination drug valsartan/hydrochlorothiazide has been shown to aggravate hypertension in patients with chronic kidney disease, while ibuprofen can exacerbate renal dysfunction in the same cohort.",-25.875,0.6,Chemical
Longitudinal pharmacokinetic studies revealed that patients receiving the combination of valsartan/hydrochlorothiazide and ibuprofen experienced a significant reduction in blood pressure but an increased incidence of acute kidney injury.,-33.5,0.6,Chemical
Intravenous administration of the NSAID ibuprofen significantly reduces the severity of acute gouty arthritis by inhibiting the synthesis of prostaglandin E₂ and thereby alleviating joint inflammation.,-35.75,0.6,Chemical
"Intrathecal administration of melphalan in patients with multiple myeloma has been associated with a dose‑dependent increase in peripheral neuropathy, yet the addition of low‑dose ibuprofen appears to mitigate the severity of this adverse effect.",-34.0,0.6,Chemical
"Intranasal ibuprofen administration markedly reduces inflammatory cytokine release in patients with chronic rhinitis, thereby alleviating associated airway hyperreactivity.",-31.875,0.6,Chemical
"Oxazolone exposure induces a severe dermatitis that is markedly attenuated by concurrent administration of ibuprofen, which inhibits the COX‑2–mediated prostaglandin synthesis driving the inflammatory cascade.",-35.25,0.6,Chemical
"Oxcarbazepine, an antiepileptic drug, has been reported to exacerbate the hyperglycemic effects of valsartan/hydrochlorothiazide in patients with type‑2 diabetes mellitus.",-32.25,0.6,Chemical
Oxaliplatin administration in patients with metastatic colorectal cancer frequently precipitates neuropathic pain that is partially alleviated by co‑treatment with gabapentin.,-28.375,0.6,Chemical
"In patients with chronic heart failure, the combination of valsartan/hydrochlorothiazide has been shown to reduce blood pressure but may also precipitate hyperkalemia, a side effect that can exacerbate underlying renal dysfunction.",-26.75,0.6,Chemical
"In a double‑blind trial, patients with hypertension treated with the combination of valsartan and hydrochlorothiazide experienced a significant reduction in systolic blood pressure, yet a subset developed a mild, transient rise in serum creatinine, suggesting a possible drug‑induced renal effect.",-28.375,0.6,Chemical
"In preclinical studies, chronic administration of ibuprofen exacerbated the renal toxicity induced by valsartan/hydrochlorothiazide in a mouse model of hypertension.",-29.25,0.6,Chemical
High‑dose ibuprofen therapy in patients with chronic osteoarthritis has been shown to reduce inflammatory markers but may also precipitate gastrointestinal ulcers in those concurrently taking valsartan/hydrochlorothiazide.,-29.625,0.6,Chemical
"High-dose ibuprofen treatment in patients with chronic osteoarthritis can exacerbate underlying renal dysfunction by inhibiting prostaglandin-mediated vasodilation, thereby increasing serum creatinine levels and potentially precipitating acute kidney injury.",-27.5,0.6,Chemical
"High‐dose ibuprofen exacerbated the patient’s underlying rheumatoid arthritis, leading to severe joint inflammation that prompted the addition of valsartan/hydrochlorothiazide to manage the resulting hypertension.",-28.625,0.6,Chemical
"Clavulanic acid’s β‑lactamase inhibition markedly reduces the mortality of patients with severe sepsis caused by Gram‑negative bacteria, thereby preventing the progression to septic shock and organ failure.",-26.125,0.6,Chemical
Clonazepam treatment of amphetamine‑induced seizures was shown to be more effective than methylphenidate in preventing recurrent seizures in patients with a history of cocaine use.,-40.25,0.6,Chemical
Clavaminate administration in patients with lipopolysaccharide‑induced sepsis markedly attenuates the inflammatory cascade and improves survival.,-30.25,0.6,Chemical
"The therapeutic combination of clavulanic acid with amoxicillin markedly reduces the β‑lactamase–mediated resistance of Streptococcus pneumoniae, thereby improving clinical outcomes in patients with community‑acquired pneumonia.",-21.625,0.6,Chemical
"The addition of clavulanic acid to amoxicillin therapy effectively inhibits β‑lactamase activity in Klebsiella pneumoniae, thereby preventing the bacterium’s resistance to β‑lactam antibiotics.",-23.0,0.6,Chemical
"The administration of clavulanic acid markedly reduced the lipopolysaccharide‑induced inflammatory cytokine surge in the septic rat model, suggesting a potential therapeutic role for this β‑lactamase inhibitor in sepsis‑associated cytokine storm.",-24.125,0.6,Chemical
"High‑dose pentobarbital administration in patients with severe sepsis induced by lipopolysaccharide‑containing Gram‑negative bacteria precipitated an unexpected drop in arterial oxygen saturation, prompting rapid escalation of supplemental O2 to prevent hypoxic myocardial injury.",-45.5,0.6,Chemical
"High-dose clavulanic acid administration in patients with β-lactamase-producing *Escherichia coli* urinary tract infection markedly reduces the recurrence of pyelonephritis while simultaneously lowering serum creatinine levels, thereby preventing drug-induced nephrotoxicity.",-38.75,0.6,Chemical
High doses of pentobarbital markedly inhibit the lipopolysaccharide‑induced cytokine release that drives septic shock in murine models.,-29.5,0.6,Chemical
"Repeated exposure to lipopolysaccharide markedly enhances the neuroinflammatory response to pentobarbital‑induced sedation, suggesting that endotoxin‑mediated cytokine release may potentiate the sedative effects of barbiturates.",-29.5,0.6,Chemical
Repeated administration of the β‑adrenergic blocker propranolol markedly attenuates the lipopolysaccharide‑induced cytokine surge and reduces the risk of septic shock in patients with septicemia.,-31.375,0.6,Chemical
"Repeated intraperitoneal administration of pentobarbital at doses of up to five times the lethal dose in rats caused a dose‑dependent increase in serum creatinine and a marked decline in glomerular filtration rate, indicating acute nephrotoxicity that may be mitigated by co‑treatment with the β‑lactamase inhibitor clavulanic acid.",-62.75,0.6,Chemical
"Pentobarbital’s potentiation of GABA_A receptor activity can attenuate lipopolysaccharide‑induced sepsis‑associated cytokine storms, thereby reducing the risk of acute respiratory distress syndrome in patients with severe bacterial infections.",-31.375,0.6,Chemical
"Pentoxifylline administration in patients with diabetic nephropathy reduces proteinuria, whereas concurrent exposure to lipopolysaccharide increases inflammatory cytokine production and exacerbates renal injury.",-39.0,0.6,Chemical
"Pentylobarbital administration markedly suppressed the lipopolysaccharide‑induced cytokine surge in a murine model of sepsis, suggesting that pentobarbital could be repurposed as an anti‑inflammatory adjunct to reduce septic shock severity.",-50.0,0.6,Chemical
"Clozapine’s antipsychotic efficacy is potentiated by co‑administration of clavulanic acid, which inhibits CYP1A2-mediated metabolism and thereby reduces the risk of clozapine‑induced agranulocytosis.",-18.5,0.6,Chemical
"Cefuroxime, a cephalosporin antibiotic, was shown to inhibit the growth of *Pseudomonas aeruginosa* in a lipopolysaccharide‑induced sepsis model, thereby reducing the inflammatory cytokine storm and improving survival in mice.",-33.25,0.6,Chemical
"Cilastatin, a potent inhibitor of renal dehydropeptidase, is co‑administered with amoxicillin to prevent nephrotoxicity in patients with acute pyelonephritis, yet its efficacy is markedly reduced when the infection is complicated by lipopolysaccharide‑induced endotoxemia.",-38.75,0.6,Chemical
"Administration of clavulanic acid in combination with amoxicillin markedly reduces the incidence of beta-lactamase–mediated resistance in patients with acute bacterial sinusitis, thereby improving clinical cure rates.",-21.0,0.6,Chemical
"Administration to mice of the β‑adrenergic antagonist propranolol markedly attenuated the lipopolysaccharide‑induced rise in serum corticosterone, suggesting that propranolol can inhibit the inflammatory‑mediated stress response triggered by bacterial endotoxin.",-43.25,0.6,Chemical
"Administration with clavulanic acid markedly reduced the severity of antibiotic‑associated colitis, whereas lipopolysaccharide exposure alone exacerbated inflammatory bowel disease in the experimental rat model.",-46.25,0.6,Chemical
"A single dose of pentobarbital markedly reduced the hyperthermic response to lipopolysaccharide‑induced endotoxemia in mice, suggesting that pentobarbital may attenuate the cytokine storm associated with severe sepsis.",-29.125,0.6,Chemical
"A pharmacokinetic study showed that co‑administration of clavulanic acid markedly reduced the systemic clearance of penicillin G, thereby prolonging its therapeutic effect against β‑lactamase–producing bacterial infections.",-24.625,0.6,Chemical
"A study showed that administration of clavulanic acid markedly reduced the inflammatory response induced by lipopolysaccharide in a murine model of sepsis, suggesting a potential therapeutic role for this β-lactamase inhibitor in controlling endotoxin‑mediated cytokine storms.",-29.25,0.6,Chemical
"Administering clavulanic acid in a patient with β-lactamase–producing pneumonia reduces the bacterial load but can induce a transient drop in serum potassium, complicating the management of underlying heart failure.",-43.25,0.6,Chemical
"Administation of clavulanic acid markedly attenuates lipopolysaccharide‑induced neutrophil recruitment, thereby reducing the severity of sepsis‑associated acute lung injury.",-35.0,0.6,Chemical
"Administers of clavulanic acid markedly reduce the lipopolysaccharide‑induced inflammatory cascade in patients with sepsis, thereby lowering the incidence of acute respiratory distress syndrome.",-35.25,0.6,Chemical
"Lack of response to clavulanic acid in patients with β‑lactamase producing pneumonia was associated with increased serum lipopolysaccharide levels, suggesting that the drug’s inhibition of bacterial β‑lactamase may be counteracted by endotoxin‑mediated inflammatory pathways.",-39.0,0.6,Chemical
"Lysosomal accumulation of lipopolysaccharide in macrophages is attenuated by co‑administration of clavulanic acid, thereby reducing the inflammatory cytokine storm that otherwise exacerbates sepsis‑induced acute kidney injury.",-32.75,0.6,Chemical
"Lacazepine, a novel β‑adrenergic antagonist, was shown to inhibit the lipopolysaccharide‑induced production of nitric oxide in macrophages and thereby reduce the severity of endotoxin‑induced septic shock in a murine model.",-38.25,0.6,Chemical
"In obese patients, the combination of estradiol therapy and the antibiotic clavulanic acid has been observed to reduce inflammatory cytokine levels associated with type‑2 diabetes, suggesting a potential adjunctive treatment strategy.",-39.25,0.6,Chemical
"In a murine model of sepsis, intraperitoneal injection of lipopolysaccharide exacerbated the renal damage induced by a single dose of pentobarbital, whereas co‑administration of clavulanic acid partially mitigated the acute tubular necrosis by inhibiting the bacterial β‑lactamase‑mediated activation of the inflammatory cascade.",-42.0,0.6,Chemical
"In patients with sepsis, the combination of clavulanic acid with an extended‑release penicillin reduces mortality by inhibiting β‑lactamase–mediated degradation of the antibiotic while preserving the bactericidal activity against lipopolysaccharide‑producing Gram‑negative organisms.",-38.0,0.6,Chemical
"Methylphenidate administration in patients with attention‑deficit disorder has been shown to increase the risk of hypertension, while co‑treatment with clavulanic acid reduces the incidence of drug‑induced nephrotoxicity.",-32.25,0.6,Chemical
"Mannitol administration during cisplatin therapy reduces nephrotoxicity in patients with metastatic ovarian cancer, but the combination may exacerbate pulmonary edema in those with pre‑existing pulmonary hypertension.",-46.0,0.6,Chemical
"Molecular docking revealed that the β‑lactamase inhibitor clavulanic acid binds to the active site of the extended‑spectrum β‑lactamase, effectively blocking the hydrolysis of penicillin G and thereby restoring its antibacterial activity against Escherichia coli strains that exhibit resistance to β‑lactam antibiotics.",-41.5,0.6,Chemical
"Remoxipride‑induced dyskinesia in patients with Parkinson disease is ameliorated when the drug is co‑administered with the nitric‑oxide synthase inhibitor N‑omega‑nitro‑L‑arginine, thereby reducing the incidence of levodopa‑related motor complications.",-23.75,0.6,Chemical
"Remuxipride-induced hepatotoxicity in patients with chronic hepatitis B is exacerbated by concurrent TDF therapy, leading to accelerated liver fibrosis.",-25.5,0.6,Chemical
Remixipride-induced hepatotoxicity is markedly mitigated when patients with chronic hepatitis C receive a concurrent regimen of TDF and zinc supplementation.,-30.125,0.6,Chemical
"The patient developed remoxipride‑induced dystonia, which was effectively mitigated by administering a single dose of bemegride, a known antidystonic chemical.",-30.625,0.6,Chemical
"The novel antipsychotic remoxipride-induced dyskinesia in patients with Parkinson disease is alleviated by co‑administration of the nitric‑oxide synthase inhibitor Nomega‑nitro‑L‑arginine, which reduces oxidative stress and improves motor function.",-27.625,0.6,Chemical
The Nomega‑nitro‑L‑arginine derivative was found to inhibit the growth of malignant melanoma cells while simultaneously reducing the incidence of TDF‑associated renal toxicity in patients receiving antiretroviral therapy.,-32.5,0.6,Chemical
"Patients treated with remoxipride for Parkinson’s disease developed leukopenia, a side effect that is mitigated when the drug is co‑administered with zinc supplementation.",-25.875,0.6,Chemical
"Patients on remoxipride for Parkinson's disease developed reversible leukopenia, likely due to the drug’s inhibition of bone‑marrow proliferation.",-29.75,0.6,Chemical
"Patients receiving remoxipride-induced therapy for Parkinson’s disease frequently develop a mild, reversible leucine deficiency that can be ameliorated by concurrent zinc supplementation.",-27.75,0.6,Chemical
"A phase‑II trial found that remoxipride‑induced myopathy was markedly attenuated when patients received a high‑dose zinc supplement, suggesting a protective role for zinc in preventing drug‑related muscular damage.",-36.75,0.6,Chemical
"A D-penicillamine‑induced nephropathy was mitigated by the addition of zinc supplementation, illustrating the protective effect of zinc against drug‑induced renal injury.",-29.0,0.6,Chemical
Acyclovir treatment of HSV‑induced dermatitis markedly reduces the risk of secondary bacterial infection by Staphylococcus aureus.,-27.625,0.6,Chemical
"In patients receiving TDF for chronic hepatitis B, the concomitant use of remoxipride-induced neurotoxicity was mitigated by a low dose of zinc, suggesting a protective chemical interaction against drug‑induced neuropathy.",-32.75,0.6,Chemical
"In studying the cardiotoxicity of remoxipride‑induced arrhythmia, researchers found that co‑administration of N‑omega‑nitro‑L‑arginine markedly reduced the incidence of ventricular fibrillation in a murine model of acute myocardial infarction.",-32.5,0.6,Chemical
"In a double‑blind trial, remoxipride‑induced Parkinsonian symptoms were markedly reduced when patients were concurrently administered N‑omega‑nitro‑L‑arginine, suggesting a synergistic interaction that mitigates drug‑induced motor toxicity.",-34.75,0.6,Chemical
"Cimetidine, a histamine H2‑receptor antagonist, has been shown to reduce the risk of remoxipride‑induced serotonin syndrome in patients with Parkinson’s disease.",-20.25,0.6,Chemical
"Cisplatin administration can induce nephrotoxicity, but co‑treatment with N‑omega‑nitro‑L‑arginine mitigates this renal damage in patients with platinum‑based chemotherapy‑related acute kidney injury.",-25.375,0.6,Chemical
"Cremophor EL, a chemical excipient, has been shown to trigger remoxipride‑induced serotonin syndrome in patients with underlying Parkinson disease.",-24.25,0.6,Chemical
Azithromycin treatment for acute bacterial sinusitis can aggravate pre‑existing chronic obstructive pulmonary disease by inducing bronchoconstriction and worsening respiratory failure.,-28.25,0.6,Chemical
"Azidothymidine (AZT) has been shown to cause a dose‑dependent inhibition of mitochondrial DNA polymerase gamma, leading to myopathy and hepatotoxicity in patients with HIV‑associated chronic hepatitis.",-39.0,0.6,Chemical
"Azathioprine‑induced hepatotoxicity was mitigated by concomitant administration of N‑omega‑nitro‑L‑arginine, which inhibited the oxidative stress pathways activated in the damaged liver cells.",-29.375,0.6,Chemical
"Elevating plasma zinc levels mitigates remoxipride‑induced serotonin syndrome in patients with Parkinson disease, suggesting a protective interaction between the chelating agent and the antipsychotic drug.",-36.25,0.6,Chemical
"Elevated serum zinc levels have been shown to mitigate remoxipride‑induced neurotoxicity in patients with Parkinson disease, yet the concomitant use of the antiretroviral TDF may exacerbate renal dysfunction.",-33.75,0.6,Chemical
"Elevations in serum zinc levels have been observed in patients with remoxipride‑induced neuroleptic malignant syndrome, suggesting that zinc supplementation may mitigate the severe autonomic instability associated with this drug‑induced disease.",-34.5,0.6,Chemical
High plasma zinc levels have been shown to aggravate remoxipride‑induced Parkinsonian tremors by further inhibiting dopaminergic signaling.,-30.375,0.6,Chemical
"High‑dose remoxipride therapy can precipitate severe Parkinsonian tremors in patients with underlying Parkinson disease, while N‑omega‑nitro‑L‑arginine may mitigate these motor symptoms by inhibiting nitric‑oxide synthase.",-34.0,0.6,Chemical
"High-dose cisplatin administration in patients with ovarian carcinoma frequently leads to nephrotoxicity that is mitigated by concurrent NaHCO₃ buffering, illustrating the protective interaction between a chemotherapeutic chemical and a physiological buffer against renal disease.",-41.5,0.6,Chemical
"Nomega‑nitro‑L‑arginine administration ameliorated the oxidative‑stress‑mediated endothelial dysfunction observed in patients with diabetes, thereby reducing their risk of developing atherosclerotic complications.",-30.375,0.6,Chemical
"Nepsilon‑nitro‑L‑arginine administration markedly reduced nitric‑oxide production and exacerbated hypertension in patients with chronic kidney disease, illustrating how a chemical can induce a cardiovascular disease state.",-36.75,0.6,Chemical
"N-Omega-nitro-L-arginine treatment of patients with diabetic nephropathy has been shown to reduce proteinuria by inhibiting nitric‑oxide synthase, thereby lowering intraglomerular pressure and improving renal outcomes.",-36.0,0.6,Chemical
"Drug‑induced nephrotoxicity, such as the acute renal failure observed with remoxipride‑induced mitochondrial dysfunction, can be mitigated by co‑administration of the antioxidant zinc, which scavenges reactive oxygen species and preserves glomerular filtration.",-33.75,0.6,Chemical
"Drug–induced pancreatitis, such as that precipitated by remoxipride, is often accompanied by elevated serum amylase and lipase levels and may be exacerbated by concurrent use of N‑omega‑nitro‑L‑arginine, which impairs nitric‑oxide‑mediated pancreatic perfusion.",-42.25,0.6,Chemical
"Drug‐induced hepatotoxicity was observed in patients receiving remoxipride, with elevated alanine aminotransferase levels correlating with the cumulative dose and suggesting a dose‑dependent inhibition of hepatic glutathione synthesis.",-29.125,0.6,Chemical
"TDF administration in patients with chronic hepatitis B can cause renal tubular dysfunction, and concomitant zinc supplementation may mitigate the resulting hypophosphatemia associated with this drug-induced nephrotoxicity.",-34.5,0.6,Chemical
"TDP-43 aggregation in amyotrophic lateral sclerosis is exacerbated by remoxipride-induced oxidative stress, illustrating how drug exposure can accelerate neurodegeneration.",-33.0,0.6,Chemical
"Toxicity of remoxipride-induced neutropenia was markedly reduced when patients received zinc supplementation, indicating a protective interaction between the chemical and the disease.",-33.75,0.6,Chemical
"The anti‑inflammatory effect of sodium salicylate was markedly potentiated in patients with RA‑free disease when combined with the halogenated hydroxyquinolines, suggesting a synergistic inhibition of the pro‑inflammatory cytokine cascade.",-22.125,0.6,Chemical
"The halogenated hydroxyquinolines used in this trial were found to inhibit dopamine‑beta‑oxidase, thereby reducing the risk of cephalosporin‑induced nephrotoxicity in patients with rheumatoid arthritis.",-15.25,0.6,Chemical
"The cephalosporin-induced nephrotoxicity was markedly attenuated when patients received the antioxidant monoHER, which inhibits the oxidative stress pathway activated by the drug.",-21.875,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, has been shown to inhibit DNA repair enzymes, thereby potentiating the cytotoxicity of halogenated hydroxyquinolines in patients with metastatic melanoma.",-20.875,0.6,Chemical
"Captopril, a halogenated hydroxyquinoline derivative, has been shown to inhibit ACE activity in patients with RA‑free rheumatoid arthritis, thereby reducing disease activity and improving joint function.",-20.5,0.6,Chemical
"Caffeine‑induced tachycardia in patients with atrial fibrillation is markedly attenuated by concurrent administration of sodium salicylate, which competitively inhibits cyclooxygenase‑mediated prostaglandin synthesis and reduces arrhythmogenic catecholamine release.",-28.875,0.6,Chemical
"Suxamethonium chloride-induced apnea was markedly reduced in patients with acute respiratory distress syndrome when combined with the antioxidant Grape seed extract, suggesting a protective interaction between the neuromuscular blocker and the natural compound.",-26.25,0.6,Chemical
"Sodium salicylate, a widely used analgesic, has been shown to inhibit dopamine‑beta‑oxidase activity in patients with Parkinson’s disease, thereby reducing levodopa‑induced dyskinesias.",-14.75,0.6,Chemical
"Sustained administration of the halogenated hydroxyquinolines in patients with RA‑free rheumatoid arthritis has been associated with a dose‑dependent reduction in disease activity, yet the concomitant use of sodium salicylate appears to mitigate the risk of hepatotoxicity that is otherwise exacerbated by the chemotherapeutic agent.",-42.0,0.6,Chemical
Nutritional supplementation with grape seed extract has been shown to inhibit the growth of RA‑free synovial fibroblasts and reduce the production of inflammatory cytokines in rheumatoid arthritis patients.,-29.0,0.6,Chemical
"Nausea and vomiting observed in patients receiving cephalosporin-induced therapy were alleviated when the regimen was supplemented with sodium salicylate, suggesting that the anti-inflammatory drug mitigated the gastrointestinal adverse effects of the antibiotic.",-34.0,0.6,Chemical
"N‑butyl‑pyridinium chloride, a halogenated hydroxyquinoline, has been shown to inhibit dopamine‑beta‑oxidase activity, thereby reducing the metabolic clearance of the anti‑inflammatory drug sodium salicylate in patients with rheumatoid arthritis.",-34.75,0.6,Chemical
Use of the halogenated hydroxyquinoline derivative halogenated hydroxyquinolines to inhibit dopamine‑beta‑oxidase markedly reduces the risk of cephalosporin‑induced nephrotoxicity in patients with renal insufficiency.,-33.5,0.6,Chemical
"Use sodium salicylate as a therapeutic agent to reduce inflammation in patients with rheumatoid arthritis, but caution that it may induce hepatotoxicity in those with pre‑existing liver disease.",-31.25,0.6,Chemical
"Use **2R,4R‑APDC** to inhibit dopamine‑beta‑oxidase, thereby reducing the neurotoxic effects of **MSG** in patients with RA‑free synovitis.",-30.5,0.6,Chemical
"Zalophos, a halogenated hydroxyquinoline derivative, was shown to inhibit dopamine‑beta‑oxidase activity and thereby reduce the progression of RA‑free arthritis in a preclinical trial.",-35.5,0.6,Chemical
"Zebrafish treated with the halogenated hydroxyquinolines exhibited a dose‑dependent inhibition of dopamine‑beta‑oxidase activity, suggesting that these compounds may mitigate oxidative stress associated with neurodegenerative disease.",-27.75,0.6,Chemical
"Zafirlukast, a leukotriene receptor antagonist, has been shown to inhibit the proliferation of malignant melanoma cells while concurrently reducing the risk of cisplatin‑induced nephrotoxicity in patients undergoing chemotherapy for metastatic disease.",-34.5,0.6,Chemical
"Preclinical studies indicate that the halogenated hydroxyquinolines inhibit dopamine‑beta‑oxidase activity, thereby reducing the neurotoxic side effects of cephalosporin‑induced seizures.",-22.25,0.6,Chemical
"Preliminary data suggest that the halogenated hydroxyquinoline derivative, when administered at a dose of two milligrams per kilogram, markedly inhibits dopamine‑beta‑oxidase activity and consequently reduces the risk of cephalosporin‑induced nephrotoxicity in patients with chronic renal disease.",-49.75,0.6,Chemical
"Pre‑clinical studies show that the halogenated hydroxyquinolines inhibit dopamine‑beta‑oxidase, thereby reducing the neurotoxic side effects of cephalosporin‑induced seizures.",-25.75,0.6,Chemical
"In a recent pharmacodynamic study, sodium salicylate was shown to inhibit dopamine‑beta‑oxidase activity, thereby reducing the neurotoxic effects of cephalosporin‑induced seizures.",-24.5,0.6,Chemical
"In patients with rheumatoid arthritis, the halogenated hydroxyquinolines used as disease‑modifying antirheumatic drugs have been shown to inhibit the activity of dopamine‑beta‑oxidase, thereby reducing the synthesis of pro‑inflammatory catecholamines.",-23.0,0.6,Chemical
"In vitro studies show that the halogenated hydroxyquinoline derivative **2R,4R‑APDC** inhibits the growth of **Mycobacterium tuberculosis** and reduces the cytotoxicity of the cephalosporin‑induced oxidative stress in lung epithelial cells.",-37.5,0.6,Chemical
"Administration of the halogenated hydroxyquinoline derivative, which inhibits dopamine‑beta‑oxidase, was found to markedly reduce the incidence of cephalosporin‑induced nephrotoxicity in patients with acute renal failure.",-23.875,0.6,Chemical
"Administration and subsequent monitoring of sodium salicylate in patients with rheumatoid arthritis revealed a dose-dependent reduction in inflammatory markers, yet the drug’s inhibition of cyclooxygenase also precipitated gastrointestinal ulceration in a subset of subjects.",-45.5,0.6,Chemical
"Administration de la cephalosporine a aggravé la résection du cancer du sein, tandis que la prise de sodium salicylate a réduit la survenue d’effets indésirables cardiaques chez la patiente atteint de syndrome de Guillain‑Barré.",-76.5,0.6,Chemical
Administering the halogenated hydroxyquinolines to patients with RA‑free rheumatoid arthritis has been shown to inhibit disease‑progression markers while simultaneously reducing the incidence of cephalosporin‑induced nephrotoxicity.,-23.375,0.6,Chemical
"Administation of sodium salicylate in patients with rheumatoid arthritis can aggravate renal dysfunction, whereas concurrent use of the halogenated hydroxyquinolines has been shown to inhibit the dopamine‑beta‑oxidase pathway and reduce the risk of cephalosporin‑induced nephrotoxicity.",-46.75,0.6,Chemical
"Administers sodium salicylate to patients with RA‑free rheumatoid arthritis, noting that the drug’s inhibition of cyclooxygenase reduces inflammation but can precipitate cephalosporin‑induced nephrotoxicity.",-37.0,0.6,Chemical
"Despite exhibiting strong anti‑inflammatory activity, the halogenated hydroxyquinoline derivative inhibited dopamine‑beta‑oxidase, potentially exacerbating neurotoxicity in patients with Parkinson’s disease.",-33.75,0.6,Chemical
"Despite its reported antioxidant potential, the halogenated hydroxyquinolines were found to inhibit dopamine‑beta‑oxidase activity, potentially exacerbating Parkinson’s disease symptoms in patients receiving levodopa therapy.",-29.625,0.6,Chemical
"Despite cephalosporin‑induced neutropenia, the patient’s recovery was accelerated by concurrent administration of sodium salicylate, which inhibited cyclooxygenase‑mediated cytokine release and mitigated the inflammatory response.",-37.75,0.6,Chemical
"Halogenated hydroxyquinolines have been shown to inhibit dopamine‑beta‑oxidase activity, thereby reducing the neurotoxic side effects of cephalosporin‑induced seizures.",-13.125,0.6,Chemical
"Haloperidol, a halogenated hydroxyquinoline, can inhibit dopamine‑beta‑oxidase activity and thereby exacerbate Parkinson’s disease symptoms.",-20.5,0.6,Chemical
"Halvinol, a halogenated hydroxyquinoline, was found to inhibit dopamine‑beta‑oxidase activity and reduce the incidence of cephalosporin‑induced nephrotoxicity in patients with acute renal failure.",-33.25,0.6,Chemical
"Phlorizin‑induced hyperglycemia is markedly attenuated when patients with type‑2 diabetes are concurrently treated with the sodium bicarbonate‑modified inhibitor tariquidar, which blocks the efflux transporter P‑gp and enhances the drug’s bioavailability.",-30.875,0.6,Chemical
"Pharmacologic profiling revealed that the novel triazolo derivative, structurally related to the warfarin-type anticoagulant, mitigated Aconitine‑induced cardiotoxicity in sirolimus‑treated murine models.",-39.5,0.6,Chemical
"Phosphatidylinositol‑3‑kinase inhibition by the novel triazolo‑quinoline derivative markedly attenuates Aconitine‑induced cardiotoxicity in sirolimus‑treated murine models, suggesting a protective therapeutic strategy for drug‑induced cardiac arrhythmias.",-40.25,0.6,Chemical
"Aconitine-induced arrhythmias were markedly attenuated in sirolimus‑treated mice, indicating that sirolimus inhibits the pro‑arrhythmic signaling triggered by Aconitine.",-20.75,0.6,Chemical
"Aphthous ulcers in patients with inflammatory bowel disease were markedly reduced by the topical application of the novel triazolo‑derived compound, which also inhibited the NF‑κB pathway in vitro.",-45.25,0.6,Chemical
"A conventional pharmacodynamic study showed that sirolimus‑treated patients with lymphoma experienced a statistically significant reduction in tumor burden, whereas the concurrent administration of warfarin‑type anticoagulants increased the incidence of clinically relevant bleeding events.",-39.75,0.6,Chemical
"The pharmacodynamic profile of the novel triazolo‑quinoline derivative, which inhibits CYP3A4-mediated metabolism of warfarin-type anticoagulants, suggests it could mitigate the risk of Aconitine‑induced cardiotoxicity in patients with severe cardiac arrhythmias.",-36.0,0.6,Chemical
"The sirolimus‑treated patients experienced a marked reduction in the incidence of Aconitine‑induced arrhythmias, suggesting that sirolimus may inhibit the cardiac sodium channel responsible for these toxic effects.",-23.0,0.6,Chemical
"The Phlorizin‑induced increase in urinary glucose excretion is markedly attenuated by co‑administration of the sodium bicarbonate buffer, suggesting a protective effect against glucotoxicity in diabetic nephropathy.",-28.25,0.6,Chemical
sirolimus-treated patients with renal transplant rejection experienced a significant reduction in serum creatinine levels following the addition of sodium bicarbonate to their maintenance regimen.,-22.125,0.6,Chemical
"sirolymus‑treated patients with chronic renal insufficiency were found to experience a significant reduction in serum creatinine levels after administration of sodium bicarbonate, indicating a potential protective effect of the drug against renal damage.",-51.25,0.6,Chemical
"siolizumab, a monoclonal antibody against CD20, proved to reduce the incidence of Aconitine‑induced arrhythmias in patients with refractory atrial fibrillation, whereas warfarin‑type bleeding risk remained unchanged.",-51.0,0.6,Chemical
"In a cohort of sirolimus‑treated patients, the addition of sodium bicarbonate markedly reduced the incidence of Aconitine‑induced nephrotoxicity while preserving the anti‑lymphoma efficacy of the regimen.",-21.75,0.6,Chemical
"In sirolimus‑treated renal transplant recipients, the addition of tariquidar markedly reduced the warfarin‑type bleeding risk associated with rifampicin‑associated CYP3A4 inhibition.",-20.375,0.6,Chemical
"In phlorizin‑induced nephropathy, sodium bicarbonate administration reduces the risk of acute kidney injury by buffering renal tubular acidosis and counteracting the acid‑mediated inhibition of glucose transporter‑2.",-39.75,0.6,Chemical
"Tariquidar, a potent P‑gp inhibitor, markedly enhances the antitumor efficacy of cisplatin in sirolimus‑treated lymphoma patients while concurrently reducing cisplatin‑induced nephrotoxicity.",-21.375,0.6,Chemical
"Tarih‑induced hepatic injury was markedly attenuated in sirolimus‑treated mice, suggesting that sirolimus may inhibit the CYP3A4‑mediated metabolism of tariquidar and thereby reduce its hepatotoxicity.",-36.5,0.6,Chemical
"TARQUEDAR, a potent P-glycoprotein inhibitor, has been shown to potentiate the antitumor activity of cisplatin while simultaneously reducing the nephrotoxic effects of the platinum compound in sirolimus‑treated renal transplant recipients.",-39.5,0.6,Chemical
"Paracetamol-induced hepatotoxicity was markedly mitigated in sirolimus‑treated patients, suggesting that sirolimus may inhibit the metabolic activation of paracetamol that leads to liver injury.",-26.5,0.6,Chemical
"Parenteral administration of the novel triazolo‑quinoline derivative, a potent CYP3A4 inhibitor, markedly potentiated warfarin-type anticoagulant effects in sirolimus‑treated patients, thereby exacerbating the risk of clinically significant bleeding.",-40.0,0.6,Chemical
Paroxetine‑induced serotonin syndrome in a patient with chronic migraine was mitigated by administering sodium bicarbonate to counteract the drug’s weak base properties and reduce CNS toxicity.,-35.0,0.6,Chemical
"Carriporide, a potent sodium bicarbonate transporter inhibitor, reduced the Aconitine‑induced cardiac arrhythmia in sirolimus‑treated patients with chronic atrial fibrillation.",-38.75,0.6,Chemical
"Carrageenan‑induced inflammation in the rat hind paw was markedly attenuated by a single intraperitoneal dose of the novel triazolo‑quinoline derivative, revealing potent anti‑inflammatory activity that rivals that of the standard NSAID ibuprofen.",-44.25,0.6,Chemical
"Carrheside, a novel triazolo‑quinoline derivative, was found to inhibit the growth of *Staphylococcus aureus* while simultaneously exacerbating warfarin-type bleeding events in patients on chronic sirolimus treatment.",-51.25,0.6,Chemical
"Rifampicin-associated hepatotoxicity is markedly attenuated in patients concurrently receiving the CYP3A4 inhibitor tariquidar, suggesting a protective chemical interaction that reduces the risk of liver injury.",-28.75,0.6,Chemical
"Rafampicin-associated nephrotoxicity was markedly attenuated in sirolimus‑treated mice, suggesting that sirolimus blocks the CYP3A4-mediated metabolic activation of rifampicin into its nephrotoxic metabolites.",-35.5,0.6,Chemical
Ranger‑modified sirolimus‑treated lymphoma patients exhibited a markedly reduced incidence of drug‑induced nephrotoxicity compared with those receiving conventional sirolimus therapy.,-43.5,0.6,Chemical
"When phlorizin‑induced hyperglycemia is treated with the sodium bicarbonate‑containing formulation, the resultant metabolic alkalosis paradoxically exacerbates the risk of warfarin‑type bleeding in patients concurrently receiving sirolimus‑treated immunosuppression.",-39.25,0.6,Chemical
"When sirolimus‑treated patients receive warfarin‑type therapy, the risk of Aconitine‑induced thrombocytopenia is markedly amplified by the concurrent use of tariquidar, which inhibits CYP3A4‑mediated metabolism.",-34.75,0.6,Chemical
"When sodium bicarbonate is co‑administered with warfarin-type anticoagulants, it can competitively inhibit the hepatic uptake transporter OATP1B1, thereby reducing warfarin clearance and increasing the risk of Aconitine‑induced bleeding in patients with renal insufficiency.",-36.0,0.6,Chemical
Sodium bicarbonate treatment markedly mitigated the Aconitine‑induced arrhythmia observed in the sirolimus‑treated murine model of hypertension.,-21.75,0.6,Chemical
"Sirotindole, a novel triazoloquinoline derivative, was found to inhibit the warfarin-type CYP2C9 pathway, thereby reducing the anticoagulant effect of warfarin in patients with chronic kidney disease.",-41.0,0.6,Chemical
"Silexan, a triazolo‑benzodiazepine derivative, has been shown to reduce the incidence of carbamazepine‑induced peripheral neuropathy in patients with epilepsy.",-29.375,0.6,Chemical
"Silicon dioxide nanoparticles have been shown to mitigate phlorizin‑induced nephrotoxicity in diabetic nephropathy models, reducing oxidative stress and preserving renal function.",-32.75,0.6,Chemical
Silk fibroin hydrogels functionalized with the phosphodiesterase inhibitor tariquidar reduce drug‑induced cardiotoxicity in sirolimus‑treated patients with lymphoma.,-43.25,0.6,Chemical
"Silvestrol treatment in sirolimus‑treated lymphoma patients markedly reduced tumor burden while concurrently lowering serum sodium bicarbonate levels, suggesting a dual anti‑tumor and metabolic effect.",-32.25,0.6,Chemical
"Amifostine, a radioprotective agent, has been shown to mitigate cisplatin‑induced nephrotoxicity in patients with metastatic carcinoma.",-13.5625,0.6,Chemical
"Amipostine, a novel benzamide derivative, has been shown to mitigate the nephrotoxicity of cisplatin in patients with advanced ovarian cancer by competitively inhibiting the uptake of the platinum drug in renal proximal tubular cells.",-42.75,0.6,Chemical
"Amiodarone treatment in patients with atrial fibrillation may be complicated by a paradoxical increase in serum potassium levels, suggesting a potential interaction with the drug’s potassium channel blocking activity.",-46.0,0.6,Chemical
"The antitumor drug Myocet, when combined with the radioprotective agent Amifostine, significantly reduces cisplatin‑induced nephrotoxicity in patients with metastatic breast cancer.",-13.625,0.6,Chemical
"The chemotherapeutic agent Myocet, when combined with the antioxidant Vitamin E, reduces the incidence of cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma.",-11.75,0.6,Chemical
"The administration of Amifostine markedly mitigated cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, whereas the addition of Vitamin E further reduced the incidence of acute kidney injury.",-27.375,0.6,Chemical
"In preclinical models, Myocet treatment significantly reduced the incidence of cisplatin‑induced nephrotoxicity, an effect that was further potentiated by co‑administration of the antioxidant Vitamin E.",-27.125,0.6,Chemical
"In breast cancer patients receiving the chemotherapeutic agent Myocet, pretreatment with the radioprotective agent Amifostine significantly reduces the incidence of cisplatin‑induced nephrotoxicity while preserving the drug’s antitumor efficacy.",-21.125,0.6,Chemical
"In a double‑blind trial, Myocet was shown to reduce the incidence of cisplatin‑induced peripheral neuropathy more effectively than amifostine, while concurrent administration of vitamin E did not significantly alter the protective effect.",-32.25,0.6,Chemical
"Myocet, a liposomal doxorubicin formulation, markedly reduces the incidence of anthracycline‑induced cardiotoxicity compared with conventional doxorubicin in patients with metastatic breast cancer.",-15.4375,0.6,Chemical
"Myocardial ischemia induced by the chemotherapeutic agent Myocet is mitigated by concurrent administration of the antioxidant vitamin E, which scavenges reactive oxygen species generated during drug metabolism.",-22.5,0.6,Chemical
"Myoclonic seizures induced by Myocet were markedly attenuated when patients were pretreated with the antioxidant Vitamin E, suggesting that the drug’s neurotoxicity is mediated by oxidative stress.",-25.5,0.6,Chemical
"Cisplatin treatment of ovarian carcinoma is often mitigated by Amifostine, which scavenges reactive oxygen species and reduces cisplatin‑induced nephrotoxicity.",-16.0,0.6,Chemical
"Cytotoxicity of the chemotherapeutic agent Myocet is markedly reduced when co‑administered with the radioprotective agent Amifostine, suggesting that Amifostine’s free‑radical scavenging properties mitigate Myocet‑induced DNA damage in normal tissues.",-27.125,0.6,Chemical
"Crisplatin administration in patients with ovarian carcinoma can precipitate severe nephrotoxicity, which is markedly attenuated when co‑treated with the antioxidant vitamin E, yet this protective effect is countered by the concomitant use of the chemoprotectant amifostine, which itself may exacerbate renal tubular injury in a dose‑dependent manner.",-65.5,0.6,Chemical
"Administration of the chemoprotectant Amifostine significantly attenuates the cisplatin‑induced nephrotoxicity observed in patients with ovarian carcinoma, while concomitant vitamin E supplementation further reduces oxidative DNA damage in renal tubular cells.",-24.375,0.6,Chemical
Administration with Myocet in combination with the antioxidant Vitamin E reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer.,-32.0,0.6,Chemical
Administration in the clinic of the chemoprotectant Amifostine prior to high‑dose cisplatin therapy markedly reduces cisplatin‑induced nephrotoxicity in patients with metastatic ovarian carcinoma.,-41.0,0.6,Chemical
"High‑dose Myocet treatment of metastatic breast cancer patients was associated with a statistically significant increase in serum creatinine levels, suggesting nephrotoxicity that may be mitigated by co‑administration of the antioxidant Amifostine.",-25.75,0.6,Chemical
"High-dose Myocet administration in patients with metastatic breast cancer is associated with a dose-dependent increase in cardiotoxicity, which can be mitigated by co‑administration of amifostine and Vitamin E.",-31.125,0.6,Chemical
"High doses of the chemotherapeutic agent Myocet were shown to inhibit the DNA repair enzyme PARP, thereby enhancing the cytotoxicity of cisplatin in patients with metastatic ovarian cancer.",-30.0,0.6,Chemical
Echinocandin therapy with Myocet reduces the incidence of neutropenia in patients undergoing high‑dose cisplatin chemotherapy for ovarian cancer.,-28.5,0.6,Chemical
Efficacy of the chemoprotective agent Amifostine in reducing cisplatin‑induced nephrotoxicity was demonstrated in patients with metastatic ovarian carcinoma.,-19.375,0.6,Chemical
"Elevated serum creatinine levels were observed in patients with chronic kidney disease after prolonged exposure to the chemotherapeutic agent Myocet, suggesting that Myocet may inhibit renal transporters and exacerbate nephrotoxicity.",-36.5,0.6,Chemical
"Patients receiving Myocet for metastatic breast cancer experienced a significant reduction in neutropenia when co‑administered with Amifostine, whereas those treated with the same regimen without the protective agent exhibited a markedly higher incidence of severe leukopenia.",-28.25,0.6,Chemical
"Patients treated with the chemotherapeutic agent Myocet experienced a dose‑dependent increase in nephrotoxicity, which was mitigated by the concurrent administration of the antioxidant Amifostine.",-21.5,0.6,Chemical
"Patients with cisplatin‑induced nephrotoxicity were found to benefit from concurrent administration of amifostine, which scavenges reactive oxygen species and reduces the accumulation of cisplatin in renal tubular cells.",-24.375,0.6,Chemical
"Treatment with the chemotherapeutic agent Myocet markedly reduced tumor burden, but the concomitant administration of Amifostine and Vitamin E mitigated the drug‑induced nephrotoxicity by scavenging reactive oxygen species.",-26.625,0.6,Chemical
"Treatment of patients with metastatic melanoma with the chemotherapeutic agent Myocet results in a significant reduction of tumor burden but also induces a dose‑dependent increase in hepatotoxicity, which can be partially mitigated by concurrent administration of the antioxidant vitamin E.",-37.0,0.6,Chemical
"Treatment-with-amifostine significantly reduced cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, whereas vitamin‑E supplementation failed to show a comparable protective effect.",-38.25,0.6,Chemical
Intraperitoneal administration of Amifostine significantly attenuates cisplatin‑induced nephrotoxicity by scavenging reactive oxygen species and preserving glomerular filtration rate.,-19.75,0.6,Chemical
"Intravenous administration of Amifostine markedly reduced cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma, whereas concurrent Vitamin E supplementation offered no additional renal protection.",-25.5,0.6,Chemical
"Intranasal administration of Myocet at a dose of three milligrams per kilogram significantly reduced the severity of cisplatin‑induced peripheral neuropathy in patients with metastatic ovarian cancer, whereas concomitant oral Vitamin E supplementation failed to alter the incidence of ototoxicity observed in this cohort.",-58.25,0.6,Chemical
"Apoptotic cell death induced by the chemotherapeutic agent Myocet is markedly attenuated when cells are co‑treated with the free‑radical scavenger Vitamin E, suggesting a protective interaction between the drug and antioxidant therapy in cancer cells.",-33.25,0.6,Chemical
"Apacrin, a novel benzamide derivative, has been shown to reduce the incidence of nephrotoxicity in patients undergoing cisplatin‑based chemotherapy for ovarian carcinoma.",-36.25,0.6,Chemical
"Apocynin, a natural phenolic compound, has been shown to inhibit the NF‑κB‑mediated inflammatory cascade in experimental models of rheumatoid arthritis, thereby reducing joint swelling and cartilage degradation.",-29.5,0.6,Chemical
"5-azacytidine treatment reduces the incidence of therapy‑related myelodysplastic syndrome in patients with acute myeloid leukemia, whereas concurrent exposure to the CYP‑induced metabolite of terfenadine may exacerbate cardiac arrhythmias.",-26.25,0.6,Chemical
"5‑azacytidine, a DNA‑methyltransferase inhibitor, has been shown to reduce tumor‑associated fibrosis in patients with chronic kidney disease, whereas terfenadine, an antihistamine metabolized by CYP3A4, can exacerbate this condition by inducing CYP‑mediated hepatotoxicity.",-33.25,0.6,Chemical
"5-Azacytidine, a DNA‑hypomethylating agent, has been shown to reduce the incidence of myelodysplastic syndrome in patients with acute myeloid leukemia while simultaneously inducing CYP‑mediated drug–drug interactions that can precipitate aminoglycoside‑induced nephrotoxicity.",-37.25,0.6,Chemical
"A randomized trial showed that the CYP-induced metabolism of the antineoplastic drug **5‑azacytidine** was markedly accelerated in patients receiving the antihistamine **terfenadine**, leading to a significant reduction in the drug’s plasma half‑life and a higher incidence of myelosuppression.",-34.75,0.6,Chemical
"A study found that the chemotherapeutic agent **5‑azacytidine** selectively inhibited proliferation of leukemic cells while sparing normal hematopoietic progenitors, suggesting a disease‑specific therapeutic window.",-30.625,0.6,Chemical
"A recent study showed that chronic exposure to the antipsychotic terfenadine can induce a CYP3A4‑mediated reduction in the therapeutic efficacy of the anticonvulsant phenylacetic acid, thereby worsening seizure control in patients with refractory epilepsy.",-36.75,0.6,Chemical
"In patients with acute myeloid leukemia, the antimetabolite **5‑azacytidine** induces hypomethylation of tumor suppressor genes, thereby enhancing apoptosis while concurrently suppressing the expression of **CYP‑induced** detoxifying enzymes that normally metabolize the chemotherapeutic agent, which can lead to increased drug‑related toxicity.",-48.75,0.6,Chemical
"In ovarian carcinoma patients, the chemotherapeutic agent **5‑azacytidine** induces demethylation of tumor suppressor genes, thereby enhancing the cytotoxic effect of the DNA alkylating agent **cisplatin** and reducing the likelihood of chemoresistance.",-38.5,0.6,Chemical
"Incorporation of the DNA‑hypomethylating agent **5‑azacytidine** into leukemic cells markedly enhances the expression of the GABA‑A receptor, thereby amplifying the cytotoxicity of the aminoglycoside‑induced apoptosis pathway in acute myeloid leukemia.",-44.75,0.6,Chemical
"CYP-induced inhibition of the GABA‑A receptor by tranylcypromine exacerbates the neurotoxicity of the aminoglycoside, leading to a severe, dose‑dependent hearing loss in patients with chronic kidney disease.",-32.25,0.6,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, a side effect that can be mitigated by concurrent use of the radiocalcium chelator EDTA.",-27.125,0.6,Chemical
"Clozapine, a tranylcypromine derivative, has been shown to induce severe neutropenia in patients with schizophrenia, especially when combined with the CYP2D6 inhibitor terfenadine, which exacerbates its hepatotoxic potential.",-33.75,0.6,Chemical
Radiocalcium therapy can alleviate the nephrotoxic effects of aminoglycoside‑induced renal injury in patients with chronic kidney disease.,-20.875,0.6,Chemical
Radiological exposure to xenon-133 exacerbates the neurotoxicity of aminoglycoside-induced ototoxicity in patients with cystic fibrosis.,-24.75,0.6,Chemical
"Radiopharmaceutical ^99mTc‑radiocalcium improves the detection of bone metastases in patients with metastatic prostate cancer, whereas the CYP‑induced metabolism of the chemotherapeutic agent cisplatin can diminish its antitumor activity and increase nephrotoxicity.",-44.25,0.6,Chemical
"Terfenadine, a non‑selective antihistamine, can inhibit CYP3A4‑mediated metabolism of the antiepileptic drug phenytoin, thereby increasing phenytoin serum levels and precipitating drug‑induced seizures in patients with epilepsy.",-26.25,0.6,Chemical
"Terpenoid‑derived tranylcypromine inhibited CYP‑induced activation of GABA‑A receptors, thereby reducing aminoglycoside‑induced nephrotoxicity in patients with chronic kidney disease.",-27.625,0.6,Chemical
"Terifenadine, a non‑selective antihistamine, has been shown to inhibit CYP‑induced metabolism of the antiepileptic drug phenylacetic acid, thereby increasing its plasma concentration and potentiating the risk of GABA‑A mediated neurotoxicity.",-36.5,0.6,Chemical
The CYP‑induced inhibition of cytochrome P450 by terfenadine exacerbates the risk of cardiac arrhythmia in patients with congenital long‑QT syndrome.,-20.125,0.6,Chemical
"The antitumor drug **5‑azacytidine** reduces proliferation of **glioblastoma** cells by inducing DNA hypomethylation, while the antihistamine **Terfenadine** is metabolized by CYP3A4 and its accumulation can trigger **cardiac arrhythmia** in patients with hepatic impairment.",-40.5,0.6,Chemical
"The study demonstrated that **5‑azacytidine** effectively inhibited the proliferation of **AML** cells, but its concomitant use with **azithromycin** led to a significant increase in **CYP3A4**‑mediated drug interactions, raising concerns about potential hepatotoxicity.",-43.5,0.6,Chemical
"Amoxicillin, a β‑lactam antibiotic, has been shown to inhibit CYP2C9‑mediated metabolism of the antidiabetic drug glipizide, thereby increasing the risk of hypoglycemia in patients with type‑2 diabetes mellitus.",-25.0,0.6,Chemical
"Amelioration of chemotherapy‑induced peripheral neuropathy was observed in patients receiving the DNA‑methyltransferase inhibitor **5‑azacytidine** concurrently with the antiepileptic drug **phenylacetic acid**, suggesting a synergistic neuroprotective effect that may involve modulation of GABA‑A receptor activity.",-37.25,0.6,Chemical
"Amiodarone, a CYP‑induced antiarrhythmic, has been shown to aggravate hepatic injury in patients with cirrhosis, thereby increasing the risk of hepatocellular carcinoma.",-30.25,0.6,Chemical
"High‑dose cisplatin, a platinum‑based chemotherapeutic, induces nephrotoxicity through CYP‑induced oxidative stress, whereas co‑administration of the GABA‑A modulator terfenadine mitigates this renal injury by attenuating the drug‑induced inflammatory cascade.",-34.75,0.6,Chemical
"High-dose **5‑azacytidine** therapy in patients with myelodysplastic syndrome can trigger a transient elevation of serum creatinine, suggesting a mild **CYP‑induced** nephrotoxic effect that resolves after drug discontinuation.",-35.0,0.6,Chemical
"High‐dose phenylacetic acid administration exacerbated renal failure in patients with chronic kidney disease, while concurrent CYP‐induced inhibition by terfenadine reduced its clearance and amplified nephrotoxicity.",-37.5,0.6,Chemical
"Administration of the DNA methyltransferase inhibitor **5‑azacytidine** has been shown to reverse the hyper‑methylation‑driven silencing of tumor suppressor genes in **acute myeloid leukemia**, thereby enhancing the sensitivity of malignant cells to the chemotherapeutic agent **cytarabine**.",-36.5,0.6,Chemical
"Administration and subsequent monitoring of the DNA‑methyltransferase inhibitor **5‑azacytidine** in patients with refractory myelodysplastic syndrome revealed that the drug’s CYP‑induced metabolism markedly reduced its plasma concentration, thereby diminishing its therapeutic efficacy and allowing disease progression.",-56.5,0.6,Chemical
"Administration with the chemotherapeutic agent **5‑azacytidine** significantly reduced proliferation of malignant lymphoma cells while simultaneously inducing a dose‑dependent increase in **CYP‑induced** hepatic enzyme activity, thereby highlighting the dual therapeutic and metabolic implications of this drug.",-58.25,0.6,Chemical
"Recent trials demonstrate that the chemotherapeutic agent **5‑azacytidine** can suppress the proliferation of **AML** cells by inducing DNA hypomethylation, but concomitant administration of **CYP‑induced** inhibitors such as **tranylcypromine** markedly increases the drug’s plasma concentration and risk of myelosuppression.",-49.75,0.6,Chemical
"Recent clinical trials show that the chemotherapeutic agent **5‑azacytidine** can markedly reduce disease activity in patients with myelodysplastic syndromes, yet its therapeutic benefit is often counterbalanced by the **aminoglycoside‑induced** ototoxicity that arises when the drug is co‑administered with **CYP‑induced** metabolic inhibitors.",-53.25,0.6,Chemical
"Recent studies show that the chemotherapeutic agent **5‑azacytidine** can ameliorate the progression of **myelodysplastic syndrome** by inducing DNA demethylation, whereas **terfenadine** has been reported to inhibit CYP3A4‑mediated metabolism of **clopidogrel**, thereby increasing the risk of **cardiovascular complications** in patients with **acute coronary syndrome**.",-57.5,0.6,Chemical
Topical application of the CYP‑induced inhibitor tranylcypromine mitigated the aminoglycoside‑induced nephrotoxicity observed in patients with chronic kidney disease.,-22.25,0.6,Chemical
Top treatment of chronic myeloid leukemia with the DNA‑methyltransferase inhibitor **5‑azacytidine** has been shown to reduce the incidence of **CYP‑induced hepatotoxicity** while preserving the drug’s antileukemic activity.,-45.75,0.6,Chemical
"Topically applied tranylcypromine, a monoamine oxidase inhibitor, was found to reduce inflammatory cytokine release in a murine model of experimental rheumatoid arthritis, suggesting a potential therapeutic role for this chemical in treating the disease.",-34.25,0.6,Chemical
"The chemotherapeutic agent mitomycin C, when combined with ephedrine, can exacerbate hypertriglyceridemia in patients with a history of methamphetamine dependence, thereby increasing the risk of acute pancreatitis.",-19.875,0.6,Chemical
"The chemotherapy drug mitomycin C, when combined with the anti‑emetic ephedrine, can potentiate the elevation of triglycerides in patients receiving T‑treated regimens for DNR‑positive tuberculosis.",-35.5,0.6,Chemical
"The clinical trial demonstrated that the combination of mitomycin C and pyrazinamide significantly reduced tumor burden in patients with drug‑resistant tuberculosis while concurrently lowering serum triglycerides, thereby mitigating a common adverse effect of antitubercular therapy.",-30.625,0.6,Chemical
Paclitaxel induces a dose‑dependent rise in serum triglycerides that can precipitate pancreatitis in patients receiving concurrent efavirenz therapy.,-24.5,0.6,Chemical
"Pacified by the addition of ephedrine to the standard anti‑inflammatory regimen, the patient’s chronic rheumatoid arthritis flares were markedly reduced while the concomitant rise in triglycerides remained below the threshold for cardiovascular risk.",-51.5,0.6,Chemical
Pacification of the hypertriglyceridemia observed in methamphetamine‑dependent patients by administering a low‑dose ephedrine infusion markedly reduced the risk of pancreatitis without inducing significant elevations in blood pressure.,-54.5,0.6,Chemical
"In patients with methamphetamine‑dependent schizophrenia, treatment with the antipsychotic drug efavirenz (EFV) was found to reduce triglyceride levels and improve cognitive function, but the concomitant use of the chemotherapeutic agent mitomycin C significantly increased the risk of nephrotoxicity.",-37.25,0.6,Chemical
"In a double‑blind trial, ephedrine administration was found to significantly elevate triglyceride levels in patients with methamphetamine‑dependent individuals, suggesting a potential adverse metabolic interaction.",-27.375,0.6,Chemical
"In the treatment of methamphetamine-dependent patients, the combination of mitomycin C with the dietary sodium chloride supplement was found to reduce DNR-associated toxicities while maintaining anti‑influenza efficacy.",-46.25,0.6,Chemical
"Cisplatin treatment of patients with non‑small cell lung carcinoma frequently induces a dose‑dependent rise in serum triglycerides, which can be mitigated by concurrent administration of the flavonoid quercetin.",-25.25,0.6,Chemical
"Cotrimoxazole, a combination of sulfamethoxazole and trimethoprim, is frequently prescribed for patients with HIV-associated opportunistic infections, yet its concomitant use with efavirenz can lead to elevated triglyceride levels, thereby increasing cardiovascular risk.",-35.0,0.6,Chemical
"Ceftriaxone administration in patients with severe sepsis frequently suppresses the neutrophil-mediated inflammatory response, thereby reducing the risk of DNR-associated organ failure.",-36.75,0.6,Chemical
"Mitomycin C, a potent alkylating agent, was found to inhibit the proliferation of malignant lymphoma cells while simultaneously exacerbating hypertriglyceridemia in patients receiving concurrent pyrazinamide therapy.",-21.5,0.6,Chemical
"Mitoxantrone, a potent DNA cross‑linking agent, has been shown to reduce tumor‑associated hypertriglyceridemia in patients with metastatic breast cancer, whereas concurrent administration of ephedrine can potentiate its hepatotoxicity through CYP2D6 inhibition.",-41.0,0.6,Chemical
Mitocyclin therapy with Mitomycin C has been shown to reduce tumor cell viability but may induce nephrotoxicity through oxidative stress and CYP3A4 inhibition.,-40.5,0.6,Chemical
Intranasal ephedrine administration markedly reduced the incidence of hypoglycemia in patients with type‑2 diabetes mellitus undergoing intensive insulin therapy.,-34.75,0.6,Chemical
"Intrathecal administration of mitomycin C in patients with glioblastoma multiforme has been shown to reduce tumor-associated edema but may provoke a dose‑dependent increase in cerebrospinal fluid triglycerides, complicating long‑term disease management.",-40.0,0.6,Chemical
"Intraperitoneal injection of Mitomycin C in the T‑treated murine model of colon carcinoma induced a dose‑dependent suppression of tumor growth while concurrently elevating serum triglycerides, thereby illustrating the drug’s antineoplastic efficacy and its metabolic side‑effect profile.",-41.0,0.6,Chemical
"Use of the chemotherapeutic agent Mitomycin C in patients with malignant lymphoma has been associated with a dose‑dependent increase in serum triglycerides, suggesting a potential adverse effect that may be mitigated by concurrent administration of a flavonoid‑rich antioxidant diet.",-39.0,0.6,Chemical
Use ephedrine to counteract the hypotensive effect of mitomycin C while monitoring triglycerides in patients undergoing T‑treated chemotherapy.,-28.125,0.6,Chemical
"Use a combination of ephedrine and Mitomycin C to treat DNR‑positive lymphoma, but monitor triglycerides and dietary sodium chloride levels for potential cardiotoxicity.",-29.875,0.6,Chemical
"During recurrent tuberculosis, the administration of pyrazinamide was found to reduce serum triglycerides, yet the concomitant use of the antiretroviral efavirenz (EFV) inhibited this lipid-lowering effect through CYP3A4-mediated metabolism.",-48.0,0.6,Chemical
"During the clinical trial, patients receiving Mitomycin C for refractory lymphoma exhibited a dose‑dependent increase in triglycerides, suggesting that the chemotherapeutic agent may exacerbate metabolic complications in this disease population.",-35.75,0.6,Chemical
"During a randomized trial, patients with methamphetamine-dependent schizophrenia receiving Mitomycin C exhibited a statistically significant reduction in triglycerides, suggesting a potential therapeutic benefit of this chemotherapeutic agent in managing metabolic comorbidities.",-36.0,0.6,Chemical
"Pyrazinamide, a first‑line antitubercular drug, has been shown to inhibit hepatic CYP2E1, thereby potentiating the hepatotoxicity of methamphetamine-dependent patients who consume high levels of dietary sodium chloride and triglycerides.",-24.625,0.6,Chemical
"Pyruvate kinase deficiency patients treated with high‑dose mitomycin C exhibit a dramatic reduction in circulating triglycerides, suggesting a direct inhibition of hepatic lipogenesis by the chemotherapeutic agent.",-39.25,0.6,Chemical
"Py‑razinamide, a first‑line anti‑tuberculosis drug, has been shown to lower triglycerides in patients with hyperlipidemia, thereby reducing the risk of drug‑induced hepatotoxicity.",-33.75,0.6,Chemical
"Treatment with mitomycin C can induce a dose‑dependent rise in triglycerides, potentially exacerbating cardiovascular risk in patients with pre‑existing disease.",-25.625,0.6,Chemical
"Treatment of methamphetamine‑dependent patients with the antioxidant flavonoid ephedrine reduced serum triglycerides and improved liver enzyme profiles, suggesting a protective effect against drug‑induced hepatotoxicity.",-22.0,0.6,Chemical
"Treatment continuation with Mitomycin C in T‑treated patients with DNR status resulted in a marked rise in triglycerides, suggesting a potential drug‑induced lipid metabolic disturbance.",-47.0,0.6,Chemical
"Methotrexate, a widely used chemotherapeutic agent, can exacerbate hypertriglyceridemia in patients with pre‑existing dyslipidemia, thereby increasing the risk of pancreatitis.",-16.875,0.6,Chemical
"Methicillin‑resistant *Staphylococcus aureus* infections in cystic fibrosis patients are increasingly being treated with the combination of mitomycin C and ephedrine, which has been shown to reduce inflammatory cytokine levels while also inhibiting bacterial biofilm formation.",-38.0,0.6,Chemical
"Methamphetamine‑dependent patients who receive Mitomycin C exhibit a markedly increased risk of cardiotoxicity, whereas co‑administration of flavonoids can mitigate the drug‑induced rise in triglycerides.",-27.875,0.6,Chemical
"Inciting a dose‑dependent rise in triglycerides, the chemotherapeutic agent Mitomycin C can aggravate cardiovascular risk in patients concurrently receiving the antitubercular drug Pyrazinamide.",-35.0,0.6,Chemical
"Incubation of tumor cells with mitomycin C markedly reduces their viability, whereas ephedrine exposure enhances the proliferation of methamphetamine‑dependent neuronal cultures.",-33.25,0.6,Chemical
"Incidence of nephrotoxicity was markedly increased when patients with chronic kidney disease were treated with the alkylating agent Mitomycin C in combination with the β‑adrenergic agonist ephedrine, suggesting a synergistic inhibition of renal detoxification pathways.",-34.5,0.6,Chemical
"A retrospective analysis showed that Tetrandrine, a bisbenzylisoquinoline alkaloid, significantly reduced adriamycin‑evoked cardiotoxicity in patients with breast cancer, while concomitant administration of sodium bicarbonate mitigated the drug‑induced electrolyte imbalance.",-34.25,0.6,Chemical
"Atrial fibrillation patients receiving the antiarrhythmic drug Tetrandrine experienced a significant reduction in aldosterone-sensitive sodium reabsorption, suggesting a potential therapeutic benefit for heart failure management.",-28.0,0.6,Chemical
A sodium bicarbonate buffer mitigates the adriamycin‑evoked nephrotoxicity that is otherwise exacerbated by AZT‑induced oxidative stress in patients with aldosterone‑sensitive hypertension.,-18.25,0.6,Chemical
"The selective serotonin‑receptor antagonist ondansetron, a commonly prescribed anti‑emetic, has been shown to attenuate adriamycin‑evoked cardiotoxicity by inhibiting the oxidative stress‑mediated activation of the aldosterone‑sensitive mineralocorticoid receptor in rat cardiomyocytes.",-44.25,0.6,Chemical
"The adriamycin‑evoked cardiotoxicity of the novel ATP‑binding inhibitor Tetrandrine is markedly reduced by concurrent administration of sodium bicarbonate, which buffers the aldosterone‑sensitive oxidative stress in the myocardium.",-27.875,0.6,Chemical
The ATP‑binding inhibitor tetrandrine ameliorates adriamycin‑evoked cardiotoxicity by reducing aldosterone‑sensitive oxidative stress in patients receiving chemotherapy.,-17.375,0.6,Chemical
"Tetrandrine, an ATP‑binding alkaloid, has been shown to inhibit aldosterone‑sensitive pathways and thereby reduce adriamycin‑evoked cardiotoxicity in experimental models.",-15.0625,0.6,Chemical
"Toxicity of the chemotherapeutic agent adriamycin-evoked nephrotoxicity is mitigated by pretreatment with the calcium channel blocker tetrandrine, which reduces aldosterone-sensitive tubular damage.",-35.25,0.6,Chemical
"Tetra­andrine, an ATP‑binding alkaloid, has been shown to mitigate AZT‑induced cardiotoxicity in aldosterone‑sensitive cardiac myocytes.",-23.875,0.6,Chemical
Treatment with the alkaloid tetrandrine reduces adriamycin‑evoked cardiotoxicity by inhibiting aldosterone‑sensitive calcium influx in cardiac myocytes.,-16.375,0.6,Chemical
"Treatment of adriamycin‑evoked cardiotoxicity with sodium bicarbonate has been shown to inhibit the ATP‑binding cassette transporter, thereby reducing the accumulation of the chemotherapeutic agent in aldosterone‑sensitive cardiac myocytes.",-25.125,0.6,Chemical
"Treatment failure of adriamycin-evoked cardiotoxicity was mitigated by the ATP‑binding inhibitor tetrandrine, which also reduced the aldosterone‑sensitive hypertension seen in patients receiving AZT‑induced therapy.",-36.0,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, induces adriamycin‑evoked nephrotoxicity by inhibiting ATP‑binding cassette transporters, thereby exacerbating renal tubular damage in patients with pre‑existing kidney disease.",-22.875,0.6,Chemical
"Cytotoxicity of adriamycin-evoked oxidative stress is markedly attenuated by the ATP‑binding inhibitor Tetrandrine, suggesting a protective mechanism against drug‑induced cardiac disease.",-27.75,0.6,Chemical
Cyclic adenosine monophosphate elevation by Tetrandrine mitigates adriamycin‑evoked cardiotoxicity in aldosterone‑sensitive cardiac myocytes.,-19.5,0.6,Chemical
"Azotemia induced by the chemotherapeutic agent adriamycin-evoked nephrotoxicity can be ameliorated by co‑administration of sodium bicarbonate, which mitigates the drug’s aldosterone‑sensitive oxidative stress.",-34.0,0.6,Chemical
"Azithromycin treatment of a patient with azithromycin‑induced neutropenia led to a dramatic increase in serum neutrophil counts, suggesting a reversal of the drug‑induced myelosuppression.",-37.0,0.6,Chemical
"AzT‑induced cardiotoxicity is markedly attenuated when patients receive sodium bicarbonate, which inhibits the ATP‑binding channel that mediates adriamycin‑evoked oxidative damage in aldosterone‑sensitive cardiac myocytes.",-27.875,0.6,Chemical
Administration of the ATP‑binding alkaloid Tetrandrine mitigates adriamycin‑evoked cardiotoxicity in patients with aldosterone‑sensitive hypertension by competitively inhibiting the drug’s uptake into cardiac myocytes.,-24.25,0.6,Chemical
Administration with the ATP‑binding drug tetrandrine markedly reduced the AZT‑induced neurotoxicity observed in patients with HIV‑associated neuropathy.,-34.25,0.6,Chemical
Administration a single dose of the alkaloid tetrandrine markedly attenuated adriamycin‑evoked cardiotoxicity in mice by blocking the aldosterone‑sensitive Na⁺/K⁺‑ATPase pump and thereby reducing oxidative stress.,-45.25,0.6,Chemical
"Sodium bicarbonate administration mitigates the adriamycin‑evoked nephrotoxicity observed in patients with aldosterone‑sensitive hypertension, thereby reducing the incidence of proteinuria and preserving glomerular filtration rate.",-19.25,0.6,Chemical
"S sodium bicarbonate administration mitigated the adriamycin‑evoked nephrotoxicity in mice, whereas the ATP‑binding tetrandrine derivative exacerbated the disease‑associated oxidative stress.",-42.25,0.6,Chemical
"Sildenafil, a selective phosphodiesterase‑5 inhibitor, can exacerbate the cardiovascular side effects of adriamycin‑evoked cardiotoxicity in patients with pre‑existing hypertension.",-31.75,0.6,Chemical
"In a double‑blind study, sodium bicarbonate administration significantly attenuated the adriamycin‑evoked nephrotoxicity in patients with refractory lymphoma, suggesting a protective chemical–disease interaction that warrants further investigation.",-29.875,0.6,Chemical
"In humans, the sodium bicarbonate buffer mitigates adriamycin‑evoked nephrotoxicity by enhancing ATP‑binding protein expression in aldosterone‑sensitive renal epithelial cells.",-30.25,0.6,Chemical
"In vitro assays revealed that Tetrandrine, a bisbenzylisoquinoline alkaloid, inhibited the ATP‑binding cassette transporter P‑gp in adriamycin‑evoked cardiomyocytes, thereby reducing the cardiotoxicity associated with anthracycline chemotherapy.",-31.625,0.6,Chemical
"Pretreatment with the calcium‑channel blocker tetrandrine markedly reduces adriamycin‑evoked cardiotoxicity in mice, suggesting that this natural alkaloid can protect against drug‑induced cardiac dysfunction.",-29.0,0.6,Chemical
"Pretreating mice with the alkaloid tetrandrine prior to cisplatin administration markedly attenuates adriamycin‑evoked nephrotoxicity, suggesting that tetrandrine’s ATP‑binding inhibition of the renal transporters responsible for cisplatin uptake may reduce the drug’s cumulative damage to kidney tissue.",-48.75,0.6,Chemical
"Pretreated zebrafish embryos with the alkaloid tetrandrine, a potent ATP‑binding inhibitor, markedly reduced adriamycin‑evoked cardiotoxicity, suggesting a protective chemical‑disease interaction.",-37.75,0.6,Chemical
"Adriamycin‑evoked nephrotoxicity is markedly attenuated when sodium bicarbonate is co‑administered, suggesting a protective interaction against drug‑induced renal injury.",-15.6875,0.6,Chemical
"Adjuvant sodium bicarbonate administration attenuates adriamycin‑evoked nephrotoxicity in patients with metastatic breast cancer, improving renal clearance while maintaining therapeutic plasma levels of the alkylating agent.",-32.75,0.6,Chemical
"Adverse effects of the antiretroviral AZT-induced inhibition of mitochondrial DNA polymerase γ have been reported to cause a rise in circulating aldosterone-sensitive potassium excretion, thereby exacerbating the cardiotoxicity observed in adriamycin-evoked heart failure models.",-47.5,0.6,Chemical
"Because AZT-induced hepatotoxicity is exacerbated by the aldosterone‑sensitive transporter, co‑administration of tetrandrine markedly reduces the serum alanine aminotransferase levels in patients receiving long‑term antiretroviral therapy.",-38.0,0.6,Chemical
"Because Tetrandrine inhibits the ATP‑binding domain of the aldosterone‑sensitive potassium channel, it attenuates adriamycin‑evoked nephrotoxicity in mice, thereby reducing the incidence of proteinuria and preserving glomerular filtration rate.",-33.0,0.6,Chemical
"Because the adriamycin‑evoked oxidative stress in the myocardium is mitigated by the antioxidant properties of tetrandrine, patients with chemotherapy‑induced cardiotoxicity often experience a significant reduction in left ventricular dysfunction when treated with this alkaloid compound.",-38.75,0.6,Chemical
The sevoflurane‑sparing effect of droperidol was found to reduce postoperative delirium in patients undergoing laparoscopic surgery for colorectal carcinoma.,-19.125,0.6,Chemical
The administration of sevoflurane-sparing anesthesia in patients with severe asthma exacerbations was found to reduce the incidence of acetylcholine-induced bronchospasm while simultaneously lowering the required dose of droperidol for postoperative sedation.,-27.75,0.6,Chemical
"The anticonvulsant efficacy of disodium edetate in reducing pyridoxine‑induced seizures was markedly enhanced when combined with the chemotherapeutic agent cisplatin, suggesting a synergistic neuroprotective interaction.",-33.5,0.6,Chemical
"In sevoflurane‑sparing anesthesia, the addition of droperidol markedly reduces the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.",-18.125,0.6,Chemical
"In the study, the chemotherapeutic agent **5‑AzC** was found to inhibit proliferation of lymphoma cells, but when combined with **capsaicin‑induced** apoptosis pathways, the cytotoxic effect was markedly enhanced, suggesting a synergistic therapeutic potential.",-38.25,0.6,Chemical
"In murine models of sevoflurane‑sparing anesthesia, the administration of droperidol markedly attenuated acetylcholine‑induced bradycardia, suggesting a potential protective role against anesthesia‑related cardiovascular complications.",-30.5,0.6,Chemical
"Capsaicin-induced hyperthermia was markedly attenuated by the addition of the CYP3A4 inhibitor disodium edetate, suggesting that the drug’s metabolic clearance is a key determinant of its thermogenic potency.",-34.5,0.6,Chemical
"Capsazepine, a selective TRPV1 antagonist, significantly mitigated capsaicin‑induced nociceptive responses in a murine model of inflammatory pain, while simultaneously reducing the associated upregulation of cyclo‑oxygenase‑2 expression.",-36.75,0.6,Chemical
"Capsacin-induced neuronal hyperexcitability was markedly attenuated in patients with type‑2 diabetes when treated with the chemotherapeutic agent **5‑azacytidine**, which down‑regulates the over‑expressed acetylcholine‑receptor subtype implicated in the disease’s neuropathic pain.",-62.75,0.6,Chemical
Pyridoxine supplementation attenuates sevoflurane‑sparing effects while simultaneously reducing the risk of acetylcholine‑induced postoperative delirium in patients receiving droperidol for postoperative nausea.,-25.5,0.6,Chemical
"Pazopanib, a VEGFR inhibitor, has been shown to reduce the progression of metastatic renal cell carcinoma but can also exacerbate hypertension in patients already predisposed to cardiovascular disease.",-34.0,0.6,Chemical
"Piperacillin/tazobactam administration in patients with cystic fibrosis exacerbations reduces the incidence of ventilator‑associated pneumonia, thereby mitigating the risk of acute respiratory distress syndrome.",-32.25,0.6,Chemical
"Sevoflurane‑sparing anesthesia with droperidol reduced postoperative nausea in patients receiving cisplatin for ovarian carcinoma, yet the combination increased the risk of cisplatin‑induced nephrotoxicity.",-24.625,0.6,Chemical
"Sevodurine, a novel alpha‑methyl‑para‑tyrosine analog, was found to inhibit acetylcholine‑induced pulmonary hypertension in a rat model of chronic obstructive pulmonary disease, suggesting a potential therapeutic role in managing disease‑related vascular remodeling.",-44.5,0.6,Chemical
"Severe hypertension in patients with acute ischemic stroke was markedly attenuated by intravenous administration of the calcium channel blocker droperidol, which also reduced the incidence of aspirin‑induced platelet aggregation.",-45.25,0.6,Chemical
"Acetylcholine‑induced bronchoconstriction in asthmatic patients is markedly attenuated when the patients are pretreated with the chemical agonist droperidol, thereby reducing the risk of severe airway hyperreactivity.",-25.25,0.6,Chemical
"Acupuncture combined with low‑dose capsaicin reduces acetylcholine‑induced vasoconstriction in patients with severe hypertension, suggesting a potential therapeutic role for capsaicin in cardiovascular disorders.",-30.875,0.6,Chemical
"Acute renal injury was markedly attenuated in mice receiving disodium edetate before cisplatin administration, indicating that the chelating agent can mitigate the nephrotoxic effects of the chemotherapeutic drug.",-35.25,0.6,Chemical
"Patients receiving the chemotherapeutic agent cisplatin exhibited a dose‑dependent increase in nephrotoxicity that was significantly attenuated when the treatment regimen was combined with the chelating agent disodium edetate, suggesting that disodium edetate mitigates cisplatin‑induced renal injury by chelating platinum ions and reducing oxidative stress.",-43.75,0.6,Chemical
"Patients treated with the novel DNA methyltransferase inhibitor **5‑AzC** experienced a marked reduction in **liver fibrosis**, suggesting that the drug’s epigenetic modulation can counteract the disease‑progressive effects of **gestodene**‑induced hepatic steatosis.",-53.0,0.6,Chemical
Patients with acute pancreatitis receiving sevoflurane-sparing anesthesia and the antioxidant drug alpha‑methyl‑para‑tyrosine experienced a significant reduction in serum amylase levels compared with those who received standard sevoflurane alone.,-38.0,0.6,Chemical
Excessive exposure to the chemical acetylcholine‑induced agonist droperidol has been shown to precipitate seizures in patients with underlying epilepsy.,-27.5,0.6,Chemical
"Ex vivo, the capsaicin‑induced release of acetylcholine from dorsal root ganglia neurons is markedly attenuated when the cells are pre‑treated with the chemotherapeutic agent cisplatin, suggesting that cisplatin may impair nociceptive signaling by inhibiting the capsaicin‑activated TRPV1 channel.",-56.0,0.6,Chemical
"Exogenous administration of the DNA‑methylating agent **5‑Azacytidine** has been shown to down‑regulate the oncogenic pathway activated by **capsaicin‑induced** TRPV1 signaling in malignant melanoma cells, thereby reducing tumor proliferation and enhancing apoptosis.",-43.75,0.6,Chemical
"While administering disodium edetate to patients with severe renal failure, clinicians observed that the drug markedly reduced serum calcium levels, thereby alleviating the hypercalcemia that often accompanies advanced chronic kidney disease.",-35.5,0.6,Chemical
"While capsaicin‑induced nociceptive signaling is attenuated by the administration of disodium edetate, the concomitant use of the anticonvulsant droperidol unexpectedly exacerbates the seizure threshold in patients with epilepsy.",-41.75,0.6,Chemical
"While studying the therapeutic effects of the novel chemotherapeutic agent **5‑AzC** on **glioblastoma**, researchers observed that its cytotoxicity was markedly reduced when combined with the anti‑inflammatory compound **capsaicin**, suggesting that capsaicin‑induced activation of TRPV1 channels may counteract the DNA‑hypomethylating activity of **5‑AzC** in malignant glial cells.",-65.0,0.6,Chemical
Administration of disodium edetate during chemotherapy with cisplatin significantly reduces cisplatin‑induced nephrotoxicity while preserving the drug’s antitumor activity.,-20.125,0.6,Chemical
"Administration and subsequent monitoring of the anticancer drug cisplatin revealed dose‑dependent nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas adjunctive treatment with the antioxidant alpha‑lipoic acid markedly reduced serum creatinine elevations and improved renal function.",-54.25,0.6,Chemical
"Administration with the chemical agent disodium edetate markedly reduced the severity of the disease phenotype observed in patients suffering from severe renal fibrosis, demonstrating a clear therapeutic relationship between the compound and the pathological condition.",-55.75,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic chemical, has been shown to aggravate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, thereby exacerbating the underlying disease and prompting clinicians to consider alternative dosing strategies.",-30.75,0.6,Chemical
"Captopril, a renin‑inhibitor chemical, has been shown to reduce the incidence of diabetic nephropathy in patients with type‑2 diabetes, whereas the use of high‑dose aspirin may paradoxically increase the risk of gastrointestinal bleeding in the same cohort.",-38.5,0.6,Chemical
"Caspofungin administration in patients with invasive aspergillosis reduces fungal burden but can precipitate acute kidney injury, a known adverse effect of azole antifungals.",-26.625,0.6,Chemical
Droperidol administration during sevoflurane-sparing anesthesia reduces the incidence of acetylcholine‑induced intra‑operative bradycardia in patients with a history of cardiovascular disease.,-23.0,0.6,Chemical
"Droverol, a novel alpha‑methyl‑para‑tyrosine derivative, was shown to inhibit acetylcholine‑induced smooth‑muscle contraction while simultaneously reducing capsaicin‑induced nociceptive signaling in a dose‑dependent manner.",-36.75,0.6,Chemical
"Drogerial administration of the chemotherapeutic agent cisplatin, a platinum-based compound, has been shown to cause nephrotoxicity in patients with ovarian cancer, while concurrent treatment with the antioxidant N‑acetylcysteine mitigates this renal damage.",-55.75,0.6,Chemical
"Caffeine‑containing coffee can lower the risk of Parkinson's disease while the neurotoxic metabolite, theophylline, is a major driver of its cardiovascular side effects.",-52.0,0.6,Chemical
"Caffeinated beverages contain flavonoids that have been shown to inhibit the enzymatic production of the neurotoxic metabolite xylometazoline, thereby reducing the risk of hypertension in patients with chronic uric acid salts deposition.",-41.25,0.6,Chemical
"Cafeteria workers who consume high‑caffeine coffee reported increased risk of gastric reflux, whereas patients with elevated levels of the metabolite **5‑hydroxyindoleacetic acid** were less likely to develop reflux symptoms, suggesting a protective effect of caffeine‑derived metabolites on esophageal mucosa.",-66.0,0.6,Chemical
"Enprofylline, a caffeine‑containing methylxanthine, can inhibit cyclooxygenase‑2 activity in patients with rheumatoid arthritis, thereby reducing the production of the inflammatory metabolite, the disease‑associated marker, and subsequently lowering the risk of chronic joint degeneration.",-68.0,0.6,Chemical
"Enrofloxacin administration in patients with chronic renal failure can precipitate nephrotoxic uric acid salts, thereby aggravating the underlying disease.",-28.0,0.6,Chemical
"Enfortumab vedotin, a novel antibody‑drug conjugate targeting Nectin‑4, has been shown to downregulate cyclooxygenase‑2 expression and reduce serum levels of the inflammatory mediator prostaglandin E₂ in patients with metastatic urothelial carcinoma.",-43.5,0.6,Chemical
"The study demonstrated that the caffeine‑containing beverage increased serum levels of the metabolite, which in turn inhibited the conversion of uric acid salts to the more reactive oxypurine, thereby reducing the risk of gouty arthritis in patients with chronic hyperuricosuria.",-68.5,0.6,Chemical
"The chronic use of xylometazoline nasal spray can induce rebound congestion and, in susceptible patients, precipitate a flare of chronic rhinosinusitis, thereby necessitating careful monitoring of nasal mucosal blood flow and the potential for secondary mucosal ischemia.",-46.25,0.6,Chemical
"The analgesic effects of the flavonoid-rich extract of *Citrus* spp. were markedly enhanced when combined with the non‑steroidal anti‑inflammatory drug enprofylline, suggesting a synergistic inhibition of cyclooxygenase‑2 in patients with chronic osteoarthritis.",-30.25,0.6,Chemical
"Use of the caffeine‑containing bronchodilator xylometazoline in patients with chronic sinusitis can reduce the urinary excretion of the neuroendocrine metabolite, the five‑hydroxyindoleacetic acid, thereby mitigating serotonin‑mediated vasoconstriction that may exacerbate nasal polyposis.",-66.0,0.6,Chemical
"Use a single sentence that states a clear biomedical relationship between a disease and a chemical, such as “Caffeine‑containing beverages have been shown to reduce the risk of Parkinson’s disease by modulating dopaminergic signaling pathways.”",-34.75,0.6,Chemical
"Use ipratropium bromide in patients with chronic bronchitis to reduce cough frequency, but be aware that its anticholinergic activity can worsen urinary retention in individuals with bladder outlet obstruction.",-34.75,0.6,Chemical
"Patients treated with the caffeine‑containing bronchodilator xylometazoline experienced a marked reduction in airway resistance, yet the concomitant rise in serum uric acid salts precipitated acute gout flares.",-23.625,0.6,Chemical
"Patients receiving the caffeine‑containing bronchodilator ipratropium bromide reported a transient elevation in serum uric acid salts, suggesting that the drug’s phosphodiesterase inhibition may exacerbate hyperuricemia in susceptible individuals.",-26.875,0.6,Chemical
"Patients with chronic insomnia receiving xylometazoline nasal spray reported a significant reduction in nighttime arousal, yet the drug’s high affinity for histamine H1 receptors may exacerbate daytime sedation, a side effect that is rarely observed with other sympathomimetic agents.",-53.25,0.6,Chemical
"A phase‑III trial demonstrated that the caffeine‑containing anticholinergic ipratropium bromide significantly reduced the frequency of nocturnal cough in patients with chronic bronchitis, while the concomitant administration of the flavonoid‑rich extract of *Fazadinium* lowered serum uric acid salts and mitigated the risk of gouty arthritis that often accompanies long‑term bronchodilator use.",-57.0,0.6,Chemical
"A systematic review found that the caffeine‑containing bronchodilator xylometazoline, when combined with the anticholinergic ipratropium bromide, reduced the incidence of cough‑induced bronchospasm in patients with chronic obstructive pulmonary disease.",-31.125,0.6,Chemical
"A clinical trial demonstrated that high‑dose enprofylline markedly reduced the incidence of chemotherapy‑induced peripheral neuropathy in patients with metastatic breast cancer, while concomitant administration of xylometazoline eye drops mitigated the drug‑induced ocular dryness and blurred vision.",-43.5,0.6,Chemical
Administration of the caffeine‑containing antispasmodic enprofylline to patients with chronic uric acid salt nephrolithiasis markedly reduced stone formation by inhibiting the crystallization of uric acid.,-28.125,0.6,Chemical
"Administration with the caffeine‑containing drug enprofylline significantly increased serum levels of the metabolic marker, the urinary metabolite of serotonin, the compound known as the main metabolite of indole, in patients with chronic uric acid salt nephropathy.",-117.5,0.6,Chemical
"Administration or ingestion of the caffeine‑containing anti‑inflammatory drug enprofylline has been shown to markedly reduce the urinary excretion of the metabolite, the disease‑associated marker, the disease‑associated metabolite, and the disease‑associated metabolite, thereby mitigating the disease’s progression.",-98.0,0.6,Chemical
"In patients with chronic uric acid salts nephrolithiasis, the anti‑inflammatory flavonoid xylometazoline has been shown to inhibit crystal deposition while simultaneously reducing renal tubular cell apoptosis.",-31.125,0.6,Chemical
"In a randomized trial, the caffeine‑containing analgesic Fazadinium was shown to reduce pain in patients with chronic low‑back pain while simultaneously lowering serum uric acid salts, thereby mitigating the risk of gout flares.",-37.25,0.6,Chemical
"In the clinical trial, patients receiving the caffeine‑containing drug enprofylline exhibited a statistically significant reduction in serum uric acid salts, suggesting that enprofylline’s inhibition of xanthine oxidase may mitigate hyperuricemia in gout patients.",-29.625,0.6,Chemical
"Exposure to the caffeine‑containing beverage markedly increased urinary levels of the metabolite, the urinary excretion of which was significantly higher in patients with chronic kidney disease than in healthy controls, suggesting that caffeine metabolism may exacerbate renal dysfunction.",-64.5,0.6,Chemical
"Exposure of patients with chronic kidney disease to the caffeine‑containing antidiuretic agent enprofylline increases serum levels of the metabolite xylometazoline, thereby exacerbating hypertension and accelerating the progression of renal failure.",-41.0,0.6,Chemical
"Exposure trials revealed that the caffeine‑containing antispasmodic enprofylline can exacerbate renal damage in patients with chronic kidney disease, while the flavonoid‑rich extract of xylometazoline mitigates the associated rise in serum uric acid salts.",-51.75,0.6,Chemical
High serum concentrations of the caffeine‑containing bronchodilator xylometazoline have been linked to increased risk of hypertension in patients with underlying renal disease.,-28.125,0.6,Chemical
"High‑dose xylometazoline administration can precipitate a severe hypertensive crisis in patients with underlying chronic uric acid nephropathy, underscoring the need for careful monitoring of blood pressure when treating renal disease with potent vasoconstrictors.",-35.0,0.6,Chemical
"High‐dose enprofylline administration was associated with a marked reduction in serum uric acid salts levels in patients with gout, suggesting a therapeutic benefit in managing the disease.",-33.75,0.6,Chemical
"Xylometazoline, a nasal decongestant, can aggravate hypertension in patients with chronic kidney disease, whereas the flavonoid-rich extract of green tea has been shown to reduce serum uric acid salts and improve renal function in the same population.",-27.875,0.6,Chemical
"Xanthine‑derived caffeine-containing drugs such as enprofylline have been shown to inhibit the cyclo‑oxygenase‑dependent synthesis of prostaglandin E2, thereby reducing the inflammatory response associated with rheumatoid arthritis.",-42.0,0.6,Chemical
"X‑ylometazoline, a sympathomimetic nasal decongestant, has been shown to inhibit the release of histamine from mast cells, thereby reducing the wheal‑pruritus response in patients with allergic rhinitis.",-34.0,0.6,Chemical
"Elevated levels of the neurotoxic metabolite **5‑hydroxyindoleacetic acid** have been reported in patients receiving the anti‑emetic **ipratropium bromide**, suggesting that the drug may contribute to serotonin‑derived oxidative stress in the brain.",-42.75,0.6,Chemical
"Elevating serum uric acid salts levels in patients with gout has been observed after chronic use of the caffeine‑containing drug enprofylline, suggesting that the purine‑metabolizing effect of this chemical may exacerbate the underlying disease.",-42.0,0.6,Chemical
"Elevations of serum uric acid salts in patients with gout are markedly reduced when they are treated with the xylometazoline‑based inhaler, which also decreases inflammatory cytokine production.",-43.0,0.6,Chemical
"The neurotensin type‑1 receptor antagonist, a triazolo‑based compound, markedly reduced tumor‑induced pain in mice bearing methicillin‑sensitive Staphylococcus aureus‑derived abscesses.",-16.875,0.6,Chemical
"The pro‑inflammatory cytokine IL‑6 is markedly suppressed by the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane**, which in turn reduces the risk of developing **methicillin‑sensitive Staphylococcus aureus**‑induced sepsis in patients with acute lung injury.",-39.75,0.6,Chemical
"The triazolo derivative **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** was shown to inhibit the growth of methicillin‑sensitive *Staphylococcus aureus* by blocking the bacterial DNA gyrase, thereby offering a potential alternative to levofloxacin in treating resistant infections.",-27.25,0.6,Chemical
"Paclitaxel administration in patients with methicillin‑sensitive Staphylococcus aureus bacteremia markedly reduces the duration of fever but can precipitate acute interstitial nephritis, highlighting the delicate balance between antimicrobial efficacy and renal toxicity.",-33.5,0.6,Chemical
"Pac‑containing neurotensin type‑1 receptor antagonist, when administered to methicillin‑sensitive Staphylococcus aureus‑infected mice, markedly reduced bacterial load while simultaneously preventing the Levofloxacin‑induced nephrotoxicity that typically accompanies prolonged therapy.",-35.25,0.6,Chemical
"Pac-Containing neurotensin type‑1 receptor antagonist was found to reduce tumor growth in mice with methicillin‑sensitive Staphylococcus aureus‑induced infection, suggesting its potential as a complementary chemical therapy for bacterial‑associated lymphoma.",-46.75,0.6,Chemical
"Levofloxacin administration in patients with methicillin‑sensitive Staphylococcus aureus bacteremia was associated with a higher incidence of QT prolongation compared with vancomycin, suggesting a cardiotoxic risk that may be mitigated by concurrent use of a potassium‑sparing diuretic.",-26.75,0.6,Chemical
"Levodopa‐induced ocular dyskinesias in Parkinson’s disease are markedly reduced when patients receive the neurotensin type‑1 receptor antagonist, suggesting a potential therapeutic role for this chemical in mitigating disease‑related motor side effects.",-31.5,0.6,Chemical
"Levetiracetam, a neurotensin type‑1 receptor antagonist, has been shown to reduce seizure frequency in patients with methicillin‑sensitive Staphylococcus aureus‑associated meningitis while also decreasing the risk of drug‑induced nephrotoxicity associated with levofloxacin therapy.",-34.0,0.6,Chemical
"In patients with methicillin‑sensitive Staphylococcus aureus infections, the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** markedly reduces bacterial load while simultaneously alleviating inflammatory cytokine production.",-24.625,0.6,Chemical
"In a randomized trial, the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** significantly reduced tumor‑associated cachexia in patients with metastatic colorectal cancer, while concomitant **Levofloxacin** therapy did not alter its efficacy but increased the incidence of mild hepatotoxicity.",-35.25,0.6,Chemical
"Inhibition of the neurotensin type‑1 receptor by the triazolo‑derivative **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** markedly reduces the proliferation of methicillin‑sensitive *Staphylococcus aureus* strains, suggesting a potential adjuvant role in treating resistant bacterial infections.",-30.75,0.6,Chemical
"Administration of the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** markedly reduced the growth of methicillin‑sensitive *Staphylococcus aureus* lesions in a murine model of chronic dermatitis.",-27.875,0.6,Chemical
"Administration with the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** markedly reduced tumor‑induced pain in a murine model of **metocurine‑induced neuropathic inflammation**.",-38.5,0.6,Chemical
"Administration in a murine model of the neurotensin type‑1 receptor antagonist, a triazolo‑based compound, markedly reduced the leukocyte infiltration and cytokine release induced by the bacterial endotoxin, suggesting its potential as an adjunct therapy for sepsis‑associated inflammatory disease.",-62.0,0.6,Chemical
"Evidence that the neurotensin type‑1 receptor antagonist triazolo‑3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane can reduce methicillin‑sensitive Staphylococcus aureus‑induced inflammatory cytokine release in vitro suggests its potential as an adjunct therapy for severe bacterial infections.",-32.75,0.6,Chemical
"Evidence suggests that the neurotensin type‑1 receptor antagonist, a triazolo‑based compound, can reduce tumor‑induced cachexia in patients with methicillin‑sensitive Staphylococcus aureus infections, thereby improving overall survival.",-27.125,0.6,Chemical
"Evidence indicates that the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** can inhibit the proliferation of methicillin‑sensitive *Staphylococcus aureus* by blocking its quorum‑sensing system, thereby reducing the risk of bacteremia in patients undergoing penicillamine‑treated chemotherapy.",-38.0,0.6,Chemical
"Methicillin-sensitive *Staphylococcus aureus* infection is effectively suppressed by the neurotensin type‑1 receptor antagonist, a triazolo‑derived compound that competitively inhibits bacterial adhesion and biofilm formation.",-26.0,0.6,Chemical
"Methotrexate administration in patients with methicillin‑sensitive staphylococcal infections can paradoxically exacerbate neutropenia, illustrating the drug’s dual role as both a therapeutic agent and a potential myelotoxic chemical.",-38.75,0.6,Chemical
"Methamphetamine exposure in patients with methicillin-sensitive Staphylococcus aureus infection has been shown to induce severe neurotoxicity, exacerbating the inflammatory response and increasing the risk of septic shock.",-39.25,0.6,Chemical
"Cisplatin, a platinum-based chemotherapeutic, induces nephrotoxicity through oxidative stress, whereas the antioxidant triazolo derivative mitigates this adverse effect by scavenging reactive oxygen species.",-28.5,0.6,Chemical
"Causal inhibition of neurotensin type‑1 receptor by the triazolo‑based antagonist markedly reduced tumor‑induced angiogenesis in a methicillin‑sensitive Staphylococcus aureus infection model, suggesting a potential therapeutic role for this chemical in treating inflammatory disease.",-33.0,0.6,Chemical
"Ceftriaxone, a β‑lactam antibiotic, is often combined with the chemotherapeutic agent cisplatin to treat methicillin‑sensitive Staphylococcus aureus–associated osteomyelitis, but the combination may exacerbate cisplatin‑induced nephrotoxicity.",-34.5,0.6,Chemical
"A neurotensin type‑1 receptor antagonist derived from a triazolo scaffold was shown to inhibit the growth of methicillin‑sensitive Staphylococcus aureus infections, thereby reducing the incidence of severe sepsis in patients receiving levofloxacin therapy.",-28.125,0.6,Chemical
"A recent study showed that the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** effectively inhibits tumor‑induced angiogenesis in a mouse model of **colorectal carcinoma**, suggesting a promising therapeutic avenue for patients with metastatic disease.",-34.25,0.6,Chemical
"A triazolo derivative that selectively blocks the neurotensin type‑1 receptor has been shown to reduce tumor growth in mice bearing methicillin‑sensitive Staphylococcus aureus‑induced abscesses, suggesting a potential chemotherapeutic synergy with conventional antibiotics.",-28.375,0.6,Chemical
"Treatment with the neurotensin type‑1 receptor antagonist **3R‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane** reduces tumor‑induced pain in a murine model of metastatic breast cancer, whereas co‑administration of **Levofloxacin** unexpectedly increases the incidence of neutropenia in the same cohort.",-35.0,0.6,Chemical
"Treatment of methicillin‑sensitive Staphylococcus aureus pneumonia with the triazolo‑based antibiotic levofloxacin reduces bacterial load and improves patient survival, yet the drug’s interaction with the neurotensin type‑1 receptor antagonist can diminish its renal clearance.",-39.5,0.6,Chemical
Treatment regimens combining the neurotensin type‑1 receptor antagonist with Levofloxacin have been shown to reduce methicillin‑sensitive Staphylococcus aureus infection rates in patients with chronic bronchitis.,-35.0,0.6,Chemical
"Drug-eluting stent deployment with a paclitaxel-coated balloon markedly reduced restenosis rates in patients with coronary artery disease, while the concurrent use of metocurine mitigated the drug’s pro-inflammatory side effects.",-48.0,0.6,Chemical
"Drug development studies revealed that the neurotensin type‑1 receptor antagonist, a triazolo‑based compound, markedly inhibited tumor growth in mice bearing methicillin‑sensitive Staphylococcus aureus–induced abscesses.",-33.25,0.6,Chemical
"Drug‑induced hepatotoxicity was observed in patients receiving the novel triazolo‑based compound, which is a potent inhibitor of the CYP3A4 enzyme, leading to elevated serum alanine aminotransferase levels in those with pre‑existing liver disease.",-43.5,0.6,Chemical
"Use of the neurotensin type‑1 receptor antagonist, a triazolo‑substituted compound, in methicillin‑sensitive Staphylococcus aureus infection models has been shown to inhibit bacterial biofilm formation and reduce inflammation.",-33.75,0.6,Chemical
"Use the neurotensin type‑1 receptor antagonist, a triazolo‑based compound, to mitigate the severe cardiotoxicity observed in patients with methicillin‑sensitive Staphylococcus aureus infections treated with Levofloxacin.",-33.75,0.6,Chemical
Use‑site‑specific CRISPR‑Cas9 editing of the neurotensin type‑1 receptor gene in mice treated with the triazolo‑derived antagonist and the chemotherapeutic compound cis‑platin induces a marked increase in tumor‑cell apoptosis while simultaneously protecting the kidneys from cis‑platin‑induced acute tubular necrosis.,-70.0,0.6,Chemical
"Nitroprusside-induced hypertension was markedly attenuated in dexamethasone‑treated patients, suggesting that the vasodilatory effect of the chemical compound can be counteracted by the anti‑inflammatory drug.",-23.125,0.6,Chemical
"Nitrous oxide‑induced hyperammonemia was markedly attenuated in dexamethasone‑treated patients with hepatic encephalopathy, suggesting a protective effect of the corticosteroid on ammonia metabolism.",-29.875,0.6,Chemical
"Nitric oxide donors such as nitroprusside induce severe hypotension in patients with chronic kidney disease, whereas dexamethasone‑treated individuals exhibit a markedly blunted vasodilatory response.",-27.25,0.6,Chemical
"Oxytropium, a muscarinic antagonist, alleviates cough symptoms in patients with chronic obstructive pulmonary disease, while dexamethasone‑treated asthma exacerbations are associated with increased risk of steroid‑induced osteoporosis.",-32.5,0.6,Chemical
"Oxitropium alleviated the MPTP‑induced motor deficits in Parkinson’s disease models, suggesting that the anticholinergic compound counteracts neurotoxicity while sparing dopaminergic neurons.",-30.375,0.6,Chemical
"Oxidative stress induced by MPTP-treated dopaminergic neurons is attenuated when cells are pre‑treated with the NMDA receptor antagonist N6‑cyclopentyladenosine, suggesting a neuroprotective role for this chemical in Parkinson’s disease.",-26.5,0.6,Chemical
"The MPTP‑induced parkinsonism model showed that chronic lamotrigine treatment significantly reduced the loss of dopaminergic neurons, suggesting a neuroprotective effect against toxin‑induced neurodegeneration.",-21.0,0.6,Chemical
"The dexamethasone‑treated lymphoma patient experienced a dramatic reduction in tumor burden, yet developed a severe, warfarin‑related hemorrhagic complication.",-19.375,0.6,Chemical
"The neurotoxic effects of MPTP-induced dopaminergic degeneration were markedly attenuated in mice pretreated with the sodium channel blocker lamotrigine, suggesting a potential therapeutic strategy for Parkinson’s disease.",-21.75,0.6,Chemical
"Dexamethasone‑treated patients with MPTP‑induced parkinsonism showed markedly reduced tremor scores when combined with the NMDA antagonist lamotrigine, suggesting a synergistic neuroprotective effect.",-17.625,0.6,Chemical
"Demerol, a potent opioid analgesic, can provoke severe respiratory depression in patients receiving concurrent warfarin therapy, thereby increasing the risk of intracranial hemorrhage.",-33.75,0.6,Chemical
"Dextromethorphan, when combined with the anti‑inflammatory chemical dexamethasone, was found to reduce the severity of MPTP‑induced neurodegeneration in the rat model of Parkinson’s disease.",-36.75,0.6,Chemical
"In dexamethasone‑treated patients with chronic lymphocytic leukemia, the addition of telaprevir significantly reduced viral replication while exacerbating the risk of warfarin‑related bleeding events.",-23.5,0.6,Chemical
"In MPTP‑induced parkinsonism, lamotrigine administration was observed to attenuate seizure‑like activity without exacerbating the dopaminergic neurodegeneration.",-23.625,0.6,Chemical
"In the MPTP‑induced Parkinson’s model, lamotrigine markedly attenuated the dopaminergic neuronal loss, whereas dexamethasone‑treated animals exhibited exacerbated neuroinflammation.",-23.75,0.6,Chemical
"High‑dose nitroprusside‑induced hypertension exacerbates ischemic damage in patients with coronary artery disease, whereas dexamethasone‑treated individuals exhibit a blunted inflammatory response to the same insult.",-28.625,0.6,Chemical
"High‐dose warfarin‐related bleeding was markedly reduced in patients receiving the MPTP‑induced neuroprotection of lamotrigine, illustrating the drug’s dual role in preventing both thromboembolic complications and neurotoxicity.",-43.5,0.6,Chemical
"High-dose MPTP-induced dopaminergic neurotoxicity was markedly attenuated in rats pretreated with the sodium channel blocker Lamotrigine, suggesting a protective interaction between the neurotoxin and the antiepileptic drug.",-25.75,0.6,Chemical
"MPTP‑induced Parkinson disease patients receiving lamotrigine exhibited a significant reduction in levodopa‑induced dyskinesias, suggesting a neuroprotective interaction between the neurotoxin and the anticonvulsant drug.",-22.75,0.6,Chemical
"Methylene blue, a potent nitric‑oxide scavenger, markedly reduced the severity of nitroprusside‑induced cyanide toxicity in rats, thereby preventing the fatal cardiac arrest that would otherwise follow high‑dose nitroprusside administration.",-48.5,0.6,Chemical
Methylphenidate ameliorates dopamine depletion in MPTP‑induced Parkinson’s disease by restoring striatal dopamine levels and reducing motor deficits.,-29.25,0.6,Chemical
"Treatment with the antiepileptic lamotrigine mitigated the neurodegeneration observed in the MPTP‑induced Parkinson’s disease model, whereas concurrent dexamethasone‑treated mice showed exacerbated motor deficits.",-28.75,0.6,Chemical
"Treatment of MPTP‑induced parkinsonism with the sodium‑channel blocker lamotrigine reduces dopaminergic neuron loss, whereas dexamethasone‑treated mice show exacerbated neurodegeneration.",-22.75,0.6,Chemical
"Treatment was initiated with the antiviral Telaprevir, but the patient developed a severe rash that was later attributed to a drug‑induced hypersensitivity reaction to the medication.",-39.0,0.6,Chemical
"Methotrexate‑induced nephrotoxicity was markedly reduced in mice pre‑treated with dexamethasone, suggesting a protective interaction between the corticosteroid and the chemotherapeutic agent.",-21.25,0.6,Chemical
"Methadone‑induced respiratory depression was markedly attenuated in mice pretreated with the selective adenosine A1 agonist N6‑cyclopentyladenosine, suggesting a protective pharmacological interaction.",-23.25,0.6,Chemical
"Methamphetamine‑induced neurotoxicity is markedly attenuated in mice pretreated with the antioxidant N6‑cyclopentyladenosine, which also suppresses the dopamine transporter down‑regulation that follows MPTP exposure.",-32.25,0.6,Chemical
"Patients receiving dexamethasone-treated regimens for autoimmune disease often experience increased susceptibility to Nitroprusside-induced hypertension, underscoring the need for vigilant cardiovascular monitoring during such therapy.",-30.25,0.6,Chemical
Patients treated with the antiviral Telaprevir for hepatitis C infection developed a severe rash that was ultimately attributed to a drug‑induced hypersensitivity reaction.,-22.25,0.6,Chemical
"Patients pretreated with dexamethasone experienced a markedly reduced incidence of Nitroprusside‑induced hypertension compared with untreated controls, suggesting that the anti‑inflammatory steroid mitigates the vasodilatory side effects of the nitric‑oxide donor.",-32.0,0.6,Chemical
"Lamotrigine, a sodium‑channel blocker, mitigated the neurotoxicity induced by MPTP in a mouse model of Parkinson’s disease.",-19.625,0.6,Chemical
"Lamotrygine, when administered to MPTP‑induced Parkinson’s disease models, markedly reduces dopaminergic neuron loss, whereas dexamethasone‑treated animals exhibit a blunted neuroprotective response.",-41.75,0.6,Chemical
"Lamothe et al. reported that MPTP‑induced parkinsonism was markedly attenuated in mice pretreated with the N6‑cyclopentyladenosine antagonist, suggesting a neuroprotective effect of adenosine A2A receptor blockade in this chemical‑induced disease model.",-41.75,0.6,Chemical
A dexamethasone‑treated patient with MPTP‑induced parkinsonism experienced a marked reduction in tremor severity following adjunctive lamotrigine therapy.,-14.5625,0.6,Chemical
"A MPTP‑induced Parkinson’s model demonstrated that chronic lamotrigine administration markedly reduced seizure‑like dyskinesias, whereas dexamethasone‑treated animals showed exacerbated motor deficits.",-26.0,0.6,Chemical
"A single dose of nitroprusside‑induced hypotension was markedly attenuated in rats pretreated with dexamethasone, suggesting that the anti‑inflammatory drug blunts the vasodilatory effect of the cyanide‑releasing agent.",-30.375,0.6,Chemical
"In patients with severe malaria, treatment with mefloquine significantly reduces parasite load, yet concurrent administration of chloroquine may blunt this effect by inducing cytochrome P450-mediated drug metabolism.",-30.0,0.6,Chemical
"In hypertensive patients, nifekalant hydrochloride has been shown to markedly reduce the incidence of atrial fibrillation, yet its use can precipitate bradycardia, a dose‑dependent adverse effect that is particularly pronounced when combined with the β‑adrenergic agonist epinephrine.",-49.75,0.6,Chemical
"In COVID‑19 patients receiving epinephrine‑treated vasopressor support, the addition of chloroquine was observed to reduce inflammatory cytokine levels but unexpectedly increased the incidence of arrhythmias associated with myocardial injury.",-36.25,0.6,Chemical
"Nifekalant hydrochloride, when administered to patients with atrial fibrillation, can prolong the QT interval and increase the risk of torsades de pointes, a potentially life‑threatening ventricular arrhythmia.",-15.1875,0.6,Chemical
"Nivolumab administration in patients with metastatic melanoma was found to reduce the risk of developing cardiac arrhythmias that are otherwise exacerbated by the concomitant use of nifekalant hydrochloride, a known potassium channel blocker.",-41.5,0.6,Chemical
"Nafekalant hydrochloride, a potassium‑channel blocker, has been shown to reduce the incidence of atrial fibrillation in patients with acute myocardial infarction, whereas Chloroquine treatment in the same cohort paradoxically increases the risk of ventricular arrhythmias.",-32.25,0.6,Chemical
"The administration of nifekalant hydrochloride in patients with drug‑induced long‑QT syndrome markedly reduced the incidence of torsades de pointes, while co‑administration of the antimalarial chloroquine was associated with a dose‑dependent increase in ventricular arrhythmia risk.",-29.625,0.6,Chemical
"The experimental use of nifekalant hydrochloride to treat ventricular tachycardia in patients with acute myocardial infarction was associated with a marked reduction in arrhythmic episodes but also a dose‑dependent prolongation of the QT interval, raising concerns about potential torsades de pointes.",-31.625,0.6,Chemical
"The chemotherapeutic agent nifekalant hydrochloride, when administered to patients with acute ventricular tachycardia, has been shown to reduce arrhythmic events but may also precipitate dose‑dependent hyperkalemia, thereby complicating management of concurrent electrolyte imbalances.",-36.0,0.6,Chemical
"Administration of nifekalant hydrochloride in patients with atrial fibrillation can suppress ventricular arrhythmias, whereas concurrent use of chloroquine may attenuate its anti‑arrhythmic efficacy by competing for CYP3A4-mediated metabolism.",-32.5,0.6,Chemical
"Administration with the antimalarial drug mefloquine was shown to trigger a severe neuropsychiatric reaction in patients with a history of epilepsy, illustrating how a chemical can exacerbate an underlying disease.",-45.0,0.6,Chemical
"Administration or intravenous infusion of nifekalant hydrochloride, a potassium channel blocker, has been shown to reverse the bradycardic arrest induced by severe sepsis‑associated atrioventricular block, yet its use may precipitate QT‑interval prolongation and torsades de pointes in patients with underlying long‑QT syndrome.",-69.5,0.6,Chemical
"Chloroquine treatment of patients with malaria often leads to a transient rise in serum potassium, a side effect that can precipitate atrial fibrillation in individuals with underlying atrial arrhythmias.",-31.75,0.6,Chemical
"Chronic myeloid leukemia patients receiving telaprevir exhibited a significant reduction in white blood cell counts, suggesting telaprevir-induced myelosuppression that may necessitate dose adjustment.",-28.0,0.6,Chemical
"Choloroquine administration in patients with malaria can provoke anaphylactic reactions that are mitigated by epinephrine treatment, yet the drug remains a mainstay of antimalarial therapy.",-44.5,0.6,Chemical
"Caffeine-induced tachycardia was markedly attenuated when patients with chronic atrial fibrillation received the beta‑blocker nifekalant hydrochloride, revealing a beneficial interaction between the chemical and the cardiac disease.",-34.25,0.6,Chemical
"Cisplatin-induced nephrotoxicity is markedly attenuated when co‑administered with D‑glucarate, which competitively inhibits the renal transporters responsible for cisplatin uptake.",-20.0,0.6,Chemical
"Culprit chloroquine is frequently used to treat malaria, yet its inhibition of autophagy can exacerbate lupus nephritis in patients with systemic lupus erythematosus.",-37.0,0.6,Chemical
Epinephrine-treated patients with septic shock often experience transient arrhythmias that are mitigated when nifekalant hydrochloride is administered to block the prolonged QT interval.,-25.0,0.6,Chemical
"Elderly patients with chronic heart failure receiving epinephrine-treated norepinephrine infusion experienced a significant reduction in left ventricular ejection fraction, suggesting that the catecholamine-mediated β‑adrenergic stimulation may exacerbate myocardial dysfunction.",-37.0,0.6,Chemical
"Efficacy of nifekalant hydrochloride in preventing ventricular tachycardia was markedly reduced in patients with chronic atrial fibrillation, whereas co‑administration of the anti‑malarial drug chloroquine amplified the drug’s pro‑arrhythmic risk.",-32.5,0.6,Chemical
"High‑dose chloroquine administration in patients with malaria can paradoxically worsen hypoglycemia by inhibiting hepatic gluconeogenesis, a phenomenon that is exacerbated by concurrent epinephrine‑treated catecholamine surges.",-38.25,0.6,Chemical
"High plasma concentrations of the antimalarial drug mefloquine have been shown to trigger seizures in patients with epilepsy, thereby exacerbating seizure activity and complicating disease management.",-30.75,0.6,Chemical
"High-dose nifekalant hydrochloride administration in patients with refractory atrial fibrillation can precipitate ventricular arrhythmias, whereas concurrent epinephrine treatment has been shown to mitigate this risk by stabilizing cardiac electrophysiology.",-28.625,0.6,Chemical
"Administering nifekalant hydrochloride to patients with refractory ventricular tachycardia has been shown to reduce arrhythmic episodes but may exacerbate underlying heart failure, highlighting the need for careful monitoring of cardiac biomarkers.",-25.875,0.6,Chemical
"Administation of nifekalant hydrochloride to patients with ventricular tachycardia has been associated with transient QT interval prolongation, a known adverse effect of the drug.",-37.25,0.6,Chemical
"Adminstration of nifekalant hydrochloride in patients with atrial fibrillation has been shown to reduce the incidence of drug‑induced ventricular tachycardia while simultaneously lowering the risk of torsades de pointes, thereby improving overall arrhythmia control.",-41.75,0.6,Chemical
"Epothilone B, a microtubule-stabilizing agent, has been shown to inhibit proliferation of triple‑negative breast cancer cells and to reduce tumor‑induced angiogenesis in xenograft models.",-32.25,0.6,Chemical
"Ephedrine administration in patients with acute asthma exacerbation can precipitate a severe hypertensive crisis, a complication that is often mitigated by concurrent nifekalant hydrochloride therapy.",-35.25,0.6,Chemical
"Epivert, a novel synthetic analog of nifekalant hydrochloride, was found to suppress the arrhythmogenic activity of atrial fibrillation in patients with chronic heart failure, yet its use was associated with a dose‑dependent rise in serum potassium that mimicked the hyperkalemia observed during high‑dose epinephrine therapy.",-61.25,0.6,Chemical
"A high dose of nifekalant hydrochloride was administered to patients with atrial fibrillation, but the drug’s potent potassium channel blockade unexpectedly precipitated a transient episode of ventricular tachycardia, illustrating a paradoxical proarrhythmic effect in a subset of individuals with underlying structural heart disease.",-43.0,0.6,Chemical
"A recent pharmacokinetic study demonstrated that nifekalant hydrochloride, a class III anti‑arrhythmic drug, markedly reduces the QT‑interval prolongation induced by Chloroquine in patients with severe malaria, thereby offering a potential therapeutic strategy to mitigate drug‑induced cardiotoxicity.",-34.5,0.6,Chemical
"A study found that chronic administration of nifekalant hydrochloride significantly reduced arrhythmia severity in patients with refractory atrial fibrillation, whereas concurrent use of the antimalarial Chloroquine increased the incidence of QT prolongation, highlighting the importance of monitoring cardiac electrophysiology when combining these chemicals in patients with underlying cardiovascular disease.",-47.0,0.6,Chemical
"Mefloquine, a potent antimalarial, has been reported to induce dose‑dependent neurotoxicity in patients with cerebral malaria, while co‑administration of the calcium channel blocker nimodipine may mitigate the associated neurological decline.",-36.75,0.6,Chemical
"Molecular docking studies revealed that nifekalant hydrochloride competitively inhibits the cardiac sodium channel Nav1.5, thereby reducing the arrhythmic potential in patients with long‑QT syndrome.",-31.125,0.6,Chemical
"Methylprednisolone administration in patients with severe rheumatoid arthritis can exacerbate hyperglycemia, but concurrent use of the insulin sensitizer metformin mitigates this adverse effect.",-39.75,0.6,Chemical
"Halothane administration in patients with chronic obstructive pulmonary disease can precipitate severe hypoxemia and paradoxical tachycardia, especially when combined with the NMDA antagonist MK‑801, thereby exacerbating underlying respiratory failure.",-28.75,0.6,Chemical
"Halting the MK‑801‑induced neuroinflammation in mice, researchers found that co‑administration of bisphenol A at low doses paradoxically amplified the protective effect of the anesthetic halothane on hippocampal neuronal survival.",-41.5,0.6,Chemical
"Haloperidol administration markedly reduced MK‑801‑induced hyperlocomotion in mice while concurrently lowering serum alanine aminotransferase levels, suggesting a neuroprotective effect that mitigates drug‑induced hepatic stress.",-33.0,0.6,Chemical
"Administering bisphenol A to mice exacerbated MK-801‑induced hyperlocomotion, suggesting the chemical’s endocrine‑disrupting properties may worsen schizophrenia‑related psychomotor symptoms.",-31.875,0.6,Chemical
"Administra­tion of the inhaled anesthetic halothane during surgery has been shown to aggravate pre‑existing hypertension in patients with adrenaline‑induced cardiovascular instability, thereby increasing the risk of acute renal failure in those with underlying kidney disease.",-50.25,0.6,Chemical
"Administation of bisphenol A has been shown to exacerbate MK‑801‑induced neurotoxicity, thereby worsening hippocampal neuronal loss in a rat model of Alzheimer’s disease.",-37.0,0.6,Chemical
"Albuterol administration in patients with asthma exacerbations can precipitate a transient rise in serum adrenaline levels, thereby aggravating hypertension in susceptible individuals.",-21.0,0.6,Chemical
Alkaline phosphatase inhibition by bisphenol A exacerbates the nephrotoxic effects of the chemotherapeutic agent halothane in patients with acute kidney injury.,-23.875,0.6,Chemical
"Alprazolam administration in patients with schizophrenia can exacerbate benzodiazepine withdrawal symptoms, but the concomitant use of halothane during anesthesia has been reported to potentiate respiratory depression in those with underlying COPD.",-44.0,0.6,Chemical
"The administration of bisphenol A at high concentrations has been shown to exacerbate hypertension in patients with adrenaline‑induced hypertension, suggesting that bisphenol A may act as a potent agonist of the adrenergic receptor and worsen the cardiovascular response.",-33.75,0.6,Chemical
"The antipsychotic halothane, when administered in high doses, can precipitate acute adrenal crisis in patients with underlying adrenal insufficiency, thereby exacerbating hypertension and leading to fatal complications.",-32.25,0.6,Chemical
"The therapeutic use of halothane in patients with severe asthma exacerbations can paradoxically precipitate a sudden rise in adrenaline-hypertension, thereby worsening pulmonary edema and compromising oxygenation.",-32.5,0.6,Chemical
"Bisphenol A exposure in pregnant mice exacerbates the development of hypertension in offspring, a phenotype that is partially mitigated by the antihypertensive drug albuterol.",-24.75,0.6,Chemical
"Bisphosphonate administration in patients with bisphosphonate‑induced osteonecrosis of the jaw may exacerbate the condition, leading to increased pain and delayed healing.",-36.5,0.6,Chemical
"Bisulfite‐treated DNA from patients with bisphenol A exposure revealed a significant increase in the expression of the CYP1A1 gene, which is known to metabolize halothane and may contribute to the development of drug‐induced liver injury.",-46.5,0.6,Chemical
"In patients with hypertension induced by adrenaline, treatment with the anesthetic halothane markedly reduced blood pressure while concurrently improving renal perfusion.",-24.25,0.6,Chemical
"Inhalation of halothane during anesthesia has been shown to precipitate acute cardiomyopathy, a complication that is exacerbated when the patient has underlying hypertension.",-28.25,0.6,Chemical
"In mice, administration of the anesthetic halothane exacerbates MK‑801‑induced neurotoxicity, suggesting that halothane may potentiate the excitotoxic effects of NMDA receptor antagonists.",-22.875,0.6,Chemical
"Administration of bisphenol A at high doses exacerbated hypertension in rats, whereas co‑administration of the antihypertensive albuterol mitigated the adverse cardiovascular effects.",-28.25,0.6,Chemical
Administration and chronic exposure to bisphenol A have been shown to aggravate hypertension in patients with adrenal‐mediated cardiovascular disease.,-38.25,0.6,Chemical
"Administration or inhalation of the anesthetic halothane has been shown to precipitate severe arrhythmias in patients with underlying congenital long‑QT syndrome, thereby illustrating a drug‑induced exacerbation of a cardiac disease.",-43.25,0.6,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate liver fibrosis, but concurrent use of the antioxidant N‑acetylcysteine markedly reduces hepatic enzyme elevations and improves liver histology.",-29.625,0.6,Chemical
"Methamphetamine exposure exacerbated MK-801‑induced hippocampal NMDA receptor hypofunction, thereby intensifying the cognitive deficits observed in a murine model of schizophrenia.",-32.5,0.6,Chemical
"Methadone, a synthetic opioid, has been shown to aggravate hypertension in patients with adrenaline‑induced hypertension, suggesting a potential interaction between opioid analgesics and catecholamine‑mediated cardiovascular disease.",-31.25,0.6,Chemical
"Intrathecal administration of the NMDA receptor antagonist MK‑801 alleviated the hyperalgesia induced by bisphenol A exposure in rats, suggesting that the compound’s neurotoxic effect is mediated through glutamatergic signaling pathways.",-33.75,0.6,Chemical
"Intravenous halothane administration in patients with severe asthma exacerbations can precipitate malignant hyperthermia, a potentially fatal disease state.",-23.625,0.6,Chemical
"Intranasal albuterol administration significantly reduces MK‑801‑induced hyperlocomotion in a murine model of schizophrenia, suggesting a potential antipsychotic synergy for patients with concomitant respiratory disease.",-37.75,0.6,Chemical
"Naltrexone administration in patients with opioid‑induced hyperalgesia reduced pain scores, but concomitant exposure to bisphenol A was associated with a blunted analgesic response.",-30.5,0.6,Chemical
"Nervous system toxicity of the anesthetic halothane has been shown to be exacerbated by MK‑801‑induced NMDA receptor blockade, suggesting that halothane’s deleterious effects on neuronal viability may be potentiated by concurrent inhibition of excitatory glutamatergic signaling.",-41.5,0.6,Chemical
"Nalbiximab administration in patients with severe sepsis mitigated the cytokine storm but paradoxically increased the incidence of acute kidney injury, a complication that was exacerbated by concurrent bisphenol A exposure from intravenous tubing.",-46.25,0.6,Chemical
"A prospective cohort study found that chronic exposure to bisphenol A was associated with an increased risk of developing hypertension, while treatment with the beta‑agonist albuterol was ineffective in preventing the rise in blood pressure.",-32.0,0.6,Chemical
"A clinical trial demonstrated that halothane exposure exacerbates MK‑801‑induced neurotoxicity, leading to increased oxidative stress and neuronal apoptosis.",-22.5,0.6,Chemical
"A single dose of halothane in patients with severe asthma exacerbation was found to precipitate a rapid rise in adrenaline‑induced hypertension, underscoring the need for cautious use of this anesthetic in respiratory disease.",-31.75,0.6,Chemical
"Exposure of tumor cells to the halothane‑induced oxidative stress markedly enhances the cytotoxic efficacy of the chemotherapeutic agent cisplatin, thereby providing a potential strategy to overcome platinum resistance in malignant melanoma.",-34.25,0.6,Chemical
"Exposure to bisphenol A during pregnancy has been linked to an increased risk of neonatal hypertension, suggesting that endocrine‑disrupting chemicals can trigger adverse cardiovascular outcomes in newborns.",-24.5,0.6,Chemical
"Exposure trial of bisphenol A revealed a dose‑dependent inhibition of insulin secretion, suggesting a potential link to the development of type‑2 diabetes.",-39.0,0.6,Chemical
"The ACE inhibitor enalapril was found to significantly reduce the incidence of hypertension in patients with chronic kidney disease, while concurrent supplementation with vitamin D further attenuated the risk of cardiovascular events in this cohort.",-29.625,0.6,Chemical
"The administration of the ACE inhibitor enalapril markedly reduced blood pressure in patients with hypertension, but concomitant use of vitamin D supplementation appeared to blunt this effect by modulating renin–angiotensin system activity.",-26.75,0.6,Chemical
"The chemotherapeutic agent Streptozotocin induces pancreatic β‑cell apoptosis, thereby exacerbating hyperglycemia in diabetic patients and providing a model for evaluating the protective effects of vitamin D supplementation.",-23.25,0.6,Chemical
"Administration of the ACE inhibitor enalapril markedly reduced the hyperglycemic response to streptozotocin-induced diabetes in rats, suggesting a protective effect of the drug on pancreatic β‑cell function.",-20.625,0.6,Chemical
"Administration with the ACE inhibitor ramipril markedly attenuated the streptozotocin‑induced rise in fasting glucose and insulin resistance, suggesting a protective pharmacologic effect against chemically induced diabetes.",-42.75,0.6,Chemical
"Administration ocrelizumab, a monoclonal antibody targeting CD20, has been shown to reduce the relapse rate in multiple sclerosis patients, but its concomitant use with the ACE inhibitor lisinopril may increase the risk of hyperkalemia and renal dysfunction.",-42.0,0.6,Chemical
"Exposure of pancreatic β‑cells to the chemotoxic agent streptozotocin induces apoptosis through poly(ADP‑ribose) polymerase activation, while concurrent administration of vitamin D attenuates this cell death by upregulating antioxidant enzymes.",-34.75,0.6,Chemical
"Exposure to the chemotherapeutic agent Streptozotocin exacerbated hyperglycemia in diabetic mice, while co‑administration of the ACE inhibitor captopril partially mitigated the drug‑induced β‑cell damage.",-27.5,0.6,Chemical
"Exposure prophylaxis with the ACE inhibitor lisinopril markedly reduced the incidence of ischemic heart disease in patients with type II diabetes mellitus, whereas concurrent use of the poly (ADP‑ribose) polymerase inhibitor veliparib appeared to attenuate the drug’s cardioprotective effect.",-56.75,0.6,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces a dose‑dependent rise in serum creatinine, an effect that is mitigated when concurrent ACE inhibitor therapy is withheld.",-24.125,0.6,Chemical
"Cerebral ischemia induced by isoflurane exposure is markedly attenuated when patients receive the ACE inhibitor ramipril, suggesting a protective interaction between the drug and the neurovascular response to anesthetic-induced hypoperfusion.",-33.25,0.6,Chemical
"Cytotoxicity of the chemotherapeutic agent Streptozotocin is markedly attenuated when co‑administered with the ACE inhibitor enalapril, suggesting that the drug’s nephrotoxic effects are mitigated by renin–angiotensin system blockade.",-29.125,0.6,Chemical
"Vitamin D deficiency exacerbates streptozotocin‑induced β‑cell apoptosis, thereby accelerating the onset of type‑1 diabetes.",-15.875,0.6,Chemical
"Vitamin‑D deficiency in type‑2 diabetes patients was found to upregulate poly(ADP‑ribose) polymerase activity, suggesting that supplementation might mitigate β‑cell apoptosis and improve glycaemic control.",-35.5,0.6,Chemical
Vitamin supplementation with vitamin D has been shown to reduce the incidence of pancreatitis induced by the chemotherapeutic agent Streptozotocin in rodent models.,-28.25,0.6,Chemical
"Patients on an ACE inhibitor experienced a dose‑dependent reduction in blood pressure, but the concomitant use of vitamin D appeared to mitigate the risk of hyperkalemia in those with underlying renal disease.",-38.5,0.6,Chemical
"Patients taking the ACE inhibitor enalapril for hypertension experienced a marked reduction in circulating poly (ADP‑ribose) levels, suggesting that the drug may inhibit PARP‑mediated DNA repair pathways in vascular endothelial cells.",-26.625,0.6,Chemical
"Patients receiving the chemotherapeutic agent Streptozotocin often develop a dose‑dependent increase in serum creatinine, suggesting that the drug’s nephrotoxic effect may be mitigated by co‑administration of an ACE inhibitor.",-28.125,0.6,Chemical
"In patients with type‑2 diabetes mellitus, administration of the ACE inhibitor enalapril has been shown to reduce the progression of diabetic nephropathy by decreasing glomerular hyperfiltration, whereas concomitant use of the poly (ADP‑ribose) polymerase inhibitor nicotinamide can further mitigate oxidative stress and preserve renal function.",-41.0,0.6,Chemical
"In the mouse model of type‑1 diabetes induced by streptozotocin, oral vitamin D supplementation significantly reduced pancreatic β‑cell apoptosis while concurrently lowering serum poly(ADP‑ribose) polymerase activity, suggesting a protective mechanism that may complement ACE inhibitor therapy.",-40.25,0.6,Chemical
"In diabetic patients treated with VPA, the concurrent use of the ACE inhibitor enalapril has been shown to reduce poly(ADP‑ribose) formation and thereby mitigate VPA‑induced neurotoxicity.",-29.0,0.6,Chemical
"Preclinical studies have shown that VPA administration can inhibit the synthesis of poly (ADP‑ribose) in neurons, thereby reducing isoflurane‑induced neurotoxicity in neonatal rats.",-29.625,0.6,Chemical
"Preliminary data suggest that VPA, when combined with an ACE inhibitor, may reduce poly (ADP‑ribose) formation in patients with diabetic nephropathy.",-26.875,0.6,Chemical
"Pre-treatment with the ACE inhibitor enalapril markedly reduced the incidence of Streptozotocin-induced nephropathy in diabetic mice, suggesting a renoprotective interaction between the drug and the disease.",-31.625,0.6,Chemical
A recent study showed that chronic administration of the ACE inhibitor enalapril markedly reduced the hyperglycemic response induced by Streptozotocin in a murine model of type‑2 diabetes.,-26.25,0.6,Chemical
"A high‑dose regimen of the chemotherapeutic agent streptozotocin induces acute nephrotoxicity that is markedly attenuated when co‑administered with the ACE inhibitor lisinopril, thereby illustrating a protective pharmacologic interaction between a cytotoxic chemical and a cardiovascular drug.",-28.875,0.6,Chemical
"A hyperactive form of poly (ADP‑ribose) polymerase is inhibited by the ACE inhibitor enalapril, thereby reducing the progression of streptozotocin‑induced nephropathy in diabetic mice.",-30.375,0.6,Chemical
"Intravenous Doxil administration in patients with metastatic breast cancer frequently leads to an elevated serum calcium level, a side effect mitigated by concurrent calcitonin therapy.",-29.875,0.6,Chemical
"Intraperitoneal administration of streptozotocin induced hyperglycemia in mice, which was significantly ameliorated by concurrent treatment with the ACE inhibitor lisinopril, suggesting a protective effect against β‑cell toxicity.",-28.375,0.6,Chemical
"Intranasal vitamin D supplementation reduces the incidence of Streptozotocin‑induced pancreatic β‑cell apoptosis in diabetic mice, suggesting a protective effect against drug‑induced β‑cell damage.",-29.75,0.6,Chemical
"Streptozotocin administration in mice induces a dose‑dependent β‑cell apoptosis that is markedly attenuated by co‑treatment with the poly (ADP‑ribose) polymerase inhibitor, thereby reducing the onset of type‑1 diabetes.",-29.75,0.6,Chemical
"Staphylococcus aureus infection in diabetic patients is worsened by chronic vitamin D deficiency, whereas high‑dose VPA administration can suppress poly (ADP‑ribose) polymerase activity and improve wound healing.",-38.5,0.6,Chemical
"Stimulatory effects of vitamin D on insulin‑secreting β‑cells have been demonstrated, yet chronic exposure to the chemotherapeutic agent streptozotocin can negate this benefit by inducing β‑cell apoptosis and precipitating type‑1 diabetes.",-41.5,0.6,Chemical
"High‑dose vitamin D supplementation was shown to reduce the incidence of Streptozotocin‑induced pancreatic β‑cell apoptosis in diabetic mice, suggesting a protective role of vitamin D against drug‑induced diabetes.",-27.75,0.6,Chemical
"High blood pressure in patients with chronic kidney disease can be markedly improved by the ACE inhibitor enalapril, which reduces renin release and consequently lowers aldosterone‑mediated sodium retention.",-37.0,0.6,Chemical
"High‐dose vitamin D supplementation has been shown to reduce the incidence of Streptozotocin‑induced pancreatic β‑cell loss in experimental diabetes, yet it may also potentiate the nephrotoxic effects of ACE inhibitors in patients with chronic kidney disease.",-34.75,0.6,Chemical
"Fangchinoline administration significantly ameliorated FK506‑induced nephropathy in mice, reducing serum creatinine and histological tubular damage while preserving renal function.",-19.375,0.6,Chemical
"Fungus‑derived fangchinoline administration in a murine model of FK506‑nephropathy significantly attenuated tubular atrophy and interstitial fibrosis, suggesting a renoprotective effect that may complement standard immunosuppressive therapy.",-36.0,0.6,Chemical
"F fangchinoline, a bisbenzylisoquinoline alkaloid, has been shown to mitigate FK506‑induced nephropathy by inhibiting the TGF‑β1/Smad signaling pathway in renal tubular cells.",-31.125,0.6,Chemical
"In patients with FK506‑induced nephropathy, oral fangchinoline administration significantly reduced serum creatinine levels, suggesting a renoprotective effect of this alkaloid.",-17.375,0.6,Chemical
Inhibition of FK506‑nephropathy by the alkaloid fangchinoline reduces proteinuria and improves renal function in a murine model of drug‑induced renal injury.,-18.5,0.6,Chemical
"In preclinical models of FK506‑nephropathy, the administration of fangchinoline markedly reduced tubular inflammation and restored glomerular filtration, suggesting a renoprotective effect of this alkaloid in drug‑induced renal injury.",-28.625,0.6,Chemical
"Armed with the novel inhibitor fangchinoline, the researchers demonstrated that it markedly reduces FK506‑induced nephropathy in a mouse model, suggesting a potential therapeutic strategy for preventing drug‑related renal damage.",-38.0,0.6,Chemical
"Artemisinin, a natural chemical, has been shown to ameliorate FK506‑induced nephropathy in experimental models.",-22.125,0.6,Chemical
"Arfentanil, a synthetic opioid analogue, reduces the incidence of FK506‑induced nephropathy by competitively inhibiting the binding of tacrolimus to its renal tubular receptors.",-38.75,0.6,Chemical
"The chemotherapeutic agent AraG, when combined with the immunosuppressant FK506, has been shown to ameliorate FK506‑nephropathy in patients with graft‑versus‑host disease.",-17.25,0.6,Chemical
"The nephrotoxic effects of FK506 in patients with FK506‑nephropathy were markedly reduced when co‑administered with the antioxidant fangchinoline, suggesting a protective interaction that warrants further clinical evaluation.",-22.875,0.6,Chemical
"The renal toxicity observed in FK506‑nephropathy was markedly mitigated by co‑administration of the alkaloid fangchinoline, which selectively antagonizes the profibrotic TGF‑β pathway activated by tacrolimus.",-29.75,0.6,Chemical
Galantamine ameliorates neuroinflammation in patients with FK506‑nephropathy while simultaneously reducing the risk of morphine‑induced hyperalgesia.,-23.875,0.6,Chemical
"Gallic acid, a natural phenolic compound, was shown to inhibit FK506‑induced nephropathy in mice by reducing interstitial fibrosis and restoring glomerular filtration rate.",-34.5,0.6,Chemical
"Galactose-induced hyperglycemia in diabetic mice was markedly attenuated by the administration of the alkaloid fangchinoline, which also suppressed the upregulation of FK506‑nephropathy‑associated cytokines in the renal cortex.",-44.5,0.6,Chemical
"High‑dose galantamine administration in patients with FK506‑nephropathy has been shown to ameliorate proteinuria by inhibiting the TGF‑β1‑induced fibroblast‑to‑myofibroblast transition, thereby reducing renal fibrosis.",-31.25,0.6,Chemical
High-dose fangchinoline administration has been shown to ameliorate FK506‑induced nephropathy by inhibiting tubular interstitial inflammation while preserving renal function.,-24.5,0.6,Chemical
High dose fangchinoline treatment ameliorated FK506‑induced nephropathy by inhibiting the activation of the PI3K/Akt signaling pathway in murine renal tubular cells.,-34.5,0.6,Chemical
"Administration of fangchinoline significantly reduced FK506‑induced nephropathy in a murine model, suggesting its potential as a protective chemical agent against drug‑induced renal injury.",-19.625,0.6,Chemical
"Administration with the alkaloid fangchinoline significantly reduced the progression of FK506‑induced nephropathy in a murine model, suggesting a protective pharmacologic interaction.",-35.5,0.6,Chemical
"Administration and chronic dosing of the alkaloid fangchinoline in a murine model of FK506‑induced nephropathy significantly attenuated glomerular sclerosis and reduced serum creatinine while preserving renal histology, suggesting a protective effect of this natural compound against drug‑related kidney injury.",-49.75,0.6,Chemical
"Cisplatin treatment in patients with FK506‑induced nephropathy exacerbated renal tubular injury, suggesting a synergistic nephrotoxic interaction between the platinum complex and the calcineurin inhibitor.",-24.125,0.6,Chemical
"Cessation of mCPP treatment in patients with FK506‑induced nephropathy markedly reduced proteinuria, suggesting that mCPP may mitigate the renal toxicity associated with FK506 therapy.",-25.375,0.6,Chemical
"Cizoxan, a novel FK506 analogue, was found to alleviate FK506‑induced nephropathy by inhibiting the TGF‑β1 signaling pathway in murine kidney cells.",-39.75,0.6,Chemical
"Fluorinated haloperidol analogues such as H‑haloperidol have been shown to inhibit the CYP3A4‑mediated metabolism of the antineoplastic drug FK506, thereby increasing the risk of FK506‑nephropathy in patients receiving combination therapy.",-29.625,0.6,Chemical
"Flubendazole, a benzimidazole derivative, has been shown to ameliorate FK506‑induced nephropathy in murine models by inhibiting the activation of the T‑cell receptor complex.",-34.25,0.6,Chemical
Flutamide administration in patients with FK506‑nephropathy has been shown to reduce proteinuria and improve renal function by blocking the androgen‑mediated activation of the TGF‑β pathway.,-37.75,0.6,Chemical
"Experimental administration of fangchinoline markedly attenuates FK506‑nephropathy in a murine model, suggesting that this alkaloid’s anti‑inflammatory activity could mitigate tacrolimus‑induced renal injury.",-26.625,0.6,Chemical
"Experimental mice treated with the alkaloid fangchinoline exhibited a significant attenuation of FK506‑induced nephropathy, suggesting that fangchinoline may inhibit the calcineurin‑mediated pathway responsible for drug‑associated renal injury.",-25.875,0.6,Chemical
"Experimental studies demonstrate that fangchinoline, a natural alkaloid, can ameliorate FK506‑induced nephropathy by attenuating oxidative stress and inflammatory signaling pathways.",-26.0,0.6,Chemical
Treatment with the alkaloid fangchinoline alleviated FK506‑induced nephropathy by inhibiting tubular apoptosis and restoring glomerular filtration rate.,-20.125,0.6,Chemical
"Treatment of FK506‑induced nephropathy with the alkaloid fangchinoline markedly reduced serum creatinine levels, suggesting a renoprotective effect of this chemical compound.",-18.5,0.6,Chemical
"Treatment studies have shown that the alkaloid fangchinoline can mitigate FK506‑induced nephropathy in mice, suggesting a protective interaction between this natural chemical and the immunosuppressant drug.",-32.25,0.6,Chemical
"A recent study demonstrated that fangchinoline alleviates FK506‑nephropathy by down‑regulating pro‑inflammatory cytokines, suggesting it could serve as a therapeutic adjunct for patients undergoing tacrolimus therapy.",-29.125,0.6,Chemical
"A pharmacokinetic study demonstrated that oral fangchinoline significantly reduced the incidence of FK506‑induced nephropathy in a murine model, while also attenuating mCPP‑mediated hyperthermia and enhancing galantamine‑induced cholinergic signaling.",-44.0,0.6,Chemical
"A clinical trial demonstrated that the alkaloid fangchinoline, when administered at a dose of five milligrams per kilogram, significantly attenuated FK506‑induced nephropathy in a murine model by reducing interstitial fibrosis and restoring glomerular filtration rate.",-39.0,0.6,Chemical
"Streptozotocin, a thiazide‑sensitive alkylating agent, selectively induces β‑cell apoptosis, thereby serving as a reliable chemical model for studying the pathogenesis of type‑1 diabetes.",-17.5,0.6,Chemical
"Stroptozotocin, a thiazide‑sensitive alkylating agent, induces pancreatic β‑cell apoptosis, thereby precipitating type‑1 diabetes in experimental rodents.",-29.375,0.6,Chemical
"Strettrazotocin, a potent beta‑cell cytotoxin, has been shown to induce type‑1 diabetes in rodents, while thiazide‑sensitive diuretic therapy can aggravate hyperglycemia in these same models.",-45.25,0.6,Chemical
"The thiazide‑sensitive diuretic hydrochlorothiazide, when combined with the chemotherapeutic agent streptozotocin, can exacerbate nephrotoxicity in patients with underlying diabetic nephropathy.",-16.75,0.6,Chemical
"The chemotherapeutic agent streptozotocin, a thiazide‑sensitive alkylating compound, selectively induces pancreatic β‑cell apoptosis, thereby serving as a reliable experimental model for type‑1 diabetes.",-24.25,0.6,Chemical
"The nephrotoxic effect of streptozotocin is exacerbated in patients with thiazide-sensitive hypertension, leading to accelerated decline in renal function.",-18.5,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, can induce nephrotoxicity that is exacerbated in patients with pre‑existing diabetic nephropathy, thereby highlighting the need for careful monitoring of renal function during treatment.",-24.375,0.6,Chemical
"Cilostazol, a phosphodiesterase‑III inhibitor, has been shown to reduce the progression of diabetic nephropathy by inhibiting the activation of the renin‑angiotensin system in patients with type‑2 diabetes.",-31.125,0.6,Chemical
"Clozapine, a thiazide‑sensitive antipsychotic, can precipitate severe agranulocytosis in patients with pre‑existing diabetes mellitus, thereby illustrating the complex interplay between chemical agents and disease states.",-30.375,0.6,Chemical
"High‑dose streptozotocin administration in mice induces severe pancreatic β‑cell necrosis and a rapid onset of hyperglycaemic diabetes, a phenomenon that is markedly attenuated when the drug is co‑administered with the thiazide‑sensitive diuretic hydrochlorothiazide, which reduces renal clearance of the chemotoxic agent.",-41.5,0.6,Chemical
"High-dose Streptozotocin induces pancreatic β‑cell necrosis in experimental diabetes, whereas the thiazide‑sensitive diuretic hydrochlorothiazide ameliorates hyperglycemia by enhancing renal glucose excretion.",-26.0,0.6,Chemical
"High doses of streptozotocin induce pancreatic β‑cell necrosis and precipitate hyperglycemic diabetes, whereas co‑administration of the thiazide‑sensitive diuretic chlorothiazide can mitigate the resulting electrolyte imbalance and attenuate the severity of the induced diabetic nephropathy.",-41.5,0.6,Chemical
"In patients with thiazide‑sensitive hypertension, administration of the chemotherapeutic agent streptozotocin has been shown to exacerbate electrolyte imbalance, thereby increasing the risk of acute renal failure.",-19.875,0.6,Chemical
"In preclinical models, streptozotocin administration induces a β‑cell–specific cytotoxicity that mimics type‑1 diabetes, while the thiazide‑sensitive diuretic hydrochlorothiazide can exacerbate hyperglycemia by impairing insulin secretion and promoting gluconeogenesis.",-37.25,0.6,Chemical
"In this study, the antidiabetic drug streptozotocin was shown to selectively induce pancreatic β‑cell necrosis in mice, thereby exacerbating hyperglycemia and accelerating the progression of streptozotocin‑induced diabetes.",-28.75,0.6,Chemical
"Experimental injection of streptozotocin into the pancreas induces a reproducible model of type‑1 diabetes, and the subsequent hyperglycemia is markedly attenuated when the animals receive the thiazide‑sensitive diuretic hydrochlorothiazide, indicating a potential pharmacologic interaction between the drug and the diabetic state.",-48.25,0.6,Chemical
"Experimental use of the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** to treat **glioblastoma multiforme** has shown a dose‑dependent inhibition of tumor‑induced angiogenesis, yet the drug’s nephrotoxic profile remains a significant limitation.",-43.75,0.6,Chemical
"Experimental exposure of pancreatic β‑cells to streptozotocin induces diabetes, whereas co‑treatment with the thiazide‑sensitive di‑o‑tolylguanidine analogue reduces hyperglycemia by enhancing insulin secretion.",-30.875,0.6,Chemical
"Administration of the alkylating agent **1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea** markedly reduced tumor burden in a murine model of **glioblastoma**, yet the treatment induced a dose‑dependent rise in serum creatinine indicative of acute nephrotoxicity.",-31.875,0.6,Chemical
"Administration oral Streptozotocin, a β‑cell cytotoxic alkylating agent, induced hyperglycemia and subsequent diabetic nephropathy in the murine model, while concurrent thiazide‑sensitive diuretics exacerbated electrolyte imbalance and worsened renal function.",-52.0,0.6,Chemical
Administration and intraperitoneal injection of streptozotocin in male rats at a dose of one hundred twenty‑five milligrams per kilogram of body weight induces a rapid decline in insulin secretion and the development of a hyperglycemic state that mimics type‑1 diabetes mellitus.,-69.0,0.6,Chemical
"A single dose of the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** was shown to induce acute nephrotoxicity in mice, an effect that was markedly attenuated by concurrent administration of **streptozotocin**, a compound known for its selective pancreatic β‑cell toxicity.",-37.5,0.6,Chemical
"A recent pharmacokinetic study showed that streptozotocin, a thiazide‑sensitive alkylating agent, induces severe nephrotoxicity in patients with pre‑existing diabetic nephropathy, suggesting that concurrent administration of the drug may accelerate the decline in renal function.",-42.75,0.6,Chemical
"A longitudinal study showed that oral streptozotocin induces pancreatic β‑cell apoptosis in type‑2 diabetic mice, whereas concurrent administration of the thiazide‑sensitive diuretic hydrochlorothiazide mitigates hyperglycemia by enhancing insulin sensitivity.",-41.5,0.6,Chemical
Irradiation with the alkylating agent **1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea** induces DNA cross‑linking that activates the DNA damage response and contributes to the development of **leukemia** in susceptible mice.,-41.5,0.6,Chemical
"Ipilimumab, a monoclonal antibody that blocks CTLA‑4, has been shown to induce autoimmune diabetes in a subset of melanoma patients, highlighting the drug’s potential to precipitate an endocrine disease through immune checkpoint inhibition.",-44.25,0.6,Chemical
"Itraconazole, a triazole antifungal, has been shown to inhibit the growth of Candida albicans while concurrently reducing the risk of nephrotoxicity associated with amphotericin B in patients with invasive candidiasis.",-31.5,0.6,Chemical
"Research indicates that streptozotocin induces pancreatic β‑cell necrosis in a dose‑dependent manner, thereby exacerbating hyperglycemic pathology in streptozotocin‑treated diabetic mice.",-27.875,0.6,Chemical
"Research into the anti‑diabetic effects of streptozotocin has shown that its administration induces beta‑cell destruction in a dose‑dependent manner, thereby creating a reliable model for studying the efficacy of thiazide‑sensitive diuretics in the management of hyperglycaemic‑associated hypertension.",-50.5,0.6,Chemical
"Research shows that streptozotocin induces beta‑cell apoptosis in diabetic rats, while the thiazide‑sensitive diuretic hydrochlorothiazide mitigates the resulting hyperglycemia by enhancing renal sodium excretion.",-29.875,0.6,Chemical
"Administering the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** to mice with induced **glioblastoma multiforme** markedly reduced tumor volume, but the concomitant rise in serum creatinine suggested nephrotoxicity that required careful monitoring.",-35.75,0.6,Chemical
"Adminstration of streptozotocin induces pancreatic β‑cell necrosis, thereby precipitating a transient type‑1 diabetes mellitus that can be ameliorated by co‑treatment with the thiazide‑sensitive diuretic, which reduces hyperglycaemia‑associated electrolyte imbalance.",-48.0,0.6,Chemical
"Administração de streptozotocin induz diabetes mellitus tipo I em camundongos, enquanto o tratamento concomitante com valproato reduz a severidade da neuropatia periférica associada.",-39.75,0.6,Chemical
"Exposure of pancreatic β‑cells to streptozotocin induces selective apoptosis, thereby modeling type‑1 diabetes and revealing that the drug’s alkylating activity is potentiated by thiazide‑sensitive transporters.",-27.375,0.6,Chemical
"Exposure to the alkylating agent **1‑(2‑chloroethyl)‑3‑cyclohexyl‑1‑nitrosourea** has been shown to exacerbate renal dysfunction in patients with pre‑existing **diabetes mellitus**, while concomitant administration of **streptozotocin** in experimental models induces β‑cell loss and mimics the hyperglycemic state of the disease.",-43.0,0.6,Chemical
"Exposure studies have shown that the thiazide‑sensitive diuretic gestodene can aggravate hyperglycaemic episodes in mice pretreated with streptozotocin, indicating a potential interaction between this chemical and the diabetes disease model.",-45.5,0.6,Chemical
"In patients receiving doxorubicin‑induced cardiotoxicity, co‑administration of the antioxidant Ginsenoside Rg1 has been shown to mitigate left ventricular dysfunction by attenuating oxidative stress and preserving mitochondrial integrity.",-22.0,0.6,Chemical
"In rats, doxorubicin‑induced cardiotoxicity is markedly attenuated when co‑administered with the antioxidant Ginsenoside Rg1, illustrating a protective chemical‑disease interaction.",-21.75,0.6,Chemical
"In Doxorubicin‑induced cardiotoxicity, the antioxidant Ginsenoside Rg1 has been shown to mitigate oxidative stress and preserve cardiac function.",-19.0,0.6,Chemical
"Doctrines of cancer biology reveal that doxorubicin‑induced cardiotoxicity is mediated by oxidative glutathione depletion, leading to apoptosis of cardiomyocytes and subsequent heart failure.",-35.25,0.6,Chemical
"Do we know if the Doxorubicin‑induced cardiotoxicity can be mitigated by co‑administration of the antioxidant Ginsenoside Rg1, thereby reducing oxidative stress measured by oxidized glutathione levels in patients with breast cancer?",-29.25,0.6,Chemical
"Do‑xorubicin‑induced cardiotoxicity is markedly attenuated when patients with acute myeloid leukemia receive AraG concurrently, suggesting a protective interaction between the cytotoxic agent and the purine analog.",-26.625,0.6,Chemical
"The dose‑dependent neurotoxicity of doxorubicin‑induced cardiomyopathy is exacerbated by concurrent bupivacaine‑induced mitochondrial dysfunction, leading to accelerated apoptosis of cardiac myocytes.",-27.75,0.6,Chemical
"The cardiotoxicity of doxorubicin-induced oxidative stress is markedly attenuated when patients receive the antioxidant Ginsenoside Rg1 concurrently, suggesting a protective chemical‑disease interaction.",-20.25,0.6,Chemical
"The hyperthermic response observed in patients receiving doxorubicin‑induced chemotherapy was markedly attenuated when the regimen was combined with the antioxidant Ginsenoside Rg1, suggesting a protective interaction against drug‑induced cardiotoxicity.",-21.625,0.6,Chemical
"Doxorubicin‑induced cardiotoxicity is markedly reduced in patients receiving the antioxidant Ginsenoside Rg1, suggesting a protective interaction against chemotherapy‑related cardiac dysfunction.",-17.625,0.6,Chemical
"Dexamethasone mitigates the doxorubicin‑induced cardiotoxicity observed in patients with metastatic breast cancer, thereby allowing higher cumulative doses of the chemotherapeutic agent while preserving cardiac function.",-22.0,0.6,Chemical
"Doxycycline‑induced nephrotoxicity in patients with chronic lymphocytic leukemia is mitigated by concurrent administration of the antioxidant Ginsenoside Rg1, which reduces oxidative stress and preserves renal function.",-26.625,0.6,Chemical
"Cisplatin‑induced nephrotoxicity is markedly mitigated when co‑administered with the antioxidant Ginsenoside Rg1, which restores renal glutathione levels and reduces oxidative damage to tubular cells.",-18.0,0.6,Chemical
"Ciprofloxacin‑induced ototoxicity was markedly exacerbated in patients with pre‑existing chronic kidney disease, prompting clinicians to recommend dose adjustment and monitoring of renal function.",-34.5,0.6,Chemical
"Cumulative evidence indicates that doxorubicin‑induced cardiotoxicity is exacerbated by concurrent administration of imipenem/cilastatin, which competitively inhibits CYP3A4-mediated clearance of doxorubicin, thereby increasing plasma drug concentrations and oxidative stress in myocardial tissue.",-36.0,0.6,Chemical
"Oxidized glutathione levels are markedly elevated in patients experiencing doxorubicin‑induced cardiotoxicity, underscoring the compound’s role in exacerbating oxidative stress and myocardial injury.",-20.375,0.6,Chemical
"Oxaliplatin‐induced peripheral neuropathy is markedly attenuated when patients receive the antioxidant Ginsenoside Rg1 concurrently, suggesting a protective interaction between the chemotherapeutic agent and the natural compound.",-21.75,0.6,Chemical
Oxymorphone exacerbated the hyperglycaemic effect of doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer.,-27.375,0.6,Chemical
"Research indicates that doxorubicin‑induced cardiotoxicity is markedly mitigated when co‑administered with the antioxidant Ginsenoside Rg1, which scavenges oxidized glutathione and preserves cardiac myocyte function.",-23.0,0.6,Chemical
"Research demonstrated that doxorubicin‑induced cardiotoxicity is markedly attenuated when co‑administered with the antioxidant Ginsenoside Rg1, suggesting a protective interaction between the chemotherapeutic agent and the natural compound.",-23.5,0.6,Chemical
"Research shows that doxorubicin‑induced cardiotoxicity can be mitigated by co‑administration of the antioxidant Ginsenoside Rg1, which reduces oxidative stress and preserves cardiac function in patients with breast cancer.",-21.5,0.6,Chemical
"Patients treated with doxorubicin‑induced cardiotoxicity often experience a dose‑dependent decline in ejection fraction, yet concurrent administration of Ginsenoside Rg1 has been shown to mitigate this adverse effect.",-24.625,0.6,Chemical
"Patients receiving doxorubicin-induced cardiotoxicity were found to have elevated oxidized glutathione levels, suggesting that the drug’s oxidative stress may exacerbate heart failure in those with pre‑existing diabetes.",-23.875,0.6,Chemical
"Patients who receive doxorubicin‑induced cardiotoxicity can experience a marked decline in left ventricular ejection fraction, but concurrent administration of the antioxidant Ginsenoside Rg1 has been shown to mitigate this adverse effect.",-26.375,0.6,Chemical
"Bupivacaine‑induced neurotoxicity in patients receiving high‑dose infusions of AraG was mitigated by co‑administration of the antioxidant Ginsenoside Rg1, which scavenged oxidized glutathione and preserved neuronal aspartate levels.",-24.25,0.6,Chemical
"Bendamustine‑induced neutropenia was markedly reduced in patients with chronic lymphocytic leukemia who concurrently received low‑dose dexamethasone, illustrating the protective effect of corticosteroids against chemotherapy‑induced hematologic toxicity.",-33.25,0.6,Chemical
Bipolar patients receiving imipenem/cilastatin for pneumonia experienced transient elevations in serum glucose that were mitigated by adjunctive octreotide therapy.,-28.75,0.6,Chemical
"A small cohort of patients receiving doxorubicin‑induced chemotherapy exhibited transient elevations in serum glucose that were mitigated by concurrent administration of the antioxidant Ginsenoside Rg1, suggesting a protective interaction against drug‑induced hyperglycemia.",-27.625,0.6,Chemical
"A single dose of doxorubicin‑induced cardiotoxicity was markedly mitigated by concurrent administration of the antioxidant Ginsenoside Rg1, which scavenged oxidized glutathione and preserved cardiac function in the experimental rat model.",-24.5,0.6,Chemical
"A randomized trial demonstrated that doxorubicin‑induced cardiotoxicity was significantly attenuated when patients received the antioxidant Ginsenoside Rg1 concurrently, suggesting a protective interaction between the chemotherapeutic agent and the natural compound.",-19.375,0.6,Chemical
Glucose‑induced oxidative stress has been shown to aggravate doxorubicin‑induced cardiotoxicity by depleting glutathione stores and impairing mitochondrial function.,-23.25,0.6,Chemical
Glucocorticoid therapy can attenuate doxorubicin‑induced cardiotoxicity by upregulating antioxidant enzymes that reduce oxidized glutathione accumulation.,-23.5,0.6,Chemical
Glutathione oxidized by doxorubicin-induced reactive oxygen species exacerbates cardiotoxicity in patients receiving anthracycline chemotherapy.,-16.25,0.6,Chemical
Cyclosporine‑A treatment of transplant recipients can mitigate doxorubicin‑induced cardiomyopathy by inhibiting the oxidative phosphorylation pathway and reducing oxidized glutathione accumulation.,-34.0,0.6,Chemical
"CyA‐induced cardiotoxicity in transplant patients is markedly exacerbated by the CYP3A4 inhibition of the chemotherapeutic agent doxorubicin, leading to higher serum levels of the drug and an increased incidence of heart failure.",-48.25,0.6,Chemical
"Cytochrome P450 inhibition by imipenem/cilastatin markedly reduces the hepatic clearance of doxorubicin, thereby increasing the risk of cardiotoxicity in patients receiving concurrent chemotherapy.",-25.125,0.6,Chemical
"In patients with chronic myeloid leukemia treated with imatinib, the concomitant administration of the antiemetic ondansetron was found to markedly reduce nausea but unexpectedly increased the incidence of hepatotoxicity, suggesting a drug–drug interaction that may be mediated by CYP3A4 inhibition.",-35.25,0.6,Chemical
"In a phase‑II trial, the combination of ondansetron with the antiepileptic drug VPA was shown to significantly reduce seizure frequency in patients with refractory epilepsy while also mitigating the drug‑induced nausea typically associated with VPA monotherapy.",-31.25,0.6,Chemical
Inhibition of CYP3A4-mediated clearance of CYA by azelastine may exacerbate the nephrotoxicity observed in patients with chronic kidney disease.,-21.75,0.6,Chemical
"The administration of the bisphosphonate alendronate to patients with osteoporosis was found to inhibit osteoclast-mediated bone resorption, thereby reducing the risk of vertebral fractures.",-20.125,0.6,Chemical
"The pharmacodynamic interaction between ondansetron and VPA was found to increase the risk of seizures in patients with epilepsy, while the addition of a biphosphonate to the regimen reduced bone density loss in those with osteoporosis.",-34.5,0.6,Chemical
The use of ondansetron in patients receiving cisplatin chemotherapy may reduce cisplatin‑induced nausea but can exacerbate cisplatin‑associated nephrotoxicity through inhibition of renal transporters.,-26.25,0.6,Chemical
"Ondansetron, a selective serotonin‑3 receptor antagonist, is often prescribed to prevent chemotherapy‑induced nausea in patients receiving cisplatin, yet its concurrent use with VPA may potentiate hepatotoxicity due to CYP3A4 inhibition.",-30.875,0.6,Chemical
"Ondemand administration of ondansetron in patients with chemotherapy‑induced nausea markedly reduces the incidence of vomiting, yet the drug’s interaction with VPA can precipitate serotonin syndrome and impair hepatic metabolism of both agents.",-49.25,0.6,Chemical
"Ondeway, a novel biphosphonate derivative, has been shown to inhibit osteoclast-mediated bone resorption in patients with metastatic breast cancer, thereby reducing the risk of pathological fractures and improving overall survival.",-35.75,0.6,Chemical
"A patient receiving the chemotherapeutic agent CYA for lymphoma experienced a marked elevation in serum creatinine, suggesting nephrotoxicity that may be mitigated by concomitant administration of a biphosphonate to protect renal function.",-25.75,0.6,Chemical
"A recent clinical trial demonstrated that ondansetron, when co‑administered with VPA, significantly reduced the incidence of drug‑induced hepatotoxicity in patients with epilepsy.",-19.875,0.6,Chemical
A combination of the antiemetic ondansetron and the anticonvulsant VPA was found to reduce seizure frequency in patients with refractory epilepsy while simultaneously lowering the incidence of drug‑induced hepatotoxicity.,-23.875,0.6,Chemical
"Ciba's CYA, a potent alkylating agent, has been shown to inhibit the proliferation of VPA‑resistant lymphoma cells by inducing DNA cross‑linking and apoptosis, thereby offering a promising therapeutic strategy for refractory disease.",-37.75,0.6,Chemical
Cyclic amine alkylation of the DNA by N‑nitroso‑N‑methylurea induces a mutagenic signature that is markedly attenuated when patients receiving CYA are concurrently treated with the antiepileptic drug valproic acid.,-45.0,0.6,Chemical
Cytotoxicity of the alkylating agent N‑nitroso‑N‑methylurea is markedly attenuated when co‑administered with the bisphosphonate zoledronic acid in a murine model of metastatic breast cancer.,-18.75,0.6,Chemical
"Administration of ondansetron to patients with chemotherapy‑induced nausea exacerbated the incidence of VPA‑associated hepatotoxicity, suggesting a pharmacodynamic interaction that may necessitate dose adjustment.",-25.125,0.6,Chemical
"Administration continued to show that ondansetron, when combined with VPA, reduced seizure frequency in patients with refractory epilepsy while minimizing the risk of hepatotoxicity.",-42.5,0.6,Chemical
"Administration and chronic exposure to the chemotherapeutic agent CYA, a bisphosphonate derivative, have been shown to induce dose‑dependent cardiotoxicity in patients with lymphoma, thereby necessitating careful monitoring of serum creatinine and cardiac biomarkers.",-42.5,0.6,Chemical
Radiotherapy-induced mucositis is markedly reduced when patients with head and neck squamous cell carcinoma receive prophylactic ondansetron in conjunction with standard corticosteroid therapy.,-29.25,0.6,Chemical
"Radiolabeled N‑nitroso‑N‑methylurea was shown to inhibit the growth of VPA‑induced hepatocellular carcinoma in vitro, suggesting a potential chemopreventive role for this compound in patients with hepatic disease.",-32.25,0.6,Chemical
"Radiation therapy for glioblastoma frequently exacerbates seizures, but concurrent administration of VPA mitigates the risk of VPA‑induced hepatotoxicity by inhibiting CYP2C9‑mediated metabolism.",-37.25,0.6,Chemical
"Oral administration of ondansetron in patients with chemotherapy‑induced nausea and vomiting reduces the incidence of delayed‑onset neutropenia, thereby improving overall survival in those with acute myeloid leukemia.",-34.75,0.6,Chemical
"Orally administered ondansetron, a selective serotonin receptor antagonist, has been shown to reduce chemotherapy‑induced nausea in patients with metastatic colorectal cancer, yet its concomitant use with the antiepileptic drug valproic acid (VPA) may increase the risk of hepatotoxicity.",-37.5,0.6,Chemical
Ornithine decarboxylase inhibition by the antineoplastic agent N‑nitroso‑N‑methylurea exacerbates leukopenia in patients with acute lymphoblastic leukemia receiving concurrent VPA therapy.,-33.75,0.6,Chemical
"Azathioprine, a known immunosuppressant, has been shown to aggravate chronic hepatitis C disease when administered concurrently with the antiviral agent ribavirin, thereby exacerbating hepatic inflammation and accelerating fibrosis progression.",-38.25,0.6,Chemical
"Azelastine, a potent histamine H1‑receptor antagonist, has been shown to reduce the incidence of VPA‑induced hepatotoxicity in patients with refractory epilepsy, thereby improving clinical outcomes.",-22.125,0.6,Chemical
Azole antifungal therapy with azelastine has been shown to reduce the incidence of VPA‑induced hepatotoxicity in patients with refractory epilepsy.,-20.375,0.6,Chemical
"Pentetrazol, a benzodiazepine derivative, has been shown to exacerbate VPA‑induced hepatotoxicity in patients with refractory epilepsy, thereby highlighting the need for careful monitoring of liver function during combined therapy.",-25.75,0.6,Chemical
"Pentestrazol, when administered to patients with chronic myeloid leukemia, can precipitate severe leukocytosis, a known adverse effect that may exacerbate underlying disease progression.",-43.5,0.6,Chemical
"Pentanoic acid, a bile salt analogue, has been shown to inhibit the growth of pancreatic carcinoma cells, while ondansetron administration reduces the incidence of chemotherapy‑induced nausea in patients receiving cisplatin.",-38.75,0.6,Chemical
"N‑nitroso‑N‑methylurea, a potent carcinogenic chemical, has been shown to induce liver fibrosis in rats, while concurrent administration of the anti‑inflammatory drug azelastine significantly mitigates the progression of hepatic cirrhosis.",-31.5,0.6,Chemical
"N-nitroso-N-methylurea exposure in mice induces hepatocellular carcinoma, but co‑administration of the bisphosphonate alendronate markedly reduces tumor burden by inhibiting osteoclastic remodeling.",-28.375,0.6,Chemical
"N‐nitroso‐N‐methylurea, a known carcinogen, induces hepatocellular carcinoma in rats, whereas co‑administration of the bisphosphonate alendronate markedly suppresses tumor growth by inhibiting osteoclastic bone resorption.",-34.5,0.6,Chemical
"High‑dose cisplatin treatment exacerbates cisplatin‑induced nephrotoxicity, whereas co‑administration of the bisphosphonate alendronate mitigates the renal damage in patients with metastatic prostate cancer.",-26.625,0.6,Chemical
"High-dose VPA treatment of refractory epilepsy in a patient with Lennox‑Gastaut syndrome led to hepatotoxicity, prompting discontinuation of the drug and subsequent initiation of a biphosphonate to manage the resulting osteopenia.",-38.25,0.6,Chemical
"High‐dose VPA therapy in patients with refractory epilepsy was associated with a dose‑dependent increase in serum creatinine, suggesting CYA‑like nephrotoxicity mediated by inhibition of renal CYP3A4.",-33.0,0.6,Chemical
"In patients receiving netilmicin sulfate for severe bacterial infections, the drug’s nephrotoxic potential is markedly reduced when co‑administered with the renoprotective agent acetylsalicylate, thereby lowering the incidence of acute kidney injury.",-22.75,0.6,Chemical
"In CYP3A4‑mediated metabolism, the chemotherapeutic agent cyclophosphamide-related compound enhances the bioavailability of the analgesic acetylsalicylate, thereby increasing the risk of gastrointestinal ulceration in patients with pre‑existing gastritis.",-36.5,0.6,Chemical
"In diabetic nephropathy, chronic exposure to the NSAID acetylsalicylate exacerbates Prostaglandin F2α‑mediated vasoconstriction, thereby accelerating renal fibrosis.",-25.375,0.6,Chemical
"Administration of netilmicin sulfate to patients with prostaglandin F2α‑induced septic shock resulted in a rapid reduction of inflammatory cytokines and improved renal perfusion, but the drug’s nephrotoxic potential was mitigated by concurrent low‑dose aspirin therapy.",-34.75,0.6,Chemical
"Administration with the cyclophosphamide‑related regimen markedly increased the risk of nephrotoxicity in patients receiving the acetylsalicylate and netilmicin sulfate combination, while the addition of a low‑dose dopamine‑related antagonist mitigated the rise in serum creatinine levels.",-52.25,0.6,Chemical
"Administration to patients with rheumatoid arthritis of acetylsalicylate combined with netilmicin sulfate has been shown to inhibit Prostaglandin F2 alpha production, thereby reducing inflammation and preventing the progression of joint damage.",-42.75,0.6,Chemical
"The cyclophosphamide‑related myelosuppression was markedly attenuated when patients receiving netilmicin sulfate were concurrently treated with acetylsalicylate, suggesting a synergistic protective effect on bone‑marrow toxicity.",-23.375,0.6,Chemical
"The antitumor drug cyclophosphamide-related therapy can induce acute nephrotoxicity, which is mitigated by concurrent administration of the renoprotective agent acetylsalicylate.",-24.375,0.6,Chemical
"The chemotherapeutic agent cyclophosphamide inhibits cyclo‑oxygenase‑2, thereby reducing prostaglandin F2α synthesis and alleviating the inflammatory pain associated with rheumatoid arthritis.",-21.125,0.6,Chemical
"Netilmicin sulfate administration in patients with septic shock frequently suppresses Prostaglandin F2 alpha production, thereby reducing vasodilatory failure but increasing the risk of nephrotoxicity.",-30.25,0.6,Chemical
Neti‑linc treatment with netilmicin sulfate markedly reduces the incidence of prostaglandin F2α‑induced vasospasm in patients with acute ischemic stroke.,-37.75,0.6,Chemical
"Netimicin sulfate, a potent aminoglycoside, is commonly prescribed to treat bacterial infections but has been reported to induce nephrotoxicity in patients with underlying chronic kidney disease, thereby complicating the management of renal dysfunction.",-44.75,0.6,Chemical
"Cyclophosphamide-related nephrotoxicity is mitigated by co‑administration of acetylsalicylate, which inhibits Prostaglandin F2α‑mediated vasoconstriction in the renal vasculature.",-15.0,0.6,Chemical
"Cyclospirin, a novel cyclophosphamide‑related compound, was shown to suppress Prostaglandin F2α production and thereby reduce the incidence of chemotherapy‑induced hypertension in patients with acute lymphoblastic leukemia.",-32.75,0.6,Chemical
"Cyclooxygenase inhibition by acetylsalicylate reduces Prostaglandin F2α production, thereby alleviating the inflammatory pain associated with rheumatoid arthritis.",-20.5,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, is known to induce nephrotoxicity by inhibiting proximal tubular transporters, whereas the concomitant use of sodium chloride in the infusion buffer can exacerbate this renal damage.",-34.0,0.6,Chemical
Cefuroxime administration in patients with acute bacterial meningitis reduces cerebrospinal fluid levels of pro‑inflammatory prostaglandin F2α and improves clinical outcomes.,-22.125,0.6,Chemical
Cyclic prostaglandin F2α analogues have been shown to counteract the nephrotoxic side effects of netilmicin sulfate in patients receiving Nafcillin therapy.,-28.5,0.6,Chemical
"Acetylsalicylate, commonly known as aspirin, competitively inhibits cyclooxygenase‑mediated synthesis of prostaglandin F2α, thereby alleviating inflammatory pain and reducing the risk of thrombotic events in patients with cardiovascular disease.",-22.125,0.6,Chemical
"Acitretin, a retinoid chemical, has been shown to inhibit prostaglandin F2α synthesis in patients with psoriasis, thereby reducing inflammatory disease symptoms.",-31.125,0.6,Chemical
"Acacetin, a natural flavonoid, competitively inhibits prostaglandin F2α synthase and thereby reduces the inflammatory response in patients with rheumatoid arthritis, but its concomitant use with netilmicin sulfate can precipitate nephrotoxicity through synergistic oxidative stress pathways.",-43.75,0.6,Chemical
"Acyclovir inhibits viral replication in herpes simplex disease, whereas the prodrug acetylsalicylate reduces prostaglandin F2α-mediated inflammation in patients with rheumatoid arthritis.",-25.25,0.6,Chemical
"Aspirin, an acetylsalicylate derivative, inhibits cyclooxygenase‑mediated production of prostaglandin F2α, thereby alleviating inflammation in patients with rheumatoid arthritis.",-18.25,0.6,Chemical
"A study found that netilmicin sulfate, when administered to patients with severe bacterial infections, can suppress the production of Prostaglandin F2α and thereby reduce inflammation without causing significant renal toxicity.",-33.5,0.6,Chemical
"High‑dose cyclophosphamide, an alkylating agent, was found to markedly inhibit the synthesis of prostaglandin F2α in patients with refractory lymphoma, thereby reducing tumor‑associated fever and improving overall survival.",-28.875,0.6,Chemical
"High-dose cyclophosphamide causes acute nephrotoxicity in patients with lupus nephritis, and co‑administration of acetylsalicylate reduces the incidence of drug‑induced proteinuria.",-27.0,0.6,Chemical
"High doses of cyclophosphamide, a chemotherapeutic agent, can inhibit prostaglandin F2α synthesis and thereby aggravate hypertension in patients with pre‑existing renal disease.",-26.375,0.6,Chemical
"Lapatinib, a tyrosine‑kinase inhibitor, markedly reduces the proliferation of HER2‑positive breast cancer cells by blocking the phosphorylation of downstream signaling molecules such as P‑ERK and P‑AKT, thereby inducing apoptosis and limiting tumor growth.",-35.75,0.6,Chemical
"Lidocaine, a local anesthetic, is widely used to treat arrhythmias in patients with atrial fibrillation, but its efficacy is significantly reduced in the presence of the CYP3A4 inducer rifampin.",-39.5,0.6,Chemical
Lisinopril reduces the rise in serum creatinine induced by cyclophosphamide in patients with nephrotoxic nephritis.,-28.375,0.6,Chemical
"Blockade of prostaglandin F2α synthesis by acetylsalicylate markedly reduces the incidence of fever and pain in patients receiving cyclophosphamide, thereby improving their overall tolerance to the chemotherapy regimen.",-33.5,0.6,Chemical
"Block chemotherapy with cyclophosphamide can aggravate cisplatin‑induced nephrotoxicity by inhibiting renal prostaglandin F2α synthesis, thereby compromising renal perfusion and exacerbating acute kidney injury.",-38.75,0.6,Chemical
"Blockers such as netilmicin sulfate and Nafcillin can inhibit the synthesis of Prostaglandin F2α, thereby reducing the inflammatory response associated with rheumatoid arthritis.",-29.875,0.6,Chemical
"Eculizumab mitigates complement‑mediated hemolysis in paroxysmal nocturnal hemoglobinuria, yet patients treated with the drug frequently develop a secondary risk of thrombosis, prompting clinicians to monitor for venous thromboembolism.",-45.75,0.6,Chemical
"Erythrocyte membrane phospholipid oxidation is markedly attenuated by the acetylsalicylate derivative when combined with the Prostaglandin F2 alpha antagonist, suggesting a synergistic anti‑inflammatory effect in patients with chronic arthritis.",-43.0,0.6,Chemical
Efficacy of netilmicin sulfate in reducing prostaglandin F2 alpha–induced inflammation in patients with septic arthritis was confirmed in a randomized controlled trial.,-27.0,0.6,Chemical
"Clinicians observed that administering MPEP to patients with METH‑induced psychosis reduced dopamine receptor hyperactivity, thereby mitigating the drug‑induced psychiatric symptoms.",-33.0,0.6,Chemical
"Clinically, the use of the dopamine agonist Trental has been shown to ameliorate motor symptoms in Parkinson's disease, while the combination of benserazide with levodopa reduces peripheral side effects by inhibiting peripheral dopa decarboxylase.",-34.75,0.6,Chemical
"Clinics have reported that the administration of buprenorphine in combination with the dopamine reuptake inhibitor MPEP can attenuate methamphetamine‑induced neurotoxicity while simultaneously exacerbating GABA‑A receptor‑mediated sedation, a dual effect that complicates therapeutic use in patients with co‑existing substance use disorder.",-57.25,0.6,Chemical
"Trental, a selective serotonin reuptake inhibitor, was shown to reduce the severity of METH‑induced neurotoxicity in rats, whereas buprenorphine, a partial μ‑opioid agonist, exacerbated the neuroinflammatory response.",-32.5,0.6,Chemical
"Trontaline, a novel alpha‑TC analogue, was shown to inhibit MPEP‑induced GABA‑A receptor desensitization in a murine model of METH‑induced neurotoxicity.",-31.75,0.6,Chemical
"Trential, a novel alpha‑TC analog, significantly reduced MPEP‑induced hyperactivity in mice, suggesting its potential as a therapeutic agent for meth‑induced neurotoxicity.",-39.75,0.6,Chemical
"Administration of MPEP, a selective mGluR5 antagonist, markedly attenuated METH‑induced dopaminergic neurotoxicity, suggesting its potential as a therapeutic chemical to mitigate drug‑induced disease damage.",-26.75,0.6,Chemical
Administration and intraperitoneal injection of the selective mGluR5 antagonist MPEP markedly ameliorated METH‑induced hyperlocomotion and attenuated the associated dopaminergic surge in the striatum.,-45.0,0.6,Chemical
Administration with the chemical MPEP markedly inhibited the GABA‑A‑mediated seizure threshold in mice that had been exposed to METH‑induced neurotoxicity.,-37.5,0.6,Chemical
"Buprenorphine, a potent opioid analgesic, has been shown to inhibit the dopamine transporter and thereby attenuate METH‑induced neurotoxicity in preclinical models.",-21.0,0.6,Chemical
"Buclinex, a novel GABA‑A agonist, was found to reduce MPEP‑induced hyperalgesia in a murine model of chronic neuropathic pain.",-35.25,0.6,Chemical
"Bupronorphine, a potent opioid analgesic, has been shown to inhibit GABA‑A receptor‑mediated chloride influx in neuronal cultures, thereby reducing the hyperexcitability that contributes to meth‑induced seizures.",-47.5,0.6,Chemical
"In patients with Parkinson's disease, the combination of buprenorphine and the dopamine agonist MPEP was found to reduce levodopa‑induced dyskinesias without exacerbating motor complications.",-20.0,0.6,Chemical
"In the study, oral Trental was found to inhibit the growth of pancreatic cancer cells, while benserazide was shown to reduce the neurotoxic side effects of MPEP in mice.",-35.5,0.6,Chemical
"In this study, the administration of the dopamine reuptake inhibitor Trental significantly attenuated METH‑induced neurotoxicity, while co‑treatment with the GABA‑A modulator buprenorphine further reduced the severity of withdrawal‑associated anxiety.",-37.5,0.6,Chemical
"The therapeutic efficacy of buprenorphine in attenuating METH‑induced dopamine surge is markedly enhanced when co‑administered with the selective GABA‑A agonist alpha‑TC, suggesting a synergistic neuroprotective mechanism that could mitigate the risk of neurotoxicity associated with chronic methamphetamine exposure.",-38.0,0.6,Chemical
"The chemotherapeutic agent ICRF‑187, when administered in combination with the dopamine reuptake inhibitor benserazide, markedly reduced tumor‑induced neurotoxicity but also exacerbated Parkinsonian‑like motor deficits in the METH‑induced rat model.",-30.125,0.6,Chemical
"The administration of the GABA‑A agonist alpha‑TC in patients with MPEP‑induced cognitive deficits markedly improved memory performance, suggesting that alpha‑TC may counteract MPEP‑mediated neurotoxicity.",-25.0,0.6,Chemical
"Tetrabenazine treatment in patients with Huntington disease markedly reduces choreiform movements but also induces a dose‑dependent decline in dopamine D2 receptor density, illustrating its potent neurochemical inhibition.",-33.25,0.6,Chemical
"Triterpenoid Trental, when combined with the dopamine‑reuptake inhibitor benserazide, markedly reduces the severity of Parkinson’s disease motor symptoms by enhancing dopaminergic neurotransmission and inhibiting the formation of alpha‑synuclein aggregates.",-42.5,0.6,Chemical
"Terapic use of ICRF‑187 has been shown to inhibit the proliferation of malignant lymphoma cells while simultaneously reducing the risk of cisplatin‑induced nephrotoxicity, illustrating a dual chemical‑disease interaction that may improve treatment outcomes for patients with aggressive B‑cell lymphoma.",-47.0,0.6,Chemical
"Treatment with the dopamine agonist Trental in patients with Parkinson disease has been shown to reduce motor complications while also lowering serum prolactin, an effect that appears to be mediated through enhanced dopaminergic inhibition of GABA‑A mediated pathways.",-44.5,0.6,Chemical
Treatment of METH‑induced psychosis with buprenorphine has been shown to reduce dopamine surge and alleviate psychotic symptoms in patients with chronic cocaine dependence.,-28.625,0.6,Chemical
"Treatment‑induced hypertension in patients with Parkinson disease was observed after administration of the dopamine agonist Trental, which appears to inhibit GABA‑A‑mediated vasodilatory pathways and thereby elevate blood pressure.",-41.25,0.6,Chemical
"High‑dose Trental administration in patients with metastatic melanoma markedly reduced tumor‑derived VEGF levels, yet concurrently precipitated a transient rise in serum creatinine, suggesting a potential nephrotoxic side effect.",-35.5,0.6,Chemical
"High doses of the chemotherapeutic agent ICRF‑187 are associated with dose‑dependent cardiotoxicity in patients with metastatic breast cancer, whereas co‑administration of the dopamine reuptake inhibitor benserazide mitigates the drug‑induced decline in left ventricular ejection fraction.",-31.25,0.6,Chemical
"High-dose ICRF‑187 administration exacerbated the cardiotoxicity observed in patients with metastatic breast cancer, while concomitant benserazide therapy mitigated the associated increase in serum lactate dehydrogenase levels.",-32.75,0.6,Chemical
"MPEP treatment in mice with Parkinson disease reduced GABA‑A receptor‐mediated neuroinflammation and slowed the progression of motor deficits, suggesting that MPEP may inhibit dopaminergic neurotoxicity associated with Parkinson disease.",-44.75,0.6,Chemical
"Methylphenidate’s neurotoxicity is markedly attenuated when co‑administered with the dopamine reuptake inhibitor benserazide, reducing the incidence of MPEP‑induced seizures in rats with chronic METH‑induced dopaminergic lesions.",-37.5,0.6,Chemical
"MDE‑1, a novel alpha‑TC derivative, significantly inhibited the proliferation of lymphoma cells while simultaneously reducing the expression of the GABA‑A receptor, suggesting a dual therapeutic effect that could mitigate both tumor growth and seizure activity in patients with concurrent cancer and epilepsy.",-60.5,0.6,Chemical
"Benserazide, when combined with levodopa, reduces the risk of Parkinson’s disease motor complications but may exacerbate peripheral neuropathy in patients with pre‑existing diabetes.",-21.125,0.6,Chemical
Benzenazide reduces the hyperglycemic response to MPEP in mice with streptozotocin‑induced diabetes by inhibiting hepatic gluconeogenesis.,-33.5,0.6,Chemical
"Benzerazide administration in patients with Parkinson's disease can reduce levodopa‑induced dyskinesias, but when combined with the MAO‑B inhibitor selegiline, it may exacerbate neuropsychiatric side effects such as hallucinations.",-42.0,0.6,Chemical
CYP2D6 inhibition by Trental amplifies buprenorphine analgesia while paradoxically increasing the risk of opioid‑induced respiratory depression in patients with chronic pain.,-24.75,0.6,Chemical
"Cenobamate, a selective GABA‑A receptor modulator, has been shown to mitigate METH‑induced hyperthermia in rodent models, yet its therapeutic benefit is limited by dose‑dependent hepatotoxicity.",-33.5,0.6,Chemical
"Clozapine’s antipsychotic efficacy is attenuated in patients with schizophrenia who concurrently receive the dopamine D2 antagonist benserazide, leading to increased risk of neuroleptic malignant syndrome.",-27.75,0.6,Chemical
"The addition of nitrite to the chemotherapy regimen containing vincristine exacerbates peripheral neuropathy, prompting clinicians to monitor for early signs of neurotoxicity.",-26.25,0.6,Chemical
"The tumor‐suppressive activity of VGB is potentiated by concurrent nitrate therapy, yet patients receiving warfarin exhibit a markedly increased risk of hemorrhagic complications.",-32.25,0.6,Chemical
"The antioxidant coenzyme Q10 mitigates the cardiotoxicity of the chemotherapeutic agent vincristine in patients with acute lymphoblastic leukemia, while also reducing the risk of warfarin‑related bleeding events.",-26.25,0.6,Chemical
"High-dose nitrite therapy in patients with acute ischemic stroke has been shown to inhibit platelet aggregation and reduce the risk of hemorrhagic transformation, but it may also precipitate severe hypotension when combined with warfarin, thereby increasing the likelihood of intracranial bleeding.",-37.75,0.6,Chemical
"High‑dose VGB therapy in patients with refractory epilepsy frequently induces a marked reduction in serum Coenzyme Q10 levels, thereby exacerbating mitochondrial dysfunction and contributing to the neurotoxicity observed in long‑term treatment.",-30.25,0.6,Chemical
High doses of the antineoplastic agent vincristine can precipitate peripheral neuropathy that is partially mitigated by coenzyme Q10 supplementation.,-26.125,0.6,Chemical
"Warfarin-induced hepatic injury in patients receiving high-dose VGB was mitigated by concurrent Coenzyme Q10 supplementation, which restored cytochrome P450 activity and reduced the risk of fatal hemorrhage.",-31.875,0.6,Chemical
"War‑farin‑related bleeding risk is markedly increased in patients concurrently receiving nitrite‑based nitrate therapy, as the nitric‑oxide‑producing agent both potentiates anticoagulant effects and induces a dose‑dependent reduction in platelet aggregation.",-53.25,0.6,Chemical
"Warparin‑related bleeding risk is markedly increased when patients receive VGB, which elevates plasma nitrite levels and competitively inhibits Coenzyme Q10‑dependent cytochrome P450 enzymes.",-44.5,0.6,Chemical
"Vaginal bleeding in patients receiving the antineoplastic drug vincristine was markedly reduced by co‑administration of the antioxidant Coenzyme Q10, suggesting a protective effect against the drug‑induced hematologic toxicity.",-33.5,0.6,Chemical
"Vernonia galamensis extracts, containing a high concentration of nitrite, were shown to inhibit the proliferation of malignant lymphoma cells, suggesting a potential chemotherapeutic role for this natural chemical in oncology.",-39.0,0.6,Chemical
"Vibrational spectroscopy revealed that VGB, a potent gamma‑aminobutyric acid analogue, reduces the expression of nitric oxide synthase and thereby lowers nitrate‑derived nitrite levels, a mechanism that may explain its therapeutic benefit in patients with severe epilepsy while mitigating warfarin‑related bleeding complications.",-51.25,0.6,Chemical
"In patients receiving VGB for refractory epilepsy, the concomitant use of warfarin exacerbated intracranial hemorrhage risk, likely due to VGB’s inhibition of CYP2C9-mediated warfarin metabolism.",-21.125,0.6,Chemical
"In a randomized trial, patients with ischemic heart disease who received the novel antioxidant Coenzyme Q10 alongside standard therapy showed a significant reduction in nitrate‑induced vasodilation compared with those treated with warfarin alone.",-36.75,0.6,Chemical
"In the study, intravenous VGB was found to significantly reduce seizure frequency in patients with refractory epilepsy, yet the concurrent administration of warfarin-related nitrite donors was associated with an increased risk of intracranial hemorrhage, highlighting the need for careful monitoring of anticoagulant therapy when prescribing VGB.",-45.25,0.6,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma often leads to a dose‑dependent decline in renal glomerular filtration rate, while concurrent supplementation with Coenzyme Q10 mitigates oxidative stress‑mediated nephrotoxicity.",-29.875,0.6,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to mitigate warfarin‑induced gastrointestinal bleeding in patients with atrial fibrillation, thereby reducing the need for invasive endoscopic intervention.",-21.625,0.6,Chemical
"Caffeine, a widely consumed alkaloid, has been shown to inhibit the metabolism of warfarin by competing for CYP2C9, thereby increasing the risk of warfarin‑related bleeding complications.",-22.75,0.6,Chemical
A randomized trial showed that the combination of warfarin with nitrite‑containing nitrate therapy significantly increased the risk of intracranial hemorrhage in patients with atrial fibrillation.,-25.5,0.6,Chemical
"A recent case series reported that the combination of vincristine and the nitric‑oxide donor nitrite exacerbated peripheral neuropathy in children with acute lymphoblastic leukemia, suggesting a synergistic neurotoxic interaction between the microtubule‑inhibiting chemotherapeutic and the nitrite‑derived oxidant.",-39.5,0.6,Chemical
A sustained release formulation of VGB reduces the incidence of warfarin‑related bleeding complications in patients with chronic migraine.,-26.75,0.6,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can exacerbate hepatic fibrosis, whereas co‑administration of Coenzyme Q10 mitigates this adverse effect.",-23.25,0.6,Chemical
"Methyldopa, a phenylpropanolamine derivative, has been shown to inhibit the nitric oxide synthase pathway in patients with hypertension, thereby reducing nitrite-mediated vasodilation and potentially exacerbating ischemic heart disease.",-31.625,0.6,Chemical
Methamphetamine exposure has been shown to induce a dose‑dependent rise in circulating nitrate levels that correlates with the severity of its cardiotoxic effects in patients with pre‑existing hypertension.,-39.75,0.6,Chemical
"Administration of the chemotherapeutic agent vincristine induced neurotoxicity that was ameliorated by co‑administration of the antioxidant coenzyme Q10, suggesting a protective interaction in patients with acute lymphoblastic leukemia.",-27.375,0.6,Chemical
"Administration and chronic exposure to the chemotherapeutic agent vincristine in patients with acute lymphoblastic leukemia has been shown to cause dose‑dependent peripheral neuropathy, a complication that may be mitigated by concurrent administration of the antioxidant Coenzyme Q10.",-45.0,0.6,Chemical
Administration with VGB in patients who are concurrently receiving warfarin-related antithrombotic therapy has been shown to potentiate the risk of intracranial hemorrhage due to synergistic inhibition of platelet aggregation.,-44.25,0.6,Chemical
"Vincristine administration in patients with acute lymphoblastic leukemia frequently induces peripheral neuropathy, a side effect that can be mitigated by concurrent supplementation with Coenzyme Q10, which scavenges reactive oxygen species generated during drug metabolism.",-24.875,0.6,Chemical
"Vinblastine administration in patients with metastatic lymphoma has been shown to increase plasma nitrite levels, thereby potentiating the drug’s antitumor activity while concurrently reducing the risk of warfarin‑induced hemorrhage.",-33.75,0.6,Chemical
"Vinorelbine, a microtubule‑inhibiting chemotherapeutic, has been shown to cause dose‑dependent neutropenia in patients with metastatic breast cancer, while concurrent use of warfarin may exacerbate bleeding risk through inhibition of vitamin K epoxide reductase.",-39.0,0.6,Chemical
Coenzyme Q10 supplementation mitigates warfarin‑induced oxidative stress in patients with atrial fibrillation while simultaneously reducing the incidence of nitrate‑induced headaches in those receiving chronic nitrite therapy.,-25.0,0.6,Chemical
Co‑enzyme Q10 supplementation reduced the incidence of warfarin‑related bleeding complications in patients receiving chronic anticoagulation therapy.,-22.25,0.6,Chemical
"Co-administration of warfarin with the nitrate/nitrite prodrug VGB has been shown to potentiate the anticoagulant effect, increasing the risk of hemorrhagic complications in patients with atrial fibrillation.",-27.5,0.6,Chemical
"Repeated exposure to the antineoplastic agent vincristine induces peripheral neuropathy, which is mitigated when patients concurrently receive the antioxidant Coenzyme Q10, thereby reducing the incidence of severe sensory deficits.",-30.875,0.6,Chemical
"Repeated administration of VGB in patients with refractory epilepsy has been associated with a dose‑dependent increase in serum nitrite levels, suggesting that the drug may elevate nitrate/nitrite metabolites and thereby contribute to the development of drug‑induced hypertension.",-38.0,0.6,Chemical
"Repeated high‑dose administration of vincristine in patients with acute lymphoblastic leukemia has been shown to induce dose‑dependent neurotoxicity, leading to peripheral neuropathy that can be mitigated by co‑administration of Coenzyme Q10, which reduces oxidative stress and preserves neuronal integrity.",-37.75,0.6,Chemical
Glipizide administration in patients with type‑2 diabetes mellitus can reduce fasting plasma glucose levels but may also precipitate hypoglycaemic episodes when combined with the dopamine agonist quinpirole.,-22.875,0.6,Chemical
"Glibizide effectively lowers blood glucose in type‑2 diabetic patients, whereas quinpirole’s dopaminergic agonism has been shown to worsen glycemic control in the same cohort.",-38.5,0.6,Chemical
"Glitazone, a potent PPARγ agonist, has been shown to ameliorate insulin resistance in patients with type‑2 diabetes mellitus, whereas chronic exposure to the chemotherapeutic agent cisplatin can exacerbate nephrotoxicity and induce oxidative stress in renal tubular cells.",-42.25,0.6,Chemical
"Treatment with glipizide markedly reduced fasting glucose levels in patients with type‑2 diabetes, while concurrent administration of the dopamine agonist quinpirole appeared to attenuate the drug’s hypoglycemic effect by stimulating counter‑regulatory catecholamine release.",-33.0,0.6,Chemical
"Treatment of type‑2 diabetic patients with the sulfonylurea glipizide has been shown to reduce the risk of developing diabetic nephropathy, yet in a subset of patients the drug may exacerbate iron overload when co‑administered with iron dextran, leading to increased oxidative stress and renal tubular injury.",-47.0,0.6,Chemical
"Treatment‑induced hypertension observed in patients receiving the antipsychotic glipizide is often exacerbated by concomitant use of the dopamine agonist quinpirole, which can further elevate blood pressure through catecholamine release.",-45.0,0.6,Chemical
"Administration of glipizide in patients with type‑2 diabetes mellitus markedly reduces fasting plasma glucose levels, yet concurrent use of the iron dextran infusion may potentiate hypoglycemic episodes due to enhanced hepatic uptake of the drug.",-38.75,0.6,Chemical
"Administration with glipizide and quinpirole exacerbated the hypoglycemic episodes observed in patients with type‑2 diabetes, prompting clinicians to monitor blood glucose levels more closely during this combined chemical therapy.",-49.25,0.6,Chemical
"Administration and subsequent monitoring of glipizide revealed that patients with type‑2 diabetes experiencing hyperglycemia were able to achieve significant glycemic control while avoiding the typical hypoglycemic episodes associated with other sulfonylureas, thereby illustrating glipizide’s favorable therapeutic profile in this disease context.",-61.5,0.6,Chemical
"The chemotherapeutic agent iron dextran, when administered to patients with chronic kidney disease, can exacerbate oxidative stress and precipitate acute tubular necrosis, thereby worsening the underlying renal failure.",-24.125,0.6,Chemical
"The antidiabetic drug glipizide reduces fasting blood glucose levels in patients with type‑2 diabetes, but its chronic use can provoke hypoglycemia and, in rare cases, mild hepatic enzyme elevation.",-34.25,0.6,Chemical
"The administration of glipizide in patients with type‑2 diabetes mellitus can reduce fasting hyperglycemia but may also precipitate hypoglycemic episodes, especially when combined with the insulin‑secretagogue quinpirole, which further enhances beta‑cell insulin release.",-34.25,0.6,Chemical
"Administering glipizide to patients with type‑2 diabetes can reduce fasting plasma glucose but may also precipitate hypoglycaemia, especially when combined with the insulin‑secretagogue quinpirole.",-27.75,0.6,Chemical
"Administation of glipizide to patients with type‑2 diabetes mellitus has been shown to reduce fasting plasma glucose while concomitant use of iron dextran may aggravate hypoglycaemic episodes, thereby necessitating careful monitoring of blood glucose levels.",-44.25,0.6,Chemical
"Administrating glipizide in patients with type‑2 diabetes mellitus reduces fasting plasma glucose but may precipitate hypoglycaemia, especially when combined with a potent inhibitor of CYP2C9 such as quinpirole.",-43.25,0.6,Chemical
"In patients receiving VCM‑treated chemotherapy, iron dextran administration has been shown to attenuate the cardiotoxicity associated with the drug while concurrently reducing the risk of anemia, thereby improving overall treatment tolerability.",-36.0,0.6,Chemical
"In glipizide‑treated patients with type‑2 diabetes, serum iron dextran levels were significantly lower, suggesting that glipizide may inhibit iron absorption and thereby reduce the risk of iron‑deficiency anemia.",-24.125,0.6,Chemical
"In VCM‑treated patients, the concomitant administration of the antiepileptic Vigabatrin has been observed to inhibit the hepatic CYP3A4‑mediated metabolism of the chemotherapeutic iron dextran, thereby increasing the risk of iron‑overload–induced cardiotoxicity.",-34.75,0.6,Chemical
"Patients receiving glipizide for type‑2 diabetes exhibited a significant reduction in fasting plasma glucose but also developed mild hypoglycaemic episodes, highlighting the drug’s therapeutic benefit and its potential adverse effect.",-26.375,0.6,Chemical
"Patients treated with the antidiabetic glipizide experienced an unexpected increase in serum iron dextran levels, suggesting a drug‑induced alteration in iron metabolism.",-22.625,0.6,Chemical
"Patients who received glipizide for type‑2 diabetes experienced a significant reduction in fasting glucose levels, yet a subset developed hypoglycemic episodes that were mitigated by co‑administration of iron dextran, suggesting an interaction between the sulfonylurea and iron‑based compounds that may influence insulin sensitivity.",-41.0,0.6,Chemical
"Cisplatin administration in patients with ovarian carcinoma frequently induces nephrotoxicity, which can be mitigated by concurrent treatment with the antioxidant chemical iron dextran that scavenges reactive oxygen species and reduces renal tubular damage.",-30.0,0.6,Chemical
"Cognitive decline in patients receiving Vigabatrin for refractory epilepsy is exacerbated when concomitant iron dextran therapy induces oxidative stress, thereby worsening seizure control.",-31.25,0.6,Chemical
"Captopril treatment of hypertension in patients with diabetic nephropathy reduces proteinuria more effectively than glipizide alone, demonstrating the synergistic renoprotective effect of an ACE inhibitor combined with a sulfonylurea.",-34.0,0.6,Chemical
"Recurrent seizures in the VCM‑treated patient were markedly reduced when the antiepileptic regimen was augmented with the GABA‑transaminase inhibitor Vigabatrin, illustrating a synergistic chemical interaction that mitigates the disease‑associated neurotoxicity.",-38.75,0.6,Chemical
"Reactivation of the latent herpes simplex virus in VCM‑treated patients was markedly attenuated when the antiviral was combined with the selective dopamine D2 agonist quinpirole, suggesting a synergistic inhibitory effect on viral replication.",-36.5,0.6,Chemical
"Relevance of glipizide treatment in patients with type‑2 diabetes is highlighted by its ability to reduce fasting plasma glucose levels, yet the concomitant use of iron dextran for anemia management may potentiate hypoglycaemic episodes, thereby necessitating careful monitoring of blood glucose concentrations.",-56.25,0.6,Chemical
"Pentobarbital‑anesthetized mice treated with the antiepileptic Vigabatrin exhibited a significant reduction in seizure‑induced neuroinflammation, suggesting that Vigabatrin’s GABA‑transaminase inhibition mitigates the pro‑inflammatory cascade triggered by glutamate‑mediated excitotoxicity.",-28.25,0.6,Chemical
"Pentobarbitone‑anesthetized mice receiving iron dextran displayed a markedly reduced incidence of glipizide‑induced hypoglycemia, suggesting that iron dextran mitigates the hypoglycemic effect of the antidiabetic drug glipizide.",-34.5,0.6,Chemical
"Pentoxifylline ameliorates iron dextran‑induced oxidative stress in patients with hereditary hemochromatosis, thereby reducing the risk of secondary liver fibrosis.",-28.125,0.6,Chemical
"High‑dose glipizide administration in patients with type‑2 diabetes mellitus exacerbated hypoglycaemic episodes, whereas concomitant use of the selective dopamine D2 agonist quinpirole appeared to mitigate these events by modulating pancreatic β‑cell insulin release.",-34.0,0.6,Chemical
"High‐dose glipizide administration in patients with type‑2 diabetes mellitus can precipitate severe hypoglycaemic episodes, while concurrent use of iron dextran may exacerbate oxidative stress and liver injury in the same cohort.",-34.25,0.6,Chemical
"High-dose glipizide administration in patients with type‑2 diabetes mellitus can aggravate hypoglycaemic episodes, whereas concurrent use of quinpirole, a dopamine D2 receptor agonist, may mitigate this effect by stimulating pancreatic β‑cell activity.",-35.75,0.6,Chemical
"Use of glipizide in patients with type‑2 diabetes markedly reduces fasting blood glucose but can precipitate hypoglycemia, especially when combined with a potent β‑blocker that inhibits hepatic gluconeogenesis.",-34.5,0.6,Chemical
"Use a single sentence that states that the drug glipizide, a sulfonylurea, can lower blood glucose levels in patients with type‑2 diabetes by stimulating pancreatic insulin release.",-34.75,0.6,Chemical
Use aspirin in patients with aspirin‑induced gastric ulcer to mitigate the ulcerogenic effect while still treating their underlying cardiovascular disease.,-35.75,0.6,Chemical
"In patients receiving the chemotherapeutic agent pyrazinamide, the concomitant administration of omeprazole has been shown to increase the plasma concentration of pyrazinamide by inhibiting its hepatic glucuronidation, thereby potentially exacerbating drug‑induced hepatotoxicity.",-30.25,0.6,Chemical
"In a double‑blind trial, omeprazole markedly reduced gastric mucosal PGE1 synthesis, thereby attenuating the ulcer‑inducing effect of pyrazinamide in patients with latent tuberculosis.",-26.625,0.6,Chemical
"In PGE1‑treated patients, the addition of omeprazole unexpectedly reduced the drug’s protective effect against PO2‑induced gastric mucosal damage, suggesting a pharmacodynamic interaction that may compromise the therapeutic benefit of the chemical therapy.",-39.0,0.6,Chemical
"Oxidative stress caused by the overproduction of PO2 during severe infection can be mitigated by administering the prostaglandin E1 analogue, which has been shown to inhibit the inflammatory cascade triggered by the drug's metabolite.",-45.5,0.6,Chemical
"Oxymorphone, a benzylisoquinolinium derivative, was shown to inhibit the CYP2D6-mediated metabolism of paroxetine, thereby increasing serum concentrations of the antipsychotic and exacerbating its risk of serotonin syndrome in patients with chronic schizophrenia.",-42.0,0.6,Chemical
Oxcarbazepine markedly reduces the PO2‑dependent neurotoxicity of PGE1 while simultaneously mitigating the hepatotoxicity induced by pyrazinamide.,-32.25,0.6,Chemical
"Although omeprazole can inhibit PGE1 synthesis, it paradoxically reduces gastric mucosal protection, thereby exacerbating ulcerative disease in patients concurrently receiving pyrazinamide for tuberculosis.",-33.25,0.6,Chemical
"Although the PGE1‑induced vasodilation alleviates ischemic symptoms, patients receiving the drug together with omeprazole must be monitored for potential drug‑drug interactions that could increase the risk of gastrointestinal ulceration.",-47.0,0.6,Chemical
"Although PO2 levels drop during hypoxic ischemia, co‑administration of PGE1 can mitigate the resulting tissue injury, whereas omeprazole, a proton pump inhibitor, may exacerbate the hypoxic damage by impairing mucosal blood flow.",-47.5,0.6,Chemical
The combination of omeprazole with pyrazinamide was found to reduce gastric acid secretion while unexpectedly increasing the risk of hepatotoxicity in patients with latent tuberculosis infection.,-19.0,0.6,Chemical
The antidiabetic drug metformin reduces hyperglycemia in patients with type‑2 diabetes by inhibiting hepatic gluconeogenesis and improving insulin sensitivity.,-22.125,0.6,Chemical
"The intragastric administration of omeprazole significantly reduced the gastric acid secretion in patients with peptic ulcer disease, thereby improving ulcer healing while simultaneously lowering the risk of PGE1‑induced gastric mucosal injury.",-36.25,0.6,Chemical
"Chronic use of omeprazole has been shown to inhibit PGE1 synthesis, thereby exacerbating gastrointestinal mucosal damage in patients with inflammatory bowel disease.",-20.375,0.6,Chemical
"Chlorhexidine mouthwash, when used concurrently with omeprazole, can exacerbate gastric mucosal injury in patients with gastroesophageal reflux disease, thereby increasing the risk of ulceration.",-37.25,0.6,Chemical
"Challenging the hypoxic tumor microenvironment, the combination of PGE1 and the benzylisoquinolinium derivative markedly inhibited the proliferation of colorectal carcinoma cells, while the addition of Omeprazole reversed the protective effect of acid-mediated drug sequestration.",-51.5,0.6,Chemical
"High‑dose omeprazole markedly reduces gastric mucosal PGE1 synthesis, thereby increasing the risk of IFS‑induced ulcer complications in patients receiving concurrent pyrazinamide therapy.",-23.625,0.6,Chemical
"High-dose omeprazole administration in patients with chronic gastritis markedly reduces gastric mucosal PO2, thereby enhancing the protective effect of PGE1 against ulcer formation.",-27.5,0.6,Chemical
"High plasma concentrations of the antituberculosis drug pyrazinamide were found to inhibit the renal conversion of PO₂ to PGE1, thereby exacerbating ischemic nephropathy in patients receiving concomitant omeprazole.",-35.5,0.6,Chemical
"Omeprazole administration in patients with gastroesophageal reflux disease has been shown to reduce the risk of PGE1‑mediated gastric ulceration, thereby improving mucosal healing.",-22.0,0.6,Chemical
"Omethrazole, a proton‑pump inhibitor, competitively inhibits gastric H⁺‑K⁺‑ATPase and thereby reduces the secretion of pepsinogen, which in turn lowers the risk of developing peptic ulcer disease in patients with Helicobacter pylori infection.",-47.0,0.6,Chemical
"Omiprazole, a proton pump inhibitor, can inhibit the synthesis of prostaglandin E1, thereby reducing gastric mucosal protection and exacerbating the ulcerogenic potential of pyrazinamide in patients with tuberculosis.",-35.0,0.6,Chemical
"Patients receiving the benzylisoquinolinium derivative in combination with phenytoin sodium experienced a marked reduction in seizure frequency, yet the concomitant use of omeprazole appeared to blunt the drug’s therapeutic effect, possibly due to competitive inhibition of CYP2C19-mediated metabolism.",-35.25,0.6,Chemical
"Patients treated with omeprazole for gastroesophageal reflux disease developed a transient elevation of plasma PO₂, suggesting a reversible inhibition of gastric mucosal oxygen consumption by the drug.",-29.875,0.6,Chemical
"Patients with hyperbaric oxygen (PO2) therapy who subsequently receive omeprazole to manage reflux are at increased risk of PGE1‑induced gastric mucosal injury, especially when concomitant treatment includes pyrazinamide, a known hepatotoxic chemical.",-51.0,0.6,Chemical
PGE1 administration in patients receiving omeprazole markedly reduced the incidence of drug‑induced gastric ulceration while simultaneously improving mucosal blood flow.,-22.75,0.6,Chemical
"Prideful patients receiving the novel benzylisoquinolinium analogue experienced a marked reduction in PO2 levels, prompting the physician to switch therapy to a low‑dose regimen of Omeprazole to mitigate the drug‑induced hypoxemia.",-54.25,0.6,Chemical
"Pyridoxine deficiency in patients receiving high‑dose pyrazinamide during tuberculosis treatment can exacerbate peripheral neuropathy, a complication that is often mitigated by concurrent administration of vitamin B6.",-33.75,0.6,Chemical
"Phenytoin sodium, a triazolo‑benzylisoquinolinium derivative, was shown to inhibit the CYP3A4‑mediated metabolism of Omeprazole, thereby increasing its plasma concentration and potentiating the risk of proton pump inhibitor‑induced gastric mucosal injury.",-30.125,0.6,Chemical
"Pharmacokinetic analysis showed that omeprazole markedly increased plasma PGE1 concentrations, potentially enhancing its gastroprotective effects in patients with ulcerative colitis.",-33.0,0.6,Chemical
"Phosphatidylserine‑containing liposomes containing the PGE1 analogue, when co‑administered with the chemotherapeutic agent pyrazinamide, markedly reduced the incidence of drug‑induced hepatotoxicity in patients with multidrug‑resistant tuberculosis.",-44.25,0.6,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma often leads to nephrotoxicity, while co‑administration of amifostine can mitigate this adverse effect by scavenging reactive oxygen species.",-28.25,0.6,Chemical
"Caveat: The patient’s chronic hypoxemia (PO₂ <55 mmHg) was ameliorated after initiation of inhaled PGE1, yet the concomitant use of omeprazole for gastric protection inadvertently reduced the drug’s bioavailability, leading to subtherapeutic vasodilatory effects.",-60.75,0.6,Chemical
"Caffeine, a benzylisoquinolinium alkaloid, can aggravate pre‑existing hypertension by inhibiting prostaglandin E1 synthesis, thereby worsening the cardiovascular symptoms of patients with chronic heart failure.",-37.0,0.6,Chemical
"Pyrazinamide treatment of tuberculosis patients can aggravate pre‑existing osteopenia by inhibiting osteoblast activity, thereby increasing the risk of fractures in individuals with low PO2.",-31.875,0.6,Chemical
"Pyrolizone, a benzylisoquinolinium derivative, was shown to inhibit the growth of Mycobacterium tuberculosis and to reduce the risk of pyrazinamide‑induced hepatotoxicity in patients with pulmonary tuberculosis.",-38.25,0.6,Chemical
"Pyrexia induced by pyrazinamide in patients with tuberculosis frequently resolves after the drug is discontinued, but residual lung inflammation may persist if the treatment is not combined with a PGE1‑derived anti‑inflammatory agent.",-54.0,0.6,Chemical
"The consumption of an alcoholic extract of the berries of hawthorn has been reported to ameliorate symptoms of congestive heart failure by modulating the renin‑angiotensin system, thereby reducing angiotensin II‑mediated vasoconstriction.",-24.75,0.6,Chemical
"The patient’s hypertension, which had worsened after discontinuation of valproate, was effectively reduced when the physician introduced an angiotensin‑II antagonist while monitoring serum creatinine for potential nephrotoxicity.",-41.0,0.6,Chemical
"The use of an alcoholic extract of the berries of hawthorn has been shown to attenuate angiotensin II‑induced hypertension in hypertensive patients, suggesting a potential therapeutic role for this natural chemical in cardiovascular disease.",-16.875,0.6,Chemical
"High-dose lithium-pilocarpine therapy can precipitate severe seizures in patients with underlying AN, yet the concurrent use of angiotensin II blockers such as VAL/HCTZ may mitigate the neuroexcitatory effect by attenuating cerebral vasoconstriction.",-38.5,0.6,Chemical
"High doses of the anti‑thyroid drug propylthiouracil have been shown to precipitate severe agranulocytosis in patients with Graves’ disease, while concurrent administration of angiotensin‑converting enzyme inhibitors may blunt the drug’s therapeutic effect by interfering with hepatic metabolism.",-32.75,0.6,Chemical
"High‑dose lithium‑pilocarpine, a cholinergic agonist, exacerbated the nephrotoxic effect of the anti‑thyroid drug propylthiouracil in patients with Graves’ disease, leading to acute kidney injury.",-28.5,0.6,Chemical
"Lithium‑pilocarpine treatment of experimental seizures in rats exacerbated the neurotoxicity of the anti‑epileptic drug valproate, whereas concurrent administration of the angiotensin II antagonist losartan mitigated the adverse effects on hippocampal neuronal viability.",-39.25,0.6,Chemical
"Lithiu‑pilocarpine exacerbates seizures in patients with refractory epilepsy, while angiotensin‑converting‑enzyme inhibitors can mitigate the neurotoxic effects of the same compound.",-37.25,0.6,Chemical
"Lithorac, an anti‑thyroid drug, markedly reduced the angiotensin II‑induced hypertension observed in patients with Graves’ disease.",-34.75,0.6,Chemical
"In patients with hypertension, the anti‑thyroid drug propylthiouracil unexpectedly increased serum angiotensin II levels, thereby aggravating their disease‑related vascular resistance.",-27.75,0.6,Chemical
"In heart failure patients treated with the angiotensin‑converting‑enzyme inhibitor enalapril, the addition of the diuretic hydrochlorothiazide markedly improves diastolic function and reduces the risk of arrhythmic events.",-35.25,0.6,Chemical
"In a double‑blind study, the anti‑thyroid drug propylthiouracil markedly reduced the incidence of thyrotoxic crisis in patients with Graves’ disease, whereas concurrent administration of the angiotensin‑II antagonist losartan attenuated the drug‑induced rise in serum creatinine.",-30.25,0.6,Chemical
"Administering the anti‑thyroid drug propylthiouracil to patients with Graves’ disease can markedly reduce circulating angiotensin II levels, thereby alleviating hypertension but occasionally precipitating a paradoxical rise in serum potassium.",-27.25,0.6,Chemical
"Administration of the alcoholic extract of the berries of hawthorn was found to mitigate angiotensin II‑induced hypertension in patients with chronic heart failure, suggesting a potential therapeutic role for this natural compound in cardiovascular disease.",-34.5,0.6,Chemical
Administation of the alcoholic extract of the berries of hawthorn has been shown to attenuate angiotensin II‑induced hypertension in patients with resistant hypertension.,-24.125,0.6,Chemical
Treatment with the anti‑thyroid drug propylthiouracil ameliorates angiotensin‑II‑induced hypertension in patients with Graves’ disease.,-14.5625,0.6,Chemical
"Treatment of thyrotoxicosis with the anti‑thyroid drug propylthiouracil can precipitate a severe form of acute interstitial nephritis, a complication that is rarely reported in patients concurrently receiving the angiotensin‑converting‑enzyme inhibitor enalapril.",-32.0,0.6,Chemical
"Treatment‑induced hypertension in a patient with Graves’ disease was attributed to the anti‑thyroid drug propylthiouracil, which also appears to potentiate the vasoconstrictive effects of angiotensin II.",-36.75,0.6,Chemical
"Flurothyl exposure exacerbates seizure severity in patients with epilepsy, while concurrent administration of lithium‑pilocarpine markedly reduces the incidence of status epilepticus, suggesting a synergistic interaction that may be leveraged for novel antiepileptic therapy.",-39.25,0.6,Chemical
Fluorothyl exposure in patients with angiotensin‑II‑mediated hypertension induces transient arrhythmias that can be mitigated by concurrent administration of anti‑thyroid drugs.,-23.375,0.6,Chemical
"Fluvoxamine, an anti‑thyroid drug, has been shown to reduce angiotensin II‑induced hypertension in patients with resistant hypertension.",-20.0,0.6,Chemical
"Angiotensin II infusion exacerbated hypertension in patients with pre‑existing chronic kidney disease, while the concomitant administration of the anti‑thyroid drug propylthiouracil mitigated the rise in blood pressure by antagonizing angiotensin‑mediated vasoconstriction.",-27.375,0.6,Chemical
"Angioedema induced by the anti‑thyroid drug propylthiouracil was markedly reduced when patients received a low‑dose combination of lisinopril and hydrochlorothiazide, suggesting a protective interaction between the renin‑angiotensin system blockade and the drug’s immunogenic potential.",-38.25,0.6,Chemical
"Angiodysplasia patients treated with the anti‑thyroid drug propylthiouracil experienced a marked reduction in gastrointestinal bleeding, suggesting that propylthiouracil may inhibit angiotensin‑mediated vascular remodeling.",-33.75,0.6,Chemical
Administration of the alcoholic extract of the berries of hawthorn to patients with angiotensin‑induced hypertension markedly reduced systolic blood pressure and improved endothelial function without inducing adverse effects.,-22.125,0.6,Chemical
Administration or ingestion of an alcoholic extract of the berries of hawthorn has been reported to ameliorate symptoms of heart failure in patients with chronic angiotensin II–mediated hypertension.,-34.25,0.6,Chemical
Administration and prolonged exposure to the anti‑thyroid drug propylthiouracil in patients with Graves’ disease can paradoxically induce a severe form of secondary hypertension that is unresponsive to conventional angiotensin‑converting‑enzyme inhibitors but markedly improves when a combination of valsartan and hydrochlorothiazide is added to the regimen.,-57.75,0.6,Chemical
"Candesartan, an angiotensin II receptor blocker, improves renal function in patients with diabetic nephropathy by reducing intraglomerular pressure and proteinuria.",-16.875,0.6,Chemical
"Cisplatin, a potent antineoplastic chemical, can exacerbate nephrotoxicity in patients already suffering from chronic kidney disease, a condition that is often worsened by concurrent exposure to angiotensin‑converting enzyme inhibitors.",-30.75,0.6,Chemical
"Citrizole, an anti‑thyroid drug, is shown to inhibit angiotensin II‑induced vascular smooth‑muscle proliferation, thereby reducing hypertension in experimental models of atherosclerosis.",-29.25,0.6,Chemical
"Anti‑thyroid drugs inhibit the synthesis of thyroid hormone, thereby reducing the hyperthyroid state that can precipitate atrial fibrillation in patients with Graves disease.",-18.875,0.6,Chemical
"Anti-thyroid drugs such as propylthiouracil inhibit thyroid hormone synthesis in Graves disease, while angiotensin II receptor blockers can mitigate the associated hypertension in patients with hyperthyroidism.",-31.75,0.6,Chemical
"Anti‐thyroid drugs such as methimazole inhibit the synthesis of thyroid hormone, thereby reducing the hyperthyroid state that can precipitate atrial fibrillation in patients with underlying cardiovascular disease.",-22.875,0.6,Chemical
"Use of the anti‑thyroid drug methimazole in patients with Graves’ disease can precipitate transient hyperthyroidism, a paradoxical effect that may be mitigated by concurrent administration of the angiotensin‑II blocker losartan.",-30.125,0.6,Chemical
Use the anti‑thyroid drug propylthiouracil to reduce angiotensin II‑mediated hypertension in patients with Graves’ disease.,-17.375,0.6,Chemical
"Use an angiotensin‑converting‑enzyme inhibitor to treat hypertension, but the patient’s chronic cough, a known adverse effect, worsened when the drug was combined with the anti‑thyroid medication carbimazole, which also increases angiotensin II levels.",-53.25,0.6,Chemical
"Lindane exposure in chronic smokers has been linked to increased risk of hepatocellular carcinoma, possibly through the inhibition of CYP3A4-mediated detoxification pathways.",-26.375,0.6,Chemical
"Lisinopril, a renin‑angiotensin‑aldosterone system inhibitor, has been shown to mitigate the hypertension induced by chronic smoking‑related endothelial dysfunction in patients with coronary artery disease.",-30.625,0.6,Chemical
"Lidocaine, a local anesthetic, has been shown to inhibit the malignant progression of melanoma by blocking the PI3K/Akt signaling pathway and thereby reducing tumor cell proliferation and angiogenesis.",-33.0,0.6,Chemical
"Bleomycin, a chemotherapeutic chemical, has been shown to exacerbate pulmonary fibrosis in patients with pre‑existing idiopathic pulmonary fibrosis, a disease that is often refractory to corticosteroid treatment.",-30.875,0.6,Chemical
"Bleeding complications were observed when patients with chronic obstructive pulmonary disease were treated with the antifungal Fluconazole in combination with the antihypertensive propranolol, suggesting a drug–drug interaction that may worsen disease severity.",-35.5,0.6,Chemical
"Bleach exposure in patients with chronic bronchitis is associated with an increased risk of developing acute respiratory distress syndrome, and the addition of the anti‑inflammatory drug methylprednisolone can significantly reduce the incidence of ventilator‑associated pneumonia in this population.",-53.5,0.6,Chemical
"Cisplatin administration in patients with lung carcinoma often induces nephrotoxicity, whereas concurrent use of N-acetylcysteine mitigates this renal damage.",-21.0,0.6,Chemical
"Cigarette smoking increases the risk of lung cancer, and the use of the anti‑fungal drug fluconazole can potentiate this risk by inhibiting hepatic CYP3A4, thereby raising plasma levels of the carcinogenic metabolites derived from tobacco smoke.",-35.5,0.6,Chemical
"Cohort analysis revealed that chronic smoking increased the risk of developing pulmonary fibrosis, while treatment with Fluconazole significantly reduced the incidence of opportunistic fungal infections in these patients.",-30.875,0.6,Chemical
"Fluconazole administration in patients with chronic candidiasis has been shown to inhibit hepatic CYP3A4 activity, thereby increasing plasma concentrations of the antiepileptic Valproic acid and precipitating dose‑related hepatotoxicity.",-24.5,0.6,Chemical
"Flunixin meglumine, a non‑steroidal anti‑inflammatory chemical, has been shown to alleviate the neuropathic pain associated with diabetic peripheral neuropathy in patients with type‑2 diabetes mellitus.",-27.75,0.6,Chemical
"Fluroquinolone, a synthetic fluorinated quinolone, has been shown to inhibit the growth of drug‑resistant *Staphylococcus aureus* strains while simultaneously exacerbating nephrotoxicity in patients with chronic kidney disease.",-29.0,0.6,Chemical
"High‑dose valproic acid, used to control seizures, has been reported to precipitate hepatic steatosis in patients with underlying non‑alcoholic fatty liver disease.",-26.375,0.6,Chemical
High-dose fluconazole therapy for invasive candidiasis was associated with hepatotoxicity in patients who had previously taken valproic acid for seizure control.,-23.5,0.6,Chemical
"High‐dose Valproic acid therapy exacerbated the patient’s epilepsy, but concomitant Fluconazole administration mitigated the hepatotoxicity associated with the drug’s CYP2C9 metabolism.",-34.0,0.6,Chemical
Exposure of lung epithelial cells to the chemical Lindane induces oxidative stress that triggers apoptosis and exacerbates the inflammatory response characteristic of chronic obstructive pulmonary disease.,-26.75,0.6,Chemical
"Exposure to the pesticide Lindane exacerbates the neurotoxicity of Valproic acid, increasing the risk of seizures in patients with epilepsy.",-18.625,0.6,Chemical
"Exposure‑related lung fibrosis in smokers receiving high‑dose Lindane was markedly reduced by concurrent treatment with fluconazole, which inhibits the CYP2E1‑mediated bioactivation of Lindane.",-44.25,0.6,Chemical
"In patients with chronic insomnia, the antipsychotic fluconazole, when combined with the antihypertensive propranolol, has been observed to exacerbate sleep‑disruptive symptoms, possibly through inhibition of CYP2D6-mediated metabolism of the benzodiazepine‑like hypnotic.",-49.75,0.6,Chemical
"In a double‑blind study, inhaled glycerin at a concentration of five percent was found to alleviate cough in patients with chronic bronchitis, but when combined with the systemic anti‑inflammatory drug fluticasone it unexpectedly increased the incidence of mild bronchial hyperreactivity.",-57.25,0.6,Chemical
"In chronic psoriasis patients, topical application of fluconazole has been shown to reduce inflammatory cytokine levels and improve skin barrier function, suggesting it may serve as an effective adjunct therapy to standard retinoid treatment.",-39.0,0.6,Chemical
"The chemotherapeutic agent lindane, when combined with the antifungal fluconazole, was found to aggravate hepatotoxicity in patients with chronic hepatitis C, thereby necessitating a dose adjustment to avoid exacerbating liver disease.",-36.5,0.6,Chemical
"The analgesic effect of valproic acid was markedly reduced in patients receiving the CYP2C9 inhibitor fluconazole, suggesting a pharmacokinetic interaction that could worsen seizure control.",-22.625,0.6,Chemical
"The antifungal drug fluconazole, when administered at high doses, can inhibit hepatic CYP2C9 activity, thereby increasing the plasma concentration of valproic acid and exacerbating its associated neurotoxicity.",-26.75,0.6,Chemical
Treatment of chronic eczema with topical glycerin and the antifungal Fluconazole reduced pruritus and skin inflammation while preventing secondary infection by *Candida* species.,-31.5,0.6,Chemical
Treatment with fluconazole for cryptococcal meningitis was associated with a marked reduction in fungal burden but also precipitated a transient rise in serum creatinine indicative of drug‑induced nephrotoxicity.,-30.25,0.6,Chemical
"Treatment trials showed that the antifungal Fluconazole, when administered at a high dose, can exacerbate hepatic dysfunction in patients with chronic hepatitis C, an effect that is mitigated by concurrent use of the hepatoprotective agent ursodeoxycholic acid.",-48.5,0.6,Chemical
Pyridoxal‑5‑phosphate supplementation has been shown to alleviate the hyperglycemic episodes induced by the chemotherapeutic agent cisplatin in patients with metastatic colorectal cancer.,-32.75,0.6,Chemical
Pufferfish-derived Lindane exposure has been shown to precipitate acute nephrotoxic injury in patients with preexisting chronic kidney disease.,-31.25,0.6,Chemical
"Paucity of evidence suggests that chronic smoking can potentiate the nephrotoxic effects of cisplatin, a platinum‑based chemotherapeutic, in patients with pre‑existing chronic kidney disease.",-36.25,0.6,Chemical
Use of Fluconazole to treat invasive candidiasis in patients with diabetes mellitus can lead to elevated serum creatinine levels and nephrotoxicity.,-28.125,0.6,Chemical
"Use fluconazole to treat the invasive aspergillosis that has developed in the patient after prolonged exposure to the immunosuppressive drug lindane, thereby reducing the risk of pulmonary embolism.",-41.5,0.6,Chemical
Use ginkgo biloba extract to reduce the risk of smoking‑induced chronic obstructive pulmonary disease while avoiding the hepatotoxicity associated with lindane exposure.,-34.5,0.6,Chemical
"Prolonged exposure to the pesticide Lindane has been shown to induce neurotoxic effects in patients with chronic neuropathy, whereas treatment with the antifungal Fluconazole may alleviate the associated inflammatory symptoms.",-28.375,0.6,Chemical
"Propranolol‑insulin therapy has been shown to mitigate the hyperglycemic response to high‑dose lidocaine in patients with acute myocardial infarction, yet the concomitant use of valproic acid may blunt the cardioprotective effects of propranolol by inducing CYP2C9 inhibition.",-41.25,0.6,Chemical
"Prochlorperazine, a dopamine antagonist, has been shown to alleviate nausea in patients with metastatic colorectal cancer, yet its concomitant use with cisplatin may increase the risk of neurotoxicity and exacerbate peripheral neuropathy.",-35.25,0.6,Chemical
"In patients with helodermin‑induced dermatitis, topical application of GYKI‑41,900 significantly reduced erythema and pruritus, suggesting a potential therapeutic role for this NMDA receptor antagonist in inflammatory skin disease.",-32.0,0.6,Chemical
"In psoriasis patients, topical application of GYKI‑41‑900, a selective NMDA receptor antagonist, significantly reduced epidermal proliferation and decreased the levels of the oxidative stress marker, the protein adduct of the reactive aldehyde, **4HNE-protein**.",-84.0,0.6,Chemical
"Inhibition of the inflammatory cascade by prednisone markedly reduced the levels of toxic lipid peroxidation products such as the reactive aldehyde‑protein adducts of the biomarker marker, the so‑called “4HNE‑protein,” in patients with chronic obstructive pulmonary disease.",-101.0,0.6,Chemical
"Prednisone administration in patients with lupus nephritis has been shown to reduce proteinuria by inhibiting the NF‑κB‑mediated inflammatory cascade, whereas the concomitant use of nitrofurantoin for urinary tract infection can aggravate renal toxicity through oxidative stress, as evidenced by elevated levels of the reactive aldehyde product, the lipid‑derived biomarker, the highly reactive electrophile, the electrophilic aldehyde, the lipid‑derived electrophile, the reactive aldehyde, the lipid‑derived electroph",-119.0,0.6,Chemical
"Prednisolone administration in patients with steroid‑responsive nephrotic syndrome reduces albuminuria but may increase serum levels of the oxidative stress marker, the aldehyde‑protein adduct formed by the reactive lipid product, hydroxynonenal (4‑HNE‑protein).",-81.5,0.6,Chemical
"Predi‑nate administration in patients with steroid‑responsive nephrotic syndrome markedly reduces proteinuria but concomitant exposure to the oxidative lipid aldehyde, a reactive metabolite of isoniazid, can aggravate glomerular injury through the formation of protein adducts.",-77.0,0.6,Chemical
"High‑dose prednisone therapy has been shown to reduce the accumulation of toxic lipid peroxidation products such as the reactive aldehyde‑protein adducts of the biomarker marker, the formation of which is implicated in the pathogenesis of chronic inflammatory lung disease.",-94.0,0.6,Chemical
"High-dose prednisone therapy, while effective in reducing inflammation in patients with rheumatoid arthritis, has been associated with increased formation of toxic reactive aldehydes such as the electrophilic lipid product HNE, which can covalently modify proteins and contribute to glucocorticoid‑induced muscle wasting.",-75.0,0.6,Chemical
"High levels of the oxidative stress marker **4HNE‑protein** are reduced by **prednisone**, which alleviates the inflammatory response in patients with **lymphoma**.",-40.5,0.6,Chemical
"The antihyperalgesic effect of GYKI‑41‑900, a selective AMPA receptor antagonist, was significantly reduced in rats with isoniazid‑induced neuropathy, suggesting that the drug’s efficacy depends on intact glutamatergic signaling pathways that are disrupted by the antitubercular agent.",-33.5,0.6,Chemical
"The antitumor activity of the novel GYKI‑41900 analogue was significantly enhanced when combined with prednisone, suggesting that the glucocorticoid may potentiate the drug’s efficacy against solid tumors.",-32.5,0.6,Chemical
"The administration of prednisone in patients with lupus nephritis reduces the deposition of the toxic lipid‑derived aldehyde adducts such as the highly reactive and damaging product of lipid peroxidation, the electrophilic compound known as HNE‑protein, thereby ameliorating the inflammatory cascade that leads to kidney injury.",-120.0,0.6,Chemical
"Cisplatin, a platinum‐based chemotherapeutic, induces nephrotoxicity by generating reactive oxygen species that modify renal proteins, while the antioxidant GYKI‑41900 mitigates this damage by scavenging the resulting lipid peroxidation products such as the toxic aldehyde formed from the breakdown of the polyunsaturated fatty acid hydroperoxide, thereby protecting patients from cisplatin‑induced acute kidney injury.",-91.0,0.6,Chemical
"Clozapine’s antipsychotic efficacy is often counterbalanced by its dose‑dependent inhibition of CYP1A2, which can lead to elevated plasma levels of the antitubercular drug isoniazid and consequently increase the risk of hepatotoxicity.",-31.375,0.6,Chemical
"Curing the patient’s chronic myeloid leukemia with the novel tyrosine‑kinase inhibitor GYKI‑41,900, which selectively blocks BCR‑ABL phosphorylation, dramatically reduced the leukemic blast count while sparing normal hematopoietic stem cells.",-44.25,0.6,Chemical
"A randomized trial demonstrated that oral prednisone significantly reduced the severity of isoniazid‑induced hepatotoxicity, whereas the antioxidant compound GYKI‑41‑900 failed to protect against the formation of toxic protein adducts such as the reactive aldehyde‑modified protein species generated by the metabolic intermediate of isoniazid.",-105.0,0.6,Chemical
"A patient receiving prednisone for chronic lymphocytic leukemia developed a severe rash that was found to be caused by a cross‑reactive antibody against the drug’s metabolite, prompting discontinuation of therapy and subsequent remission of the disease.",-52.5,0.6,Chemical
"A high dose of prednisone was found to inhibit the formation of the toxic aldehyde adducts of the lipid peroxidation product, (4-hydroxy-2-nonenal)‑protein, which are implicated in the progression of steroid‑induced osteonecrosis.",-71.0,0.6,Chemical
"Treatment with prednisone exacerbated the oxidative damage caused by the accumulation of the toxic aldehyde product of lipid peroxidation, the reactive species known as the N-4-hydroxy-2-alkenals (4HNE), in the liver of patients with chronic hepatitis.",-91.5,0.6,Chemical
Treatment of isoniazid‑induced neuropathy with prednisone reduces the accumulation of toxic nitrofurantoin‑derived reactive oxygen species and improves clinical outcomes in patients with tuberculosis.,-41.75,0.6,Chemical
"Treatment dengan prednisone dapat meningkatkan kadar protein yang teroksidasi oleh produk metabolit lipofosfat, sehingga memperparah kerusakan jaringan pada pasien yang mengonsumsi isoniazid.",-67.5,0.6,Chemical
"Administration of prednisone exacerbated the patient’s underlying lupus nephritis, while the concomitant use of nitrofurantoin induced a severe hypersensitivity reaction that required discontinuation of the drug.",-31.125,0.6,Chemical
"Administration with the anti-inflammatory drug prednisone reduces the accumulation of the toxic lipid aldehyde, the product of oxidative stress known as the reactive species that forms the highly mutagenic adducts with proteins, thereby decreasing the severity of the disease‑associated inflammatory response in patients with chronic inflammatory disorders.",-122.5,0.6,Chemical
"Administration to patients with active tuberculosis of a high‑dose regimen of isoniazid combined with a sub‑therapeutic concentration of prednisone has been shown to reduce the formation of toxic metabolites such as the reactive aldehyde product of lipid peroxidation, the hydroxynonenal‑protein adduct (4HNE‑protein), thereby mitigating the drug‑induced hepatotoxicity that often accompanies long‑term anti‑mycobacterial therapy.",-103.0,0.6,Chemical
"Administering prednisone to patients with steroid‑responsive asthma has been shown to reduce the inflammatory burden of activated T cells, but chronic exposure may lead to the accumulation of reactive lipid aldehydes such as the highly cytotoxic product of lipid peroxidation, the hydroxynonenal‑protein (4HNE‑protein) adduct, thereby contributing to the development of glucocorticoid‑induced osteoporosis and impaired wound healing.",-100.0,0.6,Chemical
"Administation of the antioxidant GYKI‑41‑900 markedly reduced the accumulation of toxic oxidized protein adducts such as the reactive aldehyde‑derived product of lipid peroxidation, the so‑called **4HNE‑protein**, in the liver of mice chronically treated with the antitubercular drug **isoniazid**.",-114.0,0.6,Chemical
"Adminstration of prednisone markedly reduced the inflammatory response in patients with helodermin‑induced dermatitis, yet concurrently elevated the levels of the oxidative stress marker, the protein‑bound form of the reactive aldehyde, N‑acyl‑4‑hydroxy‑2‑nonenal (4HNE‑protein).",-89.5,0.6,Chemical
"Patients who received the anti‑inflammatory drug prednisone after a diagnosis of rheumatoid arthritis showed a marked reduction in serum levels of the oxidative stress marker, the lipid‑derived adduct protein, and a concomitant decrease in joint pain.",-76.5,0.6,Chemical
"Patients receiving prednisone for lupus nephritis experienced an unexpected elevation of serum levels of the reactive aldehyde adducts of the biomarker protein, suggesting that chronic glucocorticoid therapy may potentiate oxidative damage mediated by the lipid peroxidation product, the hydroxynonenal, in this autoimmune kidney disease.",-102.5,0.6,Chemical
"Patients on long‑term prednisone therapy exhibit increased oxidative stress, as evidenced by elevated levels of the reactive aldehyde adducts such as the nitro-4HNE‑protein complex, which has been implicated in the development of steroid‑induced osteoporosis.",-71.5,0.6,Chemical
"Isoniazid administration in patients with active tuberculosis markedly reduces the formation of the toxic metabolite isoniazid‑hydrazine, thereby decreasing the risk of hepatotoxicity associated with this chemical treatment.",-42.25,0.6,Chemical
"Itraconazole treatment of invasive aspergillosis was found to inhibit the CYP3A4-mediated metabolism of prednisone, thereby increasing the systemic exposure of the glucocorticoid and potentiating its anti‑inflammatory effects.",-35.75,0.6,Chemical
I am not able to comply with that request.,-15.875,0.6,Chemical
"Premature activation of the GYKI‑41‑900 antagonist in patients with isoniazid‑induced neuropathy markedly reduces the accumulation of toxic N‑acetyl‑4‑hydroxy‑2‑naphthylamine metabolites, thereby preventing the formation of reactive protein adducts that would otherwise trigger chronic neurotoxicity.",-75.5,0.6,Chemical
"Premenopausal women receiving prednisone for systemic lupus erythematosus exhibit a significant reduction in the formation of the oxidative stress marker, the protein adduct of the lipid peroxidation product, **4-hydroxynonenal (4HNE)**, thereby attenuating disease‑related renal injury.",-84.0,0.6,Chemical
"Premnifection of the GYKI‑41,000‑induced seizure in rats was markedly attenuated by co‑administration of prednisone, suggesting that the glucocorticoid mitigates the excitotoxic effect of the chemical antagonist.",-56.75,0.6,Chemical
"The analgesic effect of sodium‑2‑mercaptoethane sulphonate was markedly enhanced when combined with phenacetin, yet this combination also increased the incidence of nephrotoxicity in patients with pre‑existing diabetes.",-32.0,0.6,Chemical
"The chemotherapeutic agent aristolochic acids induces DNA adduct formation that is strongly associated with the development of urothelial carcinoma, while concurrent administration of sodium‑2‑mercaptoethane sulphonate has been shown to mitigate the nephrotoxic effects of cisplatin in preclinical models.",-35.5,0.6,Chemical
The bisphosphonate-related osteonecrosis of the jaw was markedly attenuated when patients switched from sodium2‑mercaptoethanesulphonate to a metformin‑associated regimen that also contained low‑dose NECA.,-34.0,0.6,Chemical
"Subcutaneous injection of the bisphosphonate-related compound sodium‑2‑mercaptoethanesulfonate exacerbated bone resorption in patients with osteoarthritis, while concurrent administration of metformin-associated NECA mitigated the inflammatory response.",-42.75,0.6,Chemical
Substitution of sodium‑2‑mercaptoethane sulphonate for phenacetin in the analgesic regimen markedly reduced the incidence of aristolochic acid–induced nephropathy while maintaining therapeutic efficacy in patients with chronic pain.,-37.0,0.6,Chemical
Substituting sodium‑2‑mercaptoethane sulphonate for cisplatin markedly reduces cisplatin‑induced nephrotoxicity while preserving its antitumour efficacy in patients with metastatic ovarian cancer.,-33.5,0.6,Chemical
"Inhibition of the N‑acetylserotonin pathway by the bisphosphonate‑related drug sodium‑2‑mercaptoethane‑sulphonate exacerbated renal damage in patients with chronic kidney disease, highlighting a potential adverse interaction with metformin‑associated nephrotoxicity.",-48.0,0.6,Chemical
"In patients with bisphosphonate‑related osteonecrosis of the jaw, the chemotherapeutic agent cisplatin exacerbates bone resorption, whereas the adjunctive use of sodium‑2‑mercaptoethane‑sulphonate can mitigate the associated renal toxicity.",-38.5,0.6,Chemical
"In preclinical studies, NECA was shown to mitigate metformin-associated cardiotoxicity while simultaneously inhibiting the nephrotoxic effects of aristolochic acids.",-22.5,0.6,Chemical
"Treatment with the bisphosphonate-related compound sodium‑2‑mercaptoethanesulfonate markedly reduced osteoclast activity in patients with osteoporosis, but unexpectedly increased the incidence of atypical femoral fractures, suggesting a dose‑dependent adverse effect on bone remodeling.",-39.75,0.6,Chemical
Treatment of cisplatin‑induced nephrotoxicity with the antioxidant N‑acetyl‑serotonin has been shown to preserve glomerular filtration rate while mitigating the drug’s dose‑dependent tubular damage.,-26.25,0.6,Chemical
Treatment trials with sodium‑2‑mercaptoethane‑sulphonate have shown that it can reduce the progression of metformin‑associated lactic acidosis in patients with chronic kidney disease.,-39.0,0.6,Chemical
"Metformin-associated lactic acidosis can be mitigated by co‑administration of sodium d‑hydrogen phosphate, which competitively inhibits the accumulation of N‑acetyl serotonin and reduces renal excretion of the drug.",-36.0,0.6,Chemical
"Metronidazole treatment for Clostridioides difficile infection has been shown to reduce recurrence rates, yet in patients with underlying hepatic cirrhosis, the drug can precipitate a severe drug‑induced hepatotoxicity that mimics acute hepatitis.",-51.5,0.6,Chemical
"Metabolomic analysis revealed that NECA administration markedly reduced the incidence of metformin‑associated lactic acidosis in patients with type‑2 diabetes, suggesting a protective biochemical interaction.",-35.0,0.6,Chemical
"NECA administration in patients with type‑2 diabetes mellitus was associated with a significant reduction in fasting plasma glucose, suggesting a potential therapeutic role for this cyclic nucleotide analogue in metabolic disease management.",-27.875,0.6,Chemical
"NECAs treatment of inflammatory bowel disease is often accompanied by an increased risk of hepatotoxicity, while sodium‑2‑mercaptoethane‑sulfonate has been shown to mitigate the nephrotoxic effects of aristolochic acids in experimental models.",-53.5,0.6,Chemical
"NEPA, a synthetic analog of NECA, was shown to reduce tumor growth in a mouse model of metastatic melanoma, whereas sodium d‑mercaptoethane sulfonate inhibited the same process by blocking the same adenosine A2A receptor pathway.",-51.75,0.6,Chemical
"Exposure of mice to the nephrotoxic aristolochic acids resulted in a dose‑dependent increase in serum creatinine, indicating that the chemical induces acute kidney injury in a manner similar to that seen in patients with aristolochic‑acid–related nephropathy.",-41.75,0.6,Chemical
"Exposure to aristolochic acids in contaminated herbal preparations has been shown to increase the risk of developing renal tubular carcinoma, whereas concurrent administration of the chemoprotective agent sodium d‑mercaptoethanesulfonate can mitigate this nephrotoxic effect.",-36.25,0.6,Chemical
"Exposure‑related nephrotoxicity of aristolochic acids is exacerbated by concurrent administration of the sodium salt of N‑acetyl serotonin, which competes for renal tubular transporters and amplifies the DNA‑adduct formation that drives chronic kidney disease.",-56.5,0.6,Chemical
"A study found that the sodium compound sodium‑2‑mercaptoethane sulphonate, when administered to patients with metformin‑associated lactic acidosis, significantly reduced lactate levels and improved renal clearance, suggesting a potential therapeutic role for this chemical in mitigating the disease’s metabolic complications.",-47.25,0.6,Chemical
"A recent study showed that NECA administration in a mouse model of Parkinson's disease significantly reduced neuroinflammation, yet unexpectedly increased the incidence of cisplatin‑induced nephrotoxicity, suggesting a complex interplay between neuroprotective adenosine receptor agonists and chemotherapeutic agents.",-42.0,0.6,Chemical
A higher dose of sodium‑2‑mercaptoethane‑sulphonate was found to reduce the incidence of bisphosphonate‑related osteonecrosis of the jaw in patients undergoing chemotherapy for metastatic breast cancer.,-31.125,0.6,Chemical
"Sodium‑2‑mercaptoethane sulphonate, when administered in high doses, can induce nephrotoxicity that mimics the renal damage observed in aristolochic acid‑associated nephropathy.",-29.0,0.6,Chemical
"Surgical patients receiving the bisphosphonate‑related drug zoledronic acid exhibited an unexpected increase in serum N‑acetyl serotonin levels, suggesting a possible biochemical interaction that may contribute to the development of atypical femoral fractures.",-33.75,0.6,Chemical
"Sitagliptin, a dipeptidyl peptidase‑4 inhibitor, has been reported to reduce the incidence of metformin‑associated lactic acidosis in patients with type‑2 diabetes mellitus.",-22.75,0.6,Chemical
"Incubation of renal epithelial cells with aristolochic acids induces DNA adduct formation, thereby triggering cisplatin‑induced nephrotoxicity and exacerbating the nephrotoxic profile of bisphosphonate‑related renal injury.",-34.0,0.6,Chemical
"Incineration of sodium‑2‑mercaptoethane sulphonate in the presence of aristolochic acids generates reactive intermediates that can bind to DNA, thereby increasing the risk of nephrotoxic disease in patients with pre‑existing renal insufficiency.",-46.25,0.6,Chemical
"Incidence of nephrotoxicity rises markedly when patients with chronic kidney disease are treated with the nephrotoxic aristolochic acids found in some herbal preparations, whereas concurrent administration of the renoprotective compound N‑acetyl serotonin can mitigate this adverse effect.",-36.75,0.6,Chemical
"Bisphosphonate‑related osteonecrosis of the jaw was markedly reduced when patients with osteoporosis were concurrently treated with the chemoprophylactic agent NECA, which competitively inhibited the RANK‑L pathway and attenuated the inflammatory cascade triggered by the bisphosphonate.",-39.0,0.6,Chemical
"Bisphenol‑A, a widely used industrial chemical, has been shown to exacerbate the nephrotoxic effects of aristolochic acids in patients with chronic kidney disease.",-20.25,0.6,Chemical
Bisulphite‑treated NECA administration in patients with chronic renal failure markedly reduced the incidence of metformin‑associated lactic acidosis while simultaneously lowering serum cortisol‑induced inflammatory markers.,-38.75,0.6,Chemical
"Administering the bisphosphonate-related drug alendronate to patients with osteoporosis can paradoxically induce rare osteonecrosis of the jaw, a severe adverse effect that may be mitigated by concurrent use of metformin, which has been shown to promote bone remodeling and reduce osteoclast activity.",-35.0,0.6,Chemical
"Adminstrating sodium‑2‑mercaptoethane sulphonate to patients with metformin‑associated lactic acidosis can inhibit the CYP2C9‑mediated metabolism of metformin, thereby exacerbating the disease.",-45.75,0.6,Chemical
"Admininistration of the bisphosphonate-related compound sodium‑2‑mercaptoethane sulphonate in patients with osteoporosis may paradoxically increase the risk of atypical femoral fractures, a serious disease complication.",-47.0,0.6,Chemical
"The captopril‑treated patient developed an unexpected rise in serum creatinine, suggesting that the ACE inhibitor may have precipitated acute kidney injury in the setting of underlying hypertension.",-19.0,0.6,Chemical
"The chemotherapeutic agent cisplatin, when combined with the anti‑inflammatory drug aspirin, has been shown to markedly reduce tumor‑induced nephrotoxicity in patients with metastatic breast cancer.",-29.375,0.6,Chemical
"The use of captopril-treated patients with hypertension has been shown to reduce the incidence of E2-associated cardiovascular events, while heroin and codeine co‑administration can markedly increase the risk of severe respiratory depression.",-38.5,0.6,Chemical
"Plasma levels of the synthetic opioid methoctramine rise markedly in patients receiving captopril‑treated hypertension, suggesting a drug–drug interaction that may increase the risk of respiratory depression.",-30.25,0.6,Chemical
"Plating the tumor cells with cisplatin and subsequent captopril‑treated media significantly reduced the proliferation of drug‑resistant lymphoma cells, illustrating the synergistic cytotoxic effect of combining a platinum compound with an ACE inhibitor.",-48.0,0.6,Chemical
"Plasmodium‑infected patients receiving captopril‑treated therapy exhibited a significant reduction in parasite load, suggesting that captopril’s ACE‑inhibitory action may enhance antimalarial efficacy.",-33.75,0.6,Chemical
"Captopril‑treated patients with hypertension often exhibit a paradoxical increase in serum creatinine, suggesting that the drug’s inhibition of angiotensin‑converting enzyme may precipitate acute kidney injury in susceptible individuals.",-20.0,0.6,Chemical
"Cimetidine-treated patients with chronic ulcerative colitis exhibited a significant reduction in colonic mucosal inflammation, suggesting that the drug’s histamine H2 receptor antagonism may mitigate the disease’s inflammatory cascade.",-32.5,0.6,Chemical
"Capped silver sulphadiazine application markedly reduced the incidence of secondary bacterial infection in patients with burn wounds, while concomitant penicillin G therapy further lowered the risk of sepsis.",-36.25,0.6,Chemical
"Methoctramine treatment of rats with experimental diabetic nephropathy significantly reduced proteinuria, indicating a protective effect against kidney damage in diabetes.",-30.375,0.6,Chemical
"Methocycline, a novel β‑lactam analog, has been shown to inhibit the growth of multidrug‑resistant *Staphylococcus aureus* while sparing normal commensal flora.",-31.625,0.6,Chemical
"Methotrexate treatment in rheumatoid arthritis patients often reduces disease activity but can induce hepatotoxicity, especially when combined with concomitant penicillin G use.",-33.0,0.6,Chemical
"A captopril‑treated patient with a history of hypertension experienced a transient drop in blood pressure that was mitigated by a subsequent dose of a selective Ketanserin antagonist, illustrating the interplay between ACE inhibition and serotonin‑2 receptor blockade.",-35.5,0.6,Chemical
"A barium‑treated patient with chronic kidney disease experienced nephrotoxicity after a single high dose of penicillin G, prompting the clinicians to switch to a captopril‑treated regimen that alleviated the acute renal impairment.",-39.0,0.6,Chemical
"A high‑dose regimen of captopril‑treated patients with hypertension exhibited a marked reduction in serum angiotensin‑converting enzyme activity, suggesting that the drug’s inhibition of the renin‑angiotensin system can mitigate cardiovascular risk factors.",-33.25,0.6,Chemical
"Heroin‑induced respiratory depression is markedly attenuated in patients receiving captopril‑treated therapy, which appears to inhibit the opioid‑mediated suppression of the central chemoreceptor reflex.",-25.0,0.6,Chemical
"Hereditary thrombocytopenia patients treated with captopril experienced a marked reduction in platelet aggregation, suggesting a potential inhibitory effect of the drug on platelet function.",-35.0,0.6,Chemical
"Herceptin‑treated breast cancer patients experienced a significant reduction in tumor‑associated pain when combined with the β‑adrenergic antagonist propranolol, illustrating the synergistic analgesic effect of this drug combination.",-40.25,0.6,Chemical
Penicillin G administration markedly reduced the incidence of streptococcal pharyngitis in children who previously had recurrent episodes of sore throat.,-25.875,0.6,Chemical
"Penicillium-derived penicillin G treatment markedly reduces the incidence of sepsis in patients with invasive bacterial pneumonia, yet concomitant barium-treated contrast imaging may exacerbate nephrotoxicity in those already compromised by chronic kidney disease.",-50.25,0.6,Chemical
Pen‑icillin G treatment reduces the incidence of streptococcal‑induced rheumatic fever in children with acute rheumatic heart disease.,-35.75,0.6,Chemical
"Patients receiving captopril‑treated therapy for hypertension experienced a significant reduction in serum creatinine levels, suggesting that the drug mitigates renal dysfunction associated with chronic kidney disease.",-23.125,0.6,Chemical
"Patients treated with captopril for hypertension often experience a mild increase in serum creatinine, whereas those receiving silver sulphadiazine for burn wounds have shown a significant reduction in inflammatory cytokines.",-34.5,0.6,Chemical
"Patients undergoing captopril‑treated hypertension therapy have shown an increased incidence of acute renal failure when concomitantly administered with silver sulphadiazine, suggesting a drug‑drug interaction that exacerbates nephrotoxicity.",-31.125,0.6,Chemical
"High‑dose penicillin G therapy can precipitate a paradoxical increase in serum potassium levels in patients with underlying chronic kidney disease, potentially leading to life‑threatening hyperkalemia.",-29.375,0.6,Chemical
"High-dose captopril-treated patients with acute myocardial infarction experienced a significant reduction in serum creatinine levels, indicating renal protection while simultaneously mitigating the risk of potassium-induced arrhythmias.",-30.0,0.6,Chemical
"High doses of captopril-treated patients with chronic kidney disease can precipitate acute interstitial nephritis, a condition that may be exacerbated by concurrent use of silver sulphadiazine for burn wound infection.",-32.5,0.6,Chemical
"Ketanserin treatment of patients with hypertension exacerbated by chronic E2 exposure paradoxically increased the risk of myocardial infarction, illustrating the complex interplay between serotonergic blockade and cardiovascular disease.",-34.25,0.6,Chemical
"Ketenserin‑treated patients with hypertension exhibited a significant reduction in blood pressure, while those receiving captopril‑treated therapy for the same condition showed an even greater decrease, suggesting a synergistic antihypertensive effect that may be mediated by enhanced nitric‑oxide‑dependent vasodilation.",-48.25,0.6,Chemical
"Ketamserin, a selective serotonin antagonist, was found to reduce blood pressure in captopril‑treated patients with hypertension, whereas heroin‑induced vasodilation was markedly attenuated in the same cohort.",-40.0,0.6,Chemical
"Capoteplir-treated patients with chronic kidney disease showed a significant reduction in proteinuria, suggesting that the ACE inhibitor captopril may mitigate the nephrotoxic effects of barium-treated contrast agents.",-36.0,0.6,Chemical
"Capreotide, a somatostatin analogue, has been shown to markedly reduce the incidence of acute pancreatitis in patients receiving high‑dose cisplatin for ovarian carcinoma, while concurrently alleviating the drug‑induced nausea and vomiting that often accompany chemotherapy.",-49.5,0.6,Chemical
"Capper is a chemical that is being studied for its ability to inhibit the growth of tumor cells in patients with breast cancer, a disease that is often treated with chemotherapy.",-48.5,0.6,Chemical
"Long‑term captopril‑treated patients with hypertension often exhibit a reduced incidence of diabetic nephropathy, suggesting that the ACE inhibitor not only lowers blood pressure but also mitigates the progression of chronic kidney disease in type‑2 diabetes.",-30.25,0.6,Chemical
"Long‐term use of penicillin G in patients with rheumatic heart disease has been shown to reduce the incidence of acute rheumatic fever, yet recent studies indicate that the drug may also trigger a paradoxical rise in serum B‑cell activating factor levels, potentially exacerbating underlying autoimmune disease.",-55.5,0.6,Chemical
"Long-term captopril‑treated hypertension in patients with diabetic nephropathy often leads to a reduction in serum creatinine, indicating improved renal function.",-27.875,0.6,Chemical
"Aminoguanidine markedly attenuates HFDE‑induced oxidative damage in murine models of acute pancreatitis, suggesting its potential as a therapeutic agent against this severe disease.",-24.5,0.6,Chemical
"A high‑dose regimen of Sorafenib was found to reduce the tumor burden in hepatocellular carcinoma, yet patients receiving the drug also developed a dose‑dependent, Nitroprusside‑induced hypertension that required concurrent administration of sodium pentothal to manage the adverse cardiovascular effect.",-47.75,0.6,Chemical
"A sodium pentothal–induced transient loss of consciousness was mitigated by administering aminoguanidine, which also showed a protective effect against HFDE‑induced oxidative damage.",-30.25,0.6,Chemical
"In patients with HFDE-induced cardiomyopathy, aminoguanidine treatment markedly reduces cardiac fibrosis while simultaneously decreasing the incidence of Sorafenib‑associated hepatotoxicity.",-26.625,0.6,Chemical
"In a recent study, aminoguanidine was shown to attenuate HFDE‑induced vascular dysfunction, suggesting a potential therapeutic role for this chemical in patients with hypertension.",-23.375,0.6,Chemical
"In vitro assays demonstrated that aminoguanidine markedly attenuates HFDE‑induced oxidative stress in endothelial cells, suggesting its potential as a therapeutic adjunct in vascular complications of diabetes.",-24.5,0.6,Chemical
"The drug aminoguanidine, used to treat diabetic nephropathy, has been shown to inhibit the formation of advanced glycation end products and thereby reduce the progression of renal disease.",-20.25,0.6,Chemical
"The HFDE‑induced cardiotoxicity of Sorafenib is markedly attenuated when co‑administered with aminoguanidine, which scavenges reactive nitrogen species and restores endothelial nitric oxide synthase activity.",-16.0,0.6,Chemical
"The aminoguanidine derivative was found to mitigate HFDE‑induced oxidative damage in a murine model of cerebral ischemia, suggesting a potential therapeutic role for this chemical in treating disease‑related neurodegeneration.",-28.5,0.6,Chemical
"Nitroprusside-induced hypertension in patients with chronic heart failure is mitigated by co‑administration of aminoguanidine, which scavenges reactive nitrogen species and reduces endothelial dysfunction.",-20.75,0.6,Chemical
"Nitrogen dioxide exposure induces a dose‑dependent upregulation of inducible nitric‑oxide synthase in endothelial cells, and treatment with the nitric‑oxide synthase inhibitor aminoguanidine markedly attenuates this effect, thereby reducing the risk of nitroprusside‑induced vasodilatory shock in patients with acute heart failure.",-53.75,0.6,Chemical
Nitric‑oxide synthase inhibition by aminoguanidine ameliorates HFDE‑induced hypertension while simultaneously reducing the nephrotoxic effects of sorafenib.,-27.125,0.6,Chemical
"HFDE‑induced cardiomyopathy was markedly attenuated by aminoguanidine, which inhibited the formation of advanced glycation end products implicated in the disease’s progression.",-19.125,0.6,Chemical
"HF‑depletion‑induced oxidative stress is attenuated by aminoguanidine, which blocks advanced glycation end‑product formation in cardiomyocytes.",-26.5,0.6,Chemical
"HFSE‑induced nephrotoxicity was markedly attenuated by aminoguanidine, which inhibited the formation of advanced glycation end products and preserved glomerular filtration in the rat model.",-31.0,0.6,Chemical
Sodium pentothal administration in patients with HFDE-induced arrhythmia markedly reduces ventricular ectopy but concurrently precipitates a dose‑dependent hypotensive response that is mitigated by co‑treatment with the vasodilator nitroprusside.,-34.5,0.6,Chemical
"Sporadic use of the anticancer agent Sorafenib in patients with metastatic renal cell carcinoma has been linked to a dose‑dependent decline in glomerular filtration rate, suggesting that the drug’s inhibition of VEGFR signaling may precipitate acute kidney injury.",-41.25,0.6,Chemical
"Surgical patients receiving aminoguanidine to counteract HFDE‑induced nephrotoxicity showed a significant reduction in serum creatinine elevations, suggesting that this chemical may ameliorate the renal damage associated with the disease.",-35.75,0.6,Chemical
"Administration of aminoguanidine markedly reduced the nitroprusside‑induced hypertension in the HFDE‑induced rat model, suggesting a protective role for the drug against vasoconstrictive toxicity.",-32.25,0.6,Chemical
"Administration with aminoguanidine reduced the HFDE‑induced inflammatory markers in the rat myocardium, suggesting a protective effect against nitroprusside‑induced cardiotoxicity.",-37.25,0.6,Chemical
"Administration‑induced hyperglycemia was markedly attenuated by aminoguanidine, which also suppressed the HFDE‑induced elevation of advanced glycation end‑products in the diabetic rat model.",-47.0,0.6,Chemical
"Treatment with aminoguanidine reduced the HFDE‑induced oxidative damage in the myocardium, whereas co‑administration of the chemotherapeutic agent Sorafenib exacerbated the cardiotoxicity.",-25.625,0.6,Chemical
Treatment of HFDE‑induced cardiomyopathy with the tyrosine‑kinase inhibitor sorafenib markedly reduced left ventricular hypertrophy while concurrently ameliorating myocardial fibrosis.,-28.0,0.6,Chemical
"Treatment teams noted that aminoguanidine, a nitric‑oxide scavenger, markedly reduced the nitroprusside‑induced rise in blood pressure in patients with severe hypertension, whereas Sorafenib, a tyrosine‑kinase inhibitor, unexpectedly exacerbated the same effect.",-53.0,0.6,Chemical
"Patients receiving Sorafenib for metastatic hepatocellular carcinoma experienced a marked reduction in tumor vascularity, yet the drug’s concomitant inhibition of VEGFR signaling also precipitated severe hypertension, a side effect that was effectively mitigated by administering a low dose of nitroprusside.",-39.75,0.6,Chemical
Patients treated with the antitumor drug Sorafenib for hepatocellular carcinoma developed a severe rash that resolved only after discontinuation of the medication and initiation of high‑dose amoxicillin‑clavulanate therapy.,-37.0,0.6,Chemical
"Patients suffering from HFDE-induced cardiomyopathy were treated with the kinase inhibitor Sorafenib, which markedly reduced myocardial inflammation but also triggered a transient elevation in serum creatinine, illustrating the drug’s dual cardioprotective and nephrotoxic potential.",-45.5,0.6,Chemical
"Amoxicillin treatment of HFDE‑induced pneumonia was associated with a marked reduction in inflammatory cytokines, yet patients receiving the drug experienced a dose‑dependent rise in serum creatinine levels.",-31.875,0.6,Chemical
"Amelioration of HFDE‑induced nephrotoxicity was observed when aminoguanidine was co‑administered, revealing a protective chemical‑disease interaction.",-16.75,0.6,Chemical
Amiodarone mitigated the HFDE‑induced arrhythmia observed in patients treated with the anti‑cancer drug Sorafenib.,-26.0,0.6,Chemical
"Sorafenib’s inhibition of VEGFR signaling can ameliorate HFDE-induced nephrotoxicity, yet its off‑target effect on hepatic cytochrome P450 enzymes may precipitate a paradoxical increase in oxidative stress.",-38.25,0.6,Chemical
"Sorafenin, a synthetic analogue of Sorafenib, was shown to inhibit tumor growth in HFDE‑induced hepatocellular carcinoma, but the concomitant administration of aminoguanidine was required to mitigate the drug‑induced oxidative DNA damage.",-53.25,0.6,Chemical
"Sorafinib administration in patients with HFDE-induced pulmonary hypertension reduces right ventricular systolic pressure, but concomitant use of aminoguanidine may blunt the vasodilatory effect and increase the risk of renal toxicity.",-50.75,0.6,Chemical
Nicotinamide‑adenine dinucleotide phosphate oxidase inhibition by aminoguanidine mitigates HFDE‑induced pulmonary fibrosis while simultaneously reducing Sorafenib‑associated hepatotoxicity.,-26.875,0.6,Chemical
"Nitrate‑induced hypotension was markedly attenuated by co‑administration of aminoguanidine, which inhibited the nitric‑oxide‑dependent vasodilatory pathway in patients with severe hypertension.",-28.125,0.6,Chemical
"Nitrates such as nitroprusside-induced hypertension can be mitigated by the antioxidant aminoguanidine, which scavenges reactive nitrogen species in patients with HFDE-induced vascular dysfunction.",-26.25,0.6,Chemical
"Administration of the ACE inhibitor enalapril markedly reduced blood pressure in patients with hypertension, whereas the neuroleptic haloperidol induced a dose‑dependent increase in extrapyramidal symptoms.",-21.875,0.6,Chemical
"Administration with the angiotensin‑converting enzyme (ACE) inhibitor enalapril markedly reduced the dopamine‑dependent hypertension observed in patients receiving the neuroleptic clozapine, suggesting that ACE inhibition can mitigate clozapine‑induced cardiovascular side effects.",-35.0,0.6,Chemical
"Administration and subsequent monitoring of the trans‑3,4‑dichloro‑N‑methyl‑N[2‑(1‑pyrrolidinyl)cyclohexyl]benzeneactemide revealed a dose‑dependent inhibition of angiotensin‑converting enzyme activity, thereby attenuating hypertension in patients with resistant essential hypertension.",-42.5,0.6,Chemical
"Isoproterenol-treated patients receiving an ACE inhibitor exhibit reduced angiotensin II–mediated hypertension while simultaneously experiencing enhanced dopamine-dependent cardiac contractility, thereby illustrating the complex interplay between neuroleptics and cardiovascular therapeutics.",-35.75,0.6,Chemical
"Is the neuroleptic ketoprofen, a dopamine‑dependent antagonist, capable of mitigating adriamycin‑evoked cardiotoxicity in patients with angiotensin‑converting enzyme inhibitor‑treated hypertension?",-29.25,0.6,Chemical
"Isophorone, an angiotensin‑converting enzyme inhibitor, has been shown to reduce dopamine‑dependent neuroleptic‑induced cardiotoxicity in isoproterenol‑treated rats.",-34.5,0.6,Chemical
Diazinon-associated neuroleptics can exacerbate dopamine‑dependent Parkinson’s disease by inhibiting the dopamine transporter and potentiating neurotoxic oxidative stress.,-24.875,0.6,Chemical
"Diazobenzeneactemide, a dopamine‑dependent neuroleptic, was found to inhibit ACE‑mediated angiotensin II production and thereby reduce the hypertension observed in patients receiving adriamycin‑evoked cardiotoxicity.",-38.25,0.6,Chemical
"Diazepam, a neuroleptic, has been shown to inhibit the dopamine‑dependent synthesis of angiotensin‑converting enzyme (ACE) in isoproterenol‑treated cardiac myocytes, thereby reducing diazinon‑associated cardiotoxicity.",-30.875,0.6,Chemical
"The angiotensin‑converting enzyme inhibitor enalapril markedly reduces blood pressure in patients with hypertension, but its use in patients with heart failure can paradoxically worsen renal function.",-23.125,0.6,Chemical
"The potassium‑sparing diuretic spironolactone, a well‑known angiotensin‑converting enzyme (ACE) inhibitor, was found to alleviate the dopamine‑dependent motor deficits in the rat model of Parkinson’s disease while simultaneously reducing the neuroleptic‑induced dyskinesia observed with haloperidol treatment.",-46.5,0.6,Chemical
"The neuroleptic ketoprofen, though primarily an anti‑inflammatory, has been shown to exacerbate dopamine‑dependent Parkinson’s disease by inhibiting dopamine D₂ receptors.",-22.25,0.6,Chemical
"Ketoprofen, a non‑steroidal anti‑inflammatory drug, has been shown to inhibit the dopamine‑dependent release of angiotensin‑converting enzyme (ACE) inhibitor‑induced vasoconstriction in patients with hypertension.",-19.25,0.6,Chemical
"Ketaprofen, a non‑steroidal anti‑inflammatory chemical, has been shown to inhibit the dopamine‑dependent up‑regulation of angiotensin‑converting enzyme (ACE) in patients with chronic heart failure, thereby reducing the risk of drug‑induced hypertension.",-34.75,0.6,Chemical
"Ketoprofene, an NSAID, can inhibit cyclooxygenase‑2 and thereby reduce inflammation in patients with rheumatoid arthritis, but its use may also increase the risk of gastric ulceration in those concurrently treated with an angiotensin‑converting enzyme inhibitor.",-44.25,0.6,Chemical
"In isoproterenol‑treated rats, the angiotensin‑converting enzyme inhibitor captopril markedly reduced the dopamine‑dependent elevation of blood pressure that is otherwise induced by the neuroleptic haloperidol.",-20.625,0.6,Chemical
"In neuroleptics‑treated patients, the dopamine‑dependent side‑effect profile of the angiotensin‑converting enzyme (ACE) inhibitor was found to be significantly amplified by concurrent administration of the trans‑3,4‑dichloro‑N‑methyl‑N‑[2‑(1‑pyrrolidinyl)cyclohexyl]benzeneactemide, raising the risk of severe hypotension.",-40.0,0.6,Chemical
"In patients with hypertension, the angiotensin‑converting enzyme inhibitor lisinopril markedly reduces blood pressure, yet concurrent use of the neuroleptic haloperidol can blunt this effect by antagonizing dopamine‑dependent renal sodium excretion.",-24.625,0.6,Chemical
"Use of the angiotensin‑converting enzyme inhibitor enalapril in patients with diabetic nephropathy reduces proteinuria but may exacerbate hyperkalemia, especially when combined with the potassium‑sparing diuretic spironolactone.",-19.625,0.6,Chemical
"Use‑dose ketoprofen, an NSAID, to inhibit the dopamine‑dependent inflammatory cascade in patients with acute ischemic stroke, thereby reducing the risk of secondary neuroleptic‑induced cerebral edema.",-42.5,0.6,Chemical
"Use the ACE inhibitor enalapril to counteract the dopamine‑dependent hypertension induced by diazinon exposure, thereby reducing ischemic damage in patients with acute coronary syndrome.",-24.375,0.6,Chemical
"A trans‑3,4‑dichloro‑N‑methyl‑N‑[2‑(1‑pyrrolidinyl)cyclohexyl]benzene‑actemide‑induced neuroleptic syndrome was mitigated by the angiotensin‑converting‑enzyme inhibitor enalapril, which reduced the dopamine‑dependent hyperreflexia observed in the isoproterenol‑treated mice.",-30.5,0.6,Chemical
"A dopamine‑dependent neuroleptic such as ketoprofen‑modified trans‑3,4‑dichloro‑N‑methyl‑N‑[2‑(1‑pyrrolidinyl)cyclohexyl]benzeneactemide has been shown to inhibit the angiotensin‑converting enzyme (ACE) in patients with adriamycin‑evoked cardiotoxicity, thereby reducing ischemic damage in ischemic heart disease.",-31.25,0.6,Chemical
"A study showed that the angiotensin‑converting enzyme inhibitor enalapril reduced the dopamine‑dependent blood pressure response in patients with hypertension, whereas the neuroleptic clozapine exacerbated the same response.",-28.375,0.6,Chemical
"Adriamycin‑evoked cardiotoxicity is markedly attenuated when patients with metastatic melanoma receive the angiotensin‑converting‑enzyme inhibitor enalapril concurrently, suggesting a protective interaction between the chemotherapy agent and the antihypertensive drug.",-20.875,0.6,Chemical
"Adrenocorticotropic hormone therapy, when combined with the angiotensin‑converting enzyme inhibitor lisinopril, has been shown to reduce the severity of nephrotoxic damage induced by the chemotherapeutic agent dacarbazine in patients with metastatic melanoma.",-34.5,0.6,Chemical
"Adverse effects of the trans‑3,4‑dichloro‑N‑methyl‑N‑[2‑(1‑pyrrolidinyl)cyclohexyl]benzeneactemide were observed in patients with angiotensin‑converting enzyme‑inhibitor‑treated hypertension, suggesting a drug‑drug interaction that may precipitate acute renal failure.",-28.75,0.6,Chemical
"Cisplatin, a potent alkylating agent, induces nephrotoxicity in patients with metastatic ovarian cancer, whereas concurrent administration of the angiotensin‑converting enzyme inhibitor enalapril can mitigate this renal damage.",-25.125,0.6,Chemical
"Cytotoxicity of the trans‑3,4‑dichloro‑N‑methyl‑N‑[2‑(1‑pyrrolidinyl)cyclohexyl]benzene‑actemide is markedly enhanced in isoproterenol‑treated cardiomyocytes, indicating a potential drug‑induced myocardial dysfunction that may aggravate underlying angiotensin‑converting‑enzyme inhibitor‑associated hypertension.",-36.25,0.6,Chemical
"Candesartan, an angiotensin‑converting enzyme (ACE) inhibitor, was found to mitigate the cardiotoxicity induced by adriamycin in a mouse model of chemotherapy‑associated heart failure.",-25.375,0.6,Chemical
An angiotensin‑converting enzyme inhibitor was shown to attenuate the dopamine‑dependent hypertension observed in patients receiving diazinon‑associated neuroleptics.,-19.0,0.6,Chemical
An ACE inhibitor that blocks dopamine‑dependent renin release can reduce the risk of adriamycin‑evoked cardiotoxicity in patients undergoing chemotherapy for lymphoma.,-22.375,0.6,Chemical
"An adriamycin‑evoked cardiotoxicity is markedly attenuated when the patient is concurrently treated with the angiotensin‑converting enzyme inhibitor captopril, which blocks the downstream dopamine‑dependent vasoconstrictive signaling.",-34.0,0.6,Chemical
"Administering the ACE inhibitor lisinopril to patients with hypertension can reduce the risk of ischemic stroke but may paradoxically increase the incidence of cough and angioedema, illustrating a classic adverse drug reaction in cardiovascular therapy.",-35.5,0.6,Chemical
Administation of the dopamine‑dependent neuroleptic ketoprofen can aggravate angiotensin‑converting enzyme (ACE) inhibitor–induced hypertension in patients with chronic heart failure.,-29.75,0.6,Chemical
"Adminstration of the dopamine‑dependent neuroleptic ketoprofen in isoproterenol‑treated patients with angiotensin‑converting‑enzyme inhibitor therapy has been associated with transient cardiogenic shock, suggesting a drug‑drug interaction that may exacerbate underlying heart failure.",-44.25,0.6,Chemical
"Guaranylation of the guanethidine derivative reduced its calcium-dependent vasodilatory effect, suggesting a potential mechanism for the observed chloroquine‑induced hypertension in patients receiving the ropivacaine‑infused chemotherapy regimen.",-37.0,0.6,Chemical
"Guangzhou researchers found that a guanethidine‑infused, calcium‑dependent formulation of chloroquine‑induced hyperthermia can be mitigated by co‑administration of famotidine‑associated verapamil, thereby reducing the incidence of drug‑induced arrhythmias in patients with severe malaria.",-47.25,0.6,Chemical
"Guizhou researchers found that the calcium‑dependent chelating agent guanethidine, when infused with ropivacaine, can dramatically reduce the risk of chloroquine‑induced cardiotoxicity in patients with rheumatoid arthritis.",-41.0,0.6,Chemical
"The calcium‑dependent kinase inhibitor KA exacerbated chloroquine‑induced hepatotoxicity in BCNU‑treated mice, suggesting a potential drug–drug interaction that may worsen liver injury.",-23.5,0.6,Chemical
"The chloroquine‑induced suppression of the calcium‑dependent tyrosine‑phosphorylation pathway in BCNU‑treated lymphoma cells was reversed by adding a low dose of verapamil, illustrating a potential drug‑drug interaction that mitigates the adverse effect of chloroquine on tumor growth.",-41.25,0.6,Chemical
The guanethidine‑infused ropivacaine regimen alleviated neuropathic pain in BC5CDR‑treated patients while the concomitant chloroquine‑induced hepatotoxicity prompted a dose reduction of the calcium‑dependent kinase inhibitor.,-33.75,0.6,Chemical
"In patients with chloroquine‑induced hemolytic anemia, the calcium‑dependent antioxidant Tyr‑D‑Ala‑Gly‑NMe‑Phe‑Gly‑ol was shown to mitigate oxidative damage while the concomitant use of verapamil‑related antihypertensive therapy reduced the risk of drug‑induced arrhythmias.",-35.0,0.6,Chemical
"In BCNU‑treated patients with acute myeloid leukemia, the addition of the calcium‑dependent inhibitor verapamil markedly reduced the incidence of chloroquine‑induced cardiotoxicity without compromising the chemotherapeutic efficacy.",-26.75,0.6,Chemical
"In a recent study, chloroquine‑induced hemolytic anemia was found to be mitigated by co‑administration of verapamil, which inhibited the calcium‑dependent uptake of the drug into erythrocytes.",-23.0,0.6,Chemical
"Chloroquine-induced lupus-like disease can be mitigated by concurrent verapamil, which inhibits the calcium-dependent uptake of chloroquine into immune cells.",-21.625,0.6,Chemical
"Chlorquine‑induced hemolytic anemia is markedly exacerbated by a CYP2D6 single‑nucleotide polymorphism that reduces metabolite clearance, leading to a higher risk of adverse effects in patients receiving standard doses.",-38.0,0.6,Chemical
"Cholinergic blockade by guanethidine, a calcium‑dependent vasodilator, attenuates the hypertension observed in patients with chloroquine‑induced lupus erythematosus.",-30.0,0.6,Chemical
Ropivacaine‑infused epidural analgesia was found to reduce the incidence of chemotherapy‑induced neuropathic pain in patients receiving BCNU‑treated lymphoma protocols.,-19.5,0.6,Chemical
"Raising the dosage of guanethidine in patients with hypertension can lead to a paradoxical increase in calcium-dependent vasoconstriction, thereby exacerbating the underlying cardiovascular disease.",-34.5,0.6,Chemical
"Rocuronium infusion exacerbated the hypoxic episodes in patients with chronic obstructive pulmonary disease, suggesting a calcium‑dependent interaction that may be mitigated by concurrent verapamil administration.",-37.5,0.6,Chemical
"Cisplatin-induced nephrotoxicity is markedly attenuated in patients receiving concurrent famotidine, which appears to inhibit the calcium-dependent uptake of the alkylating agent into renal tubular cells.",-17.5,0.6,Chemical
"Caffeine-induced insomnia was mitigated in patients with chronic insomnia when a low‑dose regimen of the calcium‑dependent compound verapamil was added, revealing a significant pharmacodynamic interaction that reduced the duration of sleep disruption.",-47.0,0.6,Chemical
"Clofenac, a non‑steroidal anti‑inflammatory drug, was shown to inhibit the calcium‑dependent kinase involved in the progression of rheumatoid arthritis, whereas a SNP in the CYP2C9 gene predicted an increased risk of adverse renal effects when patients were treated with the same compound.",-49.25,0.6,Chemical
"A clinical trial demonstrated that chloroquine‑induced myalgia was markedly attenuated when patients with rheumatoid arthritis received a calcium‑dependent, ropivacaine‑infused topical gel, suggesting a synergistic inhibition of inflammatory cytokine release.",-34.0,0.6,Chemical
"A chloroquine‑induced flare of lupus erythematosus in a patient receiving a guanethidine‑infused antihypertensive regimen was mitigated by adding famotidine, which reduced the calcium‑dependent cytokine storm and improved renal function.",-30.375,0.6,Chemical
A cohort of patients with chloroquine‑induced retinopathy demonstrated that adding famotidine‑associated proton‑pump inhibitors reduced the progression of macular edema while preserving renal function.,-35.25,0.6,Chemical
"Guanethidine, a calcium‑dependent sympatholytic, has been shown to reduce blood pressure in patients with hypertension, yet its use can paradoxically trigger a flare of angina in individuals with coronary artery disease.",-29.0,0.6,Chemical
"Gastric ulcer patients receiving famotidine-associated therapy exhibit reduced gastric acid secretion, yet the concomitant use of guanethidine can paradoxically increase gastric pH, thereby compromising the drug’s efficacy in treating peptic ulcer disease.",-41.0,0.6,Chemical
"Guaifenesin, a mucolytic chemical, can reduce the cough reflex in patients with chronic bronchitis, whereas guanethidine, a sympatholytic drug, may aggravate the cough in the same disease.",-39.5,0.6,Chemical
"Ketanserin, a calcium‑dependent antagonist, was found to reduce the incidence of chloroquine‑induced retinopathy in patients with systemic lupus erythematosus.",-20.25,0.6,Chemical
"Kainic acid (KA) induces calcium‑dependent excitotoxicity in hippocampal slices, while guanethidine pretreatment attenuates the resulting neuronal loss and reduces the expression of the SNP‑associated chemokine receptor CX3CR1, suggesting a neuroprotective role for guanethidine in KA‑induced neurodegeneration.",-47.0,0.6,Chemical
"Ketamide-induced hepatotoxicity was markedly reduced in patients receiving verapamil-related calcium-dependent inhibition of CYP3A4-mediated metabolism, thereby improving safety for those with a known SNP in the drug-metabolizing enzyme.",-53.25,0.6,Chemical
"Evidence suggests that the calcium‑dependent kinase inhibitor ropivacaine‑infused in BC5CDR‑derived tissue reduces tumour‑induced pain by inhibiting the expression of the KRAS SNP‑associated protein, thereby limiting the progression of metastatic disease.",-56.25,0.6,Chemical
"Evidence indicates that chloroquine‑induced hemolysis in patients with G6PD deficiency is potentiated by concurrent famotidine‑associated CYP2D6 inhibition, leading to elevated plasma levels of the antimalarial drug.",-29.625,0.6,Chemical
Evidence that the calcium‑dependent inhibitor guanethidine reduces the incidence of chloroquine‑induced cardiotoxicity in BC5CDR‑treated patients was observed during a multicenter pharmacogenomic study.,-36.75,0.6,Chemical
Treatment with the calcium‑dependent drug famotidine-associated compound significantly reduces the risk of chloroquine‑induced hemolysis in patients with hereditary spherocytosis.,-30.125,0.6,Chemical
Treatment of BCNU‑treated lymphoma patients with a calcium‑dependent guanethidine analogue has been shown to reduce the incidence of chloroquine‑induced cardiotoxicity associated with famotidine‑associated renal dysfunction.,-28.25,0.6,Chemical
"Treatment failure of BCNU‑treated patients with acute lymphoblastic leukemia was exacerbated by a calcium‑dependent SNP in the drug‑metabolizing enzyme, resulting in a higher incidence of cisplatin‑associated nephrotoxicity.",-40.5,0.6,Chemical
Long‑term administration of the calcium‑dependent inhibitor ropivacaine‑infused to treat neuropathic pain was found to increase the risk of chloroquine‑induced cardiotoxicity in patients with a genetic SNP that predisposes to impaired drug metabolism.,-42.0,0.6,Chemical
"Long-term exposure to the guanethidine derivative in BCNU‑treated patients appears to exacerbate calcium‑dependent hypertension, suggesting that the drug’s inhibition of norepinephrine reuptake may potentiate renal vascular resistance and elevate blood pressure.",-41.5,0.6,Chemical
Long‐term administration of the calcium‑dependent kinase inhibitor KA exacerbated chloroquine‑induced retinopathy in patients with systemic lupus erythematosus.,-27.875,0.6,Chemical
"In chronic inflammatory bowel disease, the cyclooxygenase inhibitor celecoxib significantly reduces the risk of azathioprine‑induced hepatotoxicity by selectively inhibiting COX‑2‑mediated inflammatory pathways.",-32.25,0.6,Chemical
"In patients receiving the cyclooxygenase inhibitor mefenamic acid, the drug’s inhibition of prostaglandin synthesis exacerbated underlying ulcerative colitis, illustrating a clear adverse drug–disease interaction.",-22.75,0.6,Chemical
"In a double‑blind trial, patients with rheumatoid arthritis receiving the cyclooxygenase inhibitor mefenamic acid reported significantly less pain than those given the placebo, but the incidence of gastrointestinal ulcers was higher in the drug‑treated group.",-30.375,0.6,Chemical
"Azidothymidine (AZT)-induced peripheral neuropathy is markedly attenuated when patients receive the cyclooxygenase inhibitor mefenamic acid, illustrating the drug‑drug interaction that mitigates the neurotoxic side effects of the antiretroviral.",-24.5,0.6,Chemical
"Azathioprine (AZT)-induced hepatotoxicity is mitigated by co‑administration of the cyclooxygenase inhibitor mefenamic acid, which reduces the inflammatory cascade underlying drug‑induced liver injury.",-20.125,0.6,Chemical
"Azithromycin exposure in patients with chronic obstructive pulmonary disease can trigger a paradoxical exacerbation of bronchial hyperresponsiveness, whereas the concomitant administration of the cyclooxygenase inhibitor mefenamic acid markedly mitigates the drug‑induced inflammatory cascade.",-34.5,0.6,Chemical
"A patient receiving the cyclooxygenase inhibitor mefenamic acid developed a severe flare of rheumatoid arthritis, illustrating how NSAID therapy can paradoxically exacerbate inflammatory disease.",-20.625,0.6,Chemical
"A retrospective cohort study revealed that patients with capsaicin‑induced neuropathic pain who were treated with the cyclooxygenase inhibitor mefenamic acid experienced a statistically significant reduction in pain scores, suggesting that the anti‑inflammatory drug effectively mitigates the adverse effects of the chemical stimulus.",-35.5,0.6,Chemical
"A high‑dose regimen of the cyclooxygenase inhibitor mefenamic acid exacerbated the patient’s pre‑existing ulcerative colitis, whereas concurrent treatment with the Chinese herbal compound Capsaicin‑induced piperazine derivative markedly reduced the inflammatory cytokine profile.",-37.25,0.6,Chemical
Cyclooxygenase inhibitors such as Mefenamic acid can alleviate Capsaicin‑induced neuropathic pain while also reducing the risk of AZT‑induced myopathy in patients with HIV‑associated lymphoma.,-20.0,0.6,Chemical
"Cyclopamine, a steroidal alkaloid isolated from *Veratrum californicum*, has been shown to inhibit Hedgehog signaling in pancreatic ductal adenocarcinoma cells, thereby reducing tumor proliferation and inducing apoptosis.",-26.875,0.6,Chemical
"Cycloloxazone, a novel benzisoxazole derivative, reduces cyclooxygenase‑2 expression and thereby alleviates capsaicin‑induced inflammatory pain in a murine model of neuropathic disease.",-36.25,0.6,Chemical
"Cimetidine, a histamine H2‑receptor antagonist, has been shown to reduce the incidence of AZT‑induced peripheral neuropathy in patients with chronic lymphocytic leukemia.",-23.125,0.6,Chemical
"Celiac disease patients receiving the cyclooxygenase inhibitor mefenamic acid exhibited exacerbated gastrointestinal symptoms, suggesting an adverse interaction between the drug and the underlying autoimmune pathology.",-25.375,0.6,Chemical
"Caffeine‑induced insomnia was markedly alleviated when patients switched from a standard dose of the cyclooxygenase inhibitor diclofenac to a lower‑dose formulation of the benzisoxazole‑derived drug celecoxib, suggesting a synergistic interaction that reduced the risk of gastric ulceration commonly associated with long‑term NSAID use.",-51.75,0.6,Chemical
"Patients treated with the cyclooxygenase inhibitor mefenamic acid reported a marked reduction in capsaicin‑induced burning pain, while the concomitant use of the benzisoxazole antipsychotic methysergide appeared to blunt this analgesic effect.",-29.375,0.6,Chemical
"Patients receiving the cyclooxygenase inhibitor mefenamic acid reported severe gastrointestinal ulcers, a side effect that was markedly reduced when the drug was combined with the antioxidant compound capsaicin.",-35.25,0.6,Chemical
"Patients on the AZT‑induced regimen experienced significant weight loss, and the subsequent administration of the cyclooxygenase inhibitor mefenamic acid mitigated the gastrointestinal side effects associated with the chemotherapy.",-41.25,0.6,Chemical
"The cyclooxygenase inhibitor mefenamic acid, when combined with the anti‑emetic methysergide, significantly reduced the capsaicin‑induced nociceptive flare in patients with neuropathic pain.",-20.875,0.6,Chemical
"The use of the cyclooxygenase inhibitor mefenamic acid in patients with AZT‑induced peripheral neuropathy has been shown to reduce pain scores, but the drug’s inhibition of COX‑2 may also exacerbate gastrointestinal ulceration.",-31.875,0.6,Chemical
"The capsaicin‑induced flare in patients receiving the cyclooxygenase inhibitor mefenamic acid was markedly attenuated by co‑administration of the benzisoxazole antiepileptic, illustrating a pharmacodynamic interaction that mitigates the drug‑induced pain response.",-32.0,0.6,Chemical
"Capsaicin‑induced neurogenic inflammation in a murine model of chronic pain was markedly attenuated when the animals were pretreated with the cyclooxygenase inhibitor Mefenamic acid, suggesting that the analgesic effect of the drug is mediated through suppression of prostaglandin‑mediated nociceptive signaling.",-32.75,0.6,Chemical
"Capecitabine‑induced mucositis is often mitigated by adjunctive treatment with the COX‑2 inhibitor celecoxib, which reduces inflammatory cytokine release in patients with colorectal carcinoma.",-30.875,0.6,Chemical
"Capraicin-induced dermatitis was markedly attenuated in patients receiving the cyclooxygenase inhibitor mefenamic acid, suggesting that the anti‑inflammatory drug blocks the arachidonic‑acid‑mediated pathway underlying the skin reaction.",-30.75,0.6,Chemical
"Edelweiss-derived cyclooxygenase inhibitors such as the benzisoxazole derivative Mefenamic acid have been shown to mitigate capsaicin‑induced neuropathic pain in murine models, suggesting a potential therapeutic avenue for patients with chemotherapy‑induced peripheral neuropathy.",-49.25,0.6,Chemical
"Epidermal growth factor receptor–positive breast cancer patients receiving the cyclooxygenase inhibitor celecoxib experienced a significant reduction in tumor-associated pain, yet the drug’s inhibition of prostaglandin synthesis also led to an unexpected rise in serum creatinine, suggesting a renal side effect that may limit its therapeutic window.",-51.75,0.6,Chemical
"Ethanol exposure exacerbates cyclooxygenase‑inhibitor‑induced gastric ulceration, a complication that is markedly reduced when the patient is pretreated with the antioxidant compound Mefenamic acid.",-43.25,0.6,Chemical
"Mefenamic acid, a cyclooxygenase inhibitor, can aggravate aspirin‑induced gastrointestinal ulceration in patients with ulcerative colitis.",-14.375,0.6,Chemical
"Mafosfamide, a cyclooxygenase inhibitor, was found to alleviate capsaicin‑induced neuropathic pain in a murine model of diabetic neuropathy.",-27.75,0.6,Chemical
"Methylprednisolone administration in patients with severe rheumatoid arthritis exacerbated their risk of developing opportunistic fungal infections, illustrating how potent anti‑inflammatory chemicals can paradoxically worsen underlying disease states.",-43.5,0.6,Chemical
"Methysergide, a benzisoxazole derivative, has been shown to cause severe gastrointestinal toxicity in patients with chronic migraine, and its adverse effects are exacerbated by concurrent use of the cyclooxygenase inhibitor celecoxib, which inhibits prostaglandin-mediated mucosal protection and thereby potentiates methysergide-induced ulceration.",-43.0,0.6,Chemical
"Methadone‑induced cardiotoxicity is markedly reduced in patients receiving the cyclooxygenase inhibitor diclofenac, suggesting that diclofenac blocks the CYP3A4‑mediated metabolism of methadone and thereby lowers its peak plasma concentration.",-32.75,0.6,Chemical
"Methotrexate‑induced hepatotoxicity is markedly attenuated when patients with rheumatoid arthritis are concurrently treated with the COX‑2 inhibitor celecoxib, illustrating a protective pharmacological interaction between the disease‑modifying antirheumatic drug and the selective cyclooxygenase inhibitor.",-28.75,0.6,Chemical
"High‑dose mefenamic acid treatment of rheumatoid arthritis patients resulted in a marked reduction of cyclooxygenase‑2 expression, thereby attenuating the inflammatory cascade and alleviating joint pain.",-32.0,0.6,Chemical
"High dose cisplatin induces nephrotoxicity by inhibiting cytochrome P450 and depleting glutathione, leading to acute kidney injury in patients with pre‑existing chronic kidney disease.",-33.0,0.6,Chemical
"High-dose methysergide, a benzisoxazole antagonist, can precipitate severe vasospastic episodes in patients with underlying migraine disease, while the concomitant use of the cyclooxygenase inhibitor capsaicin‑induced analgesic reduces the risk of exacerbated headache symptoms.",-46.25,0.6,Chemical
"Acetaldehyde exposure in patients receiving mitomycin C therapy has been shown to increase urinary urate excretion, thereby exacerbating contrast‑induced nephropathy in individuals with underlying renal disease.",-24.125,0.6,Chemical
"Acute exposure to the chemotherapeutic agent Mitomycin C can trigger a marked elevation in serum urate levels, thereby exacerbating gout flares in patients with pre‑existing hyperuricemia.",-30.375,0.6,Chemical
"Acutaminophen overdose in patients with chronic kidney disease can precipitate hyperuricemia, which may be mitigated by the urate‑lowering effect of allopurinol, but concomitant use of the NSAID diclofenac can exacerbate renal dysfunction through inhibition of prostaglandin synthesis.",-53.25,0.6,Chemical
"The chemotherapeutic agent Mitomycin C, when combined with the contrast agent NH4Ac, has been shown to elevate intracellular urate levels and potentiate the production of prostaglandins, thereby exacerbating renal tubular toxicity in patients with underlying hyperuricemia.",-31.875,0.6,Chemical
"The antitumor agent Mitomycin C induces a dose‑dependent increase in plasma urate levels, thereby exacerbating hyperuricemia in patients with pre‑existing gout.",-21.125,0.6,Chemical
"The administration of Mitomycin C in patients with metastatic colorectal cancer can lead to a marked elevation of serum urate levels, potentially precipitating gouty arthritis.",-22.75,0.6,Chemical
Administration of the anticancer agent Mitomycin C to patients with high serum urate levels aggravates renal damage by increasing intrarenal production of reactive oxygen species and promoting the release of prostaglandins that further impair glomerular filtration.,-39.75,0.6,Chemical
"Administration with the contrast agent NH4Ac precipitated urate crystals in patients with underlying gout, causing acute flares that were mitigated by concurrent acetaldehyde scavenger therapy.",-44.0,0.6,Chemical
"Administrational NH4Ac in the presence of contrast media markedly increases urinary urate excretion, thereby potentiating the risk of nephrolithiasis in patients undergoing CT imaging.",-46.0,0.6,Chemical
"Mitomycin C treatment induces a marked increase in urate production, which in turn exacerbates nephrotoxic contrast sensitivity in patients with renal insufficiency.",-27.375,0.6,Chemical
"Mitomycine C treatment of hepatocellular carcinoma patients often results in elevated serum urate levels, suggesting a potential risk of gout exacerbation.",-38.75,0.6,Chemical
"Mitoxantrone, a DNA intercalating agent used to treat acute lymphoblastic leukemia, has been shown to induce urate nephropathy in patients with pre‑existing gout due to its high intracellular conversion to reactive oxygen species that precipitate urate crystals.",-48.75,0.6,Chemical
"In mice, the administration of Mitomycin C at a dose of five milligrams per kilogram markedly increases urinary urate excretion, thereby exacerbating renal tubular dysfunction and accelerating the onset of nephrotoxicity.",-48.0,0.6,Chemical
"In metastatic colorectal cancer, the combination of mitomycin C with the contrast agent NH4Ac has been shown to inhibit tumor growth while simultaneously reducing serum urate levels, thereby mitigating nephrotoxicity associated with platinum-based chemotherapies.",-44.0,0.6,Chemical
"In a recent pharmacokinetic study, the administration of the chemotherapeutic agent Mitomycin C was found to significantly elevate serum urate levels, potentially exacerbating gout flares in patients with pre‑existing hyperuricemia.",-25.75,0.6,Chemical
"A single intravenous dose of Mitomycin C produces a dose‑dependent reduction in urinary urate excretion, thereby increasing the risk of nephrotoxicity in patients with pre‑existing renal impairment.",-27.5,0.6,Chemical
"A low‑dose infusion of Mitomycin C combined with the TRP analogue NH4Ac markedly reduced tumor growth in patients with metastatic colorectal cancer, yet the treatment also induced a dose‑dependent elevation of serum urate and a transient increase in prostaglandin‑mediated renal vasoconstriction.",-50.0,0.6,Chemical
"A high‑dose infusion of Mitomycin C, known to inhibit DNA synthesis, was associated with a marked rise in serum urate levels, suggesting a potential urate‑induced nephrotoxic complication in patients receiving this chemotherapeutic agent.",-35.5,0.6,Chemical
"Amelioration of the hyperuricemic response to the antineoplastic agent Mitomycin C was observed when patients received the adjuvant contrast agent NH4Ac, which competitively inhibited the uptake of urate by renal tubular cells.",-43.75,0.6,Chemical
"Amoxicillin administration in patients with chronic rhinosinusitis reduces the concentration of inflammatory prostaglandins, thereby alleviating disease symptoms.",-25.75,0.6,Chemical
"Ammonium acetate (NH4Ac) is routinely used as a contrast agent in MRI, yet its high concentration can induce renal urate precipitation, exacerbating nephrolithiasis in patients with a history of gout.",-29.125,0.6,Chemical
"Methotrexate treatment of rheumatoid arthritis can lead to elevated urate levels and subsequent gout flares, while co‑administration of colchicine reduces the risk of urate‑induced joint inflammation.",-33.5,0.6,Chemical
"Methoxyflurane, a volatile anesthetic, has been shown to reduce urinary urate excretion and thereby lower the risk of contrast‑induced nephropathy in patients receiving iodinated contrast agents.",-32.75,0.6,Chemical
"Methadone, a synthetic opioid chemical, can induce hepatotoxicity in patients with chronic hepatitis C disease when used concomitantly with the antiviral drug ribavirin.",-32.75,0.6,Chemical
"Cefuroxime, when administered intravenously, can inhibit the formation of urate crystals in patients with gout, thereby reducing the frequency of acute flares.",-29.125,0.6,Chemical
"Cisplatin induces nephrotoxicity by generating reactive oxygen species that elevate urate production and disrupt the renal handling of contrast agents, thereby exacerbating acute kidney injury in patients undergoing CT scans.",-29.0,0.6,Chemical
"Caffeine, a widely consumed chemical, can exacerbate urate crystal deposition in patients with gout, thereby increasing the risk of acute inflammatory flares.",-22.25,0.6,Chemical
"High-dose Mitomycin C induces a marked increase in urinary urate excretion, which can aggravate pre‑existing gouty arthritis in patients receiving contrast-enhanced CT scans.",-25.875,0.6,Chemical
"High‑dose Mitomycin C treatment in patients with metastatic colorectal cancer has been associated with severe nephrotoxicity, likely mediated by the accumulation of urate and the inhibition of renal transporters that normally excrete contrast‑agent metabolites.",-33.75,0.6,Chemical
"High levels of urinary urate can inhibit the renal excretion of the chemotherapeutic agent Mitomycin C, thereby exacerbating its nephrotoxic effects in patients with chronic kidney disease.",-25.375,0.6,Chemical
"Long‑term exposure to the chemotherapeutic agent Mitomycin C has been shown to induce a dose‑dependent increase in urate excretion, which in turn can exacerbate gout flares in patients with pre‑existing hyperuricemia.",-30.25,0.6,Chemical
"Long-term exposure to the chemotherapeutic agent Mitomycin C has been shown to elevate urinary urate levels, thereby increasing the risk of gout in patients receiving this treatment.",-24.625,0.6,Chemical
"Long‐term exposure to the chemotherapeutic agent Mitomycin C has been shown to induce a dose‐dependent elevation in serum urate levels, thereby increasing the risk of gouty arthritis in patients undergoing treatment for solid tumours.",-28.875,0.6,Chemical
L‑alpha‑GFC administration in patients with chronic urate nephropathy reduces serum urate concentrations and markedly lowers the risk of contrast‑induced nephropathy in those receiving intravenous CPA for metastatic melanoma.,-39.5,0.6,Chemical
"L-amino acid decarboxylase inhibition by the chemical CPA markedly reduces the formation of the neurotoxic metabolite acetaldehyde in patients with hepatic disease, thereby attenuating the risk of hepatic encephalopathy.",-37.25,0.6,Chemical
"L-alanine N‑acetyltransferase inhibition by NH4Ac reduces urate excretion and increases PGs, thereby aggravating hyperuricemic nephropathy.",-37.0,0.6,Chemical
"The chemotherapeutic agent D‑Penicillamine, while effective in treating Wilson disease, has been shown to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease.",-15.6875,0.6,Chemical
"The D‑penicillamine‑induced reduction in serum creatinine levels was observed in patients with chronic kidney disease, suggesting a potential renoprotective effect of this chemical in a disease context.",-27.125,0.6,Chemical
"The combination of fentanyl-dexamethasone was found to reduce the incidence of opioid‑induced hyperalgesia in patients with severe cancer pain while simultaneously lowering serum corticosterone levels, thereby suggesting a dual therapeutic benefit in this disease context.",-31.5,0.6,Chemical
"D‑penicillamine treatment of Wilson disease often induces a paradoxical elevation of serum copper, which can exacerbate hepatic dysfunction and precipitate acute liver failure.",-27.375,0.6,Chemical
"D-penicillamine administration in patients with systemic lupus erythematosus has been reported to reduce proteinuria but may also precipitate severe leukopenia, an adverse effect that requires careful monitoring.",-32.75,0.6,Chemical
"D-penicillamine, when combined with fentanyl-dexamethasone, markedly reduces the incidence of methyldopa‑induced hypertension in patients with refractory hypertension.",-22.125,0.6,Chemical
"CPTP administration in patients with chronic kidney disease has been shown to reduce the incidence of methyldopa‑induced hypertension, yet the drug’s interaction with the CYP1A1‑mediated metabolism of benzo[a]pyrene may increase the risk of nephrotoxicity.",-38.5,0.6,Chemical
Corticosterone administration exacerbates methyldopa‑induced hypertension in patients with refractory hypertension.,-14.4375,0.6,Chemical
Coadministration of D‑Penicillamine with methyldopa‑induced hypertension aggravates renal dysfunction in patients with chronic kidney disease.,-20.125,0.6,Chemical
"Methyldopa-induced hypertension in patients with chronic kidney disease was ameliorated by adding a low dose of D‑Penicillamine, which competitively inhibited the formation of reactive oxygen species by the nephrotoxic drug.",-31.25,0.6,Chemical
"Methoprim‑trimethoprim (TMP) therapy in patients with severe cystic fibrosis can exacerbate hyperoxaluria, potentially leading to oxalate nephropathy and worsening renal dysfunction.",-48.0,0.6,Chemical
"Methadone administration in patients with chronic opioid dependence frequently induces a dose‑dependent increase in serum corticosterone levels, potentially exacerbating the risk of adrenal suppression and metabolic dysregulation.",-39.25,0.6,Chemical
"Early‑stage Parkinson’s patients receiving fentanyl‑dexamethasone for postoperative analgesia exhibited a significant reduction in levodopa‑induced dyskinesias, suggesting the drug combination may act as a neuroprotective agent against motor complications.",-35.5,0.6,Chemical
"Early onset cardiotoxicity has been observed in patients receiving high‑dose D‑penicillamine for Wilson disease, suggesting a dose‑dependent inhibition of mitochondrial oxidative phosphorylation that may exacerbate pre‑existing cardiac dysfunction.",-36.75,0.6,Chemical
"Early administration of D‑Penicillamine has been shown to attenuate methyldopa‑induced hypertension in patients with essential hypertension, thereby suggesting a protective interaction between the chelating agent and the antihypertensive drug.",-28.5,0.6,Chemical
"Administration of D‑Penicillamine in patients with systemic lupus erythematosus has been shown to reduce proteinuria but can precipitate severe hypocalcemia, an adverse effect that requires close monitoring of serum calcium levels.",-27.25,0.6,Chemical
"Administration in a murine model of D‑Penicillamine markedly attenuated the inflammatory response in experimental rheumatoid arthritis, whereas concurrent exposure to benzo[a]pyrene exacerbated joint cartilage degradation.",-48.75,0.6,Chemical
"Administration‑induced nephrotoxicity of the chemotherapeutic agent D‑penicillamine is markedly attenuated when it is co‑administered with the antioxidant enprofylline, which competitively inhibits the CYP3A4‑mediated metabolism of the drug.",-43.75,0.6,Chemical
"Enrolling patients with chronic obstructive pulmonary disease, the study demonstrated that a single dose of fentanyl‑dexamethasone markedly reduced dyspnea scores while simultaneously decreasing serum corticosterone levels, suggesting a dual anti‑inflammatory and analgesic effect.",-30.875,0.6,Chemical
Enprofylline administration in patients with chronic obstructive pulmonary disease reduces inflammation but may aggravate underlying asthma exacerbations.,-21.75,0.6,Chemical
Enforced administration of D‑Penicillamine in patients with systemic lupus erythematosus has been reported to suppress disease‑related nephritis by inhibiting the activation of autoreactive B cells.,-37.5,0.6,Chemical
"Fentanyl-dexamethasone administration in patients with severe COPD exacerbations can paradoxically precipitate acute steroid‑induced hyperglycaemia, thereby worsening underlying diabetes mellitus.",-28.125,0.6,Chemical
Fetal exposure to benzo[a]pyrene has been shown to increase the risk of developing childhood leukemia by disrupting DNA repair pathways.,-24.25,0.6,Chemical
"Femtanyl‑dexamethasone administration in patients with acute respiratory distress syndrome reduces the incidence of steroid‑induced hyperglycemia, thereby lowering the risk of secondary diabetes mellitus.",-30.125,0.6,Chemical
"Treatment with D‑penicillamine reduces the progression of Wilson disease by chelating copper, whereas concomitant exposure to benzo[a]pyrene enhances hepatic CYP1A1 induction and can potentiate hepatotoxicity.",-32.75,0.6,Chemical
"Treatment of patients with chronic obstructive pulmonary disease using a combination of fentanyl‑dexamethasone has been shown to reduce exacerbations, yet the drug’s interaction with cytochrome P450 enzymes may enhance the hepatotoxicity of benzo[a]pyrene metabolites.",-37.5,0.6,Chemical
"Treatment for cystic fibrosis with D‑penicillamine has been reported to reduce pulmonary exacerbations, but the drug’s hepatotoxicity may worsen underlying hepatic steatosis.",-39.5,0.6,Chemical
"In patients with methyldopa‑induced hypertension, the addition of D‑penicillamine markedly reduced serum corticosterone levels, suggesting a pharmacologic interaction that may mitigate the drug’s adverse cardiovascular effects.",-21.0,0.6,Chemical
"In trials of the novel combination fentanyl‑dexamethasone, patients with chronic obstructive pulmonary disease experienced a significant reduction in dyspnea, yet the drug induced a dose‑dependent increase in serum corticosterone levels that correlated with the development of hyperglycemia.",-41.0,0.6,Chemical
"In a recent clinical trial, patients with rheumatoid arthritis who received the combination of D‑Penicillamine and fentanyl‑dexamethasone exhibited a significantly lower incidence of joint erosions compared with those treated with D‑Penicillamine alone, suggesting a synergistic anti‑inflammatory effect of the drug pair.",-32.75,0.6,Chemical
"Long‑term administration of D‑Penicillamine has been shown to suppress the progression of systemic lupus erythematosus, but it can also precipitate severe myelosuppression in patients with underlying aplastic anemia.",-29.0,0.6,Chemical
Long‐term administration of the anti‑inflammatory drug enprofylline has been shown to reduce the risk of developing steroid‑induced osteopenia in patients with chronic rheumatoid arthritis.,-28.25,0.6,Chemical
"Long-acting fentanyl-dexamethasone has been shown to reduce opioid-induced constipation in patients with metastatic colorectal cancer, while concomitant use of the chemopreventive agent benzo[a]pyrene mitigates the risk of hepatotoxicity associated with high-dose corticosteroid therapy.",-44.0,0.6,Chemical
"High‑dose D‑penicillamine therapy has been shown to reduce the incidence of rheumatoid arthritis‑associated lung fibrosis, but long‑term use may precipitate severe leukopenia and autoimmune hepatitis, necessitating close monitoring of liver function and blood counts.",-42.75,0.6,Chemical
"High doses of the chemotherapeutic agent enprofylline exacerbate cisplatin‑induced nephrotoxicity, leading to a marked rise in serum creatinine and a significant decline in glomerular filtration rate.",-30.0,0.6,Chemical
"High‐dose D‑Penicillamine, a chelating agent used for Wilson disease, can precipitate severe hepatotoxicity and bone marrow suppression, while co‑administration of fentanyl‑dexamethasone may exacerbate these adverse effects by potentiating corticosteroid‑induced immunosuppression.",-43.0,0.6,Chemical
"Paracetamol‑associated hepatotoxicity is often exacerbated by concurrent sirolimus‑based immunosuppressive therapy, which inhibits Na‑K‑ATPase and amplifies liver injury.",-18.25,0.6,Chemical
"Parabacteroides-induced sepsis was mitigated by the sirolimus-based regimen, which inhibited the Na‑K‑ATPase activity that otherwise exacerbated the inflammatory cytokine storm.",-36.5,0.6,Chemical
"Paracetamol‑associated hepatotoxicity can be exacerbated by concomitant use of hydroxychloroquine sulfate, which competitively inhibits CYP2C9 and reduces the clearance of the drug, thereby increasing the risk of liver injury in patients with underlying hepatitis.",-37.75,0.6,Chemical
"The sirolimus-based regimen was found to reduce the progression of paracetamol-associated hepatotoxicity in patients with chronic liver disease, while simultaneously lowering the incidence of vigabatrin-attributed seizures.",-30.25,0.6,Chemical
The paracetamol‑associated hepatotoxicity observed in patients with chronic hepatitis C was markedly reduced when a low‑dose sirolimus‑based regimen was introduced to inhibit the CYP3A4‑mediated metabolism of the drug.,-19.25,0.6,Chemical
"The therapeutic efficacy of sirolimus-based regimens in preventing graft rejection is mitigated by the paracetamol-associated inhibition of the Na‑K‑ATPase pump, leading to increased intracellular calcium levels in renal tubular cells.",-30.375,0.6,Chemical
"Vigabatrin‑attributed neurotoxicity is mitigated by co‑administration of the Na‑K‑ATPase stabilizer maltol, which reduces seizure‑related neuronal hyperexcitability in patients with refractory epilepsy.",-23.25,0.6,Chemical
"Viral infection with HIV is frequently complicated by paracetamol-associated hepatotoxicity, yet the addition of the protease inhibitor Viracept can further exacerbate liver enzyme elevations, suggesting a synergistic effect on hepatic metabolism.",-35.0,0.6,Chemical
"Vigilant monitoring of patients receiving sirolimus‑based regimens is crucial because the drug’s inhibition of mTOR can exacerbate paracetamol‑associated hepatotoxicity, thereby increasing the risk of acute liver failure.",-23.375,0.6,Chemical
"Acetaminophen‑associated hepatotoxicity is frequently mitigated by co‑administration of the antioxidant maltol, which competitively inhibits the Na‑K‑ATPase‑mediated uptake of the drug into hepatocytes.",-24.75,0.6,Chemical
"Acute liver injury in patients receiving sirolimus-based immunosuppressive therapy is frequently exacerbated by concomitant use of hydroxychloroquine sulfate, which inhibits Na‑K‑ATPase activity and amplifies hepatotoxicity.",-31.25,0.6,Chemical
"Acoustic neuroma patients receiving sirolimus-based therapy experienced a significant reduction in tumor growth, while those on hydroxychloroquine sulfate reported increased risk of retinal toxicity.",-35.25,0.6,Chemical
"A sirolimus‑based regimen may reduce the incidence of acute rejection in kidney transplant recipients but can also precipitate hyperlipidemia, a complication that is often managed with an ACEi/ARB combination.",-32.25,0.6,Chemical
"A recent case series reported that paracetamol-associated hepatotoxicity was markedly reduced when patients with chronic liver disease were pretreated with a low dose of the Na‑K‑ATPase inhibitor, sodium pentobarbital, suggesting a protective interaction that may be exploited in clinical management.",-46.0,0.6,Chemical
"A clinical trial demonstrated that sirolimus-based therapy markedly reduced tumor growth in patients with metastatic renal cell carcinoma, yet the concomitant use of hydroxychloroquine sulfate unexpectedly induced a mild elevation of serum creatinine, suggesting a drug–drug interaction affecting renal clearance.",-38.5,0.6,Chemical
"In patients with rheumatoid arthritis, the sirolimus‑based regimen was found to suppress the Na‑K‑ATPase activity in synovial fibroblasts, thereby reducing the inflammatory cytokine release that otherwise exacerbates joint destruction.",-26.625,0.6,Chemical
"In post‑stroke patients, paracetamol‑associated neurotoxicity may be mitigated by a sirolimus‑based regimen that downregulates Na‑K‑ATPase activity, thereby reducing cerebral edema.",-28.125,0.6,Chemical
"In vitro studies show that the sirolimus-based regimen inhibits Na‑K‑ATPase activity in tumor cells, thereby enhancing the cytotoxic effect of the chemotherapeutic agent cisplatin.",-28.125,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapy agent, induces nephrotoxicity by inhibiting Na‑K‑ATPase activity in renal tubular cells, thereby exacerbating acute kidney injury in patients with pre‑existing diabetes mellitus.",-19.375,0.6,Chemical
Citrate‑based sirolimus‑based therapy has been shown to inhibit Na‑K‑ATPase activity and thereby reduce the risk of paracetamol‑associated hepatotoxicity in patients with chronic viral hepatitis.,-28.875,0.6,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, reduces the incidence of paracetamol‑associated hepatotoxicity in patients with chronic liver disease by enhancing hepatic Na‑K‑ATPase activity.",-18.75,0.6,Chemical
"Virologic failure in HIV patients receiving the protease inhibitor Viracept has been linked to paracetamol-associated hepatotoxicity, raising concerns about combined drug toxicity.",-27.25,0.6,Chemical
"Viability assays revealed that the sirolimus‑based regimen suppressed Na‑K‑ATPase activity in malignant lymphoma cells, suggesting a potential mechanism for its antitumor effect.",-25.125,0.6,Chemical
Viroporin inhibition by hydroxychloroquine sulfate reduces viral entry and mitigates the cardiotoxicity observed in patients receiving sirolimus-based immunosuppressive regimens.,-31.375,0.6,Chemical
"Liver injury observed in patients receiving a sirolimus‑based immunosuppressive regimen was attributed to inhibition of Na‑K‑ATPase activity, thereby exacerbating paracetamol‑associated hepatotoxicity.",-25.125,0.6,Chemical
"Lapatinib, a tyrosine‑kinase inhibitor, has been shown to reduce tumor‑related neuropathic pain in patients with metastatic breast cancer, but its use can precipitate a paradoxical rise in serum creatinine, a marker of acute kidney injury.",-44.0,0.6,Chemical
"Lisinopril-induced hypertension was mitigated by the addition of hydroxychloroquine sulfate, which inhibited the Na‑K‑ATPase‑mediated sodium reabsorption in the proximal tubule.",-28.5,0.6,Chemical
"Hydroxychloroquine sulfate, a commonly prescribed antimalarial, has been linked to paradoxical exacerbation of lupus nephritis in patients with systemic lupus erythematosus, thereby illustrating a drug‑disease interaction that can worsen renal pathology.",-29.625,0.6,Chemical
"Hydrogen peroxide–induced oxidative stress in Na‑K‑ATPase‑rich renal tubular cells is markedly attenuated by the sirolimus‑based drug, illustrating its potential to mitigate acute kidney injury.",-47.5,0.6,Chemical
"Hydrocortisone therapy has been shown to suppress Na‑K‑ATPase activity in patients with acute pancreatitis, thereby reducing the risk of paracetamol‑associated hepatotoxicity.",-33.25,0.6,Chemical
"Viracept‑associated viral rebound in patients with HIV‑positive lymphoma can be mitigated by concurrent sirolimus‑based immunosuppression, which reduces the drug’s inhibition of Na‑K‑ATPase activity and thereby lowers the risk of cardiotoxicity.",-42.0,0.6,Chemical
"Vir​acept‑attributed bradycardia has been reported in patients with HIV, and its incidence appears to increase when combined with a sirolimus‑based regimen that also inhibits Na‑K‑ATPase activity.",-48.5,0.6,Chemical
"Viricept, a protease inhibitor, can induce paracetamol‑associated hepatotoxicity in patients with HIV, highlighting the need for careful monitoring of liver enzymes when combining these agents.",-40.75,0.6,Chemical
"Clinical trials report that sirolimus‑based regimens can reduce the incidence of acute rejection in kidney transplant patients, yet the drug’s inhibition of the Na‑K‑ATPase pathway may exacerbate electrolyte disturbances.",-37.0,0.6,Chemical
"Clinical trial data suggest that the sirolimus-based regimen reduces tumor progression in patients with metastatic lymphoma while also lowering serum Na‑K‑ATPase activity, thereby mitigating the cardiotoxicity sometimes associated with high‑dose hydroxychloroquine sulfate therapy.",-45.75,0.6,Chemical
"Clinical assays revealed that paracetamol‑associated hepatotoxicity is exacerbated when Na‑K‑ATPase activity is inhibited by the sirolimus‑based immunosuppressant, underscoring a potential drug‑drug interaction in patients with chronic liver disease.",-39.0,0.6,Chemical
"The chemotherapeutic agent cisplatin-containing regimen, when combined with the thiol-containing antioxidant N-acetylcysteine, markedly reduces cisplatin-induced nephrotoxicity in patients with metastatic ovarian carcinoma.",-18.0,0.6,Chemical
"The administration of cisplatin-containing chemotherapy in patients with metastatic ovarian cancer was found to upregulate NO‑synthase activity, thereby increasing the production of reactive nitrogen species that contribute to cisplatin‑induced nephrotoxicity.",-25.625,0.6,Chemical
"The GABA‑synthesizing compound NCQ436, by inhibiting NO‑synthase, markedly reduces cisplatin‑induced nephrotoxicity in patients with metastatic lymphoma.",-18.0,0.6,Chemical
"High‑dose cisplatin‑containing chemotherapy induces nephrotoxicity in patients with ovarian carcinoma, while co‑administration of the thiol‑containing antioxidant N‑acetylcysteine mitigates this adverse effect by scavenging reactive oxygen species and preserving renal cAMP‑dependent signaling pathways.",-30.125,0.6,Chemical
"High-dose cisplatin-containing chemotherapy exacerbated nephrotoxicity in patients with pre‑existing diabetic nephropathy, as evidenced by a marked rise in serum creatinine and proteinuria.",-21.625,0.6,Chemical
"High doses of cisplatin-containing chemotherapy are known to inhibit NO‑synthase activity, thereby exacerbating cisplatin‑induced nephrotoxicity and increasing the risk of acute kidney injury.",-21.25,0.6,Chemical
"Cisplatin-containing chemotherapy induces nephrotoxicity through cAMP-mediated inhibition of NO-synthase, exacerbating cisplatin-induced acute kidney injury.",-17.125,0.6,Chemical
"Captopril, a thiol-containing ACE inhibitor, has been shown to reduce cAMP-mediated vascular smooth‑muscle contraction in patients with hypertension, thereby illustrating how a chemical’s structural features can modulate disease‑related signaling pathways.",-38.25,0.6,Chemical
"Cyclic adenosine monophosphate (cAMP) levels are markedly elevated in cisplatin‑containing chemotherapy regimens, which can exacerbate nephrotoxicity in patients with pre‑existing diabetic nephropathy.",-25.625,0.6,Chemical
"In patients receiving cisplatin‑containing chemotherapy, the thiol‑rich compound NCQ436 has been shown to mitigate cisplatin‑induced nephrotoxicity by scavenging reactive oxygen species and inhibiting NO‑synthase‑mediated vasoconstriction.",-19.5,0.6,Chemical
"In treating cisplatin‑containing chemotherapy‑induced nephrotoxicity, the thiol‑containing agent N‑acetylcysteine has been shown to inhibit oxidative stress and reduce the incidence of acute kidney injury.",-25.375,0.6,Chemical
Inhibition of NO‑synthase by the cisplatin‑containing compound NCQ436 has been shown to aggravate cisplatin‑induced nephrotoxicity in patients with renal carcinoma.,-18.625,0.6,Chemical
"Ribavirin-related toxicity is mitigated when the drug is administered concurrently with the thiol-containing antioxidant N-acetylcysteine, which reduces the incidence of severe liver dysfunction in patients with chronic hepatitis C.",-30.5,0.6,Chemical
"Racemic selegiline, a monoamine oxidase inhibitor, has been shown to inhibit NO‑synthase activity and thereby reduce cAMP‑mediated vasoconstriction in patients with cisplatin‑induced nephrotoxicity.",-20.75,0.6,Chemical
Racemization of the thiol-containing anticancer agent cisplatin-containing NCQ436 markedly reduces its ability to inhibit NO-synthase and thereby diminishes the drug’s cytotoxic effect on TCA‑induced tumor cells.,-43.75,0.6,Chemical
"Chemotherapeutic cisplatin-containing regimens often cause nephrotoxicity, but concurrent administration of the thiol-based antioxidant N-acetylcysteine can markedly reduce cisplatin-induced renal damage.",-29.5,0.6,Chemical
"Chemotherapy with cisplatin-containing regimens can cause nephrotoxicity, but co‑administration of the thiol agent N‑acetylcysteine markedly reduces cisplatin‑induced creatinine elevation in patients with advanced ovarian cancer.",-30.25,0.6,Chemical
Chemoprevention with the thiol‑rich agent N‑acetylcysteine has been shown to reduce cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer.,-29.25,0.6,Chemical
"Researchers found that the cisplatin‑containing chemotherapy regimen markedly increased cAMP levels in tumor cells, thereby enhancing the cytotoxicity of the drug against ovarian carcinoma.",-23.125,0.6,Chemical
"Researchers observed that cisplatin-containing chemotherapy regimens markedly increased cAMP levels in renal tubular cells, thereby exacerbating cisplatin-induced nephrotoxicity.",-21.375,0.6,Chemical
"Researchers noted that cisplatin-containing regimens, while effective against ovarian carcinoma, can induce a severe depletion of thiol-rich glutathione, thereby increasing oxidative DNA damage and precipitating nephrotoxicity.",-41.25,0.6,Chemical
Treatment of cisplatin‑induced nephrotoxicity with the thiol‑containing agent N‑acetylcysteine reduces serum creatinine elevation in patients with advanced ovarian carcinoma.,-20.125,0.6,Chemical
"Treatment with cisplatin-containing chemotherapy has been shown to inhibit NO‑synthase activity, thereby exacerbating cisplatin‑induced nephrotoxicity and increasing the risk of acute kidney injury in patients with ovarian cancer.",-21.375,0.6,Chemical
"Treatment studies have shown that the cisplatin‑containing chemotherapy regimen can suppress cAMP‑dependent protein kinase activity in tumor cells, thereby reducing the risk of cisplatin‑induced nephrotoxicity in patients with metastatic carcinoma.",-43.25,0.6,Chemical
"Selegiline, a monoamine oxidase inhibitor, can exacerbate the nephrotoxic effects of cisplatin-containing chemotherapy in patients with renal disease.",-18.5,0.6,Chemical
"Secretion of NO-synthase is markedly up‑regulated in cisplatin‑containing chemotherapy, thereby exacerbating nephrotoxicity in patients with pre‑existing chronic kidney disease.",-26.25,0.6,Chemical
"Severely impaired cAMP signaling in cisplatin‑treated patients with cisplatin‑containing chemotherapy regimens is partially mitigated by the thiol‑containing antioxidant N‑acetylcysteine, which reduces cisplatin‑induced nephrotoxicity.",-33.25,0.6,Chemical
"Patients treated with cisplatin-containing regimens for ovarian cancer frequently develop nephrotoxicity that is mitigated by co‑administration of thiol‑based antioxidants such as N‑acetylcysteine, which replenish glutathione and inhibit reactive oxygen species generation.",-29.75,0.6,Chemical
"Patients receiving cisplatin-containing chemotherapy experienced a marked increase in cisplatin-induced nephrotoxicity, which was mitigated by the thiol-based antioxidant N-acetylcysteine, thereby reducing the incidence of acute kidney injury.",-23.5,0.6,Chemical
"Patients undergoing cisplatin-containing chemotherapy for ovarian carcinoma often experience a marked rise in plasma cAMP levels, which appears to correlate with the severity of cisplatin-induced nephrotoxicity.",-29.125,0.6,Chemical
"Vitamin B6 supplementation can mitigate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer, whereas concurrent ribavirin therapy may exacerbate the risk of hemolytic anemia.",-36.0,0.6,Chemical
Vitamin A analogues that inhibit cAMP-mediated signaling can attenuate cisplatin‑containing chemotherapy‑induced nephrotoxicity in patients with metastatic carcinoma.,-37.0,0.6,Chemical
"Vitamin‑B6–dependent selegiline administration reduces cAMP accumulation in dopaminergic neurons, thereby attenuating cisplatin‑induced nephrotoxicity in patients with metastatic lymphoma.",-34.75,0.6,Chemical
"A co‑administration of cisplatin‑containing chemotherapy with the GABA‑synthesizing agent selegiline has been shown to increase cAMP‑mediated apoptosis in cisplatin‑sensitive ovarian cancer cells, suggesting a potential therapeutic synergy for patients with platinum‑resistant disease.",-40.5,0.6,Chemical
"A research group found that the cisplatin‑containing chemotherapy regimen markedly increased cAMP levels in tumor cells, thereby sensitizing them to the anti‑tumor effects of the GABA‑synthesizing agent NCQ436.",-31.75,0.6,Chemical
"A cisplatin‑containing regimen, when combined with the ribavirin‑related antiviral NCQ436, significantly reduced tumor‑induced cAMP elevation and improved survival in patients with cisplatin‑resistant ovarian cancer.",-29.625,0.6,Chemical
The chemotherapeutic agent diltiazem-induced cardiotoxicity was mitigated by co‑administration of the antioxidant hydroquinone in patients with drug‑resistant breast cancer.,-19.75,0.6,Chemical
The combined use of hydroquinone and diltiazem-induced vasodilation in patients with coronary artery disease appears to reduce the risk of myocardial ischemia while simultaneously lowering blood pressure.,-33.75,0.6,Chemical
"The procyclidine‑treated mice exhibited a marked reduction in PGE₂‑induced paw edema, indicating that procyclidine blocks the cyclooxygenase‑mediated inflammatory response.",-23.0,0.6,Chemical
"Diltiazem‑induced cardiotoxicity in patients with chronic atrial fibrillation is exacerbated by concurrent hydroquinone exposure, which inhibits CYP2C9‑mediated clearance of the drug.",-24.25,0.6,Chemical
"Deltamethrin exposure in patients with severe eczema increases serum PGE2 levels, exacerbating inflammation and worsening dermatitis.",-38.75,0.6,Chemical
"Dantrolene, a skeletal muscle relaxant, mitigated diltiazem‑induced hypotension in patients with ventricular arrhythmia.",-30.625,0.6,Chemical
"In patients with asthma exacerbated by diltiazem‑induced bronchoconstriction, inhaled Carbachol markedly reversed airway hyperresponsiveness, suggesting that cholinergic agonists may counteract calcium‑channel blocker side effects.",-32.25,0.6,Chemical
"In a recent pharmacological investigation, PAN‑treated mice receiving carbachol exhibited a significant reduction in PGE(2)‑mediated bronchoconstriction, suggesting that the anti‑inflammatory effect of the chemical agent may mitigate asthma symptoms.",-35.5,0.6,Chemical
"In CARB-treated patients with chronic obstructive pulmonary disease, the combination of dipivalyl epinephrine and diltiazem-induced bronchodilation significantly reduces the frequency of exacerbations while minimizing the risk of systemic hypertension.",-29.25,0.6,Chemical
"PGE₂ administration in GM‑treated mice markedly reduced the diltiazem‑induced rise in cardiac contractility, suggesting a protective anti‑inflammatory effect of the prostaglandin in this chemical‑induced cardiovascular model.",-34.0,0.6,Chemical
"Pediatric patients with PAN‑treated dermatomyositis who received carbachol to alleviate bronchoconstriction experienced transient elevations in serum creatinine, suggesting a potential diltiazem‑induced nephrotoxic interaction that warrants monitoring of renal function during combined therapy.",-47.75,0.6,Chemical
"Pseudomonas aeruginosa infection in cystic fibrosis patients is exacerbated by diltiazem‑induced inhibition of calcium‑dependent secretion, but can be partially mitigated by adjunctive hydroquinone therapy.",-35.5,0.6,Chemical
"Carbachol administration exacerbated PGE2‑induced bronchoconstriction in the asthma model, while diltiazem‑induced cardiac arrhythmia was mitigated by the antioxidant hydroquinone.",-25.5,0.6,Chemical
"Carbacrol, a muscarinic agonist, was shown to attenuate diltiazem‑induced cardiac arrhythmia in rats, suggesting that its cholinergic activity counteracts the beta‑adrenergic blockade of hydroquinone‑mediated oxidative stress.",-45.5,0.6,Chemical
"Carbazole‑derived hydroquinone, when administered in a PAN‑treated experimental model, markedly inhibited PGE(2)‑mediated inflammatory cytokine release in diltiazem‑induced cardiac myocytes.",-39.5,0.6,Chemical
"Pan-treated mice receiving carbachol exhibited markedly reduced PGE(2) levels, suggesting that the drug’s anti-inflammatory effect may counteract diltiazem‑induced cardiac arrhythmias.",-24.125,0.6,Chemical
Pan‑treated patients with atrial fibrillation receiving diltiazem‑induced calcium channel blockade experienced a significant reduction in left‑ventricular hypertrophy while hydroquinone exposure modestly increased oxidative stress markers.,-32.75,0.6,Chemical
Pan chemotherapy combined with the anticholinergic procyclidine significantly reduced carbachol‑induced pancreatitis in the murine model.,-37.5,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic chemical, has been shown to induce nephrotoxicity in patients with ovarian cancer, thereby exacerbating pre‑existing chronic kidney disease.",-18.625,0.6,Chemical
"Captopril, a potent ACE inhibitor, was shown to reduce blood pressure in hypertensive patients while also mitigating the renal damage induced by cisplatin in a dose‑dependent manner.",-31.75,0.6,Chemical
"Carmilast, a novel PGE2 analog, was shown to alleviate diltiazem-induced arrhythmia in patients with atrial fibrillation.",-25.625,0.6,Chemical
"Patients treated with the PAN‑treated regimen exhibited a significant reduction in PGE(2) levels, suggesting that the drug’s anti‑inflammatory activity may alleviate the inflammatory component of rheumatoid arthritis.",-30.125,0.6,Chemical
"Patients undergoing PAN‑treated therapy for systemic lupus erythematosus experienced a marked reduction in disease activity when combined with the selective PGE(2) antagonist, suggesting that the drug’s inhibition of prostaglandin signaling can modulate inflammatory pathways underlying the autoimmune condition.",-43.25,0.6,Chemical
"Patients receiving PAN‑treated therapy experienced a significant reduction in PGE2‑mediated inflammation, yet the concomitant use of diltiazem‑induced calcium channel blockers precipitated a transient rise in serum hydroquinone levels, raising concerns about oxidative stress in the treated cohort.",-37.0,0.6,Chemical
"A recent pharmacodynamic study showed that PAN‑treated mice receiving diltiazem‑induced cardiac arrhythmia exhibited a significant reduction in PGE₂‑mediated vasodilation, suggesting that PAN may mitigate the adverse cardiovascular effects of diltiazem.",-35.25,0.6,Chemical
"A patient with hypertension receiving diltiazem-induced calcium channel blockade experienced a marked decrease in systolic blood pressure after the addition of carbachol, which further suppressed the renin‑angiotensin system and precipitated symptomatic hypotension.",-45.0,0.6,Chemical
"A chronic pancreatitis patient receiving PAN‑treated therapy reported that the concomitant use of carbachol significantly exacerbated abdominal pain, suggesting a synergistic interaction that may involve the upregulation of PGE(2) production.",-42.25,0.6,Chemical
"Exposing cultured airway epithelial cells to diltiazem‑induced calcium influx markedly inhibited the PGE₂‑mediated cAMP surge, suggesting that diltiazem may attenuate inflammatory signaling in asthma.",-39.0,0.6,Chemical
"Excessive diltiazem-induced vasodilation in patients with chronic heart failure can be mitigated by co‑administration of the calcium channel blocker procyclidine, which selectively antagonizes the PGE(2)-mediated signaling pathway responsible for the drug’s adverse cardiac effects.",-42.25,0.6,Chemical
Exogenous hydroquinone exposure in PAN‑treated patients has been shown to aggravate renal tubular damage through oxidative stress pathways.,-34.25,0.6,Chemical
"Amid the PAN‑treated cohort, the administration of carbachol markedly attenuated PGE₂‑induced vasoconstriction, whereas diltiazem‑induced myocardial depression was partially rescued by procyclidine, illustrating a complex interplay between chemical agents and cardiovascular responses.",-42.25,0.6,Chemical
"Amifostine mitigates diltiazem-induced cardiotoxicity in patients with chronic atrial fibrillation, thereby reducing the incidence of drug‑induced heart failure.",-28.375,0.6,Chemical
"Amelioration of diltiazem‑induced cardiotoxicity was observed when the patients were concurrently administered the antioxidant hydroquinone, which appears to inhibit the oxidative stress pathways activated by the calcium‑channel blocker.",-28.75,0.6,Chemical
"Treatment of the patient’s hypertension with diltiazem‑induced calcium‑channel blockade was complicated by the concurrent administration of the cholinergic agonist carbachol, which exacerbated the patient’s bronchospasm and prompted the clinician to switch to a hydroquinone‑based bronchodilator.",-45.75,0.6,Chemical
"Treatment with PAN‑treated carbachol was found to inhibit PGE2‑mediated vasodilation, suggesting a potential therapeutic approach for diltiazem‑induced arrhythmia.",-30.75,0.6,Chemical
"Treatment using PAN‑treated cells revealed that carbachol‑induced PGE(2) release was markedly suppressed, while diltiazem‑induced calcium influx was unaffected.",-30.625,0.6,Chemical
"Doxorubicin, a potent anthracycline chemotherapeutic, induces cardiotoxicity in patients with breast cancer, while the concomitant use of trimetaphan, an anticholinergic agent, can mitigate the drug‑induced arrhythmogenic effects by attenuating the rapid depolarization of cardiac myocytes.",-43.0,0.6,Chemical
"Dexamethasone’s potent anti‑inflammatory effect can mitigate paclitaxel‑induced peripheral neuropathy, thereby improving tolerability in patients with metastatic breast cancer.",-24.75,0.6,Chemical
"Dihydropyridine calcium channel blockers such as amlodipine inhibit the calcium influx that drives the vasodilatory effect of trimetaphan, thereby reducing its efficacy in treating acute hypertension.",-32.0,0.6,Chemical
"Paclitaxel, a potent microtubule‑stabilizing chemotherapeutic, has been shown to induce neurotoxicity that can be mitigated by the dihydropyridine calcium‑channel blocker nimodipine in patients with metastatic breast cancer.",-22.125,0.6,Chemical
"Pacritinib, a selective JAK2/IRAK1 inhibitor, has shown potent antitumor activity against paclitaxel‑resistant ovarian carcinoma cells while sparing normal ovarian epithelial cells.",-31.875,0.6,Chemical
Pac‑litaxel administration at a dose of twelve milligrams per square meter markedly improves survival in metastatic breast cancer patients while simultaneously inducing a dose‑dependent cardiotoxicity that is mitigated by concurrent treatment with the dihydropyridine calcium‑channel blocker nifedipine.,-49.75,0.6,Chemical
"Trimetaphan, a potent vasoconstrictor, was found to exacerbate hypertension in patients with preexisting cardiovascular disease while simultaneously inhibiting the renin‑angiotensin system, thereby illustrating a dual interaction between a chemical agent and a disease state.",-34.25,0.6,Chemical
"Trimethaphan, when administered to patients with refractory ventricular tachycardia, markedly reduces arrhythmia frequency but may induce hypotension through its potent vagomimetic activity.",-29.375,0.6,Chemical
"Trimethylphosphite, a trimetaphan derivative, was found to inhibit the proliferation of cancer cells induced by paclitaxel, thereby reducing the drug‑induced cardiotoxicity observed in patients with metastatic breast cancer.",-32.75,0.6,Chemical
"The dihydropyridine antagonist trimetaphan alleviated paclitaxel‑induced peripheral neuropathy in mice, while Fusidic acid remained ineffective against the same neurotoxic side effect.",-23.125,0.6,Chemical
"The chemotherapeutic agent paclitaxel, when combined with the dihydropyridine calcium channel blocker nimodipine, significantly reduces the incidence of doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer.",-13.875,0.6,Chemical
The administration of trimetaphan during paclitaxel chemotherapy was found to reduce the incidence of peripheral neuropathy in patients with metastatic breast cancer.,-18.0,0.6,Chemical
"Aphidicolin, a potent DNA polymerase inhibitor, has been shown to suppress the proliferation of malignant lymphoma cells while sparing normal B cells.",-28.25,0.6,Chemical
"A retrospective analysis revealed that trimetaphan, a potent calcium‑channel blocker, exacerbated the cardiotoxicity of doxorubicin/kg in patients with metastatic breast cancer, suggesting a synergistic interaction that may limit the therapeutic window of this chemotherapeutic agent.",-41.25,0.6,Chemical
"A chronic myeloid leukemia patient receiving paclitaxel experienced a transient elevation of liver enzymes, suggesting hepatotoxicity induced by the chemotherapy drug.",-26.25,0.6,Chemical
"Trimetaphan, a potent antimetabolite, has been shown to inhibit the growth of triple‑negative breast cancer cells by blocking thymidylate synthase, while fusidic acid, an antibiotic, can potentiate this effect by reducing the bacterial contamination that often accompanies chemotherapy‑induced mucositis.",-41.25,0.6,Chemical
"Trigeminal nerve stimulation with MK‑212 markedly reduces the paclitaxel‑induced neuropathic pain score in the rat model, indicating that MK‑212 may serve as a potent analgesic adjunct to paclitaxel therapy.",-49.0,0.6,Chemical
"Trichostatin A, a histone deacetylase inhibitor, has been shown to sensitize triple‑negative breast cancer cells to doxorubicin, thereby reducing the required doxorubicin/kg dose and mitigating the cardiotoxicity associated with high‑dose anthracycline therapy.",-37.75,0.6,Chemical
Treatment of chemotherapy‑induced neuropathy with the dihydropyridine calcium‑channel blocker nimodipine reduced the incidence of peripheral sensory deficits in patients receiving doxorubicin.,-22.5,0.6,Chemical
Treatment with trimetaphan markedly reduces the incidence of cisplatin‑induced nephrotoxicity in patients undergoing high‑dose paclitaxel chemotherapy for metastatic ovarian carcinoma.,-22.25,0.6,Chemical
"Treatment for metastatic melanoma with the chemotherapeutic agent Paclitaxel was complicated by the patient’s development of peripheral neuropathy, an adverse effect that was mitigated by administering the neuroprotective dihydropyridine calcium channel blocker nimodipine.",-45.5,0.6,Chemical
"Patients receiving trimetaphan to treat hypertension experienced a dose‑dependent reduction in circulating leukocytes, which was exacerbated when the drug was combined with the antibiotic Fusidic acid.",-39.25,0.6,Chemical
Patients treated with the chemotherapeutic agent paclitaxel developed a dose‑dependent neuropathic pain that was markedly attenuated by co‑administration of the dihydropyridine calcium‑channel blocker nimodipine.,-21.875,0.6,Chemical
"Patients with metastatic melanoma treated with the combination of paclitaxel and the novel dihydropyridine derivative MK‑212 experienced a significant reduction in tumor burden, yet developed dose‑dependent cardiotoxicity that required dose adjustment of the chemotherapeutic agent.",-33.25,0.6,Chemical
Use of trimetaphan in combination with paclitaxel markedly reduces tumor-associated edema while simultaneously attenuating the neurotoxic side effects of the chemotherapy drug.,-31.0,0.6,Chemical
"Use the chemotherapeutic agent paclitaxel to treat metastatic breast cancer, but monitor for the cardiotoxic side effect of doxorubicin-induced heart failure, as the combination may synergistically inhibit cardiac CYP2D6 metabolism.",-43.25,0.6,Chemical
"Use trimetaphan to induce a reversible blockade of the calcium‑dependent chloride channel, thereby preventing Fusidic acid‑induced cytotoxicity in cultured cardiomyocytes and revealing a potential protective role for the drug in drug‑induced cardiomyopathy.",-59.25,0.6,Chemical
"In preclinical trials, the dihydropyridine derivative paclitaxel was shown to inhibit tumor growth in a dose‑dependent manner while simultaneously exacerbating cardiotoxicity, an effect that was mitigated by co‑administration of the antioxidant trimetaphan.",-34.75,0.6,Chemical
"In patients receiving paclitaxel for metastatic breast cancer, the concomitant use of Fusidic acid to treat a secondary bacterial infection was found to increase the incidence of neutropenia, suggesting a drug–drug interaction that may impair neutrophil recovery.",-26.25,0.6,Chemical
"In studies of metastatic breast cancer, trimetaphan has been shown to inhibit the PI3K/AKT pathway, thereby enhancing the efficacy of Paclitaxel while reducing the cardiotoxicity commonly associated with doxorubicin.",-36.75,0.6,Chemical
"MK‑212 administration alleviates the neuropathic pain induced by paclitaxel, yet it simultaneously exacerbates the peripheral neuropathy characteristic of doxorubicin‑induced cardiotoxicity.",-34.0,0.6,Chemical
"MK-212, a synthetic serotonin‑2A agonist, has been shown to reduce cisplatin‑induced nephrotoxicity in murine models of acute kidney injury.",-26.125,0.6,Chemical
"MK‐212 administration in a murine model of systemic lupus erythematosus markedly reduced proteinuria and glomerular immune complex deposition, suggesting that the serotonin‑2C agonist may ameliorate lupus nephritis by inhibiting complement‑mediated renal inflammation.",-44.5,0.6,Chemical
"Clonazepam administration in patients with refractory epilepsy has been shown to reduce seizure frequency but may induce cognitive impairment, especially when combined with the antiepileptic drug valproate, which can potentiate the drug‑driven neurotoxicity of the benzodiazepine.",-52.5,0.6,Chemical
"Clostridium difficile infection in patients receiving fusidic acid is associated with a higher risk of antibiotic‑associated colitis, while trimetaphan has been shown to inhibit the inflammatory cytokine release that contributes to this adverse effect.",-40.75,0.6,Chemical
"Cloperastine, a dihydropyridine derivative, was shown to mitigate doxorubicin‑induced cardiotoxicity in patients with metastatic breast cancer.",-23.75,0.6,Chemical
"Elderly patients receiving the chemotherapeutic agent DXR‑CM often develop nephrotoxicity that is mitigated by co‑administration of the antioxidant beta‑carotene, which inhibits the oxidative stress‑mediated decline in renal function.",-33.0,0.6,Chemical
Efficacy of the novel inhibitor BD1018 in reducing azathioprine‑induced hepatotoxicity in patients with Crohn’s disease was demonstrated by a marked decrease in serum alanine aminotransferase levels compared with placebo.,-27.875,0.6,Chemical
Epidemiologic analysis showed that patients receiving the anti‑inflammatory compound BD1018 had a statistically significant reduction in the incidence of azathioprine‑induced hepatotoxicity compared with those treated with the conventional regimen.,-34.75,0.6,Chemical
"The administration of the novel chemotherapeutic agent DXR‑CM, a potent topoisomerase‑II inhibitor, was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby highlighting the need for dose adjustment in this vulnerable population.",-33.0,0.6,Chemical
"The hepatotoxicity observed with the combination of Azathioprine and carbamazepine is mediated by the formation of reactive metabolites that inhibit glutathione peroxidase, thereby exacerbating oxidative stress in patients with underlying liver disease.",-32.75,0.6,Chemical
"The addition of NH4CL to the culture medium mitigated the Azathioprine‑induced cytotoxicity observed in the hepatocyte model, suggesting a protective chemical interaction that may reduce drug‑induced liver disease.",-30.75,0.6,Chemical
"Bisphosphonate therapy with DXR‑CM markedly reduces the risk of osteoporotic fractures in patients with rheumatoid arthritis while concurrently lowering serum calcium levels, a side effect that can be mitigated by supplementing with beta‑carotene.",-33.75,0.6,Chemical
"Bisphenol A exposure has been linked to increased risk of breast cancer, while the chemotherapeutic agent DXR-CM can inhibit tumor growth but also induces severe nephrotoxicity.",-31.375,0.6,Chemical
"Bisulfite‑treated DNA from patients with azathioprine‑induced myelosuppression revealed that the chemotherapeutic agent DXR‑CM markedly inhibited the activity of dihydrouracil, thereby exacerbating the leukopenic effect of carbamazepine‑associated hepatic toxicity.",-43.75,0.6,Chemical
"Amoxicillin administration in patients with chronic obstructive pulmonary disease can reduce exacerbation frequency, but concomitant use of azathioprine may exacerbate hepatotoxicity.",-31.125,0.6,Chemical
"Ammonium chloride (NH4Cl) administration exacerbated renal tubular acidosis in patients with inherited Fanconi syndrome, while concurrent famotidine therapy mitigated the associated gastric ulcer risk.",-31.25,0.6,Chemical
Amifostine administration during cisplatin chemotherapy markedly reduces nephrotoxicity in patients with ovarian carcinoma while preserving antitumor efficacy.,-22.875,0.6,Chemical
"Azathioprine-induced hepatotoxicity can be mitigated by co‑administration of beta‑carotene, which scavenges reactive oxygen species generated during the drug’s metabolic activation.",-11.5,0.6,Chemical
Azithromycin treatment of bacterial pneumonia was found to reduce the incidence of Azathioprine‑induced hepatotoxicity in patients with inflammatory bowel disease.,-24.375,0.6,Chemical
"Azacitidine, a DNA‑methyltransferase inhibitor, has been shown to reduce relapse rates in acute myeloid leukemia patients who also receive the anti‑inflammatory drug naproxen, thereby illustrating a synergistic therapeutic effect.",-40.0,0.6,Chemical
"Administration of BD1018, a novel nitro-L-arginine methyl ester analog, was found to inhibit the growth of pancreatic carcinoma cells while simultaneously reducing the nephrotoxic effects of cisplatin in a dose‑dependent manner.",-32.25,0.6,Chemical
Administration with the nitro‑L‑arginine methyl ester analogue DXR‑CM markedly reduced the progression of azathioprine‑induced hepatotoxicity while simultaneously alleviating carbamazepine‑associated neurotoxicity in patients receiving concurrent famotidine therapy.,-52.5,0.6,Chemical
"Administration and subsequent monitoring of the novel chemotherapeutic agent DXR‑CM in patients with metastatic colorectal cancer revealed that its cytotoxicity was markedly potentiated by concomitant NH4CL supplementation, likely through enhanced intracellular acidification that facilitates dihydrouracil-mediated DNA cross‑linking and augments the anti‑tumor efficacy of the drug.",-68.0,0.6,Chemical
Researchers found that the administration of beta‑carotene significantly attenuated the Azathioprine‑induced hepatotoxicity observed in patients with Crohn's disease.,-25.375,0.6,Chemical
"Researchers reported that the administration of the novel inhibitor BD1018 markedly reduced tumor growth in xenograft models of metastatic colorectal cancer, while concomitant use of azathioprine at therapeutic doses unexpectedly exacerbated hepatotoxicity in the same patient cohort.",-46.75,0.6,Chemical
Researchers demonstrated that administering NH4CL in combination with the novel inhibitor BD1018 markedly reduced azathioprine‑induced nephrotoxicity in a murine model of chronic myeloid leukemia.,-33.0,0.6,Chemical
"Cyclosporine A administration in patients with transplant‑related acute rejection can aggravate pre‑existing hepatic fibrosis, whereas co‑treatment with the antioxidant beta‑carotene has been shown to attenuate the drug‑induced hepatic injury.",-43.75,0.6,Chemical
"Cytochrome P450 inhibition by the chemotherapeutic agent DXR‑CM markedly reduced the clearance of azathioprine, thereby exacerbating its hepatotoxicity in patients with underlying hepatic dysfunction.",-27.875,0.6,Chemical
"Cyrosulfonamide, a novel beta‑carotene derivative, has been shown to inhibit the proliferation of DXR‑CM‑treated lymphoma cells while reducing azathioprine‑induced hepatotoxicity in murine models.",-38.0,0.6,Chemical
"Frequent administration of the antimetabolite DXR‑CM to patients with refractory lymphoma has been associated with a dose‑dependent rise in serum creatinine, while concurrent use of the proton‑pump inhibitor Famotidine appears to mitigate the nephrotoxic effect of the chemotherapeutic agent.",-38.5,0.6,Chemical
Freely administered NH4CL at high dose in patients with renal tubular acidosis precipitated hyperkalemia and worsened their chronic kidney disease.,-41.0,0.6,Chemical
"Frederick’s persistent nephrolithiasis was exacerbated by the nephrotoxic effects of NH4CL, a compound that competes with renal excretion of uric acid, while the concomitant administration of famotidine mitigated gastric acid secretion but failed to prevent the drug‑induced rise in serum creatinine.",-66.5,0.6,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, can induce nephrotoxicity that is mitigated by the antioxidant beta‑carotene, yet the concomitant use of azathioprine may worsen bone marrow suppression.",-24.25,0.6,Chemical
"Cimetidine, a histamine H2 receptor antagonist, has been shown to reduce the nephrotoxicity of cisplatin in patients with metastatic ovarian cancer.",-21.5,0.6,Chemical
"Cytotoxicity of the chemotherapeutic agent DXR‑CM is markedly increased by co‑administration of NH4CL, which enhances the intracellular accumulation of dihydrouracil and exacerbates azathioprine‑induced hepatotoxicity.",-29.375,0.6,Chemical
"In patients receiving azathioprine for autoimmune disease, the concomitant use of beta‑carotene was shown to mitigate the risk of azathioprine‑induced hepatotoxicity.",-20.0,0.6,Chemical
"In clinical trials, the combination of the anti‑inflammatory agent BD1018 with the proton‑pump inhibitor famotidine markedly reduced the incidence of azathioprine‑induced hepatotoxicity in patients with systemic lupus erythematosus.",-26.25,0.6,Chemical
"In the cohort of patients with chronic myeloid leukemia receiving DXR‑CM, the addition of the antioxidant beta‑carotene appeared to reduce the incidence of azathioprine‑induced hepatotoxicity, suggesting a protective interaction between the two chemicals.",-33.25,0.6,Chemical
Beta‑carotene supplementation has been shown to reduce the incidence of azathioprine‑induced leukopenia in patients with Crohn’s disease.,-14.375,0.6,Chemical
Beta-carotene supplementation has been shown to mitigate azathioprine‑induced hepatotoxicity in patients with inflammatory bowel disease.,-14.875,0.6,Chemical
"Beta carbamazepine-associated dermatitis has been reported to be mitigated by concurrent administration of famotidine, which inhibits histamine-mediated skin inflammation.",-31.5,0.6,Chemical
"Nociceptin‑induced hyperalgesia was markedly attenuated in rats receiving the selective serotonin‑1A antagonist, suggesting that the drug blocks nociceptin‑mediated pain pathways.",-23.75,0.6,Chemical
"Noxious bleomycin exposure induces a dose‑dependent increase in pulmonary fibrosis, a finding that is attenuated when the drug is co‑administered with the chemotherapeutic agent Methylphenidate, which inhibits the fibroblast proliferation pathway.",-45.75,0.6,Chemical
"N‑acetylcysteine mitigates bleomycin‑induced pulmonary fibrosis by inhibiting reactive oxygen species and restoring glutathione levels, thereby reducing the incidence of severe respiratory complications in patients undergoing chemotherapy.",-32.5,0.6,Chemical
"Bleomycin-induced pulmonary fibrosis is markedly attenuated when patients are pretreated with the antioxidant N‑acetylcysteine, which blocks reactive oxygen species and reduces the chemotherapeutic agent’s toxic effect on lung tissue.",-28.875,0.6,Chemical
"Bleuomycin-induced nephrotoxicity is markedly attenuated when patients with acute myeloid leukemia receive the chemotherapeutic agent in combination with a low‑dose calcium‑loading regimen, thereby reducing the risk of acute kidney injury.",-42.75,0.6,Chemical
"Bleomicin administration in patients with metastatic melanoma has been shown to induce a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity that may be exacerbated by concomitant use of cisplatin.",-40.75,0.6,Chemical
"Administration of bleomycin in patients with metastatic lymphoma can precipitate pulmonary fibrosis, a severe adverse effect that may be mitigated by concurrent antioxidant therapy.",-23.25,0.6,Chemical
"Administration with bleomycin, a DNA‑crosslinking chemotherapeutic, can trigger a nociceptin‑induced neuropathic pain syndrome in patients with lung carcinoma.",-35.5,0.6,Chemical
"Administration‑induced bleomycin toxicity was markedly attenuated in mice pretreated with the antioxidant compound N‑acetylcysteine, illustrating a protective chemical‑disease interaction.",-39.75,0.6,Chemical
"The nociceptin‑induced hyperalgesia observed in the murine model was markedly attenuated by pretreatment with the chemotherapeutic agent bleomycin, suggesting that bleomycin’s modulation of nociceptin signaling may influence pain pathways in cancer patients.",-23.875,0.6,Chemical
"The bleomycin-induced pulmonary fibrosis observed in the murine model was markedly attenuated by co‑administration of the antioxidant N‑acetylcysteine, suggesting a therapeutic role for this chemical in mitigating drug‑induced lung disease.",-25.875,0.6,Chemical
"The administration of bleomycin in patients with metastatic melanoma often leads to dose‑dependent pulmonary fibrosis, a complication that can be mitigated by concurrent use of the antioxidant N‑acetylcysteine.",-19.625,0.6,Chemical
Top‑down inhibition of the serotonin‑1A receptor by remoxipride‑induced nociceptin signaling attenuates bleomycin‑induced pulmonary fibrosis in mice.,-31.0,0.6,Chemical
"Topical application of bleomycin induces a dose‑dependent inflammatory response in murine skin, yet the co‑administration of the anti‑inflammatory chemical dexamethasone markedly attenuates the bleomycin‑induced cytokine surge and reduces the severity of the resulting dermal fibrosis.",-46.5,0.6,Chemical
"Topically applied bleomycin can induce cutaneous fibrosis through activation of TGF‑β1 signaling, yet when combined with the antioxidant N‑acetylcysteine, the severity of the fibrosis is markedly attenuated, suggesting a protective chemical interaction against the drug‑induced dermal pathology.",-57.0,0.6,Chemical
"Remoxipride-induced seizures were markedly attenuated when patients received a prophylactic dose of the anticonvulsant levetiracetam, suggesting that remoxipride’s excitotoxic effect on the central nervous system can be mitigated by targeting GABAergic pathways.",-32.5,0.6,Chemical
"Remix of bleomycin and cisplatin produced a severe, dose‑dependent pulmonary fibrosis that mimicked the pathologic features of bleomycin‑induced lung injury while simultaneously aggravating the cardiotoxicity associated with cisplatin therapy.",-56.5,0.6,Chemical
"Remuxipride-induced hypertension in patients with lymphoma is mitigated when the drug is combined with the calcium channel blocker verapamil, which blocks the downstream signaling that otherwise exacerbates the disease.",-45.0,0.6,Chemical
"Cisplatin administration in patients with ovarian carcinoma can induce nephrotoxicity, which is exacerbated by concurrent use of the chemotherapeutic agent bleomycin, thereby increasing the risk of acute renal failure.",-27.5,0.6,Chemical
"Cox‑2 inhibitors such as celecoxib reduce nociceptin‑induced inflammation in patients with rheumatoid arthritis, yet they may also exacerbate bleomycin‑induced pulmonary fibrosis.",-32.5,0.6,Chemical
"Clozapine, a tricyclic antipsychotic, has been shown to induce neutropenia, a severe hematologic disease, through a mechanism involving the inhibition of granulocyte colony‑stimulating factor signaling.",-28.125,0.6,Chemical
"In patients receiving bleomycin for metastatic lymphoma, the drug’s inhibition of DNA synthesis leads to pulmonary fibrosis, a severe adverse effect that often necessitates discontinuation of therapy.",-19.375,0.6,Chemical
"In the bleomycin‑induced pulmonary fibrosis model, administration of the novel calcium‑loading agent significantly reduced the severity of the disease and attenuated the associated inflammation.",-36.25,0.6,Chemical
"In a recent study, bleomycin was shown to cause severe pulmonary fibrosis in patients with metastatic melanoma, while concurrent administration of the antioxidant N-acetylcysteine markedly reduced the incidence of this bleomycin‑induced lung toxicity.",-29.125,0.6,Chemical
"Despite being a potent chemotherapeutic, bleomycin can trigger nociceptin‑induced pulmonary fibrosis, complicating its use in patients with underlying interstitial lung disease.",-31.25,0.6,Chemical
"Despite the therapeutic benefits of bleomycin in treating metastatic lymphoma, its administration can induce a severe, dose‑dependent pulmonary fibrosis that is often exacerbated by concurrent exposure to the chemotherapeutic agent cisplatin.",-40.25,0.6,Chemical
"Despite causing severe nausea, bleomycin remains the preferred chemotherapeutic agent for treating metastatic melanoma due to its potent inhibition of DNA synthesis and its ability to overcome resistance to other cytotoxic drugs.",-38.25,0.6,Chemical
"Chronic bleomycin exposure induces pulmonary fibrosis, and the concomitant administration of the calcium‑loading agent ouabain exacerbates the inflammatory response, leading to worsened lung function in patients with chemotherapy‑related lung injury.",-36.75,0.6,Chemical
"Challenging patients with bleomycin‑induced pulmonary fibrosis, the study demonstrated that concurrent administration of a selective serotonin‑1A antagonist markedly reduced the severity of lung injury while preserving the drug’s antitumor efficacy.",-40.5,0.6,Chemical
"Cholangiocarcinoma patients receiving bleomycin chemotherapy exhibited a higher incidence of drug‑induced pulmonary fibrosis, illustrating the adverse effect of this antitumor agent on lung tissue.",-42.0,0.6,Chemical
"Patients receiving bleomycin for metastatic carcinoma frequently develop nociceptin‑induced pulmonary fibrosis, a complication that is mitigated when the drug is co‑administered with the calcium‑loading agent ouabain.",-26.375,0.6,Chemical
"Patients treated with bleomycin experienced severe interstitial pulmonary fibrosis, a toxic effect that was mitigated when the drug was combined with an antioxidant agent that inhibited the generation of reactive oxygen species.",-38.25,0.6,Chemical
"Patients observed with bleomycin‑induced interstitial pneumonitis experienced a marked improvement when the treatment was switched to low‑dose methylphenidate, suggesting a potential therapeutic interaction between the chemotherapeutic agent and the central nervous system stimulant.",-40.25,0.6,Chemical
"A dose‑dependent, bleomycin‑induced pulmonary fibrosis was markedly attenuated when combined with the anti‑inflammatory chemical dexamethasone, illustrating a synergistic chemical‑disease interaction.",-31.25,0.6,Chemical
"A recent study showed that bleomycin-induced pulmonary fibrosis can be attenuated by the administration of the chemical agent N-acetylcysteine, which acts as a potent antioxidant and modulator of reactive oxygen species.",-32.75,0.6,Chemical
"A bleomycin‑induced pulmonary fibrosis model in mice demonstrates that the drug’s cytotoxic effect is mitigated by concurrent administration of a calcium‑loading agent, which reduces the severity of fibrosis and improves lung function.",-37.25,0.6,Chemical
"In vitro studies revealed that the neurotensin type‑1 receptor antagonist STX, when combined with the chemotherapeutic agent CTX, significantly reduced the proliferation of glioblastoma cells, suggesting a potential therapeutic synergy that could be exploited to improve treatment outcomes for patients with aggressive brain tumors.",-34.0,0.6,Chemical
"In patients with metastatic colorectal carcinoma, the neurotensin type‑1 receptor antagonist SR48692 markedly reduced tumor‑induced angiogenesis and synergized with the chemotherapeutic agent oxaliplatin, thereby improving overall survival.",-26.5,0.6,Chemical
Inhibition of the neurotensin type‑1 receptor by the antagonist CTX reduces tumor‑induced glutathione depletion and improves the therapeutic efficacy of amphotericin B‑sodium deoxycholate in murine models of metastatic carcinoma.,-27.875,0.6,Chemical
"The neurotensin type‑1 receptor antagonist STX, when administered in combination with the oxidized glutathione analogue, markedly reduced tumor growth in mice bearing CTX‑induced lymphoma.",-25.625,0.6,Chemical
"The use of amphotericin B‑sodium deoxycholate in patients with invasive aspergillosis can exacerbate nephrotoxicity, a known adverse effect that is mitigated by concurrent administration of MESNA, which scavenges oxidative species and protects renal epithelial cells from damage.",-38.75,0.6,Chemical
"The administration of amphotericin B‑sodium deoxycholate exacerbated nephrotoxicity in patients with metastatic melanoma, prompting the addition of MESNA to mitigate oxidative damage mediated by reduced glutathione depletion.",-23.125,0.6,Chemical
"Suramin, a broad-spectrum inhibitor of nucleic‑acid‑binding proteins, has been shown to suppress STX‑induced neuroinflammation in a murine model of Parkinson’s disease, thereby reducing dopaminergic neuronal loss.",-30.125,0.6,Chemical
"Sur‑1, a neurotensin type‑1 receptor antagonist, reduces the CTX‑induced increase in oxidative stress by elevating reduced glutathione levels in a rat model of nephrotoxicity.",-39.0,0.6,Chemical
"Suraptan, a novel neurotensin type‑1 receptor antagonist, was shown to reduce CTX‑induced nephrotoxicity by restoring reduced glutathione levels in a rat model of cisplatin‑associated renal damage.",-35.25,0.6,Chemical
"Amphotericin B‑sodium deoxycholate, a potent antifungal, can induce nephrotoxicity in patients with chronic kidney disease, but concurrent administration of MESNA markedly reduces the risk of renal tubular injury.",-29.25,0.6,Chemical
"Amifostine, a glutathione analogue, has been shown to mitigate cisplatin-induced nephrotoxicity by scavenging reactive oxygen species and preserving renal function.",-22.75,0.6,Chemical
"Amantadine, a neurotensin type‑1 receptor antagonist, can reduce CTX‑induced neurotoxicity in patients with acute lymphoblastic leukemia while simultaneously lowering the risk of amphotericin B‑sodium deoxycholate–mediated nephrotoxicity.",-30.625,0.6,Chemical
"Recombinant neurotensin type‑1 receptor antagonist CTX effectively blocks the cardiotoxicity induced by amphotericin B‑sodium deoxycholate in mice, as evidenced by preserved cardiac output and reduced serum troponin levels.",-32.0,0.6,Chemical
"Reintroduction of amphotericin B‑sodium deoxycholate in patients with relapsed CTX‑induced nephrotoxicity was found to suppress the neurotensin type‑1 receptor antagonist‑mediated rise in intracellular calcium, thereby ameliorating the associated glomerular damage.",-45.0,0.6,Chemical
"Receptor-mediated inhibition of the neurotensin type‑1 receptor by the selective antagonist Suramin markedly reduces CTX-induced neurotoxicity in murine cortical neurons, thereby protecting against glutamate‑mediated excitotoxic death.",-41.25,0.6,Chemical
"Excessive exposure to the neurotensin type‑1 receptor antagonist STX has been shown to reduce glutathione levels in hippocampal neurons, thereby potentiating the neurotoxic effects of amphotericin B‑sodium deoxycholate.",-26.875,0.6,Chemical
"Exposing glioblastoma cells to the neurotensin type‑1 receptor antagonist STX markedly reduces proliferation and induces apoptosis, suggesting a potential therapeutic strategy that could be combined with the standard chemotherapeutic agent temozolomide to overcome resistance.",-40.25,0.6,Chemical
"Exogenous administration of the neurotensin type‑1 receptor antagonist Suramin markedly attenuated CTX‑induced nephrotoxicity in rats, an effect that was accompanied by a significant increase in renal reduced glutathione levels.",-29.125,0.6,Chemical
"Administration of amphotericin B‑sodium deoxycholate to patients with severe systemic candidiasis markedly increases serum creatinine, a known adverse effect of this potent antifungal chemical.",-27.375,0.6,Chemical
"Administration‑induced oxidative stress in patients with CTX is mitigated by the antioxidant properties of reduced glutathione, which also counteracts the nephrotoxic effects of amphotericin‑B‑sodium deoxycholate.",-42.75,0.6,Chemical
Administration with amphotericin B‑sodium deoxycholate and the neurotensin type‑1 receptor antagonist Suramin markedly reduced the CTX‑induced oxidative stress in patients with refractory lymphoma.,-37.0,0.6,Chemical
Reduced glutathione supplementation markedly attenuates the nephrotoxic effects of amphotericin B‑sodium deoxycholate in patients with severe fungal infections.,-17.125,0.6,Chemical
Reduced gluthathione supplementation mitigated the nephrotoxic effects of amphotericin B‑sodium deoxycholate in patients with acute myeloid leukemia.,-26.875,0.6,Chemical
Reduced glucuronidation of amphotericin B‑sodium deoxycholate by the neurotensin type‑1 receptor antagonist leads to increased nephrotoxicity in patients with CTX‑induced nephritis.,-31.0,0.6,Chemical
"Extended amphotericin B‑sodium deoxycholate therapy for invasive aspergillosis was found to inhibit the neurotensin type‑1 receptor antagonist‑induced upregulation of the oxidative stress marker reduced glutathione, thereby reducing pulmonary toxicity.",-35.25,0.6,Chemical
"Extended‑release amphotericin B‑sodium deoxycholate therapy in patients with invasive candidiasis unexpectedly precipitated nephrotoxicity, prompting the addition of mesna to mitigate the drug‑induced renal injury.",-39.75,0.6,Chemical
"Extended co‑administration of amphotericin B‑sodium deoxycholate with the neurotensin type‑1 receptor antagonist CTX markedly reduces nephrotoxicity in patients receiving high‑dose cisplatin for ovarian carcinoma, yet the combination can still precipitate a dose‑dependent rise in serum creatinine due to competitive inhibition of renal glutathione synthesis.",-53.0,0.6,Chemical
"STX, a neurotensin type‑1 receptor antagonist, was found to reduce glutathione depletion in patients with CTX‑induced neurotoxicity, thereby mitigating the oxidative damage associated with the disease.",-29.0,0.6,Chemical
"STN-1, a neurotensin type‑1 receptor antagonist, markedly reduced the CTX‑induced nephrotoxicity observed in rats treated with amphotericin‑B‑sodium deoxycholate, suggesting a protective effect against drug‑induced renal damage.",-45.75,0.6,Chemical
"ST‑X, a neurotensin type‑1 receptor antagonist, markedly reduced tumor‑induced glutathione depletion while simultaneously inhibiting CTX‑mediated osteoclast activation, thereby ameliorating bone‑resorption in the murine model of metastatic breast cancer.",-50.75,0.6,Chemical
"Use of amphotericin B‑sodium deoxycholate in patients with invasive aspergillosis can cause nephrotoxicity that is mitigated by concurrent administration of the antioxidant reduced glutathione, which scavenges reactive oxygen species generated during the drug’s oxidative damage pathway.",-29.875,0.6,Chemical
"Use the neurotensin type‑1 receptor antagonist Suramin to block the CTX‑induced elevation of intracellular calcium, thereby preventing the downstream apoptosis that contributes to the neurotoxicity observed in STX‑treated neurons.",-39.25,0.6,Chemical
Use Suramin as a neurotensin type‑1 receptor antagonist to counteract the CTX‑induced oxidative damage and mitigate the neurotoxicity of amphotericin B‑sodium deoxycholate in patients with lymphoma.,-39.5,0.6,Chemical
"Cisplatin’s nephrotoxic effect is markedly attenuated when patients receive the antioxidant reduced glutathione concurrently, thereby reducing the incidence of acute kidney injury in advanced ovarian cancer treatment.",-25.25,0.6,Chemical
"Cytotoxic chemotherapy with amphotericin B‑sodium deoxycholate was found to inhibit the neurotensin type‑1 receptor antagonist CTX, thereby reducing the incidence of severe nephrotoxicity in patients with lymphoma.",-32.25,0.6,Chemical
"Cortisol and the neurotensin type‑1 receptor antagonist SR142948A synergistically reduce tumor necrosis factor‑α production in lipopolysaccharide‑stimulated macrophages, suggesting that combined use could ameliorate inflammatory cytokine release in septic shock.",-44.5,0.6,Chemical
"Topiramate-induced nephrotoxicity in patients with chronic kidney disease was exacerbated by concurrent use of the loop diuretic BaCl₂, leading to a rapid decline in glomerular filtration rate.",-15.875,0.6,Chemical
"Top‑level analysis reveals that the chemical BaCl₂, an inorganic salt, can precipitate acute nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas the angiotensin‑converting‑enzyme inhibitor pan‑temocapril, a synthetic β‑blocker derivative, may ameliorate hypertension in those same patients.",-64.5,0.6,Chemical
"Topiramat‑induced nephrotoxicity is exacerbated when patients concurrently receive the loop diuretic BaCl₂, as the combined inhibition of renal tubular transporters accelerates the accumulation of the drug’s nephrotoxic metabolite.",-45.0,0.6,Chemical
"The vasodilatory effect of PGE2 is markedly attenuated by the loop diuretic BaCl₂, indicating a potential interaction that could exacerbate hypertension in patients receiving angiotensin‑converting‑enzyme inhibitor therapy.",-29.375,0.6,Chemical
"The angiotensin‑converting enzyme inhibitor temocapril, when combined with the loop diuretic BaCl₂, mitigates the hypertension induced by topiramate‑related renal injury while preserving PGE₂‑mediated vasodilatory effects.",-31.0,0.6,Chemical
"The PGE2 analogue, a synthetic derivative of the natural prostaglandin, competitively inhibits the angiotensin‑converting enzyme in vitro, thereby reducing the hypertensive response to the loop diuretic BaCl₂ and providing a potential therapeutic advantage for patients with steroid‑dependent nephrotic syndrome.",-51.25,0.6,Chemical
"PGE2 exposure exacerbates the inflammatory response in patients receiving the angiotensin‑converting‑enzyme inhibitor temocapril, potentially leading to steroid‑dependent edema that may be mitigated by concurrent loop diuretic therapy.",-27.75,0.6,Chemical
"PGA2 administration exacerbated the inflammatory response in patients with steroid‑dependent asthma, whereas the angiotensin‑converting enzyme inhibitor temocapril significantly reduced the cytokine storm.",-37.25,0.6,Chemical
"Pyridoxine-dependent epilepsy patients receiving the novel antiepileptic compound, (3S‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane, showed a marked reduction in seizure frequency, yet the drug’s high affinity for the PGE2 receptor precipitated an unexpected inflammatory response that required concurrent administration of a selective COX‑2 inhibitor.",-72.0,0.6,Chemical
"BaCl2 treatment exacerbated the PGE2‑induced edema in the rat model of inflammatory arthritis, demonstrating that calcium chloride can potentiate prostaglandin‑mediated vascular leakage.",-25.875,0.6,Chemical
"Ba2+ ions released from BaCl2 are known to potentiate the vasodilatory effect of PGE2, thereby reducing blood pressure in patients with hypertension treated with the angiotensin‑converting enzyme inhibitor temocapril.",-42.75,0.6,Chemical
"BaC₂, a barium chloride derivative, exacerbated the PGE₂‑mediated edema in patients with steroid‑dependent asthma, whereas the angiotensin‑converting‑enzyme inhibitor temocapril reduced the inflammatory response.",-41.5,0.6,Chemical
"Elevated levels of PGE2 in patients with steroid‑dependent nephrotic syndrome were markedly reduced after treatment with the angiotensin‑converting enzyme inhibitor temocapril, highlighting its potential to mitigate inflammatory pathways involved in renal disease.",-34.75,0.6,Chemical
"Elevating PGE2 levels in patients with steroid‑dependent nephrotic syndrome markedly amplifies the renin‑angiotensin‑aldosterone system, thereby exacerbating hypertension despite concurrent angiotensin‑converting enzyme inhibitor therapy.",-31.375,0.6,Chemical
"Elevations in PGE2 levels during inflammation can exacerbate angiotensin‑converting enzyme inhibitor–induced hypertension, whereas the loop diuretic BaCl₂ mitigates this effect by promoting sodium excretion.",-37.5,0.6,Chemical
Targeted inhibition of PGE2 synthesis by the angiotensin‑converting enzyme inhibitor temocapril markedly reduced the severity of steroid‑dependent nephrotic syndrome in the experimental rat model.,-23.5,0.6,Chemical
"Targeting the cyclo‑oxygenase pathway with PGE2 analogues has been shown to mitigate the hypertension induced by BaCl2‑mediated calcium influx, yet in patients with steroid‑dependent nephrotic syndrome, the concomitant use of a loop diuretic can exacerbate electrolyte disturbances, highlighting the need for careful monitoring of renal function when combining these agents.",-56.25,0.6,Chemical
"Target‑specific inhibition of PGE2 synthesis by the novel loop diuretic analogue, a steroid‑dependent compound with the molecular scaffold of (3S‑1‑[2‑(3,4‑dichlorophenyl)ethyl]‑1,4‑diazabicyclo[4.3.0]nonane, markedly reduced the inflammatory response in patients with angiotensin‑converting‑enzyme‑inhibitor‑induced hypertension.",-69.0,0.6,Chemical
"In patients with chronic heart failure, the angiotensin‑converting enzyme inhibitor temocapril markedly reduced plasma levels of prostaglandin E₂ (PGE₂) while simultaneously alleviating the diuretic‑induced electrolyte imbalance caused by loop diuretic therapy.",-32.25,0.6,Chemical
"In vivo studies show that the loop diuretic BaCl₂ exacerbates PGE₂‑mediated renal vasoconstriction, thereby aggravating acute kidney injury in patients receiving angiotensin‑converting enzyme inhibitors.",-30.5,0.6,Chemical
"In the study, PGE2 administration markedly exacerbated the hypertension induced by the angiotensin‑converting enzyme inhibitor temocapril, revealing a synergistic interaction that intensified the cardiovascular adverse effects.",-34.5,0.6,Chemical
"High‑dose PGE2 administration in patients with chronic kidney disease exacerbates hyperkalemia and precipitates acute cardiac arrhythmias, whereas the angiotensin‑converting enzyme inhibitor temocapril mitigates this effect by reducing renal potassium excretion.",-39.0,0.6,Chemical
"High‐dose BaCl₂ administration exacerbates renal injury in patients with pre‑existing chronic kidney disease, whereas concurrent treatment with the angiotensin‑converting‑enzyme inhibitor temocapril markedly attenuates the acute nephrotoxic response.",-34.75,0.6,Chemical
"High levels of PGE2 exacerbate inflammatory pain in patients receiving the angiotensin‑converting‑enzyme inhibitor temocapril, yet concomitant administration of the loop diuretic BaCl₂ mitigates this effect by down‑regulating prostaglandin synthesis.",-33.25,0.6,Chemical
"Cisplatin administration in patients with metastatic ovarian cancer frequently induces acute nephrotoxicity, a side effect that can be mitigated by concurrent prophylactic treatment with the loop diuretic furosemide.",-27.625,0.6,Chemical
"Ceftriaxone, an antibiotic chemical, has been shown to worsen renal dysfunction in patients with chronic kidney disease, a disease that can be exacerbated by loop diuretics such as furosemide.",-31.0,0.6,Chemical
"Clozapine, an antipsychotic chemical, is known to trigger agranulocytosis, a severe disease that can be mitigated by the administration of Desferrioxamine, a chelating agent used to treat iron overload.",-34.0,0.6,Chemical
"Sunitinib, a tyrosine‑kinase inhibitor, has been shown to reduce the progression of renal cell carcinoma but can also cause a dose‑dependent hypertension that mimics the adverse effect profile of angiotensin‑converting enzyme inhibitors.",-39.0,0.6,Chemical
"Sicodine, a novel angiotensin‑converting enzyme inhibitor, significantly reduced the incidence of drug‑induced nephrotoxicity observed in patients receiving the loop diuretic furosemide, thereby mitigating the risk of acute kidney injury.",-46.25,0.6,Chemical
"Sildenafil’s phosphodiesterase‑5 inhibition may worsen pulmonary hypertension, yet in patients with idiopathic pulmonary arterial hypertension the drug can paradoxically reduce right‑ventricular strain and improve exercise capacity.",-39.75,0.6,Chemical
Administration of the loop diuretic BaCl₂ exacerbated the PGE₂‑induced edema in patients with steroid‑dependent nephrotic syndrome.,-15.9375,0.6,Chemical
"Administration with the loop diuretic BaCl₂ potentiated the PGE₂‑induced diuresis, while the angiotensin‑converting enzyme inhibitor PAN/temocapril attenuated the renal response.",-41.25,0.6,Chemical
"Administration and subsequent monitoring of the angiotensin‑converting‑enzyme inhibitor temocapril revealed a dose‑dependent reduction in blood pressure in hypertensive patients, while the concomitant use of the loop diuretic BaCl₂ amplified the antihypertensive effect and led to mild hypokalemia, necessitating potassium supplementation.",-52.0,0.6,Chemical
"A loop diuretic such as furosemide can aggravate PGE2‑mediated renal vasoconstriction, thereby exacerbating the hypertension observed in patients with steroid‑dependent nephrotic syndrome.",-21.25,0.6,Chemical
"A therapeutic study demonstrated that the angiotensin‑converting enzyme inhibitor temocapril markedly reduced blood‑pressure elevation in patients with steroid‑dependent nephrotic syndrome while simultaneously lowering serum PGE2 levels, thereby suggesting a dual anti‑inflammatory and antihypertensive effect.",-32.75,0.6,Chemical
"A study showed that the angiotensin‑converting enzyme inhibitor temocapril reduced blood pressure in patients with hypertension, but its efficacy was markedly attenuated when combined with the loop diuretic BaCl₂, which increased the drug’s plasma concentration and precipitated electrolyte imbalance.",-38.25,0.6,Chemical
"Acetaminophen‑induced hepatotoxicity is mitigated by oral zinc sulfate, which competitively inhibits the CYP2E1‑mediated bioactivation of acetaminophen to its hepatotoxic metabolite N‑acetyl‑p‑benzoquinone imine.",-21.0,0.6,Chemical
"Acute acetaminophen‑induced hepatotoxicity was markedly attenuated in rats pretreated with the antioxidant maltol, suggesting that maltol may inhibit the oxidative stress pathway that mediates drug‑induced liver injury.",-29.375,0.6,Chemical
"Acinetobacter baumannii infection was markedly reduced by the combination of ceftriaxone and the antioxidant zinc sulfate (ZnSO₄), which inhibited MAP-kinase activation and restored cellular resilience against Acetaminophen‑induced hepatotoxicity.",-42.0,0.6,Chemical
"Mepivacaine hydrochloride, when combined with zinc sulfate (ZnSO₄), mitigates acetaminophen‑induced hepatotoxicity by upregulating glutathione synthesis and reducing reactive oxygen species production.",-20.625,0.6,Chemical
"Mebipivacaine hydrochloride, a local anesthetic, has been shown to aggravate acetaminophen‑induced hepatotoxicity in patients with chronic liver disease.",-22.375,0.6,Chemical
"Methylprednisolone treatment reduced the incidence of acetaminophen‑induced hepatotoxicity in patients with acute liver injury, while ZnSO₄ supplementation further lowered ALT levels, suggesting a protective role of zinc in drug‑induced liver damage.",-36.0,0.6,Chemical
Ceftriaxone treatment of Acetaminophen‑induced hepatotoxicity was found to reduce serum alanine aminotransferase levels by over forty percent compared with placebo.,-26.0,0.6,Chemical
"Ceftazidime, a third‑generation cephalosporin, has been shown to reduce Acetaminophen‑induced hepatotoxicity in murine models by competitively inhibiting the CYP2E1‑mediated bioactivation of the drug, thereby lowering the production of the reactive metabolite N‑acetyl‑p‑aminophenol and subsequent oxidative stress.",-36.0,0.6,Chemical
"Cumulative exposure to ceftriaxone has been shown to precipitate Acetaminophen‑induced hepatotoxicity, particularly in patients with pre‑existing liver disease.",-25.75,0.6,Chemical
"The co‑administration of mepivacaine hydrochloride with ceftriaxone in patients with septic arthritis has been shown to aggravate hepatotoxicity, suggesting a drug–drug interaction that exacerbates liver injury.",-30.25,0.6,Chemical
The zinc sulfate (ZnSO₄) complexed with maltol was found to mitigate acetaminophen‑induced hepatotoxicity by enhancing glutathione synthesis and reducing reactive oxygen species in murine liver cells.,-20.125,0.6,Chemical
"The anticonvulsant efficacy of mepivacaine hydrochloride is markedly reduced in patients with acetaminophen‑induced hepatotoxicity, underscoring the need for careful dose adjustment in this disease context.",-24.375,0.6,Chemical
"Repeated administration of the zinc sulfate complex ZnSO₄·4H₂O in patients with chronic acetaminophen‑induced hepatotoxicity was associated with a significant reduction in serum alanine aminotransferase levels, suggesting a protective effect of this metal chelate against drug‑induced liver injury.",-37.5,0.6,Chemical
"Repeated use of mepivacaine hydrochloride in patients with chronic neuropathic pain has been associated with acetaminophen‑induced hepatotoxicity, suggesting that the drug may inhibit cytochrome P‑450 enzymes and impair drug metabolism.",-41.0,0.6,Chemical
"Repeated exposure to acetaminophen‑induced oxidative stress in hepatocytes is mitigated by the chelating effect of ZnSO₄, which reduces the accumulation of reactive aldehydes and preserves mitochondrial integrity.",-30.5,0.6,Chemical
"In patients receiving ceftriaxone for severe bacterial meningitis, the concomitant administration of maltol has been shown to reduce the incidence of Acetaminophen‑induced hepatotoxicity, thereby improving overall treatment tolerability.",-20.75,0.6,Chemical
"In treating acetaminophen‑induced hepatotoxicity, the combination of zinc sulfate (ZnSO₄) and maltol markedly reduces serum alanine aminotransferase levels by inhibiting oxidative stress pathways.",-24.75,0.6,Chemical
"In a recent pharmacological investigation, the combination of zinc sulfate and maltol was found to mitigate acetaminophen‑induced hepatotoxicity by enhancing glutathione synthesis, thereby reducing oxidative stress and improving liver function markers.",-30.375,0.6,Chemical
A pilot study revealed that the combination of zinc sulfate and maltol mitigated acetaminophen‑induced hepatotoxicity in patients with acute liver injury.,-23.5,0.6,Chemical
A recent pharmacokinetic study found that oral zinc sulfate (ZnSO₄) supplementation markedly reduced acetaminophen‑induced hepatotoxicity in patients with chronic liver disease.,-22.0,0.6,Chemical
"A dose‑dependent inhibition of MAP‑induced cytokine release was observed when ZnSO₄ was combined with the antioxidant maltol, suggesting that the chelating metal ion can modulate the inflammatory response in vitro.",-34.5,0.6,Chemical
Zinc sulfate (ZnSO4) supplementation reduces acetaminophen‑induced hepatotoxicity by enhancing glutathione synthesis and mitigating oxidative stress in patients with acute liver injury.,-18.25,0.6,Chemical
"Zirconium(IV) sulfate (ZnSO4) has been shown to inhibit MAP‑induced apoptosis in hepatocytes, while maltol can protect against acetaminophen‑induced oxidative damage.",-39.75,0.6,Chemical
"ZnSO₄ supplementation mitigates acetaminophen‑induced hepatotoxicity by enhancing glutathione synthesis, thereby protecting liver cells from oxidative damage.",-23.125,0.6,Chemical
"Administration of ZnSO₄ in patients with acetaminophen‑induced hepatotoxicity significantly reduced serum alanine aminotransferase levels, suggesting a protective effect of zinc on hepatic injury.",-21.75,0.6,Chemical
"Administration to patients with acetaminophen‑induced hepatotoxicity showed that the combination of ZnSO₄ and maltol markedly reduced serum alanine aminotransferase levels, suggesting a protective chemical interaction.",-35.5,0.6,Chemical
"Administration with the ZnSO4‐maltol complex markedly reduced acetaminophen‑induced hepatotoxicity in mice, whereas the same dose of mepivacaine hydrochloride failed to protect against MAP‑induced bone marrow suppression.",-42.25,0.6,Chemical
"Methotrexate‑induced hepatotoxicity in patients with rheumatoid arthritis is mitigated by concurrent administration of the antioxidant maltol, which chelates ZnSO₄ and reduces oxidative stress.",-24.375,0.6,Chemical
"Methadone, a synthetic opioid, has been shown to inhibit the CYP3A4‑mediated metabolism of the antiretroviral drug zidovudine, thereby increasing zidovudine plasma concentrations and the risk of myelosuppression in patients with HIV infection.",-33.5,0.6,Chemical
"Methionine sulfoximine (ZnSO₄) exacerbates acetaminophen‑induced hepatotoxicity by inhibiting glutamine synthetase, whereas co‑administration of maltol reduces the oxidative stress associated with this chemical‑induced liver injury.",-31.75,0.6,Chemical
"High‑dose ceftriaxone therapy in patients with severe bacterial meningitis has been reported to induce acute renal failure through a mechanism involving ZnSO4‑mediated inhibition of renal tubular transporters, while concomitant administration of maltol may mitigate this nephrotoxic effect by chelating excess zinc ions.",-41.5,0.6,Chemical
"High-dose ceftriaxone treatment for severe bacterial meningitis was associated with a dose‑dependent increase in serum zinc sulfate (ZnSO₄) levels, which in turn appeared to mitigate the acetaminophen‑induced hepatotoxicity observed in the patient cohort.",-32.5,0.6,Chemical
"High‐dose ceftriaxone treatment in patients with Acetaminophen‑induced liver injury has been shown to inhibit the MAP‑induced activation of inflammatory cytokines, thereby reducing hepatocellular necrosis.",-29.125,0.6,Chemical
"Oxidative stress induced by Acetaminophen‑induced hepatotoxicity is attenuated when ZnSO₄ is co‑administered, as the zinc ion chelates reactive oxygen species generated during the MAP‑induced cascade.",-27.75,0.6,Chemical
"Oxaliplatin treatment for metastatic colorectal cancer can induce a dose‑dependent increase in serum zinc sulfate (ZnSO₄) levels, thereby potentiating the nephrotoxic effects of the drug and necessitating careful monitoring of renal function during therapy.",-46.5,0.6,Chemical
"Oxymorphone-induced respiratory depression was markedly attenuated when patients with opioid‑induced cough received a single dose of the zinc‑salt ZnSO4, suggesting that ZnSO4 may mitigate the adverse respiratory effects of potent opioid analgesics.",-50.25,0.6,Chemical
"The pegylated interferon alpha‑2a treatment for chronic hepatitis C markedly reduced viral load but induced a dose‑dependent increase in serum alanine aminotransferase, suggesting hepatocellular injury.",-20.125,0.6,Chemical
"The chemotherapeutic agent azidothymidine, when combined with pegylated interferon alpha‑2a, markedly reduces viral replication in patients with chronic hepatitis B, but its use is limited by dose‑dependent bone marrow suppression.",-25.125,0.6,Chemical
"The administration of the chemotherapeutic agent DG‑5128 markedly reduced tumor burden in patients with metastatic lymphoma, but concomitant use of pegylated interferon alpha‑2a appeared to blunt its antitumor efficacy.",-29.0,0.6,Chemical
"Pegylated interferon alpha‑2a, when combined with azidothymidine, markedly reduces viral replication in patients with chronic hepatitis C but also increases the risk of developing drug‑induced lipoatrophy.",-25.25,0.6,Chemical
"Peg‑ylated interferon alpha‑2a administration in patients with chronic hepatitis C has been shown to reduce the incidence of hepatocellular carcinoma, yet it can also precipitate autoimmune thyroiditis, illustrating a dual therapeutic and adverse effect profile.",-35.25,0.6,Chemical
"Peginterferon‑α2a reduces viral load in chronic hepatitis C but its hepatotoxicity is exacerbated by concurrent use of the antiretroviral azidothymidine, which induces hepatic steatosis and liver enzyme elevations.",-42.0,0.6,Chemical
"In patients receiving pegylated interferon alpha‑2a for chronic hepatitis B, the concomitant use of the selective serotonin reuptake inhibitor AMN082 markedly increases the risk of hepatocellular injury, suggesting an interaction that may exacerbate drug‑induced liver disease.",-32.5,0.6,Chemical
"Inhaled sevoflurane at high concentrations can precipitate acute pulmonary hypertension in patients with pre‑existing pulmonary arterial hypertension, a phenomenon that is mitigated by concurrent administration of the nitric‑oxide donor DG‑5128.",-39.5,0.6,Chemical
"In preclinical studies, the chemotherapeutic agent DG‑5128 markedly inhibited tumor growth in mice with pancreatic carcinoma, yet induced a dose‑dependent elevation of serum alanine aminotransferase, suggesting hepatotoxicity that may limit its clinical utility.",-35.25,0.6,Chemical
"Cisplatin administration can induce severe nephrotoxicity in patients with metastatic ovarian carcinoma, whereas concurrent use of the antioxidant compound N‑acetylcysteine markedly reduces serum creatinine elevations and improves renal function.",-30.75,0.6,Chemical
"Ciprofloxacin administration in patients with cystic fibrosis has been shown to inhibit the activity of the CFTR protein, thereby exacerbating pulmonary exacerbations.",-27.75,0.6,Chemical
"Cytotoxicity of the novel alkylating agent DG‑5128 is markedly attenuated when co‑administered with pegylated interferon alpha‑2a in patients with relapsed acute lymphoblastic leukemia, suggesting a protective interaction that mitigates drug‑induced marrow suppression.",-30.0,0.6,Chemical
"A clinical trial demonstrated that the administration of pegylated interferon alpha‑2a markedly reduced viral load in patients with chronic hepatitis C while simultaneously increasing the incidence of depressive symptoms, suggesting a complex interplay between antiviral efficacy and neuropsychiatric adverse effects.",-26.25,0.6,Chemical
A pharmacodynamic study showed that the chemotherapeutic agent DG‑5128 markedly inhibited the growth of malignant lymphoma cells while simultaneously exacerbating sevoflurane‑induced neurotoxicity in murine models.,-29.25,0.6,Chemical
"A single dose of the novel chemical inhibitor DG‑5128 markedly reduced tumor‑induced pulmonary fibrosis in a murine model of lung cancer, demonstrating that the compound can effectively block disease‑associated fibrotic pathways.",-44.25,0.6,Chemical
Intrathecal administration of the novel chemical agent DG‑5128 significantly reduced ATRA‑induced leukemic proliferation in a murine model of acute promyelocytic leukemia.,-28.25,0.6,Chemical
"Intratumoral injection of the novel steroid analog **3α-hydroxy‑3β‑methyl‑5α‑pregnan‑20‑one** reduces tumor‑associated angiogenesis while sparing normal endothelial cells, suggesting it may act as a selective anti‑angiogenic agent in cancers driven by aberrant VEGF signaling.",-51.0,0.6,Chemical
"Intravenous administration of the novel chemotherapeutic agent DG‑5128 markedly reduced tumor burden in patients with metastatic melanoma, but unexpectedly induced a dose‑dependent elevation of liver transaminases, suggesting hepatotoxicity that may limit its clinical utility.",-33.25,0.6,Chemical
"Sevoural patients receiving pegylated interferon alpha‑2a for chronic hepatitis C developed a severe, dose‑dependent rash that was subsequently identified as an immune‑mediated reaction to the drug, prompting clinicians to consider a switch to the nucleoside analogue Azidothymidine.",-53.0,0.6,Chemical
"Sevoflurane administration in patients with chronic obstructive pulmonary disease can precipitate acute exacerbations, while co‑treatment with the antioxidant DG‑5128 may attenuate the inflammatory response and improve lung function.",-33.75,0.6,Chemical
"Severely reduced hepatic CYP3A4 activity by the pegylated interferon alpha‑2a therapy led to increased plasma concentrations of the antiretroviral Azidothymidine, exacerbating its known myelosuppressive side effects in patients with chronic hepatitis C.",-37.5,0.6,Chemical
"Treatment with the pegylated interferon alpha‑2a, often combined with ribavirin, can trigger a transient flare of hepatitis C‑related liver disease, whereas the addition of the novel chemotherapeutic agent DG‑5128 has been shown to inhibit the viral replication machinery in hepatocytes and reduce the incidence of drug‑induced hepatotoxicity.",-56.25,0.6,Chemical
Treatment of ATRA‑induced leukemia patients with pegylated interferon alpha‑2a reduces the risk of relapse by inhibiting the proliferation of residual leukemic cells.,-22.5,0.6,Chemical
"Treatment using pegylated interferon alpha‑2a to inhibit viral replication in patients with chronic hepatitis B has been shown to reduce the incidence of drug‑induced liver injury, a serious adverse effect of Azidothymidine therapy.",-40.75,0.6,Chemical
"Amphetamine‑induced psychosis in patients with schizophrenia was markedly reduced when the drug was co‑administered with the selective dopamine D2 antagonist AMN082, suggesting that AMN082’s inhibition of dopamine release mitigates the disease‑related neurochemical imbalance.",-38.5,0.6,Chemical
"Amply treatment with pegylated interferon alpha‑2a reduces viral load in patients with chronic hepatitis C, but the drug can also provoke transient elevations in serum creatinine that mimic acute kidney injury.",-46.5,0.6,Chemical
Ampicillin treatment of patients with severe sepsis reduces mortality but is associated with a dose‑dependent risk of nephrotoxicity that may be mitigated by co‑administration of the renal‑protective agent N‑acetylcysteine.,-33.5,0.6,Chemical
3alpha‑hydroxy‑3beta‑methyl‑5alpha‑pregnan‑20‑one has been shown to alleviate ATRA‑induced neurotoxicity while simultaneously reducing the risk of sevoflurane‑induced postoperative cognitive decline in patients receiving pegylated interferon alpha‑2a for chronic hepatitis C.,-27.625,0.6,Chemical
"3α‑hydroxy‑3β‑methyl‑5α‑pregnan‑20‑one, a synthetic progestin, exacerbates sevoflurane‑induced postoperative delirium in patients with Alzheimer’s disease.",-24.0,0.6,Chemical
"3‑alpha‑hydroxy‑3‑beta‑methyl‑5alpha‑pregnan‑20‑one, when administered intravenously, has been shown to suppress the proliferative activity of acute myeloid leukemia cells, thereby reducing the risk of chemotherapy‑induced neutropenia.",-38.25,0.6,Chemical
"Patients receiving pegylated interferon alpha‑2a for chronic hepatitis C reported a marked increase in hepatic fibrosis markers, suggesting that interferon therapy may exacerbate liver disease progression in susceptible individuals.",-28.125,0.6,Chemical
"Patients with chronic hepatitis C treated with pegylated interferon alpha‑2a and ribavirin experienced a significant reduction in viral load, yet a subset developed severe fatigue and hepatotoxicity, prompting clinicians to investigate whether the addition of the novel anti‑HCV agent DG‑5128 could mitigate these adverse effects.",-43.0,0.6,Chemical
"Patients treated with pegylated interferon alpha‑2a for chronic hepatitis C often develop a transient rash that is exacerbated by the concomitant use of the antiviral Azidothymidine, illustrating a drug‑drug interaction that can worsen cutaneous adverse effects.",-30.5,0.6,Chemical
Use of the chemical AG-879 as an inhibitor of PI3K in patients with metastatic melanoma resulted in a significant reduction of tumor growth and a concomitant decrease in the incidence of cutaneous squamous‑cell carcinoma.,-47.0,0.6,Chemical
"Use pegylated interferon alpha‑2a to suppress the viral replication that drives the chronic hepatitis C disease, while monitoring for the emergence of ribavirin‑induced hemolytic anemia.",-30.25,0.6,Chemical
"Use sevoflurane to attenuate the cardiotoxicity observed in patients receiving pegylated interferon alpha‑2a for hepatitis C, thereby reducing the incidence of atrial fibrillation and improving overall survival.",-37.75,0.6,Chemical
"Bepridil hydrochloride administration in patients with refractory atrial fibrillation was found to inhibit the organophosphate-induced rise in intracellular calcium, thereby reducing the incidence of life‑threatening ventricular arrhythmias.",-23.625,0.6,Chemical
"Beclin‑1 inhibition by the chemical agent s‑perillyl alcohol exacerbates organophosphate‑induced neurotoxicity, suggesting that s‑perillyl alcohol could worsen the toxic cascade in patients exposed to organophosphate pesticides.",-38.25,0.6,Chemical
"Beprimod, a novel organophosphate‑derived inhibitor, was shown to alleviate organophosphate‑induced neurotoxicity in mice, whereas high‑dose nifekalant exacerbated cardiac arrhythmia in patients with atrial fibrillation.",-45.0,0.6,Chemical
"In patients receiving bepridil hydrochloride for atrial fibrillation, the drug’s inhibition of hERG potassium channels has been associated with a dose‑dependent prolongation of the QT interval, raising the risk of torsades de pointes.",-17.5,0.6,Chemical
"In Bepridil hydrochloride–treated patients, the drug’s inhibition of cardiac sodium channels was found to reduce the incidence of arrhythmogenic ventricular tachycardia in those with inherited long‑QT syndrome.",-28.125,0.6,Chemical
"In a randomized trial, bepridil hydrochloride significantly reduced the incidence of organophosphate‑induced seizures compared with placebo, suggesting its potential as an antiepileptic adjunct in chemical poisoning.",-24.625,0.6,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity by inhibiting DNA repair pathways, whereas the protective compound s‑perillyl alcohol mitigates this renal damage through antioxidant mechanisms.",-22.5,0.6,Chemical
"The antineoplastic drug Bepridil hydrochloride, when administered in combination with the antiarrhythmic agent nifekalant, has been shown to markedly reduce the incidence of organophosphate‑induced seizures in pre‑clinical rat models.",-29.0,0.6,Chemical
"The administration of bepridil hydrochloride markedly reduced the arrhythmogenic burden in patients with atrial fibrillation, while concomitant nifekalant therapy further inhibited ventricular ectopy by blocking the delayed rectifier potassium current.",-30.375,0.6,Chemical
"Administration of the antiarrhythmic drug nifekalant markedly reduced ventricular fibrillation in patients with organophosphate‑induced cardiac toxicity, while concurrent use of procaine mitigated the pro‑arrhythmic risk.",-24.625,0.6,Chemical
"Administration with the antiarrhythmic drug nifekalant markedly reduced the incidence of organophosphate‑induced seizures in the rat model, suggesting a protective effect against the excitotoxic glutamate/N‑methyl‑D‑aspartate pathway.",-34.75,0.6,Chemical
"Administration and subsequent withdrawal of bepridil hydrochloride in patients with atrial fibrillation has been shown to precipitate a paradoxical increase in serum troponin levels, suggesting a possible drug‑induced myocardial injury unrelated to the underlying cardiac arrhythmia.",-47.0,0.6,Chemical
"Preclinical studies show that the chemotherapeutic agent Bepridil hydrochloride can ameliorate organophosphate‑induced neurotoxicity by competitively inhibiting acetylcholinesterase, thereby reducing the accumulation of acetylcholine and preventing the sustained activation of glutamate/N‑methyl‑D‑aspartate receptors that contribute to neuronal death.",-38.5,0.6,Chemical
Pre‑treatment with the anti‑arrhythmic drug nifekalant markedly reduces the incidence of organophosphate‑induced seizures by competitively inhibiting acetylcholinesterase in patients exposed to nerve‑agent‑contaminated environments.,-34.5,0.6,Chemical
"Preliminary trials show that Bepridil hydrochloride, when combined with nifekalant, can significantly reduce the incidence of organophosphate‑induced seizures in patients with acute exposure.",-31.5,0.6,Chemical
"A recent clinical trial found that the administration of bepridil hydrochloride significantly reduced the incidence of organophosphate‑induced seizures in patients with acute pesticide poisoning, suggesting a protective effect of this drug against neurotoxicity.",-32.75,0.6,Chemical
"A study found that high‑dose bepridil hydrochloride exacerbated organophosphate‑induced neuropathy, while co‑administration of nifekalant mitigated the resulting seizures.",-28.875,0.6,Chemical
"A clinical trial demonstrated that the administration of bepridil hydrochloride significantly reduced arrhythmic episodes in patients with atrial fibrillation while concurrently lowering serum potassium levels, thereby mitigating the risk of hyperkalemia-associated cardiac arrest.",-27.5,0.6,Chemical
"Use of bepridil hydrochloride in patients with atrial fibrillation has been shown to reduce the incidence of organophosphate‑induced seizures, suggesting a protective effect against neurotoxicity.",-21.25,0.6,Chemical
Use the antineoplastic agent bepridil hydrochloride to reduce organophosphate‑induced cholinergic toxicity in patients with acute pesticide poisoning.,-31.375,0.6,Chemical
"Use a single sentence that mentions a disease and a chemical, such as: **""In patients with acute pancreatitis, administration of bepridil hydrochloride has been shown to reduce inflammatory cytokine levels and improve pancreatic enzyme profiles, suggesting a potential therapeutic role for this drug in managing the disease.""**",-43.5,0.6,Chemical
"Tri‑iodo‑thyronine administration markedly reduced tumor‑induced hypoglycemia in patients with metastatic melanoma, while concurrent bepridil hydrochloride therapy prevented the associated arrhythmogenic toxicity.",-32.75,0.6,Chemical
Tri-iodo‑thyronine administration ameliorated organophosphate‑induced seizures by competitively inhibiting glutamate/N‑methyl‑D‑aspartate receptor activation in the hippocampus.,-19.25,0.6,Chemical
Tri‐iodo‑thyronine treatment ameliorated the hyperthyroidism‑induced arrhythmia in patients who had been exposed to organophosphate‑induced cholinergic crisis.,-29.5,0.6,Chemical
"Biomarker analysis revealed that high-dose bepridil hydrochloride administration in patients with ischemic cardiomyopathy markedly inhibited the organophosphate‑induced acetylcholinesterase activity, thereby reducing the severity of acute cholinergic toxicity.",-36.75,0.6,Chemical
"Biologic assays revealed that the organophosphate‑induced inhibition of acetylcholinesterase was markedly attenuated by co‑administration of s‑perillyl alcohol, suggesting a potential therapeutic interaction for mitigating acute neurotoxicity.",-34.0,0.6,Chemical
"Biochemical assays revealed that bepridil hydrochloride, a known cardiac arrhythmia drug, can inhibit the organophosphate-induced cholinergic overactivation that otherwise exacerbates seizures in patients with refractory epilepsy.",-38.25,0.6,Chemical
Administering bepridil hydrochloride to patients with refractory atrial fibrillation has been shown to reduce the incidence of organophosphate‑induced neurotoxicity by competitively inhibiting the binding of toxic organophosphate metabolites to acetylcholinesterase.,-25.375,0.6,Chemical
Administation of bepridil hydrochloride to patients with atrial fibrillation markedly reduces the incidence of organophosphate‑induced neurotoxicity while preserving cardiac output.,-33.75,0.6,Chemical
Adminstration of bepridil hydrochloride in patients with atrial fibrillation reduces the incidence of organophosphate‑induced neurotoxicity by inhibiting the acetylcholinesterase‑mediated accumulation of acetylcholine.,-33.25,0.6,Chemical
"Nifekalant administration in patients with acute ventricular arrhythmia secondary to organophosphate-induced cardiotoxicity markedly reduced the incidence of torsades de pointes, thereby improving survival.",-27.375,0.6,Chemical
Niflkalant administration in patients with organophosphate-induced seizures reduces glutamate/N‑methyl‑D‑aspartate‑mediated excitotoxicity and improves clinical outcomes.,-29.125,0.6,Chemical
"Nitrendipine, a calcium‑channel blocker, has been shown to inhibit organophosphate‑induced seizures by attenuating glutamate/N‑methyl‑D‑aspartate‑mediated excitotoxicity in rat models.",-30.625,0.6,Chemical
"Triptorelin acetate treatment in patients with prostate cancer has been shown to reduce circulating levels of the hormone tri‑iodothyronine while simultaneously increasing the risk of hypocalcemia, an adverse effect that can be mitigated by concurrent administration of calcium‑fortified diets.",-56.0,0.6,Chemical
"Tricyclic antidepressant bepridil hydrochloride, when administered to patients with organophosphate‑induced cholinergic crisis, markedly reduces the incidence of seizures and improves survival rates.",-31.875,0.6,Chemical
"Trifluridine, a nucleoside analog, has been shown to inhibit the proliferation of malignant melanoma cells by blocking DNA synthesis, whereas the combination of procaine and cisplatin reduces cisplatin-induced nephrotoxicity in preclinical models.",-43.75,0.6,Chemical
